data_2lkt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lkt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.5 141.8 31.99 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.288 1.992 . . . . 0.0 110.206 170.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -91.75 142.11 26.31 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.852 0.861 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.51 128.92 22.37 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.637 2.225 . . . . 0.0 110.232 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.51 -2.38 72.73 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.503 1.525 . . . . 0.0 114.838 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.26 162.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.521 1.661 . . . . 0.0 111.163 169.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.01 146.05 42.47 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.953 1.359 . . . . 0.0 113.814 -171.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mt -123.26 129.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.341 2.257 . . . . 0.0 108.024 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -82.36 124.43 30.0 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.684 1.193 . . . . 0.0 107.798 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mm -118.44 119.5 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 110.346 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -81.79 72.81 8.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 108.536 169.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -25.91 57.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.727 1.211 . . . . 0.0 113.461 -170.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -161.62 -159.94 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.709 2.004 . . . . 0.0 108.715 -159.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.96 34.19 1.05 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.662 1.125 . . . . 0.0 112.678 169.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -169.44 158.83 8.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.427 2.691 . . . . 0.0 111.002 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -104.05 123.95 48.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -105.6 167.95 9.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.599 1.559 . . . . 0.0 110.862 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -112.69 151.81 29.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.729 0.811 . . . . 0.0 111.698 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.62 156.77 44.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.371 1.068 . . . . 0.0 112.819 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.49 120.99 34.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.032 . . . . 0.0 108.75 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -76.98 92.17 3.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.234 1.014 . . . . 0.0 111.864 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.5 pt -81.18 -21.93 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.75 173.35 31.75 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 124.199 0.904 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -68.41 90.67 0.37 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.674 0.749 . . . . 0.0 109.908 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.0 49.93 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.195 1.855 . . . . 0.0 115.581 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -126.18 140.64 52.4 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.714 1.757 . . . . 0.0 112.963 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -137.07 149.79 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.289 1.036 . . . . 0.0 113.237 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.5 mm -105.56 131.74 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -146.85 162.82 37.84 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.908 1.231 . . . . 0.0 112.069 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -100.58 134.11 44.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.315 0.646 . . . . 0.0 112.626 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.53 108.44 53.24 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 126.214 1.805 . . . . 0.0 106.232 168.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -62.75 162.18 26.03 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.373 3.382 . . . . 0.0 114.822 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 CA--C 1.545 1.065 0 C-N-CA 124.802 3.668 . . . . 0.0 113.689 175.138 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 119.816 -0.135 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 150.11 26.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.593 -0.692 . . . . 0.0 111.968 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -143.42 136.72 28.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.251 1.02 . . . . 0.0 110.944 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.51 128.35 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.617 1.167 . . . . 0.0 108.846 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -130.41 151.45 50.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.469 1.508 . . . . 0.0 112.543 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -105.37 138.75 41.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.332 1.453 . . . . 0.0 110.585 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.69 167.63 18.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.14 0.976 . . . . 0.0 111.021 -170.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -83.8 143.66 29.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.072 1.349 . . . . 0.0 110.617 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.03 -49.06 72.5 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.507 0.723 . . . . 0.0 110.522 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.7 -24.39 65.6 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.96 -46.09 15.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.355 0.98 . . . . 0.0 110.287 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.69 -30.73 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.971 0.908 . . . . 0.0 112.252 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -91.78 -21.5 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.88 1.672 . . . . 0.0 112.759 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.31 118.71 15.21 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.383 0.992 . . . . 0.0 112.048 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.46 75.49 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.445 1.021 . . . . 0.0 114.607 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.1 m -123.67 163.47 21.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.132 1.773 . . . . 0.0 111.795 -171.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -109.99 159.86 16.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.575 1.15 . . . . 0.0 109.961 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -157.89 169.2 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.9 tpp85 -163.93 132.65 3.74 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.146 1.778 . . . . 0.0 110.727 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.61 127.53 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -152.73 64.89 0.79 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.973 0.892 . . . . 0.0 110.679 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -80.57 69.11 7.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.364 1.065 . . . . 0.0 111.177 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.7 p -35.14 -64.56 0.27 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.425 2.29 . . . . 0.0 115.328 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.84 -29.24 68.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.47 -39.51 74.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.565 0.746 . . . . 0.0 112.448 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -67.99 -30.51 69.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 112.093 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -76.09 -36.98 58.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.612 1.165 . . . . 0.0 113.333 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -162.93 -52.98 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -72.24 148.73 91.38 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -153.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.06 -37.4 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.714 2.943 . . . . 0.0 113.145 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 68.64 119.64 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.602 2.361 . . . . 0.0 116.934 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.4 89.38 1.36 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.396 3.397 . . . . 0.0 110.981 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.92 -41.43 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.739 1.616 . . . . 0.0 113.956 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.03 -36.08 79.34 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.554 0.615 . . . . 0.0 111.512 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.07 -27.87 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.035 0.934 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.6 mm -68.19 -47.29 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.14 0.882 . . . . 0.0 110.647 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.03 -38.13 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.771 -0.58 . . . . 0.0 110.801 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -67.25 -41.15 86.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.705 -0.622 . . . . 0.0 111.166 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.2 m -64.82 -39.55 93.76 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.541 1.136 . . . . 0.0 111.992 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.75 95.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.36 -0.838 . . . . 0.0 111.665 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -68.75 -11.17 59.99 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 173.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.25 -35.74 14.31 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.41 1.084 . . . . 0.0 111.174 168.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.3 mmm -72.44 -20.21 61.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.712 1.605 . . . . 0.0 113.819 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.26 124.22 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.902 1.228 . . . . 0.0 111.623 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.0 -4.56 85.55 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.069 -1.406 . . . . 0.0 115.323 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 150.81 47.61 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.073 1.937 . . . . 0.0 111.009 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -129.18 149.79 50.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.874 1.67 . . . . 0.0 112.301 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.7 mtm -144.03 158.96 43.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 0.0 111.234 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -152.83 -32.88 0.13 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -171.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.59 -28.45 51.63 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -90.12 150.02 22.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.232 1.013 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.33 157.1 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.592 -0.693 . . . . 0.0 111.328 172.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.77 -42.28 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m -64.2 -45.67 87.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.899 0.772 . . . . 0.0 111.367 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -75.98 -32.16 59.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.864 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -57.85 -40.12 79.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.198 0.908 . . . . 0.0 111.366 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.04 -55.23 31.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.895 1.678 . . . . 0.0 112.938 169.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.07 -43.61 98.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.432 -0.792 . . . . 0.0 112.339 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.79 -34.94 79.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.238 1.015 . . . . 0.0 111.195 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -61.19 -55.65 29.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.829 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.39 -20.45 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 120.304 1.411 . . . . 0.0 113.992 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -73.01 -37.96 66.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.526 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -71.99 -27.64 62.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.893 1.224 . . . . 0.0 113.442 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.41 -46.89 75.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.218 0.917 . . . . 0.0 111.77 170.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -69.5 -94.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.677 1.191 . . . . 0.0 108.633 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.7 t80 70.77 -6.99 1.13 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.236 2.614 . . . . 0.0 112.993 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.28 -69.54 1.28 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 127.22 2.343 . . . . 0.0 111.92 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.84 1.14 33.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.26 1.024 . . . . 0.0 113.269 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 125.617 1.567 . . . . 0.0 112.484 170.067 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.2 150.1 36.83 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.25 2.634 . . . . 0.0 111.069 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -108.59 160.31 27.67 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.457 1.503 . . . . 0.0 111.664 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.51 134.5 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.782 1.655 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.8 -10.38 74.71 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.855 1.216 . . . . 0.0 114.685 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.13 142.76 31.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.773 1.287 . . . . 0.0 111.539 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.66 128.1 48.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.627 1.203 . . . . 0.0 108.074 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.15 126.65 61.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 105.978 -170.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -74.84 129.67 38.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.06 120.04 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.621 1.569 . . . . 0.0 109.051 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -80.93 90.27 5.92 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -81.58 31.24 0.35 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt 82.53 72.76 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.652 1.981 . . . . 0.0 110.922 155.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.79 1.46 76.94 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.829 1.204 . . . . 0.0 113.353 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -138.67 140.2 38.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.239 1.815 . . . . 0.0 110.653 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -98.06 119.71 37.18 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.645 0.778 . . . . 0.0 110.427 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -125.92 178.62 5.63 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.695 1.598 . . . . 0.0 111.042 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -137.97 157.24 46.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.441 0.696 . . . . 0.0 112.606 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.55 25.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 120.74 32.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.671 1.589 . . . . 0.0 108.589 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.0 110.24 5.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 pt -100.06 -20.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.34 170.57 42.19 Favored Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.71 0.804 . . . . 0.0 112.591 -170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 19.11 66.24 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.335 1.445 . . . . 0.0 115.749 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -127.08 141.73 51.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.62 1.71 . . . . 0.0 112.736 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.9 156.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.658 1.183 . . . . 0.0 113.117 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 mm -112.49 132.42 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.184 1.794 . . . . 0.0 107.632 169.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -149.31 148.77 29.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.737 1.153 . . . . 0.0 111.896 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.0 tp -83.41 106.35 15.1 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 91.66 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.194 1.398 . . . . 0.0 111.032 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.18 141.91 44.74 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.129 3.22 . . . . 0.0 116.289 -168.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 123.758 2.972 . . . . 0.0 111.766 169.266 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.9 p . . . . . 0 CA--C 1.545 0.769 0 CA-C-O 120.323 0.106 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.86 156.35 28.71 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.117 -0.989 . . . . 0.0 111.27 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.68 135.05 37.87 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 0.0 111.289 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.52 122.19 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -127.36 157.07 40.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.428 1.491 . . . . 0.0 112.26 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -101.55 142.39 32.99 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.139 1.375 . . . . 0.0 110.398 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.75 164.08 21.28 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.095 0.958 . . . . 0.0 111.23 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -74.67 140.67 44.39 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.23 1.412 . . . . 0.0 110.414 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.3 tp -53.81 -57.27 11.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.173 0.989 . . . . 0.0 110.873 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.54 -21.94 66.61 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.48 -41.66 65.76 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.188 0.904 . . . . 0.0 110.878 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.29 -54.55 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.616 0.766 . . . . 0.0 110.87 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.1 -6.61 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.87 -28.23 54.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.116 0.865 . . . . 0.0 113.179 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.39 22.93 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.612 1.101 . . . . 0.0 114.736 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 79.8 m -130.76 148.47 52.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.238 1.415 . . . . 0.0 112.44 -172.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.6 m -76.56 157.37 32.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -158.02 172.45 18.42 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 155.52 2.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 128.173 2.589 . . . . 0.0 112.443 169.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.34 146.72 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.983 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -130.35 -80.85 0.54 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 51.47 49.73 20.35 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.878 2.071 . . . . 0.0 112.541 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -49.35 -57.04 7.6 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.677 -1.265 . . . . 0.0 113.402 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.19 -27.14 69.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.362 1.065 . . . . 0.0 113.444 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -24.94 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.876 0.87 . . . . 0.0 112.238 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -89.55 -30.84 17.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.514 1.125 . . . . 0.0 112.646 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.58 -37.58 88.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.73 0.812 . . . . 0.0 111.898 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.7 -71.55 0.09 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.91 129.89 40.43 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -145.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.88 67.19 5.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.897 3.065 . . . . 0.0 110.46 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -66.45 137.36 95.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.39 123.11 11.84 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.155 2.57 . . . . 0.0 110.33 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.25 -31.68 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.53 -0.747 . . . . 0.0 112.297 -169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -54.74 -37.75 66.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.687 1.131 . . . . 0.0 112.4 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.04 -28.5 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.518 0.727 . . . . 0.0 110.909 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.7 mt -69.63 -44.22 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.437 1.095 . . . . 0.0 110.42 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.86 -46.43 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.291 1.037 . . . . 0.0 109.837 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -64.21 -40.73 96.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.457 0.703 . . . . 0.0 111.565 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.0 t -61.33 -43.66 98.49 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.079 -1.013 . . . . 0.0 111.639 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.8 93.78 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.104 -0.997 . . . . 0.0 111.893 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.47 -25.39 68.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.197 0.999 . . . . 0.0 113.536 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -81.35 -35.27 31.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.174 0.99 . . . . 0.0 112.999 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.2 mmm -73.38 -30.39 63.26 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -54.78 126.61 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.488 1.04 . . . . 0.0 111.193 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.88 -9.52 55.2 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.027 1.775 . . . . 0.0 114.263 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -83.5 141.32 31.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.128 1.464 . . . . 0.0 111.11 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.98 155.06 18.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.69 1.596 . . . . 0.0 111.159 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 23.2 ptp -161.85 152.71 17.84 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -150.46 41.06 0.78 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.086 1.755 . . . . 0.0 110.268 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.84 -28.46 69.5 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.305 1.842 . . . . 0.0 115.279 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -172.1 -169.83 0.68 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.679 1.992 . . . . 0.0 110.379 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 pt -54.43 150.75 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.828 0.851 . . . . 0.0 110.504 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.78 -37.95 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.2 p -62.87 -45.55 92.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.067 0.849 . . . . 0.0 111.7 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -70.56 -35.14 72.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.019 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -61.29 -41.97 97.86 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.446 1.475 . . . . 0.0 110.911 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.2 m -64.36 -48.91 73.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.759 2.024 . . . . 0.0 112.508 170.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.84 -45.74 92.51 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.478 -0.764 . . . . 0.0 112.241 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -53.01 -45.42 67.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.644 1.978 . . . . 0.0 110.683 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.22 -58.9 6.55 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.723 1.209 . . . . 0.0 112.335 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.32 -26.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.031 1.287 . . . . 0.0 113.472 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -61.86 -52.28 64.76 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 115.981 -1.961 . . . . 0.0 107.449 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -56.93 -25.4 57.38 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 122.41 2.368 . . . . 0.0 114.849 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -68.47 -33.26 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.666 1.121 . . . . 0.0 112.841 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -105.95 -13.43 15.49 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -58.11 -22.01 48.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.666 2.787 . . . . 0.0 113.069 -168.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -71.67 -11.94 73.51 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.862 -0.965 . . . . 0.0 115.414 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -134.57 2.92 3.25 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.68 1.24 . . . . 0.0 114.216 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 125.246 1.418 . . . . 0.0 112.891 177.594 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.544 0.721 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.7 142.14 25.48 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.553 2.835 . . . . 0.0 110.635 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -115.66 138.91 24.18 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.189 0.995 . . . . 0.0 111.712 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.13 130.24 28.24 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.407 2.738 . . . . 0.0 111.32 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.07 42.37 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.169 1.842 . . . . 0.0 115.304 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -89.35 164.62 14.82 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 110.446 169.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -119.65 148.6 43.16 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.582 1.182 . . . . 0.0 113.012 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -123.99 130.34 73.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.561 2.344 . . . . 0.0 108.221 -161.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -88.71 120.88 30.51 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.79 124.28 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.461 1.504 . . . . 0.0 108.456 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -90.78 63.92 5.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.304 1.441 . . . . 0.0 109.579 -173.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -61.41 2.32 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 21' ' ' TYR . 16.2 mt -148.79 -129.48 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -162.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.33 33.83 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.635 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' H ' ' C ' ' A' ' 19' ' ' LEU . 39.9 p90 -174.75 158.53 2.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.566 2.746 . . . . 0.0 112.008 -169.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -112.9 155.35 24.87 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.887 1.675 . . . . 0.0 109.783 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 164.81 34.91 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.569 -0.707 . . . . 0.0 112.885 174.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -97.88 149.82 21.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.19 140.35 27.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.424 1.09 . . . . 0.0 112.613 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.95 117.53 35.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.846 2.058 . . . . 0.0 108.983 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -76.56 86.82 3.26 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.885 1.274 . . . . 0.0 111.804 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -74.77 -23.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.11 177.88 27.03 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.584 1.088 . . . . 0.0 111.486 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.38 81.89 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.726 0.81 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.33 -11.83 31.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.33 2.395 . . . . 0.0 114.671 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.89 140.47 36.14 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.108 1.454 . . . . 0.0 113.126 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.0 149.54 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 0.0 113.703 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -108.35 123.04 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -137.8 149.76 46.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.231 -0.918 . . . . 0.0 111.512 -169.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.59 118.98 29.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.881 0.472 . . . . 0.0 110.07 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.7 130.95 62.23 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.04 158.89 45.33 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.279 2.652 . . . . 0.0 112.772 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 CA--C 1.539 0.733 0 C-N-CA 123.914 3.076 . . . . 0.0 113.456 178.629 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.16 150.42 30.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.444 -0.785 . . . . 0.0 111.23 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.94 133.7 16.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.725 0.81 . . . . 0.0 110.654 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.03 121.9 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -128.06 156.7 42.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.739 1.616 . . . . 0.0 112.853 -170.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.33 139.98 38.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.067 1.347 . . . . 0.0 110.625 171.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.74 178.87 5.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.497 1.519 . . . . 0.0 109.811 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -96.1 142.49 28.23 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.317 1.447 . . . . 0.0 110.325 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.2 tp -55.35 -49.66 71.67 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.518 -0.739 . . . . 0.0 111.099 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.77 -25.63 63.23 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.28 -42.38 14.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.995 0.816 . . . . 0.0 111.342 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.98 -40.8 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 118.13 0.423 . . . . 0.0 111.305 172.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.5 -47.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.264 1.026 . . . . 0.0 111.613 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.21 -117.55 11.81 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -171.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.58 0.86 61.54 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.039 1.304 . . . . 0.0 115.056 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.82 166.44 22.05 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.942 1.371 . . . . 0.0 113.587 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -82.35 156.26 24.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.881 0.873 . . . . 0.0 110.998 169.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -161.05 156.73 25.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.019 0.927 . . . . 0.0 113.314 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -153.08 140.04 19.19 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.92 0.888 . . . . 0.0 111.827 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.92 133.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -158.01 70.12 0.55 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.344 1.058 . . . . 0.0 111.499 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -80.12 61.06 3.84 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.807 -1.183 . . . . 0.0 111.998 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.8 p -43.2 -67.62 0.26 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.496 1.918 . . . . 0.0 114.842 -169.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.443 HD12 ' HH ' ' A' ' 84' ' ' TYR . 18.6 tp -58.08 -27.16 63.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.993 0.917 . . . . 0.0 113.142 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.2 -48.5 28.6 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.757 -0.589 . . . . 0.0 111.572 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -78.67 -7.59 57.84 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.4 -31.81 73.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 113.34 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.443 ' HH ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -148.76 -36.41 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -176.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -126.45 139.26 34.19 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -137.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -94.6 54.99 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.09 1 C-N-CA 125.439 4.093 . . . . 0.0 111.737 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 147.82 46.84 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.41 100.4 1.14 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.955 3.104 . . . . 0.0 109.211 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.14 -25.26 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.327 1.051 . . . . 0.0 113.207 -169.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.58 -33.21 75.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.74 0.816 . . . . 0.0 112.338 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.0 -34.37 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.603 -0.685 . . . . 0.0 110.172 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.5 -44.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.611 0.764 . . . . 0.0 110.756 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.08 -40.13 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.669 0.788 . . . . 0.0 111.24 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.9 m -66.44 -43.18 86.31 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.416 -0.802 . . . . 0.0 111.237 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -34.66 78.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.049 0.939 . . . . 0.0 112.71 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.22 -45.17 94.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.77 1.168 . . . . 0.0 111.812 171.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.69 -13.49 61.33 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.96 -36.46 13.42 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.556 1.143 . . . . 0.0 112.501 168.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -72.38 -30.42 64.66 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.122 1.369 . . . . 0.0 113.573 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.43 128.45 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.809 0.731 . . . . 0.0 111.159 171.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.44 -9.11 58.94 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.484 1.516 . . . . 0.0 114.468 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -71.65 145.75 48.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.387 1.594 . . . . 0.0 111.01 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.81 143.95 50.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.009 1.724 . . . . 0.0 111.549 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -141.5 158.32 44.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.077 1.351 . . . . 0.0 111.363 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -161.96 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -72.39 -34.99 68.32 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.2 m -71.74 163.15 28.32 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -175.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.69 133.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.908 0.883 . . . . 0.0 108.629 171.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.1 t -57.67 -42.75 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 m -61.05 -47.97 83.91 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.568 -0.707 . . . . 0.0 111.075 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -67.44 -34.22 76.75 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.846 -0.534 . . . . 0.0 112.235 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.15 -38.5 83.31 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.099 0.96 . . . . 0.0 111.866 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 81.7 m -69.7 -48.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.433 1.093 . . . . 0.0 111.896 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.2 -46.96 86.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.057 0.543 . . . . 0.0 112.018 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.35 -32.55 74.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.75 -1.219 . . . . 0.0 111.531 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.44 -58.6 7.55 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.307 -0.871 . . . . 0.0 110.885 170.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.76 -25.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.0 m -69.41 -39.97 77.6 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.221 173.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.62 -27.19 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.278 1.399 . . . . 0.0 113.248 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.97 -38.37 82.64 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.545 1.066 . . . . 0.0 112.983 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 34.44 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -39.44 61.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 127.238 2.215 . . . . 0.0 112.493 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.91 44.54 0.1 Allowed Glycine 0 N--CA 1.475 1.263 0 C-N-CA 126.463 1.982 . . . . 0.0 111.528 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 pttm 91.72 -22.63 0.08 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 130.451 3.501 . . . . 0.0 110.172 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.253 1.262 1 C-N-CA 132.741 4.417 . . . . 0.0 113.516 169.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.15 136.61 11.63 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.074 2.516 . . . . 0.0 110.214 169.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -85.45 154.81 59.69 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.428 0.691 . . . . 0.0 110.959 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.97 123.64 11.9 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.138 1.892 . . . . 0.0 109.228 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 -2.3 81.8 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.705 1.622 . . . . 0.0 115.198 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.95 156.79 17.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 1.587 . . . . 0.0 111.734 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -112.42 160.75 17.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.753 1.221 . . . . 0.0 113.581 -173.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mt -144.31 131.91 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.994 1.318 . . . . 0.0 110.471 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.92 121.75 33.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.822 1.249 . . . . 0.0 107.633 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.7 mt -126.6 123.54 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.945 0.898 . . . . 0.0 110.488 -172.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.93 51.72 1.8 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.895 1.678 . . . . 0.0 110.71 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.06 -40.96 82.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.726 1.21 . . . . 0.0 111.86 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 mt -158.8 172.38 18.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.624 1.969 . . . . 0.0 108.192 -168.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.65 -7.39 20.98 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -73.88 -35.52 64.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.349 1.06 . . . . 0.0 113.483 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 68.28 106.52 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.309 2.244 . . . . 0.0 109.509 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -101.39 149.39 24.1 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -94.63 136.98 34.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.062 0.945 . . . . 0.0 109.431 168.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.73 159.06 42.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.194 0.998 . . . . 0.0 112.493 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.39 121.66 29.61 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.419 2.287 . . . . 0.0 107.782 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -77.97 97.65 5.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.576 0.626 . . . . 0.0 110.26 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.7 pt -73.7 -3.54 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.79 137.14 4.07 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.526 1.06 . . . . 0.0 114.293 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.23 -20.51 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 129.953 3.301 . . . . 0.0 117.575 169.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.88 -19.81 0.05 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.211 1.386 . . . . 0.0 115.132 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -89.9 147.89 23.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.182 1.491 . . . . 0.0 113.466 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 m -127.82 146.29 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.211 1.404 . . . . 0.0 112.13 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.48 139.62 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -158.19 158.95 35.54 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.119 -0.988 . . . . 0.0 111.942 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -98.81 136.25 39.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.222 0.609 . . . . 0.0 111.124 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.89 141.16 21.91 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 109.686 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.15 165.14 33.5 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.641 2.894 . . . . 0.0 112.469 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo . . . . . 0 C--N 1.354 0.816 0 C-N-CA 123.363 2.708 . . . . 0.0 115.493 175.46 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.22 155.41 40.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.951 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -138.57 129.94 27.35 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.853 0.861 . . . . 0.0 111.095 -170.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.94 128.95 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.194 0.597 . . . . 0.0 110.11 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -137.67 169.87 17.04 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.878 1.671 . . . . 0.0 112.248 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -127.12 143.04 51.36 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.922 1.689 . . . . 0.0 111.872 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -153.76 179.54 8.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.449 1.9 . . . . 0.0 110.623 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -102.56 140.25 37.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 110.332 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.26 -47.91 71.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.015 1.326 . . . . 0.0 111.631 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.14 -33.34 70.77 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.84 -45.32 51.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.378 0.99 . . . . 0.0 110.27 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.19 -32.31 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.736 1.214 . . . . 0.0 112.605 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.82 -20.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.888 1.675 . . . . 0.0 112.547 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 116.13 8.36 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.253 0.933 . . . . 0.0 111.911 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.6 7.55 74.29 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.574 1.083 . . . . 0.0 115.041 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.3 m -121.15 143.94 48.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.121 1.369 . . . . 0.0 112.468 -171.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 80.8 m -85.04 152.11 23.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.448 0.699 . . . . 0.0 109.674 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -158.18 161.44 37.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.631 0.772 . . . . 0.0 112.977 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -144.61 139.51 28.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.861 1.664 . . . . 0.0 110.536 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.9 t -80.61 138.32 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -126.62 142.1 51.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.813 0.845 . . . . 0.0 112.846 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -137.48 39.59 2.44 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.288 1.435 . . . . 0.0 111.337 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.7 t -57.9 -69.05 0.19 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.571 -1.33 . . . . 0.0 113.725 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.7 mt -72.31 -27.05 62.2 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.39 -0.819 . . . . 0.0 112.181 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.18 -42.14 98.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.637 0.775 . . . . 0.0 112.923 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.03 -8.61 59.09 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -82.56 -36.01 26.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -113.11 -45.0 3.2 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -169.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -142.34 155.04 64.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -133.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.87 -21.36 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.606 3.537 . . . . 0.0 113.122 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 69.18 117.61 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 128.441 2.696 . . . . 0.0 115.408 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.54 88.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 123.733 2.956 . . . . 0.0 108.58 169.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.71 -38.74 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.997 -169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -38.79 81.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.539 0.609 . . . . 0.0 111.721 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.43 -38.16 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.79 0.723 . . . . 0.0 111.305 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.68 -47.36 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 119.281 0.946 . . . . 0.0 110.323 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 90.8 mt -61.41 -40.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.206 1.002 . . . . 0.0 110.94 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.1 t -63.42 -42.93 98.73 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.434 0.694 . . . . 0.0 111.408 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -58.96 -40.54 85.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.321 -0.862 . . . . 0.0 112.248 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.9 -52.57 59.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.49 0.716 . . . . 0.0 111.982 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.82 -22.72 67.05 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.34 -50.03 12.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.165 0.986 . . . . 0.0 112.367 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 ptm -83.46 -14.13 53.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -170.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -55.54 125.4 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -8.45 59.06 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.391 1.472 . . . . 0.0 114.297 -169.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -70.63 153.97 42.33 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.576 1.688 . . . . 0.0 110.779 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -127.64 142.24 51.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.79 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -140.43 149.25 42.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.072 0.949 . . . . 0.0 113.059 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -154.28 -152.33 0.4 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.664 1.586 . . . . 0.0 111.262 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.9 t80 72.35 -53.77 0.69 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.871 2.869 . . . . 0.0 113.885 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.1 m -69.41 162.99 26.22 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.734 1.214 . . . . 0.0 112.379 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 tt -63.3 144.25 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 121.378 -0.826 . . . . 0.0 109.898 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.33 -27.63 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.8 t -64.14 -49.11 73.44 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.367 -0.833 . . . . 0.0 111.151 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -68.71 -28.7 67.07 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.933 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -57.34 -42.31 81.72 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.862 1.665 . . . . 0.0 111.191 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -45.11 53.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.957 1.303 . . . . 0.0 112.968 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.24 -41.41 90.06 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.117 -0.99 . . . . 0.0 112.69 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.85 -36.36 83.24 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.602 -1.311 . . . . 0.0 110.784 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.27 -58.0 10.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.482 0.713 . . . . 0.0 110.706 170.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -65.97 -27.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.954 1.252 . . . . 0.0 113.486 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -68.92 -33.97 74.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.819 1.19 . . . . 0.0 111.429 172.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -66.38 -23.14 66.28 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.61 -61.38 1.89 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.456 -0.778 . . . . 0.0 111.758 169.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -72.63 5.6 2.99 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -53.35 -24.75 12.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.251 2.22 . . . . 0.0 112.459 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.41 -24.51 11.01 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 127.573 2.511 . . . . 0.0 114.615 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.56 -19.94 0.47 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.252 1.021 . . . . 0.0 113.019 177.617 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 119.012 -0.518 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.57 139.47 12.72 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 108.378 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -85.8 148.65 49.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.536 -0.728 . . . . 0.0 111.529 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.56 128.02 20.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.182 2.588 . . . . 0.0 109.957 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.48 82.86 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.938 1.733 . . . . 0.0 115.039 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.6 162.96 12.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -100.9 110.72 22.81 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 127.64 2.376 . . . . 0.0 113.636 -168.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.23 132.35 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.099 1.359 . . . . 0.0 109.92 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -96.54 116.98 29.98 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.07 120.29 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.317 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -81.72 63.16 5.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.675 1.19 . . . . 0.0 109.47 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -62.24 -29.38 70.36 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.317 1.047 . . . . 0.0 113.122 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.46 -144.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.092 1.357 . . . . 0.0 110.456 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.27 31.11 0.81 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.274 1.416 . . . . 0.0 114.706 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -168.44 154.87 7.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.786 2.835 . . . . 0.0 110.093 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -104.65 128.45 52.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.969 0.907 . . . . 0.0 110.812 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -108.76 134.69 51.12 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.878 1.271 . . . . 0.0 110.786 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -79.78 144.65 33.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.82 145.31 37.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.346 1.458 . . . . 0.0 111.521 169.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.14 118.19 36.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.244 1.818 . . . . 0.0 107.948 173.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -74.09 94.7 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.537 0.735 . . . . 0.0 110.64 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 pt -74.04 -8.8 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.668 -1.27 . . . . 0.0 114.15 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.97 133.83 2.91 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.738 0.685 . . . . 0.0 114.29 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 63.39 -19.56 0.06 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.634 3.173 . . . . 0.0 117.284 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.52 -21.44 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.509 1.528 . . . . 0.0 114.683 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.87 144.45 30.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.949 1.375 . . . . 0.0 113.002 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.83 145.62 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.135 1.374 . . . . 0.0 112.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.8 mm -107.45 138.64 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.753 1.621 . . . . 0.0 107.643 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -153.68 146.47 24.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.502 1.047 . . . . 0.0 112.091 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.12 118.79 31.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 109.844 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.9 119.49 75.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.855 1.262 . . . . 0.0 108.96 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -74.28 165.33 32.1 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.714 2.943 . . . . 0.0 112.261 -173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 CA--C 1.54 0.806 0 C-N-CA 122.667 2.244 . . . . 0.0 110.051 177.314 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 121.176 0.513 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.21 159.11 28.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.014 0.926 . . . . 0.0 111.04 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -152.58 138.46 18.05 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.652 -0.655 . . . . 0.0 112.197 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.4 t -82.54 125.76 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.551 1.14 . . . . 0.0 109.406 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.47 175.15 9.79 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.959 1.704 . . . . 0.0 112.004 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -141.21 143.95 34.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.645 1.578 . . . . 0.0 112.24 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -178.78 -165.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.434 2.694 . . . . 0.0 109.249 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -103.79 150.0 24.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.7 tp -50.94 -57.87 7.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.123 1.769 . . . . 0.0 111.477 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -57.27 -33.44 67.62 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.088 0.955 . . . . 0.0 113.409 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.04 -30.03 58.27 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.371 -0.831 . . . . 0.0 112.015 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.49 -45.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.204 1.401 . . . . 0.0 111.785 172.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.62 -6.13 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.4 7.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 119.145 0.884 . . . . 0.0 111.777 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.28 7.72 78.23 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.835 1.207 . . . . 0.0 115.07 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.36 151.84 42.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.593 1.557 . . . . 0.0 112.549 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.61 160.12 19.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.874 0.87 . . . . 0.0 110.63 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -161.67 168.15 23.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.339 1.056 . . . . 0.0 113.44 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -167.23 149.98 6.21 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.122 1.769 . . . . 0.0 110.147 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.16 138.82 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 119.735 1.152 . . . . 0.0 110.153 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -132.32 130.69 41.11 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.013 1.325 . . . . 0.0 111.977 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -123.43 25.84 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.202 1.801 . . . . 0.0 113.299 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.7 m -60.82 -21.45 63.16 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.547 -1.345 . . . . 0.0 114.577 -171.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 mt -93.27 -39.25 11.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.806 0.842 . . . . 0.0 113.025 169.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.58 -35.06 71.8 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.439 1.018 . . . . 0.0 111.819 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -52.88 -29.12 26.44 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.401 2.28 . . . . 0.0 113.052 171.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -87.26 -14.91 39.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.494 1.118 . . . . 0.0 112.993 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -122.03 -64.64 1.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -138.71 149.7 63.17 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -135.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 -11.55 15.27 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 125.183 3.922 . . . . 0.0 114.074 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 81.21 96.48 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 127.586 2.354 . . . . 0.0 114.012 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.99 80.89 2.74 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.745 2.963 . . . . 0.0 108.528 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.77 -29.58 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.64 -39.5 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.465 1.03 . . . . 0.0 111.428 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.09 -34.23 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.387 -0.821 . . . . 0.0 110.247 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.9 mt -76.71 -39.69 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.995 0.918 . . . . 0.0 111.566 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.04 -45.32 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.551 -0.718 . . . . 0.0 110.979 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.9 p -68.21 -29.98 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.337 -0.852 . . . . 0.0 112.413 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -59.7 -46.64 88.47 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.059 -1.025 . . . . 0.0 111.192 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.65 92.09 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.079 -1.013 . . . . 0.0 112.428 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -67.42 -15.7 63.82 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -90.14 -38.35 13.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.977 1.311 . . . . 0.0 112.113 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.4 mmm -70.46 -25.09 63.02 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.361 1.464 . . . . 0.0 113.999 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -48.59 127.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.105 0.866 . . . . 0.0 111.804 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.87 81.4 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.127 1.346 . . . . 0.0 115.114 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -73.62 138.94 45.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.6 1.7 . . . . 0.0 110.7 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -98.08 156.12 16.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.363 1.465 . . . . 0.0 112.173 170.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 mtm -144.43 159.26 43.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.33 1.852 . . . . 0.0 111.44 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -158.61 -32.8 0.07 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -70.11 151.97 44.86 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.453 1.101 . . . . 0.0 113.879 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 t 76.76 -179.04 0.14 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.858 2.063 . . . . 0.0 113.803 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 pt -76.61 149.28 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.643 1.177 . . . . 0.0 110.558 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.91 -35.43 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.833 0.742 . . . . 0.0 112.542 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 p -64.35 -47.08 80.69 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.809 0.844 . . . . 0.0 112.485 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -67.95 -37.18 81.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.229 -0.919 . . . . 0.0 111.249 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -59.58 -46.56 88.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.289 0.95 . . . . 0.0 111.819 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.7 p -73.33 -37.34 66.15 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.495 -0.753 . . . . 0.0 112.797 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.25 -54.57 44.13 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.045 0.839 . . . . 0.0 111.355 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -56.1 -39.5 72.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.607 1.163 . . . . 0.0 111.224 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -56.43 -58.64 7.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.183 0.993 . . . . 0.0 111.294 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.3 m -64.98 -33.2 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.174 1.352 . . . . 0.0 113.253 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.7 m -68.36 -31.98 71.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.135 1.334 . . . . 0.0 111.544 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.51 -25.46 66.69 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.526 1.512 . . . . 0.0 112.327 169.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.62 -56.48 5.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.155 0.889 . . . . 0.0 110.976 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -75.96 5.7 6.19 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -57.7 -23.31 51.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.798 2.039 . . . . 0.0 113.434 -170.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -40.22 -36.32 0.89 Allowed Glycine 0 N--CA 1.474 1.185 0 C-N-CA 128.839 3.114 . . . . 0.0 117.465 -169.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -138.68 16.52 2.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.2 1.0 . . . . 0.0 112.77 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 126.203 1.801 . . . . 0.0 112.565 -178.51 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.66 129.74 28.93 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.331 2.688 . . . . 0.0 113.15 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.79 140.36 21.29 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.867 1.267 . . . . 0.0 108.136 169.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.23 131.37 21.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.244 1.296 . . . . 0.0 109.919 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.99 83.27 Favored Glycine 0 N--CA 1.469 0.859 0 C-N-CA 124.678 1.132 . . . . 0.0 114.66 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.77 168.81 9.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.19 1.495 . . . . 0.0 113.103 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.4 mt -102.99 111.35 23.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.922 1.689 . . . . 0.0 113.857 -168.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.6 mt -97.17 129.06 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 109.86 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.35 120.99 37.65 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.293 1.437 . . . . 0.0 107.559 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -121.47 121.91 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.297 1.039 . . . . 0.0 109.967 -174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -77.19 67.55 3.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.638 1.175 . . . . 0.0 111.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -64.8 -47.57 77.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.011 1.324 . . . . 0.0 113.451 -170.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -148.38 37.81 0.85 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.614 0.721 . . . . 0.0 112.583 -158.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.38 72.06 Favored Glycine 0 N--CA 1.477 1.41 0 O-C-N 121.396 -0.815 . . . . 0.0 113.012 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -162.02 146.86 12.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.887 2.475 . . . . 0.0 109.498 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -89.92 116.81 28.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.493 0.663 . . . . 0.0 111.42 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -94.15 145.1 24.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.583 1.553 . . . . 0.0 109.927 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -84.07 144.61 28.95 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.08 151.79 41.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.763 1.225 . . . . 0.0 112.945 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.83 120.06 41.13 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.245 2.218 . . . . 0.0 108.565 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.49 92.92 1.93 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.576 0.751 . . . . 0.0 111.609 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 pt -81.81 -21.22 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.94 -179.17 31.68 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 124.919 1.247 . . . . 0.0 110.945 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.07 96.74 0.82 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.133 0.968 . . . . 0.0 110.764 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.44 -0.45 89.28 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.168 1.842 . . . . 0.0 114.483 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -99.67 139.32 35.5 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.031 1.916 . . . . 0.0 112.148 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -138.63 149.94 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.87 129.01 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 168.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -145.11 149.22 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.502 1.046 . . . . 0.0 111.952 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -90.93 123.8 34.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.85 111.31 41.53 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.986 1.314 . . . . 0.0 107.555 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.77 165.48 16.0 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.002 3.135 . . . . 0.0 114.016 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 C--N 1.352 0.724 0 C-N-CA 123.189 2.593 . . . . 0.0 111.159 177.793 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.79 154.37 28.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.594 1.157 . . . . 0.0 110.74 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -133.01 135.32 45.37 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.957 0.903 . . . . 0.0 111.491 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.31 125.41 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 169.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.42 156.83 42.55 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.078 1.751 . . . . 0.0 112.798 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -111.4 138.6 47.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.826 1.65 . . . . 0.0 111.016 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -170.18 173.93 5.62 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.869 1.268 . . . . 0.0 110.72 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -93.07 144.95 24.76 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.267 -0.895 . . . . 0.0 112.397 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 tp -53.75 -50.23 66.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.94 1.296 . . . . 0.0 111.07 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.61 -30.92 61.76 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.764 1.226 . . . . 0.0 114.044 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.82 -39.96 25.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.452 -0.78 . . . . 0.0 111.779 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.46 -41.01 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.195 0.598 . . . . 0.0 111.507 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.26 -40.47 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.565 1.075 . . . . 0.0 112.165 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 18.86 61.18 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.148 0.885 . . . . 0.0 115.0 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.08 -8.35 72.95 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.377 1.465 . . . . 0.0 114.633 -173.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.2 m -78.36 169.43 18.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.091 1.357 . . . . 0.0 112.305 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.3 m -71.38 155.59 40.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.84 0.856 . . . . 0.0 113.213 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.95 154.25 27.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.045 1.338 . . . . 0.0 112.664 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -142.05 167.4 22.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.467 1.907 . . . . 0.0 109.881 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.18 134.54 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 119.172 0.897 . . . . 0.0 109.744 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -158.73 129.2 6.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -139.18 57.09 1.67 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 110.566 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.8 m -49.42 -40.72 37.49 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -169.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.44 -34.43 72.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.145 0.884 . . . . 0.0 113.276 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 -26.94 60.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.653 0.781 . . . . 0.0 111.715 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -73.41 -33.73 65.13 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.989 0.916 . . . . 0.0 111.458 169.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.08 -32.86 74.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 112.01 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -168.12 150.4 5.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.841 1.656 . . . . 0.0 113.841 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 80.17 147.94 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 127.196 2.198 . . . . 0.0 115.448 152.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.26 165.4 16.74 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 124.439 3.426 . . . . 0.0 110.542 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -137.47 146.42 53.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 120.953 -1.092 . . . . 0.0 113.678 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.86 83.09 2.33 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.015 3.143 . . . . 0.0 109.476 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -36.92 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.494 1.118 . . . . 0.0 113.203 -169.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -72.23 -35.79 68.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.085 0.857 . . . . 0.0 111.793 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -74.93 -29.92 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.887 0.875 . . . . 0.0 110.13 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.92 -42.36 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.288 1.035 . . . . 0.0 111.535 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.7 -40.55 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.722 0.809 . . . . 0.0 110.449 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.1 m -65.76 -42.25 91.13 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.503 -0.748 . . . . 0.0 111.783 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.2 t -61.79 -40.96 97.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.509 1.123 . . . . 0.0 111.64 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.66 71.79 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.634 0.774 . . . . 0.0 111.308 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -67.32 -15.18 63.54 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.39 -42.84 14.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.276 1.031 . . . . 0.0 113.033 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.6 ptm -81.31 -25.26 36.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -50.01 128.56 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.685 0.755 . . . . 0.0 112.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -15.92 52.53 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.727 1.632 . . . . 0.0 113.964 -170.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -78.63 163.56 25.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.769 1.785 . . . . 0.0 112.215 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.59 150.33 50.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.7 1.6 . . . . 0.0 112.594 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -141.71 159.01 43.09 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.963 1.305 . . . . 0.0 112.407 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -154.38 -3.28 0.17 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -74.77 141.74 44.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.075 -1.016 . . . . 0.0 113.064 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.9 t 71.3 -176.19 0.19 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.346 1.859 . . . . 0.0 114.19 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.5 pt -75.12 152.35 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.644 1.177 . . . . 0.0 111.105 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.1 m -53.83 -38.4 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.1 m -70.67 -38.91 73.81 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.134 0.879 . . . . 0.0 111.904 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -72.06 -35.67 69.36 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.626 -0.671 . . . . 0.0 111.671 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.71 -42.02 82.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.113 0.965 . . . . 0.0 111.209 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -51.56 67.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.762 1.625 . . . . 0.0 113.16 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.41 -45.67 93.37 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.199 -0.938 . . . . 0.0 112.307 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -56.75 -40.33 75.58 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.988 1.715 . . . . 0.0 111.075 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -63.2 -52.69 61.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.563 1.145 . . . . 0.0 112.035 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.6 -20.7 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 120.521 1.51 . . . . 0.0 114.216 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -71.86 -43.23 65.83 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.141 0.882 . . . . 0.0 109.387 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -62.37 -25.36 67.87 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.4 mt -71.94 -58.64 3.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.863 0.756 . . . . 0.0 110.563 169.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ptt85 -76.29 9.19 2.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -58.27 -19.93 38.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.888 2.075 . . . . 0.0 113.739 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.66 -38.92 7.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.875 2.179 . . . . 0.0 114.247 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -137.23 5.47 2.76 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 C--O 1.252 1.202 0 C-N-CA 125.758 1.623 . . . . 0.0 114.821 -174.781 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.69 156.63 62.91 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.391 2.727 . . . . 0.0 111.352 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -99.84 141.31 22.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 0.0 111.664 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.01 129.82 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.255 1.97 . . . . 0.0 110.045 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.09 8.15 75.96 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 118.233 -1.315 . . . . 0.0 114.43 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -117.25 157.61 25.75 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.596 1.698 . . . . 0.0 113.935 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.75 127.32 39.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.543 1.937 . . . . 0.0 113.496 -168.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.52 126.41 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.205 1.802 . . . . 0.0 109.577 -174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.4 122.26 34.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.53 125.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.885 1.274 . . . . 0.0 109.296 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.1 53.07 1.65 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.269 1.427 . . . . 0.0 111.677 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -25.61 66.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -169.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -159.26 26.8 0.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -161.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.87 6.4 72.42 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 124.263 0.935 . . . . 0.0 114.015 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.65 148.19 30.8 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.322 2.249 . . . . 0.0 109.385 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -82.86 107.41 15.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.569 0.747 . . . . 0.0 110.116 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -107.22 154.8 20.69 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.804 1.242 . . . . 0.0 111.206 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.14 168.11 22.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.168 2.187 . . . . 0.0 110.674 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 tp -142.71 121.17 12.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.089 1.756 . . . . 0.0 109.22 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.77 116.36 14.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.421 1.088 . . . . 0.0 110.918 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.0 pt -107.2 -16.06 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.62 39.02 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 126.228 1.87 . . . . 0.0 110.294 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.31 92.31 0.28 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.066 0.936 . . . . 0.0 112.067 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.82 87.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.111 1.815 . . . . 0.0 114.503 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -100.67 135.29 42.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.238 1.519 . . . . 0.0 111.76 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.54 150.84 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.161 0.984 . . . . 0.0 113.139 -173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 mt -105.93 141.78 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -156.62 152.79 27.62 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 111.617 -169.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -96.36 125.18 40.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.472 0.709 . . . . 0.0 110.266 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.51 136.1 33.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.248 1.019 . . . . 0.0 109.215 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.95 169.4 22.5 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 112.678 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 C--N 1.354 0.827 0 C-N-CA 123.837 3.025 . . . . 0.0 115.571 177.627 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.75 159.36 33.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.838 -0.539 . . . . 0.0 111.173 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.57 134.06 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.629 0.772 . . . . 0.0 111.108 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.6 t -83.75 126.14 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.678 0.791 . . . . 0.0 109.213 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -134.36 172.06 13.42 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.787 1.635 . . . . 0.0 112.191 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -151.97 125.79 9.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.267 1.027 . . . . 0.0 112.18 -171.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -169.38 -161.47 0.3 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.861 2.064 . . . . 0.0 110.959 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 -85.34 146.43 27.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -51.0 -52.46 42.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.334 1.854 . . . . 0.0 111.374 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -56.99 -30.33 64.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.65 -45.16 17.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.381 0.992 . . . . 0.0 110.722 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.02 -34.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.122 0.569 . . . . 0.0 112.238 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -82.27 -45.49 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.144 0.978 . . . . 0.0 111.113 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.21 23.1 65.91 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 119.359 0.981 . . . . 0.0 114.867 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.3 2.26 70.99 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.206 1.384 . . . . 0.0 115.066 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -72.01 171.11 12.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 118.93 1.365 . . . . 0.0 112.852 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.85 152.17 31.44 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.428 0.691 . . . . 0.0 111.192 169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -158.81 169.65 23.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.438 1.095 . . . . 0.0 113.287 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -168.09 151.76 5.99 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.891 1.677 . . . . 0.0 110.899 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.5 t -85.86 137.76 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 169.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -161.24 108.3 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.377 1.871 . . . . 0.0 108.635 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -83.17 -32.92 26.36 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.421 -0.799 . . . . 0.0 112.95 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t 74.78 -51.47 0.68 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 129.122 2.969 . . . . 0.0 113.273 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -96.66 -33.13 11.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.91 -25.62 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.283 0.947 . . . . 0.0 112.463 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -75.19 -14.52 60.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.346 1.058 . . . . 0.0 112.963 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -96.08 -34.8 11.59 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.098 1.359 . . . . 0.0 112.327 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -172.55 165.82 5.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.118 1.767 . . . . 0.0 112.719 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 89.74 154.28 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 129.975 3.31 . . . . 0.0 115.446 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.96 -31.79 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.298 3.332 . . . . 0.0 113.434 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 ttp-105 70.76 111.99 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.611 2.764 . . . . 0.0 114.683 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -80.44 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.726 2.951 . . . . 0.0 110.329 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 t -54.43 -40.14 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.638 1.175 . . . . 0.0 112.451 -173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -68.58 -42.92 77.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 111.286 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.4 t -73.23 -30.76 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.899 0.88 . . . . 0.0 110.217 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.1 -41.06 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.425 1.09 . . . . 0.0 111.761 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.44 -36.8 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 119.642 1.11 . . . . 0.0 110.882 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -66.69 -41.46 88.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.126 -0.984 . . . . 0.0 111.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.5 m -63.84 -41.97 97.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.506 1.123 . . . . 0.0 111.655 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.86 -49.55 77.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.765 0.826 . . . . 0.0 111.411 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -56.51 -43.62 79.96 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.746 . . . . 0.0 112.332 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.28 -31.23 70.04 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.2 mtp -73.9 -17.78 60.99 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.72 125.99 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 120.549 1.522 . . . . 0.0 110.623 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.09 66.92 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.625 1.583 . . . . 0.0 114.592 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.44 151.06 32.9 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 111.797 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -87.23 158.2 19.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.011 1.324 . . . . 0.0 110.367 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtp -143.8 148.4 35.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.577 1.551 . . . . 0.0 110.866 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -167.19 -152.7 0.13 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.927 1.291 . . . . 0.0 111.646 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 62.93 22.93 13.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.117 1.767 . . . . 0.0 114.609 169.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.3 p -166.8 156.76 11.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.142 1.377 . . . . 0.0 112.274 -171.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.88 146.22 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.612 1.165 . . . . 0.0 108.606 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 96.6 t -49.93 -39.36 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.776 1.23 . . . . 0.0 113.221 -170.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -56.58 -49.52 74.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.047 0.939 . . . . 0.0 112.192 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -74.85 -34.29 62.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.485 -0.759 . . . . 0.0 111.924 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -57.84 -43.84 86.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.635 1.107 . . . . 0.0 111.917 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.68 -38.45 54.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.7 -46.53 85.06 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.941 -1.099 . . . . 0.0 112.39 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -64.19 -35.32 80.43 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.784 -1.197 . . . . 0.0 110.639 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -58.78 -59.36 5.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.986 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -64.99 -25.59 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.688 1.586 . . . . 0.0 113.662 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -69.66 -37.28 76.66 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.495 1.043 . . . . 0.0 110.805 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.59 -20.2 65.95 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.662 1.119 . . . . 0.0 112.952 170.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.1 mt -76.12 -65.16 0.95 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.385 0.993 . . . . 0.0 110.352 169.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.4 ptt85 -75.2 14.28 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -52.91 -23.67 7.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.156 2.183 . . . . 0.0 112.632 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.68 -45.05 7.04 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 128.091 2.758 . . . . 0.0 114.435 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -139.36 -5.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 124.555 1.142 . . . . 0.0 112.128 174.288 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.45 123.69 6.66 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.875 2.383 . . . . 0.0 110.422 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.35 161.27 27.71 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 125.538 1.535 . . . . 0.0 111.049 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.75 135.98 51.28 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.621 2.214 . . . . 0.0 113.145 -169.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.2 -17.59 58.89 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.381 1.467 . . . . 0.0 114.815 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.38 149.72 22.87 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.441 1.121 . . . . 0.0 112.337 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -107.51 140.3 40.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.645 1.212 . . . . 0.0 111.548 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt -125.4 127.45 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.807 2.043 . . . . 0.0 107.936 -159.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -88.68 119.78 29.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -123.19 134.71 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.459 1.104 . . . . 0.0 109.653 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -78.09 66.48 3.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.328 1.051 . . . . 0.0 110.181 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -47.16 77.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.56 1.944 . . . . 0.0 113.788 -169.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.24 37.5 0.44 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -166.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.85 12.23 56.92 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.173 0.892 . . . . 0.0 113.832 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -166.39 134.98 2.93 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.835 2.054 . . . . 0.0 109.729 -171.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.06 128.05 34.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.778 1.631 . . . . 0.0 112.386 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.596 ' CD2' ' HG ' ' A' ' 113' ' ' CYS . 0.0 OUTLIER -138.27 151.04 47.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.154 . . . . 0.0 112.063 178.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -85.7 147.29 26.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.11 138.46 37.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.41 1.484 . . . . 0.0 111.568 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.26 121.22 41.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.429 1.891 . . . . 0.0 109.111 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.8 111.62 8.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.227 1.011 . . . . 0.0 111.303 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 pt -104.16 -20.82 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.53 172.42 40.27 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.91 101.39 0.12 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.513 1.157 . . . . 0.0 112.253 -172.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.95 -2.0 76.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.691 1.615 . . . . 0.0 115.488 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -98.44 137.94 36.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.625 1.713 . . . . 0.0 112.826 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.94 153.59 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.799 1.239 . . . . 0.0 112.431 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.47 126.44 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -136.07 160.07 39.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.303 0.956 . . . . 0.0 111.345 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.3 tp -85.3 137.55 32.89 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.8 123.8 44.33 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.156 1.382 . . . . 0.0 107.626 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.85 167.41 27.3 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.168 2.579 . . . . 0.0 112.081 -172.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo . . . . . 0 C--N 1.352 0.722 0 C-N-CA 123.237 2.625 . . . . 0.0 110.649 171.79 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.55 164.7 14.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.203 1.001 . . . . 0.0 111.005 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.04 137.76 26.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.353 1.061 . . . . 0.0 111.492 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.89 127.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.57 1.148 . . . . 0.0 110.857 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -129.67 148.91 51.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.008 1.723 . . . . 0.0 112.855 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -95.05 138.86 32.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.847 1.259 . . . . 0.0 109.403 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -163.22 169.05 19.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.604 1.162 . . . . 0.0 110.8 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -90.42 141.63 28.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.245 1.018 . . . . 0.0 111.244 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 tp -53.29 -47.3 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.496 1.119 . . . . 0.0 111.494 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.78 -31.49 66.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.52 -43.59 26.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.151 0.887 . . . . 0.0 110.914 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 t -60.87 -38.36 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 122.574 0.35 . . . . 0.0 111.51 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.36 -47.01 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.34 18.19 62.77 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.48 1.036 . . . . 0.0 114.955 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.69 -2.62 82.69 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.593 1.568 . . . . 0.0 114.868 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.4 m -76.25 176.59 7.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.149 1.38 . . . . 0.0 113.065 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -71.3 150.02 45.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.355 1.062 . . . . 0.0 112.5 173.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -157.72 152.17 24.88 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.645 1.178 . . . . 0.0 113.247 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -136.02 157.86 45.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.395 1.878 . . . . 0.0 110.047 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.09 126.21 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.4 0.68 . . . . 0.0 109.977 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -167.3 113.05 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.892 1.277 . . . . 0.0 110.645 -174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -83.68 71.87 10.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.232 1.013 . . . . 0.0 108.592 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 p -33.31 -64.11 0.21 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.159 2.583 . . . . 0.0 115.823 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.0 mt -84.17 -27.1 28.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.44 -37.6 84.14 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.733 -0.604 . . . . 0.0 111.259 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.3 -28.54 66.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.015 1.326 . . . . 0.0 113.381 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -86.8 -29.16 22.49 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.77 -38.8 3.05 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 117.109 2.263 . . . . 0.0 117.109 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -155.22 159.48 31.71 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -134.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -98.3 1.51 1.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 1 C-N-CA 125.558 4.172 . . . . 0.0 114.197 169.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -12.61 125.28 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 130.401 3.48 . . . . 0.0 117.097 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.48 121.89 9.62 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.334 3.356 . . . . 0.0 112.902 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.3 -34.79 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.021 0.928 . . . . 0.0 112.473 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.84 -35.23 79.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.64 0.654 . . . . 0.0 111.707 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.37 -37.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.468 0.707 . . . . 0.0 110.211 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.46 -41.54 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.699 0.681 . . . . 0.0 110.933 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -64.26 -42.58 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.895 0.771 . . . . 0.0 111.313 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.2 m -62.88 -42.03 99.62 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.668 -0.645 . . . . 0.0 111.563 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -62.1 -45.42 93.59 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.504 1.122 . . . . 0.0 111.515 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.27 86.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.953 0.901 . . . . 0.0 112.145 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.2 -49.89 75.84 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.651 -0.656 . . . . 0.0 111.815 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -60.79 -30.91 70.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.2 mmm -73.75 -13.17 60.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 114.164 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.6 t -57.07 125.99 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.88 1.218 . . . . 0.0 110.704 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.95 75.44 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.173 1.368 . . . . 0.0 114.608 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -74.97 143.15 43.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.251 1.525 . . . . 0.0 110.45 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -112.38 151.69 29.5 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.259 1.824 . . . . 0.0 111.228 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.81 147.08 13.26 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -145.48 59.16 1.27 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.786 1.635 . . . . 0.0 109.34 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -65.8 -32.01 73.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.916 1.286 . . . . 0.0 113.618 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 t -165.58 -162.81 0.61 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.486 1.514 . . . . 0.0 110.29 -170.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.2 pt -60.1 150.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.09 0.956 . . . . 0.0 109.803 169.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.4 -36.28 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.9 m -63.37 -53.26 55.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.537 0.608 . . . . 0.0 111.363 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -70.49 -28.49 65.02 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 121.256 -0.902 . . . . 0.0 111.968 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -60.57 -33.5 72.8 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.392 1.451 . . . . 0.0 111.086 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.596 ' HG ' ' CD2' ' A' ' 23' ' ' HIS . 2.1 t -80.37 -40.93 25.63 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.624 1.169 . . . . 0.0 113.254 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.7 -41.0 98.18 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.289 -1.507 . . . . 0.0 112.073 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -65.35 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.776 -1.203 . . . . 0.0 110.701 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.84 -55.84 25.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.748 1.219 . . . . 0.0 111.749 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.01 -30.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 120.218 1.372 . . . . 0.0 112.79 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -69.13 -39.21 79.03 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.633 -1.175 . . . . 0.0 111.124 173.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.86 -28.66 66.31 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.217 1.372 . . . . 0.0 112.932 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.4 mt -67.32 -52.46 40.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.394 0.997 . . . . 0.0 111.246 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -92.68 16.05 13.08 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -62.69 -24.91 67.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.527 1.931 . . . . 0.0 114.45 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.15 -68.84 1.48 Allowed Glycine 0 N--CA 1.473 1.129 0 C-N-CA 125.661 1.6 . . . . 0.0 114.166 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -101.47 -12.13 18.78 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.254 1.312 0 C-N-CA 124.594 1.157 . . . . 0.0 113.017 -175.915 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.17 127.67 27.26 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.043 3.162 . . . . 0.0 112.795 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -103.78 143.88 27.54 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.881 1.272 . . . . 0.0 110.236 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.68 122.73 10.17 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.989 1.793 . . . . 0.0 109.816 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.52 15.42 66.14 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.682 1.134 . . . . 0.0 114.827 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -122.12 165.22 16.44 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.996 1.398 . . . . 0.0 111.924 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.76 154.64 33.88 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -169.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -128.47 142.88 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.217 2.607 . . . . 0.0 109.081 -160.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.15 123.72 48.3 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.102 1.361 . . . . 0.0 107.335 168.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.24 125.91 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 110.485 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -79.69 65.45 4.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.502 1.121 . . . . 0.0 110.366 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -61.46 -33.69 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.0 32.12 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.788 1.235 . . . . 0.0 113.757 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.63 -18.51 52.44 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.654 1.597 . . . . 0.0 114.791 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -74.08 -31.16 62.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 73.77 99.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.279 2.632 . . . . 0.0 110.302 -172.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -102.52 148.7 25.2 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.647 1.179 . . . . 0.0 111.297 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -87.82 151.54 22.79 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 169.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.01 39.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.303 1.041 . . . . 0.0 112.466 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.56 125.2 52.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.647 1.979 . . . . 0.0 108.776 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -80.29 100.35 8.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.064 0.946 . . . . 0.0 110.682 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 pt -89.01 -14.15 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.73 -171.26 37.35 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.03 97.0 0.16 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 111.675 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.92 25.15 58.58 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.15 1.833 . . . . 0.0 115.572 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.272 6.8 p90 -144.1 149.24 36.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.459 2.129 . . . . 0.0 115.503 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.06 157.15 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -168.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mm -107.44 139.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.491 2.317 . . . . 0.0 106.348 168.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -156.33 161.67 40.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.14 1.336 . . . . 0.0 112.418 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.64 123.6 48.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.033 0.933 . . . . 0.0 111.642 -171.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.6 113.11 61.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.154 1.382 . . . . 0.0 108.582 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.61 167.65 9.6 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.09 3.194 . . . . 0.0 115.734 -169.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo . . . . . 0 C--N 1.356 0.929 0 C-N-CA 124.214 3.276 . . . . 0.0 113.657 171.83 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 163.01 26.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.178 0.991 . . . . 0.0 110.206 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.81 138.56 42.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.086 0.954 . . . . 0.0 111.14 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.9 t -85.67 123.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.942 0.897 . . . . 0.0 108.707 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.83 171.6 10.56 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.796 1.638 . . . . 0.0 112.042 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -146.95 139.82 25.14 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.337 1.455 . . . . 0.0 111.841 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -176.68 -178.07 0.86 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.449 1.9 . . . . 0.0 111.866 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -72.66 148.29 44.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.11 -59.78 4.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.26 1.024 . . . . 0.0 110.617 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -65.78 -18.13 65.12 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.95 -34.28 64.24 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.431 1.014 . . . . 0.0 110.916 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.85 -54.76 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.867 0.867 . . . . 0.0 111.236 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.63 3.21 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.99 -21.0 43.95 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.51 24.34 4.16 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 125.337 1.446 . . . . 0.0 113.69 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 54.0 m -125.72 161.9 26.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.956 1.302 . . . . 0.0 114.298 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 97.4 m -96.99 149.55 21.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.917 1.287 . . . . 0.0 108.756 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -166.16 158.61 14.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -147.61 152.15 37.42 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.758 1.623 . . . . 0.0 110.792 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.54 129.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -162.79 133.52 4.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.063 0.545 . . . . 0.0 110.913 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -153.85 49.82 0.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.974 0.893 . . . . 0.0 112.635 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.8 m -56.56 -30.02 62.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 tp -71.84 -39.28 69.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.396 0.998 . . . . 0.0 112.069 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -41.6 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.186 0.994 . . . . 0.0 110.644 169.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.0 -11.82 50.66 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.16 0.984 . . . . 0.0 113.58 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.78 -22.64 60.81 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.205 0.911 . . . . 0.0 113.036 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.81 -43.23 0.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 119.619 3.192 . . . . 0.0 119.619 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -100.38 147.74 33.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 121.0 1.727 . . . . 0.0 114.031 -154.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.53 -27.99 3.06 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.769 2.979 . . . . 0.0 112.715 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ttp-105 74.12 115.03 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.613 2.765 . . . . 0.0 115.014 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.1 91.12 1.22 Allowed 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.121 3.214 . . . . 0.0 109.623 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 t -50.11 -46.72 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.476 1.511 . . . . 0.0 113.742 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -38.28 84.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.679 0.672 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.7 -35.31 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.788 0.835 . . . . 0.0 111.952 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.5 mm -63.7 -49.11 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 119.898 1.226 . . . . 0.0 110.727 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.59 -39.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.558 0.743 . . . . 0.0 110.692 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -68.07 -40.45 82.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.217 0.607 . . . . 0.0 111.107 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m -61.76 -44.77 96.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.099 0.959 . . . . 0.0 111.363 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.31 74.53 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.155 0.982 . . . . 0.0 111.578 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.91 -18.6 65.45 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.17 -44.44 16.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.649 1.113 . . . . 0.0 112.397 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.1 ptm -77.44 -17.43 58.1 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.6 p -42.23 125.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.632 0.773 . . . . 0.0 112.251 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.14 -4.16 86.42 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.988 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -72.02 160.53 32.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.407 2.103 . . . . 0.0 111.365 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.73 151.19 48.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.681 1.592 . . . . 0.0 112.213 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.6 mtm -144.41 143.74 31.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.371 1.068 . . . . 0.0 112.94 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -145.72 -151.23 0.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.659 1.184 . . . . 0.0 111.227 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.7 t80 71.22 -56.72 0.62 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.8 2.84 . . . . 0.0 114.134 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.4 m -72.77 162.75 29.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.789 1.236 . . . . 0.0 112.789 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 pt -63.6 150.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.634 0.773 . . . . 0.0 111.536 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.46 -29.56 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.7 p -67.94 -45.15 75.07 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.47 -0.769 . . . . 0.0 111.241 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.03 -30.05 67.24 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.42 -0.8 . . . . 0.0 112.213 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.99 -43.41 77.61 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.494 1.043 . . . . 0.0 110.949 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.0 m -66.39 -46.88 75.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.528 1.531 . . . . 0.0 113.22 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -64.74 -42.65 95.02 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.128 -0.982 . . . . 0.0 112.369 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -62.22 -34.12 75.88 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 111.292 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.53 -55.57 32.84 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.111 0.868 . . . . 0.0 111.274 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.56 -20.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -71.02 -42.66 69.26 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.742 1.155 . . . . 0.0 110.331 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -63.15 -24.81 68.06 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.633 1.106 . . . . 0.0 112.988 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.56 -59.52 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.661 0.664 . . . . 0.0 111.785 169.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -76.51 8.34 3.61 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -56.53 -27.34 57.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.053 2.141 . . . . 0.0 112.83 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.75 -25.42 55.85 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 126.931 2.205 . . . . 0.0 115.142 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -149.51 14.73 0.87 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.254 1.32 0 CA-C-O 116.958 -1.496 . . . . 0.0 113.552 175.4 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 119.367 -0.349 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.47 149.36 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.548 2.832 . . . . 0.0 111.364 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.29 159.82 16.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 126.528 1.931 . . . . 0.0 110.942 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.32 143.76 71.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.652 2.235 . . . . 0.0 112.818 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.38 61.96 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.495 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -114.61 157.12 23.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.203 1.502 . . . . 0.0 112.018 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.99 160.02 16.36 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 123.297 1.522 . . . . 0.0 111.044 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.2 mt -137.1 129.42 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 125.575 1.55 . . . . 0.0 107.247 -159.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.32 124.47 33.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.028 0.931 . . . . 0.0 108.516 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.16 137.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.999 2.12 . . . . 0.0 108.692 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.59 62.37 4.64 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -57.65 -45.35 85.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.003 1.721 . . . . 0.0 115.217 -169.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -145.92 29.07 1.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -156.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.84 87.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.541 1.067 . . . . 0.0 113.126 -169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.3 155.64 44.52 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 110.415 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.47 133.9 51.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.567 1.547 . . . . 0.0 111.752 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -150.85 145.9 25.98 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.259 1.424 . . . . 0.0 110.794 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -89.51 162.54 15.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.89 136.99 20.84 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.417 2.287 . . . . 0.0 109.933 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.72 117.0 33.36 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.254 1.822 . . . . 0.0 109.176 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -73.75 111.24 8.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.414 1.085 . . . . 0.0 111.753 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 pt -98.82 -20.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.83 -179.96 40.79 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.832 1.682 . . . . 0.0 110.5 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.11 95.01 0.08 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.363 1.082 . . . . 0.0 113.279 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.07 -2.08 85.08 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.664 2.078 . . . . 0.0 114.486 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -95.76 137.08 35.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.25 1.525 . . . . 0.0 112.105 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.18 152.79 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.752 1.221 . . . . 0.0 112.972 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.46 132.69 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -149.04 156.92 42.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.468 -0.77 . . . . 0.0 111.033 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.3 145.0 32.36 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.85 103.26 16.17 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 168.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.63 166.29 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.909 2.406 . . . . 0.0 113.002 -169.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--N 1.352 0.748 0 C-N-CA 123.62 2.88 . . . . 0.0 111.896 172.775 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.56 162.33 40.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.608 1.563 . . . . 0.0 110.485 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -154.16 137.95 16.18 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.122 -0.986 . . . . 0.0 112.065 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.4 t -82.27 127.97 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.469 1.108 . . . . 0.0 109.928 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -138.34 155.28 48.71 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.123 1.369 . . . . 0.0 112.898 -170.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -98.37 138.81 35.06 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 110.071 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -163.52 172.18 14.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.211 1.404 . . . . 0.0 110.087 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -94.17 144.29 25.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.07 -1.019 . . . . 0.0 112.293 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.49 -46.34 73.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.224 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.89 -34.24 58.87 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.35 -38.7 23.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.799 0.84 . . . . 0.0 111.591 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.8 -36.48 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.54 0.736 . . . . 0.0 111.744 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.6 t -80.09 -50.36 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.715 1.206 . . . . 0.0 111.182 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.42 63.59 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 119.287 0.949 . . . . 0.0 115.132 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.27 -3.94 60.15 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.736 1.636 . . . . 0.0 115.228 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -70.01 171.05 10.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.117 1.459 . . . . 0.0 113.679 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.16 149.47 39.0 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.834 0.854 . . . . 0.0 111.168 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -158.03 160.2 37.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.107 0.963 . . . . 0.0 113.535 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -157.75 144.12 17.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.307 1.043 . . . . 0.0 111.706 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.48 130.72 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.409 -0.807 . . . . 0.0 109.055 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -169.44 118.51 0.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.33 1.452 . . . . 0.0 110.415 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -98.46 0.15 44.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.9 p 56.97 -49.74 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.175 1 C-N-CA 133.397 4.679 . . . . 0.0 118.039 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 mt -114.48 -23.79 9.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.764 1.625 . . . . 0.0 113.604 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -35.75 77.69 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.283 -0.886 . . . . 0.0 112.067 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -66.65 -16.73 64.42 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.676 1.19 . . . . 0.0 112.921 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -93.25 -30.45 15.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.507 1.123 . . . . 0.0 113.15 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -114.82 -43.59 3.12 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -169.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -153.89 162.19 27.38 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -139.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -88.81 -33.16 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 124.537 3.491 . . . . 0.0 113.761 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 66.7 132.85 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 128.902 2.881 . . . . 0.0 115.984 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.37 94.09 1.07 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.49 2.793 . . . . 0.0 110.461 172.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -57.67 -39.71 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.169 0.988 . . . . 0.0 112.564 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.75 -39.81 76.52 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.634 0.652 . . . . 0.0 111.542 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.9 -35.92 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.416 0.686 . . . . 0.0 109.95 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.283 24.8 mt -77.92 -33.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.304 -0.855 . . . . 0.0 112.045 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.0 mt -65.51 -40.28 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.177 1.353 . . . . 0.0 110.369 169.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -65.81 -38.92 90.23 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.842 -0.536 . . . . 0.0 110.877 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.1 m -63.64 -46.55 85.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.208 1.003 . . . . 0.0 111.743 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.46 91.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.488 0.715 . . . . 0.0 112.082 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -62.61 -48.59 78.73 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 111.911 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -60.52 -30.3 69.65 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.197 -0.94 . . . . 0.0 113.204 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.7 mtp -75.42 -4.91 42.24 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.92 1.288 . . . . 0.0 114.454 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -56.19 121.94 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.016 1.28 . . . . 0.0 109.311 171.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.41 -2.42 60.92 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.228 1.394 . . . . 0.0 115.086 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.66 127.13 31.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.654 1.727 . . . . 0.0 110.482 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -99.93 132.52 45.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.941 2.097 . . . . 0.0 111.681 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -117.3 174.6 6.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.66 1.984 . . . . 0.0 110.38 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -126.52 -160.04 0.96 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.315 1.046 . . . . 0.0 112.442 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -73.32 150.1 42.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 112.985 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.0 m 176.82 171.8 0.47 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.299 3.039 . . . . 0.0 108.645 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.46 123.62 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.43 -35.66 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.81 0.844 . . . . 0.0 112.494 -169.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -55.43 -56.36 21.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.457 0.703 . . . . 0.0 111.423 173.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.25 -34.88 78.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.211 -0.931 . . . . 0.0 111.853 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.4 -44.77 92.75 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.901 1.228 . . . . 0.0 111.374 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.0 p -77.37 -37.25 52.55 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.907 0.883 . . . . 0.0 113.034 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.43 -45.57 92.5 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.568 1.076 . . . . 0.0 112.206 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -62.87 -36.24 82.64 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.599 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.43 -55.26 33.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.722 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.02 -24.25 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 120.545 1.521 . . . . 0.0 113.316 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -70.21 -39.09 75.34 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.446 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.38 -23.39 66.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.483 1.038 . . . . 0.0 113.367 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.45 -60.21 2.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.723 1.147 . . . . 0.0 111.01 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -77.69 6.41 7.41 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -26.04 27.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.76 2.024 . . . . 0.0 112.077 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.3 -17.67 32.65 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 127.249 2.357 . . . . 0.0 115.183 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -134.15 -28.78 1.31 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.415 1.086 . . . . 0.0 112.922 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 CA--C 1.548 0.877 0 CA-C-O 118.732 -0.652 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.63 143.72 27.45 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.805 3.003 . . . . 0.0 110.752 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.09 132.5 23.69 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.043 0.937 . . . . 0.0 111.601 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.8 132.84 25.82 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.263 2.642 . . . . 0.0 111.316 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.52 -4.23 74.35 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.714 1.149 . . . . 0.0 114.947 -175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -105.09 168.07 9.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 122.652 1.215 . . . . 0.0 113.234 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.0 113.13 25.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.814 1.646 . . . . 0.0 112.353 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.68 127.85 43.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 124.796 1.238 . . . . 0.0 108.574 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -90.91 116.72 28.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.9 mm -105.65 112.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.392 1.477 . . . . 0.0 109.142 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 73.94 8.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.783 0.72 . . . . 0.0 109.804 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.25 3.77 2.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.0 mt 102.57 126.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 131.577 3.951 . . . . 0.0 110.708 158.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.61 -3.82 39.85 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.202 0.905 . . . . 0.0 113.67 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -171.22 160.35 6.22 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.853 2.461 . . . . 0.0 110.836 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -127.41 127.32 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.994 1.318 . . . . 0.0 110.463 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -108.74 151.3 26.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.913 1.285 . . . . 0.0 111.721 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -90.18 145.07 25.31 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 122.181 -0.325 . . . . 0.0 111.057 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.55 34.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.266 1.026 . . . . 0.0 111.67 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.7 119.32 33.99 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.623 1.569 . . . . 0.0 108.42 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -72.58 96.02 1.91 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 118.558 0.617 . . . . 0.0 111.123 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 pt -84.78 -22.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.18 173.34 30.65 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 124.731 1.158 . . . . 0.0 110.344 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.55 90.76 0.56 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.688 0.756 . . . . 0.0 110.537 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.15 -0.12 47.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.895 2.188 . . . . 0.0 115.109 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.46 140.39 49.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.284 1.542 . . . . 0.0 112.544 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.58 151.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.5 mm -110.65 129.29 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 168.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.17 157.06 43.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.262 0.937 . . . . 0.0 112.773 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.75 120.9 38.96 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.782 0.833 . . . . 0.0 110.938 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.33 120.53 66.55 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.89 1.276 . . . . 0.0 108.167 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.91 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.714 2.942 . . . . 0.0 113.209 -169.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.354 0.835 0 C-N-CA 124.477 3.452 . . . . 0.0 112.926 173.014 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.01 159.88 32.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.49 1.116 . . . . 0.0 109.607 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.44 136.37 29.41 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 111.312 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.69 121.32 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.461 1.105 . . . . 0.0 108.213 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -124.92 156.61 37.71 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.219 1.407 . . . . 0.0 112.418 -171.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -111.07 137.3 48.88 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.707 1.603 . . . . 0.0 110.846 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.39 171.37 10.63 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.037 0.935 . . . . 0.0 111.426 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -84.56 140.0 31.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.694 1.598 . . . . 0.0 110.246 172.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 tp -56.33 -48.38 76.86 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.354 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.32 -28.91 63.5 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.86 -41.33 19.11 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.735 0.814 . . . . 0.0 111.23 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.56 -37.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.979 0.512 . . . . 0.0 111.441 170.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.01 -50.11 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.142 0.977 . . . . 0.0 111.915 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.46 24.16 65.52 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 119.754 1.161 . . . . 0.0 114.788 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.17 1.25 64.97 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.346 1.45 . . . . 0.0 115.305 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.1 m -71.97 170.61 13.44 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.842 1.321 . . . . 0.0 113.269 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.19 149.11 32.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.231 1.012 . . . . 0.0 111.668 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -159.27 154.2 24.88 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -148.73 157.54 43.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.401 1.88 . . . . 0.0 110.662 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.8 t -88.49 139.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-N 119.123 0.874 . . . . 0.0 110.065 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -156.17 64.5 0.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.425 1.49 . . . . 0.0 111.213 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.79 65.67 5.03 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.704 -1.248 . . . . 0.0 110.139 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -48.39 -56.64 7.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.569 1.948 . . . . 0.0 114.477 -170.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.92 -32.05 72.23 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.71 -44.3 90.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.744 -0.597 . . . . 0.0 111.626 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -61.39 -31.62 71.53 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.617 0.767 . . . . 0.0 112.393 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -40.86 63.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.427 1.091 . . . . 0.0 113.557 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.9 -39.35 4.27 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -148.58 158.15 40.57 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.671 2.101 . . . . 0.0 116.671 -134.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.83 -22.32 0.89 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.195 3.263 . . . . 0.0 114.098 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 20.97 116.63 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 131.459 3.904 . . . . 0.0 118.614 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.64 116.42 3.93 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.683 2.922 . . . . 0.0 111.7 -171.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.69 -32.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.524 1.129 . . . . 0.0 112.923 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -63.39 -35.55 80.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.591 0.632 . . . . 0.0 111.607 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.19 -38.23 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.734 0.814 . . . . 0.0 110.047 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.7 mt -74.01 -35.38 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.655 -0.653 . . . . 0.0 112.273 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.42 -37.02 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.117 -0.989 . . . . 0.0 110.399 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 m -66.41 -43.52 85.5 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.579 -0.701 . . . . 0.0 111.709 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -53.35 -43.41 67.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.144 0.978 . . . . 0.0 112.222 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.29 79.45 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.569 -0.707 . . . . 0.0 111.969 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -66.63 -14.91 63.03 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.66 -39.4 14.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.322 1.049 . . . . 0.0 111.897 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.2 mtp -75.58 -18.33 59.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.02 126.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.813 1.188 . . . . 0.0 111.845 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.65 -7.43 81.86 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.395 1.474 . . . . 0.0 115.009 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -70.65 151.67 44.7 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.621 1.711 . . . . 0.0 110.675 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -132.18 149.94 52.27 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.612 1.565 . . . . 0.0 112.385 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 69.2 mtm -149.48 158.37 44.12 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.422 1.489 . . . . 0.0 111.332 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -140.17 16.46 2.43 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.176 -0.953 . . . . 0.0 112.869 171.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.97 143.38 26.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.849 -171.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 68.73 -171.82 0.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.046 1.738 . . . . 0.0 114.24 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.0 144.97 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.305 1.442 . . . . 0.0 108.869 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -34.69 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -170.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -67.16 -35.04 78.84 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.724 -0.61 . . . . 0.0 112.157 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -77.44 -32.37 54.52 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 121.409 -0.807 . . . . 0.0 111.736 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.06 -45.34 83.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 20.7 p -74.26 -37.52 63.71 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 121.704 -0.623 . . . . 0.0 112.679 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.77 -43.22 99.36 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.26 -0.9 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -56.67 -49.01 76.32 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 110.054 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -55.3 -52.11 64.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.246 1.018 . . . . 0.0 112.441 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.0 -32.72 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 120.167 1.349 . . . . 0.0 113.09 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 m -61.44 -47.34 86.18 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 116.428 -1.749 . . . . 0.0 108.774 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -56.98 -25.56 58.43 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 121.042 1.746 . . . . 0.0 114.208 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.15 -47.11 72.03 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.016 1.28 . . . . 0.0 111.88 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -92.54 -3.1 55.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -62.49 -24.37 67.44 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.534 1.934 . . . . 0.0 112.3 -169.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.28 -24.84 76.38 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.377 0.989 . . . . 0.0 113.855 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.44 -20.64 2.63 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.255 1.364 0 C-N-CA 124.924 1.29 . . . . 0.0 112.389 177.243 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -81.41 155.67 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.283 2.656 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -102.51 151.21 38.18 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.891 . . . . 0.0 111.986 -177.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.97 136.76 39.18 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.683 2.255 . . . . 0.0 111.326 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.05 69.71 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.859 1.695 . . . . 0.0 114.637 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -94.64 165.77 12.35 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.187 1.493 . . . . 0.0 114.668 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -88.42 116.04 26.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.624 1.57 . . . . 0.0 111.892 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.43 121.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 109.229 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -99.34 103.58 15.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.574 1.95 . . . . 0.0 108.06 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.01 119.28 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.515 1.126 . . . . 0.0 109.426 -171.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.33 62.04 5.07 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.881 -1.137 . . . . 0.0 110.777 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -30.53 70.92 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -169.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.98 34.16 0.25 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -161.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.69 68.92 Favored Glycine 0 N--CA 1.479 1.531 0 C-N-CA 124.193 0.902 . . . . 0.0 113.48 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -164.47 149.08 9.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.416 2.286 . . . . 0.0 110.134 -172.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -74.22 106.34 5.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.164 1.385 . . . . 0.0 111.372 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -86.94 126.88 34.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.004 1.721 . . . . 0.0 109.279 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -82.47 150.15 27.19 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.588 -0.695 . . . . 0.0 112.814 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.94 159.84 44.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.113 1.365 . . . . 0.0 111.469 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.82 121.8 35.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.149 1.78 . . . . 0.0 108.466 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.89 90.37 3.51 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.701 0.682 . . . . 0.0 112.154 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.31 -18.43 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.23 -176.6 29.47 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 124.518 1.056 . . . . 0.0 111.629 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.83 90.0 0.78 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.007 0.908 . . . . 0.0 111.034 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 -3.78 80.06 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.348 1.928 . . . . 0.0 114.269 -174.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.68 138.64 35.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.655 1.727 . . . . 0.0 112.28 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.68 152.99 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mm -110.79 139.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.36 1.864 . . . . 0.0 106.697 168.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -157.89 134.7 9.88 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.38 0.991 . . . . 0.0 112.467 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.77 113.27 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.454 -0.779 . . . . 0.0 110.251 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.22 120.76 80.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.267 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.35 161.07 43.55 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.665 2.91 . . . . 0.0 112.943 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 C-N-CA 123.645 2.897 . . . . 0.0 111.844 -179.462 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.096 0.474 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.19 158.35 15.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.291 1.036 . . . . 0.0 111.55 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.92 135.05 32.43 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 0.0 111.83 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -80.69 114.29 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.971 1.308 . . . . 0.0 108.323 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -121.2 173.06 7.55 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.267 1.827 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.8 35.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.422 1.489 . . . . 0.0 111.82 -174.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 174.01 -159.47 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.93 2.892 . . . . 0.0 108.421 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.14 150.97 19.92 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.17 0.986 . . . . 0.0 113.446 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -50.34 -51.46 45.43 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.136 1.775 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -55.04 -29.85 58.31 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.01 -42.77 15.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.816 0.846 . . . . 0.0 111.337 174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.61 -33.47 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.913 -0.492 . . . . 0.0 111.965 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.0 t -86.77 -46.98 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.511 1.124 . . . . 0.0 111.495 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.99 -121.48 24.9 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -172.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.14 1.04 62.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.651 1.12 . . . . 0.0 114.892 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.7 m -73.13 162.43 29.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.899 1.35 . . . . 0.0 113.921 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.2 m -79.44 151.14 31.04 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.871 0.869 . . . . 0.0 110.989 169.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -156.46 167.99 28.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.962 0.905 . . . . 0.0 112.852 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -161.7 159.22 27.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.6 1.56 . . . . 0.0 109.933 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -82.75 132.5 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.723 1.147 . . . . 0.0 109.175 169.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -80.3 -70.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.492 0.717 . . . . 0.0 112.051 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 63.37 8.89 3.72 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.535 1.934 . . . . 0.0 114.332 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.6 m -69.28 -36.28 76.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 119.076 -2.265 . . . . 0.0 113.506 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.5 mt -68.9 -37.92 79.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.997 0.519 . . . . 0.0 111.718 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -64.79 -43.64 92.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.513 -0.742 . . . . 0.0 111.116 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.29 -26.15 62.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.075 1.35 . . . . 0.0 112.873 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.57 -29.99 46.55 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.132 0.973 . . . . 0.0 112.41 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -126.19 -46.52 1.65 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.51 152.51 45.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -143.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.31 -10.08 12.42 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 124.565 3.51 . . . . 0.0 114.393 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 74.32 106.79 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.595 2.358 . . . . 0.0 114.377 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.47 71.54 6.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.721 2.948 . . . . 0.0 109.03 169.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 t -46.24 -38.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 126.436 1.894 . . . . 0.0 114.687 -169.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.69 -38.17 90.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.802 0.841 . . . . 0.0 111.703 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -75.63 -30.99 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.2 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.08 -45.52 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.491 0.587 . . . . 0.0 110.78 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.41 -39.56 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.822 -0.549 . . . . 0.0 110.376 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 m -63.5 -43.5 97.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.97 0.508 . . . . 0.0 111.592 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 t -59.37 -45.47 91.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 111.658 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.42 90.75 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.218 -0.926 . . . . 0.0 112.082 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.94 -19.07 64.94 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -82.32 -37.11 26.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.687 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.0 mtp -70.98 -32.01 68.73 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.4 p -44.54 129.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.14 -8.85 79.02 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.45 1.5 . . . . 0.0 114.837 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -78.99 159.59 27.58 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.949 1.875 . . . . 0.0 112.317 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -104.5 156.91 17.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.572 1.549 . . . . 0.0 112.012 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.3 tpp -141.14 140.02 34.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.527 1.531 . . . . 0.0 110.292 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.37 -7.17 0.62 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -78.3 132.26 37.39 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.135 -0.978 . . . . 0.0 113.111 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 t 69.48 -175.9 0.2 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.3 1.84 . . . . 0.0 114.894 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.9 pt -75.14 157.64 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.822 1.649 . . . . 0.0 111.322 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.46 -38.46 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -169.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.5 m -59.11 -51.08 71.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.742 0.817 . . . . 0.0 111.679 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -75.48 -33.05 60.78 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.964 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.99 -46.08 75.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.067 1.303 . . . . 0.0 111.766 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.3 m -76.82 -38.4 53.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.055 0.942 . . . . 0.0 112.45 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.07 -45.16 93.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.249 -0.907 . . . . 0.0 112.412 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -58.36 -39.86 80.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.78 1.632 . . . . 0.0 110.565 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -61.68 -54.55 41.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.195 0.998 . . . . 0.0 112.154 171.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 m -67.67 -25.27 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.809 1.641 . . . . 0.0 113.742 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 m -72.4 -42.17 65.47 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 117.687 -1.149 . . . . 0.0 110.959 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.22 -18.11 59.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.261 1.391 . . . . 0.0 113.647 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 mt -64.41 -47.6 78.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.237 0.926 . . . . 0.0 110.12 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.3 mtm-85 -72.48 -92.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 70.36 -2.91 2.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 129.2 3.0 . . . . 0.0 113.028 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.3 -99.37 0.54 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 126.782 2.134 . . . . 0.0 114.226 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -82.65 9.46 9.5 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.174 1.39 . . . . 0.0 113.636 -171.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 127.088 2.155 . . . . 0.0 112.003 -179.18 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.51 144.87 10.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.336 2.691 . . . . 0.0 109.701 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.39 159.5 23.66 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.841 1.257 . . . . 0.0 112.312 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.43 137.27 80.72 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.411 2.74 . . . . 0.0 114.924 -168.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.24 63.94 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 126.323 1.916 . . . . 0.0 115.182 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -96.63 154.76 17.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -169.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -94.23 112.67 24.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.73 1.612 . . . . 0.0 111.51 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.9 mt -101.29 127.22 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.034 1.334 . . . . 0.0 109.858 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.51 115.58 28.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.22 117.53 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.75 1.62 . . . . 0.0 108.068 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.63 -32.22 71.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.337 0.655 . . . . 0.0 112.681 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.03 -71.3 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 129.369 3.068 . . . . 0.0 115.251 174.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.74 26.23 0.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.34 1.456 . . . . 0.0 113.715 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.21 -59.5 0.38 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.657 1.599 . . . . 0.0 109.895 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.05 122.01 21.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.974 0.509 . . . . 0.0 109.919 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -94.21 150.37 20.37 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.793 0.837 . . . . 0.0 111.972 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -121.36 148.56 44.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.714 1.206 . . . . 0.0 111.794 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -89.8 149.53 22.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.213 0.605 . . . . 0.0 110.582 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.02 146.91 33.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.031 0.932 . . . . 0.0 112.927 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.54 117.86 35.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.175 1.79 . . . . 0.0 108.143 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -73.54 109.89 7.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.475 0.71 . . . . 0.0 110.286 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -100.75 -17.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.59 175.76 31.06 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 126.061 1.791 . . . . 0.0 109.595 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -69.68 86.31 0.48 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.013 0.906 . . . . 0.0 111.315 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.05 -13.49 37.49 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.188 2.327 . . . . 0.0 114.327 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.59 139.24 33.79 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.875 1.27 . . . . 0.0 112.735 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -135.35 151.91 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.88 1.272 . . . . 0.0 113.189 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.5 128.63 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -144.02 160.28 41.14 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.142 -0.974 . . . . 0.0 111.779 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.44 122.5 45.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.881 0.872 . . . . 0.0 111.141 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.63 117.47 68.18 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.528 1.531 . . . . 0.0 107.27 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.69 162.52 39.46 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.543 2.829 . . . . 0.0 114.409 -168.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo . . . . . 0 CA--C 1.541 0.829 0 C-N-CA 123.69 2.927 . . . . 0.0 109.716 170.084 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.36 156.11 35.81 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.298 1.039 . . . . 0.0 110.404 169.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -141.58 134.75 29.28 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.806 0.843 . . . . 0.0 111.379 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.82 126.84 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.09 0.956 . . . . 0.0 109.244 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -129.26 152.64 48.6 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.614 1.566 . . . . 0.0 112.151 -170.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -105.07 139.08 40.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.551 1.54 . . . . 0.0 110.37 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -167.01 172.96 9.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.622 1.169 . . . . 0.0 110.482 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.59 143.08 27.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 111.083 170.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 tp -55.05 -49.95 70.32 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.582 -0.699 . . . . 0.0 111.561 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -30.95 62.6 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -79.36 -40.34 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.819 0.736 . . . . 0.0 111.285 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.77 -37.92 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 122.099 -0.376 . . . . 0.0 111.187 171.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.47 -37.32 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.047 1.339 . . . . 0.0 112.767 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.78 20.75 74.55 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.86 0.743 . . . . 0.0 114.333 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.32 2.64 89.09 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.211 1.386 . . . . 0.0 114.785 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.27 -167.84 1.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.149 1.38 . . . . 0.0 113.004 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 79.7 m -84.35 150.99 25.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.16 1.384 . . . . 0.0 113.139 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -163.54 160.96 23.71 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.208 1.403 . . . . 0.0 113.222 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.1 153.5 11.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.061 1.744 . . . . 0.0 111.834 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.76 140.92 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.676 1.126 . . . . 0.0 110.617 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -146.93 87.32 1.68 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.318 1.447 . . . . 0.0 111.019 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.28 69.19 4.45 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.667 1.187 . . . . 0.0 108.792 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.8 p -60.26 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.621 1.968 . . . . 0.0 114.288 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 mt -60.43 -22.97 64.02 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.297 -0.877 . . . . 0.0 113.075 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.89 -37.09 60.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.98 1.712 . . . . 0.0 111.525 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -63.48 -20.54 65.68 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.842 1.257 . . . . 0.0 112.702 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -88.0 -25.35 23.18 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.084 1.354 . . . . 0.0 112.907 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.81 -29.71 1.68 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -169.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -120.34 122.91 28.49 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -132.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -70.77 -21.26 29.04 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.454 3.436 . . . . 0.0 115.744 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 69.16 83.13 0.17 Allowed Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 127.721 2.408 . . . . 0.0 114.888 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.38 95.97 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.8 3.0 . . . . 0.0 109.158 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.2 -41.38 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.665 0.786 . . . . 0.0 111.963 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.24 -35.86 78.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.587 0.63 . . . . 0.0 112.106 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -42.73 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.595 0.758 . . . . 0.0 110.084 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.6 mt -71.55 -34.23 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.812 -0.555 . . . . 0.0 112.101 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.87 -38.83 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.26 -0.9 . . . . 0.0 110.365 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -64.4 -42.32 96.17 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.571 -0.706 . . . . 0.0 111.303 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -56.97 -44.33 82.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.263 1.025 . . . . 0.0 111.832 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.93 87.81 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.337 -0.852 . . . . 0.0 112.184 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -67.53 -14.96 63.39 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.85 -36.71 15.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 111.864 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.3 mtp -70.75 -23.56 62.45 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.911 1.284 . . . . 0.0 113.767 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -46.66 123.61 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.489 1.04 . . . . 0.0 112.309 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.78 83.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.359 1.457 . . . . 0.0 115.193 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 160.57 30.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.747 1.773 . . . . 0.0 111.327 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -131.32 157.22 43.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.162 1.385 . . . . 0.0 112.973 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.6 mtm -143.76 159.28 42.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.531 1.532 . . . . 0.0 111.298 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -143.65 -1.53 1.0 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -86.43 152.49 22.64 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.642 1.177 . . . . 0.0 113.459 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 m 75.61 168.71 0.27 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.531 2.332 . . . . 0.0 114.107 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.68 147.49 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 109.062 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -49.98 -36.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 p -64.1 -49.39 72.42 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.391 -0.818 . . . . 0.0 111.366 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.36 -30.05 65.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.575 -0.703 . . . . 0.0 112.1 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.81 -41.05 85.86 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.092 1.314 . . . . 0.0 111.5 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.63 -43.36 76.48 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.272 1.029 . . . . 0.0 112.561 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.25 -44.13 92.75 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.269 -0.894 . . . . 0.0 112.319 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -37.78 81.35 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.53 -1.356 . . . . 0.0 111.355 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -58.29 -56.81 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.68 0.792 . . . . 0.0 111.256 171.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.4 m -68.48 -23.57 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.618 1.099 . . . . 0.0 113.806 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 m -70.7 -41.66 71.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.621 1.101 . . . . 0.0 110.337 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.61 -27.94 69.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.57 1.077 . . . . 0.0 112.853 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.56 -57.23 5.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.822 0.737 . . . . 0.0 111.559 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -80.29 9.57 5.59 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -57.7 -25.25 60.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.381 1.873 . . . . 0.0 112.617 -172.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -46.12 -43.9 13.84 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 127.811 2.624 . . . . 0.0 115.178 -173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -137.54 22.15 2.93 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.715 1.206 . . . . 0.0 113.57 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.115 1.366 . . . . 0.0 111.381 -177.779 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.92 145.98 28.98 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.703 2.269 . . . . 0.0 110.261 172.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.04 149.72 38.44 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.141 0.976 . . . . 0.0 110.938 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.98 130.62 26.35 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.627 2.218 . . . . 0.0 111.3 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.59 61.37 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.361 1.934 . . . . 0.0 114.921 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -91.1 161.96 14.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.539 1.669 . . . . 0.0 114.355 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.67 110.2 22.81 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.722 1.609 . . . . 0.0 112.228 -169.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -90.49 123.03 42.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.385 1.074 . . . . 0.0 109.154 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -94.29 117.43 30.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.71 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.587 1.155 . . . . 0.0 108.762 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.27 -30.34 71.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.408 1.083 . . . . 0.0 112.907 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.259 26.1 tpt180 54.36 -111.87 0.66 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.825 2.05 . . . . 0.0 111.358 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.0 mt -133.74 42.78 2.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.119 0.968 . . . . 0.0 111.263 -161.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.94 6.52 37.15 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.872 1.225 . . . . 0.0 114.98 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -156.41 119.31 4.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.969 1.308 . . . . 0.0 111.045 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.5 142.91 48.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.792 1.237 . . . . 0.0 112.261 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.51 165.54 36.12 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.028 0.931 . . . . 0.0 112.881 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -92.45 152.53 19.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.2 150.1 43.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.979 1.711 . . . . 0.0 111.151 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.99 118.56 36.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.53 1.932 . . . . 0.0 107.586 174.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -73.7 102.91 4.09 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.658 0.663 . . . . 0.0 110.338 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.21 -17.43 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.8 -174.27 43.11 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -64.3 95.58 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.778 0.799 . . . . 0.0 111.603 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.43 6.07 64.69 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.639 2.066 . . . . 0.0 116.207 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -120.19 141.7 49.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.9 1.85 . . . . 0.0 113.3 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.87 151.36 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.901 1.281 . . . . 0.0 112.604 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 mm -111.42 134.09 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.57 152.85 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.573 1.078 . . . . 0.0 112.129 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.44 113.28 24.61 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.95 116.09 50.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.175 -0.917 . . . . 0.0 108.694 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.72 158.86 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.183 2.589 . . . . 0.0 111.931 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.546 1.094 0 C-N-CA 124.402 3.401 . . . . 0.0 111.107 171.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.53 144.78 37.37 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.097 -1.002 . . . . 0.0 110.751 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.43 133.71 38.88 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.964 0.906 . . . . 0.0 110.887 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.13 125.23 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.856 0.862 . . . . 0.0 109.803 172.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -135.31 157.14 47.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.371 1.468 . . . . 0.0 112.316 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -109.71 133.43 53.14 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.795 1.638 . . . . 0.0 110.885 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -151.99 171.85 17.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.423 1.489 . . . . 0.0 111.526 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -85.89 148.77 25.64 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.269 0.628 . . . . 0.0 111.652 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.8 tp -52.45 -62.15 1.82 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.875 1.27 . . . . 0.0 111.582 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -66.12 -20.1 66.05 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.71 -36.82 70.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.515 1.052 . . . . 0.0 111.26 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.76 -44.53 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.131 0.972 . . . . 0.0 112.125 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.67 -1.66 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.69 109.89 3.13 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.466 1.03 . . . . 0.0 112.681 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 6.78 89.22 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.998 1.285 . . . . 0.0 114.337 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -112.72 152.76 28.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 112.485 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.9 m -83.47 149.92 26.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.819 0.848 . . . . 0.0 110.227 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -160.47 159.9 31.41 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -146.05 163.08 36.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.298 2.239 . . . . 0.0 109.852 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.15 143.1 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.509 170.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.38 144.36 46.55 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.622 1.169 . . . . 0.0 113.146 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -137.52 22.62 2.93 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.757 1.623 . . . . 0.0 112.362 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.3 t -62.44 -47.78 82.56 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.219 -1.551 . . . . 0.0 113.819 -169.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -73.46 -33.93 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.596 0.358 . . . . 0.0 111.868 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.86 -36.95 77.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.806 0.842 . . . . 0.0 112.134 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -65.08 -17.97 64.91 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.381 1.072 . . . . 0.0 112.854 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -80.01 -22.64 42.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.364 -0.835 . . . . 0.0 112.53 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -117.4 -57.22 2.16 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.51 149.62 63.36 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -140.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.86 -14.98 21.36 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 124.771 3.647 . . . . 0.0 113.632 172.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 77.56 90.76 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 127.158 2.183 . . . . 0.0 112.788 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.37 81.31 2.51 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.576 2.85 . . . . 0.0 108.889 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.76 -36.27 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.162 0.985 . . . . 0.0 112.538 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.35 -36.37 76.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.72 0.691 . . . . 0.0 112.392 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.29 -40.09 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.414 0.686 . . . . 0.0 109.874 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.08 -38.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.804 . . . . 0.0 111.654 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.23 -38.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.206 -0.934 . . . . 0.0 111.049 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -64.27 -44.84 90.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.6 -0.687 . . . . 0.0 111.271 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -57.62 -44.56 85.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.339 1.055 . . . . 0.0 112.483 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.47 95.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.006 0.821 . . . . 0.0 112.49 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.54 -44.72 89.93 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.119 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.888 -1.133 . . . . 0.0 113.426 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.96 -9.49 58.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.3 t -55.47 127.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.933 1.242 . . . . 0.0 110.591 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.33 -0.59 78.28 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.177 1.37 . . . . 0.0 114.5 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -71.01 132.87 45.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.061 1.43 . . . . 0.0 110.429 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.81 138.54 48.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.753 1.621 . . . . 0.0 111.118 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.7 mtm -143.59 153.07 42.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.919 1.288 . . . . 0.0 112.127 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -149.86 -7.91 0.31 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -63.9 153.7 36.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 114.12 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t 62.91 -164.55 0.25 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 114.449 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -80.33 145.23 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.203 1.401 . . . . 0.0 108.443 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.36 -31.47 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 119.149 0.886 . . . . 0.0 112.629 -171.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 p -60.17 -53.54 56.56 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.343 1.057 . . . . 0.0 111.659 172.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.665 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -56.26 -42.42 77.39 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.23 1.377 . . . . 0.0 111.079 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.22 -44.21 54.06 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.21 1.404 . . . . 0.0 112.981 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.26 -43.65 98.34 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.799 -1.188 . . . . 0.0 112.374 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.522 ' CD2' HE22 ' A' ' 119' ' ' GLN . 8.3 t-160 -63.73 -42.88 97.81 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.692 -1.255 . . . . 0.0 110.014 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.46 -53.66 48.26 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.419 1.487 . . . . 0.0 112.589 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 m -66.08 -25.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.404 1.456 . . . . 0.0 112.917 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -65.91 -46.13 79.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 117.315 -1.326 . . . . 0.0 109.793 170.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.522 HE22 ' CD2' ' A' ' 115' ' ' HIS . 1.8 mp0 -55.85 -32.31 63.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.766 1.167 . . . . 0.0 113.459 171.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.39 -58.21 3.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.352 0.978 . . . . 0.0 111.346 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -75.27 3.99 7.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.71 -24.11 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.854 2.062 . . . . 0.0 113.338 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.24 -32.4 1.68 Allowed Glycine 0 N--CA 1.474 1.23 0 C-N-CA 128.473 2.94 . . . . 0.0 117.816 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -140.07 16.75 2.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 118.692 1.246 . . . . 0.0 112.866 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.105 1.762 . . . . 0.0 112.674 -177.155 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.17 147.97 93.6 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.666 2.244 . . . . 0.0 111.185 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -103.29 156.09 35.88 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.479 1.112 . . . . 0.0 111.57 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.59 129.89 22.25 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.529 2.152 . . . . 0.0 111.945 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.68 -2.62 82.32 Favored Glycine 0 N--CA 1.467 0.739 0 C-N-CA 125.272 1.415 . . . . 0.0 114.769 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -83.96 146.96 27.73 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.853 1.326 . . . . 0.0 110.913 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.0 139.47 40.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.546 1.165 . . . . 0.0 111.55 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.34 131.81 65.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.975 2.11 . . . . 0.0 108.198 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -92.36 115.39 28.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.87 129.03 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.531 1.932 . . . . 0.0 108.322 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.47 -33.21 71.01 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.833 0.742 . . . . 0.0 112.48 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 57.35 -119.46 1.22 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.752 2.021 . . . . 0.0 111.259 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -132.27 58.39 1.75 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.044 0.926 . . . . 0.0 110.352 -160.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.76 -1.89 75.77 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.271 1.415 . . . . 0.0 114.626 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -156.41 127.29 6.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.082 1.353 . . . . 0.0 111.552 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.25 155.25 36.94 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.83 1.252 . . . . 0.0 113.87 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -153.65 172.27 17.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.473 1.109 . . . . 0.0 112.232 170.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -93.85 161.1 14.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.72 162.83 39.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.015 2.126 . . . . 0.0 110.926 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.07 125.11 38.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.109 1.764 . . . . 0.0 108.536 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.94 93.33 5.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.236 1.014 . . . . 0.0 111.423 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 pt -81.75 -20.93 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 176.43 32.27 Favored Glycine 0 N--CA 1.465 0.579 0 C-N-CA 125.05 1.309 . . . . 0.0 110.798 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.84 88.38 0.38 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.615 0.721 . . . . 0.0 111.095 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.11 58.62 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 127.011 2.243 . . . . 0.0 114.774 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -104.74 140.47 38.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.825 1.312 . . . . 0.0 112.523 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.8 155.42 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.39 1.076 . . . . 0.0 112.954 -170.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -112.4 139.81 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -148.15 155.02 40.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.584 1.084 . . . . 0.0 111.574 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.7 115.38 27.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.3 122.87 87.57 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.53 158.06 59.27 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.776 2.984 . . . . 0.0 114.561 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 CA--C 1.541 0.826 0 C-N-CA 124.344 3.363 . . . . 0.0 111.54 173.253 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 158.65 16.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.3 1.84 . . . . 0.0 109.596 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -143.06 134.56 26.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 0.0 111.618 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.97 126.77 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.397 0.679 . . . . 0.0 109.182 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -131.98 149.75 52.34 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.619 1.568 . . . . 0.0 112.446 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -103.72 133.76 48.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.445 1.498 . . . . 0.0 110.485 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -154.74 177.69 10.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.743 1.617 . . . . 0.0 111.073 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -90.48 154.17 19.84 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 168.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 tp -53.15 -47.34 68.82 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.48 -31.17 67.6 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.04 -35.8 59.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.451 1.023 . . . . 0.0 111.104 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.09 -38.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.525 1.13 . . . . 0.0 111.9 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -80.38 -39.34 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.387 0.675 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.61 15.92 64.79 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.048 0.84 . . . . 0.0 115.016 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.53 85.72 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.389 1.471 . . . . 0.0 114.684 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.8 m -81.54 -176.41 6.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.082 1.353 . . . . 0.0 112.745 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 83.6 m -73.21 157.42 37.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.199 1.0 . . . . 0.0 112.875 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -167.14 168.06 13.88 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.525 1.93 . . . . 0.0 110.853 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.09 151.54 12.17 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 0.0 112.756 169.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.5 t -70.91 133.88 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -153.9 73.86 0.96 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.937 0.895 . . . . 0.0 110.907 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.25 58.74 0.73 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.627 1.571 . . . . 0.0 111.483 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 p -43.41 -69.35 0.14 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.516 2.327 . . . . 0.0 114.724 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -67.37 -29.2 68.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.589 0.756 . . . . 0.0 112.74 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.4 -35.59 80.71 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.185 -0.947 . . . . 0.0 111.21 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -73.98 -12.58 60.68 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.218 1.007 . . . . 0.0 112.83 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -86.18 -38.35 17.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.156 0.889 . . . . 0.0 112.078 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -71.67 0.73 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -143.7 157.37 58.67 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -145.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.6 144.24 11.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.891 3.061 . . . . 0.0 108.073 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -124.3 153.5 68.77 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -169.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.03 84.21 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.141 3.228 . . . . 0.0 109.96 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.11 -30.97 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.695 1.198 . . . . 0.0 114.019 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.41 -36.69 83.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.226 0.921 . . . . 0.0 112.643 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.74 -33.86 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.067 0.947 . . . . 0.0 110.519 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -63.98 -46.56 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.64 -0.663 . . . . 0.0 110.215 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.15 -39.38 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.814 0.846 . . . . 0.0 110.873 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.3 m -64.77 -40.93 96.08 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.615 -0.678 . . . . 0.0 111.813 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 t -58.3 -46.82 85.41 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.539 -0.725 . . . . 0.0 111.028 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.14 89.24 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.43 -0.794 . . . . 0.0 112.249 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.13 -28.12 69.85 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.49 -34.11 41.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 172.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.4 mtp -78.99 -20.28 49.49 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.96 124.57 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.603 1.547 . . . . 0.0 110.933 170.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.76 -6.92 59.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.611 1.576 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -75.43 143.66 42.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 1.515 . . . . 0.0 110.507 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.82 155.08 36.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.883 1.673 . . . . 0.0 111.833 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.1 mtm -141.62 164.14 31.01 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.113 1.365 . . . . 0.0 111.587 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -139.4 -36.13 0.53 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -76.4 154.03 35.22 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -170.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 77.57 177.68 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.259 2.224 . . . . 0.0 113.788 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -80.53 149.27 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.747 1.219 . . . . 0.0 111.276 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -52.65 -37.38 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 p -63.21 -55.34 25.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.451 0.7 . . . . 0.0 111.164 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.6 -36.37 83.54 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.58 -0.7 . . . . 0.0 111.935 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.44 -41.22 80.03 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.517 1.053 . . . . 0.0 111.686 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.6 t -77.26 -42.19 38.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.264 1.026 . . . . 0.0 112.513 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.77 -44.14 97.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.325 1.05 . . . . 0.0 112.13 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.506 ' CD2' HE22 ' A' ' 119' ' ' GLN . 59.8 t60 -60.42 -46.11 91.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.788 1.235 . . . . 0.0 110.125 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -52.76 -54.84 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.209 . . . . 0.0 112.213 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.95 -29.72 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.343 1.429 . . . . 0.0 112.8 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.3 m -65.41 -38.37 89.74 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.967 1.258 . . . . 0.0 110.504 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.506 HE22 ' CD2' ' A' ' 115' ' ' HIS . 0.8 OUTLIER -61.33 -26.89 68.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 120.415 1.461 . . . . 0.0 113.217 169.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.9 mt -74.6 -57.6 3.82 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.275 -0.891 . . . . 0.0 111.516 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -77.08 12.11 1.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -58.04 -24.41 58.28 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.314 1.846 . . . . 0.0 112.519 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.69 -22.29 39.43 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.026 2.251 . . . . 0.0 115.31 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -146.82 -11.03 0.45 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.601 1.161 . . . . 0.0 112.82 179.716 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 118.219 -0.896 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.88 144.89 12.4 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.332 2.688 . . . . 0.0 111.05 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.65 150.05 4.59 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.582 1.953 . . . . 0.0 111.053 -176.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.28 137.34 39.88 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.915 3.076 . . . . 0.0 113.553 -169.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.08 -11.41 65.15 Favored Glycine 0 N--CA 1.469 0.879 0 C-N-CA 126.028 1.775 . . . . 0.0 114.633 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.59 160.16 15.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 118.403 1.101 . . . . 0.0 113.003 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.22 113.87 27.32 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.916 1.686 . . . . 0.0 111.785 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.91 127.55 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 124.8 1.24 . . . . 0.0 109.482 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -96.01 121.12 37.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.407 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.93 130.65 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.973 1.309 . . . . 0.0 109.157 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -77.16 64.79 2.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.563 1.145 . . . . 0.0 110.442 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -54.14 -44.89 71.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.611 1.564 . . . . 0.0 114.803 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -153.29 26.93 0.52 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -160.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.9 -2.49 66.5 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.99 0.805 . . . . 0.0 113.064 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -140.78 159.86 41.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.148 2.179 . . . . 0.0 110.44 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -91.86 120.33 32.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.679 1.192 . . . . 0.0 111.464 -172.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -112.75 151.84 29.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.531 1.532 . . . . 0.0 111.09 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -86.97 153.69 21.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.42 36.22 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.354 1.462 . . . . 0.0 111.383 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.42 123.85 50.64 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.168 1.787 . . . . 0.0 108.175 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -74.32 103.11 4.59 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.5 0.591 . . . . 0.0 111.221 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -94.88 -21.69 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.78 171.94 33.77 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.31 96.08 0.22 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.164 0.982 . . . . 0.0 111.689 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.93 3.76 82.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.91 1.719 . . . . 0.0 115.244 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -110.73 139.01 46.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.502 1.651 . . . . 0.0 112.367 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.97 152.47 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 113.713 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.5 mm -107.95 134.64 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 107.109 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -151.52 159.49 44.12 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.496 1.044 . . . . 0.0 111.894 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.43 122.83 43.81 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.393 0.677 . . . . 0.0 111.304 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.49 146.39 50.21 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.861 1.664 . . . . 0.0 110.414 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.53 158.07 51.63 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.592 2.861 . . . . 0.0 113.956 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 CA--C 1.542 0.91 0 C-N-CA 123.665 2.91 . . . . 0.0 112.29 169.617 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.783 0.325 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.11 153.71 43.0 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.527 0.731 . . . . 0.0 109.637 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -138.12 131.25 30.2 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 111.106 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.05 126.16 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.989 0.915 . . . . 0.0 109.245 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -131.48 157.23 44.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.545 1.538 . . . . 0.0 112.489 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -110.48 138.81 46.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.841 1.657 . . . . 0.0 110.077 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -166.11 170.38 13.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.227 1.011 . . . . 0.0 110.703 -171.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -85.39 145.44 27.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.319 -0.863 . . . . 0.0 111.55 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.6 tp -53.1 -50.66 63.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.068 0.947 . . . . 0.0 111.529 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -58.11 -28.88 65.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -85.64 -32.11 22.19 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.53 -40.64 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.471 0.578 . . . . 0.0 111.256 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.81 -44.33 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.83 0.852 . . . . 0.0 112.118 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.74 -124.82 35.33 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -175.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.75 0.62 63.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.959 1.266 . . . . 0.0 114.973 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.58 168.3 19.06 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.64 1.22 . . . . 0.0 113.924 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -77.13 155.27 32.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.86 1.264 . . . . 0.0 112.545 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.92 165.85 31.32 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.806 1.243 . . . . 0.0 113.355 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.12 163.88 33.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.345 1.858 . . . . 0.0 111.321 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.17 136.3 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.562 1.074 . . . . 0.0 109.81 171.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -150.29 124.96 9.72 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.876 1.27 . . . . 0.0 112.451 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.26 41.43 3.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.687 1.595 . . . . 0.0 111.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.0 p -57.05 -31.21 64.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -74.54 -44.71 49.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.54 0.736 . . . . 0.0 111.434 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -63.37 -36.92 85.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.038 0.935 . . . . 0.0 110.792 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -58.14 -17.06 15.83 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.302 1.441 . . . . 0.0 113.562 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -74.42 -19.29 60.46 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.029 -1.044 . . . . 0.0 113.404 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.95 -29.74 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 -173.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.43 152.24 63.22 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -150.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.24 -49.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.512 2.808 . . . . 0.0 112.443 170.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.25 96.45 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 127.421 2.288 . . . . 0.0 111.072 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.27 124.21 11.83 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.446 3.431 . . . . 0.0 114.892 -168.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 t -49.67 -47.66 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.981 2.113 . . . . 0.0 113.801 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.36 -34.65 78.64 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.93 -36.4 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.356 0.663 . . . . 0.0 110.227 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mm -77.0 -38.57 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.758 -0.589 . . . . 0.0 110.335 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.96 -41.07 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.935 0.494 . . . . 0.0 110.914 171.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -64.83 -40.93 95.98 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.527 -0.733 . . . . 0.0 110.96 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.3 m -64.87 -39.85 94.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.363 1.065 . . . . 0.0 112.28 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.62 98.17 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.12 -0.987 . . . . 0.0 111.751 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -68.7 -13.74 62.57 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.46 -37.41 15.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.534 1.061 . . . . 0.0 111.15 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.1 mmm -69.41 -25.57 64.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.637 1.575 . . . . 0.0 113.623 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -47.0 124.36 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.83 1.195 . . . . 0.0 111.986 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.88 1.49 79.85 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.503 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.47 147.77 44.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.811 1.806 . . . . 0.0 111.405 172.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -124.15 139.97 53.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 111.362 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.0 mtm -142.52 148.33 37.45 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.196 0.998 . . . . 0.0 112.908 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -147.55 22.83 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.358 1.063 . . . . 0.0 112.345 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -80.78 -19.04 45.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 t -162.34 175.7 11.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.21 1.004 . . . . 0.0 112.956 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.17 147.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.301 1.84 . . . . 0.0 109.787 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.51 -32.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.6 p -58.72 -65.71 0.61 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.76 1.224 . . . . 0.0 111.531 173.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -65.01 -30.82 71.82 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.816 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.83 -40.41 76.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.172 1.351 . . . . 0.0 111.127 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -44.07 59.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.644 1.178 . . . . 0.0 112.962 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.14 -45.38 94.9 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.367 -0.833 . . . . 0.0 111.605 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -60.32 -36.62 78.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.03 -60.59 3.54 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.291 1.437 . . . . 0.0 111.443 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.4 m -65.88 -30.03 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 120.476 1.489 . . . . 0.0 113.157 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 m -59.36 -56.2 25.01 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 116.514 -1.707 . . . . 0.0 107.783 170.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -55.35 -31.65 61.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.736 1.607 . . . . 0.0 114.67 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.15 -33.95 75.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.397 0.999 . . . . 0.0 112.385 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -118.2 16.06 14.03 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -72.65 -19.07 61.51 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.639 1.576 . . . . 0.0 112.826 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.43 -33.82 73.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.855 0.741 . . . . 0.0 113.577 -172.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -114.55 -16.05 11.93 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.955 1.302 . . . . 0.0 112.924 179.618 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.94 145.29 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.452 2.768 . . . . 0.0 110.687 171.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.04 160.26 26.74 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.303 1.841 . . . . 0.0 110.273 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.43 130.13 32.52 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.863 1.709 . . . . 0.0 110.697 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.23 -6.07 78.34 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.091 1.329 . . . . 0.0 115.437 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -65.47 140.06 58.56 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.8 1.3 . . . . 0.0 112.43 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.5 tp -87.11 89.89 8.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.72 1.608 . . . . 0.0 108.278 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.46 132.66 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.231 1.012 . . . . 0.0 108.879 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -102.27 107.47 18.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.819 1.647 . . . . 0.0 108.179 171.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.0 mm -86.73 123.45 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.702 2.001 . . . . 0.0 107.97 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.94 -32.89 74.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.302 2.0 mmt180 43.62 -142.49 0.15 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.713 2.005 . . . . 0.0 112.975 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.55 109.37 11.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.284 -167.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.17 -9.59 6.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.762 1.172 . . . . 0.0 115.179 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -166.05 124.46 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.798 1.639 . . . . 0.0 111.989 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.64 144.88 31.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.503 1.521 . . . . 0.0 111.675 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -144.09 165.37 27.99 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.231 -0.918 . . . . 0.0 113.456 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -88.13 157.13 18.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.71 137.69 20.36 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.927 1.691 . . . . 0.0 110.41 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.46 119.46 38.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.044 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -72.01 89.49 1.12 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.803 1.241 . . . . 0.0 111.747 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 pt -77.24 -20.32 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.21 -178.31 32.12 Favored Glycine 0 N--CA 1.462 0.433 0 C-N-CA 124.916 1.246 . . . . 0.0 110.878 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.87 86.19 0.51 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.639 0.733 . . . . 0.0 111.099 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.3 -6.84 46.63 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.884 2.183 . . . . 0.0 114.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -106.65 141.95 37.08 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.95 1.375 . . . . 0.0 112.813 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -137.95 153.28 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 mt -115.88 138.38 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.641 1.576 . . . . 0.0 107.002 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -157.61 138.24 13.02 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.154 -0.966 . . . . 0.0 113.275 -168.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.58 113.6 12.03 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.719 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.95 141.52 78.49 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.399 0.679 . . . . 0.0 109.855 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.34 157.13 62.35 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.632 2.888 . . . . 0.0 113.14 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 C--N 1.353 0.769 0 C-N-CA 124.16 3.24 . . . . 0.0 114.042 -177.654 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 p . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.82 135.85 34.36 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.691 -0.631 . . . . 0.0 109.657 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.94 138.77 37.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.172 0.896 . . . . 0.0 110.318 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -80.57 118.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.168 0.587 . . . . 0.0 110.116 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -108.07 174.96 5.65 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -146.09 152.45 39.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.462 1.505 . . . . 0.0 112.298 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 175.35 -164.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.843 2.857 . . . . 0.0 109.597 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -77.0 151.08 35.78 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.21 -0.931 . . . . 0.0 112.889 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.95 -46.66 75.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.179 0.991 . . . . 0.0 111.177 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -58.82 -29.71 67.09 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -80.5 -39.29 28.23 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.445 -0.785 . . . . 0.0 111.459 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.02 -46.69 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 174.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.99 -41.97 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.827 0.851 . . . . 0.0 112.262 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.46 -116.31 9.16 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 119.342 0.974 . . . . 0.0 110.72 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.94 -2.92 64.27 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.476 1.036 . . . . 0.0 114.835 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 55.8 m -79.95 157.9 26.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.781 1.29 . . . . 0.0 113.326 -172.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 74.6 m -74.59 167.08 22.46 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.343 1.057 . . . . 0.0 111.878 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -155.16 163.21 40.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.492 1.117 . . . . 0.0 111.745 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -140.16 169.65 17.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.398 1.879 . . . . 0.0 109.961 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.35 127.55 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -103.64 -54.77 2.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 47.3 47.8 16.57 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.325 1.45 . . . . 0.0 111.797 -171.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.3 p -54.2 -60.26 3.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.674 1.589 . . . . 0.0 113.749 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.41 -29.43 70.13 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -65.15 -51.48 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.696 0.398 . . . . 0.0 110.373 169.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -60.72 -27.0 67.58 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 121.179 -0.951 . . . . 0.0 113.026 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -68.17 -33.54 74.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -158.91 -15.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -146.88 130.4 8.25 Favored Pre-proline 0 CA--C 1.55 0.967 0 O-C-N 120.728 -1.233 . . . . 0.0 113.752 -133.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.86 -46.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.749 2.3 . . . . 0.0 112.173 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 128.99 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 129.495 3.118 . . . . 0.0 114.557 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.52 97.8 0.46 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.322 2.682 . . . . 0.0 110.227 169.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -15.87 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -169.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -63.91 -34.78 78.72 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.769 0.713 . . . . 0.0 110.824 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -74.88 -32.74 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.374 0.67 . . . . 0.0 110.382 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.93 -44.56 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.522 0.729 . . . . 0.0 111.631 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.54 -36.25 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.623 0.769 . . . . 0.0 110.607 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -65.1 -45.08 86.66 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.619 0.768 . . . . 0.0 111.637 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.8 m -58.94 -40.77 85.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.584 1.153 . . . . 0.0 112.168 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.14 94.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.501 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -63.42 -21.27 66.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.36 -34.7 21.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 112.554 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 mtp -77.52 -27.81 51.82 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -56.29 123.0 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 120.076 1.307 . . . . 0.0 110.617 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.58 -9.49 62.47 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.793 1.663 . . . . 0.0 115.038 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -78.68 156.23 29.08 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.479 1.64 . . . . 0.0 110.464 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -147.35 154.59 41.09 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.104 1.362 . . . . 0.0 114.34 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.1 mtm -147.15 163.99 34.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.314 1.846 . . . . 0.0 112.022 -170.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -157.19 -45.31 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -77.94 71.13 4.4 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.04 1.336 . . . . 0.0 113.709 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 m -175.88 170.43 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.411 2.684 . . . . 0.0 110.228 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.96 146.41 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.308 -0.87 . . . . 0.0 109.252 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.46 -40.1 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 120.666 -1.271 . . . . 0.0 113.218 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.7 m -60.63 -43.44 97.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.208 0.603 . . . . 0.0 110.846 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -70.71 -29.75 66.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.774 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -58.15 -46.83 84.98 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.644 1.565 . . . . 0.0 110.911 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.0 m -66.5 -48.65 69.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.651 1.181 . . . . 0.0 112.197 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -58.52 -48.32 81.22 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.562 0.745 . . . . 0.0 111.409 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.25 -33.8 76.85 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.938 -1.101 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -58.88 -58.0 10.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.946 0.794 . . . . 0.0 110.787 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.82 -21.58 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 119.551 1.069 . . . . 0.0 113.598 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -71.93 -40.82 68.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.355 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.22 -26.21 68.24 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 120.038 1.29 . . . . 0.0 112.654 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.02 -46.48 67.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.983 0.811 . . . . 0.0 112.405 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -94.37 9.7 37.22 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.454 1.901 . . . . 0.0 114.285 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -58.65 -21.66 54.6 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.049 2.139 . . . . 0.0 113.789 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.88 68.28 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.479 1.037 . . . . 0.0 114.314 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -140.59 -22.4 0.81 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 169.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 124.945 1.298 . . . . 0.0 112.793 175.008 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 118.161 -0.923 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.5 150.12 35.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.751 2.301 . . . . 0.0 111.318 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -100.64 142.1 23.95 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.753 0.821 . . . . 0.0 110.973 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.3 132.51 24.21 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.682 1.588 . . . . 0.0 110.468 -170.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.87 66.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.691 1.615 . . . . 0.0 114.574 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.13 165.99 11.97 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.579 1.69 . . . . 0.0 113.885 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.4 mt -90.64 113.11 25.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.26 1.424 . . . . 0.0 111.655 -169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.22 117.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.966 0.906 . . . . 0.0 108.629 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.58 117.52 28.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -122.71 134.25 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.859 1.264 . . . . 0.0 109.3 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -77.76 66.05 3.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.017 0.927 . . . . 0.0 110.47 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -36.12 82.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.299 1.44 . . . . 0.0 114.41 -169.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.77 26.38 0.74 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -152.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.76 7.81 77.64 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.285 0.945 . . . . 0.0 112.965 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -167.71 160.26 12.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.746 2.819 . . . . 0.0 109.183 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -64.51 138.23 58.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.599 1.56 . . . . 0.0 113.616 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.95 151.46 40.96 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.349 1.86 . . . . 0.0 108.72 169.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -98.84 156.79 16.69 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.2 157.09 44.17 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.897 1.679 . . . . 0.0 111.87 169.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.31 121.77 45.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.79 2.036 . . . . 0.0 108.541 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -75.05 92.43 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.153 0.888 . . . . 0.0 111.774 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -84.44 -21.8 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.68 174.43 30.78 Favored Glycine 0 N--CA 1.463 0.454 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.05 94.73 0.67 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.534 0.683 . . . . 0.0 109.93 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.44 65.59 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.437 1.97 . . . . 0.0 115.273 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -113.75 140.2 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.361 1.58 . . . . 0.0 112.365 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 m -140.77 149.27 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mm -105.97 128.54 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -139.29 163.46 32.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.975 0.807 . . . . 0.0 111.043 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.23 137.51 32.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.67 138.6 21.07 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.457 1.503 . . . . 0.0 108.457 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.57 159.11 39.6 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.506 2.804 . . . . 0.0 113.728 -169.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 C-N-CA 123.676 2.917 . . . . 0.0 109.788 169.7 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.916 0.388 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.56 127.99 34.45 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -113.18 134.88 54.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.451 1.1 . . . . 0.0 111.314 -169.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.1 126.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.732 0.813 . . . . 0.0 110.515 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -139.3 153.88 47.83 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.914 1.286 . . . . 0.0 113.273 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -98.79 137.96 36.63 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.856 1.662 . . . . 0.0 110.689 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -165.7 172.22 12.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.538 1.135 . . . . 0.0 111.671 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -92.89 146.43 23.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.27 1.428 . . . . 0.0 112.103 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -51.47 -56.07 15.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 111.774 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -62.72 -25.16 68.03 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.47 -40.26 43.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.213 0.915 . . . . 0.0 111.12 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.2 t -68.13 -35.33 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.042 0.537 . . . . 0.0 111.959 173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.1 t -78.7 -39.34 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.003 0.921 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 20.11 65.35 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.007 0.822 . . . . 0.0 115.014 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.61 89.72 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.132 1.349 . . . . 0.0 114.859 -173.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.26 175.49 8.9 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.116 1.366 . . . . 0.0 112.555 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.6 m -69.68 150.72 46.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.258 1.023 . . . . 0.0 112.732 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -160.63 163.94 32.2 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.915 1.286 . . . . 0.0 113.506 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.05 163.43 23.26 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.788 2.035 . . . . 0.0 110.927 -175.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -109.0 145.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.596 1.089 . . . . 0.0 112.162 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -133.54 151.89 51.81 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.818 1.647 . . . . 0.0 113.45 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -144.93 31.11 1.15 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.989 1.716 . . . . 0.0 112.286 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -59.94 -35.82 75.74 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.23 -29.22 15.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.918 0.781 . . . . 0.0 112.54 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.62 -30.97 72.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.444 1.097 . . . . 0.0 112.213 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -67.17 -23.04 65.73 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.243 1.417 . . . . 0.0 113.093 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -88.75 -45.66 9.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -95.77 -34.64 11.83 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -168.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -141.13 158.19 65.06 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.49 -19.39 28.53 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.13 3.22 . . . . 0.0 113.207 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 66.93 75.63 0.31 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.355 1.862 . . . . 0.0 112.098 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.81 80.85 2.28 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.458 3.439 . . . . 0.0 110.257 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 t -46.45 -41.11 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.678 1.591 . . . . 0.0 114.344 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.97 -38.02 82.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.207 0.912 . . . . 0.0 111.21 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.14 -38.0 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.313 1.045 . . . . 0.0 109.902 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.53 -47.25 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.471 0.578 . . . . 0.0 110.379 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.71 -38.89 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.34 1.056 . . . . 0.0 111.852 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -65.86 -42.49 90.34 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.415 -0.803 . . . . 0.0 110.61 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.8 p -61.5 -38.57 87.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.438 0.695 . . . . 0.0 112.054 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.76 72.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.427 1.091 . . . . 0.0 111.404 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.46 -36.37 80.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.71 -37.7 79.71 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.6 ptm -81.68 -4.06 55.23 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.2 125.67 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.869 1.268 . . . . 0.0 109.227 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.99 -5.97 58.17 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.924 1.25 . . . . 0.0 114.469 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -66.06 147.82 52.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.262 1.531 . . . . 0.0 110.491 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.76 135.0 45.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.459 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -141.64 140.77 33.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.555 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -149.83 27.05 0.8 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.777 1.231 . . . . 0.0 112.318 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.8 -8.9 59.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.8 t -158.06 178.05 10.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.841 1.256 . . . . 0.0 111.842 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 146.55 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.432 1.493 . . . . 0.0 110.203 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.66 -39.33 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 124.807 1.243 . . . . 0.0 113.926 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.4 p -58.73 -57.54 12.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.831 0.852 . . . . 0.0 111.787 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -64.97 -34.32 78.15 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.519 -0.738 . . . . 0.0 112.152 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -59.54 -35.48 74.29 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.612 1.096 . . . . 0.0 111.418 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -42.6 67.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.036 0.935 . . . . 0.0 112.801 172.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -62.24 -45.99 90.85 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.97 -1.081 . . . . 0.0 112.254 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -52.87 -44.86 67.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.761 2.024 . . . . 0.0 110.615 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -61.33 -54.24 46.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.433 1.493 . . . . 0.0 112.37 173.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.3 m -69.23 -22.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 120.561 1.528 . . . . 0.0 114.215 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -70.42 -40.12 74.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.145 169.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -64.36 -23.91 67.46 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.411 1.005 . . . . 0.0 113.668 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.5 mt -72.86 -60.79 2.06 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.213 0.915 . . . . 0.0 111.337 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -73.95 4.27 5.62 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -56.7 -26.04 55.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.338 2.255 . . . . 0.0 113.219 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.98 -51.83 7.04 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 127.75 2.595 . . . . 0.0 115.645 -169.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -128.04 5.73 5.94 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 C--O 1.25 1.093 0 C-N-CA 124.787 1.235 . . . . 0.0 111.879 170.713 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 CA--C 1.544 0.731 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.11 145.21 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.587 2.192 . . . . 0.0 110.098 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.14 139.47 21.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.707 0.803 . . . . 0.0 110.83 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 127.91 15.91 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.769 2.312 . . . . 0.0 110.305 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.01 2.17 90.66 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.181 1.372 . . . . 0.0 114.246 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 169.33 8.63 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.003 1.321 . . . . 0.0 112.604 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.38 130.14 54.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.531 1.533 . . . . 0.0 113.987 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -111.77 144.15 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.365 2.266 . . . . 0.0 110.61 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -108.94 116.67 32.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.29 128.93 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.446 1.499 . . . . 0.0 109.571 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -80.24 68.61 6.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.761 1.225 . . . . 0.0 110.847 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -34.65 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -169.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -156.9 27.33 0.32 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.17 10.23 58.63 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.108 0.861 . . . . 0.0 113.844 -172.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -163.36 145.01 9.61 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.586 2.354 . . . . 0.0 110.146 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -75.32 120.73 21.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.946 1.298 . . . . 0.0 112.354 -176.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -103.07 140.58 37.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.767 1.227 . . . . 0.0 110.041 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -73.62 146.7 44.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.106 0.563 . . . . 0.0 112.123 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.74 142.14 24.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 121.67 43.72 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.029 1.732 . . . . 0.0 108.945 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -76.67 105.29 7.65 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.797 0.839 . . . . 0.0 111.005 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.3 pt -97.1 -20.83 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.91 174.16 32.46 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 124.987 1.28 . . . . 0.0 110.163 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.04 94.73 0.51 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.789 0.804 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.69 64.43 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.839 2.161 . . . . 0.0 115.446 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -112.54 133.99 54.3 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.598 1.699 . . . . 0.0 112.246 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.45 152.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.884 1.274 . . . . 0.0 112.709 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 mm -109.36 128.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.775 1.63 . . . . 0.0 106.844 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -144.95 159.52 42.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.422 1.01 . . . . 0.0 112.026 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.0 115.78 28.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.596 0.758 . . . . 0.0 110.038 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.76 70.18 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.664 1.586 . . . . 0.0 109.815 169.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.33 155.01 68.6 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.897 3.065 . . . . 0.0 114.772 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 C--N 1.354 0.855 0 C-N-CA 124.649 3.566 . . . . 0.0 114.472 176.512 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.923 0.392 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.27 159.99 33.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.515 0.726 . . . . 0.0 110.214 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -136.48 130.06 32.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.854 0.862 . . . . 0.0 109.951 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.9 t -83.79 123.19 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -145.25 153.26 41.12 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -169.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -94.1 137.77 32.91 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.186 1.794 . . . . 0.0 110.505 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -162.64 163.11 27.25 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.495 0.718 . . . . 0.0 111.893 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -76.05 140.16 41.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.829 173.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -52.56 -54.14 36.93 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.72 1.208 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.88 -23.92 67.57 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.84 -39.11 27.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.299 0.954 . . . . 0.0 111.343 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.52 -39.65 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.75 -0.594 . . . . 0.0 111.405 170.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.04 -45.55 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 112.345 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.03 61.99 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.25 0.932 . . . . 0.0 115.043 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.12 88.21 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.344 1.449 . . . . 0.0 114.891 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -82.5 171.51 14.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.956 1.302 . . . . 0.0 112.017 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.05 147.89 49.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -158.93 163.43 36.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 113.02 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.64 155.78 15.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.238 1.415 . . . . 0.0 112.354 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.73 136.96 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.662 0.664 . . . . 0.0 109.707 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -160.49 136.92 8.72 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.256 1.822 . . . . 0.0 109.516 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -154.37 52.3 0.66 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.888 0.852 . . . . 0.0 113.017 -169.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.9 m -50.67 -35.59 31.64 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.487 HD13 ' HH ' ' A' ' 84' ' ' TYR . 28.4 tp -72.54 -39.81 67.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.787 0.835 . . . . 0.0 111.715 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.37 -40.58 93.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.021 0.928 . . . . 0.0 111.439 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -62.09 -17.9 59.06 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.381 1.072 . . . . 0.0 112.862 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -79.74 -30.8 40.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HH ' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -142.65 -35.17 0.42 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 117.843 2.535 . . . . 0.0 117.843 -172.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.69 151.84 73.93 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -138.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.32 -24.11 2.1 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 124.083 3.189 . . . . 0.0 114.657 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 67.11 110.26 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 127.339 2.256 . . . . 0.0 115.668 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.64 89.92 1.25 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 124.134 3.223 . . . . 0.0 109.768 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 t -50.99 -39.67 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.275 1.43 . . . . 0.0 113.782 -169.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.4 -35.76 78.14 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.283 0.492 . . . . 0.0 111.832 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.93 -32.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.279 1.032 . . . . 0.0 110.396 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 mm -66.43 -47.68 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.93 -0.481 . . . . 0.0 110.57 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.49 -37.57 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.892 0.477 . . . . 0.0 110.763 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.1 m -65.25 -41.93 93.79 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.649 -0.657 . . . . 0.0 111.73 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -61.12 -48.13 83.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.639 -0.663 . . . . 0.0 110.909 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.13 88.15 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.7 0.8 . . . . 0.0 112.257 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -62.58 -46.76 86.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.512 0.725 . . . . 0.0 112.021 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.67 -30.79 70.12 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.259 -0.901 . . . . 0.0 113.27 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.9 mtp -75.73 -9.44 58.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.47 127.02 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.455 1.479 . . . . 0.0 111.343 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.13 -0.41 85.88 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.917 -1.491 . . . . 0.0 114.096 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -77.99 137.74 38.45 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.1 1.95 . . . . 0.0 111.023 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.93 165.22 22.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.382 1.073 . . . . 0.0 110.498 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.4 ttm -159.4 137.09 10.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 110.746 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -156.36 34.0 0.32 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.338 1.066 . . . . 0.0 111.185 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.69 -33.28 71.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.263 1.825 . . . . 0.0 114.131 -170.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.7 t -162.47 -157.05 0.44 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.174 1.39 . . . . 0.0 111.876 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.04 154.92 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.274 1.43 . . . . 0.0 109.861 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.15 -37.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -62.5 -49.11 76.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.429 0.692 . . . . 0.0 111.84 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -74.86 -27.95 60.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 117.545 -1.217 . . . . 0.0 112.238 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -58.51 -43.54 89.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.741 1.609 . . . . 0.0 110.215 170.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -51.82 68.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.476 1.91 . . . . 0.0 112.639 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -64.54 -41.89 96.06 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.051 0.841 . . . . 0.0 112.517 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -56.41 -44.11 80.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.391 1.476 . . . . 0.0 110.52 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -60.67 -56.9 15.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.468 1.507 . . . . 0.0 111.698 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.05 -19.32 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.096 1.316 . . . . 0.0 114.399 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 m -74.69 -38.22 62.44 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.112 1.324 . . . . 0.0 110.284 170.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -67.15 -28.11 67.86 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.641 1.11 . . . . 0.0 112.968 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.46 -56.79 8.17 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.442 -0.786 . . . . 0.0 110.231 169.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -78.55 5.01 11.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.594 1.558 . . . . 0.0 113.946 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.04 -20.58 17.49 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.526 2.331 . . . . 0.0 113.136 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.52 -31.15 28.54 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.285 1.898 . . . . 0.0 113.697 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -135.2 -23.64 1.48 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 124.684 1.193 . . . . 0.0 113.358 -177.665 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.42 152.37 15.62 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.647 2.898 . . . . 0.0 110.187 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.96 153.46 38.25 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.543 1.137 . . . . 0.0 111.191 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -67.89 131.88 25.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.886 1.724 . . . . 0.0 110.491 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -6.81 81.85 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 125.535 1.54 . . . . 0.0 114.525 -172.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.72 161.84 15.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.444 1.497 . . . . 0.0 111.89 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -118.83 160.12 22.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.963 1.363 . . . . 0.0 114.437 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mt -141.3 131.22 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.615 1.566 . . . . 0.0 109.57 -160.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -85.65 127.84 34.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -112.55 122.34 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.314 1.446 . . . . 0.0 109.112 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -82.27 92.9 7.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.594 1.158 . . . . 0.0 109.084 173.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -64.99 -72.02 0.17 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.438 1.095 . . . . 0.0 111.693 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.4 mt -150.37 -114.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -164.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.18 23.85 5.84 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.333 0.968 . . . . 0.0 111.957 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -169.29 167.69 10.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.987 2.515 . . . . 0.0 111.867 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -121.26 163.4 18.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.233 1.413 . . . . 0.0 111.911 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.12 -174.07 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.658 1.583 . . . . 0.0 110.872 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -120.81 157.75 29.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.7 43.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.504 1.522 . . . . 0.0 113.083 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.72 123.64 39.32 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.771 2.428 . . . . 0.0 108.162 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -79.97 104.43 10.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 0.0 111.507 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.4 pt -94.48 -15.21 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.87 177.8 37.11 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 124.39 0.995 . . . . 0.0 110.877 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.73 91.57 0.45 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.669 0.747 . . . . 0.0 110.37 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 0.73 58.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.629 2.062 . . . . 0.0 115.069 -176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.56 138.94 47.45 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.924 1.862 . . . . 0.0 112.589 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.42 152.37 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mm -108.45 137.85 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 127.044 2.138 . . . . 0.0 106.715 168.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.98 141.17 18.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.235 0.925 . . . . 0.0 111.73 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.86 121.54 30.4 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.351 0.66 . . . . 0.0 110.01 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.13 113.77 43.67 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 168.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.3 169.45 21.26 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.028 2.485 . . . . 0.0 112.75 -169.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo . . . . . 0 C--N 1.351 0.678 0 C-N-CA 124.372 3.381 . . . . 0.0 113.661 173.431 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 m . . . . . 0 CA--C 1.548 0.867 0 CA-C-O 121.088 0.47 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.58 158.82 30.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.368 1.067 . . . . 0.0 111.299 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -143.08 132.35 23.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.376 1.071 . . . . 0.0 111.167 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.65 125.82 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.074 0.95 . . . . 0.0 109.992 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.1 171.67 13.68 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.78 1.632 . . . . 0.0 112.203 -170.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -142.01 141.72 32.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.864 1.666 . . . . 0.0 111.611 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.252 14.7 pt-20 174.1 -160.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.269 3.028 . . . . 0.0 110.145 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.9 mtm105 -95.02 148.25 22.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 tp -53.88 -51.87 62.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.537 1.535 . . . . 0.0 111.229 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.45 -25.31 67.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.74 -44.57 23.1 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.418 1.008 . . . . 0.0 110.458 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.33 -34.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.155 0.982 . . . . 0.0 112.125 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.9 -17.77 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.027 1.731 . . . . 0.0 112.873 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.25 118.54 15.26 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.181 -0.95 . . . . 0.0 112.221 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 4.81 90.18 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.677 1.132 . . . . 0.0 114.619 -174.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.73 176.75 7.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.906 2.082 . . . . 0.0 112.107 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -121.02 167.96 12.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.394 1.478 . . . . 0.0 109.64 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -156.0 165.97 34.87 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -158.39 136.22 10.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.998 1.319 . . . . 0.0 110.939 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.8 136.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 118.825 0.738 . . . . 0.0 109.049 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -152.75 128.86 10.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.061 0.545 . . . . 0.0 111.672 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -145.41 40.57 1.21 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.258 1.023 . . . . 0.0 111.304 -172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -71.11 -43.92 66.68 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -169.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -62.75 -35.3 79.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.276 0.63 . . . . 0.0 111.682 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.73 -28.34 67.27 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.349 1.46 . . . . 0.0 114.16 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -64.36 -19.65 65.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.446 1.098 . . . . 0.0 112.468 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -78.66 -16.24 57.54 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.097 0.959 . . . . 0.0 112.93 173.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.41 -75.59 0.58 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -131.03 153.61 81.82 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -139.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.63 -16.93 52.1 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 124.33 3.353 . . . . 0.0 114.367 169.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 72.65 86.65 0.1 Allowed Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 127.678 2.391 . . . . 0.0 113.101 171.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.52 93.67 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.628 2.885 . . . . 0.0 110.378 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.26 -38.77 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.139 0.976 . . . . 0.0 112.14 -172.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -69.1 -41.72 77.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.74 0.7 . . . . 0.0 111.866 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.64 -35.49 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.414 0.686 . . . . 0.0 110.316 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.4 -40.18 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.046 0.938 . . . . 0.0 111.914 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.4 -39.39 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.325 0.966 . . . . 0.0 111.074 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 m -65.63 -40.26 92.34 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.733 -0.604 . . . . 0.0 110.844 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -61.9 -47.18 86.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.268 1.027 . . . . 0.0 111.243 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.05 91.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.616 0.766 . . . . 0.0 112.535 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.95 -46.05 89.6 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.587 -0.695 . . . . 0.0 112.061 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.21 -30.14 70.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.09 -1.006 . . . . 0.0 113.37 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.61 -12.72 61.49 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.81 125.75 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.719 1.145 . . . . 0.0 111.047 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.94 -1.4 80.57 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.615 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -75.46 143.35 42.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.06 1.93 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -117.89 146.2 44.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.706 1.602 . . . . 0.0 111.88 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.6 157.25 44.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.981 1.312 . . . . 0.0 112.166 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -153.02 -33.8 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -173.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -72.21 157.89 36.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -171.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.6 t 75.88 -177.55 0.14 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.191 2.196 . . . . 0.0 113.03 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.7 mm -76.11 140.87 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.63 1.172 . . . . 0.0 109.004 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.13 -32.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -170.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.7 p -63.46 -48.44 77.69 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.361 -0.837 . . . . 0.0 111.527 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -67.19 -35.8 80.41 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.597 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.16 -45.52 79.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.596 1.543 . . . . 0.0 111.437 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.8 m -65.82 -49.43 68.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.284 1.434 . . . . 0.0 113.294 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.74 -41.55 99.25 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.567 0.747 . . . . 0.0 112.262 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.531 ' CD2' HE22 ' A' ' 119' ' ' GLN . 34.4 t60 -64.76 -42.26 95.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.111 1.364 . . . . 0.0 110.221 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -54.6 -52.46 62.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.021 1.329 . . . . 0.0 112.04 169.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.8 m -68.72 -18.33 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.815 1.189 . . . . 0.0 113.992 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -75.6 -45.39 37.87 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.698 169.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.531 HE22 ' CD2' ' A' ' 115' ' ' HIS . 0.8 OUTLIER -54.49 -34.57 61.86 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.82 1.191 . . . . 0.0 113.397 170.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.98 -59.45 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.907 0.776 . . . . 0.0 111.452 171.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -80.48 11.13 3.9 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.79 -19.45 62.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.543 1.937 . . . . 0.0 113.94 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -47.29 -37.75 11.84 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.908 2.194 . . . . 0.0 116.639 -169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -140.74 7.89 2.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.623 1.211 . . . . 0.0 113.622 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.638 1.575 . . . . 0.0 112.289 175.334 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.88 -30.08 50.61 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.913 0.885 . . . . 0.0 113.385 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.1 m -67.99 149.75 98.05 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.355 1.062 . . . . 0.0 112.981 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 -24.51 14.76 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.266 2.644 . . . . 0.0 113.169 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -162.43 172.94 14.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.199 1.8 . . . . 0.0 110.952 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -72.75 140.97 48.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.228 0.611 . . . . 0.0 110.323 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -108.04 113.33 60.96 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.109 0.964 . . . . 0.0 109.461 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.5 141.8 31.99 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.288 1.992 . . . . 0.0 110.206 170.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -91.75 142.11 26.31 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.852 0.861 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.51 128.92 22.37 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.637 2.225 . . . . 0.0 110.232 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.51 -2.38 72.73 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.503 1.525 . . . . 0.0 114.838 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.26 162.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.521 1.661 . . . . 0.0 111.163 169.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.01 146.05 42.47 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.953 1.359 . . . . 0.0 113.814 -171.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mt -123.26 129.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.341 2.257 . . . . 0.0 108.024 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -82.36 124.43 30.0 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.684 1.193 . . . . 0.0 107.798 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mm -118.44 119.5 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 110.346 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -81.79 72.81 8.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 108.536 169.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -25.91 57.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.727 1.211 . . . . 0.0 113.461 -170.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -161.62 -159.94 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.709 2.004 . . . . 0.0 108.715 -159.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.96 34.19 1.05 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.662 1.125 . . . . 0.0 112.678 169.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -169.44 158.83 8.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.427 2.691 . . . . 0.0 111.002 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -104.05 123.95 48.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -105.6 167.95 9.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.599 1.559 . . . . 0.0 110.862 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -112.69 151.81 29.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.729 0.811 . . . . 0.0 111.698 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.62 156.77 44.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.371 1.068 . . . . 0.0 112.819 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.49 120.99 34.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.032 . . . . 0.0 108.75 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -76.98 92.17 3.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.234 1.014 . . . . 0.0 111.864 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.5 pt -81.18 -21.93 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.75 173.35 31.75 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 124.199 0.904 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -68.41 90.67 0.37 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.674 0.749 . . . . 0.0 109.908 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.0 49.93 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.195 1.855 . . . . 0.0 115.581 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -126.18 140.64 52.4 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.714 1.757 . . . . 0.0 112.963 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -137.07 149.79 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.289 1.036 . . . . 0.0 113.237 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.5 mm -105.56 131.74 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -146.85 162.82 37.84 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.908 1.231 . . . . 0.0 112.069 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -100.58 134.11 44.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.315 0.646 . . . . 0.0 112.626 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.53 108.44 53.24 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 126.214 1.805 . . . . 0.0 106.232 168.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -62.75 162.18 26.03 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.373 3.382 . . . . 0.0 114.822 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.02 18.59 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.802 3.668 . . . . 0.0 113.689 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.3 m -140.22 142.67 35.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.19 1.396 . . . . 0.0 110.97 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.11 166.08 21.01 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.158 1.383 . . . . 0.0 111.745 172.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -64.3 134.98 96.15 Favored Pre-proline 0 CA--C 1.555 1.138 0 O-C-N 121.027 -1.046 . . . . 0.0 110.818 169.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -66.69 142.65 64.79 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.391 2.727 . . . . 0.0 111.698 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.06 67.65 1.6 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.88 -22.99 64.84 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.74 -0.5 89.51 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 116.346 1.298 . . . . 0.0 116.346 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.2 m -89.94 142.6 27.55 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.369 1.584 . . . . 0.0 111.725 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 p -60.54 -22.55 63.75 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.287 -1.508 . . . . 0.0 113.213 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.8 p -86.64 -13.49 45.46 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.813 1.645 . . . . 0.0 114.71 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -172.81 129.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 120.066 1.303 . . . . 0.0 112.897 -171.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -131.42 -57.46 1.01 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.138 0.975 . . . . 0.0 112.78 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 t -80.26 -29.17 38.31 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.1 t -75.2 132.43 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.728 0.811 . . . . 0.0 109.983 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.21 7.84 3.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.982 1.313 . . . . 0.0 114.498 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -65.92 139.25 58.25 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.944 -1.098 . . . . 0.0 112.615 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -157.88 -162.62 1.19 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.35 1.06 . . . . 0.0 112.314 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m -124.8 146.42 49.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.451 1.5 . . . . 0.0 110.717 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 150.11 26.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.593 -0.692 . . . . 0.0 111.968 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -143.42 136.72 28.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.251 1.02 . . . . 0.0 110.944 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.51 128.35 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.617 1.167 . . . . 0.0 108.846 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -130.41 151.45 50.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.469 1.508 . . . . 0.0 112.543 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -105.37 138.75 41.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.332 1.453 . . . . 0.0 110.585 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.69 167.63 18.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.14 0.976 . . . . 0.0 111.021 -170.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -83.8 143.66 29.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.072 1.349 . . . . 0.0 110.617 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.03 -49.06 72.5 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.507 0.723 . . . . 0.0 110.522 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.7 -24.39 65.6 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.96 -46.09 15.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.355 0.98 . . . . 0.0 110.287 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.69 -30.73 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.971 0.908 . . . . 0.0 112.252 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -91.78 -21.5 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.88 1.672 . . . . 0.0 112.759 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.31 118.71 15.21 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.383 0.992 . . . . 0.0 112.048 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.46 75.49 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.445 1.021 . . . . 0.0 114.607 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.1 m -123.67 163.47 21.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.132 1.773 . . . . 0.0 111.795 -171.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -109.99 159.86 16.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.575 1.15 . . . . 0.0 109.961 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -157.89 169.2 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.9 tpp85 -163.93 132.65 3.74 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.146 1.778 . . . . 0.0 110.727 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.61 127.53 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -152.73 64.89 0.79 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.973 0.892 . . . . 0.0 110.679 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -80.57 69.11 7.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.364 1.065 . . . . 0.0 111.177 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.7 p -35.14 -64.56 0.27 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.425 2.29 . . . . 0.0 115.328 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.84 -29.24 68.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.47 -39.51 74.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.565 0.746 . . . . 0.0 112.448 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -67.99 -30.51 69.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 112.093 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -76.09 -36.98 58.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.612 1.165 . . . . 0.0 113.333 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -162.93 -52.98 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -72.24 148.73 91.38 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -153.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.06 -37.4 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.714 2.943 . . . . 0.0 113.145 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 68.64 119.64 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.602 2.361 . . . . 0.0 116.934 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.4 89.38 1.36 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.396 3.397 . . . . 0.0 110.981 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.92 -41.43 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.739 1.616 . . . . 0.0 113.956 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.03 -36.08 79.34 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.554 0.615 . . . . 0.0 111.512 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.07 -27.87 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.035 0.934 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.6 mm -68.19 -47.29 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.14 0.882 . . . . 0.0 110.647 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.03 -38.13 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.771 -0.58 . . . . 0.0 110.801 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -67.25 -41.15 86.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.705 -0.622 . . . . 0.0 111.166 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.2 m -64.82 -39.55 93.76 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.541 1.136 . . . . 0.0 111.992 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.75 95.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.36 -0.838 . . . . 0.0 111.665 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -68.75 -11.17 59.99 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 173.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.25 -35.74 14.31 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.41 1.084 . . . . 0.0 111.174 168.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.3 mmm -72.44 -20.21 61.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.712 1.605 . . . . 0.0 113.819 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.26 124.22 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.902 1.228 . . . . 0.0 111.623 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.0 -4.56 85.55 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.069 -1.406 . . . . 0.0 115.323 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 150.81 47.61 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.073 1.937 . . . . 0.0 111.009 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -129.18 149.79 50.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.874 1.67 . . . . 0.0 112.301 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.7 mtm -144.03 158.96 43.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 0.0 111.234 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -152.83 -32.88 0.13 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -171.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.59 -28.45 51.63 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -90.12 150.02 22.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.232 1.013 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.33 157.1 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.592 -0.693 . . . . 0.0 111.328 172.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.77 -42.28 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m -64.2 -45.67 87.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.899 0.772 . . . . 0.0 111.367 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -75.98 -32.16 59.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.864 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -57.85 -40.12 79.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.198 0.908 . . . . 0.0 111.366 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.04 -55.23 31.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.895 1.678 . . . . 0.0 112.938 169.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.07 -43.61 98.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.432 -0.792 . . . . 0.0 112.339 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.79 -34.94 79.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.238 1.015 . . . . 0.0 111.195 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -61.19 -55.65 29.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.829 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.39 -20.45 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 120.304 1.411 . . . . 0.0 113.992 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -73.01 -37.96 66.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.526 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -71.99 -27.64 62.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.893 1.224 . . . . 0.0 113.442 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.41 -46.89 75.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.218 0.917 . . . . 0.0 111.77 170.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -69.5 -94.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.677 1.191 . . . . 0.0 108.633 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.7 t80 70.77 -6.99 1.13 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.236 2.614 . . . . 0.0 112.993 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.28 -69.54 1.28 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 127.22 2.343 . . . . 0.0 111.92 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.84 1.14 33.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.26 1.024 . . . . 0.0 113.269 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 125.617 1.567 . . . . 0.0 112.484 170.067 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.63 162.8 28.41 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.347 1.059 . . . . 0.0 112.602 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.6 m -68.14 153.38 95.52 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.897 0.879 . . . . 0.0 112.96 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.28 149.67 53.91 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.067 3.178 . . . . 0.0 113.404 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -162.72 163.23 26.94 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.46 1.504 . . . . 0.0 111.01 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -137.54 100.17 4.14 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.551 1.14 . . . . 0.0 109.45 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -114.21 115.26 45.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.145 0.978 . . . . 0.0 110.677 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.2 150.1 36.83 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.25 2.634 . . . . 0.0 111.069 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -108.59 160.31 27.67 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.457 1.503 . . . . 0.0 111.664 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.51 134.5 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.782 1.655 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.8 -10.38 74.71 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.855 1.216 . . . . 0.0 114.685 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.13 142.76 31.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.773 1.287 . . . . 0.0 111.539 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.66 128.1 48.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.627 1.203 . . . . 0.0 108.074 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.15 126.65 61.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 105.978 -170.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -74.84 129.67 38.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.06 120.04 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.621 1.569 . . . . 0.0 109.051 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -80.93 90.27 5.92 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -81.58 31.24 0.35 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt 82.53 72.76 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.652 1.981 . . . . 0.0 110.922 155.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.79 1.46 76.94 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.829 1.204 . . . . 0.0 113.353 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -138.67 140.2 38.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.239 1.815 . . . . 0.0 110.653 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -98.06 119.71 37.18 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.645 0.778 . . . . 0.0 110.427 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -125.92 178.62 5.63 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.695 1.598 . . . . 0.0 111.042 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -137.97 157.24 46.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.441 0.696 . . . . 0.0 112.606 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.55 25.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 120.74 32.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.671 1.589 . . . . 0.0 108.589 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.0 110.24 5.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 pt -100.06 -20.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.34 170.57 42.19 Favored Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.71 0.804 . . . . 0.0 112.591 -170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 19.11 66.24 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.335 1.445 . . . . 0.0 115.749 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -127.08 141.73 51.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.62 1.71 . . . . 0.0 112.736 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.9 156.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.658 1.183 . . . . 0.0 113.117 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 mm -112.49 132.42 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.184 1.794 . . . . 0.0 107.632 169.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -149.31 148.77 29.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.737 1.153 . . . . 0.0 111.896 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.0 tp -83.41 106.35 15.1 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 91.66 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.194 1.398 . . . . 0.0 111.032 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.18 141.91 44.74 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.129 3.22 . . . . 0.0 116.289 -168.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.41 -14.38 11.78 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.758 2.972 . . . . 0.0 111.766 169.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -63.75 -2.15 1.66 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.333 2.253 . . . . 0.0 116.703 -169.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -76.15 45.18 0.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.636 1.574 . . . . 0.0 112.007 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -58.28 -35.1 29.76 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -58.58 152.03 58.34 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.985 3.124 . . . . 0.0 113.245 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.72 -44.71 2.79 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.09 1.329 . . . . 0.0 113.198 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.83 147.35 43.43 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.216 1.008 . . . . 0.0 113.035 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.33 17.36 3.13 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 125.074 1.321 . . . . 0.0 114.776 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.2 m -171.38 156.42 4.56 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.96 2.104 . . . . 0.0 110.804 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -59.9 -17.9 40.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.354 1.461 . . . . 0.0 114.427 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 p -70.96 -21.34 62.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.932 1.293 . . . . 0.0 113.585 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t 73.35 129.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 128.095 2.558 . . . . 0.0 112.551 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -107.38 -25.21 11.54 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.7 p -93.52 -88.29 0.23 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.056 0.942 . . . . 0.0 110.617 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.8 128.57 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.446 1.498 . . . . 0.0 111.543 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.2 tp 61.23 10.75 3.16 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.938 2.095 . . . . 0.0 116.029 169.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 m -66.37 -15.38 63.24 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 119.964 -1.71 . . . . 0.0 115.365 -170.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -77.08 -43.35 34.63 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.9 p -170.74 162.85 7.84 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.69 1.596 . . . . 0.0 111.084 -169.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.86 156.35 28.71 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.117 -0.989 . . . . 0.0 111.27 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.68 135.05 37.87 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 0.0 111.289 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.52 122.19 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -127.36 157.07 40.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.428 1.491 . . . . 0.0 112.26 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -101.55 142.39 32.99 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.139 1.375 . . . . 0.0 110.398 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.75 164.08 21.28 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.095 0.958 . . . . 0.0 111.23 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -74.67 140.67 44.39 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.23 1.412 . . . . 0.0 110.414 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.3 tp -53.81 -57.27 11.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.173 0.989 . . . . 0.0 110.873 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.54 -21.94 66.61 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.48 -41.66 65.76 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.188 0.904 . . . . 0.0 110.878 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.29 -54.55 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.616 0.766 . . . . 0.0 110.87 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.1 -6.61 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.87 -28.23 54.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.116 0.865 . . . . 0.0 113.179 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.39 22.93 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.612 1.101 . . . . 0.0 114.736 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 79.8 m -130.76 148.47 52.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.238 1.415 . . . . 0.0 112.44 -172.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.6 m -76.56 157.37 32.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -158.02 172.45 18.42 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 155.52 2.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 128.173 2.589 . . . . 0.0 112.443 169.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.34 146.72 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.983 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -130.35 -80.85 0.54 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 51.47 49.73 20.35 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.878 2.071 . . . . 0.0 112.541 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -49.35 -57.04 7.6 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.677 -1.265 . . . . 0.0 113.402 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.19 -27.14 69.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.362 1.065 . . . . 0.0 113.444 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -24.94 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.876 0.87 . . . . 0.0 112.238 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -89.55 -30.84 17.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.514 1.125 . . . . 0.0 112.646 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.58 -37.58 88.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.73 0.812 . . . . 0.0 111.898 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.7 -71.55 0.09 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.91 129.89 40.43 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -145.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.88 67.19 5.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.897 3.065 . . . . 0.0 110.46 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -66.45 137.36 95.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.39 123.11 11.84 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.155 2.57 . . . . 0.0 110.33 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.25 -31.68 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.53 -0.747 . . . . 0.0 112.297 -169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -54.74 -37.75 66.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.687 1.131 . . . . 0.0 112.4 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.04 -28.5 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.518 0.727 . . . . 0.0 110.909 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.7 mt -69.63 -44.22 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.437 1.095 . . . . 0.0 110.42 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.86 -46.43 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.291 1.037 . . . . 0.0 109.837 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -64.21 -40.73 96.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.457 0.703 . . . . 0.0 111.565 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.0 t -61.33 -43.66 98.49 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.079 -1.013 . . . . 0.0 111.639 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.8 93.78 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.104 -0.997 . . . . 0.0 111.893 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.47 -25.39 68.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.197 0.999 . . . . 0.0 113.536 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -81.35 -35.27 31.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.174 0.99 . . . . 0.0 112.999 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.2 mmm -73.38 -30.39 63.26 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -54.78 126.61 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.488 1.04 . . . . 0.0 111.193 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.88 -9.52 55.2 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.027 1.775 . . . . 0.0 114.263 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -83.5 141.32 31.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.128 1.464 . . . . 0.0 111.11 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.98 155.06 18.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.69 1.596 . . . . 0.0 111.159 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 23.2 ptp -161.85 152.71 17.84 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -150.46 41.06 0.78 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.086 1.755 . . . . 0.0 110.268 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.84 -28.46 69.5 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.305 1.842 . . . . 0.0 115.279 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -172.1 -169.83 0.68 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.679 1.992 . . . . 0.0 110.379 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 pt -54.43 150.75 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.828 0.851 . . . . 0.0 110.504 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.78 -37.95 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.2 p -62.87 -45.55 92.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.067 0.849 . . . . 0.0 111.7 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -70.56 -35.14 72.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.019 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -61.29 -41.97 97.86 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.446 1.475 . . . . 0.0 110.911 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.2 m -64.36 -48.91 73.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.759 2.024 . . . . 0.0 112.508 170.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.84 -45.74 92.51 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.478 -0.764 . . . . 0.0 112.241 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -53.01 -45.42 67.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.644 1.978 . . . . 0.0 110.683 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.22 -58.9 6.55 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.723 1.209 . . . . 0.0 112.335 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.32 -26.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.031 1.287 . . . . 0.0 113.472 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -61.86 -52.28 64.76 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 115.981 -1.961 . . . . 0.0 107.449 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -56.93 -25.4 57.38 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 122.41 2.368 . . . . 0.0 114.849 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -68.47 -33.26 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.666 1.121 . . . . 0.0 112.841 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -105.95 -13.43 15.49 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -58.11 -22.01 48.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.666 2.787 . . . . 0.0 113.069 -168.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -71.67 -11.94 73.51 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.862 -0.965 . . . . 0.0 115.414 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -134.57 2.92 3.25 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.68 1.24 . . . . 0.0 114.216 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 125.246 1.418 . . . . 0.0 112.891 177.594 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.02 175.96 10.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.722 1.209 . . . . 0.0 112.63 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -61.97 -38.44 49.01 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -62.11 141.54 88.96 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.878 2.385 . . . . 0.0 112.944 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.48 17.28 12.94 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.007 1.723 . . . . 0.0 111.289 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -160.2 175.69 12.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.926 2.491 . . . . 0.0 109.752 -174.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -142.87 128.06 10.07 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.96 0.904 . . . . 0.0 109.903 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.7 142.14 25.48 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.553 2.835 . . . . 0.0 110.635 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -115.66 138.91 24.18 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.189 0.995 . . . . 0.0 111.712 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.13 130.24 28.24 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.407 2.738 . . . . 0.0 111.32 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.07 42.37 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.169 1.842 . . . . 0.0 115.304 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -89.35 164.62 14.82 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 110.446 169.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -119.65 148.6 43.16 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.582 1.182 . . . . 0.0 113.012 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -123.99 130.34 73.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.561 2.344 . . . . 0.0 108.221 -161.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -88.71 120.88 30.51 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.79 124.28 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.461 1.504 . . . . 0.0 108.456 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -90.78 63.92 5.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.304 1.441 . . . . 0.0 109.579 -173.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -61.41 2.32 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 21' ' ' TYR . 16.2 mt -148.79 -129.48 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -162.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.33 33.83 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.635 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' H ' ' C ' ' A' ' 19' ' ' LEU . 39.9 p90 -174.75 158.53 2.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.566 2.746 . . . . 0.0 112.008 -169.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -112.9 155.35 24.87 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.887 1.675 . . . . 0.0 109.783 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 164.81 34.91 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.569 -0.707 . . . . 0.0 112.885 174.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -97.88 149.82 21.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.19 140.35 27.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.424 1.09 . . . . 0.0 112.613 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.95 117.53 35.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.846 2.058 . . . . 0.0 108.983 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -76.56 86.82 3.26 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.885 1.274 . . . . 0.0 111.804 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -74.77 -23.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.11 177.88 27.03 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.584 1.088 . . . . 0.0 111.486 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.38 81.89 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.726 0.81 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.33 -11.83 31.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.33 2.395 . . . . 0.0 114.671 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.89 140.47 36.14 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.108 1.454 . . . . 0.0 113.126 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.0 149.54 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 0.0 113.703 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -108.35 123.04 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -137.8 149.76 46.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.231 -0.918 . . . . 0.0 111.512 -169.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.59 118.98 29.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.881 0.472 . . . . 0.0 110.07 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.7 130.95 62.23 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.04 158.89 45.33 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.279 2.652 . . . . 0.0 112.772 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.57 -12.5 15.23 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.914 3.076 . . . . 0.0 113.456 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 t -159.93 149.41 17.95 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.454 1.025 . . . . 0.0 112.054 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -81.05 172.7 13.39 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.037 1.335 . . . . 0.0 113.001 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -49.76 123.93 15.42 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 125.215 1.406 . . . . 0.0 112.359 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.83 -19.82 58.69 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.669 2.913 . . . . 0.0 114.697 -170.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.18 -8.25 85.15 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 119.082 0.856 . . . . 0.0 114.573 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 66.8 9.71 6.98 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.694 2.397 . . . . 0.0 115.172 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.72 -1.63 73.6 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.952 1.263 . . . . 0.0 115.448 -174.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.4 p -82.83 143.51 30.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.975 1.387 . . . . 0.0 112.563 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.1 m -60.92 -11.68 8.72 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.867 -1.145 . . . . 0.0 114.047 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.3 p -68.81 -15.11 63.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.67 1.588 . . . . 0.0 114.249 169.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 136.71 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.72 1.145 . . . . 0.0 113.814 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -136.18 14.34 3.28 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.42 1.488 . . . . 0.0 112.384 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.0 p -160.82 -83.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.577 1.151 . . . . 0.0 112.021 -172.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.7 t -105.83 125.16 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.938 1.695 . . . . 0.0 110.106 -176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.4 mp -88.36 -31.92 18.65 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.362 1.065 . . . . 0.0 112.984 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.0 p -94.78 153.88 17.54 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -163.68 -145.87 0.1 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.202 2.201 . . . . 0.0 109.453 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 m -120.11 154.95 33.97 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.464 1.505 . . . . 0.0 109.985 169.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.16 150.42 30.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.444 -0.785 . . . . 0.0 111.23 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.94 133.7 16.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.725 0.81 . . . . 0.0 110.654 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.03 121.9 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -128.06 156.7 42.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.739 1.616 . . . . 0.0 112.853 -170.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.33 139.98 38.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.067 1.347 . . . . 0.0 110.625 171.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.74 178.87 5.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.497 1.519 . . . . 0.0 109.811 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -96.1 142.49 28.23 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.317 1.447 . . . . 0.0 110.325 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.2 tp -55.35 -49.66 71.67 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.518 -0.739 . . . . 0.0 111.099 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.77 -25.63 63.23 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.28 -42.38 14.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.995 0.816 . . . . 0.0 111.342 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.98 -40.8 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 118.13 0.423 . . . . 0.0 111.305 172.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.5 -47.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.264 1.026 . . . . 0.0 111.613 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.21 -117.55 11.81 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -171.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.58 0.86 61.54 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.039 1.304 . . . . 0.0 115.056 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.82 166.44 22.05 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.942 1.371 . . . . 0.0 113.587 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -82.35 156.26 24.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.881 0.873 . . . . 0.0 110.998 169.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -161.05 156.73 25.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.019 0.927 . . . . 0.0 113.314 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -153.08 140.04 19.19 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.92 0.888 . . . . 0.0 111.827 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.92 133.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -158.01 70.12 0.55 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.344 1.058 . . . . 0.0 111.499 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -80.12 61.06 3.84 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.807 -1.183 . . . . 0.0 111.998 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.8 p -43.2 -67.62 0.26 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.496 1.918 . . . . 0.0 114.842 -169.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.443 HD12 ' HH ' ' A' ' 84' ' ' TYR . 18.6 tp -58.08 -27.16 63.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.993 0.917 . . . . 0.0 113.142 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.2 -48.5 28.6 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.757 -0.589 . . . . 0.0 111.572 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -78.67 -7.59 57.84 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.4 -31.81 73.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 113.34 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.443 ' HH ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -148.76 -36.41 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -176.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -126.45 139.26 34.19 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -137.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -94.6 54.99 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.09 1 C-N-CA 125.439 4.093 . . . . 0.0 111.737 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 147.82 46.84 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.41 100.4 1.14 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.955 3.104 . . . . 0.0 109.211 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.14 -25.26 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.327 1.051 . . . . 0.0 113.207 -169.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.58 -33.21 75.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.74 0.816 . . . . 0.0 112.338 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.0 -34.37 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.603 -0.685 . . . . 0.0 110.172 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.5 -44.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.611 0.764 . . . . 0.0 110.756 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.08 -40.13 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.669 0.788 . . . . 0.0 111.24 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.9 m -66.44 -43.18 86.31 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.416 -0.802 . . . . 0.0 111.237 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -34.66 78.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.049 0.939 . . . . 0.0 112.71 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.22 -45.17 94.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.77 1.168 . . . . 0.0 111.812 171.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.69 -13.49 61.33 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.96 -36.46 13.42 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.556 1.143 . . . . 0.0 112.501 168.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -72.38 -30.42 64.66 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.122 1.369 . . . . 0.0 113.573 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.43 128.45 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.809 0.731 . . . . 0.0 111.159 171.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.44 -9.11 58.94 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.484 1.516 . . . . 0.0 114.468 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -71.65 145.75 48.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.387 1.594 . . . . 0.0 111.01 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.81 143.95 50.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.009 1.724 . . . . 0.0 111.549 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -141.5 158.32 44.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.077 1.351 . . . . 0.0 111.363 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -161.96 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -72.39 -34.99 68.32 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.2 m -71.74 163.15 28.32 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -175.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.69 133.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.908 0.883 . . . . 0.0 108.629 171.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.1 t -57.67 -42.75 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 m -61.05 -47.97 83.91 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.568 -0.707 . . . . 0.0 111.075 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -67.44 -34.22 76.75 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.846 -0.534 . . . . 0.0 112.235 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.15 -38.5 83.31 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.099 0.96 . . . . 0.0 111.866 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 81.7 m -69.7 -48.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.433 1.093 . . . . 0.0 111.896 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.2 -46.96 86.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.057 0.543 . . . . 0.0 112.018 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.35 -32.55 74.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.75 -1.219 . . . . 0.0 111.531 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.44 -58.6 7.55 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.307 -0.871 . . . . 0.0 110.885 170.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.76 -25.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.0 m -69.41 -39.97 77.6 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.221 173.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.62 -27.19 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.278 1.399 . . . . 0.0 113.248 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.97 -38.37 82.64 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.545 1.066 . . . . 0.0 112.983 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 34.44 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -39.44 61.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 127.238 2.215 . . . . 0.0 112.493 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.91 44.54 0.1 Allowed Glycine 0 N--CA 1.475 1.263 0 C-N-CA 126.463 1.982 . . . . 0.0 111.528 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 pttm 91.72 -22.63 0.08 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 130.451 3.501 . . . . 0.0 110.172 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.253 1.262 1 C-N-CA 132.741 4.417 . . . . 0.0 113.516 169.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 120.32 0.105 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.52 152.19 45.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.988 0.915 . . . . 0.0 112.628 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.6 p -167.9 155.39 7.95 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.499 1.52 . . . . 0.0 111.848 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.45 157.1 45.32 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.574 2.85 . . . . 0.0 111.587 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -73.68 -16.1 61.22 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -160.78 137.64 8.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.979 1.712 . . . . 0.0 109.749 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.84 128.92 4.01 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 111.051 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.15 136.61 11.63 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.074 2.516 . . . . 0.0 110.214 169.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -85.45 154.81 59.69 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.428 0.691 . . . . 0.0 110.959 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.97 123.64 11.9 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.138 1.892 . . . . 0.0 109.228 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 -2.3 81.8 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.705 1.622 . . . . 0.0 115.198 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.95 156.79 17.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 1.587 . . . . 0.0 111.734 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -112.42 160.75 17.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.753 1.221 . . . . 0.0 113.581 -173.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mt -144.31 131.91 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.994 1.318 . . . . 0.0 110.471 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.92 121.75 33.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.822 1.249 . . . . 0.0 107.633 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.7 mt -126.6 123.54 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.945 0.898 . . . . 0.0 110.488 -172.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.93 51.72 1.8 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.895 1.678 . . . . 0.0 110.71 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.06 -40.96 82.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.726 1.21 . . . . 0.0 111.86 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 mt -158.8 172.38 18.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.624 1.969 . . . . 0.0 108.192 -168.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.65 -7.39 20.98 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -73.88 -35.52 64.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.349 1.06 . . . . 0.0 113.483 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 68.28 106.52 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.309 2.244 . . . . 0.0 109.509 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -101.39 149.39 24.1 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -94.63 136.98 34.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.062 0.945 . . . . 0.0 109.431 168.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.73 159.06 42.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.194 0.998 . . . . 0.0 112.493 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.39 121.66 29.61 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.419 2.287 . . . . 0.0 107.782 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -77.97 97.65 5.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.576 0.626 . . . . 0.0 110.26 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.7 pt -73.7 -3.54 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.79 137.14 4.07 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.526 1.06 . . . . 0.0 114.293 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.23 -20.51 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 129.953 3.301 . . . . 0.0 117.575 169.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.88 -19.81 0.05 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.211 1.386 . . . . 0.0 115.132 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -89.9 147.89 23.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.182 1.491 . . . . 0.0 113.466 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 m -127.82 146.29 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.211 1.404 . . . . 0.0 112.13 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.48 139.62 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -158.19 158.95 35.54 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.119 -0.988 . . . . 0.0 111.942 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -98.81 136.25 39.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.222 0.609 . . . . 0.0 111.124 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.89 141.16 21.91 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 109.686 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.15 165.14 33.5 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.641 2.894 . . . . 0.0 112.469 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -70.32 -2.66 10.95 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.363 2.708 . . . . 0.0 115.493 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -57.04 132.29 52.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.584 1.154 . . . . 0.0 112.2 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.28 132.83 42.46 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.381 -0.824 . . . . 0.0 112.966 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -69.53 -50.2 19.77 Favored Pre-proline 0 CA--C 1.555 1.139 0 CA-C-O 118.005 -0.998 . . . . 0.0 113.614 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.41 168.48 22.79 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.924 3.083 . . . . 0.0 111.497 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.08 29.58 1.87 Allowed Glycine 0 N--CA 1.474 1.223 0 C-N-CA 125.058 1.313 . . . . 0.0 113.969 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 136.52 41.8 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.615 1.566 . . . . 0.0 112.503 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.02 139.89 7.28 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.207 1.384 . . . . 0.0 112.065 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.0 m 60.23 27.98 17.54 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.973 1.309 . . . . 0.0 112.855 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.3 p -151.08 -169.09 3.29 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.506 1.523 . . . . 0.0 112.009 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 t -79.44 6.72 9.53 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 120.56 -1.337 . . . . 0.0 113.275 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.88 146.92 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.894 1.278 . . . . 0.0 111.815 -175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -130.75 14.38 5.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.007 1.323 . . . . 0.0 113.535 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.8 m -73.46 63.54 0.8 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.952 1.701 . . . . 0.0 112.628 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.12 151.02 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.385 1.474 . . . . 0.0 113.076 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.3 tp -130.77 -32.52 1.67 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.238 1.415 . . . . 0.0 112.754 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.7 m -80.87 -70.86 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.514 0.726 . . . . 0.0 110.888 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 64.69 -58.15 0.25 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 128.708 2.803 . . . . 0.0 112.896 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m -120.82 169.01 10.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.454 2.301 . . . . 0.0 109.891 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.22 155.41 40.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.951 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -138.57 129.94 27.35 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.853 0.861 . . . . 0.0 111.095 -170.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.94 128.95 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.194 0.597 . . . . 0.0 110.11 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -137.67 169.87 17.04 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.878 1.671 . . . . 0.0 112.248 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -127.12 143.04 51.36 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.922 1.689 . . . . 0.0 111.872 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -153.76 179.54 8.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.449 1.9 . . . . 0.0 110.623 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -102.56 140.25 37.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 110.332 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.26 -47.91 71.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.015 1.326 . . . . 0.0 111.631 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.14 -33.34 70.77 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.84 -45.32 51.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.378 0.99 . . . . 0.0 110.27 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.19 -32.31 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.736 1.214 . . . . 0.0 112.605 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.82 -20.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.888 1.675 . . . . 0.0 112.547 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 116.13 8.36 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.253 0.933 . . . . 0.0 111.911 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.6 7.55 74.29 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.574 1.083 . . . . 0.0 115.041 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.3 m -121.15 143.94 48.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.121 1.369 . . . . 0.0 112.468 -171.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 80.8 m -85.04 152.11 23.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.448 0.699 . . . . 0.0 109.674 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -158.18 161.44 37.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.631 0.772 . . . . 0.0 112.977 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -144.61 139.51 28.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.861 1.664 . . . . 0.0 110.536 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.9 t -80.61 138.32 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -126.62 142.1 51.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.813 0.845 . . . . 0.0 112.846 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -137.48 39.59 2.44 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.288 1.435 . . . . 0.0 111.337 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.7 t -57.9 -69.05 0.19 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.571 -1.33 . . . . 0.0 113.725 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.7 mt -72.31 -27.05 62.2 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.39 -0.819 . . . . 0.0 112.181 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.18 -42.14 98.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.637 0.775 . . . . 0.0 112.923 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.03 -8.61 59.09 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -82.56 -36.01 26.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -113.11 -45.0 3.2 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -169.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -142.34 155.04 64.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -133.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.87 -21.36 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.606 3.537 . . . . 0.0 113.122 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 69.18 117.61 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 128.441 2.696 . . . . 0.0 115.408 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.54 88.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 123.733 2.956 . . . . 0.0 108.58 169.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.71 -38.74 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.997 -169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -38.79 81.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.539 0.609 . . . . 0.0 111.721 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.43 -38.16 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.79 0.723 . . . . 0.0 111.305 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.68 -47.36 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 119.281 0.946 . . . . 0.0 110.323 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 90.8 mt -61.41 -40.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.206 1.002 . . . . 0.0 110.94 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.1 t -63.42 -42.93 98.73 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.434 0.694 . . . . 0.0 111.408 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -58.96 -40.54 85.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.321 -0.862 . . . . 0.0 112.248 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.9 -52.57 59.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.49 0.716 . . . . 0.0 111.982 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.82 -22.72 67.05 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.34 -50.03 12.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.165 0.986 . . . . 0.0 112.367 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 ptm -83.46 -14.13 53.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -170.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -55.54 125.4 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -8.45 59.06 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.391 1.472 . . . . 0.0 114.297 -169.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -70.63 153.97 42.33 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.576 1.688 . . . . 0.0 110.779 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -127.64 142.24 51.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.79 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -140.43 149.25 42.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.072 0.949 . . . . 0.0 113.059 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -154.28 -152.33 0.4 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.664 1.586 . . . . 0.0 111.262 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.9 t80 72.35 -53.77 0.69 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.871 2.869 . . . . 0.0 113.885 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.1 m -69.41 162.99 26.22 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.734 1.214 . . . . 0.0 112.379 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 tt -63.3 144.25 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 121.378 -0.826 . . . . 0.0 109.898 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.33 -27.63 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.8 t -64.14 -49.11 73.44 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.367 -0.833 . . . . 0.0 111.151 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -68.71 -28.7 67.07 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.933 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -57.34 -42.31 81.72 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.862 1.665 . . . . 0.0 111.191 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -45.11 53.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.957 1.303 . . . . 0.0 112.968 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.24 -41.41 90.06 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.117 -0.99 . . . . 0.0 112.69 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.85 -36.36 83.24 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.602 -1.311 . . . . 0.0 110.784 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.27 -58.0 10.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.482 0.713 . . . . 0.0 110.706 170.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -65.97 -27.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.954 1.252 . . . . 0.0 113.486 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -68.92 -33.97 74.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.819 1.19 . . . . 0.0 111.429 172.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -66.38 -23.14 66.28 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.61 -61.38 1.89 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.456 -0.778 . . . . 0.0 111.758 169.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -72.63 5.6 2.99 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -53.35 -24.75 12.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.251 2.22 . . . . 0.0 112.459 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.41 -24.51 11.01 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 127.573 2.511 . . . . 0.0 114.615 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.56 -19.94 0.47 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.252 1.021 . . . . 0.0 113.019 177.617 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 120.464 0.173 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.15 157.57 35.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.287 1.035 . . . . 0.0 112.773 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 m -70.91 148.35 94.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.93 0.892 . . . . 0.0 112.738 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.93 163.27 37.35 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.523 2.815 . . . . 0.0 111.535 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -157.13 152.57 26.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.684 1.193 . . . . 0.0 111.771 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -160.28 132.05 6.03 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.09 1.756 . . . . 0.0 108.635 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -110.77 117.39 50.62 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.222 0.609 . . . . 0.0 112.107 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.57 139.47 12.72 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 108.378 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -85.8 148.65 49.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.536 -0.728 . . . . 0.0 111.529 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.56 128.02 20.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.182 2.588 . . . . 0.0 109.957 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.48 82.86 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.938 1.733 . . . . 0.0 115.039 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.6 162.96 12.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -100.9 110.72 22.81 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 127.64 2.376 . . . . 0.0 113.636 -168.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.23 132.35 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.099 1.359 . . . . 0.0 109.92 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -96.54 116.98 29.98 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.07 120.29 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.317 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -81.72 63.16 5.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.675 1.19 . . . . 0.0 109.47 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -62.24 -29.38 70.36 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.317 1.047 . . . . 0.0 113.122 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.46 -144.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.092 1.357 . . . . 0.0 110.456 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.27 31.11 0.81 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.274 1.416 . . . . 0.0 114.706 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -168.44 154.87 7.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.786 2.835 . . . . 0.0 110.093 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -104.65 128.45 52.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.969 0.907 . . . . 0.0 110.812 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -108.76 134.69 51.12 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.878 1.271 . . . . 0.0 110.786 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -79.78 144.65 33.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.82 145.31 37.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.346 1.458 . . . . 0.0 111.521 169.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.14 118.19 36.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.244 1.818 . . . . 0.0 107.948 173.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -74.09 94.7 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.537 0.735 . . . . 0.0 110.64 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 pt -74.04 -8.8 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.668 -1.27 . . . . 0.0 114.15 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.97 133.83 2.91 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.738 0.685 . . . . 0.0 114.29 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 63.39 -19.56 0.06 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.634 3.173 . . . . 0.0 117.284 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.52 -21.44 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.509 1.528 . . . . 0.0 114.683 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.87 144.45 30.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.949 1.375 . . . . 0.0 113.002 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.83 145.62 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.135 1.374 . . . . 0.0 112.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.8 mm -107.45 138.64 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.753 1.621 . . . . 0.0 107.643 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -153.68 146.47 24.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.502 1.047 . . . . 0.0 112.091 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.12 118.79 31.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 109.844 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.9 119.49 75.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.855 1.262 . . . . 0.0 108.96 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -74.28 165.33 32.1 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.714 2.943 . . . . 0.0 112.261 -173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.24 133.49 19.5 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.667 2.244 . . . . 0.0 110.051 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -168.85 -172.47 1.6 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.542 1.137 . . . . 0.0 112.017 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.33 162.25 23.25 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.049 1.34 . . . . 0.0 113.046 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -150.42 168.04 11.79 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 125.427 1.491 . . . . 0.0 112.328 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.07 147.88 41.8 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.017 3.144 . . . . 0.0 113.844 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.26 -10.2 50.54 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.727 1.156 . . . . 0.0 113.504 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.07 164.36 15.57 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.723 1.609 . . . . 0.0 112.902 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.53 161.37 26.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.304 0.954 . . . . 0.0 113.897 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.1 p -81.52 -10.15 59.54 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.527 1.131 . . . . 0.0 113.348 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 m -172.08 167.97 5.92 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.972 2.909 . . . . 0.0 109.777 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.0 m 70.46 -28.94 0.18 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.274 2.229 . . . . 0.0 115.515 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -155.75 144.77 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.116 1.766 . . . . 0.0 110.815 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -154.65 49.14 0.59 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.068 1.347 . . . . 0.0 110.915 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.4 m -75.71 61.06 1.34 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.577 1.551 . . . . 0.0 111.059 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.89 152.77 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.552 1.541 . . . . 0.0 111.01 -169.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.6 tp -150.66 -73.54 0.16 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.005 1.322 . . . . 0.0 109.32 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -167.07 131.85 2.01 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.232 1.813 . . . . 0.0 111.075 169.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -82.6 169.53 16.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.822 1.249 . . . . 0.0 111.805 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m -77.24 161.68 27.95 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.201 -0.937 . . . . 0.0 111.935 169.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.21 159.11 28.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.014 0.926 . . . . 0.0 111.04 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -152.58 138.46 18.05 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.652 -0.655 . . . . 0.0 112.197 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.4 t -82.54 125.76 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.551 1.14 . . . . 0.0 109.406 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.47 175.15 9.79 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.959 1.704 . . . . 0.0 112.004 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -141.21 143.95 34.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.645 1.578 . . . . 0.0 112.24 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -178.78 -165.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.434 2.694 . . . . 0.0 109.249 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -103.79 150.0 24.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.7 tp -50.94 -57.87 7.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.123 1.769 . . . . 0.0 111.477 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -57.27 -33.44 67.62 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.088 0.955 . . . . 0.0 113.409 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.04 -30.03 58.27 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.371 -0.831 . . . . 0.0 112.015 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.49 -45.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.204 1.401 . . . . 0.0 111.785 172.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.62 -6.13 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.4 7.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 119.145 0.884 . . . . 0.0 111.777 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.28 7.72 78.23 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.835 1.207 . . . . 0.0 115.07 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.36 151.84 42.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.593 1.557 . . . . 0.0 112.549 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.61 160.12 19.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.874 0.87 . . . . 0.0 110.63 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -161.67 168.15 23.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.339 1.056 . . . . 0.0 113.44 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -167.23 149.98 6.21 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.122 1.769 . . . . 0.0 110.147 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.16 138.82 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 119.735 1.152 . . . . 0.0 110.153 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -132.32 130.69 41.11 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.013 1.325 . . . . 0.0 111.977 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -123.43 25.84 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.202 1.801 . . . . 0.0 113.299 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.7 m -60.82 -21.45 63.16 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.547 -1.345 . . . . 0.0 114.577 -171.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 mt -93.27 -39.25 11.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.806 0.842 . . . . 0.0 113.025 169.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.58 -35.06 71.8 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.439 1.018 . . . . 0.0 111.819 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -52.88 -29.12 26.44 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.401 2.28 . . . . 0.0 113.052 171.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -87.26 -14.91 39.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.494 1.118 . . . . 0.0 112.993 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -122.03 -64.64 1.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -138.71 149.7 63.17 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -135.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 -11.55 15.27 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 125.183 3.922 . . . . 0.0 114.074 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 81.21 96.48 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 127.586 2.354 . . . . 0.0 114.012 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.99 80.89 2.74 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.745 2.963 . . . . 0.0 108.528 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.77 -29.58 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.64 -39.5 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.465 1.03 . . . . 0.0 111.428 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.09 -34.23 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.387 -0.821 . . . . 0.0 110.247 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.9 mt -76.71 -39.69 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.995 0.918 . . . . 0.0 111.566 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.04 -45.32 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.551 -0.718 . . . . 0.0 110.979 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.9 p -68.21 -29.98 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.337 -0.852 . . . . 0.0 112.413 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -59.7 -46.64 88.47 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.059 -1.025 . . . . 0.0 111.192 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.65 92.09 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.079 -1.013 . . . . 0.0 112.428 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -67.42 -15.7 63.82 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -90.14 -38.35 13.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.977 1.311 . . . . 0.0 112.113 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.4 mmm -70.46 -25.09 63.02 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.361 1.464 . . . . 0.0 113.999 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -48.59 127.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.105 0.866 . . . . 0.0 111.804 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.87 81.4 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.127 1.346 . . . . 0.0 115.114 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -73.62 138.94 45.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.6 1.7 . . . . 0.0 110.7 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -98.08 156.12 16.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.363 1.465 . . . . 0.0 112.173 170.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 mtm -144.43 159.26 43.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.33 1.852 . . . . 0.0 111.44 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -158.61 -32.8 0.07 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -70.11 151.97 44.86 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.453 1.101 . . . . 0.0 113.879 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 t 76.76 -179.04 0.14 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.858 2.063 . . . . 0.0 113.803 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 pt -76.61 149.28 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.643 1.177 . . . . 0.0 110.558 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.91 -35.43 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.833 0.742 . . . . 0.0 112.542 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 p -64.35 -47.08 80.69 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.809 0.844 . . . . 0.0 112.485 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -67.95 -37.18 81.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.229 -0.919 . . . . 0.0 111.249 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -59.58 -46.56 88.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.289 0.95 . . . . 0.0 111.819 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.7 p -73.33 -37.34 66.15 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.495 -0.753 . . . . 0.0 112.797 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.25 -54.57 44.13 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.045 0.839 . . . . 0.0 111.355 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -56.1 -39.5 72.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.607 1.163 . . . . 0.0 111.224 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -56.43 -58.64 7.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.183 0.993 . . . . 0.0 111.294 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.3 m -64.98 -33.2 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.174 1.352 . . . . 0.0 113.253 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.7 m -68.36 -31.98 71.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.135 1.334 . . . . 0.0 111.544 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.51 -25.46 66.69 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.526 1.512 . . . . 0.0 112.327 169.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.62 -56.48 5.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.155 0.889 . . . . 0.0 110.976 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -75.96 5.7 6.19 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -57.7 -23.31 51.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.798 2.039 . . . . 0.0 113.434 -170.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -40.22 -36.32 0.89 Allowed Glycine 0 N--CA 1.474 1.185 0 C-N-CA 128.839 3.114 . . . . 0.0 117.465 -169.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -138.68 16.52 2.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.2 1.0 . . . . 0.0 112.77 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 126.203 1.801 . . . . 0.0 112.565 -178.51 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 tpp . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.905 -0.569 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.28 157.59 27.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.477 1.035 . . . . 0.0 112.901 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -97.42 151.34 37.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.604 1.162 . . . . 0.0 112.297 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.69 163.61 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.842 3.028 . . . . 0.0 112.075 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -85.6 15.7 4.43 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.636 1.174 . . . . 0.0 113.315 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -118.3 102.08 8.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.971 1.308 . . . . 0.0 111.407 -172.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -171.07 105.04 0.4 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 126.882 2.073 . . . . 0.0 107.917 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.66 129.74 28.93 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.331 2.688 . . . . 0.0 113.15 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.79 140.36 21.29 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.867 1.267 . . . . 0.0 108.136 169.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.23 131.37 21.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.244 1.296 . . . . 0.0 109.919 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.99 83.27 Favored Glycine 0 N--CA 1.469 0.859 0 C-N-CA 124.678 1.132 . . . . 0.0 114.66 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.77 168.81 9.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.19 1.495 . . . . 0.0 113.103 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.4 mt -102.99 111.35 23.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.922 1.689 . . . . 0.0 113.857 -168.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.6 mt -97.17 129.06 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 109.86 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.35 120.99 37.65 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.293 1.437 . . . . 0.0 107.559 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -121.47 121.91 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.297 1.039 . . . . 0.0 109.967 -174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -77.19 67.55 3.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.638 1.175 . . . . 0.0 111.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -64.8 -47.57 77.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.011 1.324 . . . . 0.0 113.451 -170.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -148.38 37.81 0.85 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.614 0.721 . . . . 0.0 112.583 -158.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.38 72.06 Favored Glycine 0 N--CA 1.477 1.41 0 O-C-N 121.396 -0.815 . . . . 0.0 113.012 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -162.02 146.86 12.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.887 2.475 . . . . 0.0 109.498 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -89.92 116.81 28.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.493 0.663 . . . . 0.0 111.42 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -94.15 145.1 24.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.583 1.553 . . . . 0.0 109.927 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -84.07 144.61 28.95 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.08 151.79 41.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.763 1.225 . . . . 0.0 112.945 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.83 120.06 41.13 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.245 2.218 . . . . 0.0 108.565 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.49 92.92 1.93 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.576 0.751 . . . . 0.0 111.609 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 pt -81.81 -21.22 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.94 -179.17 31.68 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 124.919 1.247 . . . . 0.0 110.945 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.07 96.74 0.82 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.133 0.968 . . . . 0.0 110.764 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.44 -0.45 89.28 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.168 1.842 . . . . 0.0 114.483 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -99.67 139.32 35.5 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.031 1.916 . . . . 0.0 112.148 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -138.63 149.94 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.87 129.01 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 168.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -145.11 149.22 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.502 1.046 . . . . 0.0 111.952 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -90.93 123.8 34.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.85 111.31 41.53 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.986 1.314 . . . . 0.0 107.555 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.77 165.48 16.0 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.002 3.135 . . . . 0.0 114.016 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.83 160.42 37.44 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.189 2.593 . . . . 0.0 111.159 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -80.04 5.2 14.78 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -126.7 152.71 46.42 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.027 1.731 . . . . 0.0 111.176 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -160.48 158.87 25.88 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.289 1.836 . . . . 0.0 110.348 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.77 119.96 7.26 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.306 2.004 . . . . 0.0 110.318 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.5 14.06 64.3 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.378 0.989 . . . . 0.0 115.528 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.76 156.41 30.62 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.343 1.071 . . . . 0.0 113.18 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.34 120.11 3.22 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.474 1.511 . . . . 0.0 112.309 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.1 p -85.68 -23.88 27.25 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.0 p -80.54 -19.58 45.42 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.6 p -174.05 -77.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.011 1.724 . . . . 0.0 110.567 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.1 p -175.88 145.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 128.312 2.645 . . . . 0.0 109.592 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.288 17.2 p90 60.84 12.15 3.64 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.343 2.657 . . . . 0.0 115.247 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -70.03 40.79 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.986 2.514 . . . . 0.0 114.7 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.4 m -137.61 153.23 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.972 2.109 . . . . 0.0 111.274 -173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.3 tp -72.83 137.69 45.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.693 1.197 . . . . 0.0 111.117 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.6 p -77.33 136.07 38.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.703 0.763 . . . . 0.0 112.356 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -168.22 144.08 3.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.258 1.423 . . . . 0.0 110.445 -172.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 p -90.17 164.13 14.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.79 154.37 28.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.594 1.157 . . . . 0.0 110.74 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -133.01 135.32 45.37 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.957 0.903 . . . . 0.0 111.491 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.31 125.41 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 169.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.42 156.83 42.55 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.078 1.751 . . . . 0.0 112.798 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -111.4 138.6 47.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.826 1.65 . . . . 0.0 111.016 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -170.18 173.93 5.62 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.869 1.268 . . . . 0.0 110.72 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -93.07 144.95 24.76 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.267 -0.895 . . . . 0.0 112.397 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 tp -53.75 -50.23 66.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.94 1.296 . . . . 0.0 111.07 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.61 -30.92 61.76 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.764 1.226 . . . . 0.0 114.044 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.82 -39.96 25.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.452 -0.78 . . . . 0.0 111.779 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.46 -41.01 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.195 0.598 . . . . 0.0 111.507 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.26 -40.47 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.565 1.075 . . . . 0.0 112.165 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 18.86 61.18 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.148 0.885 . . . . 0.0 115.0 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.08 -8.35 72.95 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.377 1.465 . . . . 0.0 114.633 -173.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.2 m -78.36 169.43 18.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.091 1.357 . . . . 0.0 112.305 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.3 m -71.38 155.59 40.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.84 0.856 . . . . 0.0 113.213 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.95 154.25 27.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.045 1.338 . . . . 0.0 112.664 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -142.05 167.4 22.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.467 1.907 . . . . 0.0 109.881 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.18 134.54 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 119.172 0.897 . . . . 0.0 109.744 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -158.73 129.2 6.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -139.18 57.09 1.67 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 110.566 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.8 m -49.42 -40.72 37.49 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -169.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.44 -34.43 72.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.145 0.884 . . . . 0.0 113.276 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 -26.94 60.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.653 0.781 . . . . 0.0 111.715 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -73.41 -33.73 65.13 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.989 0.916 . . . . 0.0 111.458 169.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.08 -32.86 74.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 112.01 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -168.12 150.4 5.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.841 1.656 . . . . 0.0 113.841 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 80.17 147.94 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 127.196 2.198 . . . . 0.0 115.448 152.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.26 165.4 16.74 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 124.439 3.426 . . . . 0.0 110.542 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -137.47 146.42 53.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 120.953 -1.092 . . . . 0.0 113.678 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.86 83.09 2.33 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.015 3.143 . . . . 0.0 109.476 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -36.92 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.494 1.118 . . . . 0.0 113.203 -169.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -72.23 -35.79 68.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.085 0.857 . . . . 0.0 111.793 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -74.93 -29.92 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.887 0.875 . . . . 0.0 110.13 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.92 -42.36 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.288 1.035 . . . . 0.0 111.535 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.7 -40.55 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.722 0.809 . . . . 0.0 110.449 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.1 m -65.76 -42.25 91.13 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.503 -0.748 . . . . 0.0 111.783 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.2 t -61.79 -40.96 97.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.509 1.123 . . . . 0.0 111.64 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.66 71.79 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.634 0.774 . . . . 0.0 111.308 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -67.32 -15.18 63.54 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.39 -42.84 14.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.276 1.031 . . . . 0.0 113.033 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.6 ptm -81.31 -25.26 36.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -50.01 128.56 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.685 0.755 . . . . 0.0 112.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -15.92 52.53 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.727 1.632 . . . . 0.0 113.964 -170.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -78.63 163.56 25.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.769 1.785 . . . . 0.0 112.215 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.59 150.33 50.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.7 1.6 . . . . 0.0 112.594 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -141.71 159.01 43.09 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.963 1.305 . . . . 0.0 112.407 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -154.38 -3.28 0.17 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -74.77 141.74 44.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.075 -1.016 . . . . 0.0 113.064 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.9 t 71.3 -176.19 0.19 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.346 1.859 . . . . 0.0 114.19 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.5 pt -75.12 152.35 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.644 1.177 . . . . 0.0 111.105 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.1 m -53.83 -38.4 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.1 m -70.67 -38.91 73.81 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.134 0.879 . . . . 0.0 111.904 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -72.06 -35.67 69.36 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.626 -0.671 . . . . 0.0 111.671 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.71 -42.02 82.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.113 0.965 . . . . 0.0 111.209 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -51.56 67.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.762 1.625 . . . . 0.0 113.16 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.41 -45.67 93.37 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.199 -0.938 . . . . 0.0 112.307 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -56.75 -40.33 75.58 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.988 1.715 . . . . 0.0 111.075 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -63.2 -52.69 61.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.563 1.145 . . . . 0.0 112.035 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.6 -20.7 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 120.521 1.51 . . . . 0.0 114.216 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -71.86 -43.23 65.83 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.141 0.882 . . . . 0.0 109.387 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -62.37 -25.36 67.87 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.4 mt -71.94 -58.64 3.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.863 0.756 . . . . 0.0 110.563 169.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ptt85 -76.29 9.19 2.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -58.27 -19.93 38.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.888 2.075 . . . . 0.0 113.739 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.66 -38.92 7.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.875 2.179 . . . . 0.0 114.247 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -137.23 5.47 2.76 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 C--O 1.252 1.202 0 C-N-CA 125.758 1.623 . . . . 0.0 114.821 -174.781 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.8 165.2 25.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.242 1.017 . . . . 0.0 112.759 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.5 m -66.92 146.58 99.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.864 0.866 . . . . 0.0 112.848 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.59 -18.69 13.47 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.355 2.703 . . . . 0.0 113.688 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -158.45 167.32 29.99 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.361 1.464 . . . . 0.0 111.211 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -153.53 134.2 13.72 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.196 1.399 . . . . 0.0 109.52 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.26 108.65 41.64 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 124.166 0.986 . . . . 0.0 111.633 -169.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.69 156.63 62.91 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.391 2.727 . . . . 0.0 111.352 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -99.84 141.31 22.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 0.0 111.664 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.01 129.82 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.255 1.97 . . . . 0.0 110.045 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.09 8.15 75.96 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 118.233 -1.315 . . . . 0.0 114.43 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -117.25 157.61 25.75 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.596 1.698 . . . . 0.0 113.935 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.75 127.32 39.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.543 1.937 . . . . 0.0 113.496 -168.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.52 126.41 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.205 1.802 . . . . 0.0 109.577 -174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.4 122.26 34.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.53 125.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.885 1.274 . . . . 0.0 109.296 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.1 53.07 1.65 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.269 1.427 . . . . 0.0 111.677 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -25.61 66.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -169.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -159.26 26.8 0.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -161.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.87 6.4 72.42 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 124.263 0.935 . . . . 0.0 114.015 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.65 148.19 30.8 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.322 2.249 . . . . 0.0 109.385 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -82.86 107.41 15.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.569 0.747 . . . . 0.0 110.116 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -107.22 154.8 20.69 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.804 1.242 . . . . 0.0 111.206 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.14 168.11 22.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.168 2.187 . . . . 0.0 110.674 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 tp -142.71 121.17 12.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.089 1.756 . . . . 0.0 109.22 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.77 116.36 14.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.421 1.088 . . . . 0.0 110.918 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.0 pt -107.2 -16.06 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.62 39.02 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 126.228 1.87 . . . . 0.0 110.294 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.31 92.31 0.28 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.066 0.936 . . . . 0.0 112.067 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.82 87.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.111 1.815 . . . . 0.0 114.503 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -100.67 135.29 42.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.238 1.519 . . . . 0.0 111.76 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.54 150.84 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.161 0.984 . . . . 0.0 113.139 -173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 mt -105.93 141.78 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -156.62 152.79 27.62 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 111.617 -169.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -96.36 125.18 40.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.472 0.709 . . . . 0.0 110.266 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.51 136.1 33.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.248 1.019 . . . . 0.0 109.215 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.95 169.4 22.5 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 112.678 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -60.68 -28.7 86.99 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.837 3.025 . . . . 0.0 115.571 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.8 m -99.03 150.51 21.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.897 1.279 . . . . 0.0 113.031 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -62.37 136.68 58.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.787 0.835 . . . . 0.0 111.969 173.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.42 -47.04 98.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -81.73 -0.18 10.23 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.803 3.002 . . . . 0.0 113.159 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.74 -122.53 7.15 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -171.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.34 56.15 1.68 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.405 1.482 . . . . 0.0 112.936 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.55 105.05 2.04 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.1 m -56.32 -29.51 61.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.225 1.41 . . . . 0.0 114.651 -169.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -66.71 -20.53 65.99 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -113.71 -49.58 2.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.051 1.34 . . . . 0.0 113.365 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.4 m -151.78 160.49 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.898 1.279 . . . . 0.0 113.14 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -163.09 -37.0 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.156 1.383 . . . . 0.0 113.01 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.3 p -77.68 -32.97 53.44 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 p -150.94 133.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.694 1.998 . . . . 0.0 108.895 170.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.6 mt -101.41 -5.04 25.84 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.5 m -140.82 162.22 35.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.25 1.02 . . . . 0.0 113.526 -172.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -149.83 -66.16 0.21 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.427 1.091 . . . . 0.0 111.964 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 p -171.18 155.46 4.36 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.092 1.757 . . . . 0.0 110.368 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.75 159.36 33.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.838 -0.539 . . . . 0.0 111.173 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.57 134.06 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.629 0.772 . . . . 0.0 111.108 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.6 t -83.75 126.14 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.678 0.791 . . . . 0.0 109.213 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -134.36 172.06 13.42 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.787 1.635 . . . . 0.0 112.191 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -151.97 125.79 9.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.267 1.027 . . . . 0.0 112.18 -171.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -169.38 -161.47 0.3 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.861 2.064 . . . . 0.0 110.959 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 -85.34 146.43 27.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -51.0 -52.46 42.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.334 1.854 . . . . 0.0 111.374 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -56.99 -30.33 64.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.65 -45.16 17.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.381 0.992 . . . . 0.0 110.722 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.02 -34.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.122 0.569 . . . . 0.0 112.238 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -82.27 -45.49 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.144 0.978 . . . . 0.0 111.113 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.21 23.1 65.91 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 119.359 0.981 . . . . 0.0 114.867 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.3 2.26 70.99 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.206 1.384 . . . . 0.0 115.066 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -72.01 171.11 12.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 118.93 1.365 . . . . 0.0 112.852 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.85 152.17 31.44 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.428 0.691 . . . . 0.0 111.192 169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -158.81 169.65 23.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.438 1.095 . . . . 0.0 113.287 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -168.09 151.76 5.99 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.891 1.677 . . . . 0.0 110.899 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.5 t -85.86 137.76 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 169.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -161.24 108.3 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.377 1.871 . . . . 0.0 108.635 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -83.17 -32.92 26.36 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.421 -0.799 . . . . 0.0 112.95 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t 74.78 -51.47 0.68 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 129.122 2.969 . . . . 0.0 113.273 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -96.66 -33.13 11.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.91 -25.62 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.283 0.947 . . . . 0.0 112.463 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -75.19 -14.52 60.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.346 1.058 . . . . 0.0 112.963 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -96.08 -34.8 11.59 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.098 1.359 . . . . 0.0 112.327 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -172.55 165.82 5.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.118 1.767 . . . . 0.0 112.719 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 89.74 154.28 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 129.975 3.31 . . . . 0.0 115.446 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.96 -31.79 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.298 3.332 . . . . 0.0 113.434 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 ttp-105 70.76 111.99 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.611 2.764 . . . . 0.0 114.683 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -80.44 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.726 2.951 . . . . 0.0 110.329 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 t -54.43 -40.14 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.638 1.175 . . . . 0.0 112.451 -173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -68.58 -42.92 77.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 111.286 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.4 t -73.23 -30.76 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.899 0.88 . . . . 0.0 110.217 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.1 -41.06 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.425 1.09 . . . . 0.0 111.761 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.44 -36.8 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 119.642 1.11 . . . . 0.0 110.882 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -66.69 -41.46 88.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.126 -0.984 . . . . 0.0 111.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.5 m -63.84 -41.97 97.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.506 1.123 . . . . 0.0 111.655 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.86 -49.55 77.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.765 0.826 . . . . 0.0 111.411 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -56.51 -43.62 79.96 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.746 . . . . 0.0 112.332 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.28 -31.23 70.04 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.2 mtp -73.9 -17.78 60.99 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.72 125.99 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 120.549 1.522 . . . . 0.0 110.623 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.09 66.92 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.625 1.583 . . . . 0.0 114.592 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.44 151.06 32.9 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 111.797 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -87.23 158.2 19.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.011 1.324 . . . . 0.0 110.367 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtp -143.8 148.4 35.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.577 1.551 . . . . 0.0 110.866 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -167.19 -152.7 0.13 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.927 1.291 . . . . 0.0 111.646 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 62.93 22.93 13.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.117 1.767 . . . . 0.0 114.609 169.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.3 p -166.8 156.76 11.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.142 1.377 . . . . 0.0 112.274 -171.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.88 146.22 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.612 1.165 . . . . 0.0 108.606 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 96.6 t -49.93 -39.36 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.776 1.23 . . . . 0.0 113.221 -170.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -56.58 -49.52 74.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.047 0.939 . . . . 0.0 112.192 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -74.85 -34.29 62.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.485 -0.759 . . . . 0.0 111.924 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -57.84 -43.84 86.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.635 1.107 . . . . 0.0 111.917 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.68 -38.45 54.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.7 -46.53 85.06 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.941 -1.099 . . . . 0.0 112.39 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -64.19 -35.32 80.43 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.784 -1.197 . . . . 0.0 110.639 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -58.78 -59.36 5.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.986 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -64.99 -25.59 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.688 1.586 . . . . 0.0 113.662 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -69.66 -37.28 76.66 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.495 1.043 . . . . 0.0 110.805 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.59 -20.2 65.95 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.662 1.119 . . . . 0.0 112.952 170.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.1 mt -76.12 -65.16 0.95 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.385 0.993 . . . . 0.0 110.352 169.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.4 ptt85 -75.2 14.28 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -52.91 -23.67 7.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.156 2.183 . . . . 0.0 112.632 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.68 -45.05 7.04 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 128.091 2.758 . . . . 0.0 114.435 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -139.36 -5.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 124.555 1.142 . . . . 0.0 112.128 174.288 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 119.883 -0.103 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.88 -37.07 18.04 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -78.54 155.41 78.72 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.622 0.769 . . . . 0.0 113.041 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.57 158.53 31.77 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.817 3.011 . . . . 0.0 112.947 170.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -79.04 119.7 22.55 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.327 0.584 . . . . 0.0 112.297 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -135.04 105.5 6.38 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.689 1.196 . . . . 0.0 109.523 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -151.28 81.45 6.11 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.019 1.328 . . . . 0.0 109.433 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.45 123.69 6.66 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.875 2.383 . . . . 0.0 110.422 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.35 161.27 27.71 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 125.538 1.535 . . . . 0.0 111.049 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.75 135.98 51.28 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.621 2.214 . . . . 0.0 113.145 -169.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.2 -17.59 58.89 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.381 1.467 . . . . 0.0 114.815 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.38 149.72 22.87 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.441 1.121 . . . . 0.0 112.337 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -107.51 140.3 40.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.645 1.212 . . . . 0.0 111.548 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt -125.4 127.45 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.807 2.043 . . . . 0.0 107.936 -159.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -88.68 119.78 29.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -123.19 134.71 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.459 1.104 . . . . 0.0 109.653 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -78.09 66.48 3.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.328 1.051 . . . . 0.0 110.181 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -47.16 77.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.56 1.944 . . . . 0.0 113.788 -169.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.24 37.5 0.44 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -166.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.85 12.23 56.92 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.173 0.892 . . . . 0.0 113.832 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -166.39 134.98 2.93 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.835 2.054 . . . . 0.0 109.729 -171.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.06 128.05 34.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.778 1.631 . . . . 0.0 112.386 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.596 ' CD2' ' HG ' ' A' ' 113' ' ' CYS . 0.0 OUTLIER -138.27 151.04 47.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.154 . . . . 0.0 112.063 178.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -85.7 147.29 26.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.11 138.46 37.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.41 1.484 . . . . 0.0 111.568 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.26 121.22 41.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.429 1.891 . . . . 0.0 109.111 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.8 111.62 8.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.227 1.011 . . . . 0.0 111.303 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 pt -104.16 -20.82 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.53 172.42 40.27 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.91 101.39 0.12 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.513 1.157 . . . . 0.0 112.253 -172.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.95 -2.0 76.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.691 1.615 . . . . 0.0 115.488 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -98.44 137.94 36.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.625 1.713 . . . . 0.0 112.826 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.94 153.59 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.799 1.239 . . . . 0.0 112.431 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.47 126.44 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -136.07 160.07 39.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.303 0.956 . . . . 0.0 111.345 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.3 tp -85.3 137.55 32.89 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.8 123.8 44.33 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.156 1.382 . . . . 0.0 107.626 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.85 167.41 27.3 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.168 2.579 . . . . 0.0 112.081 -172.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -63.65 149.03 91.87 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.237 2.625 . . . . 0.0 110.649 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.9 m -89.74 77.56 7.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.307 0.575 . . . . 0.0 111.048 -174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -77.84 60.74 2.34 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.804 1.242 . . . . 0.0 110.584 172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -58.81 -47.73 98.14 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.43 164.09 31.25 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.284 2.656 . . . . 0.0 111.827 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.1 48.02 3.26 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 125.019 1.295 . . . . 0.0 113.182 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.39 159.9 33.31 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.439 1.895 . . . . 0.0 114.397 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.31 -130.71 4.54 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 125.705 1.621 . . . . 0.0 111.474 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.4 m -74.46 -1.93 23.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.466 1.106 . . . . 0.0 113.313 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.9 p -74.52 173.77 9.9 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.321 2.248 . . . . 0.0 113.3 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.5 m -72.26 33.74 0.06 Allowed 'General case' 0 N--CA 1.481 1.104 0 O-C-N 120.059 -1.651 . . . . 0.0 113.959 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -164.9 142.52 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.928 2.091 . . . . 0.0 110.106 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -143.83 14.99 1.74 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.034 1.334 . . . . 0.0 113.592 -172.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.3 t -83.53 -172.95 4.44 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 p -168.17 139.4 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 127.901 2.48 . . . . 0.0 109.337 -173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.0 tt -86.79 -28.73 22.79 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.033 0.933 . . . . 0.0 112.327 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -152.65 125.09 8.21 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.653 0.781 . . . . 0.0 112.133 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -83.32 136.14 34.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.151 1.38 . . . . 0.0 112.109 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m 73.53 158.58 0.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.703 2.001 . . . . 0.0 113.447 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.55 164.7 14.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.203 1.001 . . . . 0.0 111.005 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.04 137.76 26.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.353 1.061 . . . . 0.0 111.492 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.89 127.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.57 1.148 . . . . 0.0 110.857 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -129.67 148.91 51.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.008 1.723 . . . . 0.0 112.855 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -95.05 138.86 32.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.847 1.259 . . . . 0.0 109.403 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -163.22 169.05 19.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.604 1.162 . . . . 0.0 110.8 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -90.42 141.63 28.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.245 1.018 . . . . 0.0 111.244 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 tp -53.29 -47.3 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.496 1.119 . . . . 0.0 111.494 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.78 -31.49 66.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.52 -43.59 26.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.151 0.887 . . . . 0.0 110.914 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 t -60.87 -38.36 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 122.574 0.35 . . . . 0.0 111.51 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.36 -47.01 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.34 18.19 62.77 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.48 1.036 . . . . 0.0 114.955 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.69 -2.62 82.69 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.593 1.568 . . . . 0.0 114.868 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.4 m -76.25 176.59 7.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.149 1.38 . . . . 0.0 113.065 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -71.3 150.02 45.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.355 1.062 . . . . 0.0 112.5 173.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -157.72 152.17 24.88 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.645 1.178 . . . . 0.0 113.247 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -136.02 157.86 45.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.395 1.878 . . . . 0.0 110.047 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.09 126.21 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.4 0.68 . . . . 0.0 109.977 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -167.3 113.05 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.892 1.277 . . . . 0.0 110.645 -174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -83.68 71.87 10.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.232 1.013 . . . . 0.0 108.592 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 p -33.31 -64.11 0.21 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.159 2.583 . . . . 0.0 115.823 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.0 mt -84.17 -27.1 28.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.44 -37.6 84.14 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.733 -0.604 . . . . 0.0 111.259 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.3 -28.54 66.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.015 1.326 . . . . 0.0 113.381 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -86.8 -29.16 22.49 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.77 -38.8 3.05 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 117.109 2.263 . . . . 0.0 117.109 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -155.22 159.48 31.71 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -134.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -98.3 1.51 1.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 1 C-N-CA 125.558 4.172 . . . . 0.0 114.197 169.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -12.61 125.28 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 130.401 3.48 . . . . 0.0 117.097 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.48 121.89 9.62 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.334 3.356 . . . . 0.0 112.902 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.3 -34.79 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.021 0.928 . . . . 0.0 112.473 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.84 -35.23 79.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.64 0.654 . . . . 0.0 111.707 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.37 -37.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.468 0.707 . . . . 0.0 110.211 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.46 -41.54 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.699 0.681 . . . . 0.0 110.933 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -64.26 -42.58 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.895 0.771 . . . . 0.0 111.313 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.2 m -62.88 -42.03 99.62 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.668 -0.645 . . . . 0.0 111.563 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -62.1 -45.42 93.59 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.504 1.122 . . . . 0.0 111.515 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.27 86.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.953 0.901 . . . . 0.0 112.145 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.2 -49.89 75.84 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.651 -0.656 . . . . 0.0 111.815 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -60.79 -30.91 70.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.2 mmm -73.75 -13.17 60.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 114.164 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.6 t -57.07 125.99 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.88 1.218 . . . . 0.0 110.704 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.95 75.44 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.173 1.368 . . . . 0.0 114.608 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -74.97 143.15 43.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.251 1.525 . . . . 0.0 110.45 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -112.38 151.69 29.5 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.259 1.824 . . . . 0.0 111.228 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.81 147.08 13.26 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -145.48 59.16 1.27 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.786 1.635 . . . . 0.0 109.34 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -65.8 -32.01 73.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.916 1.286 . . . . 0.0 113.618 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 t -165.58 -162.81 0.61 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.486 1.514 . . . . 0.0 110.29 -170.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.2 pt -60.1 150.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.09 0.956 . . . . 0.0 109.803 169.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.4 -36.28 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.9 m -63.37 -53.26 55.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.537 0.608 . . . . 0.0 111.363 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -70.49 -28.49 65.02 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 121.256 -0.902 . . . . 0.0 111.968 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -60.57 -33.5 72.8 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.392 1.451 . . . . 0.0 111.086 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.596 ' HG ' ' CD2' ' A' ' 23' ' ' HIS . 2.1 t -80.37 -40.93 25.63 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.624 1.169 . . . . 0.0 113.254 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.7 -41.0 98.18 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.289 -1.507 . . . . 0.0 112.073 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -65.35 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.776 -1.203 . . . . 0.0 110.701 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.84 -55.84 25.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.748 1.219 . . . . 0.0 111.749 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.01 -30.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 120.218 1.372 . . . . 0.0 112.79 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -69.13 -39.21 79.03 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.633 -1.175 . . . . 0.0 111.124 173.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.86 -28.66 66.31 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.217 1.372 . . . . 0.0 112.932 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.4 mt -67.32 -52.46 40.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.394 0.997 . . . . 0.0 111.246 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -92.68 16.05 13.08 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -62.69 -24.91 67.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.527 1.931 . . . . 0.0 114.45 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.15 -68.84 1.48 Allowed Glycine 0 N--CA 1.473 1.129 0 C-N-CA 125.661 1.6 . . . . 0.0 114.166 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -101.47 -12.13 18.78 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.254 1.312 0 C-N-CA 124.594 1.157 . . . . 0.0 113.017 -175.915 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 ttm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.75 173.01 12.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.107 0.963 . . . . 0.0 112.326 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -58.93 -44.7 99.24 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.58 139.65 23.07 Favored 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 122.007 1.752 . . . . 0.0 112.876 -171.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -145.59 175.34 10.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.37 2.268 . . . . 0.0 110.012 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -120.12 151.74 38.62 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.524 -1.36 . . . . 0.0 111.419 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 102.23 95.95 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 130.954 3.702 . . . . 0.0 108.765 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.17 127.67 27.26 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.043 3.162 . . . . 0.0 112.795 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -103.78 143.88 27.54 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.881 1.272 . . . . 0.0 110.236 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.68 122.73 10.17 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.989 1.793 . . . . 0.0 109.816 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.52 15.42 66.14 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.682 1.134 . . . . 0.0 114.827 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -122.12 165.22 16.44 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.996 1.398 . . . . 0.0 111.924 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.76 154.64 33.88 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -169.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -128.47 142.88 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.217 2.607 . . . . 0.0 109.081 -160.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.15 123.72 48.3 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.102 1.361 . . . . 0.0 107.335 168.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.24 125.91 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 110.485 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -79.69 65.45 4.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.502 1.121 . . . . 0.0 110.366 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -61.46 -33.69 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.0 32.12 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.788 1.235 . . . . 0.0 113.757 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.63 -18.51 52.44 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.654 1.597 . . . . 0.0 114.791 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -74.08 -31.16 62.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 73.77 99.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.279 2.632 . . . . 0.0 110.302 -172.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -102.52 148.7 25.2 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.647 1.179 . . . . 0.0 111.297 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -87.82 151.54 22.79 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 169.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.01 39.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.303 1.041 . . . . 0.0 112.466 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.56 125.2 52.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.647 1.979 . . . . 0.0 108.776 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -80.29 100.35 8.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.064 0.946 . . . . 0.0 110.682 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 pt -89.01 -14.15 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.73 -171.26 37.35 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.03 97.0 0.16 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 111.675 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.92 25.15 58.58 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.15 1.833 . . . . 0.0 115.572 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.272 6.8 p90 -144.1 149.24 36.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.459 2.129 . . . . 0.0 115.503 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.06 157.15 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -168.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mm -107.44 139.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.491 2.317 . . . . 0.0 106.348 168.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -156.33 161.67 40.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.14 1.336 . . . . 0.0 112.418 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.64 123.6 48.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.033 0.933 . . . . 0.0 111.642 -171.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.6 113.11 61.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.154 1.382 . . . . 0.0 108.582 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.61 167.65 9.6 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.09 3.194 . . . . 0.0 115.734 -169.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -56.82 163.3 7.52 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.214 3.276 . . . . 0.0 113.657 171.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.3 p 62.19 19.25 10.79 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.408 2.283 . . . . 0.0 114.138 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 77.44 -50.4 0.53 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 128.836 2.854 . . . . 0.0 109.653 -170.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -167.7 126.28 1.0 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 127.791 2.437 . . . . 0.0 109.379 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.85 121.79 10.59 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.371 2.714 . . . . 0.0 112.399 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.48 24.3 75.23 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.139 0.876 . . . . 0.0 115.169 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.72 -29.67 69.5 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.568 1.184 . . . . 0.0 113.536 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.55 -40.3 0.93 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.581 2.039 . . . . 0.0 116.568 169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.0 t -70.28 130.63 42.53 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.288 1.044 . . . . 0.0 113.216 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.7 m -57.87 -20.48 36.93 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.211 1.404 . . . . 0.0 113.455 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.8 m -73.35 -8.92 57.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.002 1.321 . . . . 0.0 113.827 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.69 -43.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -85.78 -7.35 58.8 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.2 p -62.75 -17.22 60.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.907 1.683 . . . . 0.0 114.042 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.9 m -61.83 -21.95 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.135 0.974 . . . . 0.0 113.401 170.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 74.06 -51.19 0.69 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 128.946 2.899 . . . . 0.0 111.777 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 t -142.76 156.74 45.04 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.093 1.757 . . . . 0.0 110.546 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.06 157.41 2.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.356 1.863 . . . . 0.0 110.951 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -77.85 160.13 28.51 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 163.01 26.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.178 0.991 . . . . 0.0 110.206 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.81 138.56 42.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.086 0.954 . . . . 0.0 111.14 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.9 t -85.67 123.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.942 0.897 . . . . 0.0 108.707 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.83 171.6 10.56 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.796 1.638 . . . . 0.0 112.042 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -146.95 139.82 25.14 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.337 1.455 . . . . 0.0 111.841 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -176.68 -178.07 0.86 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.449 1.9 . . . . 0.0 111.866 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -72.66 148.29 44.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.11 -59.78 4.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.26 1.024 . . . . 0.0 110.617 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -65.78 -18.13 65.12 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.95 -34.28 64.24 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.431 1.014 . . . . 0.0 110.916 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.85 -54.76 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.867 0.867 . . . . 0.0 111.236 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.63 3.21 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.99 -21.0 43.95 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.51 24.34 4.16 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 125.337 1.446 . . . . 0.0 113.69 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 54.0 m -125.72 161.9 26.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.956 1.302 . . . . 0.0 114.298 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 97.4 m -96.99 149.55 21.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.917 1.287 . . . . 0.0 108.756 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -166.16 158.61 14.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -147.61 152.15 37.42 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.758 1.623 . . . . 0.0 110.792 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.54 129.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -162.79 133.52 4.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.063 0.545 . . . . 0.0 110.913 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -153.85 49.82 0.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.974 0.893 . . . . 0.0 112.635 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.8 m -56.56 -30.02 62.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 tp -71.84 -39.28 69.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.396 0.998 . . . . 0.0 112.069 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -41.6 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.186 0.994 . . . . 0.0 110.644 169.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.0 -11.82 50.66 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.16 0.984 . . . . 0.0 113.58 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.78 -22.64 60.81 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.205 0.911 . . . . 0.0 113.036 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.81 -43.23 0.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 119.619 3.192 . . . . 0.0 119.619 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -100.38 147.74 33.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 121.0 1.727 . . . . 0.0 114.031 -154.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.53 -27.99 3.06 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.769 2.979 . . . . 0.0 112.715 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ttp-105 74.12 115.03 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.613 2.765 . . . . 0.0 115.014 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.1 91.12 1.22 Allowed 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.121 3.214 . . . . 0.0 109.623 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 t -50.11 -46.72 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.476 1.511 . . . . 0.0 113.742 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -38.28 84.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.679 0.672 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.7 -35.31 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.788 0.835 . . . . 0.0 111.952 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.5 mm -63.7 -49.11 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 119.898 1.226 . . . . 0.0 110.727 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.59 -39.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.558 0.743 . . . . 0.0 110.692 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -68.07 -40.45 82.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.217 0.607 . . . . 0.0 111.107 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m -61.76 -44.77 96.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.099 0.959 . . . . 0.0 111.363 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.31 74.53 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.155 0.982 . . . . 0.0 111.578 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.91 -18.6 65.45 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.17 -44.44 16.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.649 1.113 . . . . 0.0 112.397 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.1 ptm -77.44 -17.43 58.1 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.6 p -42.23 125.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.632 0.773 . . . . 0.0 112.251 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.14 -4.16 86.42 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.988 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -72.02 160.53 32.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.407 2.103 . . . . 0.0 111.365 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.73 151.19 48.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.681 1.592 . . . . 0.0 112.213 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.6 mtm -144.41 143.74 31.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.371 1.068 . . . . 0.0 112.94 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -145.72 -151.23 0.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.659 1.184 . . . . 0.0 111.227 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.7 t80 71.22 -56.72 0.62 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.8 2.84 . . . . 0.0 114.134 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.4 m -72.77 162.75 29.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.789 1.236 . . . . 0.0 112.789 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 pt -63.6 150.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.634 0.773 . . . . 0.0 111.536 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.46 -29.56 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.7 p -67.94 -45.15 75.07 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.47 -0.769 . . . . 0.0 111.241 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.03 -30.05 67.24 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.42 -0.8 . . . . 0.0 112.213 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.99 -43.41 77.61 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.494 1.043 . . . . 0.0 110.949 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.0 m -66.39 -46.88 75.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.528 1.531 . . . . 0.0 113.22 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -64.74 -42.65 95.02 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.128 -0.982 . . . . 0.0 112.369 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -62.22 -34.12 75.88 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 111.292 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.53 -55.57 32.84 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.111 0.868 . . . . 0.0 111.274 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.56 -20.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -71.02 -42.66 69.26 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.742 1.155 . . . . 0.0 110.331 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -63.15 -24.81 68.06 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.633 1.106 . . . . 0.0 112.988 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.56 -59.52 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.661 0.664 . . . . 0.0 111.785 169.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -76.51 8.34 3.61 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -56.53 -27.34 57.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.053 2.141 . . . . 0.0 112.83 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.75 -25.42 55.85 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 126.931 2.205 . . . . 0.0 115.142 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -149.51 14.73 0.87 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.254 1.32 0 CA-C-O 116.958 -1.496 . . . . 0.0 113.552 175.4 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.21 -165.05 0.24 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.594 1.958 . . . . 0.0 113.325 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -170.86 156.19 4.83 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 127.142 2.177 . . . . 0.0 110.936 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.51 158.79 50.44 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.408 2.739 . . . . 0.0 111.708 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -158.14 155.88 29.92 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.091 1.356 . . . . 0.0 111.081 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.64 155.3 12.5 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.732 1.613 . . . . 0.0 110.906 -173.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.75 91.04 41.51 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.281 1.032 . . . . 0.0 110.727 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.47 149.36 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.548 2.832 . . . . 0.0 111.364 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.29 159.82 16.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 126.528 1.931 . . . . 0.0 110.942 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.32 143.76 71.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.652 2.235 . . . . 0.0 112.818 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.38 61.96 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.495 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -114.61 157.12 23.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.203 1.502 . . . . 0.0 112.018 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.99 160.02 16.36 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 123.297 1.522 . . . . 0.0 111.044 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.2 mt -137.1 129.42 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 125.575 1.55 . . . . 0.0 107.247 -159.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.32 124.47 33.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.028 0.931 . . . . 0.0 108.516 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.16 137.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.999 2.12 . . . . 0.0 108.692 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.59 62.37 4.64 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -57.65 -45.35 85.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.003 1.721 . . . . 0.0 115.217 -169.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -145.92 29.07 1.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -156.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.84 87.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.541 1.067 . . . . 0.0 113.126 -169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.3 155.64 44.52 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 110.415 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.47 133.9 51.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.567 1.547 . . . . 0.0 111.752 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -150.85 145.9 25.98 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.259 1.424 . . . . 0.0 110.794 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -89.51 162.54 15.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.89 136.99 20.84 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.417 2.287 . . . . 0.0 109.933 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.72 117.0 33.36 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.254 1.822 . . . . 0.0 109.176 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -73.75 111.24 8.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.414 1.085 . . . . 0.0 111.753 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 pt -98.82 -20.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.83 -179.96 40.79 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.832 1.682 . . . . 0.0 110.5 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.11 95.01 0.08 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.363 1.082 . . . . 0.0 113.279 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.07 -2.08 85.08 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.664 2.078 . . . . 0.0 114.486 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -95.76 137.08 35.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.25 1.525 . . . . 0.0 112.105 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.18 152.79 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.752 1.221 . . . . 0.0 112.972 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.46 132.69 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -149.04 156.92 42.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.468 -0.77 . . . . 0.0 111.033 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.3 145.0 32.36 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.85 103.26 16.17 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 168.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.63 166.29 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.909 2.406 . . . . 0.0 113.002 -169.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.56 137.51 81.72 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.62 2.88 . . . . 0.0 111.896 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.5 m -167.31 170.18 11.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.436 2.294 . . . . 0.0 109.481 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -87.46 107.2 18.45 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.866 -1.146 . . . . 0.0 108.512 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -77.74 -47.42 2.34 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -169.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -85.29 170.58 9.34 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.579 2.853 . . . . 0.0 111.73 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.33 44.99 2.75 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.198 1.38 . . . . 0.0 113.299 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.14 154.76 22.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.41 1.484 . . . . 0.0 113.503 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.91 -18.81 52.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.364 1.459 . . . . 0.0 114.325 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.0 m -72.23 141.73 48.98 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.744 1.272 . . . . 0.0 111.195 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.9 p -62.17 -14.92 42.34 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 p -74.04 -13.48 60.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.741 1.616 . . . . 0.0 114.076 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.36 174.31 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.367 1.467 . . . . 0.0 112.507 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -155.4 -29.82 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.537 1.135 . . . . 0.0 113.607 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.4 m -64.2 154.93 33.4 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.592 1.157 . . . . 0.0 112.531 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 p -155.03 145.74 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.155 0.982 . . . . 0.0 111.546 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -127.95 137.99 52.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.834 1.653 . . . . 0.0 109.763 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -172.07 -170.51 0.75 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.075 1.35 . . . . 0.0 112.074 -174.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.5 m120 71.24 -38.91 0.43 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 128.916 2.886 . . . . 0.0 115.499 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.6 m -70.46 166.95 19.34 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.194 0.998 . . . . 0.0 113.199 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.56 162.33 40.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.608 1.563 . . . . 0.0 110.485 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -154.16 137.95 16.18 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.122 -0.986 . . . . 0.0 112.065 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.4 t -82.27 127.97 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.469 1.108 . . . . 0.0 109.928 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -138.34 155.28 48.71 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.123 1.369 . . . . 0.0 112.898 -170.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -98.37 138.81 35.06 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 110.071 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -163.52 172.18 14.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.211 1.404 . . . . 0.0 110.087 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -94.17 144.29 25.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.07 -1.019 . . . . 0.0 112.293 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.49 -46.34 73.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.224 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.89 -34.24 58.87 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.35 -38.7 23.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.799 0.84 . . . . 0.0 111.591 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.8 -36.48 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.54 0.736 . . . . 0.0 111.744 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.6 t -80.09 -50.36 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.715 1.206 . . . . 0.0 111.182 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.42 63.59 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 119.287 0.949 . . . . 0.0 115.132 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.27 -3.94 60.15 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.736 1.636 . . . . 0.0 115.228 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -70.01 171.05 10.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.117 1.459 . . . . 0.0 113.679 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.16 149.47 39.0 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.834 0.854 . . . . 0.0 111.168 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -158.03 160.2 37.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.107 0.963 . . . . 0.0 113.535 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -157.75 144.12 17.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.307 1.043 . . . . 0.0 111.706 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.48 130.72 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.409 -0.807 . . . . 0.0 109.055 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -169.44 118.51 0.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.33 1.452 . . . . 0.0 110.415 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -98.46 0.15 44.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.9 p 56.97 -49.74 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.175 1 C-N-CA 133.397 4.679 . . . . 0.0 118.039 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 mt -114.48 -23.79 9.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.764 1.625 . . . . 0.0 113.604 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -35.75 77.69 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.283 -0.886 . . . . 0.0 112.067 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -66.65 -16.73 64.42 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.676 1.19 . . . . 0.0 112.921 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -93.25 -30.45 15.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.507 1.123 . . . . 0.0 113.15 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -114.82 -43.59 3.12 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -169.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -153.89 162.19 27.38 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -139.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -88.81 -33.16 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 124.537 3.491 . . . . 0.0 113.761 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 66.7 132.85 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 128.902 2.881 . . . . 0.0 115.984 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.37 94.09 1.07 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.49 2.793 . . . . 0.0 110.461 172.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -57.67 -39.71 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.169 0.988 . . . . 0.0 112.564 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.75 -39.81 76.52 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.634 0.652 . . . . 0.0 111.542 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.9 -35.92 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.416 0.686 . . . . 0.0 109.95 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.283 24.8 mt -77.92 -33.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.304 -0.855 . . . . 0.0 112.045 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.0 mt -65.51 -40.28 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.177 1.353 . . . . 0.0 110.369 169.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -65.81 -38.92 90.23 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.842 -0.536 . . . . 0.0 110.877 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.1 m -63.64 -46.55 85.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.208 1.003 . . . . 0.0 111.743 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.46 91.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.488 0.715 . . . . 0.0 112.082 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -62.61 -48.59 78.73 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 111.911 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -60.52 -30.3 69.65 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.197 -0.94 . . . . 0.0 113.204 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.7 mtp -75.42 -4.91 42.24 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.92 1.288 . . . . 0.0 114.454 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -56.19 121.94 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.016 1.28 . . . . 0.0 109.311 171.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.41 -2.42 60.92 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.228 1.394 . . . . 0.0 115.086 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.66 127.13 31.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.654 1.727 . . . . 0.0 110.482 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -99.93 132.52 45.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.941 2.097 . . . . 0.0 111.681 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -117.3 174.6 6.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.66 1.984 . . . . 0.0 110.38 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -126.52 -160.04 0.96 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.315 1.046 . . . . 0.0 112.442 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -73.32 150.1 42.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 112.985 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.0 m 176.82 171.8 0.47 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.299 3.039 . . . . 0.0 108.645 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.46 123.62 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.43 -35.66 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.81 0.844 . . . . 0.0 112.494 -169.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -55.43 -56.36 21.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.457 0.703 . . . . 0.0 111.423 173.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.25 -34.88 78.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.211 -0.931 . . . . 0.0 111.853 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.4 -44.77 92.75 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.901 1.228 . . . . 0.0 111.374 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.0 p -77.37 -37.25 52.55 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.907 0.883 . . . . 0.0 113.034 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.43 -45.57 92.5 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.568 1.076 . . . . 0.0 112.206 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -62.87 -36.24 82.64 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.599 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.43 -55.26 33.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.722 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.02 -24.25 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 120.545 1.521 . . . . 0.0 113.316 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -70.21 -39.09 75.34 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.446 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.38 -23.39 66.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.483 1.038 . . . . 0.0 113.367 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.45 -60.21 2.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.723 1.147 . . . . 0.0 111.01 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -77.69 6.41 7.41 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -26.04 27.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.76 2.024 . . . . 0.0 112.077 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.3 -17.67 32.65 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 127.249 2.357 . . . . 0.0 115.183 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -134.15 -28.78 1.31 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.415 1.086 . . . . 0.0 112.922 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.416 0.15 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.95 159.73 32.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.232 1.013 . . . . 0.0 112.822 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.5 m -70.36 147.53 95.16 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 124.05 0.94 . . . . 0.0 112.528 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.54 -16.35 9.32 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.468 2.779 . . . . 0.0 113.802 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -67.94 150.28 48.71 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.203 1.001 . . . . 0.0 113.663 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -93.04 135.07 34.55 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.774 1.23 . . . . 0.0 110.619 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -160.89 129.25 2.93 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.528 1.131 . . . . 0.0 110.178 170.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.63 143.72 27.45 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.805 3.003 . . . . 0.0 110.752 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.09 132.5 23.69 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.043 0.937 . . . . 0.0 111.601 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.8 132.84 25.82 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.263 2.642 . . . . 0.0 111.316 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.52 -4.23 74.35 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.714 1.149 . . . . 0.0 114.947 -175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -105.09 168.07 9.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 122.652 1.215 . . . . 0.0 113.234 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.0 113.13 25.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.814 1.646 . . . . 0.0 112.353 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.68 127.85 43.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 124.796 1.238 . . . . 0.0 108.574 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -90.91 116.72 28.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.9 mm -105.65 112.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.392 1.477 . . . . 0.0 109.142 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 73.94 8.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.783 0.72 . . . . 0.0 109.804 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.25 3.77 2.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.0 mt 102.57 126.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 131.577 3.951 . . . . 0.0 110.708 158.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.61 -3.82 39.85 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.202 0.905 . . . . 0.0 113.67 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -171.22 160.35 6.22 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.853 2.461 . . . . 0.0 110.836 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -127.41 127.32 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.994 1.318 . . . . 0.0 110.463 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -108.74 151.3 26.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.913 1.285 . . . . 0.0 111.721 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -90.18 145.07 25.31 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 122.181 -0.325 . . . . 0.0 111.057 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.55 34.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.266 1.026 . . . . 0.0 111.67 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.7 119.32 33.99 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.623 1.569 . . . . 0.0 108.42 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -72.58 96.02 1.91 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 118.558 0.617 . . . . 0.0 111.123 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 pt -84.78 -22.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.18 173.34 30.65 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 124.731 1.158 . . . . 0.0 110.344 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.55 90.76 0.56 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.688 0.756 . . . . 0.0 110.537 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.15 -0.12 47.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.895 2.188 . . . . 0.0 115.109 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.46 140.39 49.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.284 1.542 . . . . 0.0 112.544 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.58 151.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.5 mm -110.65 129.29 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 168.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.17 157.06 43.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.262 0.937 . . . . 0.0 112.773 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.75 120.9 38.96 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.782 0.833 . . . . 0.0 110.938 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.33 120.53 66.55 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.89 1.276 . . . . 0.0 108.167 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.91 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.714 2.942 . . . . 0.0 113.209 -169.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.44 163.59 12.43 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.477 3.452 . . . . 0.0 112.926 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 t -159.41 171.14 20.3 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 91.59 154.37 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 130.729 3.612 . . . . 0.0 112.676 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -74.21 120.33 80.82 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.22 1.008 . . . . 0.0 112.204 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.82 142.17 68.5 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.078 2.518 . . . . 0.0 110.748 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.62 -21.96 12.58 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.124 0.869 . . . . 0.0 113.896 -170.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 46.67 -132.21 1.18 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.623 1.969 . . . . 0.0 112.734 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.77 12.41 70.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.883 1.23 . . . . 0.0 115.21 174.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 83.4 p -104.95 173.95 6.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.384 1.474 . . . . 0.0 112.926 -175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 p -69.61 -22.63 63.48 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.843 -1.161 . . . . 0.0 112.322 169.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.1 p -83.29 -30.27 27.71 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.089 0.956 . . . . 0.0 113.418 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -162.8 133.27 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.676 1.19 . . . . 0.0 112.425 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -139.61 -18.06 0.97 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.074 1.35 . . . . 0.0 113.919 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 p -82.61 -31.37 28.92 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.98 149.9 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.686 1.594 . . . . 0.0 111.462 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -80.93 -33.36 34.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.555 0.742 . . . . 0.0 112.454 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 t -165.45 125.94 1.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.735 1.214 . . . . 0.0 110.583 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -84.68 147.0 27.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.237 1.015 . . . . 0.0 111.044 170.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -70.77 160.94 31.78 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.01 159.88 32.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.49 1.116 . . . . 0.0 109.607 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.44 136.37 29.41 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 111.312 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.69 121.32 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.461 1.105 . . . . 0.0 108.213 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -124.92 156.61 37.71 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.219 1.407 . . . . 0.0 112.418 -171.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -111.07 137.3 48.88 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.707 1.603 . . . . 0.0 110.846 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.39 171.37 10.63 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.037 0.935 . . . . 0.0 111.426 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -84.56 140.0 31.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.694 1.598 . . . . 0.0 110.246 172.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 tp -56.33 -48.38 76.86 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.354 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.32 -28.91 63.5 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.86 -41.33 19.11 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.735 0.814 . . . . 0.0 111.23 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.56 -37.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.979 0.512 . . . . 0.0 111.441 170.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.01 -50.11 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.142 0.977 . . . . 0.0 111.915 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.46 24.16 65.52 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 119.754 1.161 . . . . 0.0 114.788 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.17 1.25 64.97 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.346 1.45 . . . . 0.0 115.305 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.1 m -71.97 170.61 13.44 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.842 1.321 . . . . 0.0 113.269 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.19 149.11 32.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.231 1.012 . . . . 0.0 111.668 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -159.27 154.2 24.88 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -148.73 157.54 43.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.401 1.88 . . . . 0.0 110.662 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.8 t -88.49 139.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-N 119.123 0.874 . . . . 0.0 110.065 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -156.17 64.5 0.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.425 1.49 . . . . 0.0 111.213 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.79 65.67 5.03 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.704 -1.248 . . . . 0.0 110.139 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -48.39 -56.64 7.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.569 1.948 . . . . 0.0 114.477 -170.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.92 -32.05 72.23 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.71 -44.3 90.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.744 -0.597 . . . . 0.0 111.626 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -61.39 -31.62 71.53 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.617 0.767 . . . . 0.0 112.393 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -40.86 63.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.427 1.091 . . . . 0.0 113.557 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.9 -39.35 4.27 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -148.58 158.15 40.57 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.671 2.101 . . . . 0.0 116.671 -134.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.83 -22.32 0.89 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.195 3.263 . . . . 0.0 114.098 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 20.97 116.63 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 131.459 3.904 . . . . 0.0 118.614 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.64 116.42 3.93 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.683 2.922 . . . . 0.0 111.7 -171.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.69 -32.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.524 1.129 . . . . 0.0 112.923 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -63.39 -35.55 80.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.591 0.632 . . . . 0.0 111.607 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.19 -38.23 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.734 0.814 . . . . 0.0 110.047 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.7 mt -74.01 -35.38 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.655 -0.653 . . . . 0.0 112.273 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.42 -37.02 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.117 -0.989 . . . . 0.0 110.399 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 m -66.41 -43.52 85.5 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.579 -0.701 . . . . 0.0 111.709 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -53.35 -43.41 67.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.144 0.978 . . . . 0.0 112.222 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.29 79.45 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.569 -0.707 . . . . 0.0 111.969 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -66.63 -14.91 63.03 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.66 -39.4 14.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.322 1.049 . . . . 0.0 111.897 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.2 mtp -75.58 -18.33 59.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.02 126.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.813 1.188 . . . . 0.0 111.845 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.65 -7.43 81.86 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.395 1.474 . . . . 0.0 115.009 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -70.65 151.67 44.7 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.621 1.711 . . . . 0.0 110.675 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -132.18 149.94 52.27 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.612 1.565 . . . . 0.0 112.385 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 69.2 mtm -149.48 158.37 44.12 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.422 1.489 . . . . 0.0 111.332 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -140.17 16.46 2.43 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.176 -0.953 . . . . 0.0 112.869 171.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.97 143.38 26.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.849 -171.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 68.73 -171.82 0.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.046 1.738 . . . . 0.0 114.24 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.0 144.97 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.305 1.442 . . . . 0.0 108.869 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -34.69 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -170.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -67.16 -35.04 78.84 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.724 -0.61 . . . . 0.0 112.157 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -77.44 -32.37 54.52 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 121.409 -0.807 . . . . 0.0 111.736 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.06 -45.34 83.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 20.7 p -74.26 -37.52 63.71 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 121.704 -0.623 . . . . 0.0 112.679 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.77 -43.22 99.36 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.26 -0.9 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -56.67 -49.01 76.32 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 110.054 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -55.3 -52.11 64.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.246 1.018 . . . . 0.0 112.441 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.0 -32.72 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 120.167 1.349 . . . . 0.0 113.09 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 m -61.44 -47.34 86.18 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 116.428 -1.749 . . . . 0.0 108.774 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -56.98 -25.56 58.43 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 121.042 1.746 . . . . 0.0 114.208 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.15 -47.11 72.03 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.016 1.28 . . . . 0.0 111.88 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -92.54 -3.1 55.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -62.49 -24.37 67.44 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.534 1.934 . . . . 0.0 112.3 -169.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.28 -24.84 76.38 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.377 0.989 . . . . 0.0 113.855 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.44 -20.64 2.63 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.255 1.364 0 C-N-CA 124.924 1.29 . . . . 0.0 112.389 177.243 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.3 mtm . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 120.356 0.122 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.86 158.97 37.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.217 1.407 . . . . 0.0 111.998 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -72.2 151.79 92.39 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.021 0.929 . . . . 0.0 112.909 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.36 148.64 34.21 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.495 2.796 . . . . 0.0 111.059 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -146.64 159.48 43.4 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.142 1.377 . . . . 0.0 111.826 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -160.83 174.97 13.09 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.991 1.716 . . . . 0.0 110.431 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -154.13 134.85 8.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.261 1.024 . . . . 0.0 112.064 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -81.41 155.67 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.283 2.656 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -102.51 151.21 38.18 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.891 . . . . 0.0 111.986 -177.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.97 136.76 39.18 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.683 2.255 . . . . 0.0 111.326 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.05 69.71 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.859 1.695 . . . . 0.0 114.637 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -94.64 165.77 12.35 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.187 1.493 . . . . 0.0 114.668 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -88.42 116.04 26.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.624 1.57 . . . . 0.0 111.892 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.43 121.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 109.229 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -99.34 103.58 15.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.574 1.95 . . . . 0.0 108.06 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.01 119.28 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.515 1.126 . . . . 0.0 109.426 -171.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.33 62.04 5.07 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.881 -1.137 . . . . 0.0 110.777 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -30.53 70.92 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -169.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.98 34.16 0.25 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -161.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.69 68.92 Favored Glycine 0 N--CA 1.479 1.531 0 C-N-CA 124.193 0.902 . . . . 0.0 113.48 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -164.47 149.08 9.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.416 2.286 . . . . 0.0 110.134 -172.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -74.22 106.34 5.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.164 1.385 . . . . 0.0 111.372 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -86.94 126.88 34.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.004 1.721 . . . . 0.0 109.279 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -82.47 150.15 27.19 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.588 -0.695 . . . . 0.0 112.814 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.94 159.84 44.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.113 1.365 . . . . 0.0 111.469 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.82 121.8 35.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.149 1.78 . . . . 0.0 108.466 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.89 90.37 3.51 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.701 0.682 . . . . 0.0 112.154 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.31 -18.43 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.23 -176.6 29.47 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 124.518 1.056 . . . . 0.0 111.629 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.83 90.0 0.78 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.007 0.908 . . . . 0.0 111.034 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 -3.78 80.06 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.348 1.928 . . . . 0.0 114.269 -174.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.68 138.64 35.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.655 1.727 . . . . 0.0 112.28 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.68 152.99 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mm -110.79 139.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.36 1.864 . . . . 0.0 106.697 168.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -157.89 134.7 9.88 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.38 0.991 . . . . 0.0 112.467 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.77 113.27 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.454 -0.779 . . . . 0.0 110.251 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.22 120.76 80.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.267 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.35 161.07 43.55 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.665 2.91 . . . . 0.0 112.943 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.78 164.14 18.31 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.645 2.897 . . . . 0.0 111.844 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.0 m -154.04 -139.25 0.08 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.773 2.029 . . . . 0.0 110.6 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -166.24 172.71 10.87 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.382 -1.449 . . . . 0.0 112.121 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -143.33 141.42 19.21 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.842 1.657 . . . . 0.0 110.054 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.39 117.86 4.52 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.407 2.738 . . . . 0.0 113.092 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.46 7.72 88.27 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.803 1.192 . . . . 0.0 115.769 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.0 134.53 57.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.913 0.885 . . . . 0.0 111.767 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.93 12.52 43.19 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.596 1.093 . . . . 0.0 113.838 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.8 m -133.51 -40.99 0.87 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 p -162.07 -53.79 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -172.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -78.97 -32.37 45.33 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -170.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 p -168.98 147.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.398 1.879 . . . . 0.0 109.915 -171.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -125.76 -5.94 6.88 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.0 p -92.21 -0.82 57.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.197 1.399 . . . . 0.0 114.516 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.07 114.73 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.413 1.085 . . . . 0.0 110.407 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 tp -82.72 -22.31 34.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.913 1.285 . . . . 0.0 112.775 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -59.73 -15.0 16.72 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -73.27 -11.83 60.64 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.99 -1.069 . . . . 0.0 113.716 171.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 m -113.62 155.54 25.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.927 1.291 . . . . 0.0 111.029 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.19 158.35 15.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.291 1.036 . . . . 0.0 111.55 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.92 135.05 32.43 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 0.0 111.83 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -80.69 114.29 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.971 1.308 . . . . 0.0 108.323 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -121.2 173.06 7.55 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.267 1.827 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.8 35.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.422 1.489 . . . . 0.0 111.82 -174.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 174.01 -159.47 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.93 2.892 . . . . 0.0 108.421 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.14 150.97 19.92 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.17 0.986 . . . . 0.0 113.446 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -50.34 -51.46 45.43 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.136 1.775 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -55.04 -29.85 58.31 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.01 -42.77 15.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.816 0.846 . . . . 0.0 111.337 174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.61 -33.47 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.913 -0.492 . . . . 0.0 111.965 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.0 t -86.77 -46.98 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.511 1.124 . . . . 0.0 111.495 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.99 -121.48 24.9 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -172.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.14 1.04 62.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.651 1.12 . . . . 0.0 114.892 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.7 m -73.13 162.43 29.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.899 1.35 . . . . 0.0 113.921 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.2 m -79.44 151.14 31.04 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.871 0.869 . . . . 0.0 110.989 169.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -156.46 167.99 28.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.962 0.905 . . . . 0.0 112.852 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -161.7 159.22 27.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.6 1.56 . . . . 0.0 109.933 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -82.75 132.5 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.723 1.147 . . . . 0.0 109.175 169.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -80.3 -70.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.492 0.717 . . . . 0.0 112.051 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 63.37 8.89 3.72 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.535 1.934 . . . . 0.0 114.332 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.6 m -69.28 -36.28 76.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 119.076 -2.265 . . . . 0.0 113.506 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.5 mt -68.9 -37.92 79.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.997 0.519 . . . . 0.0 111.718 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -64.79 -43.64 92.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.513 -0.742 . . . . 0.0 111.116 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.29 -26.15 62.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.075 1.35 . . . . 0.0 112.873 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.57 -29.99 46.55 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.132 0.973 . . . . 0.0 112.41 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -126.19 -46.52 1.65 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.51 152.51 45.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -143.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.31 -10.08 12.42 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 124.565 3.51 . . . . 0.0 114.393 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 74.32 106.79 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.595 2.358 . . . . 0.0 114.377 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.47 71.54 6.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.721 2.948 . . . . 0.0 109.03 169.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 t -46.24 -38.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 126.436 1.894 . . . . 0.0 114.687 -169.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.69 -38.17 90.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.802 0.841 . . . . 0.0 111.703 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -75.63 -30.99 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.2 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.08 -45.52 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.491 0.587 . . . . 0.0 110.78 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.41 -39.56 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.822 -0.549 . . . . 0.0 110.376 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 m -63.5 -43.5 97.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.97 0.508 . . . . 0.0 111.592 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 t -59.37 -45.47 91.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 111.658 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.42 90.75 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.218 -0.926 . . . . 0.0 112.082 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.94 -19.07 64.94 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -82.32 -37.11 26.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.687 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.0 mtp -70.98 -32.01 68.73 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.4 p -44.54 129.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.14 -8.85 79.02 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.45 1.5 . . . . 0.0 114.837 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -78.99 159.59 27.58 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.949 1.875 . . . . 0.0 112.317 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -104.5 156.91 17.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.572 1.549 . . . . 0.0 112.012 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.3 tpp -141.14 140.02 34.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.527 1.531 . . . . 0.0 110.292 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.37 -7.17 0.62 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -78.3 132.26 37.39 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.135 -0.978 . . . . 0.0 113.111 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 t 69.48 -175.9 0.2 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.3 1.84 . . . . 0.0 114.894 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.9 pt -75.14 157.64 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.822 1.649 . . . . 0.0 111.322 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.46 -38.46 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -169.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.5 m -59.11 -51.08 71.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.742 0.817 . . . . 0.0 111.679 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -75.48 -33.05 60.78 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.964 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.99 -46.08 75.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.067 1.303 . . . . 0.0 111.766 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.3 m -76.82 -38.4 53.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.055 0.942 . . . . 0.0 112.45 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.07 -45.16 93.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.249 -0.907 . . . . 0.0 112.412 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -58.36 -39.86 80.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.78 1.632 . . . . 0.0 110.565 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -61.68 -54.55 41.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.195 0.998 . . . . 0.0 112.154 171.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 m -67.67 -25.27 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.809 1.641 . . . . 0.0 113.742 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 m -72.4 -42.17 65.47 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 117.687 -1.149 . . . . 0.0 110.959 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.22 -18.11 59.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.261 1.391 . . . . 0.0 113.647 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 mt -64.41 -47.6 78.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.237 0.926 . . . . 0.0 110.12 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.3 mtm-85 -72.48 -92.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 70.36 -2.91 2.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 129.2 3.0 . . . . 0.0 113.028 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.3 -99.37 0.54 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 126.782 2.134 . . . . 0.0 114.226 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -82.65 9.46 9.5 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.174 1.39 . . . . 0.0 113.636 -171.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 127.088 2.155 . . . . 0.0 112.003 -179.18 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.03 162.34 29.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.966 0.907 . . . . 0.0 113.147 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 p -74.04 151.88 88.44 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.018 0.927 . . . . 0.0 112.765 175.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -77.94 160.56 30.43 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.73 2.953 . . . . 0.0 112.152 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -80.79 2.69 25.17 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.401 1.08 . . . . 0.0 113.741 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -152.63 131.04 12.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.563 1.945 . . . . 0.0 108.813 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -157.63 103.63 1.81 Allowed Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.722 0.809 . . . . 0.0 111.09 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.51 144.87 10.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.336 2.691 . . . . 0.0 109.701 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.39 159.5 23.66 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.841 1.257 . . . . 0.0 112.312 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.43 137.27 80.72 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.411 2.74 . . . . 0.0 114.924 -168.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.24 63.94 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 126.323 1.916 . . . . 0.0 115.182 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -96.63 154.76 17.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -169.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -94.23 112.67 24.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.73 1.612 . . . . 0.0 111.51 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.9 mt -101.29 127.22 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.034 1.334 . . . . 0.0 109.858 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.51 115.58 28.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.22 117.53 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.75 1.62 . . . . 0.0 108.068 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.63 -32.22 71.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.337 0.655 . . . . 0.0 112.681 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.03 -71.3 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 129.369 3.068 . . . . 0.0 115.251 174.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.74 26.23 0.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.34 1.456 . . . . 0.0 113.715 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.21 -59.5 0.38 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.657 1.599 . . . . 0.0 109.895 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.05 122.01 21.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.974 0.509 . . . . 0.0 109.919 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -94.21 150.37 20.37 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.793 0.837 . . . . 0.0 111.972 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -121.36 148.56 44.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.714 1.206 . . . . 0.0 111.794 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -89.8 149.53 22.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.213 0.605 . . . . 0.0 110.582 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.02 146.91 33.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.031 0.932 . . . . 0.0 112.927 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.54 117.86 35.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.175 1.79 . . . . 0.0 108.143 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -73.54 109.89 7.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.475 0.71 . . . . 0.0 110.286 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -100.75 -17.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.59 175.76 31.06 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 126.061 1.791 . . . . 0.0 109.595 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -69.68 86.31 0.48 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.013 0.906 . . . . 0.0 111.315 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.05 -13.49 37.49 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.188 2.327 . . . . 0.0 114.327 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.59 139.24 33.79 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.875 1.27 . . . . 0.0 112.735 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -135.35 151.91 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.88 1.272 . . . . 0.0 113.189 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.5 128.63 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -144.02 160.28 41.14 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.142 -0.974 . . . . 0.0 111.779 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.44 122.5 45.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.881 0.872 . . . . 0.0 111.141 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.63 117.47 68.18 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.528 1.531 . . . . 0.0 107.27 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.69 162.52 39.46 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.543 2.829 . . . . 0.0 114.409 -168.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.72 141.79 34.66 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.69 2.927 . . . . 0.0 109.716 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -168.16 -177.79 3.43 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.94 0.896 . . . . 0.0 112.69 -170.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -166.24 160.6 16.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.831 2.052 . . . . 0.0 112.409 -177.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -68.98 155.72 92.96 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.376 1.07 . . . . 0.0 112.062 170.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.14 -6.37 15.96 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.907 3.071 . . . . 0.0 115.151 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.52 -34.51 86.01 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 119.628 1.104 . . . . 0.0 112.962 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.05 -17.11 64.75 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.0 11.41 57.35 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.987 1.756 . . . . 0.0 113.828 171.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.7 m -129.12 179.42 5.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.604 1.561 . . . . 0.0 111.885 -175.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -58.26 -20.47 42.59 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.148 -1.595 . . . . 0.0 114.025 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.0 p -81.52 5.11 18.9 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.253 1.821 . . . . 0.0 114.113 173.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -41.08 133.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.266 1.826 . . . . 0.0 114.105 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 23.3 t80 93.56 -22.4 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 130.159 3.384 . . . . 0.0 112.652 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -64.47 -31.81 73.17 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 121.242 -0.911 . . . . 0.0 111.392 169.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -104.95 134.82 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.917 2.087 . . . . 0.0 107.496 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.9 mt -124.07 161.42 25.62 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.576 1.551 . . . . 0.0 110.432 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m -68.28 134.15 49.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -77.27 161.35 28.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.62 1.168 . . . . 0.0 111.199 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -82.33 160.17 22.92 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.4 -0.812 . . . . 0.0 112.595 171.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.36 156.11 35.81 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.298 1.039 . . . . 0.0 110.404 169.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -141.58 134.75 29.28 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.806 0.843 . . . . 0.0 111.379 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.82 126.84 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.09 0.956 . . . . 0.0 109.244 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -129.26 152.64 48.6 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.614 1.566 . . . . 0.0 112.151 -170.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -105.07 139.08 40.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.551 1.54 . . . . 0.0 110.37 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -167.01 172.96 9.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.622 1.169 . . . . 0.0 110.482 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.59 143.08 27.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 111.083 170.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 tp -55.05 -49.95 70.32 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.582 -0.699 . . . . 0.0 111.561 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -30.95 62.6 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -79.36 -40.34 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.819 0.736 . . . . 0.0 111.285 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.77 -37.92 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 122.099 -0.376 . . . . 0.0 111.187 171.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.47 -37.32 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.047 1.339 . . . . 0.0 112.767 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.78 20.75 74.55 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.86 0.743 . . . . 0.0 114.333 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.32 2.64 89.09 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.211 1.386 . . . . 0.0 114.785 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.27 -167.84 1.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.149 1.38 . . . . 0.0 113.004 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 79.7 m -84.35 150.99 25.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.16 1.384 . . . . 0.0 113.139 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -163.54 160.96 23.71 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.208 1.403 . . . . 0.0 113.222 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.1 153.5 11.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.061 1.744 . . . . 0.0 111.834 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.76 140.92 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.676 1.126 . . . . 0.0 110.617 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -146.93 87.32 1.68 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.318 1.447 . . . . 0.0 111.019 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.28 69.19 4.45 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.667 1.187 . . . . 0.0 108.792 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.8 p -60.26 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.621 1.968 . . . . 0.0 114.288 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 mt -60.43 -22.97 64.02 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.297 -0.877 . . . . 0.0 113.075 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.89 -37.09 60.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.98 1.712 . . . . 0.0 111.525 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -63.48 -20.54 65.68 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.842 1.257 . . . . 0.0 112.702 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -88.0 -25.35 23.18 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.084 1.354 . . . . 0.0 112.907 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.81 -29.71 1.68 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -169.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -120.34 122.91 28.49 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -132.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -70.77 -21.26 29.04 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.454 3.436 . . . . 0.0 115.744 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 69.16 83.13 0.17 Allowed Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 127.721 2.408 . . . . 0.0 114.888 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.38 95.97 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.8 3.0 . . . . 0.0 109.158 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.2 -41.38 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.665 0.786 . . . . 0.0 111.963 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.24 -35.86 78.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.587 0.63 . . . . 0.0 112.106 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -42.73 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.595 0.758 . . . . 0.0 110.084 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.6 mt -71.55 -34.23 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.812 -0.555 . . . . 0.0 112.101 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.87 -38.83 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.26 -0.9 . . . . 0.0 110.365 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -64.4 -42.32 96.17 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.571 -0.706 . . . . 0.0 111.303 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -56.97 -44.33 82.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.263 1.025 . . . . 0.0 111.832 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.93 87.81 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.337 -0.852 . . . . 0.0 112.184 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -67.53 -14.96 63.39 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.85 -36.71 15.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 111.864 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.3 mtp -70.75 -23.56 62.45 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.911 1.284 . . . . 0.0 113.767 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -46.66 123.61 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.489 1.04 . . . . 0.0 112.309 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.78 83.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.359 1.457 . . . . 0.0 115.193 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 160.57 30.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.747 1.773 . . . . 0.0 111.327 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -131.32 157.22 43.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.162 1.385 . . . . 0.0 112.973 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.6 mtm -143.76 159.28 42.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.531 1.532 . . . . 0.0 111.298 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -143.65 -1.53 1.0 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -86.43 152.49 22.64 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.642 1.177 . . . . 0.0 113.459 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 m 75.61 168.71 0.27 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.531 2.332 . . . . 0.0 114.107 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.68 147.49 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 109.062 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -49.98 -36.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 p -64.1 -49.39 72.42 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.391 -0.818 . . . . 0.0 111.366 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.36 -30.05 65.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.575 -0.703 . . . . 0.0 112.1 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.81 -41.05 85.86 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.092 1.314 . . . . 0.0 111.5 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.63 -43.36 76.48 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.272 1.029 . . . . 0.0 112.561 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.25 -44.13 92.75 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.269 -0.894 . . . . 0.0 112.319 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -37.78 81.35 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.53 -1.356 . . . . 0.0 111.355 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -58.29 -56.81 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.68 0.792 . . . . 0.0 111.256 171.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.4 m -68.48 -23.57 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.618 1.099 . . . . 0.0 113.806 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 m -70.7 -41.66 71.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.621 1.101 . . . . 0.0 110.337 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.61 -27.94 69.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.57 1.077 . . . . 0.0 112.853 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.56 -57.23 5.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.822 0.737 . . . . 0.0 111.559 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -80.29 9.57 5.59 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -57.7 -25.25 60.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.381 1.873 . . . . 0.0 112.617 -172.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -46.12 -43.9 13.84 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 127.811 2.624 . . . . 0.0 115.178 -173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -137.54 22.15 2.93 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.715 1.206 . . . . 0.0 113.57 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.115 1.366 . . . . 0.0 111.381 -177.779 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.56 165.31 25.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.373 1.069 . . . . 0.0 112.813 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.3 p -162.57 156.3 17.69 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 125.451 1.5 . . . . 0.0 111.634 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.44 154.38 45.35 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.485 2.79 . . . . 0.0 111.837 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -81.98 -3.09 53.6 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -125.01 139.31 53.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.572 1.549 . . . . 0.0 110.686 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -150.59 132.11 7.65 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.919 1.288 . . . . 0.0 109.681 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.92 145.98 28.98 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.703 2.269 . . . . 0.0 110.261 172.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.04 149.72 38.44 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.141 0.976 . . . . 0.0 110.938 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.98 130.62 26.35 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.627 2.218 . . . . 0.0 111.3 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.59 61.37 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.361 1.934 . . . . 0.0 114.921 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -91.1 161.96 14.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.539 1.669 . . . . 0.0 114.355 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.67 110.2 22.81 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.722 1.609 . . . . 0.0 112.228 -169.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -90.49 123.03 42.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.385 1.074 . . . . 0.0 109.154 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -94.29 117.43 30.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.71 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.587 1.155 . . . . 0.0 108.762 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.27 -30.34 71.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.408 1.083 . . . . 0.0 112.907 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.259 26.1 tpt180 54.36 -111.87 0.66 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.825 2.05 . . . . 0.0 111.358 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.0 mt -133.74 42.78 2.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.119 0.968 . . . . 0.0 111.263 -161.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.94 6.52 37.15 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.872 1.225 . . . . 0.0 114.98 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -156.41 119.31 4.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.969 1.308 . . . . 0.0 111.045 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.5 142.91 48.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.792 1.237 . . . . 0.0 112.261 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.51 165.54 36.12 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.028 0.931 . . . . 0.0 112.881 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -92.45 152.53 19.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.2 150.1 43.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.979 1.711 . . . . 0.0 111.151 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.99 118.56 36.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.53 1.932 . . . . 0.0 107.586 174.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -73.7 102.91 4.09 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.658 0.663 . . . . 0.0 110.338 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.21 -17.43 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.8 -174.27 43.11 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -64.3 95.58 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.778 0.799 . . . . 0.0 111.603 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.43 6.07 64.69 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.639 2.066 . . . . 0.0 116.207 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -120.19 141.7 49.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.9 1.85 . . . . 0.0 113.3 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.87 151.36 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.901 1.281 . . . . 0.0 112.604 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 mm -111.42 134.09 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.57 152.85 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.573 1.078 . . . . 0.0 112.129 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.44 113.28 24.61 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.95 116.09 50.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.175 -0.917 . . . . 0.0 108.694 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.72 158.86 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.183 2.589 . . . . 0.0 111.931 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.12 52.62 4.14 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.402 3.401 . . . . 0.0 111.107 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.4 p -88.28 137.72 32.07 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.832 1.653 . . . . 0.0 112.633 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.77 -65.91 0.77 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -58.51 -38.38 64.89 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -170.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -60.63 -28.93 87.43 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.1 3.2 . . . . 0.0 114.683 173.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.42 -41.07 5.87 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.508 0.575 . . . . 0.0 112.411 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.82 -132.02 0.18 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.148 1.779 . . . . 0.0 111.885 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.31 -156.03 10.84 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.296 -0.878 . . . . 0.0 114.363 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.4 p -83.43 -30.46 27.27 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.8 m -76.25 -21.02 56.84 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.262 -0.899 . . . . 0.0 113.342 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 t -169.08 148.0 3.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.902 2.081 . . . . 0.0 109.747 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.75 -1.07 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -77.19 -22.89 51.71 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -169.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.4 m -76.67 53.94 0.93 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.034 1.334 . . . . 0.0 112.972 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 p -43.18 145.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.996 2.518 . . . . 0.0 113.805 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.2 tp -58.32 -33.5 69.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.245 1.018 . . . . 0.0 113.156 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.7 p -165.91 161.36 17.58 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.981 1.712 . . . . 0.0 111.464 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -70.08 -41.96 73.41 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.382 -0.824 . . . . 0.0 112.883 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m -128.95 170.85 12.94 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.723 1.609 . . . . 0.0 110.245 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.53 144.78 37.37 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.097 -1.002 . . . . 0.0 110.751 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.43 133.71 38.88 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.964 0.906 . . . . 0.0 110.887 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.13 125.23 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.856 0.862 . . . . 0.0 109.803 172.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -135.31 157.14 47.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.371 1.468 . . . . 0.0 112.316 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -109.71 133.43 53.14 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.795 1.638 . . . . 0.0 110.885 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -151.99 171.85 17.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.423 1.489 . . . . 0.0 111.526 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -85.89 148.77 25.64 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.269 0.628 . . . . 0.0 111.652 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.8 tp -52.45 -62.15 1.82 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.875 1.27 . . . . 0.0 111.582 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -66.12 -20.1 66.05 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.71 -36.82 70.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.515 1.052 . . . . 0.0 111.26 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.76 -44.53 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.131 0.972 . . . . 0.0 112.125 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.67 -1.66 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.69 109.89 3.13 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.466 1.03 . . . . 0.0 112.681 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 6.78 89.22 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.998 1.285 . . . . 0.0 114.337 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -112.72 152.76 28.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 112.485 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.9 m -83.47 149.92 26.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.819 0.848 . . . . 0.0 110.227 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -160.47 159.9 31.41 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -146.05 163.08 36.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.298 2.239 . . . . 0.0 109.852 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.15 143.1 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.509 170.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.38 144.36 46.55 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.622 1.169 . . . . 0.0 113.146 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -137.52 22.62 2.93 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.757 1.623 . . . . 0.0 112.362 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.3 t -62.44 -47.78 82.56 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.219 -1.551 . . . . 0.0 113.819 -169.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -73.46 -33.93 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.596 0.358 . . . . 0.0 111.868 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.86 -36.95 77.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.806 0.842 . . . . 0.0 112.134 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -65.08 -17.97 64.91 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.381 1.072 . . . . 0.0 112.854 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -80.01 -22.64 42.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.364 -0.835 . . . . 0.0 112.53 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -117.4 -57.22 2.16 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.51 149.62 63.36 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -140.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.86 -14.98 21.36 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 124.771 3.647 . . . . 0.0 113.632 172.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 77.56 90.76 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 127.158 2.183 . . . . 0.0 112.788 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.37 81.31 2.51 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.576 2.85 . . . . 0.0 108.889 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.76 -36.27 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.162 0.985 . . . . 0.0 112.538 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.35 -36.37 76.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.72 0.691 . . . . 0.0 112.392 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.29 -40.09 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.414 0.686 . . . . 0.0 109.874 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.08 -38.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.804 . . . . 0.0 111.654 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.23 -38.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.206 -0.934 . . . . 0.0 111.049 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -64.27 -44.84 90.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.6 -0.687 . . . . 0.0 111.271 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -57.62 -44.56 85.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.339 1.055 . . . . 0.0 112.483 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.47 95.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.006 0.821 . . . . 0.0 112.49 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.54 -44.72 89.93 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.119 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.888 -1.133 . . . . 0.0 113.426 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.96 -9.49 58.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.3 t -55.47 127.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.933 1.242 . . . . 0.0 110.591 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.33 -0.59 78.28 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.177 1.37 . . . . 0.0 114.5 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -71.01 132.87 45.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.061 1.43 . . . . 0.0 110.429 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.81 138.54 48.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.753 1.621 . . . . 0.0 111.118 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.7 mtm -143.59 153.07 42.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.919 1.288 . . . . 0.0 112.127 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -149.86 -7.91 0.31 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -63.9 153.7 36.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 114.12 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t 62.91 -164.55 0.25 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 114.449 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -80.33 145.23 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.203 1.401 . . . . 0.0 108.443 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.36 -31.47 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 119.149 0.886 . . . . 0.0 112.629 -171.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 p -60.17 -53.54 56.56 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.343 1.057 . . . . 0.0 111.659 172.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.665 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -56.26 -42.42 77.39 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.23 1.377 . . . . 0.0 111.079 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.22 -44.21 54.06 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.21 1.404 . . . . 0.0 112.981 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.26 -43.65 98.34 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.799 -1.188 . . . . 0.0 112.374 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.522 ' CD2' HE22 ' A' ' 119' ' ' GLN . 8.3 t-160 -63.73 -42.88 97.81 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.692 -1.255 . . . . 0.0 110.014 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.46 -53.66 48.26 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.419 1.487 . . . . 0.0 112.589 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 m -66.08 -25.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.404 1.456 . . . . 0.0 112.917 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -65.91 -46.13 79.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 117.315 -1.326 . . . . 0.0 109.793 170.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.522 HE22 ' CD2' ' A' ' 115' ' ' HIS . 1.8 mp0 -55.85 -32.31 63.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.766 1.167 . . . . 0.0 113.459 171.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.39 -58.21 3.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.352 0.978 . . . . 0.0 111.346 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -75.27 3.99 7.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.71 -24.11 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.854 2.062 . . . . 0.0 113.338 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.24 -32.4 1.68 Allowed Glycine 0 N--CA 1.474 1.23 0 C-N-CA 128.473 2.94 . . . . 0.0 117.816 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -140.07 16.75 2.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 118.692 1.246 . . . . 0.0 112.866 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.105 1.762 . . . . 0.0 112.674 -177.155 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.316 0.103 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.37 162.67 28.64 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.353 1.061 . . . . 0.0 112.783 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -67.25 145.76 98.7 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.955 0.902 . . . . 0.0 112.668 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.82 147.59 56.4 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.463 2.775 . . . . 0.0 111.513 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -140.54 153.21 46.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.764 1.626 . . . . 0.0 110.771 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -99.05 151.86 20.48 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.613 0.765 . . . . 0.0 112.238 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -150.7 111.37 3.15 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.818 1.647 . . . . 0.0 107.877 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.17 147.97 93.6 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.666 2.244 . . . . 0.0 111.185 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -103.29 156.09 35.88 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.479 1.112 . . . . 0.0 111.57 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.59 129.89 22.25 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.529 2.152 . . . . 0.0 111.945 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.68 -2.62 82.32 Favored Glycine 0 N--CA 1.467 0.739 0 C-N-CA 125.272 1.415 . . . . 0.0 114.769 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -83.96 146.96 27.73 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.853 1.326 . . . . 0.0 110.913 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.0 139.47 40.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.546 1.165 . . . . 0.0 111.55 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.34 131.81 65.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.975 2.11 . . . . 0.0 108.198 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -92.36 115.39 28.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.87 129.03 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.531 1.932 . . . . 0.0 108.322 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.47 -33.21 71.01 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.833 0.742 . . . . 0.0 112.48 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 57.35 -119.46 1.22 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.752 2.021 . . . . 0.0 111.259 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -132.27 58.39 1.75 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.044 0.926 . . . . 0.0 110.352 -160.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.76 -1.89 75.77 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.271 1.415 . . . . 0.0 114.626 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -156.41 127.29 6.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.082 1.353 . . . . 0.0 111.552 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.25 155.25 36.94 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.83 1.252 . . . . 0.0 113.87 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -153.65 172.27 17.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.473 1.109 . . . . 0.0 112.232 170.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -93.85 161.1 14.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.72 162.83 39.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.015 2.126 . . . . 0.0 110.926 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.07 125.11 38.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.109 1.764 . . . . 0.0 108.536 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.94 93.33 5.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.236 1.014 . . . . 0.0 111.423 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 pt -81.75 -20.93 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 176.43 32.27 Favored Glycine 0 N--CA 1.465 0.579 0 C-N-CA 125.05 1.309 . . . . 0.0 110.798 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.84 88.38 0.38 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.615 0.721 . . . . 0.0 111.095 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.11 58.62 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 127.011 2.243 . . . . 0.0 114.774 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -104.74 140.47 38.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.825 1.312 . . . . 0.0 112.523 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.8 155.42 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.39 1.076 . . . . 0.0 112.954 -170.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -112.4 139.81 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -148.15 155.02 40.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.584 1.084 . . . . 0.0 111.574 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.7 115.38 27.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.3 122.87 87.57 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.53 158.06 59.27 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.776 2.984 . . . . 0.0 114.561 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.18 169.98 19.41 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 124.344 3.363 . . . . 0.0 111.54 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -132.91 130.32 39.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.472 1.109 . . . . 0.0 110.849 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 58.09 36.17 25.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.51 1.524 . . . . 0.0 112.092 -170.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -54.28 157.9 4.32 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.163 1.785 . . . . 0.0 113.653 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.8 120.1 6.6 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.738 2.959 . . . . 0.0 111.714 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.49 29.27 6.02 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.92 1.248 . . . . 0.0 113.28 -169.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.88 -171.96 0.6 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.898 1.279 . . . . 0.0 113.127 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.48 50.67 2.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.951 1.738 . . . . 0.0 114.877 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.3 t -167.0 -154.88 0.17 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.086 2.155 . . . . 0.0 110.159 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.5 p -73.02 -13.1 61.16 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.36 -1.463 . . . . 0.0 114.462 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 m -176.96 -47.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 127.695 2.398 . . . . 0.0 112.042 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.78 148.39 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.598 1.159 . . . . 0.0 110.78 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -144.04 153.18 41.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.724 1.21 . . . . 0.0 111.919 -173.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 p 67.56 -42.66 0.45 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 129.499 3.12 . . . . 0.0 115.067 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -165.84 153.56 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 128.526 2.73 . . . . 0.0 108.708 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.07 147.73 23.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.524 0.73 . . . . 0.0 111.904 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.1 m -59.75 128.86 39.05 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.988 0.915 . . . . 0.0 113.468 -170.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -89.4 149.0 23.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.787 1.235 . . . . 0.0 111.128 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m -78.94 152.52 31.03 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 158.65 16.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.3 1.84 . . . . 0.0 109.596 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -143.06 134.56 26.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 0.0 111.618 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.97 126.77 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.397 0.679 . . . . 0.0 109.182 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -131.98 149.75 52.34 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.619 1.568 . . . . 0.0 112.446 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -103.72 133.76 48.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.445 1.498 . . . . 0.0 110.485 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -154.74 177.69 10.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.743 1.617 . . . . 0.0 111.073 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -90.48 154.17 19.84 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 168.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 tp -53.15 -47.34 68.82 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.48 -31.17 67.6 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.04 -35.8 59.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.451 1.023 . . . . 0.0 111.104 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.09 -38.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.525 1.13 . . . . 0.0 111.9 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -80.38 -39.34 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.387 0.675 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.61 15.92 64.79 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.048 0.84 . . . . 0.0 115.016 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.53 85.72 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.389 1.471 . . . . 0.0 114.684 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.8 m -81.54 -176.41 6.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.082 1.353 . . . . 0.0 112.745 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 83.6 m -73.21 157.42 37.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.199 1.0 . . . . 0.0 112.875 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -167.14 168.06 13.88 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.525 1.93 . . . . 0.0 110.853 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.09 151.54 12.17 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 0.0 112.756 169.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.5 t -70.91 133.88 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -153.9 73.86 0.96 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.937 0.895 . . . . 0.0 110.907 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.25 58.74 0.73 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.627 1.571 . . . . 0.0 111.483 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 p -43.41 -69.35 0.14 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.516 2.327 . . . . 0.0 114.724 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -67.37 -29.2 68.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.589 0.756 . . . . 0.0 112.74 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.4 -35.59 80.71 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.185 -0.947 . . . . 0.0 111.21 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -73.98 -12.58 60.68 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.218 1.007 . . . . 0.0 112.83 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -86.18 -38.35 17.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.156 0.889 . . . . 0.0 112.078 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -71.67 0.73 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -143.7 157.37 58.67 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -145.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.6 144.24 11.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.891 3.061 . . . . 0.0 108.073 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -124.3 153.5 68.77 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -169.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.03 84.21 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.141 3.228 . . . . 0.0 109.96 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.11 -30.97 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.695 1.198 . . . . 0.0 114.019 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.41 -36.69 83.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.226 0.921 . . . . 0.0 112.643 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.74 -33.86 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.067 0.947 . . . . 0.0 110.519 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -63.98 -46.56 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.64 -0.663 . . . . 0.0 110.215 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.15 -39.38 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.814 0.846 . . . . 0.0 110.873 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.3 m -64.77 -40.93 96.08 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.615 -0.678 . . . . 0.0 111.813 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 t -58.3 -46.82 85.41 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.539 -0.725 . . . . 0.0 111.028 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.14 89.24 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.43 -0.794 . . . . 0.0 112.249 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.13 -28.12 69.85 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.49 -34.11 41.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 172.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.4 mtp -78.99 -20.28 49.49 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.96 124.57 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.603 1.547 . . . . 0.0 110.933 170.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.76 -6.92 59.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.611 1.576 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -75.43 143.66 42.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 1.515 . . . . 0.0 110.507 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.82 155.08 36.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.883 1.673 . . . . 0.0 111.833 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.1 mtm -141.62 164.14 31.01 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.113 1.365 . . . . 0.0 111.587 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -139.4 -36.13 0.53 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -76.4 154.03 35.22 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -170.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 77.57 177.68 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.259 2.224 . . . . 0.0 113.788 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -80.53 149.27 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.747 1.219 . . . . 0.0 111.276 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -52.65 -37.38 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 p -63.21 -55.34 25.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.451 0.7 . . . . 0.0 111.164 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.6 -36.37 83.54 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.58 -0.7 . . . . 0.0 111.935 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.44 -41.22 80.03 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.517 1.053 . . . . 0.0 111.686 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.6 t -77.26 -42.19 38.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.264 1.026 . . . . 0.0 112.513 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.77 -44.14 97.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.325 1.05 . . . . 0.0 112.13 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.506 ' CD2' HE22 ' A' ' 119' ' ' GLN . 59.8 t60 -60.42 -46.11 91.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.788 1.235 . . . . 0.0 110.125 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -52.76 -54.84 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.209 . . . . 0.0 112.213 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.95 -29.72 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.343 1.429 . . . . 0.0 112.8 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.3 m -65.41 -38.37 89.74 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.967 1.258 . . . . 0.0 110.504 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.506 HE22 ' CD2' ' A' ' 115' ' ' HIS . 0.8 OUTLIER -61.33 -26.89 68.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 120.415 1.461 . . . . 0.0 113.217 169.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.9 mt -74.6 -57.6 3.82 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.275 -0.891 . . . . 0.0 111.516 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -77.08 12.11 1.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -58.04 -24.41 58.28 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.314 1.846 . . . . 0.0 112.519 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.69 -22.29 39.43 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.026 2.251 . . . . 0.0 115.31 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -146.82 -11.03 0.45 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.601 1.161 . . . . 0.0 112.82 179.716 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.362 0.125 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.21 162.92 27.55 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.372 1.069 . . . . 0.0 112.9 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 m -69.66 155.48 93.42 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.861 0.864 . . . . 0.0 112.918 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.5 152.61 66.74 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.554 2.836 . . . . 0.0 112.39 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 141.6 53.19 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -90.73 72.16 6.69 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.963 -1.086 . . . . 0.0 109.256 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -133.73 112.13 12.57 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.707 1.203 . . . . 0.0 108.767 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.88 144.89 12.4 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.332 2.688 . . . . 0.0 111.05 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.65 150.05 4.59 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.582 1.953 . . . . 0.0 111.053 -176.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.28 137.34 39.88 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.915 3.076 . . . . 0.0 113.553 -169.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.08 -11.41 65.15 Favored Glycine 0 N--CA 1.469 0.879 0 C-N-CA 126.028 1.775 . . . . 0.0 114.633 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.59 160.16 15.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 118.403 1.101 . . . . 0.0 113.003 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.22 113.87 27.32 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.916 1.686 . . . . 0.0 111.785 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.91 127.55 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 124.8 1.24 . . . . 0.0 109.482 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -96.01 121.12 37.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.407 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.93 130.65 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.973 1.309 . . . . 0.0 109.157 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -77.16 64.79 2.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.563 1.145 . . . . 0.0 110.442 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -54.14 -44.89 71.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.611 1.564 . . . . 0.0 114.803 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -153.29 26.93 0.52 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -160.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.9 -2.49 66.5 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.99 0.805 . . . . 0.0 113.064 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -140.78 159.86 41.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.148 2.179 . . . . 0.0 110.44 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -91.86 120.33 32.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.679 1.192 . . . . 0.0 111.464 -172.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -112.75 151.84 29.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.531 1.532 . . . . 0.0 111.09 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -86.97 153.69 21.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.42 36.22 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.354 1.462 . . . . 0.0 111.383 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.42 123.85 50.64 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.168 1.787 . . . . 0.0 108.175 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -74.32 103.11 4.59 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.5 0.591 . . . . 0.0 111.221 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -94.88 -21.69 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.78 171.94 33.77 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.31 96.08 0.22 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.164 0.982 . . . . 0.0 111.689 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.93 3.76 82.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.91 1.719 . . . . 0.0 115.244 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -110.73 139.01 46.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.502 1.651 . . . . 0.0 112.367 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.97 152.47 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 113.713 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.5 mm -107.95 134.64 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 107.109 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -151.52 159.49 44.12 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.496 1.044 . . . . 0.0 111.894 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.43 122.83 43.81 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.393 0.677 . . . . 0.0 111.304 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.49 146.39 50.21 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.861 1.664 . . . . 0.0 110.414 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.53 158.07 51.63 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.592 2.861 . . . . 0.0 113.956 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.2 -25.29 7.3 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.665 2.91 . . . . 0.0 112.29 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.0 p -75.08 151.87 38.63 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.139 0.976 . . . . 0.0 113.153 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -86.63 87.13 7.38 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.416 1.087 . . . . 0.0 109.993 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -54.89 -33.08 14.51 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.09 -23.8 54.74 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.074 3.183 . . . . 0.0 114.619 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.36 134.28 3.2 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.764 1.173 . . . . 0.0 114.553 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.12 138.28 57.92 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.08 0.952 . . . . 0.0 111.382 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.13 -51.71 3.59 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.333 1.444 . . . . 0.0 112.534 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.3 t -62.12 -39.22 91.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.445 1.098 . . . . 0.0 112.06 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.0 p -91.28 20.39 5.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.834 1.254 . . . . 0.0 113.196 173.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 m 71.4 -37.76 0.4 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 128.554 2.742 . . . . 0.0 114.053 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.26 137.84 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.484 1.114 . . . . 0.0 110.522 169.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -131.47 -5.86 3.74 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.8 p -74.51 -39.8 62.17 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.216 -0.927 . . . . 0.0 113.252 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 t 78.37 129.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 128.358 2.663 . . . . 0.0 111.033 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 tt -101.75 -49.36 4.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.417 1.487 . . . . 0.0 110.173 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.2 m 68.79 87.68 0.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.402 2.281 . . . . 0.0 111.194 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -73.27 174.33 8.22 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.636 1.175 . . . . 0.0 113.317 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 m -86.74 156.74 19.82 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.852 -1.155 . . . . 0.0 111.338 169.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.11 153.71 43.0 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.527 0.731 . . . . 0.0 109.637 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -138.12 131.25 30.2 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 111.106 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.05 126.16 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.989 0.915 . . . . 0.0 109.245 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -131.48 157.23 44.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.545 1.538 . . . . 0.0 112.489 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -110.48 138.81 46.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.841 1.657 . . . . 0.0 110.077 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -166.11 170.38 13.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.227 1.011 . . . . 0.0 110.703 -171.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -85.39 145.44 27.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.319 -0.863 . . . . 0.0 111.55 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.6 tp -53.1 -50.66 63.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.068 0.947 . . . . 0.0 111.529 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -58.11 -28.88 65.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -85.64 -32.11 22.19 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.53 -40.64 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.471 0.578 . . . . 0.0 111.256 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.81 -44.33 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.83 0.852 . . . . 0.0 112.118 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.74 -124.82 35.33 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -175.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.75 0.62 63.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.959 1.266 . . . . 0.0 114.973 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.58 168.3 19.06 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.64 1.22 . . . . 0.0 113.924 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -77.13 155.27 32.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.86 1.264 . . . . 0.0 112.545 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.92 165.85 31.32 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.806 1.243 . . . . 0.0 113.355 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.12 163.88 33.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.345 1.858 . . . . 0.0 111.321 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.17 136.3 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.562 1.074 . . . . 0.0 109.81 171.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -150.29 124.96 9.72 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.876 1.27 . . . . 0.0 112.451 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.26 41.43 3.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.687 1.595 . . . . 0.0 111.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.0 p -57.05 -31.21 64.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -74.54 -44.71 49.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.54 0.736 . . . . 0.0 111.434 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -63.37 -36.92 85.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.038 0.935 . . . . 0.0 110.792 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -58.14 -17.06 15.83 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.302 1.441 . . . . 0.0 113.562 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -74.42 -19.29 60.46 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.029 -1.044 . . . . 0.0 113.404 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.95 -29.74 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 -173.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.43 152.24 63.22 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -150.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.24 -49.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.512 2.808 . . . . 0.0 112.443 170.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.25 96.45 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 127.421 2.288 . . . . 0.0 111.072 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.27 124.21 11.83 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.446 3.431 . . . . 0.0 114.892 -168.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 t -49.67 -47.66 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.981 2.113 . . . . 0.0 113.801 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.36 -34.65 78.64 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.93 -36.4 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.356 0.663 . . . . 0.0 110.227 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mm -77.0 -38.57 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.758 -0.589 . . . . 0.0 110.335 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.96 -41.07 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.935 0.494 . . . . 0.0 110.914 171.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -64.83 -40.93 95.98 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.527 -0.733 . . . . 0.0 110.96 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.3 m -64.87 -39.85 94.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.363 1.065 . . . . 0.0 112.28 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.62 98.17 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.12 -0.987 . . . . 0.0 111.751 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -68.7 -13.74 62.57 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.46 -37.41 15.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.534 1.061 . . . . 0.0 111.15 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.1 mmm -69.41 -25.57 64.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.637 1.575 . . . . 0.0 113.623 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -47.0 124.36 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.83 1.195 . . . . 0.0 111.986 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.88 1.49 79.85 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.503 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.47 147.77 44.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.811 1.806 . . . . 0.0 111.405 172.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -124.15 139.97 53.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 111.362 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.0 mtm -142.52 148.33 37.45 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.196 0.998 . . . . 0.0 112.908 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -147.55 22.83 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.358 1.063 . . . . 0.0 112.345 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -80.78 -19.04 45.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 t -162.34 175.7 11.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.21 1.004 . . . . 0.0 112.956 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.17 147.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.301 1.84 . . . . 0.0 109.787 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.51 -32.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.6 p -58.72 -65.71 0.61 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.76 1.224 . . . . 0.0 111.531 173.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -65.01 -30.82 71.82 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.816 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.83 -40.41 76.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.172 1.351 . . . . 0.0 111.127 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -44.07 59.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.644 1.178 . . . . 0.0 112.962 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.14 -45.38 94.9 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.367 -0.833 . . . . 0.0 111.605 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -60.32 -36.62 78.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.03 -60.59 3.54 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.291 1.437 . . . . 0.0 111.443 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.4 m -65.88 -30.03 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 120.476 1.489 . . . . 0.0 113.157 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 m -59.36 -56.2 25.01 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 116.514 -1.707 . . . . 0.0 107.783 170.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -55.35 -31.65 61.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.736 1.607 . . . . 0.0 114.67 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.15 -33.95 75.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.397 0.999 . . . . 0.0 112.385 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -118.2 16.06 14.03 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -72.65 -19.07 61.51 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.639 1.576 . . . . 0.0 112.826 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.43 -33.82 73.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.855 0.741 . . . . 0.0 113.577 -172.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -114.55 -16.05 11.93 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.955 1.302 . . . . 0.0 112.924 179.618 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.414 0.15 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.0 165.32 25.13 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.239 1.016 . . . . 0.0 112.764 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.4 p -161.77 155.38 18.12 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.111 1.364 . . . . 0.0 112.025 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.02 161.79 35.3 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.52 2.813 . . . . 0.0 111.701 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -76.32 -9.62 58.78 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -157.34 139.06 14.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.026 1.73 . . . . 0.0 109.458 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -155.51 124.04 2.97 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.133 0.973 . . . . 0.0 110.342 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.94 145.29 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.452 2.768 . . . . 0.0 110.687 171.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.04 160.26 26.74 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.303 1.841 . . . . 0.0 110.273 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.43 130.13 32.52 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.863 1.709 . . . . 0.0 110.697 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.23 -6.07 78.34 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.091 1.329 . . . . 0.0 115.437 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -65.47 140.06 58.56 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.8 1.3 . . . . 0.0 112.43 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.5 tp -87.11 89.89 8.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.72 1.608 . . . . 0.0 108.278 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.46 132.66 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.231 1.012 . . . . 0.0 108.879 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -102.27 107.47 18.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.819 1.647 . . . . 0.0 108.179 171.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.0 mm -86.73 123.45 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.702 2.001 . . . . 0.0 107.97 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.94 -32.89 74.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.302 2.0 mmt180 43.62 -142.49 0.15 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.713 2.005 . . . . 0.0 112.975 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.55 109.37 11.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.284 -167.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.17 -9.59 6.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.762 1.172 . . . . 0.0 115.179 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -166.05 124.46 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.798 1.639 . . . . 0.0 111.989 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.64 144.88 31.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.503 1.521 . . . . 0.0 111.675 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -144.09 165.37 27.99 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.231 -0.918 . . . . 0.0 113.456 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -88.13 157.13 18.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.71 137.69 20.36 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.927 1.691 . . . . 0.0 110.41 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.46 119.46 38.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.044 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -72.01 89.49 1.12 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.803 1.241 . . . . 0.0 111.747 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 pt -77.24 -20.32 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.21 -178.31 32.12 Favored Glycine 0 N--CA 1.462 0.433 0 C-N-CA 124.916 1.246 . . . . 0.0 110.878 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.87 86.19 0.51 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.639 0.733 . . . . 0.0 111.099 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.3 -6.84 46.63 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.884 2.183 . . . . 0.0 114.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -106.65 141.95 37.08 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.95 1.375 . . . . 0.0 112.813 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -137.95 153.28 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 mt -115.88 138.38 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.641 1.576 . . . . 0.0 107.002 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -157.61 138.24 13.02 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.154 -0.966 . . . . 0.0 113.275 -168.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.58 113.6 12.03 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.719 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.95 141.52 78.49 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.399 0.679 . . . . 0.0 109.855 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.34 157.13 62.35 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.632 2.888 . . . . 0.0 113.14 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.89 -11.75 18.06 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 124.16 3.24 . . . . 0.0 114.042 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.1 t -139.97 152.04 45.99 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.673 1.189 . . . . 0.0 111.523 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.28 144.73 56.41 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.267 1.427 . . . . 0.0 114.285 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -72.68 159.27 85.77 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -54.74 141.98 74.72 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.726 2.951 . . . . 0.0 113.491 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.73 -11.73 70.88 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.73 1.157 . . . . 0.0 115.051 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.06 169.06 16.8 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.054 1.342 . . . . 0.0 113.414 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.78 24.98 19.03 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.608 1.099 . . . . 0.0 114.265 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.3 t -153.48 164.46 38.16 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.803 1.241 . . . . 0.0 110.682 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -57.41 -20.56 30.75 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -78.0 -25.01 47.75 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.86 1.264 . . . . 0.0 114.014 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -155.41 108.51 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.976 1.711 . . . . 0.0 109.576 -173.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -150.11 -20.26 0.25 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 t -76.22 79.58 3.01 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.673 -1.267 . . . . 0.0 111.062 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.57 140.3 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.337 1.455 . . . . 0.0 110.813 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.5 tp -68.89 132.11 46.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.829 1.252 . . . . 0.0 111.257 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 t -160.68 91.72 0.92 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.436 0.694 . . . . 0.0 110.553 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 176.98 -55.3 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.397 2.279 . . . . 0.0 110.519 -170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 p -166.27 156.49 12.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.143 2.177 . . . . 0.0 109.129 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.82 135.85 34.36 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.691 -0.631 . . . . 0.0 109.657 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.94 138.77 37.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.172 0.896 . . . . 0.0 110.318 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -80.57 118.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.168 0.587 . . . . 0.0 110.116 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -108.07 174.96 5.65 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -146.09 152.45 39.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.462 1.505 . . . . 0.0 112.298 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 175.35 -164.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.843 2.857 . . . . 0.0 109.597 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -77.0 151.08 35.78 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.21 -0.931 . . . . 0.0 112.889 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.95 -46.66 75.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.179 0.991 . . . . 0.0 111.177 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -58.82 -29.71 67.09 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -80.5 -39.29 28.23 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.445 -0.785 . . . . 0.0 111.459 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.02 -46.69 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 174.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.99 -41.97 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.827 0.851 . . . . 0.0 112.262 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.46 -116.31 9.16 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 119.342 0.974 . . . . 0.0 110.72 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.94 -2.92 64.27 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.476 1.036 . . . . 0.0 114.835 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 55.8 m -79.95 157.9 26.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.781 1.29 . . . . 0.0 113.326 -172.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 74.6 m -74.59 167.08 22.46 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.343 1.057 . . . . 0.0 111.878 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -155.16 163.21 40.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.492 1.117 . . . . 0.0 111.745 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -140.16 169.65 17.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.398 1.879 . . . . 0.0 109.961 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.35 127.55 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -103.64 -54.77 2.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 47.3 47.8 16.57 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.325 1.45 . . . . 0.0 111.797 -171.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.3 p -54.2 -60.26 3.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.674 1.589 . . . . 0.0 113.749 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.41 -29.43 70.13 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -65.15 -51.48 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.696 0.398 . . . . 0.0 110.373 169.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -60.72 -27.0 67.58 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 121.179 -0.951 . . . . 0.0 113.026 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -68.17 -33.54 74.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -158.91 -15.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -146.88 130.4 8.25 Favored Pre-proline 0 CA--C 1.55 0.967 0 O-C-N 120.728 -1.233 . . . . 0.0 113.752 -133.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.86 -46.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.749 2.3 . . . . 0.0 112.173 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 128.99 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 129.495 3.118 . . . . 0.0 114.557 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.52 97.8 0.46 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.322 2.682 . . . . 0.0 110.227 169.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -15.87 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -169.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -63.91 -34.78 78.72 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.769 0.713 . . . . 0.0 110.824 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -74.88 -32.74 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.374 0.67 . . . . 0.0 110.382 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.93 -44.56 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.522 0.729 . . . . 0.0 111.631 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.54 -36.25 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.623 0.769 . . . . 0.0 110.607 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -65.1 -45.08 86.66 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.619 0.768 . . . . 0.0 111.637 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.8 m -58.94 -40.77 85.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.584 1.153 . . . . 0.0 112.168 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.14 94.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.501 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -63.42 -21.27 66.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.36 -34.7 21.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 112.554 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 mtp -77.52 -27.81 51.82 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -56.29 123.0 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 120.076 1.307 . . . . 0.0 110.617 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.58 -9.49 62.47 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.793 1.663 . . . . 0.0 115.038 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -78.68 156.23 29.08 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.479 1.64 . . . . 0.0 110.464 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -147.35 154.59 41.09 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.104 1.362 . . . . 0.0 114.34 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.1 mtm -147.15 163.99 34.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.314 1.846 . . . . 0.0 112.022 -170.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -157.19 -45.31 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -77.94 71.13 4.4 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.04 1.336 . . . . 0.0 113.709 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 m -175.88 170.43 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.411 2.684 . . . . 0.0 110.228 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.96 146.41 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.308 -0.87 . . . . 0.0 109.252 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.46 -40.1 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 120.666 -1.271 . . . . 0.0 113.218 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.7 m -60.63 -43.44 97.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.208 0.603 . . . . 0.0 110.846 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -70.71 -29.75 66.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.774 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -58.15 -46.83 84.98 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.644 1.565 . . . . 0.0 110.911 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.0 m -66.5 -48.65 69.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.651 1.181 . . . . 0.0 112.197 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -58.52 -48.32 81.22 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.562 0.745 . . . . 0.0 111.409 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.25 -33.8 76.85 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.938 -1.101 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -58.88 -58.0 10.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.946 0.794 . . . . 0.0 110.787 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.82 -21.58 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 119.551 1.069 . . . . 0.0 113.598 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -71.93 -40.82 68.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.355 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.22 -26.21 68.24 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 120.038 1.29 . . . . 0.0 112.654 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.02 -46.48 67.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.983 0.811 . . . . 0.0 112.405 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -94.37 9.7 37.22 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.454 1.901 . . . . 0.0 114.285 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -58.65 -21.66 54.6 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.049 2.139 . . . . 0.0 113.789 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.88 68.28 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.479 1.037 . . . . 0.0 114.314 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -140.59 -22.4 0.81 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 169.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 124.945 1.298 . . . . 0.0 112.793 175.008 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttm . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 110.664 -0.124 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.02 160.57 31.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.485 1.114 . . . . 0.0 112.832 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -172.52 161.97 4.07 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 126.934 2.094 . . . . 0.0 111.122 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.09 150.83 54.19 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.782 2.988 . . . . 0.0 112.847 171.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -162.84 -65.31 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.092 0.957 . . . . 0.0 112.652 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -83.2 52.33 2.17 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.829 1.252 . . . . 0.0 110.724 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -94.89 125.21 51.86 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.161 -0.923 . . . . 0.0 109.894 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.5 150.12 35.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.751 2.301 . . . . 0.0 111.318 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -100.64 142.1 23.95 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.753 0.821 . . . . 0.0 110.973 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.3 132.51 24.21 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.682 1.588 . . . . 0.0 110.468 -170.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.87 66.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.691 1.615 . . . . 0.0 114.574 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.13 165.99 11.97 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.579 1.69 . . . . 0.0 113.885 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.4 mt -90.64 113.11 25.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.26 1.424 . . . . 0.0 111.655 -169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.22 117.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.966 0.906 . . . . 0.0 108.629 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.58 117.52 28.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -122.71 134.25 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.859 1.264 . . . . 0.0 109.3 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -77.76 66.05 3.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.017 0.927 . . . . 0.0 110.47 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -36.12 82.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.299 1.44 . . . . 0.0 114.41 -169.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.77 26.38 0.74 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -152.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.76 7.81 77.64 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.285 0.945 . . . . 0.0 112.965 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -167.71 160.26 12.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.746 2.819 . . . . 0.0 109.183 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -64.51 138.23 58.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.599 1.56 . . . . 0.0 113.616 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.95 151.46 40.96 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.349 1.86 . . . . 0.0 108.72 169.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -98.84 156.79 16.69 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.2 157.09 44.17 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.897 1.679 . . . . 0.0 111.87 169.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.31 121.77 45.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.79 2.036 . . . . 0.0 108.541 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -75.05 92.43 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.153 0.888 . . . . 0.0 111.774 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -84.44 -21.8 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.68 174.43 30.78 Favored Glycine 0 N--CA 1.463 0.454 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.05 94.73 0.67 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.534 0.683 . . . . 0.0 109.93 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.44 65.59 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.437 1.97 . . . . 0.0 115.273 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -113.75 140.2 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.361 1.58 . . . . 0.0 112.365 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 m -140.77 149.27 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mm -105.97 128.54 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -139.29 163.46 32.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.975 0.807 . . . . 0.0 111.043 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.23 137.51 32.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.67 138.6 21.07 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.457 1.503 . . . . 0.0 108.457 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.57 159.11 39.6 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.506 2.804 . . . . 0.0 113.728 -169.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.35 139.4 16.53 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.676 2.917 . . . . 0.0 109.788 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.1 m -75.54 -21.69 57.72 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -164.09 128.78 2.77 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.724 1.61 . . . . 0.0 110.196 172.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.88 -55.27 17.42 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -173.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 -30.4 16.27 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.378 2.719 . . . . 0.0 112.842 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.11 155.18 23.75 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.911 1.243 . . . . 0.0 113.672 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.35 153.32 18.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.196 1.398 . . . . 0.0 112.909 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.06 126.31 8.8 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 124.584 1.087 . . . . 0.0 110.539 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -61.33 -27.79 68.75 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -171.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.2 p -73.24 -29.68 62.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.226 1.011 . . . . 0.0 112.87 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.8 m -83.97 -39.76 19.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.325 1.05 . . . . 0.0 111.987 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.63 131.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.302 1.841 . . . . 0.0 110.805 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -109.01 -7.87 15.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.035 1.334 . . . . 0.0 113.71 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.1 m -75.4 -0.28 19.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.814 1.646 . . . . 0.0 115.246 -171.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.07 153.41 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.488 1.515 . . . . 0.0 111.526 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.92 151.44 27.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.921 0.888 . . . . 0.0 110.911 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.5 m -123.67 24.03 8.61 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.084 1.353 . . . . 0.0 111.396 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -61.35 160.67 10.37 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.2 p -85.98 163.48 17.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.131 1.372 . . . . 0.0 111.475 169.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.56 127.99 34.45 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -113.18 134.88 54.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.451 1.1 . . . . 0.0 111.314 -169.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.1 126.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.732 0.813 . . . . 0.0 110.515 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -139.3 153.88 47.83 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.914 1.286 . . . . 0.0 113.273 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -98.79 137.96 36.63 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.856 1.662 . . . . 0.0 110.689 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -165.7 172.22 12.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.538 1.135 . . . . 0.0 111.671 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -92.89 146.43 23.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.27 1.428 . . . . 0.0 112.103 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -51.47 -56.07 15.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 111.774 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -62.72 -25.16 68.03 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.47 -40.26 43.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.213 0.915 . . . . 0.0 111.12 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.2 t -68.13 -35.33 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.042 0.537 . . . . 0.0 111.959 173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.1 t -78.7 -39.34 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.003 0.921 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 20.11 65.35 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.007 0.822 . . . . 0.0 115.014 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.61 89.72 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.132 1.349 . . . . 0.0 114.859 -173.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.26 175.49 8.9 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.116 1.366 . . . . 0.0 112.555 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.6 m -69.68 150.72 46.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.258 1.023 . . . . 0.0 112.732 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -160.63 163.94 32.2 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.915 1.286 . . . . 0.0 113.506 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.05 163.43 23.26 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.788 2.035 . . . . 0.0 110.927 -175.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -109.0 145.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.596 1.089 . . . . 0.0 112.162 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -133.54 151.89 51.81 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.818 1.647 . . . . 0.0 113.45 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -144.93 31.11 1.15 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.989 1.716 . . . . 0.0 112.286 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -59.94 -35.82 75.74 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.23 -29.22 15.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.918 0.781 . . . . 0.0 112.54 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.62 -30.97 72.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.444 1.097 . . . . 0.0 112.213 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -67.17 -23.04 65.73 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.243 1.417 . . . . 0.0 113.093 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -88.75 -45.66 9.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -95.77 -34.64 11.83 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -168.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -141.13 158.19 65.06 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.49 -19.39 28.53 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.13 3.22 . . . . 0.0 113.207 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 66.93 75.63 0.31 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.355 1.862 . . . . 0.0 112.098 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.81 80.85 2.28 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.458 3.439 . . . . 0.0 110.257 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 t -46.45 -41.11 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.678 1.591 . . . . 0.0 114.344 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.97 -38.02 82.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.207 0.912 . . . . 0.0 111.21 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.14 -38.0 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.313 1.045 . . . . 0.0 109.902 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.53 -47.25 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.471 0.578 . . . . 0.0 110.379 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.71 -38.89 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.34 1.056 . . . . 0.0 111.852 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -65.86 -42.49 90.34 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.415 -0.803 . . . . 0.0 110.61 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.8 p -61.5 -38.57 87.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.438 0.695 . . . . 0.0 112.054 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.76 72.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.427 1.091 . . . . 0.0 111.404 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.46 -36.37 80.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.71 -37.7 79.71 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.6 ptm -81.68 -4.06 55.23 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.2 125.67 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.869 1.268 . . . . 0.0 109.227 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.99 -5.97 58.17 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.924 1.25 . . . . 0.0 114.469 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -66.06 147.82 52.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.262 1.531 . . . . 0.0 110.491 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.76 135.0 45.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.459 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -141.64 140.77 33.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.555 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -149.83 27.05 0.8 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.777 1.231 . . . . 0.0 112.318 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.8 -8.9 59.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.8 t -158.06 178.05 10.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.841 1.256 . . . . 0.0 111.842 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 146.55 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.432 1.493 . . . . 0.0 110.203 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.66 -39.33 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 124.807 1.243 . . . . 0.0 113.926 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.4 p -58.73 -57.54 12.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.831 0.852 . . . . 0.0 111.787 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -64.97 -34.32 78.15 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.519 -0.738 . . . . 0.0 112.152 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -59.54 -35.48 74.29 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.612 1.096 . . . . 0.0 111.418 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -42.6 67.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.036 0.935 . . . . 0.0 112.801 172.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -62.24 -45.99 90.85 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.97 -1.081 . . . . 0.0 112.254 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -52.87 -44.86 67.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.761 2.024 . . . . 0.0 110.615 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -61.33 -54.24 46.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.433 1.493 . . . . 0.0 112.37 173.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.3 m -69.23 -22.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 120.561 1.528 . . . . 0.0 114.215 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -70.42 -40.12 74.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.145 169.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -64.36 -23.91 67.46 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.411 1.005 . . . . 0.0 113.668 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.5 mt -72.86 -60.79 2.06 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.213 0.915 . . . . 0.0 111.337 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -73.95 4.27 5.62 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -56.7 -26.04 55.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.338 2.255 . . . . 0.0 113.219 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.98 -51.83 7.04 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 127.75 2.595 . . . . 0.0 115.645 -169.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -128.04 5.73 5.94 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 C--O 1.25 1.093 0 C-N-CA 124.787 1.235 . . . . 0.0 111.879 170.713 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.01 162.95 28.12 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.024 0.929 . . . . 0.0 112.627 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 m -172.4 155.37 3.36 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 126.877 2.071 . . . . 0.0 110.6 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.64 148.05 41.31 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.15 2.567 . . . . 0.0 111.627 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -137.31 24.44 2.96 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.322 1.449 . . . . 0.0 111.77 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.01 134.67 34.63 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.969 -1.082 . . . . 0.0 111.157 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -94.15 116.61 66.63 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.491 0.716 . . . . 0.0 110.111 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.11 145.21 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.587 2.192 . . . . 0.0 110.098 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.14 139.47 21.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.707 0.803 . . . . 0.0 110.83 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 127.91 15.91 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.769 2.312 . . . . 0.0 110.305 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.01 2.17 90.66 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.181 1.372 . . . . 0.0 114.246 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 169.33 8.63 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.003 1.321 . . . . 0.0 112.604 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.38 130.14 54.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.531 1.533 . . . . 0.0 113.987 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -111.77 144.15 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.365 2.266 . . . . 0.0 110.61 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -108.94 116.67 32.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.29 128.93 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.446 1.499 . . . . 0.0 109.571 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -80.24 68.61 6.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.761 1.225 . . . . 0.0 110.847 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -34.65 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -169.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -156.9 27.33 0.32 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.17 10.23 58.63 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.108 0.861 . . . . 0.0 113.844 -172.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -163.36 145.01 9.61 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.586 2.354 . . . . 0.0 110.146 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -75.32 120.73 21.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.946 1.298 . . . . 0.0 112.354 -176.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -103.07 140.58 37.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.767 1.227 . . . . 0.0 110.041 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -73.62 146.7 44.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.106 0.563 . . . . 0.0 112.123 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.74 142.14 24.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 121.67 43.72 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.029 1.732 . . . . 0.0 108.945 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -76.67 105.29 7.65 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.797 0.839 . . . . 0.0 111.005 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.3 pt -97.1 -20.83 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.91 174.16 32.46 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 124.987 1.28 . . . . 0.0 110.163 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.04 94.73 0.51 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.789 0.804 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.69 64.43 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.839 2.161 . . . . 0.0 115.446 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -112.54 133.99 54.3 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.598 1.699 . . . . 0.0 112.246 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.45 152.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.884 1.274 . . . . 0.0 112.709 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 mm -109.36 128.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.775 1.63 . . . . 0.0 106.844 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -144.95 159.52 42.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.422 1.01 . . . . 0.0 112.026 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.0 115.78 28.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.596 0.758 . . . . 0.0 110.038 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.76 70.18 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.664 1.586 . . . . 0.0 109.815 169.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.33 155.01 68.6 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.897 3.065 . . . . 0.0 114.772 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -84.53 -4.73 10.07 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 124.649 3.566 . . . . 0.0 114.472 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.2 m 76.8 -41.31 0.39 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 128.058 2.543 . . . . 0.0 112.513 -174.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -150.88 159.19 44.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.637 1.975 . . . . 0.0 111.06 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -68.01 167.07 18.86 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.712 0.805 . . . . 0.0 112.999 171.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -53.17 -27.98 39.78 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 124.28 3.32 . . . . 0.0 115.972 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.21 23.73 5.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.539 1.066 . . . . 0.0 114.907 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.7 -20.83 23.76 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.758 1.623 . . . . 0.0 114.547 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.73 101.06 0.79 Allowed Glycine 0 N--CA 1.467 0.731 0 C-N-CA 125.609 1.576 . . . . 0.0 109.408 169.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.5 p -165.44 -178.79 5.14 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.126 1.37 . . . . 0.0 112.32 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 m -68.86 -19.44 64.24 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.734 -1.229 . . . . 0.0 112.128 169.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.5 p -82.54 -37.24 25.46 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.129 -0.982 . . . . 0.0 113.217 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -157.48 154.53 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.403 1.881 . . . . 0.0 110.367 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -160.5 -34.83 0.05 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.119 0.968 . . . . 0.0 112.727 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 p -74.06 41.05 0.13 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.222 2.209 . . . . 0.0 112.964 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.26 153.65 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.668 1.987 . . . . 0.0 111.115 -170.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.7 tp -76.14 109.83 10.14 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.126 0.97 . . . . 0.0 111.322 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 t -87.51 138.41 31.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.338 0.655 . . . . 0.0 111.134 170.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.96 -170.4 2.14 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.45 1.5 . . . . 0.0 110.852 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.7 m -119.71 153.49 35.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.351 1.06 . . . . 0.0 110.784 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.27 159.99 33.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.515 0.726 . . . . 0.0 110.214 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -136.48 130.06 32.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.854 0.862 . . . . 0.0 109.951 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.9 t -83.79 123.19 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -145.25 153.26 41.12 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -169.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -94.1 137.77 32.91 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.186 1.794 . . . . 0.0 110.505 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -162.64 163.11 27.25 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.495 0.718 . . . . 0.0 111.893 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -76.05 140.16 41.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.829 173.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -52.56 -54.14 36.93 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.72 1.208 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.88 -23.92 67.57 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.84 -39.11 27.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.299 0.954 . . . . 0.0 111.343 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.52 -39.65 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.75 -0.594 . . . . 0.0 111.405 170.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.04 -45.55 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 112.345 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.03 61.99 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.25 0.932 . . . . 0.0 115.043 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.12 88.21 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.344 1.449 . . . . 0.0 114.891 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -82.5 171.51 14.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.956 1.302 . . . . 0.0 112.017 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.05 147.89 49.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -158.93 163.43 36.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 113.02 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.64 155.78 15.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.238 1.415 . . . . 0.0 112.354 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.73 136.96 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.662 0.664 . . . . 0.0 109.707 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -160.49 136.92 8.72 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.256 1.822 . . . . 0.0 109.516 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -154.37 52.3 0.66 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.888 0.852 . . . . 0.0 113.017 -169.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.9 m -50.67 -35.59 31.64 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.487 HD13 ' HH ' ' A' ' 84' ' ' TYR . 28.4 tp -72.54 -39.81 67.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.787 0.835 . . . . 0.0 111.715 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.37 -40.58 93.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.021 0.928 . . . . 0.0 111.439 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -62.09 -17.9 59.06 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.381 1.072 . . . . 0.0 112.862 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -79.74 -30.8 40.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HH ' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -142.65 -35.17 0.42 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 117.843 2.535 . . . . 0.0 117.843 -172.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.69 151.84 73.93 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -138.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.32 -24.11 2.1 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 124.083 3.189 . . . . 0.0 114.657 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 67.11 110.26 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 127.339 2.256 . . . . 0.0 115.668 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.64 89.92 1.25 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 124.134 3.223 . . . . 0.0 109.768 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 t -50.99 -39.67 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.275 1.43 . . . . 0.0 113.782 -169.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.4 -35.76 78.14 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.283 0.492 . . . . 0.0 111.832 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.93 -32.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.279 1.032 . . . . 0.0 110.396 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 mm -66.43 -47.68 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.93 -0.481 . . . . 0.0 110.57 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.49 -37.57 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.892 0.477 . . . . 0.0 110.763 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.1 m -65.25 -41.93 93.79 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.649 -0.657 . . . . 0.0 111.73 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -61.12 -48.13 83.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.639 -0.663 . . . . 0.0 110.909 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.13 88.15 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.7 0.8 . . . . 0.0 112.257 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -62.58 -46.76 86.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.512 0.725 . . . . 0.0 112.021 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.67 -30.79 70.12 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.259 -0.901 . . . . 0.0 113.27 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.9 mtp -75.73 -9.44 58.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.47 127.02 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.455 1.479 . . . . 0.0 111.343 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.13 -0.41 85.88 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.917 -1.491 . . . . 0.0 114.096 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -77.99 137.74 38.45 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.1 1.95 . . . . 0.0 111.023 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.93 165.22 22.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.382 1.073 . . . . 0.0 110.498 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.4 ttm -159.4 137.09 10.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 110.746 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -156.36 34.0 0.32 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.338 1.066 . . . . 0.0 111.185 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.69 -33.28 71.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.263 1.825 . . . . 0.0 114.131 -170.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.7 t -162.47 -157.05 0.44 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.174 1.39 . . . . 0.0 111.876 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.04 154.92 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.274 1.43 . . . . 0.0 109.861 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.15 -37.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -62.5 -49.11 76.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.429 0.692 . . . . 0.0 111.84 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -74.86 -27.95 60.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 117.545 -1.217 . . . . 0.0 112.238 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -58.51 -43.54 89.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.741 1.609 . . . . 0.0 110.215 170.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -51.82 68.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.476 1.91 . . . . 0.0 112.639 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -64.54 -41.89 96.06 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.051 0.841 . . . . 0.0 112.517 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -56.41 -44.11 80.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.391 1.476 . . . . 0.0 110.52 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -60.67 -56.9 15.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.468 1.507 . . . . 0.0 111.698 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.05 -19.32 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.096 1.316 . . . . 0.0 114.399 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 m -74.69 -38.22 62.44 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.112 1.324 . . . . 0.0 110.284 170.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -67.15 -28.11 67.86 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.641 1.11 . . . . 0.0 112.968 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.46 -56.79 8.17 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.442 -0.786 . . . . 0.0 110.231 169.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -78.55 5.01 11.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.594 1.558 . . . . 0.0 113.946 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.04 -20.58 17.49 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.526 2.331 . . . . 0.0 113.136 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.52 -31.15 28.54 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.285 1.898 . . . . 0.0 113.697 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -135.2 -23.64 1.48 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 124.684 1.193 . . . . 0.0 113.358 -177.665 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.366 0.126 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.39 161.62 28.54 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.225 1.01 . . . . 0.0 112.613 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.6 p -166.37 163.32 11.58 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 125.499 1.52 . . . . 0.0 111.678 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.35 143.28 99.78 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.591 2.861 . . . . 0.0 112.815 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -139.64 156.3 46.92 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.319 1.448 . . . . 0.0 111.599 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -157.78 141.23 15.45 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.513 1.525 . . . . 0.0 109.301 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.2 134.25 8.24 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.42 152.37 15.62 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.647 2.898 . . . . 0.0 110.187 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.96 153.46 38.25 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.543 1.137 . . . . 0.0 111.191 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -67.89 131.88 25.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.886 1.724 . . . . 0.0 110.491 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -6.81 81.85 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 125.535 1.54 . . . . 0.0 114.525 -172.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.72 161.84 15.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.444 1.497 . . . . 0.0 111.89 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -118.83 160.12 22.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.963 1.363 . . . . 0.0 114.437 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mt -141.3 131.22 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.615 1.566 . . . . 0.0 109.57 -160.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -85.65 127.84 34.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -112.55 122.34 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.314 1.446 . . . . 0.0 109.112 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -82.27 92.9 7.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.594 1.158 . . . . 0.0 109.084 173.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -64.99 -72.02 0.17 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.438 1.095 . . . . 0.0 111.693 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.4 mt -150.37 -114.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -164.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.18 23.85 5.84 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.333 0.968 . . . . 0.0 111.957 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -169.29 167.69 10.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.987 2.515 . . . . 0.0 111.867 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -121.26 163.4 18.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.233 1.413 . . . . 0.0 111.911 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.12 -174.07 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.658 1.583 . . . . 0.0 110.872 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -120.81 157.75 29.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.7 43.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.504 1.522 . . . . 0.0 113.083 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.72 123.64 39.32 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.771 2.428 . . . . 0.0 108.162 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -79.97 104.43 10.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 0.0 111.507 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.4 pt -94.48 -15.21 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.87 177.8 37.11 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 124.39 0.995 . . . . 0.0 110.877 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.73 91.57 0.45 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.669 0.747 . . . . 0.0 110.37 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 0.73 58.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.629 2.062 . . . . 0.0 115.069 -176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.56 138.94 47.45 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.924 1.862 . . . . 0.0 112.589 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.42 152.37 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mm -108.45 137.85 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 127.044 2.138 . . . . 0.0 106.715 168.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.98 141.17 18.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.235 0.925 . . . . 0.0 111.73 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.86 121.54 30.4 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.351 0.66 . . . . 0.0 110.01 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.13 113.77 43.67 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 168.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.3 169.45 21.26 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.028 2.485 . . . . 0.0 112.75 -169.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.12 153.56 32.2 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.372 3.381 . . . . 0.0 113.661 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -160.24 154.68 23.7 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.959 1.304 . . . . 0.0 110.59 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -104.7 143.15 33.49 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.314 1.045 . . . . 0.0 112.454 -173.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -63.84 153.9 82.75 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.218 0.607 . . . . 0.0 112.243 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.58 166.08 30.73 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.362 2.708 . . . . 0.0 112.223 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.71 10.76 78.62 Favored Glycine 0 N--CA 1.473 1.101 0 C-N-CA 124.48 1.038 . . . . 0.0 115.3 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.56 143.71 28.8 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.407 1.483 . . . . 0.0 113.413 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.0 21.67 79.7 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.167 0.889 . . . . 0.0 114.432 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 t -140.43 170.24 16.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.569 1.185 . . . . 0.0 111.982 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.4 m -59.56 -18.89 44.57 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.614 -1.304 . . . . 0.0 114.373 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.0 p -77.19 -21.61 53.68 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.945 1.298 . . . . 0.0 113.502 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.5 122.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 128.289 2.636 . . . . 0.0 110.599 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -132.72 0.04 3.53 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.737 1.215 . . . . 0.0 113.815 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.4 t -93.68 -168.88 1.98 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.295 1.038 . . . . 0.0 111.696 170.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.95 138.93 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.687 1.195 . . . . 0.0 111.362 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.67 27.01 0.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.659 1.183 . . . . 0.0 113.607 -172.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.0 p -86.34 136.02 33.3 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.107 0.955 . . . . 0.0 112.492 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -80.93 152.34 28.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.421 1.488 . . . . 0.0 111.618 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 m -70.86 155.16 41.13 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.248 -0.907 . . . . 0.0 111.788 170.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.58 158.82 30.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.368 1.067 . . . . 0.0 111.299 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -143.08 132.35 23.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.376 1.071 . . . . 0.0 111.167 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.65 125.82 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.074 0.95 . . . . 0.0 109.992 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.1 171.67 13.68 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.78 1.632 . . . . 0.0 112.203 -170.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -142.01 141.72 32.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.864 1.666 . . . . 0.0 111.611 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.252 14.7 pt-20 174.1 -160.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.269 3.028 . . . . 0.0 110.145 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.9 mtm105 -95.02 148.25 22.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 tp -53.88 -51.87 62.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.537 1.535 . . . . 0.0 111.229 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.45 -25.31 67.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.74 -44.57 23.1 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.418 1.008 . . . . 0.0 110.458 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.33 -34.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.155 0.982 . . . . 0.0 112.125 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.9 -17.77 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.027 1.731 . . . . 0.0 112.873 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.25 118.54 15.26 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.181 -0.95 . . . . 0.0 112.221 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 4.81 90.18 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.677 1.132 . . . . 0.0 114.619 -174.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.73 176.75 7.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.906 2.082 . . . . 0.0 112.107 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -121.02 167.96 12.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.394 1.478 . . . . 0.0 109.64 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -156.0 165.97 34.87 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -158.39 136.22 10.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.998 1.319 . . . . 0.0 110.939 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.8 136.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 118.825 0.738 . . . . 0.0 109.049 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -152.75 128.86 10.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.061 0.545 . . . . 0.0 111.672 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -145.41 40.57 1.21 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.258 1.023 . . . . 0.0 111.304 -172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -71.11 -43.92 66.68 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -169.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -62.75 -35.3 79.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.276 0.63 . . . . 0.0 111.682 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.73 -28.34 67.27 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.349 1.46 . . . . 0.0 114.16 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -64.36 -19.65 65.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.446 1.098 . . . . 0.0 112.468 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -78.66 -16.24 57.54 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.097 0.959 . . . . 0.0 112.93 173.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.41 -75.59 0.58 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -131.03 153.61 81.82 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -139.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.63 -16.93 52.1 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 124.33 3.353 . . . . 0.0 114.367 169.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 72.65 86.65 0.1 Allowed Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 127.678 2.391 . . . . 0.0 113.101 171.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.52 93.67 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.628 2.885 . . . . 0.0 110.378 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.26 -38.77 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.139 0.976 . . . . 0.0 112.14 -172.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -69.1 -41.72 77.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.74 0.7 . . . . 0.0 111.866 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.64 -35.49 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.414 0.686 . . . . 0.0 110.316 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.4 -40.18 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.046 0.938 . . . . 0.0 111.914 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.4 -39.39 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.325 0.966 . . . . 0.0 111.074 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 m -65.63 -40.26 92.34 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.733 -0.604 . . . . 0.0 110.844 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -61.9 -47.18 86.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.268 1.027 . . . . 0.0 111.243 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.05 91.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.616 0.766 . . . . 0.0 112.535 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.95 -46.05 89.6 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.587 -0.695 . . . . 0.0 112.061 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.21 -30.14 70.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.09 -1.006 . . . . 0.0 113.37 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.61 -12.72 61.49 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.81 125.75 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.719 1.145 . . . . 0.0 111.047 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.94 -1.4 80.57 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.615 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -75.46 143.35 42.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.06 1.93 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -117.89 146.2 44.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.706 1.602 . . . . 0.0 111.88 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.6 157.25 44.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.981 1.312 . . . . 0.0 112.166 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -153.02 -33.8 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -173.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -72.21 157.89 36.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -171.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.6 t 75.88 -177.55 0.14 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.191 2.196 . . . . 0.0 113.03 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.7 mm -76.11 140.87 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.63 1.172 . . . . 0.0 109.004 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.13 -32.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -170.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.7 p -63.46 -48.44 77.69 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.361 -0.837 . . . . 0.0 111.527 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -67.19 -35.8 80.41 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.597 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.16 -45.52 79.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.596 1.543 . . . . 0.0 111.437 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.8 m -65.82 -49.43 68.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.284 1.434 . . . . 0.0 113.294 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.74 -41.55 99.25 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.567 0.747 . . . . 0.0 112.262 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.531 ' CD2' HE22 ' A' ' 119' ' ' GLN . 34.4 t60 -64.76 -42.26 95.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.111 1.364 . . . . 0.0 110.221 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -54.6 -52.46 62.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.021 1.329 . . . . 0.0 112.04 169.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.8 m -68.72 -18.33 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.815 1.189 . . . . 0.0 113.992 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -75.6 -45.39 37.87 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.698 169.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.531 HE22 ' CD2' ' A' ' 115' ' ' HIS . 0.8 OUTLIER -54.49 -34.57 61.86 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.82 1.191 . . . . 0.0 113.397 170.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.98 -59.45 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.907 0.776 . . . . 0.0 111.452 171.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -80.48 11.13 3.9 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.79 -19.45 62.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.543 1.937 . . . . 0.0 113.94 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -47.29 -37.75 11.84 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.908 2.194 . . . . 0.0 116.639 -169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -140.74 7.89 2.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.623 1.211 . . . . 0.0 113.622 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.638 1.575 . . . . 0.0 112.289 175.334 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.5 141.8 31.99 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.288 1.992 . . . . 0.0 110.206 170.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -91.75 142.11 26.31 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.852 0.861 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.51 128.92 22.37 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.637 2.225 . . . . 0.0 110.232 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.51 -2.38 72.73 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.503 1.525 . . . . 0.0 114.838 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.26 162.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.521 1.661 . . . . 0.0 111.163 169.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.01 146.05 42.47 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.953 1.359 . . . . 0.0 113.814 -171.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mt -123.26 129.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.341 2.257 . . . . 0.0 108.024 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -82.36 124.43 30.0 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.684 1.193 . . . . 0.0 107.798 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mm -118.44 119.5 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 110.346 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -81.79 72.81 8.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 108.536 169.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -25.91 57.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.727 1.211 . . . . 0.0 113.461 -170.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -161.62 -159.94 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.709 2.004 . . . . 0.0 108.715 -159.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.96 34.19 1.05 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.662 1.125 . . . . 0.0 112.678 169.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -169.44 158.83 8.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.427 2.691 . . . . 0.0 111.002 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -104.05 123.95 48.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -105.6 167.95 9.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.599 1.559 . . . . 0.0 110.862 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -112.69 151.81 29.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.729 0.811 . . . . 0.0 111.698 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.62 156.77 44.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.371 1.068 . . . . 0.0 112.819 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -123.49 120.99 34.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.032 . . . . 0.0 108.75 -178.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -76.98 92.17 3.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.234 1.014 . . . . 0.0 111.864 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.5 pt -81.18 -21.93 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.75 173.35 31.75 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 124.199 0.904 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -68.41 90.67 0.37 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.674 0.749 . . . . 0.0 109.908 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.0 49.93 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.195 1.855 . . . . 0.0 115.581 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -126.18 140.64 52.4 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.714 1.757 . . . . 0.0 112.963 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -137.07 149.79 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.289 1.036 . . . . 0.0 113.237 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.5 mm -105.56 131.74 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -146.85 162.82 37.84 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.908 1.231 . . . . 0.0 112.069 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -100.58 134.11 44.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.315 0.646 . . . . 0.0 112.626 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.53 108.44 53.24 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 126.214 1.805 . . . . 0.0 106.232 168.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -62.75 162.18 26.03 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.373 3.382 . . . . 0.0 114.822 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 CA--C 1.545 1.065 0 C-N-CA 124.802 3.668 . . . . 0.0 113.689 175.138 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 119.816 -0.135 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 150.11 26.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.593 -0.692 . . . . 0.0 111.968 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -143.42 136.72 28.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.251 1.02 . . . . 0.0 110.944 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.51 128.35 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.617 1.167 . . . . 0.0 108.846 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -130.41 151.45 50.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.469 1.508 . . . . 0.0 112.543 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -105.37 138.75 41.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.332 1.453 . . . . 0.0 110.585 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.69 167.63 18.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.14 0.976 . . . . 0.0 111.021 -170.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -83.8 143.66 29.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.072 1.349 . . . . 0.0 110.617 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.03 -49.06 72.5 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.507 0.723 . . . . 0.0 110.522 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.7 -24.39 65.6 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.96 -46.09 15.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.355 0.98 . . . . 0.0 110.287 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.69 -30.73 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.971 0.908 . . . . 0.0 112.252 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -91.78 -21.5 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.88 1.672 . . . . 0.0 112.759 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.31 118.71 15.21 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.383 0.992 . . . . 0.0 112.048 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.46 75.49 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.445 1.021 . . . . 0.0 114.607 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.1 m -123.67 163.47 21.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.132 1.773 . . . . 0.0 111.795 -171.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -109.99 159.86 16.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.575 1.15 . . . . 0.0 109.961 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -157.89 169.2 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.9 tpp85 -163.93 132.65 3.74 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.146 1.778 . . . . 0.0 110.727 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.61 127.53 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -152.73 64.89 0.79 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.973 0.892 . . . . 0.0 110.679 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -80.57 69.11 7.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.364 1.065 . . . . 0.0 111.177 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.7 p -35.14 -64.56 0.27 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.425 2.29 . . . . 0.0 115.328 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.84 -29.24 68.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.47 -39.51 74.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.565 0.746 . . . . 0.0 112.448 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -67.99 -30.51 69.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 112.093 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -76.09 -36.98 58.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.612 1.165 . . . . 0.0 113.333 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -162.93 -52.98 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -72.24 148.73 91.38 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -153.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.06 -37.4 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.714 2.943 . . . . 0.0 113.145 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 68.64 119.64 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.602 2.361 . . . . 0.0 116.934 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.4 89.38 1.36 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.396 3.397 . . . . 0.0 110.981 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.92 -41.43 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.739 1.616 . . . . 0.0 113.956 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.03 -36.08 79.34 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.554 0.615 . . . . 0.0 111.512 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.07 -27.87 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.035 0.934 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.6 mm -68.19 -47.29 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.14 0.882 . . . . 0.0 110.647 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.03 -38.13 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.771 -0.58 . . . . 0.0 110.801 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -67.25 -41.15 86.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.705 -0.622 . . . . 0.0 111.166 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.2 m -64.82 -39.55 93.76 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.541 1.136 . . . . 0.0 111.992 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.75 95.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.36 -0.838 . . . . 0.0 111.665 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -68.75 -11.17 59.99 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 173.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.25 -35.74 14.31 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.41 1.084 . . . . 0.0 111.174 168.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.3 mmm -72.44 -20.21 61.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.712 1.605 . . . . 0.0 113.819 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.26 124.22 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.902 1.228 . . . . 0.0 111.623 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.0 -4.56 85.55 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.069 -1.406 . . . . 0.0 115.323 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 150.81 47.61 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.073 1.937 . . . . 0.0 111.009 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -129.18 149.79 50.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.874 1.67 . . . . 0.0 112.301 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.7 mtm -144.03 158.96 43.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 0.0 111.234 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -152.83 -32.88 0.13 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -171.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.59 -28.45 51.63 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -90.12 150.02 22.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.232 1.013 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.33 157.1 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.592 -0.693 . . . . 0.0 111.328 172.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.77 -42.28 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m -64.2 -45.67 87.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.899 0.772 . . . . 0.0 111.367 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -75.98 -32.16 59.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.864 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -57.85 -40.12 79.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.198 0.908 . . . . 0.0 111.366 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.04 -55.23 31.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.895 1.678 . . . . 0.0 112.938 169.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.07 -43.61 98.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.432 -0.792 . . . . 0.0 112.339 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.79 -34.94 79.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.238 1.015 . . . . 0.0 111.195 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.65 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 26.3 t80 -61.19 -55.65 29.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.829 169.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.39 -20.45 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 120.304 1.411 . . . . 0.0 113.992 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -73.01 -37.96 66.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.526 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -71.99 -27.64 62.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.893 1.224 . . . . 0.0 113.442 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.65 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 83.3 mt -66.41 -46.89 75.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.218 0.917 . . . . 0.0 111.77 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -69.5 -94.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.677 1.191 . . . . 0.0 108.633 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.7 t80 70.77 -6.99 1.13 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.236 2.614 . . . . 0.0 112.993 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.28 -69.54 1.28 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 127.22 2.343 . . . . 0.0 111.92 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.84 1.14 33.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.26 1.024 . . . . 0.0 113.269 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 125.617 1.567 . . . . 0.0 112.484 170.067 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.2 150.1 36.83 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.25 2.634 . . . . 0.0 111.069 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -108.59 160.31 27.67 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.457 1.503 . . . . 0.0 111.664 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.51 134.5 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.782 1.655 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.8 -10.38 74.71 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.855 1.216 . . . . 0.0 114.685 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.13 142.76 31.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.773 1.287 . . . . 0.0 111.539 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.66 128.1 48.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.627 1.203 . . . . 0.0 108.074 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.15 126.65 61.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 105.978 -170.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -74.84 129.67 38.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.06 120.04 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.621 1.569 . . . . 0.0 109.051 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -80.93 90.27 5.92 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -81.58 31.24 0.35 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt 82.53 72.76 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.652 1.981 . . . . 0.0 110.922 155.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.79 1.46 76.94 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.829 1.204 . . . . 0.0 113.353 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -138.67 140.2 38.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.239 1.815 . . . . 0.0 110.653 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -98.06 119.71 37.18 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.645 0.778 . . . . 0.0 110.427 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -125.92 178.62 5.63 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.695 1.598 . . . . 0.0 111.042 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -137.97 157.24 46.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.441 0.696 . . . . 0.0 112.606 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.55 25.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 120.74 32.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.671 1.589 . . . . 0.0 108.589 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.0 110.24 5.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 pt -100.06 -20.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.34 170.57 42.19 Favored Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.71 0.804 . . . . 0.0 112.591 -170.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 19.11 66.24 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.335 1.445 . . . . 0.0 115.749 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -127.08 141.73 51.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.62 1.71 . . . . 0.0 112.736 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.9 156.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.658 1.183 . . . . 0.0 113.117 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 mm -112.49 132.42 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.184 1.794 . . . . 0.0 107.632 169.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -149.31 148.77 29.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.737 1.153 . . . . 0.0 111.896 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.0 tp -83.41 106.35 15.1 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 91.66 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.194 1.398 . . . . 0.0 111.032 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.18 141.91 44.74 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.129 3.22 . . . . 0.0 116.289 -168.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 123.758 2.972 . . . . 0.0 111.766 169.266 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.9 p . . . . . 0 CA--C 1.545 0.769 0 CA-C-O 120.323 0.106 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.86 156.35 28.71 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.117 -0.989 . . . . 0.0 111.27 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.68 135.05 37.87 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 0.0 111.289 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.52 122.19 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -127.36 157.07 40.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.428 1.491 . . . . 0.0 112.26 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -101.55 142.39 32.99 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.139 1.375 . . . . 0.0 110.398 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.75 164.08 21.28 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.095 0.958 . . . . 0.0 111.23 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -74.67 140.67 44.39 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.23 1.412 . . . . 0.0 110.414 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.3 tp -53.81 -57.27 11.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.173 0.989 . . . . 0.0 110.873 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.54 -21.94 66.61 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.48 -41.66 65.76 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.188 0.904 . . . . 0.0 110.878 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.29 -54.55 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.616 0.766 . . . . 0.0 110.87 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.1 -6.61 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.87 -28.23 54.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.116 0.865 . . . . 0.0 113.179 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.39 22.93 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.612 1.101 . . . . 0.0 114.736 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 79.8 m -130.76 148.47 52.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.238 1.415 . . . . 0.0 112.44 -172.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.6 m -76.56 157.37 32.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -158.02 172.45 18.42 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 155.52 2.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 128.173 2.589 . . . . 0.0 112.443 169.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.34 146.72 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.983 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -130.35 -80.85 0.54 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 51.47 49.73 20.35 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.878 2.071 . . . . 0.0 112.541 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -49.35 -57.04 7.6 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.677 -1.265 . . . . 0.0 113.402 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.19 -27.14 69.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.362 1.065 . . . . 0.0 113.444 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -24.94 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.876 0.87 . . . . 0.0 112.238 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -89.55 -30.84 17.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.514 1.125 . . . . 0.0 112.646 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.58 -37.58 88.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.73 0.812 . . . . 0.0 111.898 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.7 -71.55 0.09 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.91 129.89 40.43 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -145.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.88 67.19 5.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.897 3.065 . . . . 0.0 110.46 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.413 ' HB3' HD11 ' A' ' 92' ' ' ILE . 27.8 ttt180 -66.45 137.36 95.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.39 123.11 11.84 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.155 2.57 . . . . 0.0 110.33 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.405 ' HA ' HD12 ' A' ' 92' ' ' ILE . 2.5 t -65.25 -31.68 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.53 -0.747 . . . . 0.0 112.297 -169.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -54.74 -37.75 66.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.687 1.131 . . . . 0.0 112.4 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.04 -28.5 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.518 0.727 . . . . 0.0 110.909 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 87' ' ' ARG . 21.7 mt -69.63 -44.22 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.437 1.095 . . . . 0.0 110.42 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.86 -46.43 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.291 1.037 . . . . 0.0 109.837 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -64.21 -40.73 96.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.457 0.703 . . . . 0.0 111.565 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.0 t -61.33 -43.66 98.49 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.079 -1.013 . . . . 0.0 111.639 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.8 93.78 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.104 -0.997 . . . . 0.0 111.893 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.47 -25.39 68.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.197 0.999 . . . . 0.0 113.536 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -81.35 -35.27 31.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.174 0.99 . . . . 0.0 112.999 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.2 mmm -73.38 -30.39 63.26 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -54.78 126.61 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.488 1.04 . . . . 0.0 111.193 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.88 -9.52 55.2 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.027 1.775 . . . . 0.0 114.263 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -83.5 141.32 31.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.128 1.464 . . . . 0.0 111.11 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.98 155.06 18.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.69 1.596 . . . . 0.0 111.159 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 23.2 ptp -161.85 152.71 17.84 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -150.46 41.06 0.78 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.086 1.755 . . . . 0.0 110.268 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.84 -28.46 69.5 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.305 1.842 . . . . 0.0 115.279 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -172.1 -169.83 0.68 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.679 1.992 . . . . 0.0 110.379 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 pt -54.43 150.75 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.828 0.851 . . . . 0.0 110.504 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.78 -37.95 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.2 p -62.87 -45.55 92.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.067 0.849 . . . . 0.0 111.7 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -70.56 -35.14 72.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.019 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -61.29 -41.97 97.86 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.446 1.475 . . . . 0.0 110.911 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.2 m -64.36 -48.91 73.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.759 2.024 . . . . 0.0 112.508 170.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.84 -45.74 92.51 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.478 -0.764 . . . . 0.0 112.241 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -53.01 -45.42 67.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.644 1.978 . . . . 0.0 110.683 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.22 -58.9 6.55 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.723 1.209 . . . . 0.0 112.335 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.32 -26.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.031 1.287 . . . . 0.0 113.472 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -61.86 -52.28 64.76 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 115.981 -1.961 . . . . 0.0 107.449 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -56.93 -25.4 57.38 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 122.41 2.368 . . . . 0.0 114.849 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -68.47 -33.26 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.666 1.121 . . . . 0.0 112.841 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -105.95 -13.43 15.49 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -58.11 -22.01 48.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.666 2.787 . . . . 0.0 113.069 -168.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -71.67 -11.94 73.51 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.862 -0.965 . . . . 0.0 115.414 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -134.57 2.92 3.25 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.68 1.24 . . . . 0.0 114.216 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 125.246 1.418 . . . . 0.0 112.891 177.594 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.544 0.721 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.7 142.14 25.48 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.553 2.835 . . . . 0.0 110.635 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -115.66 138.91 24.18 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.189 0.995 . . . . 0.0 111.712 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.13 130.24 28.24 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.407 2.738 . . . . 0.0 111.32 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.07 42.37 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.169 1.842 . . . . 0.0 115.304 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -89.35 164.62 14.82 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 110.446 169.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -119.65 148.6 43.16 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.582 1.182 . . . . 0.0 113.012 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -123.99 130.34 73.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.561 2.344 . . . . 0.0 108.221 -161.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -88.71 120.88 30.51 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.79 124.28 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.461 1.504 . . . . 0.0 108.456 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -90.78 63.92 5.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.304 1.441 . . . . 0.0 109.579 -173.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -61.41 2.32 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -148.79 -129.48 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -162.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.33 33.83 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.635 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.75 158.53 2.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.566 2.746 . . . . 0.0 112.008 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -112.9 155.35 24.87 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.887 1.675 . . . . 0.0 109.783 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 164.81 34.91 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.569 -0.707 . . . . 0.0 112.885 174.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -97.88 149.82 21.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.19 140.35 27.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.424 1.09 . . . . 0.0 112.613 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.95 117.53 35.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.846 2.058 . . . . 0.0 108.983 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -76.56 86.82 3.26 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.885 1.274 . . . . 0.0 111.804 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -74.77 -23.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.11 177.88 27.03 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.584 1.088 . . . . 0.0 111.486 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.38 81.89 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.726 0.81 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.33 -11.83 31.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.33 2.395 . . . . 0.0 114.671 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.89 140.47 36.14 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.108 1.454 . . . . 0.0 113.126 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.0 149.54 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 0.0 113.703 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -108.35 123.04 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -137.8 149.76 46.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.231 -0.918 . . . . 0.0 111.512 -169.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.59 118.98 29.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.881 0.472 . . . . 0.0 110.07 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.7 130.95 62.23 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.04 158.89 45.33 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.279 2.652 . . . . 0.0 112.772 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 CA--C 1.539 0.733 0 C-N-CA 123.914 3.076 . . . . 0.0 113.456 178.629 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.16 150.42 30.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.444 -0.785 . . . . 0.0 111.23 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.94 133.7 16.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.725 0.81 . . . . 0.0 110.654 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.03 121.9 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -128.06 156.7 42.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.739 1.616 . . . . 0.0 112.853 -170.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.33 139.98 38.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.067 1.347 . . . . 0.0 110.625 171.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.74 178.87 5.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.497 1.519 . . . . 0.0 109.811 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -96.1 142.49 28.23 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.317 1.447 . . . . 0.0 110.325 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.2 tp -55.35 -49.66 71.67 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.518 -0.739 . . . . 0.0 111.099 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.77 -25.63 63.23 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.28 -42.38 14.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.995 0.816 . . . . 0.0 111.342 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.98 -40.8 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 118.13 0.423 . . . . 0.0 111.305 172.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.5 -47.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.264 1.026 . . . . 0.0 111.613 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.21 -117.55 11.81 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -171.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.58 0.86 61.54 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.039 1.304 . . . . 0.0 115.056 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.82 166.44 22.05 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.942 1.371 . . . . 0.0 113.587 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -82.35 156.26 24.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.881 0.873 . . . . 0.0 110.998 169.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -161.05 156.73 25.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.019 0.927 . . . . 0.0 113.314 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -153.08 140.04 19.19 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.92 0.888 . . . . 0.0 111.827 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.92 133.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -158.01 70.12 0.55 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.344 1.058 . . . . 0.0 111.499 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -80.12 61.06 3.84 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.807 -1.183 . . . . 0.0 111.998 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.8 p -43.2 -67.62 0.26 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.496 1.918 . . . . 0.0 114.842 -169.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -58.08 -27.16 63.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.993 0.917 . . . . 0.0 113.142 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.2 -48.5 28.6 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.757 -0.589 . . . . 0.0 111.572 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -78.67 -7.59 57.84 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.4 -31.81 73.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 113.34 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.76 -36.41 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -126.45 139.26 34.19 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -137.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -94.6 54.99 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.09 1 C-N-CA 125.439 4.093 . . . . 0.0 111.737 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 147.82 46.84 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.41 100.4 1.14 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.955 3.104 . . . . 0.0 109.211 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.14 -25.26 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.327 1.051 . . . . 0.0 113.207 -169.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.58 -33.21 75.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.74 0.816 . . . . 0.0 112.338 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.0 -34.37 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.603 -0.685 . . . . 0.0 110.172 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.5 -44.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.611 0.764 . . . . 0.0 110.756 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.08 -40.13 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.669 0.788 . . . . 0.0 111.24 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.9 m -66.44 -43.18 86.31 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.416 -0.802 . . . . 0.0 111.237 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -34.66 78.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.049 0.939 . . . . 0.0 112.71 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.22 -45.17 94.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.77 1.168 . . . . 0.0 111.812 171.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.69 -13.49 61.33 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.96 -36.46 13.42 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.556 1.143 . . . . 0.0 112.501 168.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -72.38 -30.42 64.66 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.122 1.369 . . . . 0.0 113.573 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.43 128.45 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.809 0.731 . . . . 0.0 111.159 171.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.44 -9.11 58.94 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.484 1.516 . . . . 0.0 114.468 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -71.65 145.75 48.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.387 1.594 . . . . 0.0 111.01 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.81 143.95 50.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.009 1.724 . . . . 0.0 111.549 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -141.5 158.32 44.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.077 1.351 . . . . 0.0 111.363 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -161.96 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -72.39 -34.99 68.32 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.2 m -71.74 163.15 28.32 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -175.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.69 133.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.908 0.883 . . . . 0.0 108.629 171.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.1 t -57.67 -42.75 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 m -61.05 -47.97 83.91 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.568 -0.707 . . . . 0.0 111.075 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -67.44 -34.22 76.75 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.846 -0.534 . . . . 0.0 112.235 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.15 -38.5 83.31 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.099 0.96 . . . . 0.0 111.866 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 81.7 m -69.7 -48.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.433 1.093 . . . . 0.0 111.896 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.2 -46.96 86.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.057 0.543 . . . . 0.0 112.018 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.35 -32.55 74.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.75 -1.219 . . . . 0.0 111.531 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.44 -58.6 7.55 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.307 -0.871 . . . . 0.0 110.885 170.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.76 -25.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.0 m -69.41 -39.97 77.6 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.221 173.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.62 -27.19 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.278 1.399 . . . . 0.0 113.248 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.97 -38.37 82.64 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.545 1.066 . . . . 0.0 112.983 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 34.44 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -39.44 61.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 127.238 2.215 . . . . 0.0 112.493 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.91 44.54 0.1 Allowed Glycine 0 N--CA 1.475 1.263 0 C-N-CA 126.463 1.982 . . . . 0.0 111.528 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 pttm 91.72 -22.63 0.08 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 130.451 3.501 . . . . 0.0 110.172 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.253 1.262 1 C-N-CA 132.741 4.417 . . . . 0.0 113.516 169.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.15 136.61 11.63 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.074 2.516 . . . . 0.0 110.214 169.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -85.45 154.81 59.69 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.428 0.691 . . . . 0.0 110.959 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.97 123.64 11.9 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.138 1.892 . . . . 0.0 109.228 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 -2.3 81.8 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.705 1.622 . . . . 0.0 115.198 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.95 156.79 17.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 1.587 . . . . 0.0 111.734 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.2 pt? -112.42 160.75 17.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.753 1.221 . . . . 0.0 113.581 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mt -144.31 131.91 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.994 1.318 . . . . 0.0 110.471 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.92 121.75 33.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.822 1.249 . . . . 0.0 107.633 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.7 mt -126.6 123.54 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.945 0.898 . . . . 0.0 110.488 -172.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.93 51.72 1.8 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.895 1.678 . . . . 0.0 110.71 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.06 -40.96 82.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.726 1.21 . . . . 0.0 111.86 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 mt -158.8 172.38 18.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.624 1.969 . . . . 0.0 108.192 -168.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.65 -7.39 20.98 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -73.88 -35.52 64.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.349 1.06 . . . . 0.0 113.483 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 68.28 106.52 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.309 2.244 . . . . 0.0 109.509 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -101.39 149.39 24.1 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -94.63 136.98 34.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.062 0.945 . . . . 0.0 109.431 168.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.73 159.06 42.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.194 0.998 . . . . 0.0 112.493 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.39 121.66 29.61 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.419 2.287 . . . . 0.0 107.782 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -77.97 97.65 5.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.576 0.626 . . . . 0.0 110.26 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.7 pt -73.7 -3.54 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.79 137.14 4.07 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.526 1.06 . . . . 0.0 114.293 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.23 -20.51 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 129.953 3.301 . . . . 0.0 117.575 169.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.88 -19.81 0.05 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.211 1.386 . . . . 0.0 115.132 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -89.9 147.89 23.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.182 1.491 . . . . 0.0 113.466 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 m -127.82 146.29 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.211 1.404 . . . . 0.0 112.13 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.48 139.62 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -158.19 158.95 35.54 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.119 -0.988 . . . . 0.0 111.942 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -98.81 136.25 39.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.222 0.609 . . . . 0.0 111.124 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.89 141.16 21.91 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 109.686 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.15 165.14 33.5 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.641 2.894 . . . . 0.0 112.469 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo . . . . . 0 C--N 1.354 0.816 0 C-N-CA 123.363 2.708 . . . . 0.0 115.493 175.46 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.22 155.41 40.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.951 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -138.57 129.94 27.35 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.853 0.861 . . . . 0.0 111.095 -170.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.94 128.95 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.194 0.597 . . . . 0.0 110.11 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -137.67 169.87 17.04 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.878 1.671 . . . . 0.0 112.248 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -127.12 143.04 51.36 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.922 1.689 . . . . 0.0 111.872 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -153.76 179.54 8.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.449 1.9 . . . . 0.0 110.623 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -102.56 140.25 37.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 110.332 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.26 -47.91 71.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.015 1.326 . . . . 0.0 111.631 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.14 -33.34 70.77 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.84 -45.32 51.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.378 0.99 . . . . 0.0 110.27 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.19 -32.31 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.736 1.214 . . . . 0.0 112.605 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.82 -20.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.888 1.675 . . . . 0.0 112.547 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 116.13 8.36 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.253 0.933 . . . . 0.0 111.911 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.6 7.55 74.29 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.574 1.083 . . . . 0.0 115.041 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.3 m -121.15 143.94 48.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.121 1.369 . . . . 0.0 112.468 -171.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 80.8 m -85.04 152.11 23.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.448 0.699 . . . . 0.0 109.674 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -158.18 161.44 37.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.631 0.772 . . . . 0.0 112.977 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -144.61 139.51 28.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.861 1.664 . . . . 0.0 110.536 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.9 t -80.61 138.32 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -126.62 142.1 51.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.813 0.845 . . . . 0.0 112.846 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -137.48 39.59 2.44 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.288 1.435 . . . . 0.0 111.337 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.7 t -57.9 -69.05 0.19 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.571 -1.33 . . . . 0.0 113.725 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.7 mt -72.31 -27.05 62.2 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.39 -0.819 . . . . 0.0 112.181 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.18 -42.14 98.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.637 0.775 . . . . 0.0 112.923 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.03 -8.61 59.09 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -82.56 -36.01 26.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -113.11 -45.0 3.2 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -169.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -142.34 155.04 64.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -133.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.87 -21.36 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.606 3.537 . . . . 0.0 113.122 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 69.18 117.61 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 128.441 2.696 . . . . 0.0 115.408 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.54 88.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 123.733 2.956 . . . . 0.0 108.58 169.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.71 -38.74 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.997 -169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -38.79 81.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.539 0.609 . . . . 0.0 111.721 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.43 -38.16 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.79 0.723 . . . . 0.0 111.305 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.68 -47.36 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 119.281 0.946 . . . . 0.0 110.323 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 90.8 mt -61.41 -40.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.206 1.002 . . . . 0.0 110.94 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.1 t -63.42 -42.93 98.73 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.434 0.694 . . . . 0.0 111.408 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -58.96 -40.54 85.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.321 -0.862 . . . . 0.0 112.248 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.9 -52.57 59.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.49 0.716 . . . . 0.0 111.982 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.82 -22.72 67.05 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.34 -50.03 12.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.165 0.986 . . . . 0.0 112.367 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 ptm -83.46 -14.13 53.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -170.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -55.54 125.4 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -8.45 59.06 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.391 1.472 . . . . 0.0 114.297 -169.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -70.63 153.97 42.33 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.576 1.688 . . . . 0.0 110.779 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -127.64 142.24 51.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.79 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -140.43 149.25 42.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.072 0.949 . . . . 0.0 113.059 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -154.28 -152.33 0.4 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.664 1.586 . . . . 0.0 111.262 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.9 t80 72.35 -53.77 0.69 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.871 2.869 . . . . 0.0 113.885 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.1 m -69.41 162.99 26.22 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.734 1.214 . . . . 0.0 112.379 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 tt -63.3 144.25 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 121.378 -0.826 . . . . 0.0 109.898 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.33 -27.63 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.8 t -64.14 -49.11 73.44 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.367 -0.833 . . . . 0.0 111.151 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -68.71 -28.7 67.07 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.933 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -57.34 -42.31 81.72 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.862 1.665 . . . . 0.0 111.191 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -45.11 53.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.957 1.303 . . . . 0.0 112.968 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.24 -41.41 90.06 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.117 -0.99 . . . . 0.0 112.69 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.85 -36.36 83.24 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.602 -1.311 . . . . 0.0 110.784 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.27 -58.0 10.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.482 0.713 . . . . 0.0 110.706 170.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -65.97 -27.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.954 1.252 . . . . 0.0 113.486 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -68.92 -33.97 74.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.819 1.19 . . . . 0.0 111.429 172.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -66.38 -23.14 66.28 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.61 -61.38 1.89 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.456 -0.778 . . . . 0.0 111.758 169.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -72.63 5.6 2.99 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -53.35 -24.75 12.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.251 2.22 . . . . 0.0 112.459 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.41 -24.51 11.01 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 127.573 2.511 . . . . 0.0 114.615 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.56 -19.94 0.47 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.252 1.021 . . . . 0.0 113.019 177.617 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 119.012 -0.518 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.57 139.47 12.72 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 108.378 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -85.8 148.65 49.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.536 -0.728 . . . . 0.0 111.529 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.56 128.02 20.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.182 2.588 . . . . 0.0 109.957 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.48 82.86 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.938 1.733 . . . . 0.0 115.039 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.6 162.96 12.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -100.9 110.72 22.81 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 127.64 2.376 . . . . 0.0 113.636 -168.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.23 132.35 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.099 1.359 . . . . 0.0 109.92 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -96.54 116.98 29.98 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.07 120.29 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.317 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -81.72 63.16 5.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.675 1.19 . . . . 0.0 109.47 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -62.24 -29.38 70.36 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.317 1.047 . . . . 0.0 113.122 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.46 -144.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.092 1.357 . . . . 0.0 110.456 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.27 31.11 0.81 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.274 1.416 . . . . 0.0 114.706 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -168.44 154.87 7.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.786 2.835 . . . . 0.0 110.093 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -104.65 128.45 52.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.969 0.907 . . . . 0.0 110.812 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -108.76 134.69 51.12 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.878 1.271 . . . . 0.0 110.786 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -79.78 144.65 33.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.82 145.31 37.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.346 1.458 . . . . 0.0 111.521 169.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.14 118.19 36.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.244 1.818 . . . . 0.0 107.948 173.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -74.09 94.7 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.537 0.735 . . . . 0.0 110.64 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 pt -74.04 -8.8 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.668 -1.27 . . . . 0.0 114.15 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.97 133.83 2.91 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.738 0.685 . . . . 0.0 114.29 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 63.39 -19.56 0.06 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.634 3.173 . . . . 0.0 117.284 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.52 -21.44 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.509 1.528 . . . . 0.0 114.683 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.87 144.45 30.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.949 1.375 . . . . 0.0 113.002 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.83 145.62 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.135 1.374 . . . . 0.0 112.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.8 mm -107.45 138.64 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.753 1.621 . . . . 0.0 107.643 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -153.68 146.47 24.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.502 1.047 . . . . 0.0 112.091 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.12 118.79 31.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 109.844 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.9 119.49 75.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.855 1.262 . . . . 0.0 108.96 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -74.28 165.33 32.1 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.714 2.943 . . . . 0.0 112.261 -173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 CA--C 1.54 0.806 0 C-N-CA 122.667 2.244 . . . . 0.0 110.051 177.314 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 121.176 0.513 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.21 159.11 28.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.014 0.926 . . . . 0.0 111.04 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -152.58 138.46 18.05 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.652 -0.655 . . . . 0.0 112.197 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.4 t -82.54 125.76 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.551 1.14 . . . . 0.0 109.406 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.47 175.15 9.79 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.959 1.704 . . . . 0.0 112.004 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -141.21 143.95 34.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.645 1.578 . . . . 0.0 112.24 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -178.78 -165.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.434 2.694 . . . . 0.0 109.249 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -103.79 150.0 24.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.7 tp -50.94 -57.87 7.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.123 1.769 . . . . 0.0 111.477 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 69' ' ' VAL . 17.7 pm0 -57.27 -33.44 67.62 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.088 0.955 . . . . 0.0 113.409 -174.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.04 -30.03 58.27 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.371 -0.831 . . . . 0.0 112.015 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.49 -45.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.204 1.401 . . . . 0.0 111.785 172.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 66' ' ' GLU . 34.7 m -84.62 -6.13 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.4 7.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 119.145 0.884 . . . . 0.0 111.777 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.28 7.72 78.23 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.835 1.207 . . . . 0.0 115.07 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.36 151.84 42.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.593 1.557 . . . . 0.0 112.549 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.61 160.12 19.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.874 0.87 . . . . 0.0 110.63 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -161.67 168.15 23.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.339 1.056 . . . . 0.0 113.44 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -167.23 149.98 6.21 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.122 1.769 . . . . 0.0 110.147 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.16 138.82 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 119.735 1.152 . . . . 0.0 110.153 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -132.32 130.69 41.11 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.013 1.325 . . . . 0.0 111.977 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -123.43 25.84 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.202 1.801 . . . . 0.0 113.299 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.7 m -60.82 -21.45 63.16 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.547 -1.345 . . . . 0.0 114.577 -171.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 mt -93.27 -39.25 11.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.806 0.842 . . . . 0.0 113.025 169.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.58 -35.06 71.8 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.439 1.018 . . . . 0.0 111.819 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -52.88 -29.12 26.44 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.401 2.28 . . . . 0.0 113.052 171.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -87.26 -14.91 39.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.494 1.118 . . . . 0.0 112.993 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -122.03 -64.64 1.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -138.71 149.7 63.17 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -135.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 -11.55 15.27 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 125.183 3.922 . . . . 0.0 114.074 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 81.21 96.48 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 127.586 2.354 . . . . 0.0 114.012 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.99 80.89 2.74 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.745 2.963 . . . . 0.0 108.528 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.77 -29.58 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.64 -39.5 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.465 1.03 . . . . 0.0 111.428 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.09 -34.23 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.387 -0.821 . . . . 0.0 110.247 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.9 mt -76.71 -39.69 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.995 0.918 . . . . 0.0 111.566 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.04 -45.32 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.551 -0.718 . . . . 0.0 110.979 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.9 p -68.21 -29.98 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.337 -0.852 . . . . 0.0 112.413 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -59.7 -46.64 88.47 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.059 -1.025 . . . . 0.0 111.192 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.65 92.09 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.079 -1.013 . . . . 0.0 112.428 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -67.42 -15.7 63.82 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -90.14 -38.35 13.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.977 1.311 . . . . 0.0 112.113 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.4 mmm -70.46 -25.09 63.02 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.361 1.464 . . . . 0.0 113.999 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -48.59 127.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.105 0.866 . . . . 0.0 111.804 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.87 81.4 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.127 1.346 . . . . 0.0 115.114 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -73.62 138.94 45.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.6 1.7 . . . . 0.0 110.7 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -98.08 156.12 16.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.363 1.465 . . . . 0.0 112.173 170.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 mtm -144.43 159.26 43.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.33 1.852 . . . . 0.0 111.44 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -158.61 -32.8 0.07 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -70.11 151.97 44.86 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.453 1.101 . . . . 0.0 113.879 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 t 76.76 -179.04 0.14 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.858 2.063 . . . . 0.0 113.803 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 pt -76.61 149.28 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.643 1.177 . . . . 0.0 110.558 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.91 -35.43 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.833 0.742 . . . . 0.0 112.542 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 p -64.35 -47.08 80.69 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.809 0.844 . . . . 0.0 112.485 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -67.95 -37.18 81.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.229 -0.919 . . . . 0.0 111.249 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -59.58 -46.56 88.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.289 0.95 . . . . 0.0 111.819 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.7 p -73.33 -37.34 66.15 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.495 -0.753 . . . . 0.0 112.797 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.25 -54.57 44.13 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.045 0.839 . . . . 0.0 111.355 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -56.1 -39.5 72.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.607 1.163 . . . . 0.0 111.224 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -56.43 -58.64 7.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.183 0.993 . . . . 0.0 111.294 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.3 m -64.98 -33.2 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.174 1.352 . . . . 0.0 113.253 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.7 m -68.36 -31.98 71.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.135 1.334 . . . . 0.0 111.544 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.51 -25.46 66.69 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.526 1.512 . . . . 0.0 112.327 169.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.62 -56.48 5.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.155 0.889 . . . . 0.0 110.976 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -75.96 5.7 6.19 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -57.7 -23.31 51.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.798 2.039 . . . . 0.0 113.434 -170.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -40.22 -36.32 0.89 Allowed Glycine 0 N--CA 1.474 1.185 0 C-N-CA 128.839 3.114 . . . . 0.0 117.465 -169.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -138.68 16.52 2.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.2 1.0 . . . . 0.0 112.77 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 126.203 1.801 . . . . 0.0 112.565 -178.51 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.66 129.74 28.93 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.331 2.688 . . . . 0.0 113.15 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.79 140.36 21.29 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.867 1.267 . . . . 0.0 108.136 169.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.23 131.37 21.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.244 1.296 . . . . 0.0 109.919 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.99 83.27 Favored Glycine 0 N--CA 1.469 0.859 0 C-N-CA 124.678 1.132 . . . . 0.0 114.66 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.77 168.81 9.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.19 1.495 . . . . 0.0 113.103 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.4 mt -102.99 111.35 23.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.922 1.689 . . . . 0.0 113.857 -168.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.6 mt -97.17 129.06 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 109.86 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.35 120.99 37.65 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.293 1.437 . . . . 0.0 107.559 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -121.47 121.91 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.297 1.039 . . . . 0.0 109.967 -174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -77.19 67.55 3.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.638 1.175 . . . . 0.0 111.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -64.8 -47.57 77.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.011 1.324 . . . . 0.0 113.451 -170.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -148.38 37.81 0.85 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.614 0.721 . . . . 0.0 112.583 -158.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.38 72.06 Favored Glycine 0 N--CA 1.477 1.41 0 O-C-N 121.396 -0.815 . . . . 0.0 113.012 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -162.02 146.86 12.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.887 2.475 . . . . 0.0 109.498 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -89.92 116.81 28.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.493 0.663 . . . . 0.0 111.42 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -94.15 145.1 24.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.583 1.553 . . . . 0.0 109.927 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -84.07 144.61 28.95 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.08 151.79 41.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.763 1.225 . . . . 0.0 112.945 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.83 120.06 41.13 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.245 2.218 . . . . 0.0 108.565 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.49 92.92 1.93 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.576 0.751 . . . . 0.0 111.609 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 pt -81.81 -21.22 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.94 -179.17 31.68 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 124.919 1.247 . . . . 0.0 110.945 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.07 96.74 0.82 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.133 0.968 . . . . 0.0 110.764 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.44 -0.45 89.28 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.168 1.842 . . . . 0.0 114.483 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -99.67 139.32 35.5 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.031 1.916 . . . . 0.0 112.148 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -138.63 149.94 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.87 129.01 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 168.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -145.11 149.22 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.502 1.046 . . . . 0.0 111.952 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.488 HD11 ' HB1' ' A' ' 58' ' ' ALA . 58.0 tp -90.93 123.8 34.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.85 111.31 41.53 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.986 1.314 . . . . 0.0 107.555 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.77 165.48 16.0 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.002 3.135 . . . . 0.0 114.016 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 C--N 1.352 0.724 0 C-N-CA 123.189 2.593 . . . . 0.0 111.159 177.793 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 36' ' ' LEU . . . -79.79 154.37 28.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.594 1.157 . . . . 0.0 110.74 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -133.01 135.32 45.37 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.957 0.903 . . . . 0.0 111.491 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.31 125.41 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 169.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.42 156.83 42.55 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.078 1.751 . . . . 0.0 112.798 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -111.4 138.6 47.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.826 1.65 . . . . 0.0 111.016 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -170.18 173.93 5.62 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.869 1.268 . . . . 0.0 110.72 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -93.07 144.95 24.76 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.267 -0.895 . . . . 0.0 112.397 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 tp -53.75 -50.23 66.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.94 1.296 . . . . 0.0 111.07 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 69' ' ' VAL . 12.6 pt-20 -55.61 -30.92 61.76 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.764 1.226 . . . . 0.0 114.044 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.82 -39.96 25.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.452 -0.78 . . . . 0.0 111.779 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.46 -41.01 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.195 0.598 . . . . 0.0 111.507 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 66' ' ' GLU . 33.9 m -70.26 -40.47 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.565 1.075 . . . . 0.0 112.165 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 18.86 61.18 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.148 0.885 . . . . 0.0 115.0 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.08 -8.35 72.95 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.377 1.465 . . . . 0.0 114.633 -173.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.2 m -78.36 169.43 18.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.091 1.357 . . . . 0.0 112.305 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.3 m -71.38 155.59 40.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.84 0.856 . . . . 0.0 113.213 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.95 154.25 27.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.045 1.338 . . . . 0.0 112.664 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -142.05 167.4 22.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.467 1.907 . . . . 0.0 109.881 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.18 134.54 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 119.172 0.897 . . . . 0.0 109.744 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -158.73 129.2 6.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -139.18 57.09 1.67 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 110.566 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.8 m -49.42 -40.72 37.49 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -169.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.44 -34.43 72.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.145 0.884 . . . . 0.0 113.276 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 -26.94 60.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.653 0.781 . . . . 0.0 111.715 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -73.41 -33.73 65.13 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.989 0.916 . . . . 0.0 111.458 169.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.08 -32.86 74.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 112.01 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -168.12 150.4 5.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.841 1.656 . . . . 0.0 113.841 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 80.17 147.94 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 127.196 2.198 . . . . 0.0 115.448 152.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.26 165.4 16.74 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 124.439 3.426 . . . . 0.0 110.542 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -137.47 146.42 53.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 120.953 -1.092 . . . . 0.0 113.678 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.86 83.09 2.33 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.015 3.143 . . . . 0.0 109.476 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -36.92 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.494 1.118 . . . . 0.0 113.203 -169.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -72.23 -35.79 68.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.085 0.857 . . . . 0.0 111.793 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -74.93 -29.92 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.887 0.875 . . . . 0.0 110.13 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.92 -42.36 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.288 1.035 . . . . 0.0 111.535 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.7 -40.55 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.722 0.809 . . . . 0.0 110.449 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.1 m -65.76 -42.25 91.13 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.503 -0.748 . . . . 0.0 111.783 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.2 t -61.79 -40.96 97.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.509 1.123 . . . . 0.0 111.64 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.66 71.79 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.634 0.774 . . . . 0.0 111.308 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -67.32 -15.18 63.54 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.39 -42.84 14.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.276 1.031 . . . . 0.0 113.033 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.6 ptm -81.31 -25.26 36.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -50.01 128.56 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.685 0.755 . . . . 0.0 112.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -15.92 52.53 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.727 1.632 . . . . 0.0 113.964 -170.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -78.63 163.56 25.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.769 1.785 . . . . 0.0 112.215 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.59 150.33 50.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.7 1.6 . . . . 0.0 112.594 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -141.71 159.01 43.09 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.963 1.305 . . . . 0.0 112.407 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -154.38 -3.28 0.17 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -74.77 141.74 44.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.075 -1.016 . . . . 0.0 113.064 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.9 t 71.3 -176.19 0.19 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.346 1.859 . . . . 0.0 114.19 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.5 pt -75.12 152.35 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.644 1.177 . . . . 0.0 111.105 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.1 m -53.83 -38.4 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.1 m -70.67 -38.91 73.81 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.134 0.879 . . . . 0.0 111.904 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -72.06 -35.67 69.36 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.626 -0.671 . . . . 0.0 111.671 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.71 -42.02 82.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.113 0.965 . . . . 0.0 111.209 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -51.56 67.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.762 1.625 . . . . 0.0 113.16 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.41 -45.67 93.37 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.199 -0.938 . . . . 0.0 112.307 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -56.75 -40.33 75.58 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.988 1.715 . . . . 0.0 111.075 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.511 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 26.0 t80 -63.2 -52.69 61.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.563 1.145 . . . . 0.0 112.035 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.6 -20.7 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 120.521 1.51 . . . . 0.0 114.216 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -71.86 -43.23 65.83 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.141 0.882 . . . . 0.0 109.387 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -62.37 -25.36 67.87 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 53.4 mt -71.94 -58.64 3.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.863 0.756 . . . . 0.0 110.563 169.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ptt85 -76.29 9.19 2.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -58.27 -19.93 38.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.888 2.075 . . . . 0.0 113.739 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.66 -38.92 7.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.875 2.179 . . . . 0.0 114.247 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -137.23 5.47 2.76 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 C--O 1.252 1.202 0 C-N-CA 125.758 1.623 . . . . 0.0 114.821 -174.781 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.69 156.63 62.91 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.391 2.727 . . . . 0.0 111.352 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -99.84 141.31 22.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 0.0 111.664 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.01 129.82 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.255 1.97 . . . . 0.0 110.045 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.09 8.15 75.96 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 118.233 -1.315 . . . . 0.0 114.43 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -117.25 157.61 25.75 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.596 1.698 . . . . 0.0 113.935 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.75 127.32 39.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.543 1.937 . . . . 0.0 113.496 -168.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.52 126.41 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.205 1.802 . . . . 0.0 109.577 -174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.4 122.26 34.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.53 125.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.885 1.274 . . . . 0.0 109.296 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.1 53.07 1.65 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.269 1.427 . . . . 0.0 111.677 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -25.61 66.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -169.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -159.26 26.8 0.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -161.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.87 6.4 72.42 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 124.263 0.935 . . . . 0.0 114.015 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.65 148.19 30.8 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.322 2.249 . . . . 0.0 109.385 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -82.86 107.41 15.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.569 0.747 . . . . 0.0 110.116 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -107.22 154.8 20.69 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.804 1.242 . . . . 0.0 111.206 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.14 168.11 22.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.168 2.187 . . . . 0.0 110.674 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' CD2' HD13 ' A' ' 120' ' ' LEU . 8.7 tp -142.71 121.17 12.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.089 1.756 . . . . 0.0 109.22 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.77 116.36 14.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.421 1.088 . . . . 0.0 110.918 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.0 pt -107.2 -16.06 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.62 39.02 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 126.228 1.87 . . . . 0.0 110.294 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.31 92.31 0.28 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.066 0.936 . . . . 0.0 112.067 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.82 87.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.111 1.815 . . . . 0.0 114.503 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -100.67 135.29 42.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.238 1.519 . . . . 0.0 111.76 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.54 150.84 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.161 0.984 . . . . 0.0 113.139 -173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 mt -105.93 141.78 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -156.62 152.79 27.62 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 111.617 -169.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -96.36 125.18 40.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.472 0.709 . . . . 0.0 110.266 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.51 136.1 33.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.248 1.019 . . . . 0.0 109.215 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.95 169.4 22.5 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 112.678 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 C--N 1.354 0.827 0 C-N-CA 123.837 3.025 . . . . 0.0 115.571 177.627 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.75 159.36 33.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.838 -0.539 . . . . 0.0 111.173 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.57 134.06 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.629 0.772 . . . . 0.0 111.108 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.6 t -83.75 126.14 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.678 0.791 . . . . 0.0 109.213 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -134.36 172.06 13.42 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.787 1.635 . . . . 0.0 112.191 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -151.97 125.79 9.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.267 1.027 . . . . 0.0 112.18 -171.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -169.38 -161.47 0.3 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.861 2.064 . . . . 0.0 110.959 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 -85.34 146.43 27.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -51.0 -52.46 42.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.334 1.854 . . . . 0.0 111.374 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -56.99 -30.33 64.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.65 -45.16 17.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.381 0.992 . . . . 0.0 110.722 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.02 -34.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.122 0.569 . . . . 0.0 112.238 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -82.27 -45.49 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.144 0.978 . . . . 0.0 111.113 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.21 23.1 65.91 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 119.359 0.981 . . . . 0.0 114.867 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.3 2.26 70.99 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.206 1.384 . . . . 0.0 115.066 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -72.01 171.11 12.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 118.93 1.365 . . . . 0.0 112.852 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.85 152.17 31.44 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.428 0.691 . . . . 0.0 111.192 169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -158.81 169.65 23.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.438 1.095 . . . . 0.0 113.287 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -168.09 151.76 5.99 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.891 1.677 . . . . 0.0 110.899 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.5 t -85.86 137.76 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 169.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -161.24 108.3 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.377 1.871 . . . . 0.0 108.635 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -83.17 -32.92 26.36 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.421 -0.799 . . . . 0.0 112.95 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t 74.78 -51.47 0.68 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 129.122 2.969 . . . . 0.0 113.273 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -96.66 -33.13 11.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.91 -25.62 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.283 0.947 . . . . 0.0 112.463 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -75.19 -14.52 60.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.346 1.058 . . . . 0.0 112.963 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -96.08 -34.8 11.59 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.098 1.359 . . . . 0.0 112.327 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -172.55 165.82 5.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.118 1.767 . . . . 0.0 112.719 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 89.74 154.28 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 129.975 3.31 . . . . 0.0 115.446 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.96 -31.79 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.298 3.332 . . . . 0.0 113.434 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 ttp-105 70.76 111.99 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.611 2.764 . . . . 0.0 114.683 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -80.44 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.726 2.951 . . . . 0.0 110.329 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 t -54.43 -40.14 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.638 1.175 . . . . 0.0 112.451 -173.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -68.58 -42.92 77.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 111.286 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.4 t -73.23 -30.76 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.899 0.88 . . . . 0.0 110.217 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.1 -41.06 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.425 1.09 . . . . 0.0 111.761 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.44 -36.8 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 119.642 1.11 . . . . 0.0 110.882 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -66.69 -41.46 88.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.126 -0.984 . . . . 0.0 111.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.5 m -63.84 -41.97 97.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.506 1.123 . . . . 0.0 111.655 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.86 -49.55 77.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.765 0.826 . . . . 0.0 111.411 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -56.51 -43.62 79.96 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.746 . . . . 0.0 112.332 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.28 -31.23 70.04 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.2 mtp -73.9 -17.78 60.99 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.72 125.99 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 120.549 1.522 . . . . 0.0 110.623 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.09 66.92 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.625 1.583 . . . . 0.0 114.592 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.44 151.06 32.9 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 111.797 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -87.23 158.2 19.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.011 1.324 . . . . 0.0 110.367 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtp -143.8 148.4 35.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.577 1.551 . . . . 0.0 110.866 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -167.19 -152.7 0.13 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.927 1.291 . . . . 0.0 111.646 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 62.93 22.93 13.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.117 1.767 . . . . 0.0 114.609 169.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.3 p -166.8 156.76 11.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.142 1.377 . . . . 0.0 112.274 -171.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.88 146.22 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.612 1.165 . . . . 0.0 108.606 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 96.6 t -49.93 -39.36 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.776 1.23 . . . . 0.0 113.221 -170.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -56.58 -49.52 74.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.047 0.939 . . . . 0.0 112.192 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -74.85 -34.29 62.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.485 -0.759 . . . . 0.0 111.924 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -57.84 -43.84 86.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.635 1.107 . . . . 0.0 111.917 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.68 -38.45 54.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.7 -46.53 85.06 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.941 -1.099 . . . . 0.0 112.39 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -64.19 -35.32 80.43 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.784 -1.197 . . . . 0.0 110.639 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -58.78 -59.36 5.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.986 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 120' ' ' LEU . 13.0 m -64.99 -25.59 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.688 1.586 . . . . 0.0 113.662 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -69.66 -37.28 76.66 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.495 1.043 . . . . 0.0 110.805 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.59 -20.2 65.95 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.662 1.119 . . . . 0.0 112.952 170.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.441 HD13 ' CD2' ' A' ' 26' ' ' LEU . 59.1 mt -76.12 -65.16 0.95 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.385 0.993 . . . . 0.0 110.352 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.4 ptt85 -75.2 14.28 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -52.91 -23.67 7.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.156 2.183 . . . . 0.0 112.632 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.68 -45.05 7.04 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 128.091 2.758 . . . . 0.0 114.435 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -139.36 -5.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 124.555 1.142 . . . . 0.0 112.128 174.288 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.45 123.69 6.66 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.875 2.383 . . . . 0.0 110.422 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.35 161.27 27.71 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 125.538 1.535 . . . . 0.0 111.049 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.75 135.98 51.28 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.621 2.214 . . . . 0.0 113.145 -169.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.2 -17.59 58.89 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.381 1.467 . . . . 0.0 114.815 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.38 149.72 22.87 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.441 1.121 . . . . 0.0 112.337 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -107.51 140.3 40.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.645 1.212 . . . . 0.0 111.548 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt -125.4 127.45 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.807 2.043 . . . . 0.0 107.936 -159.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -88.68 119.78 29.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -123.19 134.71 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.459 1.104 . . . . 0.0 109.653 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -78.09 66.48 3.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.328 1.051 . . . . 0.0 110.181 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -47.16 77.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.56 1.944 . . . . 0.0 113.788 -169.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.24 37.5 0.44 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -166.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.85 12.23 56.92 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.173 0.892 . . . . 0.0 113.832 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -166.39 134.98 2.93 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.835 2.054 . . . . 0.0 109.729 -171.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.06 128.05 34.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.778 1.631 . . . . 0.0 112.386 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.27 151.04 47.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.154 . . . . 0.0 112.063 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -85.7 147.29 26.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.11 138.46 37.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.41 1.484 . . . . 0.0 111.568 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.26 121.22 41.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.429 1.891 . . . . 0.0 109.111 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.8 111.62 8.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.227 1.011 . . . . 0.0 111.303 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 pt -104.16 -20.82 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.53 172.42 40.27 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.91 101.39 0.12 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.513 1.157 . . . . 0.0 112.253 -172.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.95 -2.0 76.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.691 1.615 . . . . 0.0 115.488 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -98.44 137.94 36.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.625 1.713 . . . . 0.0 112.826 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.94 153.59 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.799 1.239 . . . . 0.0 112.431 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.47 126.44 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -136.07 160.07 39.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.303 0.956 . . . . 0.0 111.345 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.3 tp -85.3 137.55 32.89 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.8 123.8 44.33 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.156 1.382 . . . . 0.0 107.626 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.85 167.41 27.3 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.168 2.579 . . . . 0.0 112.081 -172.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo . . . . . 0 C--N 1.352 0.722 0 C-N-CA 123.237 2.625 . . . . 0.0 110.649 171.79 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.55 164.7 14.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.203 1.001 . . . . 0.0 111.005 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.04 137.76 26.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.353 1.061 . . . . 0.0 111.492 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.89 127.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.57 1.148 . . . . 0.0 110.857 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -129.67 148.91 51.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.008 1.723 . . . . 0.0 112.855 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -95.05 138.86 32.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.847 1.259 . . . . 0.0 109.403 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -163.22 169.05 19.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.604 1.162 . . . . 0.0 110.8 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -90.42 141.63 28.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.245 1.018 . . . . 0.0 111.244 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 tp -53.29 -47.3 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.496 1.119 . . . . 0.0 111.494 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.78 -31.49 66.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.52 -43.59 26.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.151 0.887 . . . . 0.0 110.914 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 t -60.87 -38.36 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 122.574 0.35 . . . . 0.0 111.51 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.36 -47.01 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.34 18.19 62.77 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.48 1.036 . . . . 0.0 114.955 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.69 -2.62 82.69 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.593 1.568 . . . . 0.0 114.868 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.4 m -76.25 176.59 7.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.149 1.38 . . . . 0.0 113.065 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -71.3 150.02 45.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.355 1.062 . . . . 0.0 112.5 173.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -157.72 152.17 24.88 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.645 1.178 . . . . 0.0 113.247 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -136.02 157.86 45.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.395 1.878 . . . . 0.0 110.047 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.09 126.21 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.4 0.68 . . . . 0.0 109.977 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -167.3 113.05 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.892 1.277 . . . . 0.0 110.645 -174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -83.68 71.87 10.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.232 1.013 . . . . 0.0 108.592 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 p -33.31 -64.11 0.21 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.159 2.583 . . . . 0.0 115.823 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.0 mt -84.17 -27.1 28.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.44 -37.6 84.14 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.733 -0.604 . . . . 0.0 111.259 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.3 -28.54 66.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.015 1.326 . . . . 0.0 113.381 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -86.8 -29.16 22.49 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.77 -38.8 3.05 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 117.109 2.263 . . . . 0.0 117.109 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -155.22 159.48 31.71 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -134.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -98.3 1.51 1.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 1 C-N-CA 125.558 4.172 . . . . 0.0 114.197 169.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -12.61 125.28 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 130.401 3.48 . . . . 0.0 117.097 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.48 121.89 9.62 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.334 3.356 . . . . 0.0 112.902 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.3 -34.79 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.021 0.928 . . . . 0.0 112.473 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.84 -35.23 79.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.64 0.654 . . . . 0.0 111.707 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.37 -37.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.468 0.707 . . . . 0.0 110.211 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.46 -41.54 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.699 0.681 . . . . 0.0 110.933 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -64.26 -42.58 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.895 0.771 . . . . 0.0 111.313 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.2 m -62.88 -42.03 99.62 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.668 -0.645 . . . . 0.0 111.563 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -62.1 -45.42 93.59 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.504 1.122 . . . . 0.0 111.515 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.27 86.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.953 0.901 . . . . 0.0 112.145 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.2 -49.89 75.84 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.651 -0.656 . . . . 0.0 111.815 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -60.79 -30.91 70.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.2 mmm -73.75 -13.17 60.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 114.164 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.6 t -57.07 125.99 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.88 1.218 . . . . 0.0 110.704 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.95 75.44 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.173 1.368 . . . . 0.0 114.608 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -74.97 143.15 43.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.251 1.525 . . . . 0.0 110.45 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -112.38 151.69 29.5 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.259 1.824 . . . . 0.0 111.228 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.81 147.08 13.26 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -145.48 59.16 1.27 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.786 1.635 . . . . 0.0 109.34 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -65.8 -32.01 73.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.916 1.286 . . . . 0.0 113.618 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 t -165.58 -162.81 0.61 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.486 1.514 . . . . 0.0 110.29 -170.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.2 pt -60.1 150.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.09 0.956 . . . . 0.0 109.803 169.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.4 -36.28 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.9 m -63.37 -53.26 55.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.537 0.608 . . . . 0.0 111.363 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -70.49 -28.49 65.02 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 121.256 -0.902 . . . . 0.0 111.968 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -60.57 -33.5 72.8 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.392 1.451 . . . . 0.0 111.086 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.37 -40.93 25.63 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.624 1.169 . . . . 0.0 113.254 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.7 -41.0 98.18 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.289 -1.507 . . . . 0.0 112.073 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -65.35 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.776 -1.203 . . . . 0.0 110.701 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.84 -55.84 25.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.748 1.219 . . . . 0.0 111.749 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.01 -30.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 120.218 1.372 . . . . 0.0 112.79 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -69.13 -39.21 79.03 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.633 -1.175 . . . . 0.0 111.124 173.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.86 -28.66 66.31 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.217 1.372 . . . . 0.0 112.932 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.4 mt -67.32 -52.46 40.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.394 0.997 . . . . 0.0 111.246 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -92.68 16.05 13.08 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -62.69 -24.91 67.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.527 1.931 . . . . 0.0 114.45 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.15 -68.84 1.48 Allowed Glycine 0 N--CA 1.473 1.129 0 C-N-CA 125.661 1.6 . . . . 0.0 114.166 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -101.47 -12.13 18.78 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.254 1.312 0 C-N-CA 124.594 1.157 . . . . 0.0 113.017 -175.915 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.17 127.67 27.26 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.043 3.162 . . . . 0.0 112.795 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -103.78 143.88 27.54 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.881 1.272 . . . . 0.0 110.236 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.68 122.73 10.17 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.989 1.793 . . . . 0.0 109.816 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.52 15.42 66.14 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.682 1.134 . . . . 0.0 114.827 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -122.12 165.22 16.44 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.996 1.398 . . . . 0.0 111.924 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.76 154.64 33.88 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -169.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -128.47 142.88 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.217 2.607 . . . . 0.0 109.081 -160.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.15 123.72 48.3 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.102 1.361 . . . . 0.0 107.335 168.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.24 125.91 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 110.485 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -79.69 65.45 4.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.502 1.121 . . . . 0.0 110.366 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -61.46 -33.69 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.0 32.12 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.788 1.235 . . . . 0.0 113.757 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.63 -18.51 52.44 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.654 1.597 . . . . 0.0 114.791 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -74.08 -31.16 62.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 73.77 99.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.279 2.632 . . . . 0.0 110.302 -172.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -102.52 148.7 25.2 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.647 1.179 . . . . 0.0 111.297 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -87.82 151.54 22.79 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 169.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.01 39.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.303 1.041 . . . . 0.0 112.466 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.5 OUTLIER -115.56 125.2 52.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.647 1.979 . . . . 0.0 108.776 177.112 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -80.29 100.35 8.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.064 0.946 . . . . 0.0 110.682 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 pt -89.01 -14.15 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.73 -171.26 37.35 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.03 97.0 0.16 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 111.675 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.92 25.15 58.58 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.15 1.833 . . . . 0.0 115.572 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.272 6.8 p90 -144.1 149.24 36.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.459 2.129 . . . . 0.0 115.503 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.06 157.15 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -168.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mm -107.44 139.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.491 2.317 . . . . 0.0 106.348 168.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -156.33 161.67 40.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.14 1.336 . . . . 0.0 112.418 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.64 123.6 48.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.033 0.933 . . . . 0.0 111.642 -171.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.6 113.11 61.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.154 1.382 . . . . 0.0 108.582 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.61 167.65 9.6 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.09 3.194 . . . . 0.0 115.734 -169.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo . . . . . 0 C--N 1.356 0.929 0 C-N-CA 124.214 3.276 . . . . 0.0 113.657 171.83 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 163.01 26.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.178 0.991 . . . . 0.0 110.206 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.81 138.56 42.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.086 0.954 . . . . 0.0 111.14 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.9 t -85.67 123.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.942 0.897 . . . . 0.0 108.707 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.83 171.6 10.56 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.796 1.638 . . . . 0.0 112.042 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -146.95 139.82 25.14 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.337 1.455 . . . . 0.0 111.841 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -176.68 -178.07 0.86 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.449 1.9 . . . . 0.0 111.866 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -72.66 148.29 44.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.11 -59.78 4.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.26 1.024 . . . . 0.0 110.617 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -65.78 -18.13 65.12 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.95 -34.28 64.24 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.431 1.014 . . . . 0.0 110.916 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.85 -54.76 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.867 0.867 . . . . 0.0 111.236 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.63 3.21 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.99 -21.0 43.95 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.51 24.34 4.16 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 125.337 1.446 . . . . 0.0 113.69 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 54.0 m -125.72 161.9 26.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.956 1.302 . . . . 0.0 114.298 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 97.4 m -96.99 149.55 21.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.917 1.287 . . . . 0.0 108.756 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -166.16 158.61 14.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -147.61 152.15 37.42 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.758 1.623 . . . . 0.0 110.792 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.54 129.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -162.79 133.52 4.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.063 0.545 . . . . 0.0 110.913 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -153.85 49.82 0.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.974 0.893 . . . . 0.0 112.635 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.8 m -56.56 -30.02 62.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 tp -71.84 -39.28 69.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.396 0.998 . . . . 0.0 112.069 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -41.6 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.186 0.994 . . . . 0.0 110.644 169.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.0 -11.82 50.66 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.16 0.984 . . . . 0.0 113.58 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.78 -22.64 60.81 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.205 0.911 . . . . 0.0 113.036 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.81 -43.23 0.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 119.619 3.192 . . . . 0.0 119.619 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -100.38 147.74 33.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 121.0 1.727 . . . . 0.0 114.031 -154.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.53 -27.99 3.06 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.769 2.979 . . . . 0.0 112.715 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ttp-105 74.12 115.03 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.613 2.765 . . . . 0.0 115.014 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.1 91.12 1.22 Allowed 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.121 3.214 . . . . 0.0 109.623 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 t -50.11 -46.72 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.476 1.511 . . . . 0.0 113.742 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -38.28 84.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.679 0.672 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.7 -35.31 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.788 0.835 . . . . 0.0 111.952 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.5 mm -63.7 -49.11 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 119.898 1.226 . . . . 0.0 110.727 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.59 -39.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.558 0.743 . . . . 0.0 110.692 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -68.07 -40.45 82.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.217 0.607 . . . . 0.0 111.107 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m -61.76 -44.77 96.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.099 0.959 . . . . 0.0 111.363 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.31 74.53 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.155 0.982 . . . . 0.0 111.578 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.91 -18.6 65.45 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.17 -44.44 16.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.649 1.113 . . . . 0.0 112.397 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.1 ptm -77.44 -17.43 58.1 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.6 p -42.23 125.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.632 0.773 . . . . 0.0 112.251 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.14 -4.16 86.42 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.988 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -72.02 160.53 32.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.407 2.103 . . . . 0.0 111.365 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.73 151.19 48.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.681 1.592 . . . . 0.0 112.213 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.6 mtm -144.41 143.74 31.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.371 1.068 . . . . 0.0 112.94 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -145.72 -151.23 0.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.659 1.184 . . . . 0.0 111.227 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.7 t80 71.22 -56.72 0.62 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.8 2.84 . . . . 0.0 114.134 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.4 m -72.77 162.75 29.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.789 1.236 . . . . 0.0 112.789 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 pt -63.6 150.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.634 0.773 . . . . 0.0 111.536 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.46 -29.56 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.7 p -67.94 -45.15 75.07 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.47 -0.769 . . . . 0.0 111.241 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.03 -30.05 67.24 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.42 -0.8 . . . . 0.0 112.213 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.99 -43.41 77.61 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.494 1.043 . . . . 0.0 110.949 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.0 m -66.39 -46.88 75.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.528 1.531 . . . . 0.0 113.22 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -64.74 -42.65 95.02 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.128 -0.982 . . . . 0.0 112.369 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -62.22 -34.12 75.88 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 111.292 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.524 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 29.1 t80 -59.53 -55.57 32.84 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.111 0.868 . . . . 0.0 111.274 170.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.56 -20.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -71.02 -42.66 69.26 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.742 1.155 . . . . 0.0 110.331 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -63.15 -24.81 68.06 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.633 1.106 . . . . 0.0 112.988 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 80.0 mt -73.56 -59.52 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.661 0.664 . . . . 0.0 111.785 169.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -76.51 8.34 3.61 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -56.53 -27.34 57.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.053 2.141 . . . . 0.0 112.83 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.75 -25.42 55.85 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 126.931 2.205 . . . . 0.0 115.142 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -149.51 14.73 0.87 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.254 1.32 0 CA-C-O 116.958 -1.496 . . . . 0.0 113.552 175.4 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 119.367 -0.349 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.47 149.36 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.548 2.832 . . . . 0.0 111.364 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.29 159.82 16.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 126.528 1.931 . . . . 0.0 110.942 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.32 143.76 71.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.652 2.235 . . . . 0.0 112.818 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.38 61.96 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.495 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -114.61 157.12 23.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.203 1.502 . . . . 0.0 112.018 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.99 160.02 16.36 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 123.297 1.522 . . . . 0.0 111.044 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.2 mt -137.1 129.42 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 125.575 1.55 . . . . 0.0 107.247 -159.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.32 124.47 33.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.028 0.931 . . . . 0.0 108.516 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.16 137.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.999 2.12 . . . . 0.0 108.692 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.59 62.37 4.64 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -57.65 -45.35 85.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.003 1.721 . . . . 0.0 115.217 -169.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -145.92 29.07 1.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -156.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.84 87.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.541 1.067 . . . . 0.0 113.126 -169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.3 155.64 44.52 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 110.415 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.47 133.9 51.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.567 1.547 . . . . 0.0 111.752 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -150.85 145.9 25.98 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.259 1.424 . . . . 0.0 110.794 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -89.51 162.54 15.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.89 136.99 20.84 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.417 2.287 . . . . 0.0 109.933 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.72 117.0 33.36 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.254 1.822 . . . . 0.0 109.176 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -73.75 111.24 8.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.414 1.085 . . . . 0.0 111.753 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 pt -98.82 -20.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.83 -179.96 40.79 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.832 1.682 . . . . 0.0 110.5 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.11 95.01 0.08 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.363 1.082 . . . . 0.0 113.279 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.07 -2.08 85.08 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.664 2.078 . . . . 0.0 114.486 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -95.76 137.08 35.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.25 1.525 . . . . 0.0 112.105 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.18 152.79 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.752 1.221 . . . . 0.0 112.972 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.46 132.69 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -149.04 156.92 42.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.468 -0.77 . . . . 0.0 111.033 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.3 145.0 32.36 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.85 103.26 16.17 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 168.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.63 166.29 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.909 2.406 . . . . 0.0 113.002 -169.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--N 1.352 0.748 0 C-N-CA 123.62 2.88 . . . . 0.0 111.896 172.775 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.56 162.33 40.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.608 1.563 . . . . 0.0 110.485 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -154.16 137.95 16.18 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.122 -0.986 . . . . 0.0 112.065 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.4 t -82.27 127.97 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.469 1.108 . . . . 0.0 109.928 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -138.34 155.28 48.71 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.123 1.369 . . . . 0.0 112.898 -170.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -98.37 138.81 35.06 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 110.071 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -163.52 172.18 14.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.211 1.404 . . . . 0.0 110.087 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -94.17 144.29 25.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.07 -1.019 . . . . 0.0 112.293 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.49 -46.34 73.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.224 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.89 -34.24 58.87 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.35 -38.7 23.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.799 0.84 . . . . 0.0 111.591 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.8 -36.48 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.54 0.736 . . . . 0.0 111.744 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.6 t -80.09 -50.36 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.715 1.206 . . . . 0.0 111.182 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.42 63.59 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 119.287 0.949 . . . . 0.0 115.132 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.27 -3.94 60.15 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.736 1.636 . . . . 0.0 115.228 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -70.01 171.05 10.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.117 1.459 . . . . 0.0 113.679 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.16 149.47 39.0 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.834 0.854 . . . . 0.0 111.168 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -158.03 160.2 37.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.107 0.963 . . . . 0.0 113.535 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -157.75 144.12 17.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.307 1.043 . . . . 0.0 111.706 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.48 130.72 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.409 -0.807 . . . . 0.0 109.055 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -169.44 118.51 0.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.33 1.452 . . . . 0.0 110.415 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -98.46 0.15 44.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.9 p 56.97 -49.74 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.175 1 C-N-CA 133.397 4.679 . . . . 0.0 118.039 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 mt -114.48 -23.79 9.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.764 1.625 . . . . 0.0 113.604 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -35.75 77.69 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.283 -0.886 . . . . 0.0 112.067 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -66.65 -16.73 64.42 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.676 1.19 . . . . 0.0 112.921 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -93.25 -30.45 15.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.507 1.123 . . . . 0.0 113.15 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -114.82 -43.59 3.12 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -169.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -153.89 162.19 27.38 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -139.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -88.81 -33.16 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 124.537 3.491 . . . . 0.0 113.761 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 66.7 132.85 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 128.902 2.881 . . . . 0.0 115.984 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.37 94.09 1.07 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.49 2.793 . . . . 0.0 110.461 172.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -57.67 -39.71 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.169 0.988 . . . . 0.0 112.564 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.75 -39.81 76.52 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.634 0.652 . . . . 0.0 111.542 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.9 -35.92 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.416 0.686 . . . . 0.0 109.95 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.283 24.8 mt -77.92 -33.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.304 -0.855 . . . . 0.0 112.045 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.0 mt -65.51 -40.28 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.177 1.353 . . . . 0.0 110.369 169.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -65.81 -38.92 90.23 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.842 -0.536 . . . . 0.0 110.877 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.1 m -63.64 -46.55 85.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.208 1.003 . . . . 0.0 111.743 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.46 91.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.488 0.715 . . . . 0.0 112.082 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -62.61 -48.59 78.73 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 111.911 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -60.52 -30.3 69.65 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.197 -0.94 . . . . 0.0 113.204 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.7 mtp -75.42 -4.91 42.24 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.92 1.288 . . . . 0.0 114.454 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -56.19 121.94 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.016 1.28 . . . . 0.0 109.311 171.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.41 -2.42 60.92 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.228 1.394 . . . . 0.0 115.086 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.66 127.13 31.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.654 1.727 . . . . 0.0 110.482 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -99.93 132.52 45.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.941 2.097 . . . . 0.0 111.681 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -117.3 174.6 6.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.66 1.984 . . . . 0.0 110.38 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -126.52 -160.04 0.96 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.315 1.046 . . . . 0.0 112.442 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -73.32 150.1 42.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 112.985 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.0 m 176.82 171.8 0.47 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.299 3.039 . . . . 0.0 108.645 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.46 123.62 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.43 -35.66 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.81 0.844 . . . . 0.0 112.494 -169.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -55.43 -56.36 21.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.457 0.703 . . . . 0.0 111.423 173.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.25 -34.88 78.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.211 -0.931 . . . . 0.0 111.853 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.4 -44.77 92.75 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.901 1.228 . . . . 0.0 111.374 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.0 p -77.37 -37.25 52.55 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.907 0.883 . . . . 0.0 113.034 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.43 -45.57 92.5 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.568 1.076 . . . . 0.0 112.206 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -62.87 -36.24 82.64 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.599 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.43 -55.26 33.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.722 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.02 -24.25 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 120.545 1.521 . . . . 0.0 113.316 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -70.21 -39.09 75.34 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.446 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.38 -23.39 66.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.483 1.038 . . . . 0.0 113.367 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.45 -60.21 2.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.723 1.147 . . . . 0.0 111.01 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -77.69 6.41 7.41 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -26.04 27.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.76 2.024 . . . . 0.0 112.077 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.3 -17.67 32.65 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 127.249 2.357 . . . . 0.0 115.183 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -134.15 -28.78 1.31 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.415 1.086 . . . . 0.0 112.922 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 CA--C 1.548 0.877 0 CA-C-O 118.732 -0.652 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.63 143.72 27.45 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.805 3.003 . . . . 0.0 110.752 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.09 132.5 23.69 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.043 0.937 . . . . 0.0 111.601 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.8 132.84 25.82 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.263 2.642 . . . . 0.0 111.316 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.401 ' HA3' HG13 ' A' ' 89' ' ' VAL . . . 81.52 -4.23 74.35 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.714 1.149 . . . . 0.0 114.947 -175.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -105.09 168.07 9.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 122.652 1.215 . . . . 0.0 113.234 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.0 113.13 25.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.814 1.646 . . . . 0.0 112.353 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.68 127.85 43.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 124.796 1.238 . . . . 0.0 108.574 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -90.91 116.72 28.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.9 mm -105.65 112.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.392 1.477 . . . . 0.0 109.142 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 73.94 8.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.783 0.72 . . . . 0.0 109.804 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.25 3.77 2.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.0 mt 102.57 126.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 131.577 3.951 . . . . 0.0 110.708 158.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.61 -3.82 39.85 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.202 0.905 . . . . 0.0 113.67 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -171.22 160.35 6.22 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.853 2.461 . . . . 0.0 110.836 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -127.41 127.32 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.994 1.318 . . . . 0.0 110.463 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -108.74 151.3 26.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.913 1.285 . . . . 0.0 111.721 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -90.18 145.07 25.31 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 122.181 -0.325 . . . . 0.0 111.057 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.55 34.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.266 1.026 . . . . 0.0 111.67 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.7 119.32 33.99 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.623 1.569 . . . . 0.0 108.42 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -72.58 96.02 1.91 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 118.558 0.617 . . . . 0.0 111.123 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 pt -84.78 -22.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.18 173.34 30.65 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 124.731 1.158 . . . . 0.0 110.344 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.55 90.76 0.56 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.688 0.756 . . . . 0.0 110.537 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.15 -0.12 47.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.895 2.188 . . . . 0.0 115.109 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.46 140.39 49.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.284 1.542 . . . . 0.0 112.544 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.58 151.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.5 mm -110.65 129.29 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 168.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.17 157.06 43.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.262 0.937 . . . . 0.0 112.773 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.75 120.9 38.96 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.782 0.833 . . . . 0.0 110.938 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.33 120.53 66.55 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.89 1.276 . . . . 0.0 108.167 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.91 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.714 2.942 . . . . 0.0 113.209 -169.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.354 0.835 0 C-N-CA 124.477 3.452 . . . . 0.0 112.926 173.014 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.01 159.88 32.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.49 1.116 . . . . 0.0 109.607 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.44 136.37 29.41 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 111.312 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.69 121.32 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.461 1.105 . . . . 0.0 108.213 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -124.92 156.61 37.71 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.219 1.407 . . . . 0.0 112.418 -171.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -111.07 137.3 48.88 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.707 1.603 . . . . 0.0 110.846 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.39 171.37 10.63 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.037 0.935 . . . . 0.0 111.426 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -84.56 140.0 31.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.694 1.598 . . . . 0.0 110.246 172.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 tp -56.33 -48.38 76.86 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.354 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.32 -28.91 63.5 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.86 -41.33 19.11 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.735 0.814 . . . . 0.0 111.23 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.56 -37.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.979 0.512 . . . . 0.0 111.441 170.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.01 -50.11 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.142 0.977 . . . . 0.0 111.915 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.46 24.16 65.52 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 119.754 1.161 . . . . 0.0 114.788 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.17 1.25 64.97 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.346 1.45 . . . . 0.0 115.305 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.1 m -71.97 170.61 13.44 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.842 1.321 . . . . 0.0 113.269 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.19 149.11 32.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.231 1.012 . . . . 0.0 111.668 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -159.27 154.2 24.88 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -148.73 157.54 43.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.401 1.88 . . . . 0.0 110.662 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.8 t -88.49 139.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-N 119.123 0.874 . . . . 0.0 110.065 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -156.17 64.5 0.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.425 1.49 . . . . 0.0 111.213 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.79 65.67 5.03 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.704 -1.248 . . . . 0.0 110.139 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -48.39 -56.64 7.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.569 1.948 . . . . 0.0 114.477 -170.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.92 -32.05 72.23 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.71 -44.3 90.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.744 -0.597 . . . . 0.0 111.626 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -61.39 -31.62 71.53 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.617 0.767 . . . . 0.0 112.393 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -40.86 63.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.427 1.091 . . . . 0.0 113.557 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.9 -39.35 4.27 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -148.58 158.15 40.57 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.671 2.101 . . . . 0.0 116.671 -134.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.83 -22.32 0.89 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.195 3.263 . . . . 0.0 114.098 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 20.97 116.63 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 131.459 3.904 . . . . 0.0 118.614 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.64 116.42 3.93 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.683 2.922 . . . . 0.0 111.7 -171.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.401 HG13 ' HA3' ' A' ' 11' ' ' GLY . 2.1 t -65.69 -32.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.524 1.129 . . . . 0.0 112.923 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -63.39 -35.55 80.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.591 0.632 . . . . 0.0 111.607 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.19 -38.23 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.734 0.814 . . . . 0.0 110.047 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.7 mt -74.01 -35.38 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.655 -0.653 . . . . 0.0 112.273 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.42 -37.02 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.117 -0.989 . . . . 0.0 110.399 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 m -66.41 -43.52 85.5 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.579 -0.701 . . . . 0.0 111.709 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -53.35 -43.41 67.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.144 0.978 . . . . 0.0 112.222 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.29 79.45 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.569 -0.707 . . . . 0.0 111.969 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -66.63 -14.91 63.03 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.66 -39.4 14.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.322 1.049 . . . . 0.0 111.897 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.2 mtp -75.58 -18.33 59.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.02 126.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.813 1.188 . . . . 0.0 111.845 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.65 -7.43 81.86 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.395 1.474 . . . . 0.0 115.009 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -70.65 151.67 44.7 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.621 1.711 . . . . 0.0 110.675 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -132.18 149.94 52.27 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.612 1.565 . . . . 0.0 112.385 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 69.2 mtm -149.48 158.37 44.12 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.422 1.489 . . . . 0.0 111.332 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -140.17 16.46 2.43 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.176 -0.953 . . . . 0.0 112.869 171.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.97 143.38 26.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.849 -171.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 68.73 -171.82 0.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.046 1.738 . . . . 0.0 114.24 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.0 144.97 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.305 1.442 . . . . 0.0 108.869 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -34.69 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -170.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -67.16 -35.04 78.84 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.724 -0.61 . . . . 0.0 112.157 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -77.44 -32.37 54.52 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 121.409 -0.807 . . . . 0.0 111.736 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.06 -45.34 83.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 20.7 p -74.26 -37.52 63.71 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 121.704 -0.623 . . . . 0.0 112.679 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.77 -43.22 99.36 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.26 -0.9 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -56.67 -49.01 76.32 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 110.054 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -55.3 -52.11 64.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.246 1.018 . . . . 0.0 112.441 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.0 -32.72 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 120.167 1.349 . . . . 0.0 113.09 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 m -61.44 -47.34 86.18 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 116.428 -1.749 . . . . 0.0 108.774 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -56.98 -25.56 58.43 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 121.042 1.746 . . . . 0.0 114.208 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.15 -47.11 72.03 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.016 1.28 . . . . 0.0 111.88 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -92.54 -3.1 55.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -62.49 -24.37 67.44 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.534 1.934 . . . . 0.0 112.3 -169.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.28 -24.84 76.38 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.377 0.989 . . . . 0.0 113.855 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.44 -20.64 2.63 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.255 1.364 0 C-N-CA 124.924 1.29 . . . . 0.0 112.389 177.243 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -81.41 155.67 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.283 2.656 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -102.51 151.21 38.18 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.891 . . . . 0.0 111.986 -177.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.97 136.76 39.18 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.683 2.255 . . . . 0.0 111.326 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.05 69.71 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.859 1.695 . . . . 0.0 114.637 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -94.64 165.77 12.35 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.187 1.493 . . . . 0.0 114.668 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -88.42 116.04 26.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.624 1.57 . . . . 0.0 111.892 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.43 121.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 109.229 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -99.34 103.58 15.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.574 1.95 . . . . 0.0 108.06 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.01 119.28 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.515 1.126 . . . . 0.0 109.426 -171.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.33 62.04 5.07 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.881 -1.137 . . . . 0.0 110.777 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -30.53 70.92 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -169.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.98 34.16 0.25 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -161.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.69 68.92 Favored Glycine 0 N--CA 1.479 1.531 0 C-N-CA 124.193 0.902 . . . . 0.0 113.48 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -164.47 149.08 9.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.416 2.286 . . . . 0.0 110.134 -172.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -74.22 106.34 5.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.164 1.385 . . . . 0.0 111.372 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -86.94 126.88 34.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.004 1.721 . . . . 0.0 109.279 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -82.47 150.15 27.19 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.588 -0.695 . . . . 0.0 112.814 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.94 159.84 44.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.113 1.365 . . . . 0.0 111.469 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.82 121.8 35.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.149 1.78 . . . . 0.0 108.466 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.89 90.37 3.51 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.701 0.682 . . . . 0.0 112.154 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.31 -18.43 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.23 -176.6 29.47 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 124.518 1.056 . . . . 0.0 111.629 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.83 90.0 0.78 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.007 0.908 . . . . 0.0 111.034 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 -3.78 80.06 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.348 1.928 . . . . 0.0 114.269 -174.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.68 138.64 35.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.655 1.727 . . . . 0.0 112.28 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.68 152.99 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mm -110.79 139.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.36 1.864 . . . . 0.0 106.697 168.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -157.89 134.7 9.88 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.38 0.991 . . . . 0.0 112.467 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.77 113.27 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.454 -0.779 . . . . 0.0 110.251 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.22 120.76 80.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.267 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.35 161.07 43.55 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.665 2.91 . . . . 0.0 112.943 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 C-N-CA 123.645 2.897 . . . . 0.0 111.844 -179.462 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.096 0.474 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.19 158.35 15.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.291 1.036 . . . . 0.0 111.55 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.92 135.05 32.43 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 0.0 111.83 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -80.69 114.29 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.971 1.308 . . . . 0.0 108.323 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -121.2 173.06 7.55 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.267 1.827 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.8 35.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.422 1.489 . . . . 0.0 111.82 -174.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 174.01 -159.47 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.93 2.892 . . . . 0.0 108.421 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.14 150.97 19.92 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.17 0.986 . . . . 0.0 113.446 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -50.34 -51.46 45.43 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.136 1.775 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -55.04 -29.85 58.31 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.01 -42.77 15.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.816 0.846 . . . . 0.0 111.337 174.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.61 -33.47 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.913 -0.492 . . . . 0.0 111.965 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.0 t -86.77 -46.98 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.511 1.124 . . . . 0.0 111.495 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.99 -121.48 24.9 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -172.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.14 1.04 62.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.651 1.12 . . . . 0.0 114.892 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.7 m -73.13 162.43 29.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.899 1.35 . . . . 0.0 113.921 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.2 m -79.44 151.14 31.04 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.871 0.869 . . . . 0.0 110.989 169.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -156.46 167.99 28.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.962 0.905 . . . . 0.0 112.852 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -161.7 159.22 27.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.6 1.56 . . . . 0.0 109.933 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -82.75 132.5 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.723 1.147 . . . . 0.0 109.175 169.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -80.3 -70.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.492 0.717 . . . . 0.0 112.051 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 63.37 8.89 3.72 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.535 1.934 . . . . 0.0 114.332 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.6 m -69.28 -36.28 76.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 119.076 -2.265 . . . . 0.0 113.506 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.5 mt -68.9 -37.92 79.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.997 0.519 . . . . 0.0 111.718 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -64.79 -43.64 92.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.513 -0.742 . . . . 0.0 111.116 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.29 -26.15 62.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.075 1.35 . . . . 0.0 112.873 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.57 -29.99 46.55 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.132 0.973 . . . . 0.0 112.41 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -126.19 -46.52 1.65 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.51 152.51 45.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -143.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.31 -10.08 12.42 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 124.565 3.51 . . . . 0.0 114.393 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 74.32 106.79 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.595 2.358 . . . . 0.0 114.377 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.47 71.54 6.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.721 2.948 . . . . 0.0 109.03 169.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 t -46.24 -38.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 126.436 1.894 . . . . 0.0 114.687 -169.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.69 -38.17 90.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.802 0.841 . . . . 0.0 111.703 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -75.63 -30.99 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.2 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.08 -45.52 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.491 0.587 . . . . 0.0 110.78 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.41 -39.56 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.822 -0.549 . . . . 0.0 110.376 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 m -63.5 -43.5 97.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.97 0.508 . . . . 0.0 111.592 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 t -59.37 -45.47 91.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 111.658 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.42 90.75 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.218 -0.926 . . . . 0.0 112.082 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.94 -19.07 64.94 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -82.32 -37.11 26.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.687 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.0 mtp -70.98 -32.01 68.73 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.4 p -44.54 129.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.14 -8.85 79.02 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.45 1.5 . . . . 0.0 114.837 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -78.99 159.59 27.58 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.949 1.875 . . . . 0.0 112.317 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -104.5 156.91 17.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.572 1.549 . . . . 0.0 112.012 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.3 tpp -141.14 140.02 34.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.527 1.531 . . . . 0.0 110.292 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.37 -7.17 0.62 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -78.3 132.26 37.39 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.135 -0.978 . . . . 0.0 113.111 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 t 69.48 -175.9 0.2 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.3 1.84 . . . . 0.0 114.894 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.9 pt -75.14 157.64 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.822 1.649 . . . . 0.0 111.322 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.46 -38.46 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -169.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.5 m -59.11 -51.08 71.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.742 0.817 . . . . 0.0 111.679 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -75.48 -33.05 60.78 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.964 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.99 -46.08 75.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.067 1.303 . . . . 0.0 111.766 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.3 m -76.82 -38.4 53.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.055 0.942 . . . . 0.0 112.45 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.07 -45.16 93.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.249 -0.907 . . . . 0.0 112.412 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -58.36 -39.86 80.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.78 1.632 . . . . 0.0 110.565 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 10.9 t80 -61.68 -54.55 41.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.195 0.998 . . . . 0.0 112.154 171.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 m -67.67 -25.27 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.809 1.641 . . . . 0.0 113.742 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 m -72.4 -42.17 65.47 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 117.687 -1.149 . . . . 0.0 110.959 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.22 -18.11 59.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.261 1.391 . . . . 0.0 113.647 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 14.0 mt -64.41 -47.6 78.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.237 0.926 . . . . 0.0 110.12 168.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.3 mtm-85 -72.48 -92.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 70.36 -2.91 2.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 129.2 3.0 . . . . 0.0 113.028 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.3 -99.37 0.54 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 126.782 2.134 . . . . 0.0 114.226 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -82.65 9.46 9.5 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.174 1.39 . . . . 0.0 113.636 -171.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 127.088 2.155 . . . . 0.0 112.003 -179.18 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.51 144.87 10.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.336 2.691 . . . . 0.0 109.701 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.39 159.5 23.66 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.841 1.257 . . . . 0.0 112.312 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.43 137.27 80.72 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.411 2.74 . . . . 0.0 114.924 -168.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.24 63.94 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 126.323 1.916 . . . . 0.0 115.182 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -96.63 154.76 17.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -169.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -94.23 112.67 24.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.73 1.612 . . . . 0.0 111.51 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.9 mt -101.29 127.22 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.034 1.334 . . . . 0.0 109.858 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.51 115.58 28.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.22 117.53 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.75 1.62 . . . . 0.0 108.068 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.63 -32.22 71.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.337 0.655 . . . . 0.0 112.681 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.03 -71.3 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 129.369 3.068 . . . . 0.0 115.251 174.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.74 26.23 0.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.34 1.456 . . . . 0.0 113.715 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.21 -59.5 0.38 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.657 1.599 . . . . 0.0 109.895 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.05 122.01 21.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.974 0.509 . . . . 0.0 109.919 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -94.21 150.37 20.37 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.793 0.837 . . . . 0.0 111.972 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -121.36 148.56 44.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.714 1.206 . . . . 0.0 111.794 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -89.8 149.53 22.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.213 0.605 . . . . 0.0 110.582 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.02 146.91 33.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.031 0.932 . . . . 0.0 112.927 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.54 117.86 35.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.175 1.79 . . . . 0.0 108.143 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -73.54 109.89 7.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.475 0.71 . . . . 0.0 110.286 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -100.75 -17.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.59 175.76 31.06 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 126.061 1.791 . . . . 0.0 109.595 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -69.68 86.31 0.48 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.013 0.906 . . . . 0.0 111.315 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.05 -13.49 37.49 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.188 2.327 . . . . 0.0 114.327 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.59 139.24 33.79 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.875 1.27 . . . . 0.0 112.735 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -135.35 151.91 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.88 1.272 . . . . 0.0 113.189 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.5 128.63 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -144.02 160.28 41.14 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.142 -0.974 . . . . 0.0 111.779 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.44 122.5 45.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.881 0.872 . . . . 0.0 111.141 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.63 117.47 68.18 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.528 1.531 . . . . 0.0 107.27 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.69 162.52 39.46 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.543 2.829 . . . . 0.0 114.409 -168.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 58' ' ' ALA . 86.7 Cg_endo . . . . . 0 CA--C 1.541 0.829 0 C-N-CA 123.69 2.927 . . . . 0.0 109.716 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.427 ' HB2' ' HD3' ' A' ' 39' ' ' PRO . . . -75.36 156.11 35.81 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.298 1.039 . . . . 0.0 110.404 169.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -141.58 134.75 29.28 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.806 0.843 . . . . 0.0 111.379 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.82 126.84 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.09 0.956 . . . . 0.0 109.244 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -129.26 152.64 48.6 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.614 1.566 . . . . 0.0 112.151 -170.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -105.07 139.08 40.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.551 1.54 . . . . 0.0 110.37 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -167.01 172.96 9.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.622 1.169 . . . . 0.0 110.482 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.59 143.08 27.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 111.083 170.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 tp -55.05 -49.95 70.32 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.582 -0.699 . . . . 0.0 111.561 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -30.95 62.6 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -79.36 -40.34 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.819 0.736 . . . . 0.0 111.285 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.77 -37.92 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 122.099 -0.376 . . . . 0.0 111.187 171.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.47 -37.32 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.047 1.339 . . . . 0.0 112.767 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.78 20.75 74.55 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.86 0.743 . . . . 0.0 114.333 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.32 2.64 89.09 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.211 1.386 . . . . 0.0 114.785 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.27 -167.84 1.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.149 1.38 . . . . 0.0 113.004 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 79.7 m -84.35 150.99 25.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.16 1.384 . . . . 0.0 113.139 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -163.54 160.96 23.71 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.208 1.403 . . . . 0.0 113.222 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.1 153.5 11.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.061 1.744 . . . . 0.0 111.834 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.76 140.92 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.676 1.126 . . . . 0.0 110.617 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -146.93 87.32 1.68 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.318 1.447 . . . . 0.0 111.019 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.28 69.19 4.45 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.667 1.187 . . . . 0.0 108.792 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.8 p -60.26 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.621 1.968 . . . . 0.0 114.288 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 mt -60.43 -22.97 64.02 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.297 -0.877 . . . . 0.0 113.075 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.89 -37.09 60.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.98 1.712 . . . . 0.0 111.525 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -63.48 -20.54 65.68 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.842 1.257 . . . . 0.0 112.702 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -88.0 -25.35 23.18 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.084 1.354 . . . . 0.0 112.907 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.81 -29.71 1.68 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -169.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -120.34 122.91 28.49 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -132.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -70.77 -21.26 29.04 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.454 3.436 . . . . 0.0 115.744 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 69.16 83.13 0.17 Allowed Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 127.721 2.408 . . . . 0.0 114.888 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.38 95.97 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.8 3.0 . . . . 0.0 109.158 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.2 -41.38 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.665 0.786 . . . . 0.0 111.963 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.24 -35.86 78.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.587 0.63 . . . . 0.0 112.106 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -42.73 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.595 0.758 . . . . 0.0 110.084 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.6 mt -71.55 -34.23 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.812 -0.555 . . . . 0.0 112.101 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.87 -38.83 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.26 -0.9 . . . . 0.0 110.365 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -64.4 -42.32 96.17 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.571 -0.706 . . . . 0.0 111.303 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -56.97 -44.33 82.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.263 1.025 . . . . 0.0 111.832 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.93 87.81 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.337 -0.852 . . . . 0.0 112.184 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -67.53 -14.96 63.39 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.85 -36.71 15.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 111.864 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.3 mtp -70.75 -23.56 62.45 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.911 1.284 . . . . 0.0 113.767 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -46.66 123.61 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.489 1.04 . . . . 0.0 112.309 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.78 83.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.359 1.457 . . . . 0.0 115.193 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 160.57 30.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.747 1.773 . . . . 0.0 111.327 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -131.32 157.22 43.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.162 1.385 . . . . 0.0 112.973 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.6 mtm -143.76 159.28 42.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.531 1.532 . . . . 0.0 111.298 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -143.65 -1.53 1.0 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -86.43 152.49 22.64 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.642 1.177 . . . . 0.0 113.459 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 m 75.61 168.71 0.27 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.531 2.332 . . . . 0.0 114.107 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.68 147.49 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 109.062 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -49.98 -36.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 p -64.1 -49.39 72.42 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.391 -0.818 . . . . 0.0 111.366 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.36 -30.05 65.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.575 -0.703 . . . . 0.0 112.1 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.81 -41.05 85.86 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.092 1.314 . . . . 0.0 111.5 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.63 -43.36 76.48 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.272 1.029 . . . . 0.0 112.561 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.25 -44.13 92.75 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.269 -0.894 . . . . 0.0 112.319 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -37.78 81.35 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.53 -1.356 . . . . 0.0 111.355 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.521 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 9.5 t80 -58.29 -56.81 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.68 0.792 . . . . 0.0 111.256 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.4 m -68.48 -23.57 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.618 1.099 . . . . 0.0 113.806 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 m -70.7 -41.66 71.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.621 1.101 . . . . 0.0 110.337 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.61 -27.94 69.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.57 1.077 . . . . 0.0 112.853 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.521 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 73.8 mt -69.56 -57.23 5.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.822 0.737 . . . . 0.0 111.559 170.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -80.29 9.57 5.59 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -57.7 -25.25 60.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.381 1.873 . . . . 0.0 112.617 -172.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -46.12 -43.9 13.84 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 127.811 2.624 . . . . 0.0 115.178 -173.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -137.54 22.15 2.93 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.715 1.206 . . . . 0.0 113.57 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.115 1.366 . . . . 0.0 111.381 -177.779 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.92 145.98 28.98 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.703 2.269 . . . . 0.0 110.261 172.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.04 149.72 38.44 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.141 0.976 . . . . 0.0 110.938 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.98 130.62 26.35 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.627 2.218 . . . . 0.0 111.3 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.59 61.37 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.361 1.934 . . . . 0.0 114.921 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -91.1 161.96 14.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.539 1.669 . . . . 0.0 114.355 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.67 110.2 22.81 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.722 1.609 . . . . 0.0 112.228 -169.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -90.49 123.03 42.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.385 1.074 . . . . 0.0 109.154 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -94.29 117.43 30.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.71 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.587 1.155 . . . . 0.0 108.762 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.27 -30.34 71.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.408 1.083 . . . . 0.0 112.907 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.259 26.1 tpt180 54.36 -111.87 0.66 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.825 2.05 . . . . 0.0 111.358 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.0 mt -133.74 42.78 2.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.119 0.968 . . . . 0.0 111.263 -161.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.94 6.52 37.15 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.872 1.225 . . . . 0.0 114.98 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -156.41 119.31 4.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.969 1.308 . . . . 0.0 111.045 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.5 142.91 48.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.792 1.237 . . . . 0.0 112.261 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.51 165.54 36.12 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.028 0.931 . . . . 0.0 112.881 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -92.45 152.53 19.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.2 150.1 43.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.979 1.711 . . . . 0.0 111.151 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.99 118.56 36.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.53 1.932 . . . . 0.0 107.586 174.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -73.7 102.91 4.09 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.658 0.663 . . . . 0.0 110.338 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.21 -17.43 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.8 -174.27 43.11 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -64.3 95.58 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.778 0.799 . . . . 0.0 111.603 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.43 6.07 64.69 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.639 2.066 . . . . 0.0 116.207 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -120.19 141.7 49.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.9 1.85 . . . . 0.0 113.3 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.87 151.36 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.901 1.281 . . . . 0.0 112.604 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 mm -111.42 134.09 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.57 152.85 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.573 1.078 . . . . 0.0 112.129 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.44 113.28 24.61 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.95 116.09 50.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.175 -0.917 . . . . 0.0 108.694 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.72 158.86 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.183 2.589 . . . . 0.0 111.931 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.546 1.094 0 C-N-CA 124.402 3.401 . . . . 0.0 111.107 171.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.53 144.78 37.37 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.097 -1.002 . . . . 0.0 110.751 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.43 133.71 38.88 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.964 0.906 . . . . 0.0 110.887 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.13 125.23 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.856 0.862 . . . . 0.0 109.803 172.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -135.31 157.14 47.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.371 1.468 . . . . 0.0 112.316 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -109.71 133.43 53.14 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.795 1.638 . . . . 0.0 110.885 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -151.99 171.85 17.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.423 1.489 . . . . 0.0 111.526 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -85.89 148.77 25.64 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.269 0.628 . . . . 0.0 111.652 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.8 tp -52.45 -62.15 1.82 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.875 1.27 . . . . 0.0 111.582 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -66.12 -20.1 66.05 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.71 -36.82 70.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.515 1.052 . . . . 0.0 111.26 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.76 -44.53 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.131 0.972 . . . . 0.0 112.125 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.67 -1.66 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.69 109.89 3.13 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.466 1.03 . . . . 0.0 112.681 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 6.78 89.22 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.998 1.285 . . . . 0.0 114.337 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -112.72 152.76 28.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 112.485 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.9 m -83.47 149.92 26.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.819 0.848 . . . . 0.0 110.227 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -160.47 159.9 31.41 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -146.05 163.08 36.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.298 2.239 . . . . 0.0 109.852 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.15 143.1 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.509 170.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.38 144.36 46.55 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.622 1.169 . . . . 0.0 113.146 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -137.52 22.62 2.93 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.757 1.623 . . . . 0.0 112.362 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.3 t -62.44 -47.78 82.56 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.219 -1.551 . . . . 0.0 113.819 -169.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -73.46 -33.93 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.596 0.358 . . . . 0.0 111.868 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.86 -36.95 77.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.806 0.842 . . . . 0.0 112.134 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -65.08 -17.97 64.91 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.381 1.072 . . . . 0.0 112.854 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -80.01 -22.64 42.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.364 -0.835 . . . . 0.0 112.53 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -117.4 -57.22 2.16 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.51 149.62 63.36 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -140.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.86 -14.98 21.36 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 124.771 3.647 . . . . 0.0 113.632 172.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 77.56 90.76 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 127.158 2.183 . . . . 0.0 112.788 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.37 81.31 2.51 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.576 2.85 . . . . 0.0 108.889 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.76 -36.27 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.162 0.985 . . . . 0.0 112.538 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.35 -36.37 76.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.72 0.691 . . . . 0.0 112.392 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.29 -40.09 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.414 0.686 . . . . 0.0 109.874 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.08 -38.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.804 . . . . 0.0 111.654 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.23 -38.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.206 -0.934 . . . . 0.0 111.049 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -64.27 -44.84 90.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.6 -0.687 . . . . 0.0 111.271 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -57.62 -44.56 85.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.339 1.055 . . . . 0.0 112.483 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.47 95.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.006 0.821 . . . . 0.0 112.49 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.54 -44.72 89.93 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.119 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.888 -1.133 . . . . 0.0 113.426 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.96 -9.49 58.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.3 t -55.47 127.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.933 1.242 . . . . 0.0 110.591 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.33 -0.59 78.28 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.177 1.37 . . . . 0.0 114.5 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -71.01 132.87 45.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.061 1.43 . . . . 0.0 110.429 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.81 138.54 48.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.753 1.621 . . . . 0.0 111.118 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.7 mtm -143.59 153.07 42.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.919 1.288 . . . . 0.0 112.127 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -149.86 -7.91 0.31 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -63.9 153.7 36.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 114.12 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t 62.91 -164.55 0.25 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 114.449 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -80.33 145.23 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.203 1.401 . . . . 0.0 108.443 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.36 -31.47 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 119.149 0.886 . . . . 0.0 112.629 -171.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 p -60.17 -53.54 56.56 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.343 1.057 . . . . 0.0 111.659 172.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.665 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -56.26 -42.42 77.39 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.23 1.377 . . . . 0.0 111.079 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.22 -44.21 54.06 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.21 1.404 . . . . 0.0 112.981 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.26 -43.65 98.34 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.799 -1.188 . . . . 0.0 112.374 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -63.73 -42.88 97.81 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.692 -1.255 . . . . 0.0 110.014 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.46 -53.66 48.26 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.419 1.487 . . . . 0.0 112.589 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 m -66.08 -25.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.404 1.456 . . . . 0.0 112.917 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -65.91 -46.13 79.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 117.315 -1.326 . . . . 0.0 109.793 170.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -32.31 63.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.766 1.167 . . . . 0.0 113.459 171.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.39 -58.21 3.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.352 0.978 . . . . 0.0 111.346 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -75.27 3.99 7.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.71 -24.11 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.854 2.062 . . . . 0.0 113.338 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.24 -32.4 1.68 Allowed Glycine 0 N--CA 1.474 1.23 0 C-N-CA 128.473 2.94 . . . . 0.0 117.816 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -140.07 16.75 2.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 118.692 1.246 . . . . 0.0 112.866 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.105 1.762 . . . . 0.0 112.674 -177.155 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.17 147.97 93.6 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.666 2.244 . . . . 0.0 111.185 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -103.29 156.09 35.88 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.479 1.112 . . . . 0.0 111.57 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.59 129.89 22.25 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.529 2.152 . . . . 0.0 111.945 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.68 -2.62 82.32 Favored Glycine 0 N--CA 1.467 0.739 0 C-N-CA 125.272 1.415 . . . . 0.0 114.769 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -83.96 146.96 27.73 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.853 1.326 . . . . 0.0 110.913 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.0 139.47 40.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.546 1.165 . . . . 0.0 111.55 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.34 131.81 65.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.975 2.11 . . . . 0.0 108.198 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -92.36 115.39 28.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.87 129.03 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.531 1.932 . . . . 0.0 108.322 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.47 -33.21 71.01 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.833 0.742 . . . . 0.0 112.48 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 57.35 -119.46 1.22 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.752 2.021 . . . . 0.0 111.259 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -132.27 58.39 1.75 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.044 0.926 . . . . 0.0 110.352 -160.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.76 -1.89 75.77 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.271 1.415 . . . . 0.0 114.626 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -156.41 127.29 6.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.082 1.353 . . . . 0.0 111.552 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.25 155.25 36.94 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.83 1.252 . . . . 0.0 113.87 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -153.65 172.27 17.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.473 1.109 . . . . 0.0 112.232 170.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -93.85 161.1 14.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.72 162.83 39.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.015 2.126 . . . . 0.0 110.926 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.07 125.11 38.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.109 1.764 . . . . 0.0 108.536 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.94 93.33 5.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.236 1.014 . . . . 0.0 111.423 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 pt -81.75 -20.93 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 176.43 32.27 Favored Glycine 0 N--CA 1.465 0.579 0 C-N-CA 125.05 1.309 . . . . 0.0 110.798 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.84 88.38 0.38 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.615 0.721 . . . . 0.0 111.095 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.11 58.62 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 127.011 2.243 . . . . 0.0 114.774 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -104.74 140.47 38.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.825 1.312 . . . . 0.0 112.523 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.8 155.42 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.39 1.076 . . . . 0.0 112.954 -170.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -112.4 139.81 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -148.15 155.02 40.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.584 1.084 . . . . 0.0 111.574 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.7 115.38 27.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.3 122.87 87.57 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.53 158.06 59.27 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.776 2.984 . . . . 0.0 114.561 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 CA--C 1.541 0.826 0 C-N-CA 124.344 3.363 . . . . 0.0 111.54 173.253 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 158.65 16.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.3 1.84 . . . . 0.0 109.596 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -143.06 134.56 26.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 0.0 111.618 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.97 126.77 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.397 0.679 . . . . 0.0 109.182 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -131.98 149.75 52.34 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.619 1.568 . . . . 0.0 112.446 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -103.72 133.76 48.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.445 1.498 . . . . 0.0 110.485 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -154.74 177.69 10.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.743 1.617 . . . . 0.0 111.073 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -90.48 154.17 19.84 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 168.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 tp -53.15 -47.34 68.82 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.48 -31.17 67.6 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.04 -35.8 59.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.451 1.023 . . . . 0.0 111.104 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.09 -38.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.525 1.13 . . . . 0.0 111.9 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -80.38 -39.34 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.387 0.675 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.61 15.92 64.79 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.048 0.84 . . . . 0.0 115.016 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.53 85.72 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.389 1.471 . . . . 0.0 114.684 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.8 m -81.54 -176.41 6.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.082 1.353 . . . . 0.0 112.745 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 83.6 m -73.21 157.42 37.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.199 1.0 . . . . 0.0 112.875 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -167.14 168.06 13.88 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.525 1.93 . . . . 0.0 110.853 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.09 151.54 12.17 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 0.0 112.756 169.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.5 t -70.91 133.88 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -153.9 73.86 0.96 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.937 0.895 . . . . 0.0 110.907 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.25 58.74 0.73 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.627 1.571 . . . . 0.0 111.483 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 p -43.41 -69.35 0.14 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.516 2.327 . . . . 0.0 114.724 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -67.37 -29.2 68.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.589 0.756 . . . . 0.0 112.74 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.4 -35.59 80.71 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.185 -0.947 . . . . 0.0 111.21 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -73.98 -12.58 60.68 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.218 1.007 . . . . 0.0 112.83 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -86.18 -38.35 17.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.156 0.889 . . . . 0.0 112.078 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -71.67 0.73 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -143.7 157.37 58.67 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -145.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.6 144.24 11.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.891 3.061 . . . . 0.0 108.073 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -124.3 153.5 68.77 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -169.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.03 84.21 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.141 3.228 . . . . 0.0 109.96 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.11 -30.97 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.695 1.198 . . . . 0.0 114.019 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.41 -36.69 83.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.226 0.921 . . . . 0.0 112.643 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.74 -33.86 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.067 0.947 . . . . 0.0 110.519 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -63.98 -46.56 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.64 -0.663 . . . . 0.0 110.215 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.15 -39.38 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.814 0.846 . . . . 0.0 110.873 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.3 m -64.77 -40.93 96.08 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.615 -0.678 . . . . 0.0 111.813 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 t -58.3 -46.82 85.41 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.539 -0.725 . . . . 0.0 111.028 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.14 89.24 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.43 -0.794 . . . . 0.0 112.249 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.13 -28.12 69.85 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.49 -34.11 41.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 172.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.4 mtp -78.99 -20.28 49.49 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.96 124.57 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.603 1.547 . . . . 0.0 110.933 170.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.76 -6.92 59.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.611 1.576 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -75.43 143.66 42.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 1.515 . . . . 0.0 110.507 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.82 155.08 36.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.883 1.673 . . . . 0.0 111.833 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.1 mtm -141.62 164.14 31.01 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.113 1.365 . . . . 0.0 111.587 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -139.4 -36.13 0.53 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -76.4 154.03 35.22 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -170.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 77.57 177.68 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.259 2.224 . . . . 0.0 113.788 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -80.53 149.27 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.747 1.219 . . . . 0.0 111.276 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -52.65 -37.38 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 p -63.21 -55.34 25.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.451 0.7 . . . . 0.0 111.164 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.6 -36.37 83.54 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.58 -0.7 . . . . 0.0 111.935 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.44 -41.22 80.03 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.517 1.053 . . . . 0.0 111.686 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.6 t -77.26 -42.19 38.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.264 1.026 . . . . 0.0 112.513 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.77 -44.14 97.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.325 1.05 . . . . 0.0 112.13 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -60.42 -46.11 91.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.788 1.235 . . . . 0.0 110.125 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -52.76 -54.84 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.209 . . . . 0.0 112.213 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.95 -29.72 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.343 1.429 . . . . 0.0 112.8 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.3 m -65.41 -38.37 89.74 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.967 1.258 . . . . 0.0 110.504 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -26.89 68.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 120.415 1.461 . . . . 0.0 113.217 169.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.9 mt -74.6 -57.6 3.82 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.275 -0.891 . . . . 0.0 111.516 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -77.08 12.11 1.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -58.04 -24.41 58.28 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.314 1.846 . . . . 0.0 112.519 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.69 -22.29 39.43 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.026 2.251 . . . . 0.0 115.31 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -146.82 -11.03 0.45 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.601 1.161 . . . . 0.0 112.82 179.716 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 118.219 -0.896 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.88 144.89 12.4 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.332 2.688 . . . . 0.0 111.05 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.65 150.05 4.59 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.582 1.953 . . . . 0.0 111.053 -176.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.28 137.34 39.88 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.915 3.076 . . . . 0.0 113.553 -169.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.08 -11.41 65.15 Favored Glycine 0 N--CA 1.469 0.879 0 C-N-CA 126.028 1.775 . . . . 0.0 114.633 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.59 160.16 15.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 118.403 1.101 . . . . 0.0 113.003 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.22 113.87 27.32 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.916 1.686 . . . . 0.0 111.785 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.91 127.55 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 124.8 1.24 . . . . 0.0 109.482 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -96.01 121.12 37.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.407 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.93 130.65 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.973 1.309 . . . . 0.0 109.157 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -77.16 64.79 2.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.563 1.145 . . . . 0.0 110.442 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -54.14 -44.89 71.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.611 1.564 . . . . 0.0 114.803 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -153.29 26.93 0.52 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -160.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.9 -2.49 66.5 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.99 0.805 . . . . 0.0 113.064 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -140.78 159.86 41.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.148 2.179 . . . . 0.0 110.44 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -91.86 120.33 32.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.679 1.192 . . . . 0.0 111.464 -172.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -112.75 151.84 29.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.531 1.532 . . . . 0.0 111.09 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -86.97 153.69 21.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.42 36.22 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.354 1.462 . . . . 0.0 111.383 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.42 123.85 50.64 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.168 1.787 . . . . 0.0 108.175 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -74.32 103.11 4.59 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.5 0.591 . . . . 0.0 111.221 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -94.88 -21.69 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.78 171.94 33.77 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.31 96.08 0.22 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.164 0.982 . . . . 0.0 111.689 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.93 3.76 82.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.91 1.719 . . . . 0.0 115.244 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -110.73 139.01 46.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.502 1.651 . . . . 0.0 112.367 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.97 152.47 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 113.713 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.5 mm -107.95 134.64 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 107.109 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -151.52 159.49 44.12 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.496 1.044 . . . . 0.0 111.894 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.43 122.83 43.81 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.393 0.677 . . . . 0.0 111.304 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.49 146.39 50.21 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.861 1.664 . . . . 0.0 110.414 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.53 158.07 51.63 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.592 2.861 . . . . 0.0 113.956 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 CA--C 1.542 0.91 0 C-N-CA 123.665 2.91 . . . . 0.0 112.29 169.617 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.783 0.325 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.11 153.71 43.0 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.527 0.731 . . . . 0.0 109.637 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -138.12 131.25 30.2 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 111.106 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.05 126.16 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.989 0.915 . . . . 0.0 109.245 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -131.48 157.23 44.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.545 1.538 . . . . 0.0 112.489 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -110.48 138.81 46.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.841 1.657 . . . . 0.0 110.077 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -166.11 170.38 13.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.227 1.011 . . . . 0.0 110.703 -171.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -85.39 145.44 27.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.319 -0.863 . . . . 0.0 111.55 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.6 tp -53.1 -50.66 63.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.068 0.947 . . . . 0.0 111.529 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -58.11 -28.88 65.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -85.64 -32.11 22.19 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.53 -40.64 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.471 0.578 . . . . 0.0 111.256 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.81 -44.33 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.83 0.852 . . . . 0.0 112.118 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.74 -124.82 35.33 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -175.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.75 0.62 63.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.959 1.266 . . . . 0.0 114.973 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.58 168.3 19.06 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.64 1.22 . . . . 0.0 113.924 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -77.13 155.27 32.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.86 1.264 . . . . 0.0 112.545 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.92 165.85 31.32 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.806 1.243 . . . . 0.0 113.355 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.12 163.88 33.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.345 1.858 . . . . 0.0 111.321 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.17 136.3 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.562 1.074 . . . . 0.0 109.81 171.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -150.29 124.96 9.72 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.876 1.27 . . . . 0.0 112.451 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.26 41.43 3.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.687 1.595 . . . . 0.0 111.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.0 p -57.05 -31.21 64.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -74.54 -44.71 49.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.54 0.736 . . . . 0.0 111.434 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -63.37 -36.92 85.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.038 0.935 . . . . 0.0 110.792 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -58.14 -17.06 15.83 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.302 1.441 . . . . 0.0 113.562 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -74.42 -19.29 60.46 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.029 -1.044 . . . . 0.0 113.404 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.95 -29.74 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 -173.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.43 152.24 63.22 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -150.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.24 -49.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.512 2.808 . . . . 0.0 112.443 170.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.25 96.45 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 127.421 2.288 . . . . 0.0 111.072 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.27 124.21 11.83 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.446 3.431 . . . . 0.0 114.892 -168.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 t -49.67 -47.66 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.981 2.113 . . . . 0.0 113.801 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.36 -34.65 78.64 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.93 -36.4 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.356 0.663 . . . . 0.0 110.227 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mm -77.0 -38.57 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.758 -0.589 . . . . 0.0 110.335 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.96 -41.07 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.935 0.494 . . . . 0.0 110.914 171.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -64.83 -40.93 95.98 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.527 -0.733 . . . . 0.0 110.96 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.3 m -64.87 -39.85 94.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.363 1.065 . . . . 0.0 112.28 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.62 98.17 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.12 -0.987 . . . . 0.0 111.751 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -68.7 -13.74 62.57 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.46 -37.41 15.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.534 1.061 . . . . 0.0 111.15 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.1 mmm -69.41 -25.57 64.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.637 1.575 . . . . 0.0 113.623 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -47.0 124.36 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.83 1.195 . . . . 0.0 111.986 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.88 1.49 79.85 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.503 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.47 147.77 44.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.811 1.806 . . . . 0.0 111.405 172.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -124.15 139.97 53.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 111.362 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.0 mtm -142.52 148.33 37.45 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.196 0.998 . . . . 0.0 112.908 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -147.55 22.83 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.358 1.063 . . . . 0.0 112.345 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -80.78 -19.04 45.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 t -162.34 175.7 11.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.21 1.004 . . . . 0.0 112.956 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.17 147.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.301 1.84 . . . . 0.0 109.787 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.51 -32.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.6 p -58.72 -65.71 0.61 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.76 1.224 . . . . 0.0 111.531 173.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -65.01 -30.82 71.82 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.816 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.83 -40.41 76.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.172 1.351 . . . . 0.0 111.127 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -44.07 59.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.644 1.178 . . . . 0.0 112.962 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.14 -45.38 94.9 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.367 -0.833 . . . . 0.0 111.605 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -60.32 -36.62 78.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.03 -60.59 3.54 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.291 1.437 . . . . 0.0 111.443 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.4 m -65.88 -30.03 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 120.476 1.489 . . . . 0.0 113.157 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 m -59.36 -56.2 25.01 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 116.514 -1.707 . . . . 0.0 107.783 170.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -55.35 -31.65 61.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.736 1.607 . . . . 0.0 114.67 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.15 -33.95 75.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.397 0.999 . . . . 0.0 112.385 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -118.2 16.06 14.03 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -72.65 -19.07 61.51 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.639 1.576 . . . . 0.0 112.826 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.43 -33.82 73.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.855 0.741 . . . . 0.0 113.577 -172.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -114.55 -16.05 11.93 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.955 1.302 . . . . 0.0 112.924 179.618 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.94 145.29 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.452 2.768 . . . . 0.0 110.687 171.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.04 160.26 26.74 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.303 1.841 . . . . 0.0 110.273 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.43 130.13 32.52 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.863 1.709 . . . . 0.0 110.697 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.23 -6.07 78.34 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.091 1.329 . . . . 0.0 115.437 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -65.47 140.06 58.56 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.8 1.3 . . . . 0.0 112.43 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.5 tp -87.11 89.89 8.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.72 1.608 . . . . 0.0 108.278 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.46 132.66 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.231 1.012 . . . . 0.0 108.879 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -102.27 107.47 18.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.819 1.647 . . . . 0.0 108.179 171.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.0 mm -86.73 123.45 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.702 2.001 . . . . 0.0 107.97 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.94 -32.89 74.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.302 2.0 mmt180 43.62 -142.49 0.15 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.713 2.005 . . . . 0.0 112.975 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.55 109.37 11.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.284 -167.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.17 -9.59 6.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.762 1.172 . . . . 0.0 115.179 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -166.05 124.46 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.798 1.639 . . . . 0.0 111.989 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.64 144.88 31.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.503 1.521 . . . . 0.0 111.675 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -144.09 165.37 27.99 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.231 -0.918 . . . . 0.0 113.456 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -88.13 157.13 18.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.71 137.69 20.36 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.927 1.691 . . . . 0.0 110.41 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.46 119.46 38.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.044 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -72.01 89.49 1.12 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.803 1.241 . . . . 0.0 111.747 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 pt -77.24 -20.32 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.21 -178.31 32.12 Favored Glycine 0 N--CA 1.462 0.433 0 C-N-CA 124.916 1.246 . . . . 0.0 110.878 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.87 86.19 0.51 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.639 0.733 . . . . 0.0 111.099 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.3 -6.84 46.63 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.884 2.183 . . . . 0.0 114.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -106.65 141.95 37.08 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.95 1.375 . . . . 0.0 112.813 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -137.95 153.28 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 mt -115.88 138.38 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.641 1.576 . . . . 0.0 107.002 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -157.61 138.24 13.02 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.154 -0.966 . . . . 0.0 113.275 -168.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.58 113.6 12.03 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.719 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.95 141.52 78.49 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.399 0.679 . . . . 0.0 109.855 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.34 157.13 62.35 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.632 2.888 . . . . 0.0 113.14 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 C--N 1.353 0.769 0 C-N-CA 124.16 3.24 . . . . 0.0 114.042 -177.654 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 p . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.82 135.85 34.36 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.691 -0.631 . . . . 0.0 109.657 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.94 138.77 37.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.172 0.896 . . . . 0.0 110.318 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -80.57 118.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.168 0.587 . . . . 0.0 110.116 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -108.07 174.96 5.65 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -146.09 152.45 39.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.462 1.505 . . . . 0.0 112.298 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 175.35 -164.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.843 2.857 . . . . 0.0 109.597 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -77.0 151.08 35.78 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.21 -0.931 . . . . 0.0 112.889 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.95 -46.66 75.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.179 0.991 . . . . 0.0 111.177 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 69' ' ' VAL . 16.4 pt-20 -58.82 -29.71 67.09 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -80.5 -39.29 28.23 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.445 -0.785 . . . . 0.0 111.459 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.02 -46.69 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 174.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 66' ' ' GLU . 31.7 m -70.99 -41.97 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.827 0.851 . . . . 0.0 112.262 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.46 -116.31 9.16 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 119.342 0.974 . . . . 0.0 110.72 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.94 -2.92 64.27 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.476 1.036 . . . . 0.0 114.835 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 55.8 m -79.95 157.9 26.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.781 1.29 . . . . 0.0 113.326 -172.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 74.6 m -74.59 167.08 22.46 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.343 1.057 . . . . 0.0 111.878 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -155.16 163.21 40.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.492 1.117 . . . . 0.0 111.745 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -140.16 169.65 17.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.398 1.879 . . . . 0.0 109.961 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.35 127.55 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -103.64 -54.77 2.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 47.3 47.8 16.57 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.325 1.45 . . . . 0.0 111.797 -171.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.3 p -54.2 -60.26 3.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.674 1.589 . . . . 0.0 113.749 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.41 -29.43 70.13 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -65.15 -51.48 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.696 0.398 . . . . 0.0 110.373 169.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -60.72 -27.0 67.58 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 121.179 -0.951 . . . . 0.0 113.026 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -68.17 -33.54 74.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -158.91 -15.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -146.88 130.4 8.25 Favored Pre-proline 0 CA--C 1.55 0.967 0 O-C-N 120.728 -1.233 . . . . 0.0 113.752 -133.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.86 -46.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.749 2.3 . . . . 0.0 112.173 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 128.99 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 129.495 3.118 . . . . 0.0 114.557 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.52 97.8 0.46 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.322 2.682 . . . . 0.0 110.227 169.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -15.87 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -169.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -63.91 -34.78 78.72 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.769 0.713 . . . . 0.0 110.824 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -74.88 -32.74 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.374 0.67 . . . . 0.0 110.382 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.93 -44.56 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.522 0.729 . . . . 0.0 111.631 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.54 -36.25 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.623 0.769 . . . . 0.0 110.607 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -65.1 -45.08 86.66 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.619 0.768 . . . . 0.0 111.637 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.8 m -58.94 -40.77 85.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.584 1.153 . . . . 0.0 112.168 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.14 94.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.501 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -63.42 -21.27 66.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.36 -34.7 21.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 112.554 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 mtp -77.52 -27.81 51.82 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -56.29 123.0 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 120.076 1.307 . . . . 0.0 110.617 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.58 -9.49 62.47 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.793 1.663 . . . . 0.0 115.038 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -78.68 156.23 29.08 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.479 1.64 . . . . 0.0 110.464 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -147.35 154.59 41.09 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.104 1.362 . . . . 0.0 114.34 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.1 mtm -147.15 163.99 34.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.314 1.846 . . . . 0.0 112.022 -170.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -157.19 -45.31 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -77.94 71.13 4.4 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.04 1.336 . . . . 0.0 113.709 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 m -175.88 170.43 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.411 2.684 . . . . 0.0 110.228 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.96 146.41 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.308 -0.87 . . . . 0.0 109.252 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.46 -40.1 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 120.666 -1.271 . . . . 0.0 113.218 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.7 m -60.63 -43.44 97.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.208 0.603 . . . . 0.0 110.846 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -70.71 -29.75 66.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.774 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -58.15 -46.83 84.98 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.644 1.565 . . . . 0.0 110.911 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.0 m -66.5 -48.65 69.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.651 1.181 . . . . 0.0 112.197 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -58.52 -48.32 81.22 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.562 0.745 . . . . 0.0 111.409 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.25 -33.8 76.85 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.938 -1.101 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -58.88 -58.0 10.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.946 0.794 . . . . 0.0 110.787 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.82 -21.58 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 119.551 1.069 . . . . 0.0 113.598 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -71.93 -40.82 68.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.355 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.22 -26.21 68.24 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 120.038 1.29 . . . . 0.0 112.654 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.02 -46.48 67.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.983 0.811 . . . . 0.0 112.405 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -94.37 9.7 37.22 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.454 1.901 . . . . 0.0 114.285 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -58.65 -21.66 54.6 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.049 2.139 . . . . 0.0 113.789 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.88 68.28 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.479 1.037 . . . . 0.0 114.314 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -140.59 -22.4 0.81 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 169.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 124.945 1.298 . . . . 0.0 112.793 175.008 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 118.161 -0.923 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.5 150.12 35.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.751 2.301 . . . . 0.0 111.318 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -100.64 142.1 23.95 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.753 0.821 . . . . 0.0 110.973 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.3 132.51 24.21 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.682 1.588 . . . . 0.0 110.468 -170.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.87 66.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.691 1.615 . . . . 0.0 114.574 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.13 165.99 11.97 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.579 1.69 . . . . 0.0 113.885 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.4 mt -90.64 113.11 25.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.26 1.424 . . . . 0.0 111.655 -169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.22 117.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.966 0.906 . . . . 0.0 108.629 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.58 117.52 28.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -122.71 134.25 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.859 1.264 . . . . 0.0 109.3 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -77.76 66.05 3.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.017 0.927 . . . . 0.0 110.47 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -36.12 82.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.299 1.44 . . . . 0.0 114.41 -169.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.77 26.38 0.74 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -152.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.76 7.81 77.64 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.285 0.945 . . . . 0.0 112.965 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -167.71 160.26 12.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.746 2.819 . . . . 0.0 109.183 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -64.51 138.23 58.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.599 1.56 . . . . 0.0 113.616 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.95 151.46 40.96 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.349 1.86 . . . . 0.0 108.72 169.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -98.84 156.79 16.69 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.2 157.09 44.17 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.897 1.679 . . . . 0.0 111.87 169.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.31 121.77 45.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.79 2.036 . . . . 0.0 108.541 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -75.05 92.43 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.153 0.888 . . . . 0.0 111.774 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -84.44 -21.8 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.68 174.43 30.78 Favored Glycine 0 N--CA 1.463 0.454 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.05 94.73 0.67 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.534 0.683 . . . . 0.0 109.93 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.44 65.59 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.437 1.97 . . . . 0.0 115.273 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -113.75 140.2 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.361 1.58 . . . . 0.0 112.365 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 m -140.77 149.27 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mm -105.97 128.54 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -139.29 163.46 32.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.975 0.807 . . . . 0.0 111.043 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.23 137.51 32.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.67 138.6 21.07 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.457 1.503 . . . . 0.0 108.457 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.57 159.11 39.6 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.506 2.804 . . . . 0.0 113.728 -169.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 C-N-CA 123.676 2.917 . . . . 0.0 109.788 169.7 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.916 0.388 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.56 127.99 34.45 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -113.18 134.88 54.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.451 1.1 . . . . 0.0 111.314 -169.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.1 126.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.732 0.813 . . . . 0.0 110.515 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -139.3 153.88 47.83 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.914 1.286 . . . . 0.0 113.273 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -98.79 137.96 36.63 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.856 1.662 . . . . 0.0 110.689 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -165.7 172.22 12.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.538 1.135 . . . . 0.0 111.671 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -92.89 146.43 23.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.27 1.428 . . . . 0.0 112.103 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -51.47 -56.07 15.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 111.774 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -62.72 -25.16 68.03 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.47 -40.26 43.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.213 0.915 . . . . 0.0 111.12 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.2 t -68.13 -35.33 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.042 0.537 . . . . 0.0 111.959 173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.1 t -78.7 -39.34 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.003 0.921 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 20.11 65.35 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.007 0.822 . . . . 0.0 115.014 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.61 89.72 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.132 1.349 . . . . 0.0 114.859 -173.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.26 175.49 8.9 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.116 1.366 . . . . 0.0 112.555 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.6 m -69.68 150.72 46.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.258 1.023 . . . . 0.0 112.732 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -160.63 163.94 32.2 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.915 1.286 . . . . 0.0 113.506 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.05 163.43 23.26 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.788 2.035 . . . . 0.0 110.927 -175.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -109.0 145.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.596 1.089 . . . . 0.0 112.162 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -133.54 151.89 51.81 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.818 1.647 . . . . 0.0 113.45 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -144.93 31.11 1.15 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.989 1.716 . . . . 0.0 112.286 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -59.94 -35.82 75.74 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.23 -29.22 15.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.918 0.781 . . . . 0.0 112.54 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.62 -30.97 72.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.444 1.097 . . . . 0.0 112.213 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -67.17 -23.04 65.73 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.243 1.417 . . . . 0.0 113.093 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -88.75 -45.66 9.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -95.77 -34.64 11.83 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -168.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -141.13 158.19 65.06 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.49 -19.39 28.53 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.13 3.22 . . . . 0.0 113.207 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 66.93 75.63 0.31 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.355 1.862 . . . . 0.0 112.098 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.81 80.85 2.28 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.458 3.439 . . . . 0.0 110.257 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 t -46.45 -41.11 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.678 1.591 . . . . 0.0 114.344 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.97 -38.02 82.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.207 0.912 . . . . 0.0 111.21 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.14 -38.0 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.313 1.045 . . . . 0.0 109.902 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.53 -47.25 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.471 0.578 . . . . 0.0 110.379 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.71 -38.89 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.34 1.056 . . . . 0.0 111.852 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -65.86 -42.49 90.34 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.415 -0.803 . . . . 0.0 110.61 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.8 p -61.5 -38.57 87.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.438 0.695 . . . . 0.0 112.054 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.76 72.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.427 1.091 . . . . 0.0 111.404 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.46 -36.37 80.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.71 -37.7 79.71 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.6 ptm -81.68 -4.06 55.23 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.2 125.67 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.869 1.268 . . . . 0.0 109.227 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.99 -5.97 58.17 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.924 1.25 . . . . 0.0 114.469 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -66.06 147.82 52.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.262 1.531 . . . . 0.0 110.491 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.76 135.0 45.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.459 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -141.64 140.77 33.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.555 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -149.83 27.05 0.8 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.777 1.231 . . . . 0.0 112.318 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.8 -8.9 59.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.8 t -158.06 178.05 10.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.841 1.256 . . . . 0.0 111.842 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 146.55 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.432 1.493 . . . . 0.0 110.203 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.66 -39.33 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 124.807 1.243 . . . . 0.0 113.926 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.4 p -58.73 -57.54 12.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.831 0.852 . . . . 0.0 111.787 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -64.97 -34.32 78.15 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.519 -0.738 . . . . 0.0 112.152 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -59.54 -35.48 74.29 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.612 1.096 . . . . 0.0 111.418 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -42.6 67.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.036 0.935 . . . . 0.0 112.801 172.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -62.24 -45.99 90.85 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.97 -1.081 . . . . 0.0 112.254 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -52.87 -44.86 67.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.761 2.024 . . . . 0.0 110.615 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.47 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 11.3 t80 -61.33 -54.24 46.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.433 1.493 . . . . 0.0 112.37 173.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.3 m -69.23 -22.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 120.561 1.528 . . . . 0.0 114.215 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -70.42 -40.12 74.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.145 169.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -64.36 -23.91 67.46 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.411 1.005 . . . . 0.0 113.668 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.47 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 36.5 mt -72.86 -60.79 2.06 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.213 0.915 . . . . 0.0 111.337 169.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -73.95 4.27 5.62 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -56.7 -26.04 55.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.338 2.255 . . . . 0.0 113.219 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.98 -51.83 7.04 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 127.75 2.595 . . . . 0.0 115.645 -169.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -128.04 5.73 5.94 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 C--O 1.25 1.093 0 C-N-CA 124.787 1.235 . . . . 0.0 111.879 170.713 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 CA--C 1.544 0.731 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.11 145.21 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.587 2.192 . . . . 0.0 110.098 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.14 139.47 21.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.707 0.803 . . . . 0.0 110.83 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 127.91 15.91 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.769 2.312 . . . . 0.0 110.305 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.01 2.17 90.66 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.181 1.372 . . . . 0.0 114.246 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 169.33 8.63 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.003 1.321 . . . . 0.0 112.604 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.38 130.14 54.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.531 1.533 . . . . 0.0 113.987 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -111.77 144.15 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.365 2.266 . . . . 0.0 110.61 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -108.94 116.67 32.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.29 128.93 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.446 1.499 . . . . 0.0 109.571 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -80.24 68.61 6.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.761 1.225 . . . . 0.0 110.847 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -34.65 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -169.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -156.9 27.33 0.32 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.17 10.23 58.63 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.108 0.861 . . . . 0.0 113.844 -172.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -163.36 145.01 9.61 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.586 2.354 . . . . 0.0 110.146 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -75.32 120.73 21.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.946 1.298 . . . . 0.0 112.354 -176.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -103.07 140.58 37.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.767 1.227 . . . . 0.0 110.041 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -73.62 146.7 44.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.106 0.563 . . . . 0.0 112.123 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.74 142.14 24.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 121.67 43.72 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.029 1.732 . . . . 0.0 108.945 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -76.67 105.29 7.65 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.797 0.839 . . . . 0.0 111.005 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.3 pt -97.1 -20.83 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.91 174.16 32.46 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 124.987 1.28 . . . . 0.0 110.163 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.04 94.73 0.51 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.789 0.804 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.69 64.43 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.839 2.161 . . . . 0.0 115.446 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -112.54 133.99 54.3 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.598 1.699 . . . . 0.0 112.246 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.45 152.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.884 1.274 . . . . 0.0 112.709 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 mm -109.36 128.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.775 1.63 . . . . 0.0 106.844 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -144.95 159.52 42.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.422 1.01 . . . . 0.0 112.026 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.0 115.78 28.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.596 0.758 . . . . 0.0 110.038 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.76 70.18 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.664 1.586 . . . . 0.0 109.815 169.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.33 155.01 68.6 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.897 3.065 . . . . 0.0 114.772 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 C--N 1.354 0.855 0 C-N-CA 124.649 3.566 . . . . 0.0 114.472 176.512 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.923 0.392 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.27 159.99 33.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.515 0.726 . . . . 0.0 110.214 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -136.48 130.06 32.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.854 0.862 . . . . 0.0 109.951 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.9 t -83.79 123.19 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -145.25 153.26 41.12 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -94.1 137.77 32.91 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.186 1.794 . . . . 0.0 110.505 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -162.64 163.11 27.25 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.495 0.718 . . . . 0.0 111.893 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -76.05 140.16 41.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.829 173.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -52.56 -54.14 36.93 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.72 1.208 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.88 -23.92 67.57 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.84 -39.11 27.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.299 0.954 . . . . 0.0 111.343 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.52 -39.65 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.75 -0.594 . . . . 0.0 111.405 170.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.04 -45.55 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 112.345 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.03 61.99 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.25 0.932 . . . . 0.0 115.043 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.12 88.21 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.344 1.449 . . . . 0.0 114.891 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -82.5 171.51 14.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.956 1.302 . . . . 0.0 112.017 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.05 147.89 49.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -158.93 163.43 36.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 113.02 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.64 155.78 15.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.238 1.415 . . . . 0.0 112.354 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.73 136.96 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.662 0.664 . . . . 0.0 109.707 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -160.49 136.92 8.72 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.256 1.822 . . . . 0.0 109.516 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -154.37 52.3 0.66 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.888 0.852 . . . . 0.0 113.017 -169.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.9 m -50.67 -35.59 31.64 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -72.54 -39.81 67.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.787 0.835 . . . . 0.0 111.715 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.37 -40.58 93.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.021 0.928 . . . . 0.0 111.439 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -62.09 -17.9 59.06 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.381 1.072 . . . . 0.0 112.862 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -79.74 -30.8 40.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 -35.17 0.42 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 117.843 2.535 . . . . 0.0 117.843 -172.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.69 151.84 73.93 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -138.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.32 -24.11 2.1 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 124.083 3.189 . . . . 0.0 114.657 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 67.11 110.26 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 127.339 2.256 . . . . 0.0 115.668 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.64 89.92 1.25 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 124.134 3.223 . . . . 0.0 109.768 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 t -50.99 -39.67 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.275 1.43 . . . . 0.0 113.782 -169.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.4 -35.76 78.14 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.283 0.492 . . . . 0.0 111.832 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.93 -32.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.279 1.032 . . . . 0.0 110.396 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 mm -66.43 -47.68 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.93 -0.481 . . . . 0.0 110.57 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.49 -37.57 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.892 0.477 . . . . 0.0 110.763 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.1 m -65.25 -41.93 93.79 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.649 -0.657 . . . . 0.0 111.73 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -61.12 -48.13 83.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.639 -0.663 . . . . 0.0 110.909 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.13 88.15 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.7 0.8 . . . . 0.0 112.257 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -62.58 -46.76 86.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.512 0.725 . . . . 0.0 112.021 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.67 -30.79 70.12 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.259 -0.901 . . . . 0.0 113.27 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.9 mtp -75.73 -9.44 58.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.47 127.02 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.455 1.479 . . . . 0.0 111.343 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.13 -0.41 85.88 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.917 -1.491 . . . . 0.0 114.096 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -77.99 137.74 38.45 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.1 1.95 . . . . 0.0 111.023 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.93 165.22 22.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.382 1.073 . . . . 0.0 110.498 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.4 ttm -159.4 137.09 10.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 110.746 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -156.36 34.0 0.32 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.338 1.066 . . . . 0.0 111.185 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.69 -33.28 71.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.263 1.825 . . . . 0.0 114.131 -170.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.7 t -162.47 -157.05 0.44 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.174 1.39 . . . . 0.0 111.876 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.04 154.92 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.274 1.43 . . . . 0.0 109.861 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.15 -37.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -62.5 -49.11 76.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.429 0.692 . . . . 0.0 111.84 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -74.86 -27.95 60.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 117.545 -1.217 . . . . 0.0 112.238 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -58.51 -43.54 89.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.741 1.609 . . . . 0.0 110.215 170.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -51.82 68.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.476 1.91 . . . . 0.0 112.639 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -64.54 -41.89 96.06 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.051 0.841 . . . . 0.0 112.517 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -56.41 -44.11 80.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.391 1.476 . . . . 0.0 110.52 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 19.3 t80 -60.67 -56.9 15.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.468 1.507 . . . . 0.0 111.698 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.05 -19.32 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.096 1.316 . . . . 0.0 114.399 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 m -74.69 -38.22 62.44 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.112 1.324 . . . . 0.0 110.284 170.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -67.15 -28.11 67.86 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.641 1.11 . . . . 0.0 112.968 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.645 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 94.1 mt -67.46 -56.79 8.17 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.442 -0.786 . . . . 0.0 110.231 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -78.55 5.01 11.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.594 1.558 . . . . 0.0 113.946 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.04 -20.58 17.49 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.526 2.331 . . . . 0.0 113.136 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.52 -31.15 28.54 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.285 1.898 . . . . 0.0 113.697 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -135.2 -23.64 1.48 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 124.684 1.193 . . . . 0.0 113.358 -177.665 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.42 152.37 15.62 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.647 2.898 . . . . 0.0 110.187 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.96 153.46 38.25 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.543 1.137 . . . . 0.0 111.191 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -67.89 131.88 25.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.886 1.724 . . . . 0.0 110.491 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -6.81 81.85 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 125.535 1.54 . . . . 0.0 114.525 -172.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.72 161.84 15.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.444 1.497 . . . . 0.0 111.89 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -118.83 160.12 22.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.963 1.363 . . . . 0.0 114.437 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mt -141.3 131.22 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.615 1.566 . . . . 0.0 109.57 -160.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -85.65 127.84 34.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -112.55 122.34 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.314 1.446 . . . . 0.0 109.112 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -82.27 92.9 7.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.594 1.158 . . . . 0.0 109.084 173.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -64.99 -72.02 0.17 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.438 1.095 . . . . 0.0 111.693 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.4 mt -150.37 -114.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -164.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.18 23.85 5.84 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.333 0.968 . . . . 0.0 111.957 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -169.29 167.69 10.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.987 2.515 . . . . 0.0 111.867 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -121.26 163.4 18.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.233 1.413 . . . . 0.0 111.911 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.12 -174.07 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.658 1.583 . . . . 0.0 110.872 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -120.81 157.75 29.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.7 43.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.504 1.522 . . . . 0.0 113.083 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.433 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -125.72 123.64 39.32 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.771 2.428 . . . . 0.0 108.162 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -79.97 104.43 10.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 0.0 111.507 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.4 pt -94.48 -15.21 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.87 177.8 37.11 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 124.39 0.995 . . . . 0.0 110.877 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.73 91.57 0.45 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.669 0.747 . . . . 0.0 110.37 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 0.73 58.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.629 2.062 . . . . 0.0 115.069 -176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.56 138.94 47.45 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.924 1.862 . . . . 0.0 112.589 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.42 152.37 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mm -108.45 137.85 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 127.044 2.138 . . . . 0.0 106.715 168.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.98 141.17 18.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.235 0.925 . . . . 0.0 111.73 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.86 121.54 30.4 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.351 0.66 . . . . 0.0 110.01 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.13 113.77 43.67 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 168.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.3 169.45 21.26 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.028 2.485 . . . . 0.0 112.75 -169.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo . . . . . 0 C--N 1.351 0.678 0 C-N-CA 124.372 3.381 . . . . 0.0 113.661 173.431 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 m . . . . . 0 CA--C 1.548 0.867 0 CA-C-O 121.088 0.47 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.58 158.82 30.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.368 1.067 . . . . 0.0 111.299 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -143.08 132.35 23.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.376 1.071 . . . . 0.0 111.167 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.65 125.82 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.074 0.95 . . . . 0.0 109.992 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.1 171.67 13.68 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.78 1.632 . . . . 0.0 112.203 -170.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -142.01 141.72 32.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.864 1.666 . . . . 0.0 111.611 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.252 14.7 pt-20 174.1 -160.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.269 3.028 . . . . 0.0 110.145 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.9 mtm105 -95.02 148.25 22.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 tp -53.88 -51.87 62.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.537 1.535 . . . . 0.0 111.229 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.45 -25.31 67.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.74 -44.57 23.1 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.418 1.008 . . . . 0.0 110.458 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.33 -34.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.155 0.982 . . . . 0.0 112.125 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.9 -17.77 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.027 1.731 . . . . 0.0 112.873 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.25 118.54 15.26 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.181 -0.95 . . . . 0.0 112.221 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 4.81 90.18 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.677 1.132 . . . . 0.0 114.619 -174.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.73 176.75 7.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.906 2.082 . . . . 0.0 112.107 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -121.02 167.96 12.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.394 1.478 . . . . 0.0 109.64 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -156.0 165.97 34.87 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -158.39 136.22 10.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.998 1.319 . . . . 0.0 110.939 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.8 136.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 118.825 0.738 . . . . 0.0 109.049 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -152.75 128.86 10.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.061 0.545 . . . . 0.0 111.672 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -145.41 40.57 1.21 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.258 1.023 . . . . 0.0 111.304 -172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -71.11 -43.92 66.68 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -169.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -62.75 -35.3 79.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.276 0.63 . . . . 0.0 111.682 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.73 -28.34 67.27 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.349 1.46 . . . . 0.0 114.16 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -64.36 -19.65 65.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.446 1.098 . . . . 0.0 112.468 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -78.66 -16.24 57.54 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.097 0.959 . . . . 0.0 112.93 173.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.41 -75.59 0.58 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -131.03 153.61 81.82 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -139.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.63 -16.93 52.1 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 124.33 3.353 . . . . 0.0 114.367 169.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 72.65 86.65 0.1 Allowed Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 127.678 2.391 . . . . 0.0 113.101 171.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.52 93.67 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.628 2.885 . . . . 0.0 110.378 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.26 -38.77 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.139 0.976 . . . . 0.0 112.14 -172.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -69.1 -41.72 77.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.74 0.7 . . . . 0.0 111.866 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.64 -35.49 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.414 0.686 . . . . 0.0 110.316 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.4 -40.18 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.046 0.938 . . . . 0.0 111.914 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.4 -39.39 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.325 0.966 . . . . 0.0 111.074 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 m -65.63 -40.26 92.34 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.733 -0.604 . . . . 0.0 110.844 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -61.9 -47.18 86.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.268 1.027 . . . . 0.0 111.243 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.05 91.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.616 0.766 . . . . 0.0 112.535 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.95 -46.05 89.6 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.587 -0.695 . . . . 0.0 112.061 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.21 -30.14 70.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.09 -1.006 . . . . 0.0 113.37 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.61 -12.72 61.49 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.81 125.75 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.719 1.145 . . . . 0.0 111.047 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.94 -1.4 80.57 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.615 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -75.46 143.35 42.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.06 1.93 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -117.89 146.2 44.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.706 1.602 . . . . 0.0 111.88 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.6 157.25 44.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.981 1.312 . . . . 0.0 112.166 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -153.02 -33.8 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -173.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -72.21 157.89 36.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -171.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.6 t 75.88 -177.55 0.14 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.191 2.196 . . . . 0.0 113.03 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.7 mm -76.11 140.87 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.63 1.172 . . . . 0.0 109.004 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.13 -32.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -170.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.7 p -63.46 -48.44 77.69 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.361 -0.837 . . . . 0.0 111.527 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -67.19 -35.8 80.41 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.597 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.16 -45.52 79.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.596 1.543 . . . . 0.0 111.437 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.8 m -65.82 -49.43 68.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.284 1.434 . . . . 0.0 113.294 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.74 -41.55 99.25 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.567 0.747 . . . . 0.0 112.262 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -64.76 -42.26 95.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.111 1.364 . . . . 0.0 110.221 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 8.6 t80 -54.6 -52.46 62.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.021 1.329 . . . . 0.0 112.04 169.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.421 ' HA ' HD12 ' A' ' 120' ' ' LEU . 13.8 m -68.72 -18.33 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.815 1.189 . . . . 0.0 113.992 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -75.6 -45.39 37.87 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.698 169.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -34.57 61.86 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.82 1.191 . . . . 0.0 113.397 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.615 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 78.7 mt -64.98 -59.45 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.907 0.776 . . . . 0.0 111.452 171.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -80.48 11.13 3.9 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.79 -19.45 62.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.543 1.937 . . . . 0.0 113.94 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -47.29 -37.75 11.84 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.908 2.194 . . . . 0.0 116.639 -169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -140.74 7.89 2.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.623 1.211 . . . . 0.0 113.622 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.638 1.575 . . . . 0.0 112.289 175.334 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.88 -30.08 50.61 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.913 0.885 . . . . 0.0 113.385 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.1 m -67.99 149.75 98.05 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.355 1.062 . . . . 0.0 112.981 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 -24.51 14.76 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.266 2.644 . . . . 0.0 113.169 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -162.43 172.94 14.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.199 1.8 . . . . 0.0 110.952 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -72.75 140.97 48.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.228 0.611 . . . . 0.0 110.323 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -108.04 113.33 60.96 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.109 0.964 . . . . 0.0 109.461 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.5 141.8 31.99 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.288 1.992 . . . . 0.0 110.206 170.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -91.75 142.11 26.31 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.852 0.861 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.51 128.92 22.37 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.637 2.225 . . . . 0.0 110.232 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.51 -2.38 72.73 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.503 1.525 . . . . 0.0 114.838 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.26 162.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.521 1.661 . . . . 0.0 111.163 169.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.01 146.05 42.47 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.953 1.359 . . . . 0.0 113.814 -171.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mt -123.26 129.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.341 2.257 . . . . 0.0 108.024 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -82.36 124.43 30.0 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.684 1.193 . . . . 0.0 107.798 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mm -118.44 119.5 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 110.346 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -81.79 72.81 8.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 108.536 169.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -25.91 57.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.727 1.211 . . . . 0.0 113.461 -170.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -161.62 -159.94 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.709 2.004 . . . . 0.0 108.715 -159.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.96 34.19 1.05 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.662 1.125 . . . . 0.0 112.678 169.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -169.44 158.83 8.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.427 2.691 . . . . 0.0 111.002 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -104.05 123.95 48.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -105.6 167.95 9.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.599 1.559 . . . . 0.0 110.862 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -112.69 151.81 29.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.729 0.811 . . . . 0.0 111.698 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.62 156.77 44.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.371 1.068 . . . . 0.0 112.819 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -123.49 120.99 34.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.032 . . . . 0.0 108.75 -178.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -76.98 92.17 3.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.234 1.014 . . . . 0.0 111.864 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.5 pt -81.18 -21.93 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.75 173.35 31.75 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 124.199 0.904 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -68.41 90.67 0.37 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.674 0.749 . . . . 0.0 109.908 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.0 49.93 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.195 1.855 . . . . 0.0 115.581 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -126.18 140.64 52.4 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.714 1.757 . . . . 0.0 112.963 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -137.07 149.79 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.289 1.036 . . . . 0.0 113.237 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.5 mm -105.56 131.74 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -146.85 162.82 37.84 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.908 1.231 . . . . 0.0 112.069 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -100.58 134.11 44.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.315 0.646 . . . . 0.0 112.626 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.53 108.44 53.24 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 126.214 1.805 . . . . 0.0 106.232 168.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -62.75 162.18 26.03 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.373 3.382 . . . . 0.0 114.822 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.02 18.59 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.802 3.668 . . . . 0.0 113.689 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.3 m -140.22 142.67 35.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.19 1.396 . . . . 0.0 110.97 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.11 166.08 21.01 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.158 1.383 . . . . 0.0 111.745 172.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -64.3 134.98 96.15 Favored Pre-proline 0 CA--C 1.555 1.138 0 O-C-N 121.027 -1.046 . . . . 0.0 110.818 169.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -66.69 142.65 64.79 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.391 2.727 . . . . 0.0 111.698 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.06 67.65 1.6 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.88 -22.99 64.84 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.74 -0.5 89.51 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 116.346 1.298 . . . . 0.0 116.346 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.2 m -89.94 142.6 27.55 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.369 1.584 . . . . 0.0 111.725 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 p -60.54 -22.55 63.75 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.287 -1.508 . . . . 0.0 113.213 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.8 p -86.64 -13.49 45.46 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.813 1.645 . . . . 0.0 114.71 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -172.81 129.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 120.066 1.303 . . . . 0.0 112.897 -171.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -131.42 -57.46 1.01 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.138 0.975 . . . . 0.0 112.78 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 t -80.26 -29.17 38.31 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.1 t -75.2 132.43 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.728 0.811 . . . . 0.0 109.983 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.21 7.84 3.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.982 1.313 . . . . 0.0 114.498 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -65.92 139.25 58.25 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.944 -1.098 . . . . 0.0 112.615 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -157.88 -162.62 1.19 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.35 1.06 . . . . 0.0 112.314 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m -124.8 146.42 49.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.451 1.5 . . . . 0.0 110.717 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 150.11 26.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.593 -0.692 . . . . 0.0 111.968 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -143.42 136.72 28.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.251 1.02 . . . . 0.0 110.944 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.51 128.35 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.617 1.167 . . . . 0.0 108.846 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -130.41 151.45 50.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.469 1.508 . . . . 0.0 112.543 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -105.37 138.75 41.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.332 1.453 . . . . 0.0 110.585 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.69 167.63 18.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.14 0.976 . . . . 0.0 111.021 -170.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -83.8 143.66 29.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.072 1.349 . . . . 0.0 110.617 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.03 -49.06 72.5 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.507 0.723 . . . . 0.0 110.522 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.7 -24.39 65.6 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.96 -46.09 15.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.355 0.98 . . . . 0.0 110.287 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.69 -30.73 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.971 0.908 . . . . 0.0 112.252 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -91.78 -21.5 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.88 1.672 . . . . 0.0 112.759 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.31 118.71 15.21 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.383 0.992 . . . . 0.0 112.048 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.46 75.49 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.445 1.021 . . . . 0.0 114.607 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.1 m -123.67 163.47 21.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.132 1.773 . . . . 0.0 111.795 -171.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -109.99 159.86 16.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.575 1.15 . . . . 0.0 109.961 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -157.89 169.2 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.9 tpp85 -163.93 132.65 3.74 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.146 1.778 . . . . 0.0 110.727 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.61 127.53 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -152.73 64.89 0.79 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.973 0.892 . . . . 0.0 110.679 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -80.57 69.11 7.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.364 1.065 . . . . 0.0 111.177 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.7 p -35.14 -64.56 0.27 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.425 2.29 . . . . 0.0 115.328 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.84 -29.24 68.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.47 -39.51 74.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.565 0.746 . . . . 0.0 112.448 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -67.99 -30.51 69.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 112.093 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -76.09 -36.98 58.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.612 1.165 . . . . 0.0 113.333 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -162.93 -52.98 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -72.24 148.73 91.38 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -153.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.06 -37.4 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.714 2.943 . . . . 0.0 113.145 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 68.64 119.64 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.602 2.361 . . . . 0.0 116.934 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.4 89.38 1.36 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.396 3.397 . . . . 0.0 110.981 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.92 -41.43 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.739 1.616 . . . . 0.0 113.956 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.03 -36.08 79.34 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.554 0.615 . . . . 0.0 111.512 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.07 -27.87 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.035 0.934 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.6 mm -68.19 -47.29 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.14 0.882 . . . . 0.0 110.647 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.03 -38.13 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.771 -0.58 . . . . 0.0 110.801 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -67.25 -41.15 86.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.705 -0.622 . . . . 0.0 111.166 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.2 m -64.82 -39.55 93.76 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.541 1.136 . . . . 0.0 111.992 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.75 95.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.36 -0.838 . . . . 0.0 111.665 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -68.75 -11.17 59.99 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 173.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.25 -35.74 14.31 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.41 1.084 . . . . 0.0 111.174 168.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.3 mmm -72.44 -20.21 61.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.712 1.605 . . . . 0.0 113.819 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.26 124.22 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.902 1.228 . . . . 0.0 111.623 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.0 -4.56 85.55 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.069 -1.406 . . . . 0.0 115.323 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 150.81 47.61 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.073 1.937 . . . . 0.0 111.009 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -129.18 149.79 50.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.874 1.67 . . . . 0.0 112.301 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.7 mtm -144.03 158.96 43.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 0.0 111.234 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -152.83 -32.88 0.13 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -171.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.59 -28.45 51.63 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -90.12 150.02 22.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.232 1.013 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.33 157.1 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.592 -0.693 . . . . 0.0 111.328 172.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.77 -42.28 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m -64.2 -45.67 87.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.899 0.772 . . . . 0.0 111.367 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -75.98 -32.16 59.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.864 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -57.85 -40.12 79.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.198 0.908 . . . . 0.0 111.366 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.04 -55.23 31.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.895 1.678 . . . . 0.0 112.938 169.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.07 -43.61 98.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.432 -0.792 . . . . 0.0 112.339 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.79 -34.94 79.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.238 1.015 . . . . 0.0 111.195 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.65 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 26.3 t80 -61.19 -55.65 29.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.829 169.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.39 -20.45 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 120.304 1.411 . . . . 0.0 113.992 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -73.01 -37.96 66.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.526 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -71.99 -27.64 62.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.893 1.224 . . . . 0.0 113.442 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.65 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 83.3 mt -66.41 -46.89 75.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.218 0.917 . . . . 0.0 111.77 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -69.5 -94.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.677 1.191 . . . . 0.0 108.633 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.7 t80 70.77 -6.99 1.13 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.236 2.614 . . . . 0.0 112.993 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.28 -69.54 1.28 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 127.22 2.343 . . . . 0.0 111.92 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.84 1.14 33.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.26 1.024 . . . . 0.0 113.269 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 125.617 1.567 . . . . 0.0 112.484 170.067 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.63 162.8 28.41 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.347 1.059 . . . . 0.0 112.602 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.6 m -68.14 153.38 95.52 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.897 0.879 . . . . 0.0 112.96 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.28 149.67 53.91 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.067 3.178 . . . . 0.0 113.404 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -162.72 163.23 26.94 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.46 1.504 . . . . 0.0 111.01 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -137.54 100.17 4.14 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.551 1.14 . . . . 0.0 109.45 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -114.21 115.26 45.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.145 0.978 . . . . 0.0 110.677 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.2 150.1 36.83 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.25 2.634 . . . . 0.0 111.069 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -108.59 160.31 27.67 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.457 1.503 . . . . 0.0 111.664 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.51 134.5 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.782 1.655 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.8 -10.38 74.71 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.855 1.216 . . . . 0.0 114.685 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.13 142.76 31.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.773 1.287 . . . . 0.0 111.539 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.66 128.1 48.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.627 1.203 . . . . 0.0 108.074 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.15 126.65 61.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 105.978 -170.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -74.84 129.67 38.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.06 120.04 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.621 1.569 . . . . 0.0 109.051 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -80.93 90.27 5.92 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -81.58 31.24 0.35 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt 82.53 72.76 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.652 1.981 . . . . 0.0 110.922 155.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.79 1.46 76.94 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.829 1.204 . . . . 0.0 113.353 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -138.67 140.2 38.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.239 1.815 . . . . 0.0 110.653 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -98.06 119.71 37.18 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.645 0.778 . . . . 0.0 110.427 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -125.92 178.62 5.63 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.695 1.598 . . . . 0.0 111.042 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -137.97 157.24 46.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.441 0.696 . . . . 0.0 112.606 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.55 25.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 120.74 32.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.671 1.589 . . . . 0.0 108.589 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.0 110.24 5.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 pt -100.06 -20.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.34 170.57 42.19 Favored Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.71 0.804 . . . . 0.0 112.591 -170.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 19.11 66.24 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.335 1.445 . . . . 0.0 115.749 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -127.08 141.73 51.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.62 1.71 . . . . 0.0 112.736 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.9 156.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.658 1.183 . . . . 0.0 113.117 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 mm -112.49 132.42 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.184 1.794 . . . . 0.0 107.632 169.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -149.31 148.77 29.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.737 1.153 . . . . 0.0 111.896 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.0 tp -83.41 106.35 15.1 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 91.66 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.194 1.398 . . . . 0.0 111.032 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.18 141.91 44.74 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.129 3.22 . . . . 0.0 116.289 -168.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.41 -14.38 11.78 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.758 2.972 . . . . 0.0 111.766 169.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -63.75 -2.15 1.66 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.333 2.253 . . . . 0.0 116.703 -169.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -76.15 45.18 0.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.636 1.574 . . . . 0.0 112.007 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -58.28 -35.1 29.76 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -58.58 152.03 58.34 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.985 3.124 . . . . 0.0 113.245 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.72 -44.71 2.79 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.09 1.329 . . . . 0.0 113.198 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.83 147.35 43.43 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.216 1.008 . . . . 0.0 113.035 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.33 17.36 3.13 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 125.074 1.321 . . . . 0.0 114.776 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.2 m -171.38 156.42 4.56 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.96 2.104 . . . . 0.0 110.804 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -59.9 -17.9 40.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.354 1.461 . . . . 0.0 114.427 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 p -70.96 -21.34 62.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.932 1.293 . . . . 0.0 113.585 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t 73.35 129.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 128.095 2.558 . . . . 0.0 112.551 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -107.38 -25.21 11.54 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.7 p -93.52 -88.29 0.23 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.056 0.942 . . . . 0.0 110.617 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.8 128.57 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.446 1.498 . . . . 0.0 111.543 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.2 tp 61.23 10.75 3.16 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.938 2.095 . . . . 0.0 116.029 169.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 m -66.37 -15.38 63.24 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 119.964 -1.71 . . . . 0.0 115.365 -170.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -77.08 -43.35 34.63 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.9 p -170.74 162.85 7.84 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.69 1.596 . . . . 0.0 111.084 -169.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.86 156.35 28.71 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.117 -0.989 . . . . 0.0 111.27 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.68 135.05 37.87 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 0.0 111.289 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.52 122.19 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -127.36 157.07 40.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.428 1.491 . . . . 0.0 112.26 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -101.55 142.39 32.99 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.139 1.375 . . . . 0.0 110.398 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.75 164.08 21.28 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.095 0.958 . . . . 0.0 111.23 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -74.67 140.67 44.39 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.23 1.412 . . . . 0.0 110.414 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.3 tp -53.81 -57.27 11.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.173 0.989 . . . . 0.0 110.873 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.54 -21.94 66.61 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.48 -41.66 65.76 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.188 0.904 . . . . 0.0 110.878 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.29 -54.55 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.616 0.766 . . . . 0.0 110.87 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.1 -6.61 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.87 -28.23 54.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.116 0.865 . . . . 0.0 113.179 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.39 22.93 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.612 1.101 . . . . 0.0 114.736 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 79.8 m -130.76 148.47 52.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.238 1.415 . . . . 0.0 112.44 -172.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.6 m -76.56 157.37 32.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -158.02 172.45 18.42 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 155.52 2.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 128.173 2.589 . . . . 0.0 112.443 169.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.34 146.72 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.983 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -130.35 -80.85 0.54 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 51.47 49.73 20.35 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.878 2.071 . . . . 0.0 112.541 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -49.35 -57.04 7.6 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.677 -1.265 . . . . 0.0 113.402 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.19 -27.14 69.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.362 1.065 . . . . 0.0 113.444 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -24.94 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.876 0.87 . . . . 0.0 112.238 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -89.55 -30.84 17.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.514 1.125 . . . . 0.0 112.646 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.58 -37.58 88.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.73 0.812 . . . . 0.0 111.898 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.7 -71.55 0.09 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.91 129.89 40.43 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -145.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.88 67.19 5.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.897 3.065 . . . . 0.0 110.46 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.413 ' HB3' HD11 ' A' ' 92' ' ' ILE . 27.8 ttt180 -66.45 137.36 95.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.39 123.11 11.84 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.155 2.57 . . . . 0.0 110.33 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' HA ' HD12 ' A' ' 92' ' ' ILE . 2.5 t -65.25 -31.68 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.53 -0.747 . . . . 0.0 112.297 -169.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -54.74 -37.75 66.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.687 1.131 . . . . 0.0 112.4 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.04 -28.5 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.518 0.727 . . . . 0.0 110.909 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 87' ' ' ARG . 21.7 mt -69.63 -44.22 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.437 1.095 . . . . 0.0 110.42 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.86 -46.43 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.291 1.037 . . . . 0.0 109.837 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -64.21 -40.73 96.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.457 0.703 . . . . 0.0 111.565 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.0 t -61.33 -43.66 98.49 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.079 -1.013 . . . . 0.0 111.639 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.8 93.78 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.104 -0.997 . . . . 0.0 111.893 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.47 -25.39 68.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.197 0.999 . . . . 0.0 113.536 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -81.35 -35.27 31.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.174 0.99 . . . . 0.0 112.999 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.2 mmm -73.38 -30.39 63.26 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -54.78 126.61 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.488 1.04 . . . . 0.0 111.193 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.88 -9.52 55.2 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.027 1.775 . . . . 0.0 114.263 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -83.5 141.32 31.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.128 1.464 . . . . 0.0 111.11 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.98 155.06 18.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.69 1.596 . . . . 0.0 111.159 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 23.2 ptp -161.85 152.71 17.84 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -150.46 41.06 0.78 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.086 1.755 . . . . 0.0 110.268 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.84 -28.46 69.5 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.305 1.842 . . . . 0.0 115.279 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -172.1 -169.83 0.68 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.679 1.992 . . . . 0.0 110.379 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 pt -54.43 150.75 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.828 0.851 . . . . 0.0 110.504 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.78 -37.95 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.2 p -62.87 -45.55 92.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.067 0.849 . . . . 0.0 111.7 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -70.56 -35.14 72.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.019 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -61.29 -41.97 97.86 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.446 1.475 . . . . 0.0 110.911 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.2 m -64.36 -48.91 73.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.759 2.024 . . . . 0.0 112.508 170.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.84 -45.74 92.51 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.478 -0.764 . . . . 0.0 112.241 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -53.01 -45.42 67.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.644 1.978 . . . . 0.0 110.683 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.22 -58.9 6.55 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.723 1.209 . . . . 0.0 112.335 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.32 -26.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.031 1.287 . . . . 0.0 113.472 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -61.86 -52.28 64.76 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 115.981 -1.961 . . . . 0.0 107.449 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -56.93 -25.4 57.38 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 122.41 2.368 . . . . 0.0 114.849 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -68.47 -33.26 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.666 1.121 . . . . 0.0 112.841 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -105.95 -13.43 15.49 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -58.11 -22.01 48.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.666 2.787 . . . . 0.0 113.069 -168.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -71.67 -11.94 73.51 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.862 -0.965 . . . . 0.0 115.414 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -134.57 2.92 3.25 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.68 1.24 . . . . 0.0 114.216 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 125.246 1.418 . . . . 0.0 112.891 177.594 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.02 175.96 10.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.722 1.209 . . . . 0.0 112.63 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -61.97 -38.44 49.01 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -62.11 141.54 88.96 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.878 2.385 . . . . 0.0 112.944 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.48 17.28 12.94 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.007 1.723 . . . . 0.0 111.289 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -160.2 175.69 12.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.926 2.491 . . . . 0.0 109.752 -174.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -142.87 128.06 10.07 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.96 0.904 . . . . 0.0 109.903 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.7 142.14 25.48 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.553 2.835 . . . . 0.0 110.635 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -115.66 138.91 24.18 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.189 0.995 . . . . 0.0 111.712 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.13 130.24 28.24 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.407 2.738 . . . . 0.0 111.32 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.07 42.37 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.169 1.842 . . . . 0.0 115.304 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -89.35 164.62 14.82 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 110.446 169.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -119.65 148.6 43.16 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.582 1.182 . . . . 0.0 113.012 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -123.99 130.34 73.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.561 2.344 . . . . 0.0 108.221 -161.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -88.71 120.88 30.51 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.79 124.28 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.461 1.504 . . . . 0.0 108.456 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -90.78 63.92 5.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.304 1.441 . . . . 0.0 109.579 -173.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -61.41 2.32 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -148.79 -129.48 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -162.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.33 33.83 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.635 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.75 158.53 2.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.566 2.746 . . . . 0.0 112.008 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -112.9 155.35 24.87 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.887 1.675 . . . . 0.0 109.783 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 164.81 34.91 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.569 -0.707 . . . . 0.0 112.885 174.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -97.88 149.82 21.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.19 140.35 27.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.424 1.09 . . . . 0.0 112.613 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.95 117.53 35.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.846 2.058 . . . . 0.0 108.983 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -76.56 86.82 3.26 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.885 1.274 . . . . 0.0 111.804 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -74.77 -23.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.11 177.88 27.03 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.584 1.088 . . . . 0.0 111.486 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.38 81.89 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.726 0.81 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.33 -11.83 31.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.33 2.395 . . . . 0.0 114.671 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.89 140.47 36.14 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.108 1.454 . . . . 0.0 113.126 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.0 149.54 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 0.0 113.703 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -108.35 123.04 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -137.8 149.76 46.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.231 -0.918 . . . . 0.0 111.512 -169.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.59 118.98 29.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.881 0.472 . . . . 0.0 110.07 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.7 130.95 62.23 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.04 158.89 45.33 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.279 2.652 . . . . 0.0 112.772 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.57 -12.5 15.23 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.914 3.076 . . . . 0.0 113.456 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 t -159.93 149.41 17.95 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.454 1.025 . . . . 0.0 112.054 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -81.05 172.7 13.39 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.037 1.335 . . . . 0.0 113.001 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -49.76 123.93 15.42 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 125.215 1.406 . . . . 0.0 112.359 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.83 -19.82 58.69 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.669 2.913 . . . . 0.0 114.697 -170.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.18 -8.25 85.15 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 119.082 0.856 . . . . 0.0 114.573 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 66.8 9.71 6.98 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.694 2.397 . . . . 0.0 115.172 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.72 -1.63 73.6 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.952 1.263 . . . . 0.0 115.448 -174.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.4 p -82.83 143.51 30.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.975 1.387 . . . . 0.0 112.563 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.1 m -60.92 -11.68 8.72 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.867 -1.145 . . . . 0.0 114.047 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.3 p -68.81 -15.11 63.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.67 1.588 . . . . 0.0 114.249 169.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 136.71 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.72 1.145 . . . . 0.0 113.814 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -136.18 14.34 3.28 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.42 1.488 . . . . 0.0 112.384 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.0 p -160.82 -83.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.577 1.151 . . . . 0.0 112.021 -172.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.7 t -105.83 125.16 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.938 1.695 . . . . 0.0 110.106 -176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.4 mp -88.36 -31.92 18.65 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.362 1.065 . . . . 0.0 112.984 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.0 p -94.78 153.88 17.54 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -163.68 -145.87 0.1 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.202 2.201 . . . . 0.0 109.453 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 m -120.11 154.95 33.97 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.464 1.505 . . . . 0.0 109.985 169.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.16 150.42 30.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.444 -0.785 . . . . 0.0 111.23 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.94 133.7 16.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.725 0.81 . . . . 0.0 110.654 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.03 121.9 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -128.06 156.7 42.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.739 1.616 . . . . 0.0 112.853 -170.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.33 139.98 38.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.067 1.347 . . . . 0.0 110.625 171.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.74 178.87 5.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.497 1.519 . . . . 0.0 109.811 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -96.1 142.49 28.23 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.317 1.447 . . . . 0.0 110.325 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.2 tp -55.35 -49.66 71.67 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.518 -0.739 . . . . 0.0 111.099 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.77 -25.63 63.23 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.28 -42.38 14.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.995 0.816 . . . . 0.0 111.342 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.98 -40.8 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 118.13 0.423 . . . . 0.0 111.305 172.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.5 -47.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.264 1.026 . . . . 0.0 111.613 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.21 -117.55 11.81 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -171.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.58 0.86 61.54 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.039 1.304 . . . . 0.0 115.056 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.82 166.44 22.05 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.942 1.371 . . . . 0.0 113.587 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -82.35 156.26 24.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.881 0.873 . . . . 0.0 110.998 169.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -161.05 156.73 25.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.019 0.927 . . . . 0.0 113.314 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -153.08 140.04 19.19 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.92 0.888 . . . . 0.0 111.827 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.92 133.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -158.01 70.12 0.55 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.344 1.058 . . . . 0.0 111.499 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -80.12 61.06 3.84 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.807 -1.183 . . . . 0.0 111.998 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.8 p -43.2 -67.62 0.26 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.496 1.918 . . . . 0.0 114.842 -169.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -58.08 -27.16 63.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.993 0.917 . . . . 0.0 113.142 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.2 -48.5 28.6 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.757 -0.589 . . . . 0.0 111.572 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -78.67 -7.59 57.84 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.4 -31.81 73.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 113.34 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.76 -36.41 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -126.45 139.26 34.19 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -137.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -94.6 54.99 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.09 1 C-N-CA 125.439 4.093 . . . . 0.0 111.737 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 147.82 46.84 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.41 100.4 1.14 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.955 3.104 . . . . 0.0 109.211 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.14 -25.26 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.327 1.051 . . . . 0.0 113.207 -169.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.58 -33.21 75.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.74 0.816 . . . . 0.0 112.338 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.0 -34.37 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.603 -0.685 . . . . 0.0 110.172 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.5 -44.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.611 0.764 . . . . 0.0 110.756 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.08 -40.13 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.669 0.788 . . . . 0.0 111.24 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.9 m -66.44 -43.18 86.31 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.416 -0.802 . . . . 0.0 111.237 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -34.66 78.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.049 0.939 . . . . 0.0 112.71 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.22 -45.17 94.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.77 1.168 . . . . 0.0 111.812 171.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.69 -13.49 61.33 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.96 -36.46 13.42 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.556 1.143 . . . . 0.0 112.501 168.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -72.38 -30.42 64.66 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.122 1.369 . . . . 0.0 113.573 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.43 128.45 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.809 0.731 . . . . 0.0 111.159 171.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.44 -9.11 58.94 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.484 1.516 . . . . 0.0 114.468 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -71.65 145.75 48.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.387 1.594 . . . . 0.0 111.01 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.81 143.95 50.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.009 1.724 . . . . 0.0 111.549 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -141.5 158.32 44.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.077 1.351 . . . . 0.0 111.363 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -161.96 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -72.39 -34.99 68.32 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.2 m -71.74 163.15 28.32 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -175.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.69 133.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.908 0.883 . . . . 0.0 108.629 171.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.1 t -57.67 -42.75 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 m -61.05 -47.97 83.91 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.568 -0.707 . . . . 0.0 111.075 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -67.44 -34.22 76.75 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.846 -0.534 . . . . 0.0 112.235 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.15 -38.5 83.31 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.099 0.96 . . . . 0.0 111.866 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 81.7 m -69.7 -48.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.433 1.093 . . . . 0.0 111.896 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.2 -46.96 86.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.057 0.543 . . . . 0.0 112.018 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.35 -32.55 74.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.75 -1.219 . . . . 0.0 111.531 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.44 -58.6 7.55 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.307 -0.871 . . . . 0.0 110.885 170.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.76 -25.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.0 m -69.41 -39.97 77.6 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.221 173.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.62 -27.19 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.278 1.399 . . . . 0.0 113.248 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.97 -38.37 82.64 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.545 1.066 . . . . 0.0 112.983 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 34.44 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -39.44 61.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 127.238 2.215 . . . . 0.0 112.493 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.91 44.54 0.1 Allowed Glycine 0 N--CA 1.475 1.263 0 C-N-CA 126.463 1.982 . . . . 0.0 111.528 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 pttm 91.72 -22.63 0.08 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 130.451 3.501 . . . . 0.0 110.172 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.253 1.262 1 C-N-CA 132.741 4.417 . . . . 0.0 113.516 169.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 120.32 0.105 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.52 152.19 45.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.988 0.915 . . . . 0.0 112.628 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.6 p -167.9 155.39 7.95 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.499 1.52 . . . . 0.0 111.848 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.45 157.1 45.32 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.574 2.85 . . . . 0.0 111.587 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -73.68 -16.1 61.22 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -160.78 137.64 8.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.979 1.712 . . . . 0.0 109.749 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.84 128.92 4.01 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 111.051 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.15 136.61 11.63 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.074 2.516 . . . . 0.0 110.214 169.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -85.45 154.81 59.69 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.428 0.691 . . . . 0.0 110.959 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.97 123.64 11.9 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.138 1.892 . . . . 0.0 109.228 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 -2.3 81.8 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.705 1.622 . . . . 0.0 115.198 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.95 156.79 17.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 1.587 . . . . 0.0 111.734 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.2 pt? -112.42 160.75 17.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.753 1.221 . . . . 0.0 113.581 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mt -144.31 131.91 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.994 1.318 . . . . 0.0 110.471 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.92 121.75 33.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.822 1.249 . . . . 0.0 107.633 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.7 mt -126.6 123.54 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.945 0.898 . . . . 0.0 110.488 -172.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.93 51.72 1.8 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.895 1.678 . . . . 0.0 110.71 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.06 -40.96 82.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.726 1.21 . . . . 0.0 111.86 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 mt -158.8 172.38 18.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.624 1.969 . . . . 0.0 108.192 -168.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.65 -7.39 20.98 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -73.88 -35.52 64.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.349 1.06 . . . . 0.0 113.483 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 68.28 106.52 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.309 2.244 . . . . 0.0 109.509 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -101.39 149.39 24.1 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -94.63 136.98 34.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.062 0.945 . . . . 0.0 109.431 168.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.73 159.06 42.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.194 0.998 . . . . 0.0 112.493 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.39 121.66 29.61 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.419 2.287 . . . . 0.0 107.782 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -77.97 97.65 5.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.576 0.626 . . . . 0.0 110.26 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.7 pt -73.7 -3.54 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.79 137.14 4.07 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.526 1.06 . . . . 0.0 114.293 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.23 -20.51 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 129.953 3.301 . . . . 0.0 117.575 169.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.88 -19.81 0.05 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.211 1.386 . . . . 0.0 115.132 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -89.9 147.89 23.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.182 1.491 . . . . 0.0 113.466 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 m -127.82 146.29 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.211 1.404 . . . . 0.0 112.13 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.48 139.62 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -158.19 158.95 35.54 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.119 -0.988 . . . . 0.0 111.942 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -98.81 136.25 39.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.222 0.609 . . . . 0.0 111.124 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.89 141.16 21.91 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 109.686 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.15 165.14 33.5 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.641 2.894 . . . . 0.0 112.469 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -70.32 -2.66 10.95 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.363 2.708 . . . . 0.0 115.493 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -57.04 132.29 52.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.584 1.154 . . . . 0.0 112.2 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.28 132.83 42.46 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.381 -0.824 . . . . 0.0 112.966 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -69.53 -50.2 19.77 Favored Pre-proline 0 CA--C 1.555 1.139 0 CA-C-O 118.005 -0.998 . . . . 0.0 113.614 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.41 168.48 22.79 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.924 3.083 . . . . 0.0 111.497 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.08 29.58 1.87 Allowed Glycine 0 N--CA 1.474 1.223 0 C-N-CA 125.058 1.313 . . . . 0.0 113.969 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 136.52 41.8 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.615 1.566 . . . . 0.0 112.503 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.02 139.89 7.28 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.207 1.384 . . . . 0.0 112.065 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.0 m 60.23 27.98 17.54 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.973 1.309 . . . . 0.0 112.855 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.3 p -151.08 -169.09 3.29 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.506 1.523 . . . . 0.0 112.009 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 t -79.44 6.72 9.53 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 120.56 -1.337 . . . . 0.0 113.275 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 52' ' ' SER . 15.0 p -146.88 146.92 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.894 1.278 . . . . 0.0 111.815 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -130.75 14.38 5.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.007 1.323 . . . . 0.0 113.535 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.403 ' H ' HG22 ' A' ' 50' ' ' VAL . 22.8 m -73.46 63.54 0.8 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.952 1.701 . . . . 0.0 112.628 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.12 151.02 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.385 1.474 . . . . 0.0 113.076 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.3 tp -130.77 -32.52 1.67 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.238 1.415 . . . . 0.0 112.754 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.7 m -80.87 -70.86 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.514 0.726 . . . . 0.0 110.888 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 64.69 -58.15 0.25 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 128.708 2.803 . . . . 0.0 112.896 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m -120.82 169.01 10.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.454 2.301 . . . . 0.0 109.891 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.22 155.41 40.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.951 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -138.57 129.94 27.35 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.853 0.861 . . . . 0.0 111.095 -170.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.94 128.95 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.194 0.597 . . . . 0.0 110.11 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -137.67 169.87 17.04 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.878 1.671 . . . . 0.0 112.248 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -127.12 143.04 51.36 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.922 1.689 . . . . 0.0 111.872 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -153.76 179.54 8.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.449 1.9 . . . . 0.0 110.623 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -102.56 140.25 37.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 110.332 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.26 -47.91 71.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.015 1.326 . . . . 0.0 111.631 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.14 -33.34 70.77 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.84 -45.32 51.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.378 0.99 . . . . 0.0 110.27 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.19 -32.31 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.736 1.214 . . . . 0.0 112.605 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.82 -20.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.888 1.675 . . . . 0.0 112.547 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 116.13 8.36 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.253 0.933 . . . . 0.0 111.911 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.6 7.55 74.29 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.574 1.083 . . . . 0.0 115.041 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.3 m -121.15 143.94 48.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.121 1.369 . . . . 0.0 112.468 -171.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 80.8 m -85.04 152.11 23.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.448 0.699 . . . . 0.0 109.674 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -158.18 161.44 37.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.631 0.772 . . . . 0.0 112.977 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -144.61 139.51 28.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.861 1.664 . . . . 0.0 110.536 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.9 t -80.61 138.32 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -126.62 142.1 51.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.813 0.845 . . . . 0.0 112.846 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -137.48 39.59 2.44 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.288 1.435 . . . . 0.0 111.337 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.7 t -57.9 -69.05 0.19 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.571 -1.33 . . . . 0.0 113.725 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.7 mt -72.31 -27.05 62.2 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.39 -0.819 . . . . 0.0 112.181 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.18 -42.14 98.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.637 0.775 . . . . 0.0 112.923 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.03 -8.61 59.09 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -82.56 -36.01 26.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -113.11 -45.0 3.2 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -169.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -142.34 155.04 64.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -133.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.87 -21.36 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.606 3.537 . . . . 0.0 113.122 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 69.18 117.61 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 128.441 2.696 . . . . 0.0 115.408 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.54 88.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 123.733 2.956 . . . . 0.0 108.58 169.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.71 -38.74 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.997 -169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -38.79 81.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.539 0.609 . . . . 0.0 111.721 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.43 -38.16 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.79 0.723 . . . . 0.0 111.305 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.68 -47.36 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 119.281 0.946 . . . . 0.0 110.323 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 90.8 mt -61.41 -40.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.206 1.002 . . . . 0.0 110.94 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.1 t -63.42 -42.93 98.73 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.434 0.694 . . . . 0.0 111.408 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -58.96 -40.54 85.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.321 -0.862 . . . . 0.0 112.248 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.9 -52.57 59.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.49 0.716 . . . . 0.0 111.982 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.82 -22.72 67.05 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.34 -50.03 12.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.165 0.986 . . . . 0.0 112.367 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 ptm -83.46 -14.13 53.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -170.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -55.54 125.4 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -8.45 59.06 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.391 1.472 . . . . 0.0 114.297 -169.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -70.63 153.97 42.33 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.576 1.688 . . . . 0.0 110.779 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -127.64 142.24 51.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.79 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -140.43 149.25 42.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.072 0.949 . . . . 0.0 113.059 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -154.28 -152.33 0.4 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.664 1.586 . . . . 0.0 111.262 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.9 t80 72.35 -53.77 0.69 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.871 2.869 . . . . 0.0 113.885 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.1 m -69.41 162.99 26.22 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.734 1.214 . . . . 0.0 112.379 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 tt -63.3 144.25 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 121.378 -0.826 . . . . 0.0 109.898 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.33 -27.63 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.8 t -64.14 -49.11 73.44 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.367 -0.833 . . . . 0.0 111.151 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -68.71 -28.7 67.07 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.933 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -57.34 -42.31 81.72 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.862 1.665 . . . . 0.0 111.191 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -45.11 53.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.957 1.303 . . . . 0.0 112.968 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.24 -41.41 90.06 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.117 -0.99 . . . . 0.0 112.69 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.85 -36.36 83.24 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.602 -1.311 . . . . 0.0 110.784 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.27 -58.0 10.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.482 0.713 . . . . 0.0 110.706 170.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -65.97 -27.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.954 1.252 . . . . 0.0 113.486 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -68.92 -33.97 74.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.819 1.19 . . . . 0.0 111.429 172.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -66.38 -23.14 66.28 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.61 -61.38 1.89 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.456 -0.778 . . . . 0.0 111.758 169.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -72.63 5.6 2.99 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -53.35 -24.75 12.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.251 2.22 . . . . 0.0 112.459 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.41 -24.51 11.01 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 127.573 2.511 . . . . 0.0 114.615 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.56 -19.94 0.47 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.252 1.021 . . . . 0.0 113.019 177.617 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 120.464 0.173 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.15 157.57 35.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.287 1.035 . . . . 0.0 112.773 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 m -70.91 148.35 94.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.93 0.892 . . . . 0.0 112.738 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.93 163.27 37.35 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.523 2.815 . . . . 0.0 111.535 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -157.13 152.57 26.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.684 1.193 . . . . 0.0 111.771 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -160.28 132.05 6.03 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.09 1.756 . . . . 0.0 108.635 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -110.77 117.39 50.62 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.222 0.609 . . . . 0.0 112.107 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.57 139.47 12.72 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 108.378 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -85.8 148.65 49.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.536 -0.728 . . . . 0.0 111.529 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.56 128.02 20.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.182 2.588 . . . . 0.0 109.957 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.48 82.86 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.938 1.733 . . . . 0.0 115.039 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.6 162.96 12.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -100.9 110.72 22.81 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 127.64 2.376 . . . . 0.0 113.636 -168.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.23 132.35 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.099 1.359 . . . . 0.0 109.92 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -96.54 116.98 29.98 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.07 120.29 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.317 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -81.72 63.16 5.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.675 1.19 . . . . 0.0 109.47 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -62.24 -29.38 70.36 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.317 1.047 . . . . 0.0 113.122 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.46 -144.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.092 1.357 . . . . 0.0 110.456 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.27 31.11 0.81 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.274 1.416 . . . . 0.0 114.706 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -168.44 154.87 7.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.786 2.835 . . . . 0.0 110.093 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -104.65 128.45 52.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.969 0.907 . . . . 0.0 110.812 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -108.76 134.69 51.12 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.878 1.271 . . . . 0.0 110.786 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -79.78 144.65 33.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.82 145.31 37.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.346 1.458 . . . . 0.0 111.521 169.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.14 118.19 36.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.244 1.818 . . . . 0.0 107.948 173.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -74.09 94.7 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.537 0.735 . . . . 0.0 110.64 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 pt -74.04 -8.8 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.668 -1.27 . . . . 0.0 114.15 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.97 133.83 2.91 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.738 0.685 . . . . 0.0 114.29 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 63.39 -19.56 0.06 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.634 3.173 . . . . 0.0 117.284 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.52 -21.44 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.509 1.528 . . . . 0.0 114.683 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.87 144.45 30.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.949 1.375 . . . . 0.0 113.002 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.83 145.62 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.135 1.374 . . . . 0.0 112.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.8 mm -107.45 138.64 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.753 1.621 . . . . 0.0 107.643 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -153.68 146.47 24.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.502 1.047 . . . . 0.0 112.091 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.12 118.79 31.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 109.844 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.9 119.49 75.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.855 1.262 . . . . 0.0 108.96 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -74.28 165.33 32.1 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.714 2.943 . . . . 0.0 112.261 -173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.24 133.49 19.5 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.667 2.244 . . . . 0.0 110.051 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -168.85 -172.47 1.6 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.542 1.137 . . . . 0.0 112.017 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.33 162.25 23.25 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.049 1.34 . . . . 0.0 113.046 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -150.42 168.04 11.79 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 125.427 1.491 . . . . 0.0 112.328 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.07 147.88 41.8 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.017 3.144 . . . . 0.0 113.844 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.26 -10.2 50.54 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.727 1.156 . . . . 0.0 113.504 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.07 164.36 15.57 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.723 1.609 . . . . 0.0 112.902 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.53 161.37 26.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.304 0.954 . . . . 0.0 113.897 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.1 p -81.52 -10.15 59.54 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.527 1.131 . . . . 0.0 113.348 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 m -172.08 167.97 5.92 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.972 2.909 . . . . 0.0 109.777 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.0 m 70.46 -28.94 0.18 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.274 2.229 . . . . 0.0 115.515 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -155.75 144.77 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.116 1.766 . . . . 0.0 110.815 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -154.65 49.14 0.59 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.068 1.347 . . . . 0.0 110.915 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.4 m -75.71 61.06 1.34 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.577 1.551 . . . . 0.0 111.059 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.89 152.77 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.552 1.541 . . . . 0.0 111.01 -169.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.6 tp -150.66 -73.54 0.16 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.005 1.322 . . . . 0.0 109.32 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -167.07 131.85 2.01 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.232 1.813 . . . . 0.0 111.075 169.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -82.6 169.53 16.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.822 1.249 . . . . 0.0 111.805 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m -77.24 161.68 27.95 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.201 -0.937 . . . . 0.0 111.935 169.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.21 159.11 28.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.014 0.926 . . . . 0.0 111.04 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -152.58 138.46 18.05 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.652 -0.655 . . . . 0.0 112.197 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.4 t -82.54 125.76 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.551 1.14 . . . . 0.0 109.406 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.47 175.15 9.79 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.959 1.704 . . . . 0.0 112.004 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -141.21 143.95 34.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.645 1.578 . . . . 0.0 112.24 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -178.78 -165.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.434 2.694 . . . . 0.0 109.249 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -103.79 150.0 24.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.7 tp -50.94 -57.87 7.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.123 1.769 . . . . 0.0 111.477 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 69' ' ' VAL . 17.7 pm0 -57.27 -33.44 67.62 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.088 0.955 . . . . 0.0 113.409 -174.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.04 -30.03 58.27 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.371 -0.831 . . . . 0.0 112.015 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.49 -45.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.204 1.401 . . . . 0.0 111.785 172.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 66' ' ' GLU . 34.7 m -84.62 -6.13 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.4 7.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 119.145 0.884 . . . . 0.0 111.777 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.28 7.72 78.23 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.835 1.207 . . . . 0.0 115.07 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.36 151.84 42.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.593 1.557 . . . . 0.0 112.549 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.61 160.12 19.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.874 0.87 . . . . 0.0 110.63 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -161.67 168.15 23.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.339 1.056 . . . . 0.0 113.44 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -167.23 149.98 6.21 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.122 1.769 . . . . 0.0 110.147 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.16 138.82 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 119.735 1.152 . . . . 0.0 110.153 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -132.32 130.69 41.11 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.013 1.325 . . . . 0.0 111.977 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -123.43 25.84 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.202 1.801 . . . . 0.0 113.299 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.7 m -60.82 -21.45 63.16 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.547 -1.345 . . . . 0.0 114.577 -171.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 mt -93.27 -39.25 11.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.806 0.842 . . . . 0.0 113.025 169.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.58 -35.06 71.8 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.439 1.018 . . . . 0.0 111.819 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -52.88 -29.12 26.44 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.401 2.28 . . . . 0.0 113.052 171.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -87.26 -14.91 39.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.494 1.118 . . . . 0.0 112.993 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -122.03 -64.64 1.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -138.71 149.7 63.17 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -135.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 -11.55 15.27 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 125.183 3.922 . . . . 0.0 114.074 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 81.21 96.48 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 127.586 2.354 . . . . 0.0 114.012 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.99 80.89 2.74 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.745 2.963 . . . . 0.0 108.528 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.77 -29.58 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.64 -39.5 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.465 1.03 . . . . 0.0 111.428 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.09 -34.23 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.387 -0.821 . . . . 0.0 110.247 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.9 mt -76.71 -39.69 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.995 0.918 . . . . 0.0 111.566 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.04 -45.32 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.551 -0.718 . . . . 0.0 110.979 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.9 p -68.21 -29.98 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.337 -0.852 . . . . 0.0 112.413 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -59.7 -46.64 88.47 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.059 -1.025 . . . . 0.0 111.192 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.65 92.09 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.079 -1.013 . . . . 0.0 112.428 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -67.42 -15.7 63.82 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -90.14 -38.35 13.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.977 1.311 . . . . 0.0 112.113 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.4 mmm -70.46 -25.09 63.02 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.361 1.464 . . . . 0.0 113.999 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -48.59 127.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.105 0.866 . . . . 0.0 111.804 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.87 81.4 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.127 1.346 . . . . 0.0 115.114 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -73.62 138.94 45.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.6 1.7 . . . . 0.0 110.7 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -98.08 156.12 16.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.363 1.465 . . . . 0.0 112.173 170.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 mtm -144.43 159.26 43.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.33 1.852 . . . . 0.0 111.44 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -158.61 -32.8 0.07 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -70.11 151.97 44.86 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.453 1.101 . . . . 0.0 113.879 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 t 76.76 -179.04 0.14 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.858 2.063 . . . . 0.0 113.803 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 pt -76.61 149.28 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.643 1.177 . . . . 0.0 110.558 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.91 -35.43 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.833 0.742 . . . . 0.0 112.542 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 p -64.35 -47.08 80.69 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.809 0.844 . . . . 0.0 112.485 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -67.95 -37.18 81.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.229 -0.919 . . . . 0.0 111.249 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -59.58 -46.56 88.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.289 0.95 . . . . 0.0 111.819 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.7 p -73.33 -37.34 66.15 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.495 -0.753 . . . . 0.0 112.797 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.25 -54.57 44.13 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.045 0.839 . . . . 0.0 111.355 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -56.1 -39.5 72.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.607 1.163 . . . . 0.0 111.224 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -56.43 -58.64 7.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.183 0.993 . . . . 0.0 111.294 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.3 m -64.98 -33.2 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.174 1.352 . . . . 0.0 113.253 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.7 m -68.36 -31.98 71.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.135 1.334 . . . . 0.0 111.544 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.51 -25.46 66.69 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.526 1.512 . . . . 0.0 112.327 169.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.62 -56.48 5.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.155 0.889 . . . . 0.0 110.976 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -75.96 5.7 6.19 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -57.7 -23.31 51.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.798 2.039 . . . . 0.0 113.434 -170.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -40.22 -36.32 0.89 Allowed Glycine 0 N--CA 1.474 1.185 0 C-N-CA 128.839 3.114 . . . . 0.0 117.465 -169.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -138.68 16.52 2.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.2 1.0 . . . . 0.0 112.77 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 126.203 1.801 . . . . 0.0 112.565 -178.51 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 tpp . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.905 -0.569 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.28 157.59 27.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.477 1.035 . . . . 0.0 112.901 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -97.42 151.34 37.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.604 1.162 . . . . 0.0 112.297 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.69 163.61 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.842 3.028 . . . . 0.0 112.075 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -85.6 15.7 4.43 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.636 1.174 . . . . 0.0 113.315 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -118.3 102.08 8.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.971 1.308 . . . . 0.0 111.407 -172.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -171.07 105.04 0.4 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 126.882 2.073 . . . . 0.0 107.917 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.66 129.74 28.93 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.331 2.688 . . . . 0.0 113.15 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.79 140.36 21.29 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.867 1.267 . . . . 0.0 108.136 169.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.23 131.37 21.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.244 1.296 . . . . 0.0 109.919 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.99 83.27 Favored Glycine 0 N--CA 1.469 0.859 0 C-N-CA 124.678 1.132 . . . . 0.0 114.66 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.77 168.81 9.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.19 1.495 . . . . 0.0 113.103 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.4 mt -102.99 111.35 23.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.922 1.689 . . . . 0.0 113.857 -168.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.6 mt -97.17 129.06 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 109.86 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.35 120.99 37.65 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.293 1.437 . . . . 0.0 107.559 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -121.47 121.91 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.297 1.039 . . . . 0.0 109.967 -174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -77.19 67.55 3.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.638 1.175 . . . . 0.0 111.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -64.8 -47.57 77.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.011 1.324 . . . . 0.0 113.451 -170.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -148.38 37.81 0.85 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.614 0.721 . . . . 0.0 112.583 -158.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.38 72.06 Favored Glycine 0 N--CA 1.477 1.41 0 O-C-N 121.396 -0.815 . . . . 0.0 113.012 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -162.02 146.86 12.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.887 2.475 . . . . 0.0 109.498 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -89.92 116.81 28.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.493 0.663 . . . . 0.0 111.42 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -94.15 145.1 24.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.583 1.553 . . . . 0.0 109.927 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -84.07 144.61 28.95 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.08 151.79 41.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.763 1.225 . . . . 0.0 112.945 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.83 120.06 41.13 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.245 2.218 . . . . 0.0 108.565 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.49 92.92 1.93 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.576 0.751 . . . . 0.0 111.609 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 pt -81.81 -21.22 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.94 -179.17 31.68 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 124.919 1.247 . . . . 0.0 110.945 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.07 96.74 0.82 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.133 0.968 . . . . 0.0 110.764 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.44 -0.45 89.28 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.168 1.842 . . . . 0.0 114.483 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -99.67 139.32 35.5 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.031 1.916 . . . . 0.0 112.148 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -138.63 149.94 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.87 129.01 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 168.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -145.11 149.22 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.502 1.046 . . . . 0.0 111.952 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.488 HD11 ' HB1' ' A' ' 58' ' ' ALA . 58.0 tp -90.93 123.8 34.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.85 111.31 41.53 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.986 1.314 . . . . 0.0 107.555 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.77 165.48 16.0 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.002 3.135 . . . . 0.0 114.016 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.83 160.42 37.44 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.189 2.593 . . . . 0.0 111.159 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -80.04 5.2 14.78 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -126.7 152.71 46.42 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.027 1.731 . . . . 0.0 111.176 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -160.48 158.87 25.88 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.289 1.836 . . . . 0.0 110.348 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.77 119.96 7.26 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.306 2.004 . . . . 0.0 110.318 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.5 14.06 64.3 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.378 0.989 . . . . 0.0 115.528 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.76 156.41 30.62 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.343 1.071 . . . . 0.0 113.18 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.34 120.11 3.22 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.474 1.511 . . . . 0.0 112.309 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.1 p -85.68 -23.88 27.25 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.0 p -80.54 -19.58 45.42 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.6 p -174.05 -77.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.011 1.724 . . . . 0.0 110.567 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.1 p -175.88 145.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 128.312 2.645 . . . . 0.0 109.592 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.288 17.2 p90 60.84 12.15 3.64 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.343 2.657 . . . . 0.0 115.247 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -70.03 40.79 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.986 2.514 . . . . 0.0 114.7 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.4 m -137.61 153.23 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.972 2.109 . . . . 0.0 111.274 -173.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.3 tp -72.83 137.69 45.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.693 1.197 . . . . 0.0 111.117 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.6 p -77.33 136.07 38.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.703 0.763 . . . . 0.0 112.356 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -168.22 144.08 3.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.258 1.423 . . . . 0.0 110.445 -172.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 p -90.17 164.13 14.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 36' ' ' LEU . . . -79.79 154.37 28.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.594 1.157 . . . . 0.0 110.74 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -133.01 135.32 45.37 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.957 0.903 . . . . 0.0 111.491 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.31 125.41 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 169.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.42 156.83 42.55 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.078 1.751 . . . . 0.0 112.798 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -111.4 138.6 47.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.826 1.65 . . . . 0.0 111.016 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -170.18 173.93 5.62 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.869 1.268 . . . . 0.0 110.72 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -93.07 144.95 24.76 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.267 -0.895 . . . . 0.0 112.397 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 tp -53.75 -50.23 66.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.94 1.296 . . . . 0.0 111.07 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 69' ' ' VAL . 12.6 pt-20 -55.61 -30.92 61.76 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.764 1.226 . . . . 0.0 114.044 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.82 -39.96 25.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.452 -0.78 . . . . 0.0 111.779 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.46 -41.01 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.195 0.598 . . . . 0.0 111.507 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 66' ' ' GLU . 33.9 m -70.26 -40.47 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.565 1.075 . . . . 0.0 112.165 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 18.86 61.18 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.148 0.885 . . . . 0.0 115.0 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.08 -8.35 72.95 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.377 1.465 . . . . 0.0 114.633 -173.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.2 m -78.36 169.43 18.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.091 1.357 . . . . 0.0 112.305 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.3 m -71.38 155.59 40.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.84 0.856 . . . . 0.0 113.213 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.95 154.25 27.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.045 1.338 . . . . 0.0 112.664 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -142.05 167.4 22.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.467 1.907 . . . . 0.0 109.881 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.18 134.54 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 119.172 0.897 . . . . 0.0 109.744 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -158.73 129.2 6.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -139.18 57.09 1.67 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 110.566 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.8 m -49.42 -40.72 37.49 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -169.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.44 -34.43 72.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.145 0.884 . . . . 0.0 113.276 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 -26.94 60.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.653 0.781 . . . . 0.0 111.715 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -73.41 -33.73 65.13 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.989 0.916 . . . . 0.0 111.458 169.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.08 -32.86 74.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 112.01 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -168.12 150.4 5.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.841 1.656 . . . . 0.0 113.841 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 80.17 147.94 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 127.196 2.198 . . . . 0.0 115.448 152.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.26 165.4 16.74 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 124.439 3.426 . . . . 0.0 110.542 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -137.47 146.42 53.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 120.953 -1.092 . . . . 0.0 113.678 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.86 83.09 2.33 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.015 3.143 . . . . 0.0 109.476 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -36.92 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.494 1.118 . . . . 0.0 113.203 -169.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -72.23 -35.79 68.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.085 0.857 . . . . 0.0 111.793 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -74.93 -29.92 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.887 0.875 . . . . 0.0 110.13 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.92 -42.36 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.288 1.035 . . . . 0.0 111.535 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.7 -40.55 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.722 0.809 . . . . 0.0 110.449 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.1 m -65.76 -42.25 91.13 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.503 -0.748 . . . . 0.0 111.783 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.2 t -61.79 -40.96 97.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.509 1.123 . . . . 0.0 111.64 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.66 71.79 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.634 0.774 . . . . 0.0 111.308 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -67.32 -15.18 63.54 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.39 -42.84 14.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.276 1.031 . . . . 0.0 113.033 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.6 ptm -81.31 -25.26 36.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -50.01 128.56 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.685 0.755 . . . . 0.0 112.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -15.92 52.53 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.727 1.632 . . . . 0.0 113.964 -170.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -78.63 163.56 25.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.769 1.785 . . . . 0.0 112.215 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.59 150.33 50.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.7 1.6 . . . . 0.0 112.594 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -141.71 159.01 43.09 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.963 1.305 . . . . 0.0 112.407 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -154.38 -3.28 0.17 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -74.77 141.74 44.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.075 -1.016 . . . . 0.0 113.064 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.9 t 71.3 -176.19 0.19 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.346 1.859 . . . . 0.0 114.19 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.5 pt -75.12 152.35 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.644 1.177 . . . . 0.0 111.105 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.1 m -53.83 -38.4 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.1 m -70.67 -38.91 73.81 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.134 0.879 . . . . 0.0 111.904 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -72.06 -35.67 69.36 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.626 -0.671 . . . . 0.0 111.671 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.71 -42.02 82.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.113 0.965 . . . . 0.0 111.209 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -51.56 67.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.762 1.625 . . . . 0.0 113.16 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.41 -45.67 93.37 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.199 -0.938 . . . . 0.0 112.307 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -56.75 -40.33 75.58 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.988 1.715 . . . . 0.0 111.075 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.511 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 26.0 t80 -63.2 -52.69 61.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.563 1.145 . . . . 0.0 112.035 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.6 -20.7 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 120.521 1.51 . . . . 0.0 114.216 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -71.86 -43.23 65.83 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.141 0.882 . . . . 0.0 109.387 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -62.37 -25.36 67.87 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 53.4 mt -71.94 -58.64 3.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.863 0.756 . . . . 0.0 110.563 169.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ptt85 -76.29 9.19 2.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -58.27 -19.93 38.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.888 2.075 . . . . 0.0 113.739 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.66 -38.92 7.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.875 2.179 . . . . 0.0 114.247 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -137.23 5.47 2.76 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 C--O 1.252 1.202 0 C-N-CA 125.758 1.623 . . . . 0.0 114.821 -174.781 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.8 165.2 25.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.242 1.017 . . . . 0.0 112.759 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.5 m -66.92 146.58 99.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.864 0.866 . . . . 0.0 112.848 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.59 -18.69 13.47 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.355 2.703 . . . . 0.0 113.688 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -158.45 167.32 29.99 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.361 1.464 . . . . 0.0 111.211 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -153.53 134.2 13.72 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.196 1.399 . . . . 0.0 109.52 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.26 108.65 41.64 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 124.166 0.986 . . . . 0.0 111.633 -169.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.69 156.63 62.91 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.391 2.727 . . . . 0.0 111.352 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -99.84 141.31 22.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 0.0 111.664 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.01 129.82 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.255 1.97 . . . . 0.0 110.045 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.09 8.15 75.96 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 118.233 -1.315 . . . . 0.0 114.43 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -117.25 157.61 25.75 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.596 1.698 . . . . 0.0 113.935 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.75 127.32 39.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.543 1.937 . . . . 0.0 113.496 -168.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.52 126.41 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.205 1.802 . . . . 0.0 109.577 -174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.4 122.26 34.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.53 125.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.885 1.274 . . . . 0.0 109.296 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.1 53.07 1.65 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.269 1.427 . . . . 0.0 111.677 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -25.61 66.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -169.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -159.26 26.8 0.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -161.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.87 6.4 72.42 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 124.263 0.935 . . . . 0.0 114.015 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.65 148.19 30.8 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.322 2.249 . . . . 0.0 109.385 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -82.86 107.41 15.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.569 0.747 . . . . 0.0 110.116 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -107.22 154.8 20.69 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.804 1.242 . . . . 0.0 111.206 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.14 168.11 22.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.168 2.187 . . . . 0.0 110.674 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' CD2' HD13 ' A' ' 120' ' ' LEU . 8.7 tp -142.71 121.17 12.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.089 1.756 . . . . 0.0 109.22 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.77 116.36 14.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.421 1.088 . . . . 0.0 110.918 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.0 pt -107.2 -16.06 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.62 39.02 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 126.228 1.87 . . . . 0.0 110.294 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.31 92.31 0.28 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.066 0.936 . . . . 0.0 112.067 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.82 87.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.111 1.815 . . . . 0.0 114.503 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -100.67 135.29 42.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.238 1.519 . . . . 0.0 111.76 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.54 150.84 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.161 0.984 . . . . 0.0 113.139 -173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 mt -105.93 141.78 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -156.62 152.79 27.62 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 111.617 -169.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -96.36 125.18 40.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.472 0.709 . . . . 0.0 110.266 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.51 136.1 33.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.248 1.019 . . . . 0.0 109.215 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.95 169.4 22.5 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 112.678 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -60.68 -28.7 86.99 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.837 3.025 . . . . 0.0 115.571 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.8 m -99.03 150.51 21.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.897 1.279 . . . . 0.0 113.031 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -62.37 136.68 58.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.787 0.835 . . . . 0.0 111.969 173.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.42 -47.04 98.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -81.73 -0.18 10.23 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.803 3.002 . . . . 0.0 113.159 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.74 -122.53 7.15 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -171.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.34 56.15 1.68 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.405 1.482 . . . . 0.0 112.936 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.55 105.05 2.04 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.1 m -56.32 -29.51 61.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.225 1.41 . . . . 0.0 114.651 -169.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -66.71 -20.53 65.99 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -113.71 -49.58 2.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.051 1.34 . . . . 0.0 113.365 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.4 m -151.78 160.49 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.898 1.279 . . . . 0.0 113.14 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -163.09 -37.0 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.156 1.383 . . . . 0.0 113.01 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.3 p -77.68 -32.97 53.44 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 p -150.94 133.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.694 1.998 . . . . 0.0 108.895 170.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.6 mt -101.41 -5.04 25.84 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.5 m -140.82 162.22 35.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.25 1.02 . . . . 0.0 113.526 -172.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -149.83 -66.16 0.21 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.427 1.091 . . . . 0.0 111.964 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 p -171.18 155.46 4.36 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.092 1.757 . . . . 0.0 110.368 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.75 159.36 33.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.838 -0.539 . . . . 0.0 111.173 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.57 134.06 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.629 0.772 . . . . 0.0 111.108 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.6 t -83.75 126.14 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.678 0.791 . . . . 0.0 109.213 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -134.36 172.06 13.42 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.787 1.635 . . . . 0.0 112.191 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -151.97 125.79 9.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.267 1.027 . . . . 0.0 112.18 -171.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -169.38 -161.47 0.3 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.861 2.064 . . . . 0.0 110.959 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 -85.34 146.43 27.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -51.0 -52.46 42.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.334 1.854 . . . . 0.0 111.374 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -56.99 -30.33 64.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.65 -45.16 17.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.381 0.992 . . . . 0.0 110.722 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.02 -34.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.122 0.569 . . . . 0.0 112.238 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -82.27 -45.49 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.144 0.978 . . . . 0.0 111.113 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.21 23.1 65.91 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 119.359 0.981 . . . . 0.0 114.867 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.3 2.26 70.99 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.206 1.384 . . . . 0.0 115.066 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -72.01 171.11 12.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 118.93 1.365 . . . . 0.0 112.852 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.85 152.17 31.44 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.428 0.691 . . . . 0.0 111.192 169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -158.81 169.65 23.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.438 1.095 . . . . 0.0 113.287 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -168.09 151.76 5.99 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.891 1.677 . . . . 0.0 110.899 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.5 t -85.86 137.76 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 169.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -161.24 108.3 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.377 1.871 . . . . 0.0 108.635 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -83.17 -32.92 26.36 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.421 -0.799 . . . . 0.0 112.95 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t 74.78 -51.47 0.68 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 129.122 2.969 . . . . 0.0 113.273 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -96.66 -33.13 11.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.91 -25.62 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.283 0.947 . . . . 0.0 112.463 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -75.19 -14.52 60.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.346 1.058 . . . . 0.0 112.963 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -96.08 -34.8 11.59 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.098 1.359 . . . . 0.0 112.327 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -172.55 165.82 5.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.118 1.767 . . . . 0.0 112.719 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 89.74 154.28 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 129.975 3.31 . . . . 0.0 115.446 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.96 -31.79 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.298 3.332 . . . . 0.0 113.434 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 ttp-105 70.76 111.99 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.611 2.764 . . . . 0.0 114.683 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -80.44 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.726 2.951 . . . . 0.0 110.329 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 t -54.43 -40.14 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.638 1.175 . . . . 0.0 112.451 -173.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -68.58 -42.92 77.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 111.286 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.4 t -73.23 -30.76 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.899 0.88 . . . . 0.0 110.217 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.1 -41.06 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.425 1.09 . . . . 0.0 111.761 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.44 -36.8 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 119.642 1.11 . . . . 0.0 110.882 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -66.69 -41.46 88.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.126 -0.984 . . . . 0.0 111.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.5 m -63.84 -41.97 97.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.506 1.123 . . . . 0.0 111.655 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.86 -49.55 77.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.765 0.826 . . . . 0.0 111.411 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -56.51 -43.62 79.96 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.746 . . . . 0.0 112.332 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.28 -31.23 70.04 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.2 mtp -73.9 -17.78 60.99 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.72 125.99 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 120.549 1.522 . . . . 0.0 110.623 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.09 66.92 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.625 1.583 . . . . 0.0 114.592 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.44 151.06 32.9 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 111.797 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -87.23 158.2 19.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.011 1.324 . . . . 0.0 110.367 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtp -143.8 148.4 35.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.577 1.551 . . . . 0.0 110.866 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -167.19 -152.7 0.13 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.927 1.291 . . . . 0.0 111.646 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 62.93 22.93 13.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.117 1.767 . . . . 0.0 114.609 169.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.3 p -166.8 156.76 11.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.142 1.377 . . . . 0.0 112.274 -171.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.88 146.22 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.612 1.165 . . . . 0.0 108.606 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 96.6 t -49.93 -39.36 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.776 1.23 . . . . 0.0 113.221 -170.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -56.58 -49.52 74.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.047 0.939 . . . . 0.0 112.192 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -74.85 -34.29 62.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.485 -0.759 . . . . 0.0 111.924 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -57.84 -43.84 86.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.635 1.107 . . . . 0.0 111.917 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.68 -38.45 54.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.7 -46.53 85.06 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.941 -1.099 . . . . 0.0 112.39 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -64.19 -35.32 80.43 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.784 -1.197 . . . . 0.0 110.639 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -58.78 -59.36 5.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.986 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 120' ' ' LEU . 13.0 m -64.99 -25.59 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.688 1.586 . . . . 0.0 113.662 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -69.66 -37.28 76.66 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.495 1.043 . . . . 0.0 110.805 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.59 -20.2 65.95 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.662 1.119 . . . . 0.0 112.952 170.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.441 HD13 ' CD2' ' A' ' 26' ' ' LEU . 59.1 mt -76.12 -65.16 0.95 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.385 0.993 . . . . 0.0 110.352 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.4 ptt85 -75.2 14.28 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -52.91 -23.67 7.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.156 2.183 . . . . 0.0 112.632 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.68 -45.05 7.04 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 128.091 2.758 . . . . 0.0 114.435 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -139.36 -5.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 124.555 1.142 . . . . 0.0 112.128 174.288 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 119.883 -0.103 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.88 -37.07 18.04 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -78.54 155.41 78.72 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.622 0.769 . . . . 0.0 113.041 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.57 158.53 31.77 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.817 3.011 . . . . 0.0 112.947 170.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -79.04 119.7 22.55 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.327 0.584 . . . . 0.0 112.297 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -135.04 105.5 6.38 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.689 1.196 . . . . 0.0 109.523 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -151.28 81.45 6.11 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.019 1.328 . . . . 0.0 109.433 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.45 123.69 6.66 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.875 2.383 . . . . 0.0 110.422 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.35 161.27 27.71 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 125.538 1.535 . . . . 0.0 111.049 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.75 135.98 51.28 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.621 2.214 . . . . 0.0 113.145 -169.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.2 -17.59 58.89 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.381 1.467 . . . . 0.0 114.815 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.38 149.72 22.87 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.441 1.121 . . . . 0.0 112.337 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -107.51 140.3 40.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.645 1.212 . . . . 0.0 111.548 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt -125.4 127.45 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.807 2.043 . . . . 0.0 107.936 -159.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -88.68 119.78 29.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -123.19 134.71 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.459 1.104 . . . . 0.0 109.653 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -78.09 66.48 3.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.328 1.051 . . . . 0.0 110.181 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -47.16 77.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.56 1.944 . . . . 0.0 113.788 -169.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.24 37.5 0.44 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -166.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.85 12.23 56.92 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.173 0.892 . . . . 0.0 113.832 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -166.39 134.98 2.93 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.835 2.054 . . . . 0.0 109.729 -171.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.06 128.05 34.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.778 1.631 . . . . 0.0 112.386 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.27 151.04 47.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.154 . . . . 0.0 112.063 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -85.7 147.29 26.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.11 138.46 37.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.41 1.484 . . . . 0.0 111.568 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.26 121.22 41.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.429 1.891 . . . . 0.0 109.111 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.8 111.62 8.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.227 1.011 . . . . 0.0 111.303 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 pt -104.16 -20.82 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.53 172.42 40.27 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.91 101.39 0.12 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.513 1.157 . . . . 0.0 112.253 -172.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.95 -2.0 76.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.691 1.615 . . . . 0.0 115.488 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -98.44 137.94 36.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.625 1.713 . . . . 0.0 112.826 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.94 153.59 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.799 1.239 . . . . 0.0 112.431 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.47 126.44 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -136.07 160.07 39.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.303 0.956 . . . . 0.0 111.345 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.3 tp -85.3 137.55 32.89 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.8 123.8 44.33 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.156 1.382 . . . . 0.0 107.626 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.85 167.41 27.3 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.168 2.579 . . . . 0.0 112.081 -172.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -63.65 149.03 91.87 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.237 2.625 . . . . 0.0 110.649 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.9 m -89.74 77.56 7.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.307 0.575 . . . . 0.0 111.048 -174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -77.84 60.74 2.34 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.804 1.242 . . . . 0.0 110.584 172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -58.81 -47.73 98.14 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.43 164.09 31.25 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.284 2.656 . . . . 0.0 111.827 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.1 48.02 3.26 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 125.019 1.295 . . . . 0.0 113.182 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.39 159.9 33.31 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.439 1.895 . . . . 0.0 114.397 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.31 -130.71 4.54 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 125.705 1.621 . . . . 0.0 111.474 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.4 m -74.46 -1.93 23.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.466 1.106 . . . . 0.0 113.313 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.9 p -74.52 173.77 9.9 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.321 2.248 . . . . 0.0 113.3 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.5 m -72.26 33.74 0.06 Allowed 'General case' 0 N--CA 1.481 1.104 0 O-C-N 120.059 -1.651 . . . . 0.0 113.959 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -164.9 142.52 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.928 2.091 . . . . 0.0 110.106 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -143.83 14.99 1.74 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.034 1.334 . . . . 0.0 113.592 -172.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.3 t -83.53 -172.95 4.44 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 p -168.17 139.4 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 127.901 2.48 . . . . 0.0 109.337 -173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.0 tt -86.79 -28.73 22.79 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.033 0.933 . . . . 0.0 112.327 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -152.65 125.09 8.21 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.653 0.781 . . . . 0.0 112.133 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -83.32 136.14 34.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.151 1.38 . . . . 0.0 112.109 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m 73.53 158.58 0.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.703 2.001 . . . . 0.0 113.447 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.55 164.7 14.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.203 1.001 . . . . 0.0 111.005 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.04 137.76 26.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.353 1.061 . . . . 0.0 111.492 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.89 127.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.57 1.148 . . . . 0.0 110.857 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -129.67 148.91 51.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.008 1.723 . . . . 0.0 112.855 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -95.05 138.86 32.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.847 1.259 . . . . 0.0 109.403 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -163.22 169.05 19.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.604 1.162 . . . . 0.0 110.8 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -90.42 141.63 28.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.245 1.018 . . . . 0.0 111.244 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 tp -53.29 -47.3 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.496 1.119 . . . . 0.0 111.494 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.78 -31.49 66.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.52 -43.59 26.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.151 0.887 . . . . 0.0 110.914 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 t -60.87 -38.36 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 122.574 0.35 . . . . 0.0 111.51 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.36 -47.01 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.34 18.19 62.77 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.48 1.036 . . . . 0.0 114.955 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.69 -2.62 82.69 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.593 1.568 . . . . 0.0 114.868 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.4 m -76.25 176.59 7.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.149 1.38 . . . . 0.0 113.065 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -71.3 150.02 45.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.355 1.062 . . . . 0.0 112.5 173.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -157.72 152.17 24.88 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.645 1.178 . . . . 0.0 113.247 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -136.02 157.86 45.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.395 1.878 . . . . 0.0 110.047 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.09 126.21 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.4 0.68 . . . . 0.0 109.977 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -167.3 113.05 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.892 1.277 . . . . 0.0 110.645 -174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -83.68 71.87 10.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.232 1.013 . . . . 0.0 108.592 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 p -33.31 -64.11 0.21 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.159 2.583 . . . . 0.0 115.823 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.0 mt -84.17 -27.1 28.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.44 -37.6 84.14 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.733 -0.604 . . . . 0.0 111.259 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.3 -28.54 66.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.015 1.326 . . . . 0.0 113.381 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -86.8 -29.16 22.49 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.77 -38.8 3.05 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 117.109 2.263 . . . . 0.0 117.109 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -155.22 159.48 31.71 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -134.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -98.3 1.51 1.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 1 C-N-CA 125.558 4.172 . . . . 0.0 114.197 169.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -12.61 125.28 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 130.401 3.48 . . . . 0.0 117.097 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.48 121.89 9.62 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.334 3.356 . . . . 0.0 112.902 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.3 -34.79 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.021 0.928 . . . . 0.0 112.473 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.84 -35.23 79.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.64 0.654 . . . . 0.0 111.707 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.37 -37.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.468 0.707 . . . . 0.0 110.211 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.46 -41.54 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.699 0.681 . . . . 0.0 110.933 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -64.26 -42.58 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.895 0.771 . . . . 0.0 111.313 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.2 m -62.88 -42.03 99.62 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.668 -0.645 . . . . 0.0 111.563 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -62.1 -45.42 93.59 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.504 1.122 . . . . 0.0 111.515 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.27 86.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.953 0.901 . . . . 0.0 112.145 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.2 -49.89 75.84 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.651 -0.656 . . . . 0.0 111.815 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -60.79 -30.91 70.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.2 mmm -73.75 -13.17 60.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 114.164 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.6 t -57.07 125.99 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.88 1.218 . . . . 0.0 110.704 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.95 75.44 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.173 1.368 . . . . 0.0 114.608 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -74.97 143.15 43.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.251 1.525 . . . . 0.0 110.45 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -112.38 151.69 29.5 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.259 1.824 . . . . 0.0 111.228 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.81 147.08 13.26 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -145.48 59.16 1.27 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.786 1.635 . . . . 0.0 109.34 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -65.8 -32.01 73.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.916 1.286 . . . . 0.0 113.618 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 t -165.58 -162.81 0.61 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.486 1.514 . . . . 0.0 110.29 -170.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.2 pt -60.1 150.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.09 0.956 . . . . 0.0 109.803 169.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.4 -36.28 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.9 m -63.37 -53.26 55.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.537 0.608 . . . . 0.0 111.363 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -70.49 -28.49 65.02 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 121.256 -0.902 . . . . 0.0 111.968 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -60.57 -33.5 72.8 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.392 1.451 . . . . 0.0 111.086 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.37 -40.93 25.63 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.624 1.169 . . . . 0.0 113.254 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.7 -41.0 98.18 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.289 -1.507 . . . . 0.0 112.073 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -65.35 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.776 -1.203 . . . . 0.0 110.701 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.84 -55.84 25.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.748 1.219 . . . . 0.0 111.749 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.01 -30.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 120.218 1.372 . . . . 0.0 112.79 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -69.13 -39.21 79.03 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.633 -1.175 . . . . 0.0 111.124 173.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.86 -28.66 66.31 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.217 1.372 . . . . 0.0 112.932 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.4 mt -67.32 -52.46 40.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.394 0.997 . . . . 0.0 111.246 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -92.68 16.05 13.08 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -62.69 -24.91 67.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.527 1.931 . . . . 0.0 114.45 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.15 -68.84 1.48 Allowed Glycine 0 N--CA 1.473 1.129 0 C-N-CA 125.661 1.6 . . . . 0.0 114.166 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -101.47 -12.13 18.78 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.254 1.312 0 C-N-CA 124.594 1.157 . . . . 0.0 113.017 -175.915 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 ttm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.75 173.01 12.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.107 0.963 . . . . 0.0 112.326 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -58.93 -44.7 99.24 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.58 139.65 23.07 Favored 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 122.007 1.752 . . . . 0.0 112.876 -171.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -145.59 175.34 10.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.37 2.268 . . . . 0.0 110.012 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -120.12 151.74 38.62 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.524 -1.36 . . . . 0.0 111.419 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 102.23 95.95 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 130.954 3.702 . . . . 0.0 108.765 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.17 127.67 27.26 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.043 3.162 . . . . 0.0 112.795 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -103.78 143.88 27.54 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.881 1.272 . . . . 0.0 110.236 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.68 122.73 10.17 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.989 1.793 . . . . 0.0 109.816 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.52 15.42 66.14 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.682 1.134 . . . . 0.0 114.827 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -122.12 165.22 16.44 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.996 1.398 . . . . 0.0 111.924 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.76 154.64 33.88 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -169.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -128.47 142.88 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.217 2.607 . . . . 0.0 109.081 -160.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.15 123.72 48.3 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.102 1.361 . . . . 0.0 107.335 168.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.24 125.91 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 110.485 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -79.69 65.45 4.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.502 1.121 . . . . 0.0 110.366 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -61.46 -33.69 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.0 32.12 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.788 1.235 . . . . 0.0 113.757 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.63 -18.51 52.44 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.654 1.597 . . . . 0.0 114.791 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -74.08 -31.16 62.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 73.77 99.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.279 2.632 . . . . 0.0 110.302 -172.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -102.52 148.7 25.2 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.647 1.179 . . . . 0.0 111.297 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -87.82 151.54 22.79 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 169.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.01 39.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.303 1.041 . . . . 0.0 112.466 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.5 OUTLIER -115.56 125.2 52.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.647 1.979 . . . . 0.0 108.776 177.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -80.29 100.35 8.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.064 0.946 . . . . 0.0 110.682 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 pt -89.01 -14.15 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.73 -171.26 37.35 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.03 97.0 0.16 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 111.675 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.92 25.15 58.58 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.15 1.833 . . . . 0.0 115.572 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.272 6.8 p90 -144.1 149.24 36.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.459 2.129 . . . . 0.0 115.503 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.06 157.15 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -168.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mm -107.44 139.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.491 2.317 . . . . 0.0 106.348 168.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -156.33 161.67 40.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.14 1.336 . . . . 0.0 112.418 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.64 123.6 48.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.033 0.933 . . . . 0.0 111.642 -171.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.6 113.11 61.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.154 1.382 . . . . 0.0 108.582 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.61 167.65 9.6 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.09 3.194 . . . . 0.0 115.734 -169.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -56.82 163.3 7.52 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.214 3.276 . . . . 0.0 113.657 171.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.3 p 62.19 19.25 10.79 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.408 2.283 . . . . 0.0 114.138 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 77.44 -50.4 0.53 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 128.836 2.854 . . . . 0.0 109.653 -170.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -167.7 126.28 1.0 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 127.791 2.437 . . . . 0.0 109.379 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.85 121.79 10.59 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.371 2.714 . . . . 0.0 112.399 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.48 24.3 75.23 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.139 0.876 . . . . 0.0 115.169 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.72 -29.67 69.5 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.568 1.184 . . . . 0.0 113.536 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.55 -40.3 0.93 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.581 2.039 . . . . 0.0 116.568 169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.0 t -70.28 130.63 42.53 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.288 1.044 . . . . 0.0 113.216 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.7 m -57.87 -20.48 36.93 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.211 1.404 . . . . 0.0 113.455 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.8 m -73.35 -8.92 57.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.002 1.321 . . . . 0.0 113.827 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.69 -43.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -85.78 -7.35 58.8 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.2 p -62.75 -17.22 60.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.907 1.683 . . . . 0.0 114.042 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.9 m -61.83 -21.95 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.135 0.974 . . . . 0.0 113.401 170.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 74.06 -51.19 0.69 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 128.946 2.899 . . . . 0.0 111.777 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 t -142.76 156.74 45.04 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.093 1.757 . . . . 0.0 110.546 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.06 157.41 2.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.356 1.863 . . . . 0.0 110.951 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -77.85 160.13 28.51 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 163.01 26.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.178 0.991 . . . . 0.0 110.206 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.81 138.56 42.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.086 0.954 . . . . 0.0 111.14 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.9 t -85.67 123.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.942 0.897 . . . . 0.0 108.707 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.83 171.6 10.56 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.796 1.638 . . . . 0.0 112.042 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -146.95 139.82 25.14 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.337 1.455 . . . . 0.0 111.841 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -176.68 -178.07 0.86 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.449 1.9 . . . . 0.0 111.866 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -72.66 148.29 44.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.11 -59.78 4.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.26 1.024 . . . . 0.0 110.617 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -65.78 -18.13 65.12 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.95 -34.28 64.24 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.431 1.014 . . . . 0.0 110.916 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.85 -54.76 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.867 0.867 . . . . 0.0 111.236 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.63 3.21 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.99 -21.0 43.95 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.51 24.34 4.16 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 125.337 1.446 . . . . 0.0 113.69 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 54.0 m -125.72 161.9 26.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.956 1.302 . . . . 0.0 114.298 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 97.4 m -96.99 149.55 21.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.917 1.287 . . . . 0.0 108.756 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -166.16 158.61 14.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -147.61 152.15 37.42 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.758 1.623 . . . . 0.0 110.792 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.54 129.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -162.79 133.52 4.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.063 0.545 . . . . 0.0 110.913 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -153.85 49.82 0.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.974 0.893 . . . . 0.0 112.635 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.8 m -56.56 -30.02 62.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 tp -71.84 -39.28 69.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.396 0.998 . . . . 0.0 112.069 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -41.6 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.186 0.994 . . . . 0.0 110.644 169.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.0 -11.82 50.66 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.16 0.984 . . . . 0.0 113.58 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.78 -22.64 60.81 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.205 0.911 . . . . 0.0 113.036 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.81 -43.23 0.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 119.619 3.192 . . . . 0.0 119.619 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -100.38 147.74 33.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 121.0 1.727 . . . . 0.0 114.031 -154.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.53 -27.99 3.06 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.769 2.979 . . . . 0.0 112.715 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ttp-105 74.12 115.03 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.613 2.765 . . . . 0.0 115.014 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.1 91.12 1.22 Allowed 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.121 3.214 . . . . 0.0 109.623 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 t -50.11 -46.72 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.476 1.511 . . . . 0.0 113.742 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -38.28 84.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.679 0.672 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.7 -35.31 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.788 0.835 . . . . 0.0 111.952 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.5 mm -63.7 -49.11 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 119.898 1.226 . . . . 0.0 110.727 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.59 -39.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.558 0.743 . . . . 0.0 110.692 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -68.07 -40.45 82.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.217 0.607 . . . . 0.0 111.107 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m -61.76 -44.77 96.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.099 0.959 . . . . 0.0 111.363 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.31 74.53 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.155 0.982 . . . . 0.0 111.578 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.91 -18.6 65.45 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.17 -44.44 16.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.649 1.113 . . . . 0.0 112.397 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.1 ptm -77.44 -17.43 58.1 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.6 p -42.23 125.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.632 0.773 . . . . 0.0 112.251 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.14 -4.16 86.42 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.988 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -72.02 160.53 32.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.407 2.103 . . . . 0.0 111.365 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.73 151.19 48.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.681 1.592 . . . . 0.0 112.213 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.6 mtm -144.41 143.74 31.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.371 1.068 . . . . 0.0 112.94 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -145.72 -151.23 0.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.659 1.184 . . . . 0.0 111.227 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.7 t80 71.22 -56.72 0.62 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.8 2.84 . . . . 0.0 114.134 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.4 m -72.77 162.75 29.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.789 1.236 . . . . 0.0 112.789 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 pt -63.6 150.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.634 0.773 . . . . 0.0 111.536 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.46 -29.56 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.7 p -67.94 -45.15 75.07 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.47 -0.769 . . . . 0.0 111.241 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.03 -30.05 67.24 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.42 -0.8 . . . . 0.0 112.213 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.99 -43.41 77.61 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.494 1.043 . . . . 0.0 110.949 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.0 m -66.39 -46.88 75.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.528 1.531 . . . . 0.0 113.22 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -64.74 -42.65 95.02 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.128 -0.982 . . . . 0.0 112.369 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -62.22 -34.12 75.88 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 111.292 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.524 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 29.1 t80 -59.53 -55.57 32.84 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.111 0.868 . . . . 0.0 111.274 170.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.56 -20.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -71.02 -42.66 69.26 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.742 1.155 . . . . 0.0 110.331 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -63.15 -24.81 68.06 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.633 1.106 . . . . 0.0 112.988 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 80.0 mt -73.56 -59.52 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.661 0.664 . . . . 0.0 111.785 169.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -76.51 8.34 3.61 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -56.53 -27.34 57.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.053 2.141 . . . . 0.0 112.83 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.75 -25.42 55.85 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 126.931 2.205 . . . . 0.0 115.142 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -149.51 14.73 0.87 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.254 1.32 0 CA-C-O 116.958 -1.496 . . . . 0.0 113.552 175.4 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.21 -165.05 0.24 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.594 1.958 . . . . 0.0 113.325 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -170.86 156.19 4.83 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 127.142 2.177 . . . . 0.0 110.936 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.51 158.79 50.44 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.408 2.739 . . . . 0.0 111.708 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -158.14 155.88 29.92 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.091 1.356 . . . . 0.0 111.081 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.64 155.3 12.5 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.732 1.613 . . . . 0.0 110.906 -173.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.75 91.04 41.51 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.281 1.032 . . . . 0.0 110.727 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.47 149.36 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.548 2.832 . . . . 0.0 111.364 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.29 159.82 16.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 126.528 1.931 . . . . 0.0 110.942 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.32 143.76 71.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.652 2.235 . . . . 0.0 112.818 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.38 61.96 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.495 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -114.61 157.12 23.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.203 1.502 . . . . 0.0 112.018 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.99 160.02 16.36 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 123.297 1.522 . . . . 0.0 111.044 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.2 mt -137.1 129.42 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 125.575 1.55 . . . . 0.0 107.247 -159.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.32 124.47 33.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.028 0.931 . . . . 0.0 108.516 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.16 137.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.999 2.12 . . . . 0.0 108.692 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.59 62.37 4.64 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -57.65 -45.35 85.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.003 1.721 . . . . 0.0 115.217 -169.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -145.92 29.07 1.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -156.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.84 87.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.541 1.067 . . . . 0.0 113.126 -169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.3 155.64 44.52 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 110.415 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.47 133.9 51.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.567 1.547 . . . . 0.0 111.752 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -150.85 145.9 25.98 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.259 1.424 . . . . 0.0 110.794 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -89.51 162.54 15.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.89 136.99 20.84 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.417 2.287 . . . . 0.0 109.933 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.72 117.0 33.36 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.254 1.822 . . . . 0.0 109.176 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -73.75 111.24 8.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.414 1.085 . . . . 0.0 111.753 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 pt -98.82 -20.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.83 -179.96 40.79 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.832 1.682 . . . . 0.0 110.5 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.11 95.01 0.08 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.363 1.082 . . . . 0.0 113.279 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.07 -2.08 85.08 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.664 2.078 . . . . 0.0 114.486 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -95.76 137.08 35.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.25 1.525 . . . . 0.0 112.105 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.18 152.79 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.752 1.221 . . . . 0.0 112.972 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.46 132.69 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -149.04 156.92 42.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.468 -0.77 . . . . 0.0 111.033 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.3 145.0 32.36 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.85 103.26 16.17 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 168.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.63 166.29 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.909 2.406 . . . . 0.0 113.002 -169.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.56 137.51 81.72 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.62 2.88 . . . . 0.0 111.896 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.5 m -167.31 170.18 11.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.436 2.294 . . . . 0.0 109.481 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -87.46 107.2 18.45 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.866 -1.146 . . . . 0.0 108.512 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -77.74 -47.42 2.34 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -169.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -85.29 170.58 9.34 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.579 2.853 . . . . 0.0 111.73 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.33 44.99 2.75 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.198 1.38 . . . . 0.0 113.299 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.14 154.76 22.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.41 1.484 . . . . 0.0 113.503 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.91 -18.81 52.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.364 1.459 . . . . 0.0 114.325 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.0 m -72.23 141.73 48.98 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.744 1.272 . . . . 0.0 111.195 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.9 p -62.17 -14.92 42.34 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 p -74.04 -13.48 60.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.741 1.616 . . . . 0.0 114.076 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.36 174.31 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.367 1.467 . . . . 0.0 112.507 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -155.4 -29.82 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.537 1.135 . . . . 0.0 113.607 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.4 m -64.2 154.93 33.4 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.592 1.157 . . . . 0.0 112.531 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 p -155.03 145.74 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.155 0.982 . . . . 0.0 111.546 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -127.95 137.99 52.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.834 1.653 . . . . 0.0 109.763 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -172.07 -170.51 0.75 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.075 1.35 . . . . 0.0 112.074 -174.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.5 m120 71.24 -38.91 0.43 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 128.916 2.886 . . . . 0.0 115.499 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.6 m -70.46 166.95 19.34 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.194 0.998 . . . . 0.0 113.199 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.56 162.33 40.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.608 1.563 . . . . 0.0 110.485 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -154.16 137.95 16.18 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.122 -0.986 . . . . 0.0 112.065 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.4 t -82.27 127.97 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.469 1.108 . . . . 0.0 109.928 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -138.34 155.28 48.71 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.123 1.369 . . . . 0.0 112.898 -170.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -98.37 138.81 35.06 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 110.071 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -163.52 172.18 14.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.211 1.404 . . . . 0.0 110.087 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -94.17 144.29 25.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.07 -1.019 . . . . 0.0 112.293 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.49 -46.34 73.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.224 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.89 -34.24 58.87 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.35 -38.7 23.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.799 0.84 . . . . 0.0 111.591 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.8 -36.48 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.54 0.736 . . . . 0.0 111.744 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.6 t -80.09 -50.36 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.715 1.206 . . . . 0.0 111.182 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.42 63.59 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 119.287 0.949 . . . . 0.0 115.132 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.27 -3.94 60.15 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.736 1.636 . . . . 0.0 115.228 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -70.01 171.05 10.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.117 1.459 . . . . 0.0 113.679 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.16 149.47 39.0 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.834 0.854 . . . . 0.0 111.168 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -158.03 160.2 37.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.107 0.963 . . . . 0.0 113.535 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -157.75 144.12 17.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.307 1.043 . . . . 0.0 111.706 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.48 130.72 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.409 -0.807 . . . . 0.0 109.055 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -169.44 118.51 0.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.33 1.452 . . . . 0.0 110.415 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -98.46 0.15 44.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.9 p 56.97 -49.74 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.175 1 C-N-CA 133.397 4.679 . . . . 0.0 118.039 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 mt -114.48 -23.79 9.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.764 1.625 . . . . 0.0 113.604 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -35.75 77.69 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.283 -0.886 . . . . 0.0 112.067 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -66.65 -16.73 64.42 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.676 1.19 . . . . 0.0 112.921 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -93.25 -30.45 15.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.507 1.123 . . . . 0.0 113.15 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -114.82 -43.59 3.12 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -169.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -153.89 162.19 27.38 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -139.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -88.81 -33.16 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 124.537 3.491 . . . . 0.0 113.761 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 66.7 132.85 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 128.902 2.881 . . . . 0.0 115.984 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.37 94.09 1.07 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.49 2.793 . . . . 0.0 110.461 172.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -57.67 -39.71 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.169 0.988 . . . . 0.0 112.564 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.75 -39.81 76.52 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.634 0.652 . . . . 0.0 111.542 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.9 -35.92 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.416 0.686 . . . . 0.0 109.95 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.283 24.8 mt -77.92 -33.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.304 -0.855 . . . . 0.0 112.045 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.0 mt -65.51 -40.28 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.177 1.353 . . . . 0.0 110.369 169.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -65.81 -38.92 90.23 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.842 -0.536 . . . . 0.0 110.877 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.1 m -63.64 -46.55 85.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.208 1.003 . . . . 0.0 111.743 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.46 91.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.488 0.715 . . . . 0.0 112.082 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -62.61 -48.59 78.73 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 111.911 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -60.52 -30.3 69.65 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.197 -0.94 . . . . 0.0 113.204 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.7 mtp -75.42 -4.91 42.24 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.92 1.288 . . . . 0.0 114.454 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -56.19 121.94 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.016 1.28 . . . . 0.0 109.311 171.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.41 -2.42 60.92 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.228 1.394 . . . . 0.0 115.086 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.66 127.13 31.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.654 1.727 . . . . 0.0 110.482 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -99.93 132.52 45.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.941 2.097 . . . . 0.0 111.681 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -117.3 174.6 6.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.66 1.984 . . . . 0.0 110.38 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -126.52 -160.04 0.96 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.315 1.046 . . . . 0.0 112.442 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -73.32 150.1 42.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 112.985 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.0 m 176.82 171.8 0.47 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.299 3.039 . . . . 0.0 108.645 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.46 123.62 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.43 -35.66 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.81 0.844 . . . . 0.0 112.494 -169.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -55.43 -56.36 21.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.457 0.703 . . . . 0.0 111.423 173.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.25 -34.88 78.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.211 -0.931 . . . . 0.0 111.853 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.4 -44.77 92.75 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.901 1.228 . . . . 0.0 111.374 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.0 p -77.37 -37.25 52.55 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.907 0.883 . . . . 0.0 113.034 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.43 -45.57 92.5 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.568 1.076 . . . . 0.0 112.206 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -62.87 -36.24 82.64 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.599 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.43 -55.26 33.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.722 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.02 -24.25 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 120.545 1.521 . . . . 0.0 113.316 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -70.21 -39.09 75.34 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.446 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.38 -23.39 66.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.483 1.038 . . . . 0.0 113.367 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.45 -60.21 2.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.723 1.147 . . . . 0.0 111.01 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -77.69 6.41 7.41 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -26.04 27.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.76 2.024 . . . . 0.0 112.077 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.3 -17.67 32.65 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 127.249 2.357 . . . . 0.0 115.183 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -134.15 -28.78 1.31 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.415 1.086 . . . . 0.0 112.922 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.416 0.15 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.95 159.73 32.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.232 1.013 . . . . 0.0 112.822 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.5 m -70.36 147.53 95.16 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 124.05 0.94 . . . . 0.0 112.528 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.54 -16.35 9.32 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.468 2.779 . . . . 0.0 113.802 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -67.94 150.28 48.71 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.203 1.001 . . . . 0.0 113.663 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -93.04 135.07 34.55 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.774 1.23 . . . . 0.0 110.619 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -160.89 129.25 2.93 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.528 1.131 . . . . 0.0 110.178 170.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.63 143.72 27.45 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.805 3.003 . . . . 0.0 110.752 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.09 132.5 23.69 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.043 0.937 . . . . 0.0 111.601 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.8 132.84 25.82 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.263 2.642 . . . . 0.0 111.316 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.401 ' HA3' HG13 ' A' ' 89' ' ' VAL . . . 81.52 -4.23 74.35 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.714 1.149 . . . . 0.0 114.947 -175.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -105.09 168.07 9.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 122.652 1.215 . . . . 0.0 113.234 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.0 113.13 25.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.814 1.646 . . . . 0.0 112.353 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.68 127.85 43.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 124.796 1.238 . . . . 0.0 108.574 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -90.91 116.72 28.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.9 mm -105.65 112.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.392 1.477 . . . . 0.0 109.142 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 73.94 8.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.783 0.72 . . . . 0.0 109.804 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.25 3.77 2.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.0 mt 102.57 126.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 131.577 3.951 . . . . 0.0 110.708 158.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.61 -3.82 39.85 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.202 0.905 . . . . 0.0 113.67 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -171.22 160.35 6.22 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.853 2.461 . . . . 0.0 110.836 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -127.41 127.32 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.994 1.318 . . . . 0.0 110.463 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -108.74 151.3 26.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.913 1.285 . . . . 0.0 111.721 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -90.18 145.07 25.31 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 122.181 -0.325 . . . . 0.0 111.057 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.55 34.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.266 1.026 . . . . 0.0 111.67 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.7 119.32 33.99 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.623 1.569 . . . . 0.0 108.42 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -72.58 96.02 1.91 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 118.558 0.617 . . . . 0.0 111.123 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 pt -84.78 -22.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.18 173.34 30.65 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 124.731 1.158 . . . . 0.0 110.344 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.55 90.76 0.56 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.688 0.756 . . . . 0.0 110.537 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.15 -0.12 47.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.895 2.188 . . . . 0.0 115.109 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.46 140.39 49.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.284 1.542 . . . . 0.0 112.544 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.58 151.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.5 mm -110.65 129.29 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 168.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.17 157.06 43.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.262 0.937 . . . . 0.0 112.773 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.75 120.9 38.96 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.782 0.833 . . . . 0.0 110.938 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.33 120.53 66.55 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.89 1.276 . . . . 0.0 108.167 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.91 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.714 2.942 . . . . 0.0 113.209 -169.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.44 163.59 12.43 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.477 3.452 . . . . 0.0 112.926 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 t -159.41 171.14 20.3 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 91.59 154.37 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 130.729 3.612 . . . . 0.0 112.676 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -74.21 120.33 80.82 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.22 1.008 . . . . 0.0 112.204 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.82 142.17 68.5 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.078 2.518 . . . . 0.0 110.748 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.62 -21.96 12.58 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.124 0.869 . . . . 0.0 113.896 -170.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 46.67 -132.21 1.18 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.623 1.969 . . . . 0.0 112.734 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.77 12.41 70.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.883 1.23 . . . . 0.0 115.21 174.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 83.4 p -104.95 173.95 6.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.384 1.474 . . . . 0.0 112.926 -175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 p -69.61 -22.63 63.48 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.843 -1.161 . . . . 0.0 112.322 169.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.1 p -83.29 -30.27 27.71 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.089 0.956 . . . . 0.0 113.418 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -162.8 133.27 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.676 1.19 . . . . 0.0 112.425 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -139.61 -18.06 0.97 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.074 1.35 . . . . 0.0 113.919 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 p -82.61 -31.37 28.92 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.98 149.9 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.686 1.594 . . . . 0.0 111.462 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -80.93 -33.36 34.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.555 0.742 . . . . 0.0 112.454 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 t -165.45 125.94 1.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.735 1.214 . . . . 0.0 110.583 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -84.68 147.0 27.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.237 1.015 . . . . 0.0 111.044 170.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -70.77 160.94 31.78 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.01 159.88 32.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.49 1.116 . . . . 0.0 109.607 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.44 136.37 29.41 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 111.312 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.69 121.32 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.461 1.105 . . . . 0.0 108.213 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -124.92 156.61 37.71 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.219 1.407 . . . . 0.0 112.418 -171.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -111.07 137.3 48.88 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.707 1.603 . . . . 0.0 110.846 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.39 171.37 10.63 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.037 0.935 . . . . 0.0 111.426 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -84.56 140.0 31.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.694 1.598 . . . . 0.0 110.246 172.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 tp -56.33 -48.38 76.86 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.354 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.32 -28.91 63.5 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.86 -41.33 19.11 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.735 0.814 . . . . 0.0 111.23 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.56 -37.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.979 0.512 . . . . 0.0 111.441 170.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.01 -50.11 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.142 0.977 . . . . 0.0 111.915 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.46 24.16 65.52 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 119.754 1.161 . . . . 0.0 114.788 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.17 1.25 64.97 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.346 1.45 . . . . 0.0 115.305 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.1 m -71.97 170.61 13.44 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.842 1.321 . . . . 0.0 113.269 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.19 149.11 32.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.231 1.012 . . . . 0.0 111.668 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -159.27 154.2 24.88 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -148.73 157.54 43.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.401 1.88 . . . . 0.0 110.662 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.8 t -88.49 139.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-N 119.123 0.874 . . . . 0.0 110.065 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -156.17 64.5 0.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.425 1.49 . . . . 0.0 111.213 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.79 65.67 5.03 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.704 -1.248 . . . . 0.0 110.139 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -48.39 -56.64 7.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.569 1.948 . . . . 0.0 114.477 -170.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.92 -32.05 72.23 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.71 -44.3 90.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.744 -0.597 . . . . 0.0 111.626 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -61.39 -31.62 71.53 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.617 0.767 . . . . 0.0 112.393 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -40.86 63.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.427 1.091 . . . . 0.0 113.557 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.9 -39.35 4.27 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -148.58 158.15 40.57 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.671 2.101 . . . . 0.0 116.671 -134.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.83 -22.32 0.89 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.195 3.263 . . . . 0.0 114.098 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 20.97 116.63 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 131.459 3.904 . . . . 0.0 118.614 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.64 116.42 3.93 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.683 2.922 . . . . 0.0 111.7 -171.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.401 HG13 ' HA3' ' A' ' 11' ' ' GLY . 2.1 t -65.69 -32.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.524 1.129 . . . . 0.0 112.923 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -63.39 -35.55 80.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.591 0.632 . . . . 0.0 111.607 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.19 -38.23 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.734 0.814 . . . . 0.0 110.047 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.7 mt -74.01 -35.38 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.655 -0.653 . . . . 0.0 112.273 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.42 -37.02 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.117 -0.989 . . . . 0.0 110.399 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 m -66.41 -43.52 85.5 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.579 -0.701 . . . . 0.0 111.709 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -53.35 -43.41 67.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.144 0.978 . . . . 0.0 112.222 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.29 79.45 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.569 -0.707 . . . . 0.0 111.969 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -66.63 -14.91 63.03 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.66 -39.4 14.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.322 1.049 . . . . 0.0 111.897 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.2 mtp -75.58 -18.33 59.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.02 126.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.813 1.188 . . . . 0.0 111.845 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.65 -7.43 81.86 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.395 1.474 . . . . 0.0 115.009 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -70.65 151.67 44.7 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.621 1.711 . . . . 0.0 110.675 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -132.18 149.94 52.27 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.612 1.565 . . . . 0.0 112.385 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 69.2 mtm -149.48 158.37 44.12 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.422 1.489 . . . . 0.0 111.332 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -140.17 16.46 2.43 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.176 -0.953 . . . . 0.0 112.869 171.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.97 143.38 26.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.849 -171.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 68.73 -171.82 0.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.046 1.738 . . . . 0.0 114.24 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.0 144.97 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.305 1.442 . . . . 0.0 108.869 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -34.69 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -170.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -67.16 -35.04 78.84 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.724 -0.61 . . . . 0.0 112.157 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -77.44 -32.37 54.52 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 121.409 -0.807 . . . . 0.0 111.736 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.06 -45.34 83.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 20.7 p -74.26 -37.52 63.71 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 121.704 -0.623 . . . . 0.0 112.679 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.77 -43.22 99.36 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.26 -0.9 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -56.67 -49.01 76.32 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 110.054 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -55.3 -52.11 64.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.246 1.018 . . . . 0.0 112.441 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.0 -32.72 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 120.167 1.349 . . . . 0.0 113.09 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 m -61.44 -47.34 86.18 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 116.428 -1.749 . . . . 0.0 108.774 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -56.98 -25.56 58.43 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 121.042 1.746 . . . . 0.0 114.208 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.15 -47.11 72.03 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.016 1.28 . . . . 0.0 111.88 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -92.54 -3.1 55.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -62.49 -24.37 67.44 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.534 1.934 . . . . 0.0 112.3 -169.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.28 -24.84 76.38 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.377 0.989 . . . . 0.0 113.855 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.44 -20.64 2.63 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.255 1.364 0 C-N-CA 124.924 1.29 . . . . 0.0 112.389 177.243 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.3 mtm . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 120.356 0.122 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.86 158.97 37.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.217 1.407 . . . . 0.0 111.998 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -72.2 151.79 92.39 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.021 0.929 . . . . 0.0 112.909 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.36 148.64 34.21 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.495 2.796 . . . . 0.0 111.059 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -146.64 159.48 43.4 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.142 1.377 . . . . 0.0 111.826 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -160.83 174.97 13.09 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.991 1.716 . . . . 0.0 110.431 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -154.13 134.85 8.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.261 1.024 . . . . 0.0 112.064 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -81.41 155.67 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.283 2.656 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -102.51 151.21 38.18 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.891 . . . . 0.0 111.986 -177.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.97 136.76 39.18 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.683 2.255 . . . . 0.0 111.326 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.05 69.71 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.859 1.695 . . . . 0.0 114.637 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -94.64 165.77 12.35 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.187 1.493 . . . . 0.0 114.668 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -88.42 116.04 26.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.624 1.57 . . . . 0.0 111.892 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.43 121.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 109.229 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -99.34 103.58 15.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.574 1.95 . . . . 0.0 108.06 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.01 119.28 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.515 1.126 . . . . 0.0 109.426 -171.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.33 62.04 5.07 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.881 -1.137 . . . . 0.0 110.777 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -30.53 70.92 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -169.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.98 34.16 0.25 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -161.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.69 68.92 Favored Glycine 0 N--CA 1.479 1.531 0 C-N-CA 124.193 0.902 . . . . 0.0 113.48 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -164.47 149.08 9.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.416 2.286 . . . . 0.0 110.134 -172.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -74.22 106.34 5.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.164 1.385 . . . . 0.0 111.372 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -86.94 126.88 34.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.004 1.721 . . . . 0.0 109.279 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -82.47 150.15 27.19 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.588 -0.695 . . . . 0.0 112.814 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.94 159.84 44.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.113 1.365 . . . . 0.0 111.469 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.82 121.8 35.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.149 1.78 . . . . 0.0 108.466 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.89 90.37 3.51 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.701 0.682 . . . . 0.0 112.154 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.31 -18.43 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.23 -176.6 29.47 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 124.518 1.056 . . . . 0.0 111.629 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.83 90.0 0.78 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.007 0.908 . . . . 0.0 111.034 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 -3.78 80.06 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.348 1.928 . . . . 0.0 114.269 -174.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.68 138.64 35.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.655 1.727 . . . . 0.0 112.28 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.68 152.99 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mm -110.79 139.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.36 1.864 . . . . 0.0 106.697 168.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -157.89 134.7 9.88 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.38 0.991 . . . . 0.0 112.467 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.77 113.27 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.454 -0.779 . . . . 0.0 110.251 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.22 120.76 80.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.267 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.35 161.07 43.55 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.665 2.91 . . . . 0.0 112.943 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.78 164.14 18.31 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.645 2.897 . . . . 0.0 111.844 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.0 m -154.04 -139.25 0.08 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.773 2.029 . . . . 0.0 110.6 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -166.24 172.71 10.87 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.382 -1.449 . . . . 0.0 112.121 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -143.33 141.42 19.21 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.842 1.657 . . . . 0.0 110.054 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.39 117.86 4.52 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.407 2.738 . . . . 0.0 113.092 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.46 7.72 88.27 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.803 1.192 . . . . 0.0 115.769 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.0 134.53 57.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.913 0.885 . . . . 0.0 111.767 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.93 12.52 43.19 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.596 1.093 . . . . 0.0 113.838 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.8 m -133.51 -40.99 0.87 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 p -162.07 -53.79 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -172.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -78.97 -32.37 45.33 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -170.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 p -168.98 147.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.398 1.879 . . . . 0.0 109.915 -171.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -125.76 -5.94 6.88 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.0 p -92.21 -0.82 57.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.197 1.399 . . . . 0.0 114.516 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.07 114.73 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.413 1.085 . . . . 0.0 110.407 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 tp -82.72 -22.31 34.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.913 1.285 . . . . 0.0 112.775 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -59.73 -15.0 16.72 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -73.27 -11.83 60.64 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.99 -1.069 . . . . 0.0 113.716 171.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 m -113.62 155.54 25.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.927 1.291 . . . . 0.0 111.029 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.19 158.35 15.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.291 1.036 . . . . 0.0 111.55 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.92 135.05 32.43 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 0.0 111.83 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -80.69 114.29 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.971 1.308 . . . . 0.0 108.323 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -121.2 173.06 7.55 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.267 1.827 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.8 35.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.422 1.489 . . . . 0.0 111.82 -174.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 174.01 -159.47 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.93 2.892 . . . . 0.0 108.421 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.14 150.97 19.92 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.17 0.986 . . . . 0.0 113.446 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -50.34 -51.46 45.43 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.136 1.775 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -55.04 -29.85 58.31 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.01 -42.77 15.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.816 0.846 . . . . 0.0 111.337 174.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.61 -33.47 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.913 -0.492 . . . . 0.0 111.965 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.0 t -86.77 -46.98 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.511 1.124 . . . . 0.0 111.495 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.99 -121.48 24.9 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -172.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.14 1.04 62.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.651 1.12 . . . . 0.0 114.892 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.7 m -73.13 162.43 29.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.899 1.35 . . . . 0.0 113.921 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.2 m -79.44 151.14 31.04 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.871 0.869 . . . . 0.0 110.989 169.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -156.46 167.99 28.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.962 0.905 . . . . 0.0 112.852 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -161.7 159.22 27.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.6 1.56 . . . . 0.0 109.933 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -82.75 132.5 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.723 1.147 . . . . 0.0 109.175 169.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -80.3 -70.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.492 0.717 . . . . 0.0 112.051 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 63.37 8.89 3.72 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.535 1.934 . . . . 0.0 114.332 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.6 m -69.28 -36.28 76.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 119.076 -2.265 . . . . 0.0 113.506 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.5 mt -68.9 -37.92 79.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.997 0.519 . . . . 0.0 111.718 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -64.79 -43.64 92.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.513 -0.742 . . . . 0.0 111.116 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.29 -26.15 62.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.075 1.35 . . . . 0.0 112.873 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.57 -29.99 46.55 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.132 0.973 . . . . 0.0 112.41 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -126.19 -46.52 1.65 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.51 152.51 45.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -143.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.31 -10.08 12.42 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 124.565 3.51 . . . . 0.0 114.393 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 74.32 106.79 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.595 2.358 . . . . 0.0 114.377 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.47 71.54 6.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.721 2.948 . . . . 0.0 109.03 169.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 t -46.24 -38.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 126.436 1.894 . . . . 0.0 114.687 -169.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.69 -38.17 90.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.802 0.841 . . . . 0.0 111.703 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -75.63 -30.99 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.2 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.08 -45.52 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.491 0.587 . . . . 0.0 110.78 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.41 -39.56 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.822 -0.549 . . . . 0.0 110.376 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 m -63.5 -43.5 97.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.97 0.508 . . . . 0.0 111.592 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 t -59.37 -45.47 91.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 111.658 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.42 90.75 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.218 -0.926 . . . . 0.0 112.082 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.94 -19.07 64.94 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -82.32 -37.11 26.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.687 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.0 mtp -70.98 -32.01 68.73 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.4 p -44.54 129.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.14 -8.85 79.02 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.45 1.5 . . . . 0.0 114.837 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -78.99 159.59 27.58 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.949 1.875 . . . . 0.0 112.317 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -104.5 156.91 17.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.572 1.549 . . . . 0.0 112.012 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.3 tpp -141.14 140.02 34.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.527 1.531 . . . . 0.0 110.292 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.37 -7.17 0.62 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -78.3 132.26 37.39 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.135 -0.978 . . . . 0.0 113.111 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 t 69.48 -175.9 0.2 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.3 1.84 . . . . 0.0 114.894 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.9 pt -75.14 157.64 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.822 1.649 . . . . 0.0 111.322 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.46 -38.46 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -169.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.5 m -59.11 -51.08 71.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.742 0.817 . . . . 0.0 111.679 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -75.48 -33.05 60.78 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.964 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.99 -46.08 75.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.067 1.303 . . . . 0.0 111.766 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.3 m -76.82 -38.4 53.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.055 0.942 . . . . 0.0 112.45 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.07 -45.16 93.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.249 -0.907 . . . . 0.0 112.412 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -58.36 -39.86 80.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.78 1.632 . . . . 0.0 110.565 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 10.9 t80 -61.68 -54.55 41.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.195 0.998 . . . . 0.0 112.154 171.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 m -67.67 -25.27 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.809 1.641 . . . . 0.0 113.742 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 m -72.4 -42.17 65.47 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 117.687 -1.149 . . . . 0.0 110.959 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.22 -18.11 59.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.261 1.391 . . . . 0.0 113.647 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 14.0 mt -64.41 -47.6 78.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.237 0.926 . . . . 0.0 110.12 168.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.3 mtm-85 -72.48 -92.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 70.36 -2.91 2.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 129.2 3.0 . . . . 0.0 113.028 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.3 -99.37 0.54 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 126.782 2.134 . . . . 0.0 114.226 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -82.65 9.46 9.5 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.174 1.39 . . . . 0.0 113.636 -171.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 127.088 2.155 . . . . 0.0 112.003 -179.18 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.03 162.34 29.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.966 0.907 . . . . 0.0 113.147 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 p -74.04 151.88 88.44 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.018 0.927 . . . . 0.0 112.765 175.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -77.94 160.56 30.43 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.73 2.953 . . . . 0.0 112.152 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -80.79 2.69 25.17 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.401 1.08 . . . . 0.0 113.741 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -152.63 131.04 12.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.563 1.945 . . . . 0.0 108.813 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -157.63 103.63 1.81 Allowed Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.722 0.809 . . . . 0.0 111.09 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.51 144.87 10.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.336 2.691 . . . . 0.0 109.701 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.39 159.5 23.66 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.841 1.257 . . . . 0.0 112.312 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.43 137.27 80.72 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.411 2.74 . . . . 0.0 114.924 -168.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.24 63.94 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 126.323 1.916 . . . . 0.0 115.182 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -96.63 154.76 17.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -169.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -94.23 112.67 24.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.73 1.612 . . . . 0.0 111.51 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.9 mt -101.29 127.22 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.034 1.334 . . . . 0.0 109.858 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.51 115.58 28.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.22 117.53 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.75 1.62 . . . . 0.0 108.068 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.63 -32.22 71.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.337 0.655 . . . . 0.0 112.681 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.03 -71.3 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 129.369 3.068 . . . . 0.0 115.251 174.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.74 26.23 0.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.34 1.456 . . . . 0.0 113.715 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.21 -59.5 0.38 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.657 1.599 . . . . 0.0 109.895 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.05 122.01 21.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.974 0.509 . . . . 0.0 109.919 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -94.21 150.37 20.37 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.793 0.837 . . . . 0.0 111.972 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -121.36 148.56 44.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.714 1.206 . . . . 0.0 111.794 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -89.8 149.53 22.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.213 0.605 . . . . 0.0 110.582 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.02 146.91 33.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.031 0.932 . . . . 0.0 112.927 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.54 117.86 35.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.175 1.79 . . . . 0.0 108.143 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -73.54 109.89 7.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.475 0.71 . . . . 0.0 110.286 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -100.75 -17.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.59 175.76 31.06 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 126.061 1.791 . . . . 0.0 109.595 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -69.68 86.31 0.48 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.013 0.906 . . . . 0.0 111.315 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.05 -13.49 37.49 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.188 2.327 . . . . 0.0 114.327 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.59 139.24 33.79 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.875 1.27 . . . . 0.0 112.735 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -135.35 151.91 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.88 1.272 . . . . 0.0 113.189 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.5 128.63 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -144.02 160.28 41.14 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.142 -0.974 . . . . 0.0 111.779 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.44 122.5 45.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.881 0.872 . . . . 0.0 111.141 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.63 117.47 68.18 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.528 1.531 . . . . 0.0 107.27 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.69 162.52 39.46 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.543 2.829 . . . . 0.0 114.409 -168.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 58' ' ' ALA . 86.7 Cg_endo -72.72 141.79 34.66 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.69 2.927 . . . . 0.0 109.716 170.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -168.16 -177.79 3.43 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.94 0.896 . . . . 0.0 112.69 -170.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -166.24 160.6 16.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.831 2.052 . . . . 0.0 112.409 -177.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -68.98 155.72 92.96 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.376 1.07 . . . . 0.0 112.062 170.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.14 -6.37 15.96 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.907 3.071 . . . . 0.0 115.151 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.52 -34.51 86.01 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 119.628 1.104 . . . . 0.0 112.962 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.05 -17.11 64.75 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.0 11.41 57.35 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.987 1.756 . . . . 0.0 113.828 171.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.7 m -129.12 179.42 5.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.604 1.561 . . . . 0.0 111.885 -175.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -58.26 -20.47 42.59 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.148 -1.595 . . . . 0.0 114.025 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.0 p -81.52 5.11 18.9 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.253 1.821 . . . . 0.0 114.113 173.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -41.08 133.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.266 1.826 . . . . 0.0 114.105 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 23.3 t80 93.56 -22.4 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 130.159 3.384 . . . . 0.0 112.652 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -64.47 -31.81 73.17 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 121.242 -0.911 . . . . 0.0 111.392 169.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -104.95 134.82 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.917 2.087 . . . . 0.0 107.496 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.9 mt -124.07 161.42 25.62 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.576 1.551 . . . . 0.0 110.432 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m -68.28 134.15 49.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -77.27 161.35 28.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.62 1.168 . . . . 0.0 111.199 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -82.33 160.17 22.92 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.4 -0.812 . . . . 0.0 112.595 171.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.427 ' HB2' ' HD3' ' A' ' 39' ' ' PRO . . . -75.36 156.11 35.81 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.298 1.039 . . . . 0.0 110.404 169.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -141.58 134.75 29.28 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.806 0.843 . . . . 0.0 111.379 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.82 126.84 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.09 0.956 . . . . 0.0 109.244 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -129.26 152.64 48.6 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.614 1.566 . . . . 0.0 112.151 -170.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -105.07 139.08 40.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.551 1.54 . . . . 0.0 110.37 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -167.01 172.96 9.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.622 1.169 . . . . 0.0 110.482 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.59 143.08 27.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 111.083 170.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 tp -55.05 -49.95 70.32 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.582 -0.699 . . . . 0.0 111.561 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -30.95 62.6 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -79.36 -40.34 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.819 0.736 . . . . 0.0 111.285 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.77 -37.92 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 122.099 -0.376 . . . . 0.0 111.187 171.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.47 -37.32 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.047 1.339 . . . . 0.0 112.767 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.78 20.75 74.55 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.86 0.743 . . . . 0.0 114.333 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.32 2.64 89.09 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.211 1.386 . . . . 0.0 114.785 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.27 -167.84 1.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.149 1.38 . . . . 0.0 113.004 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 79.7 m -84.35 150.99 25.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.16 1.384 . . . . 0.0 113.139 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -163.54 160.96 23.71 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.208 1.403 . . . . 0.0 113.222 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.1 153.5 11.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.061 1.744 . . . . 0.0 111.834 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.76 140.92 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.676 1.126 . . . . 0.0 110.617 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -146.93 87.32 1.68 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.318 1.447 . . . . 0.0 111.019 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.28 69.19 4.45 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.667 1.187 . . . . 0.0 108.792 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.8 p -60.26 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.621 1.968 . . . . 0.0 114.288 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 mt -60.43 -22.97 64.02 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.297 -0.877 . . . . 0.0 113.075 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.89 -37.09 60.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.98 1.712 . . . . 0.0 111.525 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -63.48 -20.54 65.68 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.842 1.257 . . . . 0.0 112.702 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -88.0 -25.35 23.18 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.084 1.354 . . . . 0.0 112.907 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.81 -29.71 1.68 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -169.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -120.34 122.91 28.49 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -132.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -70.77 -21.26 29.04 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.454 3.436 . . . . 0.0 115.744 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 69.16 83.13 0.17 Allowed Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 127.721 2.408 . . . . 0.0 114.888 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.38 95.97 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.8 3.0 . . . . 0.0 109.158 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.2 -41.38 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.665 0.786 . . . . 0.0 111.963 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.24 -35.86 78.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.587 0.63 . . . . 0.0 112.106 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -42.73 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.595 0.758 . . . . 0.0 110.084 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.6 mt -71.55 -34.23 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.812 -0.555 . . . . 0.0 112.101 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.87 -38.83 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.26 -0.9 . . . . 0.0 110.365 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -64.4 -42.32 96.17 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.571 -0.706 . . . . 0.0 111.303 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -56.97 -44.33 82.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.263 1.025 . . . . 0.0 111.832 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.93 87.81 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.337 -0.852 . . . . 0.0 112.184 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -67.53 -14.96 63.39 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.85 -36.71 15.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 111.864 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.3 mtp -70.75 -23.56 62.45 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.911 1.284 . . . . 0.0 113.767 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -46.66 123.61 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.489 1.04 . . . . 0.0 112.309 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.78 83.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.359 1.457 . . . . 0.0 115.193 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 160.57 30.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.747 1.773 . . . . 0.0 111.327 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -131.32 157.22 43.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.162 1.385 . . . . 0.0 112.973 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.6 mtm -143.76 159.28 42.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.531 1.532 . . . . 0.0 111.298 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -143.65 -1.53 1.0 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -86.43 152.49 22.64 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.642 1.177 . . . . 0.0 113.459 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 m 75.61 168.71 0.27 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.531 2.332 . . . . 0.0 114.107 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.68 147.49 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 109.062 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -49.98 -36.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 p -64.1 -49.39 72.42 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.391 -0.818 . . . . 0.0 111.366 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.36 -30.05 65.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.575 -0.703 . . . . 0.0 112.1 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.81 -41.05 85.86 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.092 1.314 . . . . 0.0 111.5 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.63 -43.36 76.48 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.272 1.029 . . . . 0.0 112.561 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.25 -44.13 92.75 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.269 -0.894 . . . . 0.0 112.319 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -37.78 81.35 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.53 -1.356 . . . . 0.0 111.355 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.521 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 9.5 t80 -58.29 -56.81 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.68 0.792 . . . . 0.0 111.256 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.4 m -68.48 -23.57 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.618 1.099 . . . . 0.0 113.806 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 m -70.7 -41.66 71.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.621 1.101 . . . . 0.0 110.337 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.61 -27.94 69.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.57 1.077 . . . . 0.0 112.853 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.521 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 73.8 mt -69.56 -57.23 5.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.822 0.737 . . . . 0.0 111.559 170.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -80.29 9.57 5.59 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -57.7 -25.25 60.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.381 1.873 . . . . 0.0 112.617 -172.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -46.12 -43.9 13.84 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 127.811 2.624 . . . . 0.0 115.178 -173.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -137.54 22.15 2.93 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.715 1.206 . . . . 0.0 113.57 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.115 1.366 . . . . 0.0 111.381 -177.779 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.56 165.31 25.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.373 1.069 . . . . 0.0 112.813 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.3 p -162.57 156.3 17.69 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 125.451 1.5 . . . . 0.0 111.634 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.44 154.38 45.35 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.485 2.79 . . . . 0.0 111.837 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -81.98 -3.09 53.6 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -125.01 139.31 53.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.572 1.549 . . . . 0.0 110.686 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -150.59 132.11 7.65 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.919 1.288 . . . . 0.0 109.681 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.92 145.98 28.98 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.703 2.269 . . . . 0.0 110.261 172.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.04 149.72 38.44 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.141 0.976 . . . . 0.0 110.938 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.98 130.62 26.35 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.627 2.218 . . . . 0.0 111.3 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.59 61.37 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.361 1.934 . . . . 0.0 114.921 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -91.1 161.96 14.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.539 1.669 . . . . 0.0 114.355 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.67 110.2 22.81 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.722 1.609 . . . . 0.0 112.228 -169.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -90.49 123.03 42.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.385 1.074 . . . . 0.0 109.154 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -94.29 117.43 30.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.71 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.587 1.155 . . . . 0.0 108.762 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.27 -30.34 71.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.408 1.083 . . . . 0.0 112.907 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.259 26.1 tpt180 54.36 -111.87 0.66 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.825 2.05 . . . . 0.0 111.358 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.0 mt -133.74 42.78 2.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.119 0.968 . . . . 0.0 111.263 -161.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.94 6.52 37.15 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.872 1.225 . . . . 0.0 114.98 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -156.41 119.31 4.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.969 1.308 . . . . 0.0 111.045 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.5 142.91 48.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.792 1.237 . . . . 0.0 112.261 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.51 165.54 36.12 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.028 0.931 . . . . 0.0 112.881 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -92.45 152.53 19.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.2 150.1 43.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.979 1.711 . . . . 0.0 111.151 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.99 118.56 36.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.53 1.932 . . . . 0.0 107.586 174.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -73.7 102.91 4.09 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.658 0.663 . . . . 0.0 110.338 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.21 -17.43 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.8 -174.27 43.11 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -64.3 95.58 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.778 0.799 . . . . 0.0 111.603 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.43 6.07 64.69 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.639 2.066 . . . . 0.0 116.207 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -120.19 141.7 49.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.9 1.85 . . . . 0.0 113.3 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.87 151.36 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.901 1.281 . . . . 0.0 112.604 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 mm -111.42 134.09 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.57 152.85 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.573 1.078 . . . . 0.0 112.129 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.44 113.28 24.61 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.95 116.09 50.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.175 -0.917 . . . . 0.0 108.694 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.72 158.86 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.183 2.589 . . . . 0.0 111.931 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.12 52.62 4.14 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.402 3.401 . . . . 0.0 111.107 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.4 p -88.28 137.72 32.07 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.832 1.653 . . . . 0.0 112.633 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.77 -65.91 0.77 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -58.51 -38.38 64.89 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -170.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -60.63 -28.93 87.43 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.1 3.2 . . . . 0.0 114.683 173.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.42 -41.07 5.87 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.508 0.575 . . . . 0.0 112.411 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.82 -132.02 0.18 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.148 1.779 . . . . 0.0 111.885 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.31 -156.03 10.84 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.296 -0.878 . . . . 0.0 114.363 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.4 p -83.43 -30.46 27.27 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.8 m -76.25 -21.02 56.84 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.262 -0.899 . . . . 0.0 113.342 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 t -169.08 148.0 3.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.902 2.081 . . . . 0.0 109.747 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.75 -1.07 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -77.19 -22.89 51.71 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -169.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.4 m -76.67 53.94 0.93 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.034 1.334 . . . . 0.0 112.972 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 p -43.18 145.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.996 2.518 . . . . 0.0 113.805 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.2 tp -58.32 -33.5 69.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.245 1.018 . . . . 0.0 113.156 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.7 p -165.91 161.36 17.58 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.981 1.712 . . . . 0.0 111.464 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -70.08 -41.96 73.41 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.382 -0.824 . . . . 0.0 112.883 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m -128.95 170.85 12.94 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.723 1.609 . . . . 0.0 110.245 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.53 144.78 37.37 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.097 -1.002 . . . . 0.0 110.751 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.43 133.71 38.88 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.964 0.906 . . . . 0.0 110.887 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.13 125.23 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.856 0.862 . . . . 0.0 109.803 172.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -135.31 157.14 47.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.371 1.468 . . . . 0.0 112.316 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -109.71 133.43 53.14 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.795 1.638 . . . . 0.0 110.885 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -151.99 171.85 17.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.423 1.489 . . . . 0.0 111.526 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -85.89 148.77 25.64 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.269 0.628 . . . . 0.0 111.652 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.8 tp -52.45 -62.15 1.82 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.875 1.27 . . . . 0.0 111.582 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -66.12 -20.1 66.05 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.71 -36.82 70.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.515 1.052 . . . . 0.0 111.26 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.76 -44.53 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.131 0.972 . . . . 0.0 112.125 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.67 -1.66 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.69 109.89 3.13 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.466 1.03 . . . . 0.0 112.681 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 6.78 89.22 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.998 1.285 . . . . 0.0 114.337 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -112.72 152.76 28.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 112.485 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.9 m -83.47 149.92 26.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.819 0.848 . . . . 0.0 110.227 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -160.47 159.9 31.41 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -146.05 163.08 36.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.298 2.239 . . . . 0.0 109.852 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.15 143.1 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.509 170.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.38 144.36 46.55 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.622 1.169 . . . . 0.0 113.146 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -137.52 22.62 2.93 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.757 1.623 . . . . 0.0 112.362 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.3 t -62.44 -47.78 82.56 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.219 -1.551 . . . . 0.0 113.819 -169.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -73.46 -33.93 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.596 0.358 . . . . 0.0 111.868 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.86 -36.95 77.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.806 0.842 . . . . 0.0 112.134 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -65.08 -17.97 64.91 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.381 1.072 . . . . 0.0 112.854 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -80.01 -22.64 42.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.364 -0.835 . . . . 0.0 112.53 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -117.4 -57.22 2.16 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.51 149.62 63.36 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -140.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.86 -14.98 21.36 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 124.771 3.647 . . . . 0.0 113.632 172.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 77.56 90.76 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 127.158 2.183 . . . . 0.0 112.788 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.37 81.31 2.51 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.576 2.85 . . . . 0.0 108.889 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.76 -36.27 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.162 0.985 . . . . 0.0 112.538 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.35 -36.37 76.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.72 0.691 . . . . 0.0 112.392 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.29 -40.09 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.414 0.686 . . . . 0.0 109.874 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.08 -38.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.804 . . . . 0.0 111.654 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.23 -38.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.206 -0.934 . . . . 0.0 111.049 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -64.27 -44.84 90.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.6 -0.687 . . . . 0.0 111.271 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -57.62 -44.56 85.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.339 1.055 . . . . 0.0 112.483 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.47 95.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.006 0.821 . . . . 0.0 112.49 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.54 -44.72 89.93 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.119 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.888 -1.133 . . . . 0.0 113.426 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.96 -9.49 58.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.3 t -55.47 127.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.933 1.242 . . . . 0.0 110.591 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.33 -0.59 78.28 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.177 1.37 . . . . 0.0 114.5 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -71.01 132.87 45.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.061 1.43 . . . . 0.0 110.429 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.81 138.54 48.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.753 1.621 . . . . 0.0 111.118 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.7 mtm -143.59 153.07 42.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.919 1.288 . . . . 0.0 112.127 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -149.86 -7.91 0.31 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -63.9 153.7 36.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 114.12 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t 62.91 -164.55 0.25 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 114.449 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -80.33 145.23 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.203 1.401 . . . . 0.0 108.443 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.36 -31.47 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 119.149 0.886 . . . . 0.0 112.629 -171.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 p -60.17 -53.54 56.56 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.343 1.057 . . . . 0.0 111.659 172.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.665 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -56.26 -42.42 77.39 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.23 1.377 . . . . 0.0 111.079 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.22 -44.21 54.06 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.21 1.404 . . . . 0.0 112.981 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.26 -43.65 98.34 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.799 -1.188 . . . . 0.0 112.374 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -63.73 -42.88 97.81 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.692 -1.255 . . . . 0.0 110.014 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.46 -53.66 48.26 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.419 1.487 . . . . 0.0 112.589 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 m -66.08 -25.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.404 1.456 . . . . 0.0 112.917 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -65.91 -46.13 79.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 117.315 -1.326 . . . . 0.0 109.793 170.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -32.31 63.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.766 1.167 . . . . 0.0 113.459 171.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.39 -58.21 3.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.352 0.978 . . . . 0.0 111.346 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -75.27 3.99 7.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.71 -24.11 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.854 2.062 . . . . 0.0 113.338 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.24 -32.4 1.68 Allowed Glycine 0 N--CA 1.474 1.23 0 C-N-CA 128.473 2.94 . . . . 0.0 117.816 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -140.07 16.75 2.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 118.692 1.246 . . . . 0.0 112.866 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.105 1.762 . . . . 0.0 112.674 -177.155 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.316 0.103 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.37 162.67 28.64 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.353 1.061 . . . . 0.0 112.783 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -67.25 145.76 98.7 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.955 0.902 . . . . 0.0 112.668 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.82 147.59 56.4 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.463 2.775 . . . . 0.0 111.513 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -140.54 153.21 46.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.764 1.626 . . . . 0.0 110.771 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -99.05 151.86 20.48 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.613 0.765 . . . . 0.0 112.238 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -150.7 111.37 3.15 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.818 1.647 . . . . 0.0 107.877 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.17 147.97 93.6 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.666 2.244 . . . . 0.0 111.185 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -103.29 156.09 35.88 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.479 1.112 . . . . 0.0 111.57 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.59 129.89 22.25 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.529 2.152 . . . . 0.0 111.945 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.68 -2.62 82.32 Favored Glycine 0 N--CA 1.467 0.739 0 C-N-CA 125.272 1.415 . . . . 0.0 114.769 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -83.96 146.96 27.73 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.853 1.326 . . . . 0.0 110.913 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.0 139.47 40.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.546 1.165 . . . . 0.0 111.55 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.34 131.81 65.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.975 2.11 . . . . 0.0 108.198 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -92.36 115.39 28.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.87 129.03 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.531 1.932 . . . . 0.0 108.322 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.47 -33.21 71.01 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.833 0.742 . . . . 0.0 112.48 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 57.35 -119.46 1.22 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.752 2.021 . . . . 0.0 111.259 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -132.27 58.39 1.75 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.044 0.926 . . . . 0.0 110.352 -160.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.76 -1.89 75.77 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.271 1.415 . . . . 0.0 114.626 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -156.41 127.29 6.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.082 1.353 . . . . 0.0 111.552 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.25 155.25 36.94 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.83 1.252 . . . . 0.0 113.87 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -153.65 172.27 17.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.473 1.109 . . . . 0.0 112.232 170.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -93.85 161.1 14.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.72 162.83 39.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.015 2.126 . . . . 0.0 110.926 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.07 125.11 38.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.109 1.764 . . . . 0.0 108.536 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.94 93.33 5.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.236 1.014 . . . . 0.0 111.423 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 pt -81.75 -20.93 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 176.43 32.27 Favored Glycine 0 N--CA 1.465 0.579 0 C-N-CA 125.05 1.309 . . . . 0.0 110.798 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.84 88.38 0.38 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.615 0.721 . . . . 0.0 111.095 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.11 58.62 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 127.011 2.243 . . . . 0.0 114.774 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -104.74 140.47 38.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.825 1.312 . . . . 0.0 112.523 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.8 155.42 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.39 1.076 . . . . 0.0 112.954 -170.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -112.4 139.81 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -148.15 155.02 40.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.584 1.084 . . . . 0.0 111.574 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.7 115.38 27.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.3 122.87 87.57 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.53 158.06 59.27 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.776 2.984 . . . . 0.0 114.561 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.18 169.98 19.41 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 124.344 3.363 . . . . 0.0 111.54 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -132.91 130.32 39.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.472 1.109 . . . . 0.0 110.849 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 58.09 36.17 25.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.51 1.524 . . . . 0.0 112.092 -170.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -54.28 157.9 4.32 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.163 1.785 . . . . 0.0 113.653 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.8 120.1 6.6 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.738 2.959 . . . . 0.0 111.714 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.49 29.27 6.02 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.92 1.248 . . . . 0.0 113.28 -169.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.88 -171.96 0.6 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.898 1.279 . . . . 0.0 113.127 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.48 50.67 2.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.951 1.738 . . . . 0.0 114.877 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.3 t -167.0 -154.88 0.17 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.086 2.155 . . . . 0.0 110.159 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.5 p -73.02 -13.1 61.16 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.36 -1.463 . . . . 0.0 114.462 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 m -176.96 -47.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 127.695 2.398 . . . . 0.0 112.042 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.78 148.39 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.598 1.159 . . . . 0.0 110.78 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -144.04 153.18 41.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.724 1.21 . . . . 0.0 111.919 -173.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 p 67.56 -42.66 0.45 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 129.499 3.12 . . . . 0.0 115.067 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -165.84 153.56 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 128.526 2.73 . . . . 0.0 108.708 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.07 147.73 23.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.524 0.73 . . . . 0.0 111.904 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.1 m -59.75 128.86 39.05 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.988 0.915 . . . . 0.0 113.468 -170.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -89.4 149.0 23.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.787 1.235 . . . . 0.0 111.128 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m -78.94 152.52 31.03 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 158.65 16.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.3 1.84 . . . . 0.0 109.596 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -143.06 134.56 26.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 0.0 111.618 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.97 126.77 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.397 0.679 . . . . 0.0 109.182 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -131.98 149.75 52.34 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.619 1.568 . . . . 0.0 112.446 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -103.72 133.76 48.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.445 1.498 . . . . 0.0 110.485 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -154.74 177.69 10.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.743 1.617 . . . . 0.0 111.073 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -90.48 154.17 19.84 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 168.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 tp -53.15 -47.34 68.82 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.48 -31.17 67.6 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.04 -35.8 59.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.451 1.023 . . . . 0.0 111.104 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.09 -38.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.525 1.13 . . . . 0.0 111.9 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -80.38 -39.34 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.387 0.675 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.61 15.92 64.79 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.048 0.84 . . . . 0.0 115.016 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.53 85.72 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.389 1.471 . . . . 0.0 114.684 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.8 m -81.54 -176.41 6.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.082 1.353 . . . . 0.0 112.745 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 83.6 m -73.21 157.42 37.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.199 1.0 . . . . 0.0 112.875 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -167.14 168.06 13.88 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.525 1.93 . . . . 0.0 110.853 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.09 151.54 12.17 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 0.0 112.756 169.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.5 t -70.91 133.88 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -153.9 73.86 0.96 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.937 0.895 . . . . 0.0 110.907 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.25 58.74 0.73 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.627 1.571 . . . . 0.0 111.483 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 p -43.41 -69.35 0.14 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.516 2.327 . . . . 0.0 114.724 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -67.37 -29.2 68.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.589 0.756 . . . . 0.0 112.74 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.4 -35.59 80.71 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.185 -0.947 . . . . 0.0 111.21 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -73.98 -12.58 60.68 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.218 1.007 . . . . 0.0 112.83 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -86.18 -38.35 17.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.156 0.889 . . . . 0.0 112.078 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -71.67 0.73 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -143.7 157.37 58.67 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -145.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.6 144.24 11.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.891 3.061 . . . . 0.0 108.073 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -124.3 153.5 68.77 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -169.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.03 84.21 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.141 3.228 . . . . 0.0 109.96 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.11 -30.97 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.695 1.198 . . . . 0.0 114.019 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.41 -36.69 83.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.226 0.921 . . . . 0.0 112.643 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.74 -33.86 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.067 0.947 . . . . 0.0 110.519 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -63.98 -46.56 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.64 -0.663 . . . . 0.0 110.215 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.15 -39.38 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.814 0.846 . . . . 0.0 110.873 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.3 m -64.77 -40.93 96.08 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.615 -0.678 . . . . 0.0 111.813 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 t -58.3 -46.82 85.41 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.539 -0.725 . . . . 0.0 111.028 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.14 89.24 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.43 -0.794 . . . . 0.0 112.249 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.13 -28.12 69.85 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.49 -34.11 41.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 172.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.4 mtp -78.99 -20.28 49.49 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.96 124.57 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.603 1.547 . . . . 0.0 110.933 170.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.76 -6.92 59.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.611 1.576 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -75.43 143.66 42.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 1.515 . . . . 0.0 110.507 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.82 155.08 36.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.883 1.673 . . . . 0.0 111.833 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.1 mtm -141.62 164.14 31.01 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.113 1.365 . . . . 0.0 111.587 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -139.4 -36.13 0.53 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -76.4 154.03 35.22 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -170.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 77.57 177.68 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.259 2.224 . . . . 0.0 113.788 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -80.53 149.27 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.747 1.219 . . . . 0.0 111.276 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -52.65 -37.38 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 p -63.21 -55.34 25.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.451 0.7 . . . . 0.0 111.164 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.6 -36.37 83.54 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.58 -0.7 . . . . 0.0 111.935 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.44 -41.22 80.03 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.517 1.053 . . . . 0.0 111.686 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.6 t -77.26 -42.19 38.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.264 1.026 . . . . 0.0 112.513 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.77 -44.14 97.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.325 1.05 . . . . 0.0 112.13 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -60.42 -46.11 91.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.788 1.235 . . . . 0.0 110.125 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -52.76 -54.84 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.209 . . . . 0.0 112.213 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.95 -29.72 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.343 1.429 . . . . 0.0 112.8 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.3 m -65.41 -38.37 89.74 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.967 1.258 . . . . 0.0 110.504 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -26.89 68.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 120.415 1.461 . . . . 0.0 113.217 169.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.9 mt -74.6 -57.6 3.82 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.275 -0.891 . . . . 0.0 111.516 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -77.08 12.11 1.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -58.04 -24.41 58.28 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.314 1.846 . . . . 0.0 112.519 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.69 -22.29 39.43 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.026 2.251 . . . . 0.0 115.31 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -146.82 -11.03 0.45 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.601 1.161 . . . . 0.0 112.82 179.716 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.362 0.125 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.21 162.92 27.55 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.372 1.069 . . . . 0.0 112.9 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 m -69.66 155.48 93.42 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.861 0.864 . . . . 0.0 112.918 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.5 152.61 66.74 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.554 2.836 . . . . 0.0 112.39 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 141.6 53.19 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -90.73 72.16 6.69 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.963 -1.086 . . . . 0.0 109.256 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -133.73 112.13 12.57 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.707 1.203 . . . . 0.0 108.767 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.88 144.89 12.4 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.332 2.688 . . . . 0.0 111.05 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.65 150.05 4.59 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.582 1.953 . . . . 0.0 111.053 -176.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.28 137.34 39.88 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.915 3.076 . . . . 0.0 113.553 -169.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.08 -11.41 65.15 Favored Glycine 0 N--CA 1.469 0.879 0 C-N-CA 126.028 1.775 . . . . 0.0 114.633 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.59 160.16 15.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 118.403 1.101 . . . . 0.0 113.003 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.22 113.87 27.32 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.916 1.686 . . . . 0.0 111.785 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.91 127.55 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 124.8 1.24 . . . . 0.0 109.482 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -96.01 121.12 37.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.407 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.93 130.65 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.973 1.309 . . . . 0.0 109.157 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -77.16 64.79 2.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.563 1.145 . . . . 0.0 110.442 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -54.14 -44.89 71.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.611 1.564 . . . . 0.0 114.803 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -153.29 26.93 0.52 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -160.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.9 -2.49 66.5 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.99 0.805 . . . . 0.0 113.064 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -140.78 159.86 41.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.148 2.179 . . . . 0.0 110.44 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -91.86 120.33 32.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.679 1.192 . . . . 0.0 111.464 -172.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -112.75 151.84 29.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.531 1.532 . . . . 0.0 111.09 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -86.97 153.69 21.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.42 36.22 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.354 1.462 . . . . 0.0 111.383 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.42 123.85 50.64 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.168 1.787 . . . . 0.0 108.175 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -74.32 103.11 4.59 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.5 0.591 . . . . 0.0 111.221 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -94.88 -21.69 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.78 171.94 33.77 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.31 96.08 0.22 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.164 0.982 . . . . 0.0 111.689 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.93 3.76 82.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.91 1.719 . . . . 0.0 115.244 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -110.73 139.01 46.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.502 1.651 . . . . 0.0 112.367 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.97 152.47 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 113.713 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.5 mm -107.95 134.64 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 107.109 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -151.52 159.49 44.12 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.496 1.044 . . . . 0.0 111.894 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.43 122.83 43.81 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.393 0.677 . . . . 0.0 111.304 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.49 146.39 50.21 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.861 1.664 . . . . 0.0 110.414 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.53 158.07 51.63 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.592 2.861 . . . . 0.0 113.956 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.2 -25.29 7.3 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.665 2.91 . . . . 0.0 112.29 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.0 p -75.08 151.87 38.63 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.139 0.976 . . . . 0.0 113.153 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -86.63 87.13 7.38 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.416 1.087 . . . . 0.0 109.993 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -54.89 -33.08 14.51 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.09 -23.8 54.74 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.074 3.183 . . . . 0.0 114.619 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.36 134.28 3.2 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.764 1.173 . . . . 0.0 114.553 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.12 138.28 57.92 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.08 0.952 . . . . 0.0 111.382 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.13 -51.71 3.59 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.333 1.444 . . . . 0.0 112.534 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.3 t -62.12 -39.22 91.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.445 1.098 . . . . 0.0 112.06 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.0 p -91.28 20.39 5.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.834 1.254 . . . . 0.0 113.196 173.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 m 71.4 -37.76 0.4 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 128.554 2.742 . . . . 0.0 114.053 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.26 137.84 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.484 1.114 . . . . 0.0 110.522 169.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -131.47 -5.86 3.74 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.8 p -74.51 -39.8 62.17 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.216 -0.927 . . . . 0.0 113.252 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 t 78.37 129.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 128.358 2.663 . . . . 0.0 111.033 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 tt -101.75 -49.36 4.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.417 1.487 . . . . 0.0 110.173 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.2 m 68.79 87.68 0.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.402 2.281 . . . . 0.0 111.194 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -73.27 174.33 8.22 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.636 1.175 . . . . 0.0 113.317 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 m -86.74 156.74 19.82 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.852 -1.155 . . . . 0.0 111.338 169.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.11 153.71 43.0 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.527 0.731 . . . . 0.0 109.637 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -138.12 131.25 30.2 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 111.106 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.05 126.16 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.989 0.915 . . . . 0.0 109.245 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -131.48 157.23 44.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.545 1.538 . . . . 0.0 112.489 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -110.48 138.81 46.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.841 1.657 . . . . 0.0 110.077 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -166.11 170.38 13.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.227 1.011 . . . . 0.0 110.703 -171.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -85.39 145.44 27.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.319 -0.863 . . . . 0.0 111.55 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.6 tp -53.1 -50.66 63.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.068 0.947 . . . . 0.0 111.529 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -58.11 -28.88 65.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -85.64 -32.11 22.19 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.53 -40.64 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.471 0.578 . . . . 0.0 111.256 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.81 -44.33 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.83 0.852 . . . . 0.0 112.118 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.74 -124.82 35.33 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -175.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.75 0.62 63.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.959 1.266 . . . . 0.0 114.973 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.58 168.3 19.06 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.64 1.22 . . . . 0.0 113.924 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -77.13 155.27 32.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.86 1.264 . . . . 0.0 112.545 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.92 165.85 31.32 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.806 1.243 . . . . 0.0 113.355 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.12 163.88 33.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.345 1.858 . . . . 0.0 111.321 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.17 136.3 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.562 1.074 . . . . 0.0 109.81 171.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -150.29 124.96 9.72 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.876 1.27 . . . . 0.0 112.451 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.26 41.43 3.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.687 1.595 . . . . 0.0 111.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.0 p -57.05 -31.21 64.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -74.54 -44.71 49.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.54 0.736 . . . . 0.0 111.434 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -63.37 -36.92 85.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.038 0.935 . . . . 0.0 110.792 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -58.14 -17.06 15.83 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.302 1.441 . . . . 0.0 113.562 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -74.42 -19.29 60.46 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.029 -1.044 . . . . 0.0 113.404 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.95 -29.74 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 -173.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.43 152.24 63.22 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -150.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.24 -49.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.512 2.808 . . . . 0.0 112.443 170.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.25 96.45 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 127.421 2.288 . . . . 0.0 111.072 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.27 124.21 11.83 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.446 3.431 . . . . 0.0 114.892 -168.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 t -49.67 -47.66 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.981 2.113 . . . . 0.0 113.801 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.36 -34.65 78.64 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.93 -36.4 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.356 0.663 . . . . 0.0 110.227 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mm -77.0 -38.57 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.758 -0.589 . . . . 0.0 110.335 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.96 -41.07 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.935 0.494 . . . . 0.0 110.914 171.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -64.83 -40.93 95.98 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.527 -0.733 . . . . 0.0 110.96 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.3 m -64.87 -39.85 94.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.363 1.065 . . . . 0.0 112.28 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.62 98.17 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.12 -0.987 . . . . 0.0 111.751 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -68.7 -13.74 62.57 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.46 -37.41 15.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.534 1.061 . . . . 0.0 111.15 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.1 mmm -69.41 -25.57 64.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.637 1.575 . . . . 0.0 113.623 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -47.0 124.36 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.83 1.195 . . . . 0.0 111.986 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.88 1.49 79.85 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.503 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.47 147.77 44.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.811 1.806 . . . . 0.0 111.405 172.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -124.15 139.97 53.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 111.362 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.0 mtm -142.52 148.33 37.45 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.196 0.998 . . . . 0.0 112.908 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -147.55 22.83 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.358 1.063 . . . . 0.0 112.345 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -80.78 -19.04 45.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 t -162.34 175.7 11.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.21 1.004 . . . . 0.0 112.956 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.17 147.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.301 1.84 . . . . 0.0 109.787 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.51 -32.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.6 p -58.72 -65.71 0.61 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.76 1.224 . . . . 0.0 111.531 173.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -65.01 -30.82 71.82 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.816 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.83 -40.41 76.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.172 1.351 . . . . 0.0 111.127 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -44.07 59.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.644 1.178 . . . . 0.0 112.962 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.14 -45.38 94.9 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.367 -0.833 . . . . 0.0 111.605 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -60.32 -36.62 78.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.03 -60.59 3.54 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.291 1.437 . . . . 0.0 111.443 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.4 m -65.88 -30.03 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 120.476 1.489 . . . . 0.0 113.157 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 m -59.36 -56.2 25.01 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 116.514 -1.707 . . . . 0.0 107.783 170.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -55.35 -31.65 61.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.736 1.607 . . . . 0.0 114.67 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.15 -33.95 75.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.397 0.999 . . . . 0.0 112.385 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -118.2 16.06 14.03 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -72.65 -19.07 61.51 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.639 1.576 . . . . 0.0 112.826 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.43 -33.82 73.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.855 0.741 . . . . 0.0 113.577 -172.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -114.55 -16.05 11.93 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.955 1.302 . . . . 0.0 112.924 179.618 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.414 0.15 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.0 165.32 25.13 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.239 1.016 . . . . 0.0 112.764 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.4 p -161.77 155.38 18.12 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.111 1.364 . . . . 0.0 112.025 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.02 161.79 35.3 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.52 2.813 . . . . 0.0 111.701 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -76.32 -9.62 58.78 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -157.34 139.06 14.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.026 1.73 . . . . 0.0 109.458 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -155.51 124.04 2.97 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.133 0.973 . . . . 0.0 110.342 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.94 145.29 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.452 2.768 . . . . 0.0 110.687 171.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.04 160.26 26.74 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.303 1.841 . . . . 0.0 110.273 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.43 130.13 32.52 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.863 1.709 . . . . 0.0 110.697 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.23 -6.07 78.34 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.091 1.329 . . . . 0.0 115.437 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -65.47 140.06 58.56 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.8 1.3 . . . . 0.0 112.43 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.5 tp -87.11 89.89 8.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.72 1.608 . . . . 0.0 108.278 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.46 132.66 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.231 1.012 . . . . 0.0 108.879 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -102.27 107.47 18.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.819 1.647 . . . . 0.0 108.179 171.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.0 mm -86.73 123.45 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.702 2.001 . . . . 0.0 107.97 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.94 -32.89 74.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.302 2.0 mmt180 43.62 -142.49 0.15 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.713 2.005 . . . . 0.0 112.975 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.55 109.37 11.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.284 -167.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.17 -9.59 6.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.762 1.172 . . . . 0.0 115.179 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -166.05 124.46 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.798 1.639 . . . . 0.0 111.989 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.64 144.88 31.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.503 1.521 . . . . 0.0 111.675 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -144.09 165.37 27.99 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.231 -0.918 . . . . 0.0 113.456 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -88.13 157.13 18.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.71 137.69 20.36 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.927 1.691 . . . . 0.0 110.41 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.46 119.46 38.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.044 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -72.01 89.49 1.12 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.803 1.241 . . . . 0.0 111.747 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 pt -77.24 -20.32 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.21 -178.31 32.12 Favored Glycine 0 N--CA 1.462 0.433 0 C-N-CA 124.916 1.246 . . . . 0.0 110.878 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.87 86.19 0.51 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.639 0.733 . . . . 0.0 111.099 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.3 -6.84 46.63 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.884 2.183 . . . . 0.0 114.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -106.65 141.95 37.08 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.95 1.375 . . . . 0.0 112.813 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -137.95 153.28 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 mt -115.88 138.38 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.641 1.576 . . . . 0.0 107.002 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -157.61 138.24 13.02 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.154 -0.966 . . . . 0.0 113.275 -168.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.58 113.6 12.03 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.719 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.95 141.52 78.49 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.399 0.679 . . . . 0.0 109.855 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.34 157.13 62.35 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.632 2.888 . . . . 0.0 113.14 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.89 -11.75 18.06 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 124.16 3.24 . . . . 0.0 114.042 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.1 t -139.97 152.04 45.99 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.673 1.189 . . . . 0.0 111.523 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.28 144.73 56.41 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.267 1.427 . . . . 0.0 114.285 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -72.68 159.27 85.77 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -54.74 141.98 74.72 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.726 2.951 . . . . 0.0 113.491 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.73 -11.73 70.88 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.73 1.157 . . . . 0.0 115.051 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.06 169.06 16.8 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.054 1.342 . . . . 0.0 113.414 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.78 24.98 19.03 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.608 1.099 . . . . 0.0 114.265 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.3 t -153.48 164.46 38.16 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.803 1.241 . . . . 0.0 110.682 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -57.41 -20.56 30.75 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -78.0 -25.01 47.75 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.86 1.264 . . . . 0.0 114.014 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -155.41 108.51 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.976 1.711 . . . . 0.0 109.576 -173.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -150.11 -20.26 0.25 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 t -76.22 79.58 3.01 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.673 -1.267 . . . . 0.0 111.062 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.57 140.3 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.337 1.455 . . . . 0.0 110.813 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.5 tp -68.89 132.11 46.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.829 1.252 . . . . 0.0 111.257 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 t -160.68 91.72 0.92 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.436 0.694 . . . . 0.0 110.553 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 176.98 -55.3 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.397 2.279 . . . . 0.0 110.519 -170.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 p -166.27 156.49 12.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.143 2.177 . . . . 0.0 109.129 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.82 135.85 34.36 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.691 -0.631 . . . . 0.0 109.657 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.94 138.77 37.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.172 0.896 . . . . 0.0 110.318 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -80.57 118.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.168 0.587 . . . . 0.0 110.116 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -108.07 174.96 5.65 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -146.09 152.45 39.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.462 1.505 . . . . 0.0 112.298 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 175.35 -164.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.843 2.857 . . . . 0.0 109.597 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -77.0 151.08 35.78 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.21 -0.931 . . . . 0.0 112.889 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.95 -46.66 75.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.179 0.991 . . . . 0.0 111.177 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 69' ' ' VAL . 16.4 pt-20 -58.82 -29.71 67.09 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -80.5 -39.29 28.23 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.445 -0.785 . . . . 0.0 111.459 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.02 -46.69 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 174.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 66' ' ' GLU . 31.7 m -70.99 -41.97 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.827 0.851 . . . . 0.0 112.262 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.46 -116.31 9.16 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 119.342 0.974 . . . . 0.0 110.72 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.94 -2.92 64.27 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.476 1.036 . . . . 0.0 114.835 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 55.8 m -79.95 157.9 26.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.781 1.29 . . . . 0.0 113.326 -172.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 74.6 m -74.59 167.08 22.46 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.343 1.057 . . . . 0.0 111.878 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -155.16 163.21 40.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.492 1.117 . . . . 0.0 111.745 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -140.16 169.65 17.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.398 1.879 . . . . 0.0 109.961 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.35 127.55 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -103.64 -54.77 2.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 47.3 47.8 16.57 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.325 1.45 . . . . 0.0 111.797 -171.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.3 p -54.2 -60.26 3.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.674 1.589 . . . . 0.0 113.749 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.41 -29.43 70.13 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -65.15 -51.48 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.696 0.398 . . . . 0.0 110.373 169.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -60.72 -27.0 67.58 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 121.179 -0.951 . . . . 0.0 113.026 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -68.17 -33.54 74.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -158.91 -15.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -146.88 130.4 8.25 Favored Pre-proline 0 CA--C 1.55 0.967 0 O-C-N 120.728 -1.233 . . . . 0.0 113.752 -133.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.86 -46.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.749 2.3 . . . . 0.0 112.173 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 128.99 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 129.495 3.118 . . . . 0.0 114.557 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.52 97.8 0.46 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.322 2.682 . . . . 0.0 110.227 169.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -15.87 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -169.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -63.91 -34.78 78.72 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.769 0.713 . . . . 0.0 110.824 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -74.88 -32.74 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.374 0.67 . . . . 0.0 110.382 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.93 -44.56 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.522 0.729 . . . . 0.0 111.631 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.54 -36.25 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.623 0.769 . . . . 0.0 110.607 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -65.1 -45.08 86.66 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.619 0.768 . . . . 0.0 111.637 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.8 m -58.94 -40.77 85.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.584 1.153 . . . . 0.0 112.168 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.14 94.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.501 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -63.42 -21.27 66.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.36 -34.7 21.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 112.554 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 mtp -77.52 -27.81 51.82 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -56.29 123.0 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 120.076 1.307 . . . . 0.0 110.617 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.58 -9.49 62.47 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.793 1.663 . . . . 0.0 115.038 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -78.68 156.23 29.08 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.479 1.64 . . . . 0.0 110.464 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -147.35 154.59 41.09 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.104 1.362 . . . . 0.0 114.34 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.1 mtm -147.15 163.99 34.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.314 1.846 . . . . 0.0 112.022 -170.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -157.19 -45.31 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -77.94 71.13 4.4 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.04 1.336 . . . . 0.0 113.709 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 m -175.88 170.43 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.411 2.684 . . . . 0.0 110.228 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.96 146.41 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.308 -0.87 . . . . 0.0 109.252 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.46 -40.1 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 120.666 -1.271 . . . . 0.0 113.218 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.7 m -60.63 -43.44 97.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.208 0.603 . . . . 0.0 110.846 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -70.71 -29.75 66.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.774 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -58.15 -46.83 84.98 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.644 1.565 . . . . 0.0 110.911 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.0 m -66.5 -48.65 69.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.651 1.181 . . . . 0.0 112.197 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -58.52 -48.32 81.22 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.562 0.745 . . . . 0.0 111.409 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.25 -33.8 76.85 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.938 -1.101 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -58.88 -58.0 10.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.946 0.794 . . . . 0.0 110.787 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.82 -21.58 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 119.551 1.069 . . . . 0.0 113.598 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -71.93 -40.82 68.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.355 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.22 -26.21 68.24 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 120.038 1.29 . . . . 0.0 112.654 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.02 -46.48 67.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.983 0.811 . . . . 0.0 112.405 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -94.37 9.7 37.22 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.454 1.901 . . . . 0.0 114.285 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -58.65 -21.66 54.6 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.049 2.139 . . . . 0.0 113.789 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.88 68.28 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.479 1.037 . . . . 0.0 114.314 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -140.59 -22.4 0.81 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 169.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 124.945 1.298 . . . . 0.0 112.793 175.008 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttm . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 110.664 -0.124 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.02 160.57 31.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.485 1.114 . . . . 0.0 112.832 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -172.52 161.97 4.07 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 126.934 2.094 . . . . 0.0 111.122 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.09 150.83 54.19 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.782 2.988 . . . . 0.0 112.847 171.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -162.84 -65.31 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.092 0.957 . . . . 0.0 112.652 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -83.2 52.33 2.17 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.829 1.252 . . . . 0.0 110.724 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -94.89 125.21 51.86 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.161 -0.923 . . . . 0.0 109.894 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.5 150.12 35.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.751 2.301 . . . . 0.0 111.318 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -100.64 142.1 23.95 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.753 0.821 . . . . 0.0 110.973 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.3 132.51 24.21 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.682 1.588 . . . . 0.0 110.468 -170.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.87 66.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.691 1.615 . . . . 0.0 114.574 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.13 165.99 11.97 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.579 1.69 . . . . 0.0 113.885 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.4 mt -90.64 113.11 25.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.26 1.424 . . . . 0.0 111.655 -169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.22 117.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.966 0.906 . . . . 0.0 108.629 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.58 117.52 28.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -122.71 134.25 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.859 1.264 . . . . 0.0 109.3 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -77.76 66.05 3.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.017 0.927 . . . . 0.0 110.47 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -36.12 82.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.299 1.44 . . . . 0.0 114.41 -169.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.77 26.38 0.74 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -152.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.76 7.81 77.64 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.285 0.945 . . . . 0.0 112.965 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -167.71 160.26 12.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.746 2.819 . . . . 0.0 109.183 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -64.51 138.23 58.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.599 1.56 . . . . 0.0 113.616 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.95 151.46 40.96 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.349 1.86 . . . . 0.0 108.72 169.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -98.84 156.79 16.69 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.2 157.09 44.17 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.897 1.679 . . . . 0.0 111.87 169.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.31 121.77 45.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.79 2.036 . . . . 0.0 108.541 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -75.05 92.43 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.153 0.888 . . . . 0.0 111.774 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -84.44 -21.8 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.68 174.43 30.78 Favored Glycine 0 N--CA 1.463 0.454 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.05 94.73 0.67 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.534 0.683 . . . . 0.0 109.93 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.44 65.59 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.437 1.97 . . . . 0.0 115.273 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -113.75 140.2 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.361 1.58 . . . . 0.0 112.365 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 m -140.77 149.27 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mm -105.97 128.54 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -139.29 163.46 32.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.975 0.807 . . . . 0.0 111.043 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.23 137.51 32.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.67 138.6 21.07 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.457 1.503 . . . . 0.0 108.457 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.57 159.11 39.6 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.506 2.804 . . . . 0.0 113.728 -169.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.35 139.4 16.53 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.676 2.917 . . . . 0.0 109.788 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.1 m -75.54 -21.69 57.72 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -164.09 128.78 2.77 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.724 1.61 . . . . 0.0 110.196 172.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.88 -55.27 17.42 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -173.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 -30.4 16.27 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.378 2.719 . . . . 0.0 112.842 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.11 155.18 23.75 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.911 1.243 . . . . 0.0 113.672 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.35 153.32 18.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.196 1.398 . . . . 0.0 112.909 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.06 126.31 8.8 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 124.584 1.087 . . . . 0.0 110.539 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -61.33 -27.79 68.75 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -171.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.2 p -73.24 -29.68 62.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.226 1.011 . . . . 0.0 112.87 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.8 m -83.97 -39.76 19.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.325 1.05 . . . . 0.0 111.987 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.63 131.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.302 1.841 . . . . 0.0 110.805 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -109.01 -7.87 15.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.035 1.334 . . . . 0.0 113.71 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.1 m -75.4 -0.28 19.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.814 1.646 . . . . 0.0 115.246 -171.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.07 153.41 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.488 1.515 . . . . 0.0 111.526 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.92 151.44 27.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.921 0.888 . . . . 0.0 110.911 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.5 m -123.67 24.03 8.61 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.084 1.353 . . . . 0.0 111.396 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -61.35 160.67 10.37 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.2 p -85.98 163.48 17.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.131 1.372 . . . . 0.0 111.475 169.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.56 127.99 34.45 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -113.18 134.88 54.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.451 1.1 . . . . 0.0 111.314 -169.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.1 126.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.732 0.813 . . . . 0.0 110.515 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -139.3 153.88 47.83 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.914 1.286 . . . . 0.0 113.273 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -98.79 137.96 36.63 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.856 1.662 . . . . 0.0 110.689 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -165.7 172.22 12.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.538 1.135 . . . . 0.0 111.671 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -92.89 146.43 23.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.27 1.428 . . . . 0.0 112.103 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -51.47 -56.07 15.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 111.774 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -62.72 -25.16 68.03 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.47 -40.26 43.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.213 0.915 . . . . 0.0 111.12 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.2 t -68.13 -35.33 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.042 0.537 . . . . 0.0 111.959 173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.1 t -78.7 -39.34 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.003 0.921 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 20.11 65.35 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.007 0.822 . . . . 0.0 115.014 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.61 89.72 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.132 1.349 . . . . 0.0 114.859 -173.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.26 175.49 8.9 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.116 1.366 . . . . 0.0 112.555 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.6 m -69.68 150.72 46.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.258 1.023 . . . . 0.0 112.732 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -160.63 163.94 32.2 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.915 1.286 . . . . 0.0 113.506 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.05 163.43 23.26 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.788 2.035 . . . . 0.0 110.927 -175.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -109.0 145.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.596 1.089 . . . . 0.0 112.162 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -133.54 151.89 51.81 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.818 1.647 . . . . 0.0 113.45 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -144.93 31.11 1.15 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.989 1.716 . . . . 0.0 112.286 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -59.94 -35.82 75.74 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.23 -29.22 15.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.918 0.781 . . . . 0.0 112.54 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.62 -30.97 72.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.444 1.097 . . . . 0.0 112.213 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -67.17 -23.04 65.73 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.243 1.417 . . . . 0.0 113.093 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -88.75 -45.66 9.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -95.77 -34.64 11.83 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -168.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -141.13 158.19 65.06 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.49 -19.39 28.53 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.13 3.22 . . . . 0.0 113.207 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 66.93 75.63 0.31 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.355 1.862 . . . . 0.0 112.098 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.81 80.85 2.28 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.458 3.439 . . . . 0.0 110.257 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 t -46.45 -41.11 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.678 1.591 . . . . 0.0 114.344 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.97 -38.02 82.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.207 0.912 . . . . 0.0 111.21 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.14 -38.0 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.313 1.045 . . . . 0.0 109.902 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.53 -47.25 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.471 0.578 . . . . 0.0 110.379 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.71 -38.89 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.34 1.056 . . . . 0.0 111.852 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -65.86 -42.49 90.34 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.415 -0.803 . . . . 0.0 110.61 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.8 p -61.5 -38.57 87.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.438 0.695 . . . . 0.0 112.054 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.76 72.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.427 1.091 . . . . 0.0 111.404 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.46 -36.37 80.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.71 -37.7 79.71 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.6 ptm -81.68 -4.06 55.23 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.2 125.67 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.869 1.268 . . . . 0.0 109.227 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.99 -5.97 58.17 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.924 1.25 . . . . 0.0 114.469 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -66.06 147.82 52.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.262 1.531 . . . . 0.0 110.491 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.76 135.0 45.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.459 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -141.64 140.77 33.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.555 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -149.83 27.05 0.8 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.777 1.231 . . . . 0.0 112.318 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.8 -8.9 59.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.8 t -158.06 178.05 10.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.841 1.256 . . . . 0.0 111.842 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 146.55 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.432 1.493 . . . . 0.0 110.203 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.66 -39.33 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 124.807 1.243 . . . . 0.0 113.926 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.4 p -58.73 -57.54 12.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.831 0.852 . . . . 0.0 111.787 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -64.97 -34.32 78.15 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.519 -0.738 . . . . 0.0 112.152 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -59.54 -35.48 74.29 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.612 1.096 . . . . 0.0 111.418 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -42.6 67.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.036 0.935 . . . . 0.0 112.801 172.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -62.24 -45.99 90.85 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.97 -1.081 . . . . 0.0 112.254 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -52.87 -44.86 67.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.761 2.024 . . . . 0.0 110.615 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.47 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 11.3 t80 -61.33 -54.24 46.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.433 1.493 . . . . 0.0 112.37 173.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.3 m -69.23 -22.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 120.561 1.528 . . . . 0.0 114.215 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -70.42 -40.12 74.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.145 169.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -64.36 -23.91 67.46 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.411 1.005 . . . . 0.0 113.668 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.47 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 36.5 mt -72.86 -60.79 2.06 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.213 0.915 . . . . 0.0 111.337 169.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -73.95 4.27 5.62 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -56.7 -26.04 55.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.338 2.255 . . . . 0.0 113.219 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.98 -51.83 7.04 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 127.75 2.595 . . . . 0.0 115.645 -169.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -128.04 5.73 5.94 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 C--O 1.25 1.093 0 C-N-CA 124.787 1.235 . . . . 0.0 111.879 170.713 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.01 162.95 28.12 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.024 0.929 . . . . 0.0 112.627 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 m -172.4 155.37 3.36 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 126.877 2.071 . . . . 0.0 110.6 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.64 148.05 41.31 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.15 2.567 . . . . 0.0 111.627 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -137.31 24.44 2.96 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.322 1.449 . . . . 0.0 111.77 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.01 134.67 34.63 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.969 -1.082 . . . . 0.0 111.157 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -94.15 116.61 66.63 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.491 0.716 . . . . 0.0 110.111 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.11 145.21 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.587 2.192 . . . . 0.0 110.098 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.14 139.47 21.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.707 0.803 . . . . 0.0 110.83 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 127.91 15.91 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.769 2.312 . . . . 0.0 110.305 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.01 2.17 90.66 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.181 1.372 . . . . 0.0 114.246 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 169.33 8.63 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.003 1.321 . . . . 0.0 112.604 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.38 130.14 54.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.531 1.533 . . . . 0.0 113.987 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -111.77 144.15 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.365 2.266 . . . . 0.0 110.61 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -108.94 116.67 32.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.29 128.93 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.446 1.499 . . . . 0.0 109.571 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -80.24 68.61 6.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.761 1.225 . . . . 0.0 110.847 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -34.65 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -169.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -156.9 27.33 0.32 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.17 10.23 58.63 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.108 0.861 . . . . 0.0 113.844 -172.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -163.36 145.01 9.61 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.586 2.354 . . . . 0.0 110.146 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -75.32 120.73 21.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.946 1.298 . . . . 0.0 112.354 -176.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -103.07 140.58 37.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.767 1.227 . . . . 0.0 110.041 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -73.62 146.7 44.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.106 0.563 . . . . 0.0 112.123 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.74 142.14 24.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 121.67 43.72 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.029 1.732 . . . . 0.0 108.945 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -76.67 105.29 7.65 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.797 0.839 . . . . 0.0 111.005 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.3 pt -97.1 -20.83 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.91 174.16 32.46 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 124.987 1.28 . . . . 0.0 110.163 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.04 94.73 0.51 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.789 0.804 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.69 64.43 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.839 2.161 . . . . 0.0 115.446 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -112.54 133.99 54.3 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.598 1.699 . . . . 0.0 112.246 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.45 152.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.884 1.274 . . . . 0.0 112.709 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 mm -109.36 128.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.775 1.63 . . . . 0.0 106.844 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -144.95 159.52 42.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.422 1.01 . . . . 0.0 112.026 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.0 115.78 28.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.596 0.758 . . . . 0.0 110.038 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.76 70.18 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.664 1.586 . . . . 0.0 109.815 169.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.33 155.01 68.6 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.897 3.065 . . . . 0.0 114.772 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -84.53 -4.73 10.07 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 124.649 3.566 . . . . 0.0 114.472 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.2 m 76.8 -41.31 0.39 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 128.058 2.543 . . . . 0.0 112.513 -174.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -150.88 159.19 44.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.637 1.975 . . . . 0.0 111.06 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -68.01 167.07 18.86 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.712 0.805 . . . . 0.0 112.999 171.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -53.17 -27.98 39.78 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 124.28 3.32 . . . . 0.0 115.972 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.21 23.73 5.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.539 1.066 . . . . 0.0 114.907 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.7 -20.83 23.76 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.758 1.623 . . . . 0.0 114.547 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.73 101.06 0.79 Allowed Glycine 0 N--CA 1.467 0.731 0 C-N-CA 125.609 1.576 . . . . 0.0 109.408 169.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.5 p -165.44 -178.79 5.14 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.126 1.37 . . . . 0.0 112.32 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 m -68.86 -19.44 64.24 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.734 -1.229 . . . . 0.0 112.128 169.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.5 p -82.54 -37.24 25.46 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.129 -0.982 . . . . 0.0 113.217 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -157.48 154.53 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.403 1.881 . . . . 0.0 110.367 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -160.5 -34.83 0.05 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.119 0.968 . . . . 0.0 112.727 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 p -74.06 41.05 0.13 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.222 2.209 . . . . 0.0 112.964 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.26 153.65 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.668 1.987 . . . . 0.0 111.115 -170.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.7 tp -76.14 109.83 10.14 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.126 0.97 . . . . 0.0 111.322 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 t -87.51 138.41 31.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.338 0.655 . . . . 0.0 111.134 170.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.96 -170.4 2.14 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.45 1.5 . . . . 0.0 110.852 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.7 m -119.71 153.49 35.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.351 1.06 . . . . 0.0 110.784 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.27 159.99 33.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.515 0.726 . . . . 0.0 110.214 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -136.48 130.06 32.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.854 0.862 . . . . 0.0 109.951 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.9 t -83.79 123.19 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -145.25 153.26 41.12 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -94.1 137.77 32.91 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.186 1.794 . . . . 0.0 110.505 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -162.64 163.11 27.25 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.495 0.718 . . . . 0.0 111.893 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -76.05 140.16 41.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.829 173.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -52.56 -54.14 36.93 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.72 1.208 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.88 -23.92 67.57 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.84 -39.11 27.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.299 0.954 . . . . 0.0 111.343 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.52 -39.65 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.75 -0.594 . . . . 0.0 111.405 170.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.04 -45.55 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 112.345 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.03 61.99 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.25 0.932 . . . . 0.0 115.043 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.12 88.21 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.344 1.449 . . . . 0.0 114.891 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -82.5 171.51 14.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.956 1.302 . . . . 0.0 112.017 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.05 147.89 49.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -158.93 163.43 36.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 113.02 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.64 155.78 15.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.238 1.415 . . . . 0.0 112.354 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.73 136.96 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.662 0.664 . . . . 0.0 109.707 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -160.49 136.92 8.72 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.256 1.822 . . . . 0.0 109.516 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -154.37 52.3 0.66 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.888 0.852 . . . . 0.0 113.017 -169.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.9 m -50.67 -35.59 31.64 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -72.54 -39.81 67.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.787 0.835 . . . . 0.0 111.715 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.37 -40.58 93.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.021 0.928 . . . . 0.0 111.439 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -62.09 -17.9 59.06 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.381 1.072 . . . . 0.0 112.862 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -79.74 -30.8 40.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 -35.17 0.42 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 117.843 2.535 . . . . 0.0 117.843 -172.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.69 151.84 73.93 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -138.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.32 -24.11 2.1 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 124.083 3.189 . . . . 0.0 114.657 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 67.11 110.26 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 127.339 2.256 . . . . 0.0 115.668 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.64 89.92 1.25 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 124.134 3.223 . . . . 0.0 109.768 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 t -50.99 -39.67 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.275 1.43 . . . . 0.0 113.782 -169.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.4 -35.76 78.14 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.283 0.492 . . . . 0.0 111.832 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.93 -32.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.279 1.032 . . . . 0.0 110.396 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 mm -66.43 -47.68 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.93 -0.481 . . . . 0.0 110.57 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.49 -37.57 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.892 0.477 . . . . 0.0 110.763 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.1 m -65.25 -41.93 93.79 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.649 -0.657 . . . . 0.0 111.73 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -61.12 -48.13 83.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.639 -0.663 . . . . 0.0 110.909 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.13 88.15 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.7 0.8 . . . . 0.0 112.257 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -62.58 -46.76 86.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.512 0.725 . . . . 0.0 112.021 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.67 -30.79 70.12 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.259 -0.901 . . . . 0.0 113.27 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.9 mtp -75.73 -9.44 58.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.47 127.02 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.455 1.479 . . . . 0.0 111.343 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.13 -0.41 85.88 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.917 -1.491 . . . . 0.0 114.096 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -77.99 137.74 38.45 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.1 1.95 . . . . 0.0 111.023 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.93 165.22 22.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.382 1.073 . . . . 0.0 110.498 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.4 ttm -159.4 137.09 10.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 110.746 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -156.36 34.0 0.32 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.338 1.066 . . . . 0.0 111.185 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.69 -33.28 71.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.263 1.825 . . . . 0.0 114.131 -170.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.7 t -162.47 -157.05 0.44 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.174 1.39 . . . . 0.0 111.876 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.04 154.92 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.274 1.43 . . . . 0.0 109.861 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.15 -37.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -62.5 -49.11 76.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.429 0.692 . . . . 0.0 111.84 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -74.86 -27.95 60.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 117.545 -1.217 . . . . 0.0 112.238 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -58.51 -43.54 89.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.741 1.609 . . . . 0.0 110.215 170.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -51.82 68.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.476 1.91 . . . . 0.0 112.639 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -64.54 -41.89 96.06 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.051 0.841 . . . . 0.0 112.517 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -56.41 -44.11 80.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.391 1.476 . . . . 0.0 110.52 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 19.3 t80 -60.67 -56.9 15.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.468 1.507 . . . . 0.0 111.698 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.05 -19.32 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.096 1.316 . . . . 0.0 114.399 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 m -74.69 -38.22 62.44 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.112 1.324 . . . . 0.0 110.284 170.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -67.15 -28.11 67.86 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.641 1.11 . . . . 0.0 112.968 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.645 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 94.1 mt -67.46 -56.79 8.17 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.442 -0.786 . . . . 0.0 110.231 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -78.55 5.01 11.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.594 1.558 . . . . 0.0 113.946 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.04 -20.58 17.49 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.526 2.331 . . . . 0.0 113.136 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.52 -31.15 28.54 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.285 1.898 . . . . 0.0 113.697 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -135.2 -23.64 1.48 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 124.684 1.193 . . . . 0.0 113.358 -177.665 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.366 0.126 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.39 161.62 28.54 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.225 1.01 . . . . 0.0 112.613 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.6 p -166.37 163.32 11.58 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 125.499 1.52 . . . . 0.0 111.678 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.35 143.28 99.78 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.591 2.861 . . . . 0.0 112.815 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -139.64 156.3 46.92 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.319 1.448 . . . . 0.0 111.599 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -157.78 141.23 15.45 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.513 1.525 . . . . 0.0 109.301 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.2 134.25 8.24 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.42 152.37 15.62 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.647 2.898 . . . . 0.0 110.187 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.96 153.46 38.25 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.543 1.137 . . . . 0.0 111.191 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -67.89 131.88 25.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.886 1.724 . . . . 0.0 110.491 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -6.81 81.85 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 125.535 1.54 . . . . 0.0 114.525 -172.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.72 161.84 15.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.444 1.497 . . . . 0.0 111.89 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -118.83 160.12 22.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.963 1.363 . . . . 0.0 114.437 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mt -141.3 131.22 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.615 1.566 . . . . 0.0 109.57 -160.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -85.65 127.84 34.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -112.55 122.34 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.314 1.446 . . . . 0.0 109.112 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -82.27 92.9 7.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.594 1.158 . . . . 0.0 109.084 173.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -64.99 -72.02 0.17 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.438 1.095 . . . . 0.0 111.693 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.4 mt -150.37 -114.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -164.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.18 23.85 5.84 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.333 0.968 . . . . 0.0 111.957 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -169.29 167.69 10.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.987 2.515 . . . . 0.0 111.867 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -121.26 163.4 18.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.233 1.413 . . . . 0.0 111.911 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.12 -174.07 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.658 1.583 . . . . 0.0 110.872 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -120.81 157.75 29.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.7 43.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.504 1.522 . . . . 0.0 113.083 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -125.72 123.64 39.32 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.771 2.428 . . . . 0.0 108.162 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -79.97 104.43 10.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 0.0 111.507 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.4 pt -94.48 -15.21 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.87 177.8 37.11 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 124.39 0.995 . . . . 0.0 110.877 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.73 91.57 0.45 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.669 0.747 . . . . 0.0 110.37 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 0.73 58.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.629 2.062 . . . . 0.0 115.069 -176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.56 138.94 47.45 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.924 1.862 . . . . 0.0 112.589 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.42 152.37 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mm -108.45 137.85 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 127.044 2.138 . . . . 0.0 106.715 168.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.98 141.17 18.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.235 0.925 . . . . 0.0 111.73 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.86 121.54 30.4 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.351 0.66 . . . . 0.0 110.01 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.13 113.77 43.67 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 168.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.3 169.45 21.26 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.028 2.485 . . . . 0.0 112.75 -169.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.12 153.56 32.2 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.372 3.381 . . . . 0.0 113.661 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -160.24 154.68 23.7 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.959 1.304 . . . . 0.0 110.59 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -104.7 143.15 33.49 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.314 1.045 . . . . 0.0 112.454 -173.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -63.84 153.9 82.75 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.218 0.607 . . . . 0.0 112.243 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.58 166.08 30.73 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.362 2.708 . . . . 0.0 112.223 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.71 10.76 78.62 Favored Glycine 0 N--CA 1.473 1.101 0 C-N-CA 124.48 1.038 . . . . 0.0 115.3 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.56 143.71 28.8 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.407 1.483 . . . . 0.0 113.413 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.0 21.67 79.7 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.167 0.889 . . . . 0.0 114.432 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 t -140.43 170.24 16.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.569 1.185 . . . . 0.0 111.982 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.4 m -59.56 -18.89 44.57 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.614 -1.304 . . . . 0.0 114.373 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.0 p -77.19 -21.61 53.68 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.945 1.298 . . . . 0.0 113.502 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.5 122.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 128.289 2.636 . . . . 0.0 110.599 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -132.72 0.04 3.53 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.737 1.215 . . . . 0.0 113.815 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.4 t -93.68 -168.88 1.98 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.295 1.038 . . . . 0.0 111.696 170.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.95 138.93 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.687 1.195 . . . . 0.0 111.362 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.67 27.01 0.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.659 1.183 . . . . 0.0 113.607 -172.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.0 p -86.34 136.02 33.3 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.107 0.955 . . . . 0.0 112.492 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -80.93 152.34 28.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.421 1.488 . . . . 0.0 111.618 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 m -70.86 155.16 41.13 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.248 -0.907 . . . . 0.0 111.788 170.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.58 158.82 30.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.368 1.067 . . . . 0.0 111.299 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -143.08 132.35 23.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.376 1.071 . . . . 0.0 111.167 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.65 125.82 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.074 0.95 . . . . 0.0 109.992 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.1 171.67 13.68 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.78 1.632 . . . . 0.0 112.203 -170.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -142.01 141.72 32.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.864 1.666 . . . . 0.0 111.611 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.252 14.7 pt-20 174.1 -160.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.269 3.028 . . . . 0.0 110.145 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.9 mtm105 -95.02 148.25 22.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 tp -53.88 -51.87 62.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.537 1.535 . . . . 0.0 111.229 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.45 -25.31 67.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.74 -44.57 23.1 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.418 1.008 . . . . 0.0 110.458 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.33 -34.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.155 0.982 . . . . 0.0 112.125 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.9 -17.77 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.027 1.731 . . . . 0.0 112.873 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.25 118.54 15.26 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.181 -0.95 . . . . 0.0 112.221 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 4.81 90.18 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.677 1.132 . . . . 0.0 114.619 -174.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.73 176.75 7.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.906 2.082 . . . . 0.0 112.107 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -121.02 167.96 12.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.394 1.478 . . . . 0.0 109.64 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -156.0 165.97 34.87 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -158.39 136.22 10.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.998 1.319 . . . . 0.0 110.939 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.8 136.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 118.825 0.738 . . . . 0.0 109.049 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -152.75 128.86 10.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.061 0.545 . . . . 0.0 111.672 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -145.41 40.57 1.21 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.258 1.023 . . . . 0.0 111.304 -172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -71.11 -43.92 66.68 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -169.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -62.75 -35.3 79.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.276 0.63 . . . . 0.0 111.682 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.73 -28.34 67.27 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.349 1.46 . . . . 0.0 114.16 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -64.36 -19.65 65.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.446 1.098 . . . . 0.0 112.468 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -78.66 -16.24 57.54 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.097 0.959 . . . . 0.0 112.93 173.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.41 -75.59 0.58 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -131.03 153.61 81.82 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -139.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.63 -16.93 52.1 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 124.33 3.353 . . . . 0.0 114.367 169.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 72.65 86.65 0.1 Allowed Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 127.678 2.391 . . . . 0.0 113.101 171.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.52 93.67 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.628 2.885 . . . . 0.0 110.378 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.26 -38.77 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.139 0.976 . . . . 0.0 112.14 -172.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -69.1 -41.72 77.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.74 0.7 . . . . 0.0 111.866 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.64 -35.49 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.414 0.686 . . . . 0.0 110.316 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.4 -40.18 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.046 0.938 . . . . 0.0 111.914 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.4 -39.39 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.325 0.966 . . . . 0.0 111.074 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 m -65.63 -40.26 92.34 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.733 -0.604 . . . . 0.0 110.844 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -61.9 -47.18 86.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.268 1.027 . . . . 0.0 111.243 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.05 91.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.616 0.766 . . . . 0.0 112.535 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.95 -46.05 89.6 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.587 -0.695 . . . . 0.0 112.061 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.21 -30.14 70.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.09 -1.006 . . . . 0.0 113.37 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.61 -12.72 61.49 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.81 125.75 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.719 1.145 . . . . 0.0 111.047 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.94 -1.4 80.57 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.615 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -75.46 143.35 42.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.06 1.93 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -117.89 146.2 44.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.706 1.602 . . . . 0.0 111.88 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.6 157.25 44.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.981 1.312 . . . . 0.0 112.166 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -153.02 -33.8 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -173.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -72.21 157.89 36.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -171.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.6 t 75.88 -177.55 0.14 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.191 2.196 . . . . 0.0 113.03 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.7 mm -76.11 140.87 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.63 1.172 . . . . 0.0 109.004 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.13 -32.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -170.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.7 p -63.46 -48.44 77.69 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.361 -0.837 . . . . 0.0 111.527 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -67.19 -35.8 80.41 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.597 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.16 -45.52 79.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.596 1.543 . . . . 0.0 111.437 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.8 m -65.82 -49.43 68.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.284 1.434 . . . . 0.0 113.294 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.74 -41.55 99.25 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.567 0.747 . . . . 0.0 112.262 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -64.76 -42.26 95.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.111 1.364 . . . . 0.0 110.221 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 8.6 t80 -54.6 -52.46 62.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.021 1.329 . . . . 0.0 112.04 169.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.421 ' HA ' HD12 ' A' ' 120' ' ' LEU . 13.8 m -68.72 -18.33 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.815 1.189 . . . . 0.0 113.992 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -75.6 -45.39 37.87 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.698 169.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -34.57 61.86 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.82 1.191 . . . . 0.0 113.397 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.615 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 78.7 mt -64.98 -59.45 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.907 0.776 . . . . 0.0 111.452 171.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -80.48 11.13 3.9 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.79 -19.45 62.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.543 1.937 . . . . 0.0 113.94 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -47.29 -37.75 11.84 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.908 2.194 . . . . 0.0 116.639 -169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -140.74 7.89 2.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.623 1.211 . . . . 0.0 113.622 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.638 1.575 . . . . 0.0 112.289 175.334 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.5 141.8 31.99 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.288 1.992 . . . . 0.0 110.206 170.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -91.75 142.11 26.31 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.852 0.861 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.51 128.92 22.37 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.637 2.225 . . . . 0.0 110.232 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.51 -2.38 72.73 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.503 1.525 . . . . 0.0 114.838 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.26 162.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.521 1.661 . . . . 0.0 111.163 169.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.01 146.05 42.47 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.953 1.359 . . . . 0.0 113.814 -171.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mt -123.26 129.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.341 2.257 . . . . 0.0 108.024 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -82.36 124.43 30.0 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.684 1.193 . . . . 0.0 107.798 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mm -118.44 119.5 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 110.346 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -81.79 72.81 8.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 108.536 169.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -25.91 57.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.727 1.211 . . . . 0.0 113.461 -170.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -161.62 -159.94 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.709 2.004 . . . . 0.0 108.715 -159.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.96 34.19 1.05 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.662 1.125 . . . . 0.0 112.678 169.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -169.44 158.83 8.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.427 2.691 . . . . 0.0 111.002 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -104.05 123.95 48.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -105.6 167.95 9.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.599 1.559 . . . . 0.0 110.862 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -112.69 151.81 29.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.729 0.811 . . . . 0.0 111.698 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.62 156.77 44.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.371 1.068 . . . . 0.0 112.819 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -123.49 120.99 34.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.032 . . . . 0.0 108.75 -178.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -76.98 92.17 3.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.234 1.014 . . . . 0.0 111.864 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.5 pt -81.18 -21.93 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.75 173.35 31.75 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 124.199 0.904 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -68.41 90.67 0.37 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.674 0.749 . . . . 0.0 109.908 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.0 49.93 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.195 1.855 . . . . 0.0 115.581 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -126.18 140.64 52.4 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.714 1.757 . . . . 0.0 112.963 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -137.07 149.79 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.289 1.036 . . . . 0.0 113.237 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.5 mm -105.56 131.74 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -146.85 162.82 37.84 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.908 1.231 . . . . 0.0 112.069 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -100.58 134.11 44.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.315 0.646 . . . . 0.0 112.626 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.53 108.44 53.24 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 126.214 1.805 . . . . 0.0 106.232 168.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -62.75 162.18 26.03 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.373 3.382 . . . . 0.0 114.822 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 CA--C 1.545 1.065 0 C-N-CA 124.802 3.668 . . . . 0.0 113.689 175.138 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 119.816 -0.135 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 150.11 26.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.593 -0.692 . . . . 0.0 111.968 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -143.42 136.72 28.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.251 1.02 . . . . 0.0 110.944 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.51 128.35 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.617 1.167 . . . . 0.0 108.846 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -130.41 151.45 50.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.469 1.508 . . . . 0.0 112.543 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -105.37 138.75 41.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.332 1.453 . . . . 0.0 110.585 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.69 167.63 18.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.14 0.976 . . . . 0.0 111.021 -170.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -83.8 143.66 29.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.072 1.349 . . . . 0.0 110.617 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.03 -49.06 72.5 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.507 0.723 . . . . 0.0 110.522 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.7 -24.39 65.6 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.96 -46.09 15.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.355 0.98 . . . . 0.0 110.287 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.69 -30.73 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.971 0.908 . . . . 0.0 112.252 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -91.78 -21.5 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.88 1.672 . . . . 0.0 112.759 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.31 118.71 15.21 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.383 0.992 . . . . 0.0 112.048 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.46 75.49 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.445 1.021 . . . . 0.0 114.607 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.1 m -123.67 163.47 21.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.132 1.773 . . . . 0.0 111.795 -171.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -109.99 159.86 16.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.575 1.15 . . . . 0.0 109.961 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -157.89 169.2 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.9 tpp85 -163.93 132.65 3.74 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.146 1.778 . . . . 0.0 110.727 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.61 127.53 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -152.73 64.89 0.79 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.973 0.892 . . . . 0.0 110.679 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -80.57 69.11 7.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.364 1.065 . . . . 0.0 111.177 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.7 p -35.14 -64.56 0.27 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.425 2.29 . . . . 0.0 115.328 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.84 -29.24 68.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.47 -39.51 74.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.565 0.746 . . . . 0.0 112.448 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -67.99 -30.51 69.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 112.093 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -76.09 -36.98 58.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.612 1.165 . . . . 0.0 113.333 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -162.93 -52.98 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -72.24 148.73 91.38 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -153.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.06 -37.4 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.714 2.943 . . . . 0.0 113.145 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 68.64 119.64 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.602 2.361 . . . . 0.0 116.934 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.4 89.38 1.36 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.396 3.397 . . . . 0.0 110.981 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.92 -41.43 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.739 1.616 . . . . 0.0 113.956 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.03 -36.08 79.34 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.554 0.615 . . . . 0.0 111.512 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.07 -27.87 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.035 0.934 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.6 mm -68.19 -47.29 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.14 0.882 . . . . 0.0 110.647 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.03 -38.13 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.771 -0.58 . . . . 0.0 110.801 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -67.25 -41.15 86.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.705 -0.622 . . . . 0.0 111.166 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.2 m -64.82 -39.55 93.76 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.541 1.136 . . . . 0.0 111.992 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.75 95.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.36 -0.838 . . . . 0.0 111.665 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -68.75 -11.17 59.99 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 173.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.25 -35.74 14.31 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.41 1.084 . . . . 0.0 111.174 168.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.3 mmm -72.44 -20.21 61.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.712 1.605 . . . . 0.0 113.819 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.26 124.22 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.902 1.228 . . . . 0.0 111.623 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.0 -4.56 85.55 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.069 -1.406 . . . . 0.0 115.323 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 150.81 47.61 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.073 1.937 . . . . 0.0 111.009 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -129.18 149.79 50.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.874 1.67 . . . . 0.0 112.301 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.7 mtm -144.03 158.96 43.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 0.0 111.234 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -152.83 -32.88 0.13 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -171.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.59 -28.45 51.63 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -90.12 150.02 22.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.232 1.013 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.33 157.1 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.592 -0.693 . . . . 0.0 111.328 172.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.77 -42.28 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m -64.2 -45.67 87.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.899 0.772 . . . . 0.0 111.367 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -75.98 -32.16 59.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.864 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -57.85 -40.12 79.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.198 0.908 . . . . 0.0 111.366 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.04 -55.23 31.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.895 1.678 . . . . 0.0 112.938 169.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.07 -43.61 98.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.432 -0.792 . . . . 0.0 112.339 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.79 -34.94 79.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.238 1.015 . . . . 0.0 111.195 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.65 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 26.3 t80 -61.19 -55.65 29.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.829 169.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.39 -20.45 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 120.304 1.411 . . . . 0.0 113.992 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -73.01 -37.96 66.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.526 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -71.99 -27.64 62.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.893 1.224 . . . . 0.0 113.442 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.65 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 83.3 mt -66.41 -46.89 75.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.218 0.917 . . . . 0.0 111.77 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -69.5 -94.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.677 1.191 . . . . 0.0 108.633 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.7 t80 70.77 -6.99 1.13 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.236 2.614 . . . . 0.0 112.993 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.28 -69.54 1.28 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 127.22 2.343 . . . . 0.0 111.92 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.84 1.14 33.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.26 1.024 . . . . 0.0 113.269 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 125.617 1.567 . . . . 0.0 112.484 170.067 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.2 150.1 36.83 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.25 2.634 . . . . 0.0 111.069 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -108.59 160.31 27.67 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.457 1.503 . . . . 0.0 111.664 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.51 134.5 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.782 1.655 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.8 -10.38 74.71 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.855 1.216 . . . . 0.0 114.685 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.13 142.76 31.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.773 1.287 . . . . 0.0 111.539 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.66 128.1 48.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.627 1.203 . . . . 0.0 108.074 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.15 126.65 61.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 105.978 -170.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -74.84 129.67 38.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.06 120.04 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.621 1.569 . . . . 0.0 109.051 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -80.93 90.27 5.92 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -81.58 31.24 0.35 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt 82.53 72.76 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.652 1.981 . . . . 0.0 110.922 155.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.79 1.46 76.94 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.829 1.204 . . . . 0.0 113.353 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -138.67 140.2 38.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.239 1.815 . . . . 0.0 110.653 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -98.06 119.71 37.18 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.645 0.778 . . . . 0.0 110.427 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -125.92 178.62 5.63 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.695 1.598 . . . . 0.0 111.042 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -137.97 157.24 46.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.441 0.696 . . . . 0.0 112.606 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.55 25.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 120.74 32.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.671 1.589 . . . . 0.0 108.589 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.0 110.24 5.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 pt -100.06 -20.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.34 170.57 42.19 Favored Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.71 0.804 . . . . 0.0 112.591 -170.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 19.11 66.24 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.335 1.445 . . . . 0.0 115.749 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -127.08 141.73 51.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.62 1.71 . . . . 0.0 112.736 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.9 156.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.658 1.183 . . . . 0.0 113.117 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 mm -112.49 132.42 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.184 1.794 . . . . 0.0 107.632 169.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -149.31 148.77 29.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.737 1.153 . . . . 0.0 111.896 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.0 tp -83.41 106.35 15.1 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 91.66 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.194 1.398 . . . . 0.0 111.032 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.18 141.91 44.74 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.129 3.22 . . . . 0.0 116.289 -168.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 123.758 2.972 . . . . 0.0 111.766 169.266 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.9 p . . . . . 0 CA--C 1.545 0.769 0 CA-C-O 120.323 0.106 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.86 156.35 28.71 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.117 -0.989 . . . . 0.0 111.27 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.68 135.05 37.87 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 0.0 111.289 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.52 122.19 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -127.36 157.07 40.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.428 1.491 . . . . 0.0 112.26 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -101.55 142.39 32.99 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.139 1.375 . . . . 0.0 110.398 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.75 164.08 21.28 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.095 0.958 . . . . 0.0 111.23 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -74.67 140.67 44.39 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.23 1.412 . . . . 0.0 110.414 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.3 tp -53.81 -57.27 11.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.173 0.989 . . . . 0.0 110.873 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.54 -21.94 66.61 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.48 -41.66 65.76 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.188 0.904 . . . . 0.0 110.878 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.29 -54.55 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.616 0.766 . . . . 0.0 110.87 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.1 -6.61 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.87 -28.23 54.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.116 0.865 . . . . 0.0 113.179 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.39 22.93 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.612 1.101 . . . . 0.0 114.736 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 79.8 m -130.76 148.47 52.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.238 1.415 . . . . 0.0 112.44 -172.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.6 m -76.56 157.37 32.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -158.02 172.45 18.42 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 155.52 2.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 128.173 2.589 . . . . 0.0 112.443 169.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.34 146.72 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.983 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -130.35 -80.85 0.54 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 51.47 49.73 20.35 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.878 2.071 . . . . 0.0 112.541 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -49.35 -57.04 7.6 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.677 -1.265 . . . . 0.0 113.402 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.19 -27.14 69.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.362 1.065 . . . . 0.0 113.444 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -24.94 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.876 0.87 . . . . 0.0 112.238 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -89.55 -30.84 17.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.514 1.125 . . . . 0.0 112.646 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.58 -37.58 88.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.73 0.812 . . . . 0.0 111.898 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.7 -71.55 0.09 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.91 129.89 40.43 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -145.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.88 67.19 5.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.897 3.065 . . . . 0.0 110.46 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.413 ' HB3' HD11 ' A' ' 92' ' ' ILE . 27.8 ttt180 -66.45 137.36 95.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.39 123.11 11.84 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.155 2.57 . . . . 0.0 110.33 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.405 ' HA ' HD12 ' A' ' 92' ' ' ILE . 2.5 t -65.25 -31.68 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.53 -0.747 . . . . 0.0 112.297 -169.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -54.74 -37.75 66.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.687 1.131 . . . . 0.0 112.4 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.04 -28.5 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.518 0.727 . . . . 0.0 110.909 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 87' ' ' ARG . 21.7 mt -69.63 -44.22 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.437 1.095 . . . . 0.0 110.42 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.86 -46.43 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.291 1.037 . . . . 0.0 109.837 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -64.21 -40.73 96.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.457 0.703 . . . . 0.0 111.565 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.0 t -61.33 -43.66 98.49 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.079 -1.013 . . . . 0.0 111.639 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.8 93.78 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.104 -0.997 . . . . 0.0 111.893 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.47 -25.39 68.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.197 0.999 . . . . 0.0 113.536 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -81.35 -35.27 31.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.174 0.99 . . . . 0.0 112.999 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.2 mmm -73.38 -30.39 63.26 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -54.78 126.61 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.488 1.04 . . . . 0.0 111.193 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.88 -9.52 55.2 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.027 1.775 . . . . 0.0 114.263 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -83.5 141.32 31.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.128 1.464 . . . . 0.0 111.11 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.98 155.06 18.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.69 1.596 . . . . 0.0 111.159 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 23.2 ptp -161.85 152.71 17.84 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -150.46 41.06 0.78 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.086 1.755 . . . . 0.0 110.268 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.84 -28.46 69.5 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.305 1.842 . . . . 0.0 115.279 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -172.1 -169.83 0.68 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.679 1.992 . . . . 0.0 110.379 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 pt -54.43 150.75 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.828 0.851 . . . . 0.0 110.504 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.78 -37.95 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.2 p -62.87 -45.55 92.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.067 0.849 . . . . 0.0 111.7 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -70.56 -35.14 72.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.019 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -61.29 -41.97 97.86 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.446 1.475 . . . . 0.0 110.911 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.2 m -64.36 -48.91 73.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.759 2.024 . . . . 0.0 112.508 170.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.84 -45.74 92.51 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.478 -0.764 . . . . 0.0 112.241 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -53.01 -45.42 67.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.644 1.978 . . . . 0.0 110.683 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.22 -58.9 6.55 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.723 1.209 . . . . 0.0 112.335 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.32 -26.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.031 1.287 . . . . 0.0 113.472 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -61.86 -52.28 64.76 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 115.981 -1.961 . . . . 0.0 107.449 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -56.93 -25.4 57.38 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 122.41 2.368 . . . . 0.0 114.849 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -68.47 -33.26 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.666 1.121 . . . . 0.0 112.841 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -105.95 -13.43 15.49 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -58.11 -22.01 48.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.666 2.787 . . . . 0.0 113.069 -168.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -71.67 -11.94 73.51 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.862 -0.965 . . . . 0.0 115.414 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -134.57 2.92 3.25 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.68 1.24 . . . . 0.0 114.216 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 125.246 1.418 . . . . 0.0 112.891 177.594 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.544 0.721 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.7 142.14 25.48 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.553 2.835 . . . . 0.0 110.635 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -115.66 138.91 24.18 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.189 0.995 . . . . 0.0 111.712 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.13 130.24 28.24 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.407 2.738 . . . . 0.0 111.32 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.07 42.37 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.169 1.842 . . . . 0.0 115.304 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -89.35 164.62 14.82 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 110.446 169.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -119.65 148.6 43.16 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.582 1.182 . . . . 0.0 113.012 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -123.99 130.34 73.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.561 2.344 . . . . 0.0 108.221 -161.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -88.71 120.88 30.51 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.79 124.28 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.461 1.504 . . . . 0.0 108.456 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -90.78 63.92 5.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.304 1.441 . . . . 0.0 109.579 -173.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -61.41 2.32 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -148.79 -129.48 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -162.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.33 33.83 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.635 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.75 158.53 2.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.566 2.746 . . . . 0.0 112.008 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -112.9 155.35 24.87 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.887 1.675 . . . . 0.0 109.783 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 164.81 34.91 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.569 -0.707 . . . . 0.0 112.885 174.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -97.88 149.82 21.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.19 140.35 27.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.424 1.09 . . . . 0.0 112.613 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.95 117.53 35.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.846 2.058 . . . . 0.0 108.983 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -76.56 86.82 3.26 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.885 1.274 . . . . 0.0 111.804 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -74.77 -23.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.11 177.88 27.03 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.584 1.088 . . . . 0.0 111.486 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.38 81.89 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.726 0.81 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.33 -11.83 31.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.33 2.395 . . . . 0.0 114.671 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.89 140.47 36.14 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.108 1.454 . . . . 0.0 113.126 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.0 149.54 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 0.0 113.703 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -108.35 123.04 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -137.8 149.76 46.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.231 -0.918 . . . . 0.0 111.512 -169.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.59 118.98 29.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.881 0.472 . . . . 0.0 110.07 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.7 130.95 62.23 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.04 158.89 45.33 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.279 2.652 . . . . 0.0 112.772 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 CA--C 1.539 0.733 0 C-N-CA 123.914 3.076 . . . . 0.0 113.456 178.629 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.16 150.42 30.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.444 -0.785 . . . . 0.0 111.23 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.94 133.7 16.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.725 0.81 . . . . 0.0 110.654 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.03 121.9 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -128.06 156.7 42.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.739 1.616 . . . . 0.0 112.853 -170.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.33 139.98 38.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.067 1.347 . . . . 0.0 110.625 171.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.74 178.87 5.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.497 1.519 . . . . 0.0 109.811 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -96.1 142.49 28.23 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.317 1.447 . . . . 0.0 110.325 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.2 tp -55.35 -49.66 71.67 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.518 -0.739 . . . . 0.0 111.099 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.77 -25.63 63.23 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.28 -42.38 14.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.995 0.816 . . . . 0.0 111.342 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.98 -40.8 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 118.13 0.423 . . . . 0.0 111.305 172.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.5 -47.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.264 1.026 . . . . 0.0 111.613 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.21 -117.55 11.81 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -171.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.58 0.86 61.54 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.039 1.304 . . . . 0.0 115.056 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.82 166.44 22.05 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.942 1.371 . . . . 0.0 113.587 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -82.35 156.26 24.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.881 0.873 . . . . 0.0 110.998 169.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -161.05 156.73 25.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.019 0.927 . . . . 0.0 113.314 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -153.08 140.04 19.19 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.92 0.888 . . . . 0.0 111.827 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.92 133.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -158.01 70.12 0.55 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.344 1.058 . . . . 0.0 111.499 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -80.12 61.06 3.84 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.807 -1.183 . . . . 0.0 111.998 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.8 p -43.2 -67.62 0.26 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.496 1.918 . . . . 0.0 114.842 -169.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -58.08 -27.16 63.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.993 0.917 . . . . 0.0 113.142 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.2 -48.5 28.6 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.757 -0.589 . . . . 0.0 111.572 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -78.67 -7.59 57.84 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.4 -31.81 73.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 113.34 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.76 -36.41 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -126.45 139.26 34.19 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -137.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -94.6 54.99 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.09 1 C-N-CA 125.439 4.093 . . . . 0.0 111.737 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 147.82 46.84 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.41 100.4 1.14 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.955 3.104 . . . . 0.0 109.211 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.14 -25.26 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.327 1.051 . . . . 0.0 113.207 -169.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.58 -33.21 75.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.74 0.816 . . . . 0.0 112.338 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.0 -34.37 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.603 -0.685 . . . . 0.0 110.172 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.5 -44.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.611 0.764 . . . . 0.0 110.756 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.08 -40.13 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.669 0.788 . . . . 0.0 111.24 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.9 m -66.44 -43.18 86.31 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.416 -0.802 . . . . 0.0 111.237 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -34.66 78.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.049 0.939 . . . . 0.0 112.71 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.22 -45.17 94.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.77 1.168 . . . . 0.0 111.812 171.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.69 -13.49 61.33 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.96 -36.46 13.42 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.556 1.143 . . . . 0.0 112.501 168.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -72.38 -30.42 64.66 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.122 1.369 . . . . 0.0 113.573 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.43 128.45 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.809 0.731 . . . . 0.0 111.159 171.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.44 -9.11 58.94 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.484 1.516 . . . . 0.0 114.468 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -71.65 145.75 48.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.387 1.594 . . . . 0.0 111.01 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.81 143.95 50.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.009 1.724 . . . . 0.0 111.549 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -141.5 158.32 44.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.077 1.351 . . . . 0.0 111.363 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -161.96 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -72.39 -34.99 68.32 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.2 m -71.74 163.15 28.32 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -175.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.69 133.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.908 0.883 . . . . 0.0 108.629 171.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.1 t -57.67 -42.75 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 m -61.05 -47.97 83.91 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.568 -0.707 . . . . 0.0 111.075 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -67.44 -34.22 76.75 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.846 -0.534 . . . . 0.0 112.235 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.15 -38.5 83.31 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.099 0.96 . . . . 0.0 111.866 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 81.7 m -69.7 -48.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.433 1.093 . . . . 0.0 111.896 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.2 -46.96 86.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.057 0.543 . . . . 0.0 112.018 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.35 -32.55 74.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.75 -1.219 . . . . 0.0 111.531 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.44 -58.6 7.55 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.307 -0.871 . . . . 0.0 110.885 170.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.76 -25.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.0 m -69.41 -39.97 77.6 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.221 173.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.62 -27.19 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.278 1.399 . . . . 0.0 113.248 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.97 -38.37 82.64 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.545 1.066 . . . . 0.0 112.983 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 34.44 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -39.44 61.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 127.238 2.215 . . . . 0.0 112.493 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.91 44.54 0.1 Allowed Glycine 0 N--CA 1.475 1.263 0 C-N-CA 126.463 1.982 . . . . 0.0 111.528 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 pttm 91.72 -22.63 0.08 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 130.451 3.501 . . . . 0.0 110.172 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.253 1.262 1 C-N-CA 132.741 4.417 . . . . 0.0 113.516 169.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.15 136.61 11.63 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.074 2.516 . . . . 0.0 110.214 169.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -85.45 154.81 59.69 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.428 0.691 . . . . 0.0 110.959 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.97 123.64 11.9 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.138 1.892 . . . . 0.0 109.228 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 -2.3 81.8 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.705 1.622 . . . . 0.0 115.198 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.95 156.79 17.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 1.587 . . . . 0.0 111.734 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.2 pt? -112.42 160.75 17.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.753 1.221 . . . . 0.0 113.581 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mt -144.31 131.91 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.994 1.318 . . . . 0.0 110.471 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.92 121.75 33.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.822 1.249 . . . . 0.0 107.633 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.7 mt -126.6 123.54 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.945 0.898 . . . . 0.0 110.488 -172.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.93 51.72 1.8 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.895 1.678 . . . . 0.0 110.71 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.06 -40.96 82.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.726 1.21 . . . . 0.0 111.86 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 mt -158.8 172.38 18.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.624 1.969 . . . . 0.0 108.192 -168.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.65 -7.39 20.98 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -73.88 -35.52 64.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.349 1.06 . . . . 0.0 113.483 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 68.28 106.52 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.309 2.244 . . . . 0.0 109.509 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -101.39 149.39 24.1 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -94.63 136.98 34.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.062 0.945 . . . . 0.0 109.431 168.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.73 159.06 42.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.194 0.998 . . . . 0.0 112.493 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.39 121.66 29.61 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.419 2.287 . . . . 0.0 107.782 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -77.97 97.65 5.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.576 0.626 . . . . 0.0 110.26 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.7 pt -73.7 -3.54 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.79 137.14 4.07 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.526 1.06 . . . . 0.0 114.293 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.23 -20.51 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 129.953 3.301 . . . . 0.0 117.575 169.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.88 -19.81 0.05 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.211 1.386 . . . . 0.0 115.132 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -89.9 147.89 23.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.182 1.491 . . . . 0.0 113.466 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 m -127.82 146.29 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.211 1.404 . . . . 0.0 112.13 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.48 139.62 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -158.19 158.95 35.54 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.119 -0.988 . . . . 0.0 111.942 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -98.81 136.25 39.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.222 0.609 . . . . 0.0 111.124 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.89 141.16 21.91 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 109.686 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.15 165.14 33.5 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.641 2.894 . . . . 0.0 112.469 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo . . . . . 0 C--N 1.354 0.816 0 C-N-CA 123.363 2.708 . . . . 0.0 115.493 175.46 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.22 155.41 40.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.951 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -138.57 129.94 27.35 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.853 0.861 . . . . 0.0 111.095 -170.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.94 128.95 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.194 0.597 . . . . 0.0 110.11 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -137.67 169.87 17.04 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.878 1.671 . . . . 0.0 112.248 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -127.12 143.04 51.36 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.922 1.689 . . . . 0.0 111.872 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -153.76 179.54 8.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.449 1.9 . . . . 0.0 110.623 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -102.56 140.25 37.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 110.332 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.26 -47.91 71.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.015 1.326 . . . . 0.0 111.631 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.14 -33.34 70.77 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.84 -45.32 51.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.378 0.99 . . . . 0.0 110.27 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.19 -32.31 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.736 1.214 . . . . 0.0 112.605 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.82 -20.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.888 1.675 . . . . 0.0 112.547 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 116.13 8.36 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.253 0.933 . . . . 0.0 111.911 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.6 7.55 74.29 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.574 1.083 . . . . 0.0 115.041 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.3 m -121.15 143.94 48.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.121 1.369 . . . . 0.0 112.468 -171.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 80.8 m -85.04 152.11 23.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.448 0.699 . . . . 0.0 109.674 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -158.18 161.44 37.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.631 0.772 . . . . 0.0 112.977 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -144.61 139.51 28.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.861 1.664 . . . . 0.0 110.536 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.9 t -80.61 138.32 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -126.62 142.1 51.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.813 0.845 . . . . 0.0 112.846 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -137.48 39.59 2.44 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.288 1.435 . . . . 0.0 111.337 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.7 t -57.9 -69.05 0.19 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.571 -1.33 . . . . 0.0 113.725 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.7 mt -72.31 -27.05 62.2 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.39 -0.819 . . . . 0.0 112.181 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.18 -42.14 98.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.637 0.775 . . . . 0.0 112.923 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.03 -8.61 59.09 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -82.56 -36.01 26.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -113.11 -45.0 3.2 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -169.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -142.34 155.04 64.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -133.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.87 -21.36 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.606 3.537 . . . . 0.0 113.122 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 69.18 117.61 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 128.441 2.696 . . . . 0.0 115.408 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.54 88.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 123.733 2.956 . . . . 0.0 108.58 169.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.71 -38.74 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.997 -169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -38.79 81.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.539 0.609 . . . . 0.0 111.721 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.43 -38.16 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.79 0.723 . . . . 0.0 111.305 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.68 -47.36 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 119.281 0.946 . . . . 0.0 110.323 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 90.8 mt -61.41 -40.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.206 1.002 . . . . 0.0 110.94 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.1 t -63.42 -42.93 98.73 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.434 0.694 . . . . 0.0 111.408 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -58.96 -40.54 85.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.321 -0.862 . . . . 0.0 112.248 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.9 -52.57 59.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.49 0.716 . . . . 0.0 111.982 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.82 -22.72 67.05 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.34 -50.03 12.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.165 0.986 . . . . 0.0 112.367 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 ptm -83.46 -14.13 53.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -170.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -55.54 125.4 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -8.45 59.06 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.391 1.472 . . . . 0.0 114.297 -169.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -70.63 153.97 42.33 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.576 1.688 . . . . 0.0 110.779 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -127.64 142.24 51.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.79 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -140.43 149.25 42.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.072 0.949 . . . . 0.0 113.059 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -154.28 -152.33 0.4 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.664 1.586 . . . . 0.0 111.262 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.9 t80 72.35 -53.77 0.69 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.871 2.869 . . . . 0.0 113.885 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.1 m -69.41 162.99 26.22 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.734 1.214 . . . . 0.0 112.379 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 tt -63.3 144.25 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 121.378 -0.826 . . . . 0.0 109.898 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.33 -27.63 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.8 t -64.14 -49.11 73.44 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.367 -0.833 . . . . 0.0 111.151 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -68.71 -28.7 67.07 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.933 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -57.34 -42.31 81.72 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.862 1.665 . . . . 0.0 111.191 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -45.11 53.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.957 1.303 . . . . 0.0 112.968 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.24 -41.41 90.06 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.117 -0.99 . . . . 0.0 112.69 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.85 -36.36 83.24 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.602 -1.311 . . . . 0.0 110.784 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.27 -58.0 10.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.482 0.713 . . . . 0.0 110.706 170.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -65.97 -27.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.954 1.252 . . . . 0.0 113.486 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -68.92 -33.97 74.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.819 1.19 . . . . 0.0 111.429 172.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -66.38 -23.14 66.28 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.61 -61.38 1.89 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.456 -0.778 . . . . 0.0 111.758 169.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -72.63 5.6 2.99 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -53.35 -24.75 12.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.251 2.22 . . . . 0.0 112.459 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.41 -24.51 11.01 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 127.573 2.511 . . . . 0.0 114.615 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.56 -19.94 0.47 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.252 1.021 . . . . 0.0 113.019 177.617 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 119.012 -0.518 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.57 139.47 12.72 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 108.378 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -85.8 148.65 49.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.536 -0.728 . . . . 0.0 111.529 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.56 128.02 20.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.182 2.588 . . . . 0.0 109.957 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.48 82.86 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.938 1.733 . . . . 0.0 115.039 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.6 162.96 12.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -100.9 110.72 22.81 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 127.64 2.376 . . . . 0.0 113.636 -168.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.23 132.35 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.099 1.359 . . . . 0.0 109.92 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -96.54 116.98 29.98 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.07 120.29 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.317 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -81.72 63.16 5.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.675 1.19 . . . . 0.0 109.47 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -62.24 -29.38 70.36 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.317 1.047 . . . . 0.0 113.122 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.46 -144.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.092 1.357 . . . . 0.0 110.456 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.27 31.11 0.81 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.274 1.416 . . . . 0.0 114.706 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -168.44 154.87 7.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.786 2.835 . . . . 0.0 110.093 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -104.65 128.45 52.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.969 0.907 . . . . 0.0 110.812 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -108.76 134.69 51.12 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.878 1.271 . . . . 0.0 110.786 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -79.78 144.65 33.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.82 145.31 37.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.346 1.458 . . . . 0.0 111.521 169.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.14 118.19 36.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.244 1.818 . . . . 0.0 107.948 173.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -74.09 94.7 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.537 0.735 . . . . 0.0 110.64 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 pt -74.04 -8.8 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.668 -1.27 . . . . 0.0 114.15 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.97 133.83 2.91 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.738 0.685 . . . . 0.0 114.29 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 63.39 -19.56 0.06 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.634 3.173 . . . . 0.0 117.284 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.52 -21.44 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.509 1.528 . . . . 0.0 114.683 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.87 144.45 30.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.949 1.375 . . . . 0.0 113.002 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.83 145.62 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.135 1.374 . . . . 0.0 112.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.8 mm -107.45 138.64 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.753 1.621 . . . . 0.0 107.643 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -153.68 146.47 24.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.502 1.047 . . . . 0.0 112.091 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.12 118.79 31.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 109.844 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.9 119.49 75.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.855 1.262 . . . . 0.0 108.96 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -74.28 165.33 32.1 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.714 2.943 . . . . 0.0 112.261 -173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 CA--C 1.54 0.806 0 C-N-CA 122.667 2.244 . . . . 0.0 110.051 177.314 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 121.176 0.513 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.21 159.11 28.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.014 0.926 . . . . 0.0 111.04 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -152.58 138.46 18.05 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.652 -0.655 . . . . 0.0 112.197 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.4 t -82.54 125.76 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.551 1.14 . . . . 0.0 109.406 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.47 175.15 9.79 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.959 1.704 . . . . 0.0 112.004 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -141.21 143.95 34.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.645 1.578 . . . . 0.0 112.24 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -178.78 -165.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.434 2.694 . . . . 0.0 109.249 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -103.79 150.0 24.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.7 tp -50.94 -57.87 7.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.123 1.769 . . . . 0.0 111.477 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 69' ' ' VAL . 17.7 pm0 -57.27 -33.44 67.62 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.088 0.955 . . . . 0.0 113.409 -174.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.04 -30.03 58.27 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.371 -0.831 . . . . 0.0 112.015 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.49 -45.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.204 1.401 . . . . 0.0 111.785 172.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 66' ' ' GLU . 34.7 m -84.62 -6.13 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.4 7.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 119.145 0.884 . . . . 0.0 111.777 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.28 7.72 78.23 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.835 1.207 . . . . 0.0 115.07 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.36 151.84 42.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.593 1.557 . . . . 0.0 112.549 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.61 160.12 19.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.874 0.87 . . . . 0.0 110.63 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -161.67 168.15 23.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.339 1.056 . . . . 0.0 113.44 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -167.23 149.98 6.21 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.122 1.769 . . . . 0.0 110.147 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.16 138.82 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 119.735 1.152 . . . . 0.0 110.153 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -132.32 130.69 41.11 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.013 1.325 . . . . 0.0 111.977 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -123.43 25.84 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.202 1.801 . . . . 0.0 113.299 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.7 m -60.82 -21.45 63.16 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.547 -1.345 . . . . 0.0 114.577 -171.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 mt -93.27 -39.25 11.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.806 0.842 . . . . 0.0 113.025 169.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.58 -35.06 71.8 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.439 1.018 . . . . 0.0 111.819 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -52.88 -29.12 26.44 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.401 2.28 . . . . 0.0 113.052 171.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -87.26 -14.91 39.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.494 1.118 . . . . 0.0 112.993 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -122.03 -64.64 1.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -138.71 149.7 63.17 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -135.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 -11.55 15.27 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 125.183 3.922 . . . . 0.0 114.074 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 81.21 96.48 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 127.586 2.354 . . . . 0.0 114.012 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.99 80.89 2.74 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.745 2.963 . . . . 0.0 108.528 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.77 -29.58 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.64 -39.5 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.465 1.03 . . . . 0.0 111.428 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.09 -34.23 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.387 -0.821 . . . . 0.0 110.247 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.9 mt -76.71 -39.69 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.995 0.918 . . . . 0.0 111.566 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.04 -45.32 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.551 -0.718 . . . . 0.0 110.979 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.9 p -68.21 -29.98 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.337 -0.852 . . . . 0.0 112.413 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -59.7 -46.64 88.47 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.059 -1.025 . . . . 0.0 111.192 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.65 92.09 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.079 -1.013 . . . . 0.0 112.428 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -67.42 -15.7 63.82 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -90.14 -38.35 13.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.977 1.311 . . . . 0.0 112.113 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.4 mmm -70.46 -25.09 63.02 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.361 1.464 . . . . 0.0 113.999 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -48.59 127.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.105 0.866 . . . . 0.0 111.804 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.87 81.4 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.127 1.346 . . . . 0.0 115.114 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -73.62 138.94 45.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.6 1.7 . . . . 0.0 110.7 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -98.08 156.12 16.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.363 1.465 . . . . 0.0 112.173 170.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 mtm -144.43 159.26 43.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.33 1.852 . . . . 0.0 111.44 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -158.61 -32.8 0.07 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -70.11 151.97 44.86 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.453 1.101 . . . . 0.0 113.879 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 t 76.76 -179.04 0.14 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.858 2.063 . . . . 0.0 113.803 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 pt -76.61 149.28 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.643 1.177 . . . . 0.0 110.558 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.91 -35.43 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.833 0.742 . . . . 0.0 112.542 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 p -64.35 -47.08 80.69 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.809 0.844 . . . . 0.0 112.485 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -67.95 -37.18 81.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.229 -0.919 . . . . 0.0 111.249 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -59.58 -46.56 88.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.289 0.95 . . . . 0.0 111.819 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.7 p -73.33 -37.34 66.15 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.495 -0.753 . . . . 0.0 112.797 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.25 -54.57 44.13 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.045 0.839 . . . . 0.0 111.355 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -56.1 -39.5 72.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.607 1.163 . . . . 0.0 111.224 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -56.43 -58.64 7.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.183 0.993 . . . . 0.0 111.294 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.3 m -64.98 -33.2 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.174 1.352 . . . . 0.0 113.253 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.7 m -68.36 -31.98 71.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.135 1.334 . . . . 0.0 111.544 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.51 -25.46 66.69 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.526 1.512 . . . . 0.0 112.327 169.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.62 -56.48 5.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.155 0.889 . . . . 0.0 110.976 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -75.96 5.7 6.19 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -57.7 -23.31 51.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.798 2.039 . . . . 0.0 113.434 -170.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -40.22 -36.32 0.89 Allowed Glycine 0 N--CA 1.474 1.185 0 C-N-CA 128.839 3.114 . . . . 0.0 117.465 -169.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -138.68 16.52 2.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.2 1.0 . . . . 0.0 112.77 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 126.203 1.801 . . . . 0.0 112.565 -178.51 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.66 129.74 28.93 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.331 2.688 . . . . 0.0 113.15 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.79 140.36 21.29 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.867 1.267 . . . . 0.0 108.136 169.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.23 131.37 21.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.244 1.296 . . . . 0.0 109.919 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.99 83.27 Favored Glycine 0 N--CA 1.469 0.859 0 C-N-CA 124.678 1.132 . . . . 0.0 114.66 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.77 168.81 9.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.19 1.495 . . . . 0.0 113.103 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.4 mt -102.99 111.35 23.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.922 1.689 . . . . 0.0 113.857 -168.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.6 mt -97.17 129.06 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 109.86 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.35 120.99 37.65 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.293 1.437 . . . . 0.0 107.559 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -121.47 121.91 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.297 1.039 . . . . 0.0 109.967 -174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -77.19 67.55 3.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.638 1.175 . . . . 0.0 111.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -64.8 -47.57 77.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.011 1.324 . . . . 0.0 113.451 -170.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -148.38 37.81 0.85 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.614 0.721 . . . . 0.0 112.583 -158.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.38 72.06 Favored Glycine 0 N--CA 1.477 1.41 0 O-C-N 121.396 -0.815 . . . . 0.0 113.012 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -162.02 146.86 12.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.887 2.475 . . . . 0.0 109.498 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -89.92 116.81 28.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.493 0.663 . . . . 0.0 111.42 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -94.15 145.1 24.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.583 1.553 . . . . 0.0 109.927 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -84.07 144.61 28.95 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.08 151.79 41.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.763 1.225 . . . . 0.0 112.945 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.83 120.06 41.13 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.245 2.218 . . . . 0.0 108.565 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.49 92.92 1.93 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.576 0.751 . . . . 0.0 111.609 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 pt -81.81 -21.22 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.94 -179.17 31.68 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 124.919 1.247 . . . . 0.0 110.945 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.07 96.74 0.82 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.133 0.968 . . . . 0.0 110.764 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.44 -0.45 89.28 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.168 1.842 . . . . 0.0 114.483 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -99.67 139.32 35.5 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.031 1.916 . . . . 0.0 112.148 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -138.63 149.94 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.87 129.01 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 168.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -145.11 149.22 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.502 1.046 . . . . 0.0 111.952 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.488 HD11 ' HB1' ' A' ' 58' ' ' ALA . 58.0 tp -90.93 123.8 34.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.85 111.31 41.53 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.986 1.314 . . . . 0.0 107.555 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.77 165.48 16.0 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.002 3.135 . . . . 0.0 114.016 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 C--N 1.352 0.724 0 C-N-CA 123.189 2.593 . . . . 0.0 111.159 177.793 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 36' ' ' LEU . . . -79.79 154.37 28.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.594 1.157 . . . . 0.0 110.74 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -133.01 135.32 45.37 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.957 0.903 . . . . 0.0 111.491 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.31 125.41 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 169.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.42 156.83 42.55 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.078 1.751 . . . . 0.0 112.798 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -111.4 138.6 47.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.826 1.65 . . . . 0.0 111.016 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -170.18 173.93 5.62 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.869 1.268 . . . . 0.0 110.72 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -93.07 144.95 24.76 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.267 -0.895 . . . . 0.0 112.397 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 tp -53.75 -50.23 66.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.94 1.296 . . . . 0.0 111.07 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 69' ' ' VAL . 12.6 pt-20 -55.61 -30.92 61.76 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.764 1.226 . . . . 0.0 114.044 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.82 -39.96 25.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.452 -0.78 . . . . 0.0 111.779 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.46 -41.01 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.195 0.598 . . . . 0.0 111.507 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 66' ' ' GLU . 33.9 m -70.26 -40.47 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.565 1.075 . . . . 0.0 112.165 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 18.86 61.18 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.148 0.885 . . . . 0.0 115.0 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.08 -8.35 72.95 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.377 1.465 . . . . 0.0 114.633 -173.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.2 m -78.36 169.43 18.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.091 1.357 . . . . 0.0 112.305 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.3 m -71.38 155.59 40.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.84 0.856 . . . . 0.0 113.213 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.95 154.25 27.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.045 1.338 . . . . 0.0 112.664 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -142.05 167.4 22.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.467 1.907 . . . . 0.0 109.881 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.18 134.54 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 119.172 0.897 . . . . 0.0 109.744 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -158.73 129.2 6.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -139.18 57.09 1.67 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 110.566 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.8 m -49.42 -40.72 37.49 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -169.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.44 -34.43 72.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.145 0.884 . . . . 0.0 113.276 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 -26.94 60.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.653 0.781 . . . . 0.0 111.715 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -73.41 -33.73 65.13 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.989 0.916 . . . . 0.0 111.458 169.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.08 -32.86 74.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 112.01 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -168.12 150.4 5.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.841 1.656 . . . . 0.0 113.841 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 80.17 147.94 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 127.196 2.198 . . . . 0.0 115.448 152.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.26 165.4 16.74 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 124.439 3.426 . . . . 0.0 110.542 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -137.47 146.42 53.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 120.953 -1.092 . . . . 0.0 113.678 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.86 83.09 2.33 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.015 3.143 . . . . 0.0 109.476 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -36.92 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.494 1.118 . . . . 0.0 113.203 -169.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -72.23 -35.79 68.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.085 0.857 . . . . 0.0 111.793 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -74.93 -29.92 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.887 0.875 . . . . 0.0 110.13 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.92 -42.36 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.288 1.035 . . . . 0.0 111.535 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.7 -40.55 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.722 0.809 . . . . 0.0 110.449 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.1 m -65.76 -42.25 91.13 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.503 -0.748 . . . . 0.0 111.783 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.2 t -61.79 -40.96 97.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.509 1.123 . . . . 0.0 111.64 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.66 71.79 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.634 0.774 . . . . 0.0 111.308 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -67.32 -15.18 63.54 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.39 -42.84 14.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.276 1.031 . . . . 0.0 113.033 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.6 ptm -81.31 -25.26 36.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -50.01 128.56 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.685 0.755 . . . . 0.0 112.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -15.92 52.53 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.727 1.632 . . . . 0.0 113.964 -170.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -78.63 163.56 25.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.769 1.785 . . . . 0.0 112.215 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.59 150.33 50.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.7 1.6 . . . . 0.0 112.594 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -141.71 159.01 43.09 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.963 1.305 . . . . 0.0 112.407 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -154.38 -3.28 0.17 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -74.77 141.74 44.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.075 -1.016 . . . . 0.0 113.064 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.9 t 71.3 -176.19 0.19 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.346 1.859 . . . . 0.0 114.19 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.5 pt -75.12 152.35 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.644 1.177 . . . . 0.0 111.105 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.1 m -53.83 -38.4 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.1 m -70.67 -38.91 73.81 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.134 0.879 . . . . 0.0 111.904 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -72.06 -35.67 69.36 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.626 -0.671 . . . . 0.0 111.671 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.71 -42.02 82.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.113 0.965 . . . . 0.0 111.209 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -51.56 67.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.762 1.625 . . . . 0.0 113.16 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.41 -45.67 93.37 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.199 -0.938 . . . . 0.0 112.307 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -56.75 -40.33 75.58 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.988 1.715 . . . . 0.0 111.075 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.511 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 26.0 t80 -63.2 -52.69 61.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.563 1.145 . . . . 0.0 112.035 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.6 -20.7 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 120.521 1.51 . . . . 0.0 114.216 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -71.86 -43.23 65.83 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.141 0.882 . . . . 0.0 109.387 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -62.37 -25.36 67.87 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 53.4 mt -71.94 -58.64 3.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.863 0.756 . . . . 0.0 110.563 169.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ptt85 -76.29 9.19 2.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -58.27 -19.93 38.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.888 2.075 . . . . 0.0 113.739 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.66 -38.92 7.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.875 2.179 . . . . 0.0 114.247 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -137.23 5.47 2.76 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 C--O 1.252 1.202 0 C-N-CA 125.758 1.623 . . . . 0.0 114.821 -174.781 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.69 156.63 62.91 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.391 2.727 . . . . 0.0 111.352 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -99.84 141.31 22.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 0.0 111.664 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.01 129.82 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.255 1.97 . . . . 0.0 110.045 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.09 8.15 75.96 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 118.233 -1.315 . . . . 0.0 114.43 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -117.25 157.61 25.75 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.596 1.698 . . . . 0.0 113.935 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.75 127.32 39.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.543 1.937 . . . . 0.0 113.496 -168.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.52 126.41 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.205 1.802 . . . . 0.0 109.577 -174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.4 122.26 34.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.53 125.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.885 1.274 . . . . 0.0 109.296 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.1 53.07 1.65 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.269 1.427 . . . . 0.0 111.677 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -25.61 66.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -169.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -159.26 26.8 0.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -161.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.87 6.4 72.42 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 124.263 0.935 . . . . 0.0 114.015 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.65 148.19 30.8 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.322 2.249 . . . . 0.0 109.385 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -82.86 107.41 15.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.569 0.747 . . . . 0.0 110.116 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -107.22 154.8 20.69 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.804 1.242 . . . . 0.0 111.206 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.14 168.11 22.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.168 2.187 . . . . 0.0 110.674 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' CD2' HD13 ' A' ' 120' ' ' LEU . 8.7 tp -142.71 121.17 12.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.089 1.756 . . . . 0.0 109.22 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.77 116.36 14.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.421 1.088 . . . . 0.0 110.918 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.0 pt -107.2 -16.06 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.62 39.02 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 126.228 1.87 . . . . 0.0 110.294 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.31 92.31 0.28 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.066 0.936 . . . . 0.0 112.067 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.82 87.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.111 1.815 . . . . 0.0 114.503 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -100.67 135.29 42.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.238 1.519 . . . . 0.0 111.76 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.54 150.84 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.161 0.984 . . . . 0.0 113.139 -173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 mt -105.93 141.78 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -156.62 152.79 27.62 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 111.617 -169.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -96.36 125.18 40.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.472 0.709 . . . . 0.0 110.266 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.51 136.1 33.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.248 1.019 . . . . 0.0 109.215 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.95 169.4 22.5 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 112.678 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 C--N 1.354 0.827 0 C-N-CA 123.837 3.025 . . . . 0.0 115.571 177.627 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.75 159.36 33.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.838 -0.539 . . . . 0.0 111.173 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.57 134.06 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.629 0.772 . . . . 0.0 111.108 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.6 t -83.75 126.14 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.678 0.791 . . . . 0.0 109.213 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -134.36 172.06 13.42 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.787 1.635 . . . . 0.0 112.191 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -151.97 125.79 9.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.267 1.027 . . . . 0.0 112.18 -171.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -169.38 -161.47 0.3 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.861 2.064 . . . . 0.0 110.959 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 -85.34 146.43 27.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -51.0 -52.46 42.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.334 1.854 . . . . 0.0 111.374 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -56.99 -30.33 64.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.65 -45.16 17.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.381 0.992 . . . . 0.0 110.722 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.02 -34.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.122 0.569 . . . . 0.0 112.238 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -82.27 -45.49 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.144 0.978 . . . . 0.0 111.113 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.21 23.1 65.91 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 119.359 0.981 . . . . 0.0 114.867 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.3 2.26 70.99 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.206 1.384 . . . . 0.0 115.066 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -72.01 171.11 12.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 118.93 1.365 . . . . 0.0 112.852 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.85 152.17 31.44 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.428 0.691 . . . . 0.0 111.192 169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -158.81 169.65 23.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.438 1.095 . . . . 0.0 113.287 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -168.09 151.76 5.99 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.891 1.677 . . . . 0.0 110.899 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.5 t -85.86 137.76 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 169.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -161.24 108.3 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.377 1.871 . . . . 0.0 108.635 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -83.17 -32.92 26.36 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.421 -0.799 . . . . 0.0 112.95 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t 74.78 -51.47 0.68 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 129.122 2.969 . . . . 0.0 113.273 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -96.66 -33.13 11.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.91 -25.62 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.283 0.947 . . . . 0.0 112.463 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -75.19 -14.52 60.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.346 1.058 . . . . 0.0 112.963 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -96.08 -34.8 11.59 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.098 1.359 . . . . 0.0 112.327 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -172.55 165.82 5.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.118 1.767 . . . . 0.0 112.719 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 89.74 154.28 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 129.975 3.31 . . . . 0.0 115.446 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.96 -31.79 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.298 3.332 . . . . 0.0 113.434 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 ttp-105 70.76 111.99 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.611 2.764 . . . . 0.0 114.683 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -80.44 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.726 2.951 . . . . 0.0 110.329 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 t -54.43 -40.14 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.638 1.175 . . . . 0.0 112.451 -173.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -68.58 -42.92 77.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 111.286 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.4 t -73.23 -30.76 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.899 0.88 . . . . 0.0 110.217 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.1 -41.06 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.425 1.09 . . . . 0.0 111.761 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.44 -36.8 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 119.642 1.11 . . . . 0.0 110.882 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -66.69 -41.46 88.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.126 -0.984 . . . . 0.0 111.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.5 m -63.84 -41.97 97.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.506 1.123 . . . . 0.0 111.655 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.86 -49.55 77.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.765 0.826 . . . . 0.0 111.411 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -56.51 -43.62 79.96 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.746 . . . . 0.0 112.332 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.28 -31.23 70.04 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.2 mtp -73.9 -17.78 60.99 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.72 125.99 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 120.549 1.522 . . . . 0.0 110.623 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.09 66.92 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.625 1.583 . . . . 0.0 114.592 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.44 151.06 32.9 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 111.797 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -87.23 158.2 19.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.011 1.324 . . . . 0.0 110.367 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtp -143.8 148.4 35.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.577 1.551 . . . . 0.0 110.866 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -167.19 -152.7 0.13 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.927 1.291 . . . . 0.0 111.646 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 62.93 22.93 13.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.117 1.767 . . . . 0.0 114.609 169.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.3 p -166.8 156.76 11.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.142 1.377 . . . . 0.0 112.274 -171.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.88 146.22 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.612 1.165 . . . . 0.0 108.606 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 96.6 t -49.93 -39.36 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.776 1.23 . . . . 0.0 113.221 -170.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -56.58 -49.52 74.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.047 0.939 . . . . 0.0 112.192 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -74.85 -34.29 62.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.485 -0.759 . . . . 0.0 111.924 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -57.84 -43.84 86.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.635 1.107 . . . . 0.0 111.917 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.68 -38.45 54.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.7 -46.53 85.06 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.941 -1.099 . . . . 0.0 112.39 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -64.19 -35.32 80.43 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.784 -1.197 . . . . 0.0 110.639 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -58.78 -59.36 5.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.986 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 120' ' ' LEU . 13.0 m -64.99 -25.59 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.688 1.586 . . . . 0.0 113.662 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -69.66 -37.28 76.66 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.495 1.043 . . . . 0.0 110.805 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.59 -20.2 65.95 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.662 1.119 . . . . 0.0 112.952 170.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.441 HD13 ' CD2' ' A' ' 26' ' ' LEU . 59.1 mt -76.12 -65.16 0.95 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.385 0.993 . . . . 0.0 110.352 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.4 ptt85 -75.2 14.28 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -52.91 -23.67 7.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.156 2.183 . . . . 0.0 112.632 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.68 -45.05 7.04 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 128.091 2.758 . . . . 0.0 114.435 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -139.36 -5.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 124.555 1.142 . . . . 0.0 112.128 174.288 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.45 123.69 6.66 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.875 2.383 . . . . 0.0 110.422 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.35 161.27 27.71 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 125.538 1.535 . . . . 0.0 111.049 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.75 135.98 51.28 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.621 2.214 . . . . 0.0 113.145 -169.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.2 -17.59 58.89 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.381 1.467 . . . . 0.0 114.815 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.38 149.72 22.87 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.441 1.121 . . . . 0.0 112.337 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -107.51 140.3 40.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.645 1.212 . . . . 0.0 111.548 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt -125.4 127.45 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.807 2.043 . . . . 0.0 107.936 -159.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -88.68 119.78 29.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -123.19 134.71 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.459 1.104 . . . . 0.0 109.653 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -78.09 66.48 3.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.328 1.051 . . . . 0.0 110.181 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -47.16 77.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.56 1.944 . . . . 0.0 113.788 -169.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.24 37.5 0.44 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -166.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.85 12.23 56.92 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.173 0.892 . . . . 0.0 113.832 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -166.39 134.98 2.93 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.835 2.054 . . . . 0.0 109.729 -171.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.06 128.05 34.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.778 1.631 . . . . 0.0 112.386 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.27 151.04 47.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.154 . . . . 0.0 112.063 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -85.7 147.29 26.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.11 138.46 37.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.41 1.484 . . . . 0.0 111.568 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.26 121.22 41.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.429 1.891 . . . . 0.0 109.111 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.8 111.62 8.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.227 1.011 . . . . 0.0 111.303 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 pt -104.16 -20.82 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.53 172.42 40.27 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.91 101.39 0.12 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.513 1.157 . . . . 0.0 112.253 -172.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.95 -2.0 76.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.691 1.615 . . . . 0.0 115.488 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -98.44 137.94 36.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.625 1.713 . . . . 0.0 112.826 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.94 153.59 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.799 1.239 . . . . 0.0 112.431 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.47 126.44 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -136.07 160.07 39.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.303 0.956 . . . . 0.0 111.345 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.3 tp -85.3 137.55 32.89 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.8 123.8 44.33 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.156 1.382 . . . . 0.0 107.626 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.85 167.41 27.3 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.168 2.579 . . . . 0.0 112.081 -172.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo . . . . . 0 C--N 1.352 0.722 0 C-N-CA 123.237 2.625 . . . . 0.0 110.649 171.79 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.55 164.7 14.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.203 1.001 . . . . 0.0 111.005 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.04 137.76 26.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.353 1.061 . . . . 0.0 111.492 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.89 127.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.57 1.148 . . . . 0.0 110.857 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -129.67 148.91 51.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.008 1.723 . . . . 0.0 112.855 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -95.05 138.86 32.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.847 1.259 . . . . 0.0 109.403 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -163.22 169.05 19.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.604 1.162 . . . . 0.0 110.8 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -90.42 141.63 28.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.245 1.018 . . . . 0.0 111.244 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 tp -53.29 -47.3 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.496 1.119 . . . . 0.0 111.494 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.78 -31.49 66.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.52 -43.59 26.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.151 0.887 . . . . 0.0 110.914 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 t -60.87 -38.36 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 122.574 0.35 . . . . 0.0 111.51 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.36 -47.01 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.34 18.19 62.77 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.48 1.036 . . . . 0.0 114.955 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.69 -2.62 82.69 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.593 1.568 . . . . 0.0 114.868 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.4 m -76.25 176.59 7.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.149 1.38 . . . . 0.0 113.065 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -71.3 150.02 45.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.355 1.062 . . . . 0.0 112.5 173.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -157.72 152.17 24.88 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.645 1.178 . . . . 0.0 113.247 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -136.02 157.86 45.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.395 1.878 . . . . 0.0 110.047 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.09 126.21 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.4 0.68 . . . . 0.0 109.977 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -167.3 113.05 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.892 1.277 . . . . 0.0 110.645 -174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -83.68 71.87 10.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.232 1.013 . . . . 0.0 108.592 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 p -33.31 -64.11 0.21 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.159 2.583 . . . . 0.0 115.823 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.0 mt -84.17 -27.1 28.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.44 -37.6 84.14 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.733 -0.604 . . . . 0.0 111.259 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.3 -28.54 66.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.015 1.326 . . . . 0.0 113.381 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -86.8 -29.16 22.49 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.77 -38.8 3.05 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 117.109 2.263 . . . . 0.0 117.109 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -155.22 159.48 31.71 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -134.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -98.3 1.51 1.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 1 C-N-CA 125.558 4.172 . . . . 0.0 114.197 169.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -12.61 125.28 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 130.401 3.48 . . . . 0.0 117.097 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.48 121.89 9.62 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.334 3.356 . . . . 0.0 112.902 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.3 -34.79 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.021 0.928 . . . . 0.0 112.473 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.84 -35.23 79.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.64 0.654 . . . . 0.0 111.707 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.37 -37.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.468 0.707 . . . . 0.0 110.211 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.46 -41.54 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.699 0.681 . . . . 0.0 110.933 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -64.26 -42.58 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.895 0.771 . . . . 0.0 111.313 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.2 m -62.88 -42.03 99.62 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.668 -0.645 . . . . 0.0 111.563 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -62.1 -45.42 93.59 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.504 1.122 . . . . 0.0 111.515 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.27 86.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.953 0.901 . . . . 0.0 112.145 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.2 -49.89 75.84 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.651 -0.656 . . . . 0.0 111.815 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -60.79 -30.91 70.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.2 mmm -73.75 -13.17 60.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 114.164 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.6 t -57.07 125.99 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.88 1.218 . . . . 0.0 110.704 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.95 75.44 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.173 1.368 . . . . 0.0 114.608 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -74.97 143.15 43.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.251 1.525 . . . . 0.0 110.45 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -112.38 151.69 29.5 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.259 1.824 . . . . 0.0 111.228 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.81 147.08 13.26 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -145.48 59.16 1.27 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.786 1.635 . . . . 0.0 109.34 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -65.8 -32.01 73.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.916 1.286 . . . . 0.0 113.618 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 t -165.58 -162.81 0.61 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.486 1.514 . . . . 0.0 110.29 -170.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.2 pt -60.1 150.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.09 0.956 . . . . 0.0 109.803 169.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.4 -36.28 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.9 m -63.37 -53.26 55.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.537 0.608 . . . . 0.0 111.363 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -70.49 -28.49 65.02 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 121.256 -0.902 . . . . 0.0 111.968 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -60.57 -33.5 72.8 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.392 1.451 . . . . 0.0 111.086 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.37 -40.93 25.63 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.624 1.169 . . . . 0.0 113.254 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.7 -41.0 98.18 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.289 -1.507 . . . . 0.0 112.073 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -65.35 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.776 -1.203 . . . . 0.0 110.701 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.84 -55.84 25.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.748 1.219 . . . . 0.0 111.749 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.01 -30.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 120.218 1.372 . . . . 0.0 112.79 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -69.13 -39.21 79.03 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.633 -1.175 . . . . 0.0 111.124 173.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.86 -28.66 66.31 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.217 1.372 . . . . 0.0 112.932 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.4 mt -67.32 -52.46 40.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.394 0.997 . . . . 0.0 111.246 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -92.68 16.05 13.08 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -62.69 -24.91 67.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.527 1.931 . . . . 0.0 114.45 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.15 -68.84 1.48 Allowed Glycine 0 N--CA 1.473 1.129 0 C-N-CA 125.661 1.6 . . . . 0.0 114.166 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -101.47 -12.13 18.78 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.254 1.312 0 C-N-CA 124.594 1.157 . . . . 0.0 113.017 -175.915 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.17 127.67 27.26 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.043 3.162 . . . . 0.0 112.795 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -103.78 143.88 27.54 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.881 1.272 . . . . 0.0 110.236 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.68 122.73 10.17 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.989 1.793 . . . . 0.0 109.816 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.52 15.42 66.14 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.682 1.134 . . . . 0.0 114.827 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -122.12 165.22 16.44 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.996 1.398 . . . . 0.0 111.924 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.76 154.64 33.88 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -169.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -128.47 142.88 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.217 2.607 . . . . 0.0 109.081 -160.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.15 123.72 48.3 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.102 1.361 . . . . 0.0 107.335 168.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.24 125.91 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 110.485 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -79.69 65.45 4.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.502 1.121 . . . . 0.0 110.366 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -61.46 -33.69 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.0 32.12 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.788 1.235 . . . . 0.0 113.757 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.63 -18.51 52.44 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.654 1.597 . . . . 0.0 114.791 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -74.08 -31.16 62.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 73.77 99.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.279 2.632 . . . . 0.0 110.302 -172.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -102.52 148.7 25.2 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.647 1.179 . . . . 0.0 111.297 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -87.82 151.54 22.79 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 169.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.01 39.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.303 1.041 . . . . 0.0 112.466 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.5 OUTLIER -115.56 125.2 52.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.647 1.979 . . . . 0.0 108.776 177.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -80.29 100.35 8.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.064 0.946 . . . . 0.0 110.682 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 pt -89.01 -14.15 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.73 -171.26 37.35 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.03 97.0 0.16 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 111.675 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.92 25.15 58.58 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.15 1.833 . . . . 0.0 115.572 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.272 6.8 p90 -144.1 149.24 36.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.459 2.129 . . . . 0.0 115.503 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.06 157.15 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -168.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mm -107.44 139.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.491 2.317 . . . . 0.0 106.348 168.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -156.33 161.67 40.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.14 1.336 . . . . 0.0 112.418 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.64 123.6 48.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.033 0.933 . . . . 0.0 111.642 -171.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.6 113.11 61.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.154 1.382 . . . . 0.0 108.582 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.61 167.65 9.6 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.09 3.194 . . . . 0.0 115.734 -169.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo . . . . . 0 C--N 1.356 0.929 0 C-N-CA 124.214 3.276 . . . . 0.0 113.657 171.83 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 163.01 26.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.178 0.991 . . . . 0.0 110.206 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.81 138.56 42.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.086 0.954 . . . . 0.0 111.14 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.9 t -85.67 123.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.942 0.897 . . . . 0.0 108.707 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.83 171.6 10.56 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.796 1.638 . . . . 0.0 112.042 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -146.95 139.82 25.14 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.337 1.455 . . . . 0.0 111.841 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -176.68 -178.07 0.86 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.449 1.9 . . . . 0.0 111.866 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -72.66 148.29 44.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.11 -59.78 4.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.26 1.024 . . . . 0.0 110.617 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -65.78 -18.13 65.12 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.95 -34.28 64.24 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.431 1.014 . . . . 0.0 110.916 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.85 -54.76 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.867 0.867 . . . . 0.0 111.236 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.63 3.21 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.99 -21.0 43.95 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.51 24.34 4.16 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 125.337 1.446 . . . . 0.0 113.69 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 54.0 m -125.72 161.9 26.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.956 1.302 . . . . 0.0 114.298 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 97.4 m -96.99 149.55 21.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.917 1.287 . . . . 0.0 108.756 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -166.16 158.61 14.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -147.61 152.15 37.42 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.758 1.623 . . . . 0.0 110.792 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.54 129.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -162.79 133.52 4.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.063 0.545 . . . . 0.0 110.913 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -153.85 49.82 0.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.974 0.893 . . . . 0.0 112.635 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.8 m -56.56 -30.02 62.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 tp -71.84 -39.28 69.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.396 0.998 . . . . 0.0 112.069 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -41.6 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.186 0.994 . . . . 0.0 110.644 169.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.0 -11.82 50.66 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.16 0.984 . . . . 0.0 113.58 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.78 -22.64 60.81 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.205 0.911 . . . . 0.0 113.036 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.81 -43.23 0.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 119.619 3.192 . . . . 0.0 119.619 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -100.38 147.74 33.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 121.0 1.727 . . . . 0.0 114.031 -154.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.53 -27.99 3.06 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.769 2.979 . . . . 0.0 112.715 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ttp-105 74.12 115.03 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.613 2.765 . . . . 0.0 115.014 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.1 91.12 1.22 Allowed 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.121 3.214 . . . . 0.0 109.623 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 t -50.11 -46.72 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.476 1.511 . . . . 0.0 113.742 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -38.28 84.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.679 0.672 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.7 -35.31 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.788 0.835 . . . . 0.0 111.952 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.5 mm -63.7 -49.11 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 119.898 1.226 . . . . 0.0 110.727 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.59 -39.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.558 0.743 . . . . 0.0 110.692 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -68.07 -40.45 82.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.217 0.607 . . . . 0.0 111.107 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m -61.76 -44.77 96.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.099 0.959 . . . . 0.0 111.363 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.31 74.53 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.155 0.982 . . . . 0.0 111.578 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.91 -18.6 65.45 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.17 -44.44 16.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.649 1.113 . . . . 0.0 112.397 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.1 ptm -77.44 -17.43 58.1 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.6 p -42.23 125.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.632 0.773 . . . . 0.0 112.251 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.14 -4.16 86.42 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.988 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -72.02 160.53 32.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.407 2.103 . . . . 0.0 111.365 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.73 151.19 48.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.681 1.592 . . . . 0.0 112.213 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.6 mtm -144.41 143.74 31.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.371 1.068 . . . . 0.0 112.94 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -145.72 -151.23 0.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.659 1.184 . . . . 0.0 111.227 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.7 t80 71.22 -56.72 0.62 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.8 2.84 . . . . 0.0 114.134 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.4 m -72.77 162.75 29.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.789 1.236 . . . . 0.0 112.789 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 pt -63.6 150.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.634 0.773 . . . . 0.0 111.536 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.46 -29.56 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.7 p -67.94 -45.15 75.07 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.47 -0.769 . . . . 0.0 111.241 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.03 -30.05 67.24 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.42 -0.8 . . . . 0.0 112.213 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.99 -43.41 77.61 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.494 1.043 . . . . 0.0 110.949 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.0 m -66.39 -46.88 75.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.528 1.531 . . . . 0.0 113.22 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -64.74 -42.65 95.02 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.128 -0.982 . . . . 0.0 112.369 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -62.22 -34.12 75.88 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 111.292 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.524 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 29.1 t80 -59.53 -55.57 32.84 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.111 0.868 . . . . 0.0 111.274 170.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.56 -20.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -71.02 -42.66 69.26 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.742 1.155 . . . . 0.0 110.331 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -63.15 -24.81 68.06 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.633 1.106 . . . . 0.0 112.988 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 80.0 mt -73.56 -59.52 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.661 0.664 . . . . 0.0 111.785 169.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -76.51 8.34 3.61 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -56.53 -27.34 57.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.053 2.141 . . . . 0.0 112.83 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.75 -25.42 55.85 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 126.931 2.205 . . . . 0.0 115.142 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -149.51 14.73 0.87 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.254 1.32 0 CA-C-O 116.958 -1.496 . . . . 0.0 113.552 175.4 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 119.367 -0.349 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.47 149.36 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.548 2.832 . . . . 0.0 111.364 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.29 159.82 16.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 126.528 1.931 . . . . 0.0 110.942 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.32 143.76 71.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.652 2.235 . . . . 0.0 112.818 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.38 61.96 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.495 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -114.61 157.12 23.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.203 1.502 . . . . 0.0 112.018 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.99 160.02 16.36 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 123.297 1.522 . . . . 0.0 111.044 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.2 mt -137.1 129.42 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 125.575 1.55 . . . . 0.0 107.247 -159.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.32 124.47 33.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.028 0.931 . . . . 0.0 108.516 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.16 137.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.999 2.12 . . . . 0.0 108.692 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.59 62.37 4.64 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -57.65 -45.35 85.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.003 1.721 . . . . 0.0 115.217 -169.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -145.92 29.07 1.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -156.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.84 87.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.541 1.067 . . . . 0.0 113.126 -169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.3 155.64 44.52 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 110.415 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.47 133.9 51.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.567 1.547 . . . . 0.0 111.752 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -150.85 145.9 25.98 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.259 1.424 . . . . 0.0 110.794 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -89.51 162.54 15.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.89 136.99 20.84 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.417 2.287 . . . . 0.0 109.933 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.72 117.0 33.36 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.254 1.822 . . . . 0.0 109.176 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -73.75 111.24 8.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.414 1.085 . . . . 0.0 111.753 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 pt -98.82 -20.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.83 -179.96 40.79 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.832 1.682 . . . . 0.0 110.5 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.11 95.01 0.08 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.363 1.082 . . . . 0.0 113.279 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.07 -2.08 85.08 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.664 2.078 . . . . 0.0 114.486 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -95.76 137.08 35.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.25 1.525 . . . . 0.0 112.105 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.18 152.79 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.752 1.221 . . . . 0.0 112.972 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.46 132.69 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -149.04 156.92 42.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.468 -0.77 . . . . 0.0 111.033 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.3 145.0 32.36 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.85 103.26 16.17 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 168.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.63 166.29 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.909 2.406 . . . . 0.0 113.002 -169.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--N 1.352 0.748 0 C-N-CA 123.62 2.88 . . . . 0.0 111.896 172.775 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.56 162.33 40.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.608 1.563 . . . . 0.0 110.485 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -154.16 137.95 16.18 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.122 -0.986 . . . . 0.0 112.065 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.4 t -82.27 127.97 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.469 1.108 . . . . 0.0 109.928 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -138.34 155.28 48.71 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.123 1.369 . . . . 0.0 112.898 -170.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -98.37 138.81 35.06 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 110.071 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -163.52 172.18 14.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.211 1.404 . . . . 0.0 110.087 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -94.17 144.29 25.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.07 -1.019 . . . . 0.0 112.293 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.49 -46.34 73.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.224 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.89 -34.24 58.87 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.35 -38.7 23.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.799 0.84 . . . . 0.0 111.591 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.8 -36.48 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.54 0.736 . . . . 0.0 111.744 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.6 t -80.09 -50.36 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.715 1.206 . . . . 0.0 111.182 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.42 63.59 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 119.287 0.949 . . . . 0.0 115.132 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.27 -3.94 60.15 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.736 1.636 . . . . 0.0 115.228 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -70.01 171.05 10.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.117 1.459 . . . . 0.0 113.679 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.16 149.47 39.0 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.834 0.854 . . . . 0.0 111.168 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -158.03 160.2 37.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.107 0.963 . . . . 0.0 113.535 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -157.75 144.12 17.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.307 1.043 . . . . 0.0 111.706 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.48 130.72 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.409 -0.807 . . . . 0.0 109.055 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -169.44 118.51 0.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.33 1.452 . . . . 0.0 110.415 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -98.46 0.15 44.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.9 p 56.97 -49.74 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.175 1 C-N-CA 133.397 4.679 . . . . 0.0 118.039 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 mt -114.48 -23.79 9.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.764 1.625 . . . . 0.0 113.604 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -35.75 77.69 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.283 -0.886 . . . . 0.0 112.067 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -66.65 -16.73 64.42 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.676 1.19 . . . . 0.0 112.921 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -93.25 -30.45 15.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.507 1.123 . . . . 0.0 113.15 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -114.82 -43.59 3.12 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -169.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -153.89 162.19 27.38 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -139.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -88.81 -33.16 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 124.537 3.491 . . . . 0.0 113.761 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 66.7 132.85 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 128.902 2.881 . . . . 0.0 115.984 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.37 94.09 1.07 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.49 2.793 . . . . 0.0 110.461 172.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -57.67 -39.71 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.169 0.988 . . . . 0.0 112.564 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.75 -39.81 76.52 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.634 0.652 . . . . 0.0 111.542 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.9 -35.92 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.416 0.686 . . . . 0.0 109.95 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.283 24.8 mt -77.92 -33.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.304 -0.855 . . . . 0.0 112.045 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.0 mt -65.51 -40.28 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.177 1.353 . . . . 0.0 110.369 169.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -65.81 -38.92 90.23 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.842 -0.536 . . . . 0.0 110.877 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.1 m -63.64 -46.55 85.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.208 1.003 . . . . 0.0 111.743 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.46 91.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.488 0.715 . . . . 0.0 112.082 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -62.61 -48.59 78.73 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 111.911 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -60.52 -30.3 69.65 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.197 -0.94 . . . . 0.0 113.204 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.7 mtp -75.42 -4.91 42.24 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.92 1.288 . . . . 0.0 114.454 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -56.19 121.94 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.016 1.28 . . . . 0.0 109.311 171.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.41 -2.42 60.92 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.228 1.394 . . . . 0.0 115.086 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.66 127.13 31.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.654 1.727 . . . . 0.0 110.482 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -99.93 132.52 45.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.941 2.097 . . . . 0.0 111.681 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -117.3 174.6 6.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.66 1.984 . . . . 0.0 110.38 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -126.52 -160.04 0.96 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.315 1.046 . . . . 0.0 112.442 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -73.32 150.1 42.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 112.985 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.0 m 176.82 171.8 0.47 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.299 3.039 . . . . 0.0 108.645 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.46 123.62 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.43 -35.66 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.81 0.844 . . . . 0.0 112.494 -169.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -55.43 -56.36 21.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.457 0.703 . . . . 0.0 111.423 173.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.25 -34.88 78.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.211 -0.931 . . . . 0.0 111.853 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.4 -44.77 92.75 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.901 1.228 . . . . 0.0 111.374 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.0 p -77.37 -37.25 52.55 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.907 0.883 . . . . 0.0 113.034 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.43 -45.57 92.5 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.568 1.076 . . . . 0.0 112.206 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -62.87 -36.24 82.64 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.599 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.43 -55.26 33.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.722 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.02 -24.25 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 120.545 1.521 . . . . 0.0 113.316 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -70.21 -39.09 75.34 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.446 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.38 -23.39 66.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.483 1.038 . . . . 0.0 113.367 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.45 -60.21 2.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.723 1.147 . . . . 0.0 111.01 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -77.69 6.41 7.41 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -26.04 27.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.76 2.024 . . . . 0.0 112.077 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.3 -17.67 32.65 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 127.249 2.357 . . . . 0.0 115.183 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -134.15 -28.78 1.31 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.415 1.086 . . . . 0.0 112.922 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 CA--C 1.548 0.877 0 CA-C-O 118.732 -0.652 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.63 143.72 27.45 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.805 3.003 . . . . 0.0 110.752 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.09 132.5 23.69 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.043 0.937 . . . . 0.0 111.601 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.8 132.84 25.82 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.263 2.642 . . . . 0.0 111.316 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.401 ' HA3' HG13 ' A' ' 89' ' ' VAL . . . 81.52 -4.23 74.35 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.714 1.149 . . . . 0.0 114.947 -175.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -105.09 168.07 9.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 122.652 1.215 . . . . 0.0 113.234 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.0 113.13 25.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.814 1.646 . . . . 0.0 112.353 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.68 127.85 43.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 124.796 1.238 . . . . 0.0 108.574 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -90.91 116.72 28.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.9 mm -105.65 112.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.392 1.477 . . . . 0.0 109.142 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 73.94 8.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.783 0.72 . . . . 0.0 109.804 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.25 3.77 2.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.0 mt 102.57 126.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 131.577 3.951 . . . . 0.0 110.708 158.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.61 -3.82 39.85 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.202 0.905 . . . . 0.0 113.67 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -171.22 160.35 6.22 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.853 2.461 . . . . 0.0 110.836 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -127.41 127.32 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.994 1.318 . . . . 0.0 110.463 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -108.74 151.3 26.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.913 1.285 . . . . 0.0 111.721 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -90.18 145.07 25.31 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 122.181 -0.325 . . . . 0.0 111.057 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.55 34.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.266 1.026 . . . . 0.0 111.67 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.7 119.32 33.99 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.623 1.569 . . . . 0.0 108.42 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -72.58 96.02 1.91 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 118.558 0.617 . . . . 0.0 111.123 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 pt -84.78 -22.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.18 173.34 30.65 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 124.731 1.158 . . . . 0.0 110.344 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.55 90.76 0.56 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.688 0.756 . . . . 0.0 110.537 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.15 -0.12 47.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.895 2.188 . . . . 0.0 115.109 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.46 140.39 49.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.284 1.542 . . . . 0.0 112.544 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.58 151.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.5 mm -110.65 129.29 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 168.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.17 157.06 43.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.262 0.937 . . . . 0.0 112.773 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.75 120.9 38.96 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.782 0.833 . . . . 0.0 110.938 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.33 120.53 66.55 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.89 1.276 . . . . 0.0 108.167 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.91 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.714 2.942 . . . . 0.0 113.209 -169.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.354 0.835 0 C-N-CA 124.477 3.452 . . . . 0.0 112.926 173.014 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.01 159.88 32.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.49 1.116 . . . . 0.0 109.607 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.44 136.37 29.41 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 111.312 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.69 121.32 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.461 1.105 . . . . 0.0 108.213 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -124.92 156.61 37.71 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.219 1.407 . . . . 0.0 112.418 -171.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -111.07 137.3 48.88 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.707 1.603 . . . . 0.0 110.846 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.39 171.37 10.63 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.037 0.935 . . . . 0.0 111.426 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -84.56 140.0 31.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.694 1.598 . . . . 0.0 110.246 172.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 tp -56.33 -48.38 76.86 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.354 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.32 -28.91 63.5 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.86 -41.33 19.11 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.735 0.814 . . . . 0.0 111.23 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.56 -37.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.979 0.512 . . . . 0.0 111.441 170.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.01 -50.11 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.142 0.977 . . . . 0.0 111.915 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.46 24.16 65.52 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 119.754 1.161 . . . . 0.0 114.788 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.17 1.25 64.97 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.346 1.45 . . . . 0.0 115.305 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.1 m -71.97 170.61 13.44 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.842 1.321 . . . . 0.0 113.269 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.19 149.11 32.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.231 1.012 . . . . 0.0 111.668 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -159.27 154.2 24.88 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -148.73 157.54 43.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.401 1.88 . . . . 0.0 110.662 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.8 t -88.49 139.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-N 119.123 0.874 . . . . 0.0 110.065 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -156.17 64.5 0.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.425 1.49 . . . . 0.0 111.213 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.79 65.67 5.03 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.704 -1.248 . . . . 0.0 110.139 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -48.39 -56.64 7.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.569 1.948 . . . . 0.0 114.477 -170.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.92 -32.05 72.23 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.71 -44.3 90.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.744 -0.597 . . . . 0.0 111.626 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -61.39 -31.62 71.53 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.617 0.767 . . . . 0.0 112.393 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -40.86 63.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.427 1.091 . . . . 0.0 113.557 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.9 -39.35 4.27 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -148.58 158.15 40.57 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.671 2.101 . . . . 0.0 116.671 -134.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.83 -22.32 0.89 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.195 3.263 . . . . 0.0 114.098 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 20.97 116.63 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 131.459 3.904 . . . . 0.0 118.614 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.64 116.42 3.93 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.683 2.922 . . . . 0.0 111.7 -171.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.401 HG13 ' HA3' ' A' ' 11' ' ' GLY . 2.1 t -65.69 -32.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.524 1.129 . . . . 0.0 112.923 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -63.39 -35.55 80.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.591 0.632 . . . . 0.0 111.607 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.19 -38.23 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.734 0.814 . . . . 0.0 110.047 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.7 mt -74.01 -35.38 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.655 -0.653 . . . . 0.0 112.273 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.42 -37.02 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.117 -0.989 . . . . 0.0 110.399 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 m -66.41 -43.52 85.5 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.579 -0.701 . . . . 0.0 111.709 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -53.35 -43.41 67.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.144 0.978 . . . . 0.0 112.222 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.29 79.45 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.569 -0.707 . . . . 0.0 111.969 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -66.63 -14.91 63.03 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.66 -39.4 14.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.322 1.049 . . . . 0.0 111.897 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.2 mtp -75.58 -18.33 59.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.02 126.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.813 1.188 . . . . 0.0 111.845 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.65 -7.43 81.86 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.395 1.474 . . . . 0.0 115.009 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -70.65 151.67 44.7 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.621 1.711 . . . . 0.0 110.675 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -132.18 149.94 52.27 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.612 1.565 . . . . 0.0 112.385 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 69.2 mtm -149.48 158.37 44.12 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.422 1.489 . . . . 0.0 111.332 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -140.17 16.46 2.43 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.176 -0.953 . . . . 0.0 112.869 171.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.97 143.38 26.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.849 -171.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 68.73 -171.82 0.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.046 1.738 . . . . 0.0 114.24 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.0 144.97 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.305 1.442 . . . . 0.0 108.869 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -34.69 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -170.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -67.16 -35.04 78.84 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.724 -0.61 . . . . 0.0 112.157 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -77.44 -32.37 54.52 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 121.409 -0.807 . . . . 0.0 111.736 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.06 -45.34 83.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 20.7 p -74.26 -37.52 63.71 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 121.704 -0.623 . . . . 0.0 112.679 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.77 -43.22 99.36 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.26 -0.9 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -56.67 -49.01 76.32 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 110.054 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -55.3 -52.11 64.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.246 1.018 . . . . 0.0 112.441 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.0 -32.72 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 120.167 1.349 . . . . 0.0 113.09 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 m -61.44 -47.34 86.18 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 116.428 -1.749 . . . . 0.0 108.774 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -56.98 -25.56 58.43 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 121.042 1.746 . . . . 0.0 114.208 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.15 -47.11 72.03 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.016 1.28 . . . . 0.0 111.88 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -92.54 -3.1 55.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -62.49 -24.37 67.44 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.534 1.934 . . . . 0.0 112.3 -169.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.28 -24.84 76.38 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.377 0.989 . . . . 0.0 113.855 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.44 -20.64 2.63 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.255 1.364 0 C-N-CA 124.924 1.29 . . . . 0.0 112.389 177.243 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -81.41 155.67 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.283 2.656 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -102.51 151.21 38.18 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.891 . . . . 0.0 111.986 -177.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.97 136.76 39.18 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.683 2.255 . . . . 0.0 111.326 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.05 69.71 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.859 1.695 . . . . 0.0 114.637 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -94.64 165.77 12.35 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.187 1.493 . . . . 0.0 114.668 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -88.42 116.04 26.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.624 1.57 . . . . 0.0 111.892 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.43 121.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 109.229 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -99.34 103.58 15.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.574 1.95 . . . . 0.0 108.06 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.01 119.28 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.515 1.126 . . . . 0.0 109.426 -171.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.33 62.04 5.07 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.881 -1.137 . . . . 0.0 110.777 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -30.53 70.92 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -169.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.98 34.16 0.25 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -161.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.69 68.92 Favored Glycine 0 N--CA 1.479 1.531 0 C-N-CA 124.193 0.902 . . . . 0.0 113.48 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -164.47 149.08 9.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.416 2.286 . . . . 0.0 110.134 -172.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -74.22 106.34 5.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.164 1.385 . . . . 0.0 111.372 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -86.94 126.88 34.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.004 1.721 . . . . 0.0 109.279 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -82.47 150.15 27.19 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.588 -0.695 . . . . 0.0 112.814 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.94 159.84 44.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.113 1.365 . . . . 0.0 111.469 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.82 121.8 35.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.149 1.78 . . . . 0.0 108.466 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.89 90.37 3.51 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.701 0.682 . . . . 0.0 112.154 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.31 -18.43 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.23 -176.6 29.47 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 124.518 1.056 . . . . 0.0 111.629 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.83 90.0 0.78 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.007 0.908 . . . . 0.0 111.034 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 -3.78 80.06 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.348 1.928 . . . . 0.0 114.269 -174.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.68 138.64 35.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.655 1.727 . . . . 0.0 112.28 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.68 152.99 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mm -110.79 139.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.36 1.864 . . . . 0.0 106.697 168.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -157.89 134.7 9.88 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.38 0.991 . . . . 0.0 112.467 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.77 113.27 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.454 -0.779 . . . . 0.0 110.251 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.22 120.76 80.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.267 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.35 161.07 43.55 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.665 2.91 . . . . 0.0 112.943 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 C-N-CA 123.645 2.897 . . . . 0.0 111.844 -179.462 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.096 0.474 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.19 158.35 15.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.291 1.036 . . . . 0.0 111.55 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.92 135.05 32.43 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 0.0 111.83 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -80.69 114.29 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.971 1.308 . . . . 0.0 108.323 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -121.2 173.06 7.55 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.267 1.827 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.8 35.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.422 1.489 . . . . 0.0 111.82 -174.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 174.01 -159.47 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.93 2.892 . . . . 0.0 108.421 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.14 150.97 19.92 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.17 0.986 . . . . 0.0 113.446 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -50.34 -51.46 45.43 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.136 1.775 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -55.04 -29.85 58.31 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.01 -42.77 15.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.816 0.846 . . . . 0.0 111.337 174.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.61 -33.47 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.913 -0.492 . . . . 0.0 111.965 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.0 t -86.77 -46.98 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.511 1.124 . . . . 0.0 111.495 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.99 -121.48 24.9 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -172.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.14 1.04 62.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.651 1.12 . . . . 0.0 114.892 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.7 m -73.13 162.43 29.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.899 1.35 . . . . 0.0 113.921 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.2 m -79.44 151.14 31.04 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.871 0.869 . . . . 0.0 110.989 169.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -156.46 167.99 28.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.962 0.905 . . . . 0.0 112.852 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -161.7 159.22 27.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.6 1.56 . . . . 0.0 109.933 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -82.75 132.5 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.723 1.147 . . . . 0.0 109.175 169.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -80.3 -70.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.492 0.717 . . . . 0.0 112.051 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 63.37 8.89 3.72 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.535 1.934 . . . . 0.0 114.332 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.6 m -69.28 -36.28 76.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 119.076 -2.265 . . . . 0.0 113.506 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.5 mt -68.9 -37.92 79.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.997 0.519 . . . . 0.0 111.718 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -64.79 -43.64 92.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.513 -0.742 . . . . 0.0 111.116 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.29 -26.15 62.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.075 1.35 . . . . 0.0 112.873 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.57 -29.99 46.55 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.132 0.973 . . . . 0.0 112.41 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -126.19 -46.52 1.65 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.51 152.51 45.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -143.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.31 -10.08 12.42 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 124.565 3.51 . . . . 0.0 114.393 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 74.32 106.79 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.595 2.358 . . . . 0.0 114.377 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.47 71.54 6.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.721 2.948 . . . . 0.0 109.03 169.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 t -46.24 -38.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 126.436 1.894 . . . . 0.0 114.687 -169.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.69 -38.17 90.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.802 0.841 . . . . 0.0 111.703 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -75.63 -30.99 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.2 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.08 -45.52 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.491 0.587 . . . . 0.0 110.78 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.41 -39.56 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.822 -0.549 . . . . 0.0 110.376 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 m -63.5 -43.5 97.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.97 0.508 . . . . 0.0 111.592 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 t -59.37 -45.47 91.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 111.658 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.42 90.75 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.218 -0.926 . . . . 0.0 112.082 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.94 -19.07 64.94 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -82.32 -37.11 26.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.687 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.0 mtp -70.98 -32.01 68.73 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.4 p -44.54 129.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.14 -8.85 79.02 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.45 1.5 . . . . 0.0 114.837 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -78.99 159.59 27.58 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.949 1.875 . . . . 0.0 112.317 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -104.5 156.91 17.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.572 1.549 . . . . 0.0 112.012 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.3 tpp -141.14 140.02 34.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.527 1.531 . . . . 0.0 110.292 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.37 -7.17 0.62 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -78.3 132.26 37.39 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.135 -0.978 . . . . 0.0 113.111 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 t 69.48 -175.9 0.2 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.3 1.84 . . . . 0.0 114.894 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.9 pt -75.14 157.64 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.822 1.649 . . . . 0.0 111.322 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.46 -38.46 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -169.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.5 m -59.11 -51.08 71.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.742 0.817 . . . . 0.0 111.679 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -75.48 -33.05 60.78 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.964 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.99 -46.08 75.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.067 1.303 . . . . 0.0 111.766 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.3 m -76.82 -38.4 53.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.055 0.942 . . . . 0.0 112.45 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.07 -45.16 93.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.249 -0.907 . . . . 0.0 112.412 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -58.36 -39.86 80.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.78 1.632 . . . . 0.0 110.565 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 10.9 t80 -61.68 -54.55 41.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.195 0.998 . . . . 0.0 112.154 171.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 m -67.67 -25.27 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.809 1.641 . . . . 0.0 113.742 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 m -72.4 -42.17 65.47 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 117.687 -1.149 . . . . 0.0 110.959 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.22 -18.11 59.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.261 1.391 . . . . 0.0 113.647 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 14.0 mt -64.41 -47.6 78.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.237 0.926 . . . . 0.0 110.12 168.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.3 mtm-85 -72.48 -92.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 70.36 -2.91 2.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 129.2 3.0 . . . . 0.0 113.028 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.3 -99.37 0.54 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 126.782 2.134 . . . . 0.0 114.226 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -82.65 9.46 9.5 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.174 1.39 . . . . 0.0 113.636 -171.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 127.088 2.155 . . . . 0.0 112.003 -179.18 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.51 144.87 10.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.336 2.691 . . . . 0.0 109.701 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.39 159.5 23.66 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.841 1.257 . . . . 0.0 112.312 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.43 137.27 80.72 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.411 2.74 . . . . 0.0 114.924 -168.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.24 63.94 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 126.323 1.916 . . . . 0.0 115.182 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -96.63 154.76 17.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -169.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -94.23 112.67 24.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.73 1.612 . . . . 0.0 111.51 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.9 mt -101.29 127.22 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.034 1.334 . . . . 0.0 109.858 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.51 115.58 28.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.22 117.53 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.75 1.62 . . . . 0.0 108.068 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.63 -32.22 71.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.337 0.655 . . . . 0.0 112.681 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.03 -71.3 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 129.369 3.068 . . . . 0.0 115.251 174.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.74 26.23 0.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.34 1.456 . . . . 0.0 113.715 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.21 -59.5 0.38 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.657 1.599 . . . . 0.0 109.895 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.05 122.01 21.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.974 0.509 . . . . 0.0 109.919 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -94.21 150.37 20.37 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.793 0.837 . . . . 0.0 111.972 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -121.36 148.56 44.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.714 1.206 . . . . 0.0 111.794 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -89.8 149.53 22.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.213 0.605 . . . . 0.0 110.582 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.02 146.91 33.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.031 0.932 . . . . 0.0 112.927 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.54 117.86 35.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.175 1.79 . . . . 0.0 108.143 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -73.54 109.89 7.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.475 0.71 . . . . 0.0 110.286 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -100.75 -17.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.59 175.76 31.06 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 126.061 1.791 . . . . 0.0 109.595 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -69.68 86.31 0.48 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.013 0.906 . . . . 0.0 111.315 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.05 -13.49 37.49 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.188 2.327 . . . . 0.0 114.327 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.59 139.24 33.79 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.875 1.27 . . . . 0.0 112.735 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -135.35 151.91 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.88 1.272 . . . . 0.0 113.189 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.5 128.63 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -144.02 160.28 41.14 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.142 -0.974 . . . . 0.0 111.779 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.44 122.5 45.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.881 0.872 . . . . 0.0 111.141 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.63 117.47 68.18 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.528 1.531 . . . . 0.0 107.27 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.69 162.52 39.46 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.543 2.829 . . . . 0.0 114.409 -168.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 58' ' ' ALA . 86.7 Cg_endo . . . . . 0 CA--C 1.541 0.829 0 C-N-CA 123.69 2.927 . . . . 0.0 109.716 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.427 ' HB2' ' HD3' ' A' ' 39' ' ' PRO . . . -75.36 156.11 35.81 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.298 1.039 . . . . 0.0 110.404 169.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -141.58 134.75 29.28 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.806 0.843 . . . . 0.0 111.379 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.82 126.84 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.09 0.956 . . . . 0.0 109.244 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -129.26 152.64 48.6 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.614 1.566 . . . . 0.0 112.151 -170.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -105.07 139.08 40.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.551 1.54 . . . . 0.0 110.37 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -167.01 172.96 9.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.622 1.169 . . . . 0.0 110.482 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.59 143.08 27.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 111.083 170.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 tp -55.05 -49.95 70.32 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.582 -0.699 . . . . 0.0 111.561 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -30.95 62.6 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -79.36 -40.34 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.819 0.736 . . . . 0.0 111.285 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.77 -37.92 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 122.099 -0.376 . . . . 0.0 111.187 171.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.47 -37.32 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.047 1.339 . . . . 0.0 112.767 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.78 20.75 74.55 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.86 0.743 . . . . 0.0 114.333 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.32 2.64 89.09 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.211 1.386 . . . . 0.0 114.785 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.27 -167.84 1.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.149 1.38 . . . . 0.0 113.004 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 79.7 m -84.35 150.99 25.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.16 1.384 . . . . 0.0 113.139 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -163.54 160.96 23.71 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.208 1.403 . . . . 0.0 113.222 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.1 153.5 11.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.061 1.744 . . . . 0.0 111.834 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.76 140.92 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.676 1.126 . . . . 0.0 110.617 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -146.93 87.32 1.68 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.318 1.447 . . . . 0.0 111.019 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.28 69.19 4.45 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.667 1.187 . . . . 0.0 108.792 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.8 p -60.26 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.621 1.968 . . . . 0.0 114.288 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 mt -60.43 -22.97 64.02 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.297 -0.877 . . . . 0.0 113.075 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.89 -37.09 60.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.98 1.712 . . . . 0.0 111.525 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -63.48 -20.54 65.68 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.842 1.257 . . . . 0.0 112.702 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -88.0 -25.35 23.18 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.084 1.354 . . . . 0.0 112.907 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.81 -29.71 1.68 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -169.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -120.34 122.91 28.49 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -132.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -70.77 -21.26 29.04 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.454 3.436 . . . . 0.0 115.744 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 69.16 83.13 0.17 Allowed Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 127.721 2.408 . . . . 0.0 114.888 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.38 95.97 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.8 3.0 . . . . 0.0 109.158 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.2 -41.38 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.665 0.786 . . . . 0.0 111.963 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.24 -35.86 78.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.587 0.63 . . . . 0.0 112.106 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -42.73 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.595 0.758 . . . . 0.0 110.084 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.6 mt -71.55 -34.23 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.812 -0.555 . . . . 0.0 112.101 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.87 -38.83 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.26 -0.9 . . . . 0.0 110.365 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -64.4 -42.32 96.17 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.571 -0.706 . . . . 0.0 111.303 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -56.97 -44.33 82.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.263 1.025 . . . . 0.0 111.832 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.93 87.81 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.337 -0.852 . . . . 0.0 112.184 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -67.53 -14.96 63.39 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.85 -36.71 15.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 111.864 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.3 mtp -70.75 -23.56 62.45 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.911 1.284 . . . . 0.0 113.767 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -46.66 123.61 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.489 1.04 . . . . 0.0 112.309 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.78 83.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.359 1.457 . . . . 0.0 115.193 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 160.57 30.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.747 1.773 . . . . 0.0 111.327 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -131.32 157.22 43.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.162 1.385 . . . . 0.0 112.973 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.6 mtm -143.76 159.28 42.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.531 1.532 . . . . 0.0 111.298 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -143.65 -1.53 1.0 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -86.43 152.49 22.64 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.642 1.177 . . . . 0.0 113.459 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 m 75.61 168.71 0.27 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.531 2.332 . . . . 0.0 114.107 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.68 147.49 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 109.062 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -49.98 -36.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 p -64.1 -49.39 72.42 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.391 -0.818 . . . . 0.0 111.366 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.36 -30.05 65.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.575 -0.703 . . . . 0.0 112.1 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.81 -41.05 85.86 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.092 1.314 . . . . 0.0 111.5 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.63 -43.36 76.48 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.272 1.029 . . . . 0.0 112.561 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.25 -44.13 92.75 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.269 -0.894 . . . . 0.0 112.319 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -37.78 81.35 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.53 -1.356 . . . . 0.0 111.355 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.521 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 9.5 t80 -58.29 -56.81 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.68 0.792 . . . . 0.0 111.256 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.4 m -68.48 -23.57 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.618 1.099 . . . . 0.0 113.806 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 m -70.7 -41.66 71.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.621 1.101 . . . . 0.0 110.337 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.61 -27.94 69.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.57 1.077 . . . . 0.0 112.853 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.521 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 73.8 mt -69.56 -57.23 5.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.822 0.737 . . . . 0.0 111.559 170.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -80.29 9.57 5.59 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -57.7 -25.25 60.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.381 1.873 . . . . 0.0 112.617 -172.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -46.12 -43.9 13.84 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 127.811 2.624 . . . . 0.0 115.178 -173.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -137.54 22.15 2.93 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.715 1.206 . . . . 0.0 113.57 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.115 1.366 . . . . 0.0 111.381 -177.779 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.92 145.98 28.98 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.703 2.269 . . . . 0.0 110.261 172.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.04 149.72 38.44 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.141 0.976 . . . . 0.0 110.938 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.98 130.62 26.35 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.627 2.218 . . . . 0.0 111.3 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.59 61.37 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.361 1.934 . . . . 0.0 114.921 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -91.1 161.96 14.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.539 1.669 . . . . 0.0 114.355 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.67 110.2 22.81 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.722 1.609 . . . . 0.0 112.228 -169.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -90.49 123.03 42.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.385 1.074 . . . . 0.0 109.154 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -94.29 117.43 30.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.71 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.587 1.155 . . . . 0.0 108.762 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.27 -30.34 71.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.408 1.083 . . . . 0.0 112.907 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.259 26.1 tpt180 54.36 -111.87 0.66 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.825 2.05 . . . . 0.0 111.358 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.0 mt -133.74 42.78 2.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.119 0.968 . . . . 0.0 111.263 -161.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.94 6.52 37.15 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.872 1.225 . . . . 0.0 114.98 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -156.41 119.31 4.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.969 1.308 . . . . 0.0 111.045 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.5 142.91 48.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.792 1.237 . . . . 0.0 112.261 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.51 165.54 36.12 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.028 0.931 . . . . 0.0 112.881 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -92.45 152.53 19.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.2 150.1 43.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.979 1.711 . . . . 0.0 111.151 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.99 118.56 36.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.53 1.932 . . . . 0.0 107.586 174.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -73.7 102.91 4.09 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.658 0.663 . . . . 0.0 110.338 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.21 -17.43 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.8 -174.27 43.11 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -64.3 95.58 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.778 0.799 . . . . 0.0 111.603 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.43 6.07 64.69 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.639 2.066 . . . . 0.0 116.207 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -120.19 141.7 49.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.9 1.85 . . . . 0.0 113.3 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.87 151.36 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.901 1.281 . . . . 0.0 112.604 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 mm -111.42 134.09 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.57 152.85 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.573 1.078 . . . . 0.0 112.129 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.44 113.28 24.61 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.95 116.09 50.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.175 -0.917 . . . . 0.0 108.694 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.72 158.86 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.183 2.589 . . . . 0.0 111.931 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.546 1.094 0 C-N-CA 124.402 3.401 . . . . 0.0 111.107 171.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.53 144.78 37.37 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.097 -1.002 . . . . 0.0 110.751 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.43 133.71 38.88 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.964 0.906 . . . . 0.0 110.887 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.13 125.23 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.856 0.862 . . . . 0.0 109.803 172.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -135.31 157.14 47.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.371 1.468 . . . . 0.0 112.316 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -109.71 133.43 53.14 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.795 1.638 . . . . 0.0 110.885 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -151.99 171.85 17.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.423 1.489 . . . . 0.0 111.526 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -85.89 148.77 25.64 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.269 0.628 . . . . 0.0 111.652 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.8 tp -52.45 -62.15 1.82 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.875 1.27 . . . . 0.0 111.582 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -66.12 -20.1 66.05 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.71 -36.82 70.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.515 1.052 . . . . 0.0 111.26 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.76 -44.53 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.131 0.972 . . . . 0.0 112.125 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.67 -1.66 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.69 109.89 3.13 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.466 1.03 . . . . 0.0 112.681 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 6.78 89.22 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.998 1.285 . . . . 0.0 114.337 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -112.72 152.76 28.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 112.485 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.9 m -83.47 149.92 26.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.819 0.848 . . . . 0.0 110.227 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -160.47 159.9 31.41 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -146.05 163.08 36.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.298 2.239 . . . . 0.0 109.852 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.15 143.1 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.509 170.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.38 144.36 46.55 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.622 1.169 . . . . 0.0 113.146 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -137.52 22.62 2.93 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.757 1.623 . . . . 0.0 112.362 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.3 t -62.44 -47.78 82.56 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.219 -1.551 . . . . 0.0 113.819 -169.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -73.46 -33.93 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.596 0.358 . . . . 0.0 111.868 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.86 -36.95 77.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.806 0.842 . . . . 0.0 112.134 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -65.08 -17.97 64.91 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.381 1.072 . . . . 0.0 112.854 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -80.01 -22.64 42.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.364 -0.835 . . . . 0.0 112.53 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -117.4 -57.22 2.16 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.51 149.62 63.36 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -140.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.86 -14.98 21.36 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 124.771 3.647 . . . . 0.0 113.632 172.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 77.56 90.76 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 127.158 2.183 . . . . 0.0 112.788 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.37 81.31 2.51 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.576 2.85 . . . . 0.0 108.889 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.76 -36.27 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.162 0.985 . . . . 0.0 112.538 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.35 -36.37 76.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.72 0.691 . . . . 0.0 112.392 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.29 -40.09 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.414 0.686 . . . . 0.0 109.874 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.08 -38.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.804 . . . . 0.0 111.654 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.23 -38.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.206 -0.934 . . . . 0.0 111.049 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -64.27 -44.84 90.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.6 -0.687 . . . . 0.0 111.271 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -57.62 -44.56 85.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.339 1.055 . . . . 0.0 112.483 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.47 95.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.006 0.821 . . . . 0.0 112.49 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.54 -44.72 89.93 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.119 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.888 -1.133 . . . . 0.0 113.426 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.96 -9.49 58.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.3 t -55.47 127.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.933 1.242 . . . . 0.0 110.591 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.33 -0.59 78.28 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.177 1.37 . . . . 0.0 114.5 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -71.01 132.87 45.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.061 1.43 . . . . 0.0 110.429 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.81 138.54 48.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.753 1.621 . . . . 0.0 111.118 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.7 mtm -143.59 153.07 42.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.919 1.288 . . . . 0.0 112.127 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -149.86 -7.91 0.31 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -63.9 153.7 36.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 114.12 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t 62.91 -164.55 0.25 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 114.449 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -80.33 145.23 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.203 1.401 . . . . 0.0 108.443 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.36 -31.47 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 119.149 0.886 . . . . 0.0 112.629 -171.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 p -60.17 -53.54 56.56 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.343 1.057 . . . . 0.0 111.659 172.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.665 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -56.26 -42.42 77.39 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.23 1.377 . . . . 0.0 111.079 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.22 -44.21 54.06 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.21 1.404 . . . . 0.0 112.981 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.26 -43.65 98.34 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.799 -1.188 . . . . 0.0 112.374 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.543 ' CD2' HE22 ' A' ' 119' ' ' GLN . 8.3 t-160 -63.73 -42.88 97.81 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.692 -1.255 . . . . 0.0 110.014 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.46 -53.66 48.26 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.419 1.487 . . . . 0.0 112.589 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 m -66.08 -25.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.404 1.456 . . . . 0.0 112.917 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -65.91 -46.13 79.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 117.315 -1.326 . . . . 0.0 109.793 170.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.543 HE22 ' CD2' ' A' ' 115' ' ' HIS . 1.8 mp0 -55.85 -32.31 63.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.766 1.167 . . . . 0.0 113.459 171.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.39 -58.21 3.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.352 0.978 . . . . 0.0 111.346 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -75.27 3.99 7.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.71 -24.11 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.854 2.062 . . . . 0.0 113.338 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.24 -32.4 1.68 Allowed Glycine 0 N--CA 1.474 1.23 0 C-N-CA 128.473 2.94 . . . . 0.0 117.816 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -140.07 16.75 2.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 118.692 1.246 . . . . 0.0 112.866 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.105 1.762 . . . . 0.0 112.674 -177.155 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.17 147.97 93.6 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.666 2.244 . . . . 0.0 111.185 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -103.29 156.09 35.88 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.479 1.112 . . . . 0.0 111.57 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.59 129.89 22.25 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.529 2.152 . . . . 0.0 111.945 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.68 -2.62 82.32 Favored Glycine 0 N--CA 1.467 0.739 0 C-N-CA 125.272 1.415 . . . . 0.0 114.769 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -83.96 146.96 27.73 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.853 1.326 . . . . 0.0 110.913 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.0 139.47 40.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.546 1.165 . . . . 0.0 111.55 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.34 131.81 65.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.975 2.11 . . . . 0.0 108.198 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -92.36 115.39 28.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.87 129.03 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.531 1.932 . . . . 0.0 108.322 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.47 -33.21 71.01 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.833 0.742 . . . . 0.0 112.48 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 57.35 -119.46 1.22 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.752 2.021 . . . . 0.0 111.259 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -132.27 58.39 1.75 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.044 0.926 . . . . 0.0 110.352 -160.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.76 -1.89 75.77 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.271 1.415 . . . . 0.0 114.626 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -156.41 127.29 6.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.082 1.353 . . . . 0.0 111.552 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.25 155.25 36.94 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.83 1.252 . . . . 0.0 113.87 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -153.65 172.27 17.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.473 1.109 . . . . 0.0 112.232 170.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -93.85 161.1 14.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.72 162.83 39.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.015 2.126 . . . . 0.0 110.926 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.07 125.11 38.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.109 1.764 . . . . 0.0 108.536 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.94 93.33 5.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.236 1.014 . . . . 0.0 111.423 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 pt -81.75 -20.93 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 176.43 32.27 Favored Glycine 0 N--CA 1.465 0.579 0 C-N-CA 125.05 1.309 . . . . 0.0 110.798 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.84 88.38 0.38 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.615 0.721 . . . . 0.0 111.095 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.11 58.62 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 127.011 2.243 . . . . 0.0 114.774 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -104.74 140.47 38.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.825 1.312 . . . . 0.0 112.523 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.8 155.42 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.39 1.076 . . . . 0.0 112.954 -170.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -112.4 139.81 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -148.15 155.02 40.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.584 1.084 . . . . 0.0 111.574 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.7 115.38 27.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.3 122.87 87.57 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.53 158.06 59.27 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.776 2.984 . . . . 0.0 114.561 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 CA--C 1.541 0.826 0 C-N-CA 124.344 3.363 . . . . 0.0 111.54 173.253 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 158.65 16.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.3 1.84 . . . . 0.0 109.596 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -143.06 134.56 26.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 0.0 111.618 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.97 126.77 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.397 0.679 . . . . 0.0 109.182 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -131.98 149.75 52.34 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.619 1.568 . . . . 0.0 112.446 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -103.72 133.76 48.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.445 1.498 . . . . 0.0 110.485 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -154.74 177.69 10.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.743 1.617 . . . . 0.0 111.073 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -90.48 154.17 19.84 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 168.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 tp -53.15 -47.34 68.82 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.48 -31.17 67.6 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.04 -35.8 59.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.451 1.023 . . . . 0.0 111.104 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.09 -38.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.525 1.13 . . . . 0.0 111.9 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -80.38 -39.34 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.387 0.675 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.61 15.92 64.79 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.048 0.84 . . . . 0.0 115.016 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.53 85.72 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.389 1.471 . . . . 0.0 114.684 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.8 m -81.54 -176.41 6.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.082 1.353 . . . . 0.0 112.745 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 83.6 m -73.21 157.42 37.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.199 1.0 . . . . 0.0 112.875 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -167.14 168.06 13.88 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.525 1.93 . . . . 0.0 110.853 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.09 151.54 12.17 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 0.0 112.756 169.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.5 t -70.91 133.88 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -153.9 73.86 0.96 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.937 0.895 . . . . 0.0 110.907 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.25 58.74 0.73 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.627 1.571 . . . . 0.0 111.483 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 p -43.41 -69.35 0.14 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.516 2.327 . . . . 0.0 114.724 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -67.37 -29.2 68.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.589 0.756 . . . . 0.0 112.74 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.4 -35.59 80.71 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.185 -0.947 . . . . 0.0 111.21 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -73.98 -12.58 60.68 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.218 1.007 . . . . 0.0 112.83 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -86.18 -38.35 17.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.156 0.889 . . . . 0.0 112.078 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -71.67 0.73 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -143.7 157.37 58.67 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -145.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.6 144.24 11.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.891 3.061 . . . . 0.0 108.073 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -124.3 153.5 68.77 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -169.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.03 84.21 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.141 3.228 . . . . 0.0 109.96 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.11 -30.97 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.695 1.198 . . . . 0.0 114.019 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.41 -36.69 83.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.226 0.921 . . . . 0.0 112.643 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.74 -33.86 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.067 0.947 . . . . 0.0 110.519 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -63.98 -46.56 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.64 -0.663 . . . . 0.0 110.215 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.15 -39.38 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.814 0.846 . . . . 0.0 110.873 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.3 m -64.77 -40.93 96.08 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.615 -0.678 . . . . 0.0 111.813 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 t -58.3 -46.82 85.41 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.539 -0.725 . . . . 0.0 111.028 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.14 89.24 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.43 -0.794 . . . . 0.0 112.249 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.13 -28.12 69.85 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.49 -34.11 41.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 172.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.4 mtp -78.99 -20.28 49.49 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.96 124.57 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.603 1.547 . . . . 0.0 110.933 170.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.76 -6.92 59.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.611 1.576 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -75.43 143.66 42.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 1.515 . . . . 0.0 110.507 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.82 155.08 36.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.883 1.673 . . . . 0.0 111.833 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.1 mtm -141.62 164.14 31.01 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.113 1.365 . . . . 0.0 111.587 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -139.4 -36.13 0.53 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -76.4 154.03 35.22 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -170.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 77.57 177.68 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.259 2.224 . . . . 0.0 113.788 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -80.53 149.27 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.747 1.219 . . . . 0.0 111.276 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -52.65 -37.38 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 p -63.21 -55.34 25.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.451 0.7 . . . . 0.0 111.164 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.6 -36.37 83.54 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.58 -0.7 . . . . 0.0 111.935 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.44 -41.22 80.03 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.517 1.053 . . . . 0.0 111.686 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.6 t -77.26 -42.19 38.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.264 1.026 . . . . 0.0 112.513 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.77 -44.14 97.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.325 1.05 . . . . 0.0 112.13 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.54 ' CD2' HE22 ' A' ' 119' ' ' GLN . 59.8 t60 -60.42 -46.11 91.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.788 1.235 . . . . 0.0 110.125 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -52.76 -54.84 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.209 . . . . 0.0 112.213 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.95 -29.72 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.343 1.429 . . . . 0.0 112.8 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.3 m -65.41 -38.37 89.74 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.967 1.258 . . . . 0.0 110.504 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.54 HE22 ' CD2' ' A' ' 115' ' ' HIS . 0.8 OUTLIER -61.33 -26.89 68.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 120.415 1.461 . . . . 0.0 113.217 169.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.9 mt -74.6 -57.6 3.82 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.275 -0.891 . . . . 0.0 111.516 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -77.08 12.11 1.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -58.04 -24.41 58.28 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.314 1.846 . . . . 0.0 112.519 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.69 -22.29 39.43 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.026 2.251 . . . . 0.0 115.31 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -146.82 -11.03 0.45 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.601 1.161 . . . . 0.0 112.82 179.716 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 118.219 -0.896 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.88 144.89 12.4 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.332 2.688 . . . . 0.0 111.05 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.65 150.05 4.59 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.582 1.953 . . . . 0.0 111.053 -176.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.28 137.34 39.88 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.915 3.076 . . . . 0.0 113.553 -169.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.08 -11.41 65.15 Favored Glycine 0 N--CA 1.469 0.879 0 C-N-CA 126.028 1.775 . . . . 0.0 114.633 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.59 160.16 15.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 118.403 1.101 . . . . 0.0 113.003 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.22 113.87 27.32 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.916 1.686 . . . . 0.0 111.785 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.91 127.55 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 124.8 1.24 . . . . 0.0 109.482 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -96.01 121.12 37.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.407 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.93 130.65 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.973 1.309 . . . . 0.0 109.157 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -77.16 64.79 2.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.563 1.145 . . . . 0.0 110.442 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -54.14 -44.89 71.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.611 1.564 . . . . 0.0 114.803 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -153.29 26.93 0.52 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -160.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.9 -2.49 66.5 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.99 0.805 . . . . 0.0 113.064 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -140.78 159.86 41.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.148 2.179 . . . . 0.0 110.44 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -91.86 120.33 32.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.679 1.192 . . . . 0.0 111.464 -172.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -112.75 151.84 29.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.531 1.532 . . . . 0.0 111.09 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -86.97 153.69 21.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.42 36.22 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.354 1.462 . . . . 0.0 111.383 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.42 123.85 50.64 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.168 1.787 . . . . 0.0 108.175 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -74.32 103.11 4.59 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.5 0.591 . . . . 0.0 111.221 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -94.88 -21.69 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.78 171.94 33.77 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.31 96.08 0.22 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.164 0.982 . . . . 0.0 111.689 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.93 3.76 82.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.91 1.719 . . . . 0.0 115.244 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -110.73 139.01 46.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.502 1.651 . . . . 0.0 112.367 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.97 152.47 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 113.713 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.5 mm -107.95 134.64 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 107.109 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -151.52 159.49 44.12 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.496 1.044 . . . . 0.0 111.894 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.43 122.83 43.81 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.393 0.677 . . . . 0.0 111.304 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.49 146.39 50.21 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.861 1.664 . . . . 0.0 110.414 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.53 158.07 51.63 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.592 2.861 . . . . 0.0 113.956 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 CA--C 1.542 0.91 0 C-N-CA 123.665 2.91 . . . . 0.0 112.29 169.617 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.783 0.325 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.11 153.71 43.0 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.527 0.731 . . . . 0.0 109.637 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -138.12 131.25 30.2 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 111.106 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.05 126.16 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.989 0.915 . . . . 0.0 109.245 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -131.48 157.23 44.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.545 1.538 . . . . 0.0 112.489 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -110.48 138.81 46.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.841 1.657 . . . . 0.0 110.077 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -166.11 170.38 13.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.227 1.011 . . . . 0.0 110.703 -171.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -85.39 145.44 27.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.319 -0.863 . . . . 0.0 111.55 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.6 tp -53.1 -50.66 63.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.068 0.947 . . . . 0.0 111.529 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -58.11 -28.88 65.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -85.64 -32.11 22.19 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.53 -40.64 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.471 0.578 . . . . 0.0 111.256 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.81 -44.33 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.83 0.852 . . . . 0.0 112.118 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.74 -124.82 35.33 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -175.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.75 0.62 63.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.959 1.266 . . . . 0.0 114.973 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.58 168.3 19.06 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.64 1.22 . . . . 0.0 113.924 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -77.13 155.27 32.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.86 1.264 . . . . 0.0 112.545 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.92 165.85 31.32 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.806 1.243 . . . . 0.0 113.355 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.12 163.88 33.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.345 1.858 . . . . 0.0 111.321 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.17 136.3 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.562 1.074 . . . . 0.0 109.81 171.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -150.29 124.96 9.72 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.876 1.27 . . . . 0.0 112.451 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.26 41.43 3.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.687 1.595 . . . . 0.0 111.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.0 p -57.05 -31.21 64.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -74.54 -44.71 49.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.54 0.736 . . . . 0.0 111.434 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -63.37 -36.92 85.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.038 0.935 . . . . 0.0 110.792 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -58.14 -17.06 15.83 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.302 1.441 . . . . 0.0 113.562 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -74.42 -19.29 60.46 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.029 -1.044 . . . . 0.0 113.404 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.95 -29.74 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 -173.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.43 152.24 63.22 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -150.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.24 -49.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.512 2.808 . . . . 0.0 112.443 170.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.25 96.45 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 127.421 2.288 . . . . 0.0 111.072 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.27 124.21 11.83 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.446 3.431 . . . . 0.0 114.892 -168.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 t -49.67 -47.66 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.981 2.113 . . . . 0.0 113.801 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.36 -34.65 78.64 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.93 -36.4 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.356 0.663 . . . . 0.0 110.227 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mm -77.0 -38.57 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.758 -0.589 . . . . 0.0 110.335 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.96 -41.07 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.935 0.494 . . . . 0.0 110.914 171.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -64.83 -40.93 95.98 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.527 -0.733 . . . . 0.0 110.96 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.3 m -64.87 -39.85 94.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.363 1.065 . . . . 0.0 112.28 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.62 98.17 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.12 -0.987 . . . . 0.0 111.751 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -68.7 -13.74 62.57 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.46 -37.41 15.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.534 1.061 . . . . 0.0 111.15 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.1 mmm -69.41 -25.57 64.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.637 1.575 . . . . 0.0 113.623 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -47.0 124.36 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.83 1.195 . . . . 0.0 111.986 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.88 1.49 79.85 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.503 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.47 147.77 44.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.811 1.806 . . . . 0.0 111.405 172.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -124.15 139.97 53.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 111.362 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.0 mtm -142.52 148.33 37.45 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.196 0.998 . . . . 0.0 112.908 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -147.55 22.83 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.358 1.063 . . . . 0.0 112.345 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -80.78 -19.04 45.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 t -162.34 175.7 11.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.21 1.004 . . . . 0.0 112.956 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.17 147.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.301 1.84 . . . . 0.0 109.787 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.51 -32.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.6 p -58.72 -65.71 0.61 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.76 1.224 . . . . 0.0 111.531 173.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -65.01 -30.82 71.82 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.816 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.83 -40.41 76.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.172 1.351 . . . . 0.0 111.127 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -44.07 59.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.644 1.178 . . . . 0.0 112.962 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.14 -45.38 94.9 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.367 -0.833 . . . . 0.0 111.605 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -60.32 -36.62 78.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.03 -60.59 3.54 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.291 1.437 . . . . 0.0 111.443 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.4 m -65.88 -30.03 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 120.476 1.489 . . . . 0.0 113.157 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 m -59.36 -56.2 25.01 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 116.514 -1.707 . . . . 0.0 107.783 170.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -55.35 -31.65 61.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.736 1.607 . . . . 0.0 114.67 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.15 -33.95 75.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.397 0.999 . . . . 0.0 112.385 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -118.2 16.06 14.03 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -72.65 -19.07 61.51 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.639 1.576 . . . . 0.0 112.826 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.43 -33.82 73.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.855 0.741 . . . . 0.0 113.577 -172.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -114.55 -16.05 11.93 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.955 1.302 . . . . 0.0 112.924 179.618 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.94 145.29 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.452 2.768 . . . . 0.0 110.687 171.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.04 160.26 26.74 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.303 1.841 . . . . 0.0 110.273 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.43 130.13 32.52 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.863 1.709 . . . . 0.0 110.697 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.23 -6.07 78.34 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.091 1.329 . . . . 0.0 115.437 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -65.47 140.06 58.56 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.8 1.3 . . . . 0.0 112.43 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.5 tp -87.11 89.89 8.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.72 1.608 . . . . 0.0 108.278 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.46 132.66 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.231 1.012 . . . . 0.0 108.879 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -102.27 107.47 18.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.819 1.647 . . . . 0.0 108.179 171.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.0 mm -86.73 123.45 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.702 2.001 . . . . 0.0 107.97 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.94 -32.89 74.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.302 2.0 mmt180 43.62 -142.49 0.15 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.713 2.005 . . . . 0.0 112.975 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.55 109.37 11.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.284 -167.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.17 -9.59 6.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.762 1.172 . . . . 0.0 115.179 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -166.05 124.46 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.798 1.639 . . . . 0.0 111.989 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.64 144.88 31.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.503 1.521 . . . . 0.0 111.675 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -144.09 165.37 27.99 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.231 -0.918 . . . . 0.0 113.456 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -88.13 157.13 18.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.71 137.69 20.36 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.927 1.691 . . . . 0.0 110.41 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.46 119.46 38.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.044 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -72.01 89.49 1.12 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.803 1.241 . . . . 0.0 111.747 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 pt -77.24 -20.32 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.21 -178.31 32.12 Favored Glycine 0 N--CA 1.462 0.433 0 C-N-CA 124.916 1.246 . . . . 0.0 110.878 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.87 86.19 0.51 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.639 0.733 . . . . 0.0 111.099 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.3 -6.84 46.63 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.884 2.183 . . . . 0.0 114.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -106.65 141.95 37.08 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.95 1.375 . . . . 0.0 112.813 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -137.95 153.28 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 mt -115.88 138.38 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.641 1.576 . . . . 0.0 107.002 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -157.61 138.24 13.02 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.154 -0.966 . . . . 0.0 113.275 -168.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.58 113.6 12.03 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.719 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.95 141.52 78.49 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.399 0.679 . . . . 0.0 109.855 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.34 157.13 62.35 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.632 2.888 . . . . 0.0 113.14 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 C--N 1.353 0.769 0 C-N-CA 124.16 3.24 . . . . 0.0 114.042 -177.654 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 p . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.82 135.85 34.36 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.691 -0.631 . . . . 0.0 109.657 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.94 138.77 37.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.172 0.896 . . . . 0.0 110.318 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -80.57 118.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.168 0.587 . . . . 0.0 110.116 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -108.07 174.96 5.65 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -146.09 152.45 39.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.462 1.505 . . . . 0.0 112.298 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 175.35 -164.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.843 2.857 . . . . 0.0 109.597 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -77.0 151.08 35.78 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.21 -0.931 . . . . 0.0 112.889 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.95 -46.66 75.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.179 0.991 . . . . 0.0 111.177 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 69' ' ' VAL . 16.4 pt-20 -58.82 -29.71 67.09 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -80.5 -39.29 28.23 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.445 -0.785 . . . . 0.0 111.459 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.02 -46.69 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 174.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 66' ' ' GLU . 31.7 m -70.99 -41.97 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.827 0.851 . . . . 0.0 112.262 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.46 -116.31 9.16 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 119.342 0.974 . . . . 0.0 110.72 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.94 -2.92 64.27 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.476 1.036 . . . . 0.0 114.835 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 55.8 m -79.95 157.9 26.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.781 1.29 . . . . 0.0 113.326 -172.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 74.6 m -74.59 167.08 22.46 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.343 1.057 . . . . 0.0 111.878 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -155.16 163.21 40.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.492 1.117 . . . . 0.0 111.745 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -140.16 169.65 17.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.398 1.879 . . . . 0.0 109.961 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.35 127.55 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -103.64 -54.77 2.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 47.3 47.8 16.57 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.325 1.45 . . . . 0.0 111.797 -171.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.3 p -54.2 -60.26 3.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.674 1.589 . . . . 0.0 113.749 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.41 -29.43 70.13 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -65.15 -51.48 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.696 0.398 . . . . 0.0 110.373 169.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -60.72 -27.0 67.58 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 121.179 -0.951 . . . . 0.0 113.026 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -68.17 -33.54 74.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -158.91 -15.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -146.88 130.4 8.25 Favored Pre-proline 0 CA--C 1.55 0.967 0 O-C-N 120.728 -1.233 . . . . 0.0 113.752 -133.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.86 -46.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.749 2.3 . . . . 0.0 112.173 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 128.99 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 129.495 3.118 . . . . 0.0 114.557 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.52 97.8 0.46 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.322 2.682 . . . . 0.0 110.227 169.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -15.87 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -169.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -63.91 -34.78 78.72 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.769 0.713 . . . . 0.0 110.824 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -74.88 -32.74 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.374 0.67 . . . . 0.0 110.382 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.93 -44.56 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.522 0.729 . . . . 0.0 111.631 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.54 -36.25 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.623 0.769 . . . . 0.0 110.607 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -65.1 -45.08 86.66 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.619 0.768 . . . . 0.0 111.637 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.8 m -58.94 -40.77 85.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.584 1.153 . . . . 0.0 112.168 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.14 94.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.501 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -63.42 -21.27 66.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.36 -34.7 21.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 112.554 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 mtp -77.52 -27.81 51.82 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -56.29 123.0 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 120.076 1.307 . . . . 0.0 110.617 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.58 -9.49 62.47 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.793 1.663 . . . . 0.0 115.038 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -78.68 156.23 29.08 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.479 1.64 . . . . 0.0 110.464 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -147.35 154.59 41.09 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.104 1.362 . . . . 0.0 114.34 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.1 mtm -147.15 163.99 34.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.314 1.846 . . . . 0.0 112.022 -170.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -157.19 -45.31 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -77.94 71.13 4.4 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.04 1.336 . . . . 0.0 113.709 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 m -175.88 170.43 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.411 2.684 . . . . 0.0 110.228 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.96 146.41 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.308 -0.87 . . . . 0.0 109.252 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.46 -40.1 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 120.666 -1.271 . . . . 0.0 113.218 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.7 m -60.63 -43.44 97.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.208 0.603 . . . . 0.0 110.846 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -70.71 -29.75 66.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.774 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -58.15 -46.83 84.98 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.644 1.565 . . . . 0.0 110.911 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.0 m -66.5 -48.65 69.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.651 1.181 . . . . 0.0 112.197 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -58.52 -48.32 81.22 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.562 0.745 . . . . 0.0 111.409 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.25 -33.8 76.85 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.938 -1.101 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -58.88 -58.0 10.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.946 0.794 . . . . 0.0 110.787 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.82 -21.58 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 119.551 1.069 . . . . 0.0 113.598 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -71.93 -40.82 68.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.355 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.22 -26.21 68.24 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 120.038 1.29 . . . . 0.0 112.654 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.02 -46.48 67.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.983 0.811 . . . . 0.0 112.405 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -94.37 9.7 37.22 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.454 1.901 . . . . 0.0 114.285 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -58.65 -21.66 54.6 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.049 2.139 . . . . 0.0 113.789 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.88 68.28 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.479 1.037 . . . . 0.0 114.314 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -140.59 -22.4 0.81 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 169.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 124.945 1.298 . . . . 0.0 112.793 175.008 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 118.161 -0.923 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.5 150.12 35.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.751 2.301 . . . . 0.0 111.318 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -100.64 142.1 23.95 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.753 0.821 . . . . 0.0 110.973 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.3 132.51 24.21 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.682 1.588 . . . . 0.0 110.468 -170.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.87 66.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.691 1.615 . . . . 0.0 114.574 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.13 165.99 11.97 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.579 1.69 . . . . 0.0 113.885 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.4 mt -90.64 113.11 25.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.26 1.424 . . . . 0.0 111.655 -169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.22 117.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.966 0.906 . . . . 0.0 108.629 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.58 117.52 28.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -122.71 134.25 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.859 1.264 . . . . 0.0 109.3 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -77.76 66.05 3.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.017 0.927 . . . . 0.0 110.47 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -36.12 82.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.299 1.44 . . . . 0.0 114.41 -169.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.77 26.38 0.74 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -152.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.76 7.81 77.64 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.285 0.945 . . . . 0.0 112.965 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -167.71 160.26 12.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.746 2.819 . . . . 0.0 109.183 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -64.51 138.23 58.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.599 1.56 . . . . 0.0 113.616 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.95 151.46 40.96 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.349 1.86 . . . . 0.0 108.72 169.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -98.84 156.79 16.69 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.2 157.09 44.17 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.897 1.679 . . . . 0.0 111.87 169.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.31 121.77 45.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.79 2.036 . . . . 0.0 108.541 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -75.05 92.43 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.153 0.888 . . . . 0.0 111.774 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -84.44 -21.8 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.68 174.43 30.78 Favored Glycine 0 N--CA 1.463 0.454 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.05 94.73 0.67 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.534 0.683 . . . . 0.0 109.93 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.44 65.59 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.437 1.97 . . . . 0.0 115.273 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -113.75 140.2 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.361 1.58 . . . . 0.0 112.365 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 m -140.77 149.27 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mm -105.97 128.54 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -139.29 163.46 32.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.975 0.807 . . . . 0.0 111.043 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.23 137.51 32.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.67 138.6 21.07 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.457 1.503 . . . . 0.0 108.457 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.57 159.11 39.6 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.506 2.804 . . . . 0.0 113.728 -169.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 C-N-CA 123.676 2.917 . . . . 0.0 109.788 169.7 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.916 0.388 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.56 127.99 34.45 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -113.18 134.88 54.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.451 1.1 . . . . 0.0 111.314 -169.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.1 126.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.732 0.813 . . . . 0.0 110.515 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -139.3 153.88 47.83 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.914 1.286 . . . . 0.0 113.273 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -98.79 137.96 36.63 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.856 1.662 . . . . 0.0 110.689 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -165.7 172.22 12.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.538 1.135 . . . . 0.0 111.671 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -92.89 146.43 23.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.27 1.428 . . . . 0.0 112.103 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -51.47 -56.07 15.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 111.774 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -62.72 -25.16 68.03 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.47 -40.26 43.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.213 0.915 . . . . 0.0 111.12 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.2 t -68.13 -35.33 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.042 0.537 . . . . 0.0 111.959 173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.1 t -78.7 -39.34 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.003 0.921 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 20.11 65.35 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.007 0.822 . . . . 0.0 115.014 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.61 89.72 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.132 1.349 . . . . 0.0 114.859 -173.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.26 175.49 8.9 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.116 1.366 . . . . 0.0 112.555 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.6 m -69.68 150.72 46.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.258 1.023 . . . . 0.0 112.732 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -160.63 163.94 32.2 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.915 1.286 . . . . 0.0 113.506 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.05 163.43 23.26 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.788 2.035 . . . . 0.0 110.927 -175.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -109.0 145.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.596 1.089 . . . . 0.0 112.162 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -133.54 151.89 51.81 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.818 1.647 . . . . 0.0 113.45 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -144.93 31.11 1.15 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.989 1.716 . . . . 0.0 112.286 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -59.94 -35.82 75.74 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.23 -29.22 15.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.918 0.781 . . . . 0.0 112.54 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.62 -30.97 72.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.444 1.097 . . . . 0.0 112.213 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -67.17 -23.04 65.73 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.243 1.417 . . . . 0.0 113.093 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -88.75 -45.66 9.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -95.77 -34.64 11.83 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -168.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -141.13 158.19 65.06 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.49 -19.39 28.53 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.13 3.22 . . . . 0.0 113.207 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 66.93 75.63 0.31 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.355 1.862 . . . . 0.0 112.098 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.81 80.85 2.28 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.458 3.439 . . . . 0.0 110.257 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 t -46.45 -41.11 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.678 1.591 . . . . 0.0 114.344 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.97 -38.02 82.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.207 0.912 . . . . 0.0 111.21 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.14 -38.0 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.313 1.045 . . . . 0.0 109.902 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.53 -47.25 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.471 0.578 . . . . 0.0 110.379 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.71 -38.89 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.34 1.056 . . . . 0.0 111.852 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -65.86 -42.49 90.34 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.415 -0.803 . . . . 0.0 110.61 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.8 p -61.5 -38.57 87.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.438 0.695 . . . . 0.0 112.054 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.76 72.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.427 1.091 . . . . 0.0 111.404 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.46 -36.37 80.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.71 -37.7 79.71 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.6 ptm -81.68 -4.06 55.23 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.2 125.67 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.869 1.268 . . . . 0.0 109.227 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.99 -5.97 58.17 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.924 1.25 . . . . 0.0 114.469 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -66.06 147.82 52.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.262 1.531 . . . . 0.0 110.491 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.76 135.0 45.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.459 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -141.64 140.77 33.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.555 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -149.83 27.05 0.8 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.777 1.231 . . . . 0.0 112.318 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.8 -8.9 59.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.8 t -158.06 178.05 10.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.841 1.256 . . . . 0.0 111.842 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 146.55 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.432 1.493 . . . . 0.0 110.203 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.66 -39.33 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 124.807 1.243 . . . . 0.0 113.926 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.4 p -58.73 -57.54 12.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.831 0.852 . . . . 0.0 111.787 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -64.97 -34.32 78.15 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.519 -0.738 . . . . 0.0 112.152 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -59.54 -35.48 74.29 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.612 1.096 . . . . 0.0 111.418 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -42.6 67.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.036 0.935 . . . . 0.0 112.801 172.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -62.24 -45.99 90.85 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.97 -1.081 . . . . 0.0 112.254 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -52.87 -44.86 67.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.761 2.024 . . . . 0.0 110.615 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.47 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 11.3 t80 -61.33 -54.24 46.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.433 1.493 . . . . 0.0 112.37 173.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.3 m -69.23 -22.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 120.561 1.528 . . . . 0.0 114.215 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -70.42 -40.12 74.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.145 169.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -64.36 -23.91 67.46 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.411 1.005 . . . . 0.0 113.668 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.47 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 36.5 mt -72.86 -60.79 2.06 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.213 0.915 . . . . 0.0 111.337 169.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -73.95 4.27 5.62 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -56.7 -26.04 55.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.338 2.255 . . . . 0.0 113.219 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.98 -51.83 7.04 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 127.75 2.595 . . . . 0.0 115.645 -169.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -128.04 5.73 5.94 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 C--O 1.25 1.093 0 C-N-CA 124.787 1.235 . . . . 0.0 111.879 170.713 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 CA--C 1.544 0.731 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.11 145.21 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.587 2.192 . . . . 0.0 110.098 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.14 139.47 21.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.707 0.803 . . . . 0.0 110.83 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 127.91 15.91 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.769 2.312 . . . . 0.0 110.305 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.01 2.17 90.66 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.181 1.372 . . . . 0.0 114.246 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 169.33 8.63 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.003 1.321 . . . . 0.0 112.604 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.38 130.14 54.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.531 1.533 . . . . 0.0 113.987 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -111.77 144.15 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.365 2.266 . . . . 0.0 110.61 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -108.94 116.67 32.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.29 128.93 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.446 1.499 . . . . 0.0 109.571 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -80.24 68.61 6.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.761 1.225 . . . . 0.0 110.847 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -34.65 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -169.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -156.9 27.33 0.32 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.17 10.23 58.63 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.108 0.861 . . . . 0.0 113.844 -172.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -163.36 145.01 9.61 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.586 2.354 . . . . 0.0 110.146 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -75.32 120.73 21.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.946 1.298 . . . . 0.0 112.354 -176.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -103.07 140.58 37.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.767 1.227 . . . . 0.0 110.041 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -73.62 146.7 44.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.106 0.563 . . . . 0.0 112.123 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.74 142.14 24.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 121.67 43.72 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.029 1.732 . . . . 0.0 108.945 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -76.67 105.29 7.65 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.797 0.839 . . . . 0.0 111.005 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.3 pt -97.1 -20.83 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.91 174.16 32.46 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 124.987 1.28 . . . . 0.0 110.163 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.04 94.73 0.51 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.789 0.804 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.69 64.43 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.839 2.161 . . . . 0.0 115.446 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -112.54 133.99 54.3 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.598 1.699 . . . . 0.0 112.246 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.45 152.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.884 1.274 . . . . 0.0 112.709 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 mm -109.36 128.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.775 1.63 . . . . 0.0 106.844 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -144.95 159.52 42.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.422 1.01 . . . . 0.0 112.026 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.0 115.78 28.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.596 0.758 . . . . 0.0 110.038 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.76 70.18 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.664 1.586 . . . . 0.0 109.815 169.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.33 155.01 68.6 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.897 3.065 . . . . 0.0 114.772 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 C--N 1.354 0.855 0 C-N-CA 124.649 3.566 . . . . 0.0 114.472 176.512 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.923 0.392 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.27 159.99 33.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.515 0.726 . . . . 0.0 110.214 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -136.48 130.06 32.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.854 0.862 . . . . 0.0 109.951 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.9 t -83.79 123.19 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -145.25 153.26 41.12 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -94.1 137.77 32.91 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.186 1.794 . . . . 0.0 110.505 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -162.64 163.11 27.25 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.495 0.718 . . . . 0.0 111.893 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -76.05 140.16 41.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.829 173.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -52.56 -54.14 36.93 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.72 1.208 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.88 -23.92 67.57 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.84 -39.11 27.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.299 0.954 . . . . 0.0 111.343 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.52 -39.65 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.75 -0.594 . . . . 0.0 111.405 170.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.04 -45.55 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 112.345 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.03 61.99 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.25 0.932 . . . . 0.0 115.043 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.12 88.21 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.344 1.449 . . . . 0.0 114.891 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -82.5 171.51 14.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.956 1.302 . . . . 0.0 112.017 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.05 147.89 49.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -158.93 163.43 36.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 113.02 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.64 155.78 15.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.238 1.415 . . . . 0.0 112.354 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.73 136.96 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.662 0.664 . . . . 0.0 109.707 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -160.49 136.92 8.72 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.256 1.822 . . . . 0.0 109.516 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -154.37 52.3 0.66 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.888 0.852 . . . . 0.0 113.017 -169.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.9 m -50.67 -35.59 31.64 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -72.54 -39.81 67.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.787 0.835 . . . . 0.0 111.715 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.37 -40.58 93.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.021 0.928 . . . . 0.0 111.439 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -62.09 -17.9 59.06 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.381 1.072 . . . . 0.0 112.862 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -79.74 -30.8 40.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 -35.17 0.42 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 117.843 2.535 . . . . 0.0 117.843 -172.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.69 151.84 73.93 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -138.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.32 -24.11 2.1 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 124.083 3.189 . . . . 0.0 114.657 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 67.11 110.26 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 127.339 2.256 . . . . 0.0 115.668 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.64 89.92 1.25 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 124.134 3.223 . . . . 0.0 109.768 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 t -50.99 -39.67 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.275 1.43 . . . . 0.0 113.782 -169.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.4 -35.76 78.14 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.283 0.492 . . . . 0.0 111.832 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.93 -32.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.279 1.032 . . . . 0.0 110.396 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 mm -66.43 -47.68 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.93 -0.481 . . . . 0.0 110.57 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.49 -37.57 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.892 0.477 . . . . 0.0 110.763 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.1 m -65.25 -41.93 93.79 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.649 -0.657 . . . . 0.0 111.73 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -61.12 -48.13 83.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.639 -0.663 . . . . 0.0 110.909 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.13 88.15 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.7 0.8 . . . . 0.0 112.257 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -62.58 -46.76 86.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.512 0.725 . . . . 0.0 112.021 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.67 -30.79 70.12 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.259 -0.901 . . . . 0.0 113.27 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.9 mtp -75.73 -9.44 58.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.47 127.02 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.455 1.479 . . . . 0.0 111.343 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.13 -0.41 85.88 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.917 -1.491 . . . . 0.0 114.096 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -77.99 137.74 38.45 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.1 1.95 . . . . 0.0 111.023 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.93 165.22 22.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.382 1.073 . . . . 0.0 110.498 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.4 ttm -159.4 137.09 10.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 110.746 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -156.36 34.0 0.32 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.338 1.066 . . . . 0.0 111.185 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.69 -33.28 71.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.263 1.825 . . . . 0.0 114.131 -170.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.7 t -162.47 -157.05 0.44 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.174 1.39 . . . . 0.0 111.876 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.04 154.92 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.274 1.43 . . . . 0.0 109.861 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.15 -37.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -62.5 -49.11 76.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.429 0.692 . . . . 0.0 111.84 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -74.86 -27.95 60.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 117.545 -1.217 . . . . 0.0 112.238 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -58.51 -43.54 89.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.741 1.609 . . . . 0.0 110.215 170.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -51.82 68.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.476 1.91 . . . . 0.0 112.639 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -64.54 -41.89 96.06 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.051 0.841 . . . . 0.0 112.517 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -56.41 -44.11 80.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.391 1.476 . . . . 0.0 110.52 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 19.3 t80 -60.67 -56.9 15.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.468 1.507 . . . . 0.0 111.698 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.05 -19.32 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.096 1.316 . . . . 0.0 114.399 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 m -74.69 -38.22 62.44 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.112 1.324 . . . . 0.0 110.284 170.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -67.15 -28.11 67.86 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.641 1.11 . . . . 0.0 112.968 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.645 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 94.1 mt -67.46 -56.79 8.17 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.442 -0.786 . . . . 0.0 110.231 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -78.55 5.01 11.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.594 1.558 . . . . 0.0 113.946 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.04 -20.58 17.49 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.526 2.331 . . . . 0.0 113.136 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.52 -31.15 28.54 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.285 1.898 . . . . 0.0 113.697 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -135.2 -23.64 1.48 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 124.684 1.193 . . . . 0.0 113.358 -177.665 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.42 152.37 15.62 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.647 2.898 . . . . 0.0 110.187 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.96 153.46 38.25 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.543 1.137 . . . . 0.0 111.191 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -67.89 131.88 25.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.886 1.724 . . . . 0.0 110.491 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -6.81 81.85 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 125.535 1.54 . . . . 0.0 114.525 -172.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.72 161.84 15.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.444 1.497 . . . . 0.0 111.89 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -118.83 160.12 22.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.963 1.363 . . . . 0.0 114.437 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mt -141.3 131.22 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.615 1.566 . . . . 0.0 109.57 -160.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -85.65 127.84 34.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -112.55 122.34 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.314 1.446 . . . . 0.0 109.112 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -82.27 92.9 7.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.594 1.158 . . . . 0.0 109.084 173.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -64.99 -72.02 0.17 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.438 1.095 . . . . 0.0 111.693 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.4 mt -150.37 -114.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -164.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.18 23.85 5.84 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.333 0.968 . . . . 0.0 111.957 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -169.29 167.69 10.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.987 2.515 . . . . 0.0 111.867 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -121.26 163.4 18.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.233 1.413 . . . . 0.0 111.911 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.12 -174.07 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.658 1.583 . . . . 0.0 110.872 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -120.81 157.75 29.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.7 43.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.504 1.522 . . . . 0.0 113.083 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.433 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -125.72 123.64 39.32 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.771 2.428 . . . . 0.0 108.162 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -79.97 104.43 10.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 0.0 111.507 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.4 pt -94.48 -15.21 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.87 177.8 37.11 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 124.39 0.995 . . . . 0.0 110.877 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.73 91.57 0.45 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.669 0.747 . . . . 0.0 110.37 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 0.73 58.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.629 2.062 . . . . 0.0 115.069 -176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.56 138.94 47.45 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.924 1.862 . . . . 0.0 112.589 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.42 152.37 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mm -108.45 137.85 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 127.044 2.138 . . . . 0.0 106.715 168.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.98 141.17 18.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.235 0.925 . . . . 0.0 111.73 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.86 121.54 30.4 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.351 0.66 . . . . 0.0 110.01 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.13 113.77 43.67 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 168.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.3 169.45 21.26 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.028 2.485 . . . . 0.0 112.75 -169.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo . . . . . 0 C--N 1.351 0.678 0 C-N-CA 124.372 3.381 . . . . 0.0 113.661 173.431 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 m . . . . . 0 CA--C 1.548 0.867 0 CA-C-O 121.088 0.47 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.58 158.82 30.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.368 1.067 . . . . 0.0 111.299 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -143.08 132.35 23.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.376 1.071 . . . . 0.0 111.167 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.65 125.82 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.074 0.95 . . . . 0.0 109.992 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.1 171.67 13.68 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.78 1.632 . . . . 0.0 112.203 -170.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -142.01 141.72 32.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.864 1.666 . . . . 0.0 111.611 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.252 14.7 pt-20 174.1 -160.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.269 3.028 . . . . 0.0 110.145 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.9 mtm105 -95.02 148.25 22.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 tp -53.88 -51.87 62.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.537 1.535 . . . . 0.0 111.229 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.45 -25.31 67.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.74 -44.57 23.1 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.418 1.008 . . . . 0.0 110.458 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.33 -34.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.155 0.982 . . . . 0.0 112.125 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.9 -17.77 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.027 1.731 . . . . 0.0 112.873 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.25 118.54 15.26 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.181 -0.95 . . . . 0.0 112.221 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 4.81 90.18 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.677 1.132 . . . . 0.0 114.619 -174.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.73 176.75 7.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.906 2.082 . . . . 0.0 112.107 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -121.02 167.96 12.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.394 1.478 . . . . 0.0 109.64 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -156.0 165.97 34.87 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -158.39 136.22 10.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.998 1.319 . . . . 0.0 110.939 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.8 136.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 118.825 0.738 . . . . 0.0 109.049 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -152.75 128.86 10.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.061 0.545 . . . . 0.0 111.672 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -145.41 40.57 1.21 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.258 1.023 . . . . 0.0 111.304 -172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -71.11 -43.92 66.68 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -169.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -62.75 -35.3 79.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.276 0.63 . . . . 0.0 111.682 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.73 -28.34 67.27 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.349 1.46 . . . . 0.0 114.16 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -64.36 -19.65 65.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.446 1.098 . . . . 0.0 112.468 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -78.66 -16.24 57.54 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.097 0.959 . . . . 0.0 112.93 173.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.41 -75.59 0.58 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -131.03 153.61 81.82 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -139.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.63 -16.93 52.1 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 124.33 3.353 . . . . 0.0 114.367 169.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 72.65 86.65 0.1 Allowed Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 127.678 2.391 . . . . 0.0 113.101 171.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.52 93.67 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.628 2.885 . . . . 0.0 110.378 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.26 -38.77 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.139 0.976 . . . . 0.0 112.14 -172.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -69.1 -41.72 77.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.74 0.7 . . . . 0.0 111.866 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.64 -35.49 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.414 0.686 . . . . 0.0 110.316 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.4 -40.18 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.046 0.938 . . . . 0.0 111.914 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.4 -39.39 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.325 0.966 . . . . 0.0 111.074 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 m -65.63 -40.26 92.34 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.733 -0.604 . . . . 0.0 110.844 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -61.9 -47.18 86.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.268 1.027 . . . . 0.0 111.243 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.05 91.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.616 0.766 . . . . 0.0 112.535 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.95 -46.05 89.6 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.587 -0.695 . . . . 0.0 112.061 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.21 -30.14 70.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.09 -1.006 . . . . 0.0 113.37 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.61 -12.72 61.49 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.81 125.75 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.719 1.145 . . . . 0.0 111.047 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.94 -1.4 80.57 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.615 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -75.46 143.35 42.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.06 1.93 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -117.89 146.2 44.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.706 1.602 . . . . 0.0 111.88 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.6 157.25 44.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.981 1.312 . . . . 0.0 112.166 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -153.02 -33.8 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -173.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -72.21 157.89 36.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -171.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.6 t 75.88 -177.55 0.14 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.191 2.196 . . . . 0.0 113.03 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.7 mm -76.11 140.87 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.63 1.172 . . . . 0.0 109.004 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.13 -32.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -170.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.7 p -63.46 -48.44 77.69 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.361 -0.837 . . . . 0.0 111.527 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -67.19 -35.8 80.41 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.597 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.16 -45.52 79.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.596 1.543 . . . . 0.0 111.437 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.8 m -65.82 -49.43 68.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.284 1.434 . . . . 0.0 113.294 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.74 -41.55 99.25 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.567 0.747 . . . . 0.0 112.262 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.561 ' CD2' HE22 ' A' ' 119' ' ' GLN . 34.4 t60 -64.76 -42.26 95.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.111 1.364 . . . . 0.0 110.221 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 8.6 t80 -54.6 -52.46 62.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.021 1.329 . . . . 0.0 112.04 169.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.421 ' HA ' HD12 ' A' ' 120' ' ' LEU . 13.8 m -68.72 -18.33 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.815 1.189 . . . . 0.0 113.992 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -75.6 -45.39 37.87 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.698 169.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.561 HE22 ' CD2' ' A' ' 115' ' ' HIS . 0.8 OUTLIER -54.49 -34.57 61.86 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.82 1.191 . . . . 0.0 113.397 170.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.615 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 78.7 mt -64.98 -59.45 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.907 0.776 . . . . 0.0 111.452 171.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -80.48 11.13 3.9 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.79 -19.45 62.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.543 1.937 . . . . 0.0 113.94 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -47.29 -37.75 11.84 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.908 2.194 . . . . 0.0 116.639 -169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -140.74 7.89 2.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.623 1.211 . . . . 0.0 113.622 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.638 1.575 . . . . 0.0 112.289 175.334 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.88 -30.08 50.61 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.913 0.885 . . . . 0.0 113.385 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.1 m -67.99 149.75 98.05 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.355 1.062 . . . . 0.0 112.981 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 -24.51 14.76 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.266 2.644 . . . . 0.0 113.169 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -162.43 172.94 14.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.199 1.8 . . . . 0.0 110.952 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -72.75 140.97 48.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.228 0.611 . . . . 0.0 110.323 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -108.04 113.33 60.96 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.109 0.964 . . . . 0.0 109.461 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.5 141.8 31.99 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.288 1.992 . . . . 0.0 110.206 170.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -91.75 142.11 26.31 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.852 0.861 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.51 128.92 22.37 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.637 2.225 . . . . 0.0 110.232 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.51 -2.38 72.73 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.503 1.525 . . . . 0.0 114.838 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.26 162.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.521 1.661 . . . . 0.0 111.163 169.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.01 146.05 42.47 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.953 1.359 . . . . 0.0 113.814 -171.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mt -123.26 129.33 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.341 2.257 . . . . 0.0 108.024 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -82.36 124.43 30.0 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.684 1.193 . . . . 0.0 107.798 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mm -118.44 119.5 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 110.346 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -81.79 72.81 8.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 108.536 169.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -25.91 57.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.727 1.211 . . . . 0.0 113.461 -170.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -161.62 -159.94 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.709 2.004 . . . . 0.0 108.715 -159.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.96 34.19 1.05 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.662 1.125 . . . . 0.0 112.678 169.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -169.44 158.83 8.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.427 2.691 . . . . 0.0 111.002 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -104.05 123.95 48.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -105.6 167.95 9.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.599 1.559 . . . . 0.0 110.862 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -112.69 151.81 29.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.729 0.811 . . . . 0.0 111.698 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.62 156.77 44.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.371 1.068 . . . . 0.0 112.819 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -123.49 120.99 34.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.032 . . . . 0.0 108.75 -178.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -76.98 92.17 3.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.234 1.014 . . . . 0.0 111.864 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.5 pt -81.18 -21.93 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.75 173.35 31.75 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 124.199 0.904 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -68.41 90.67 0.37 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.674 0.749 . . . . 0.0 109.908 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.0 49.93 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.195 1.855 . . . . 0.0 115.581 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -126.18 140.64 52.4 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.714 1.757 . . . . 0.0 112.963 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -137.07 149.79 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.289 1.036 . . . . 0.0 113.237 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.5 mm -105.56 131.74 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -146.85 162.82 37.84 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.908 1.231 . . . . 0.0 112.069 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -100.58 134.11 44.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.315 0.646 . . . . 0.0 112.626 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.53 108.44 53.24 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 126.214 1.805 . . . . 0.0 106.232 168.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -62.75 162.18 26.03 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.373 3.382 . . . . 0.0 114.822 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.02 18.59 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.802 3.668 . . . . 0.0 113.689 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.3 m -140.22 142.67 35.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.19 1.396 . . . . 0.0 110.97 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.11 166.08 21.01 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.158 1.383 . . . . 0.0 111.745 172.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -64.3 134.98 96.15 Favored Pre-proline 0 CA--C 1.555 1.138 0 O-C-N 121.027 -1.046 . . . . 0.0 110.818 169.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -66.69 142.65 64.79 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.391 2.727 . . . . 0.0 111.698 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.06 67.65 1.6 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.88 -22.99 64.84 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.74 -0.5 89.51 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 116.346 1.298 . . . . 0.0 116.346 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.2 m -89.94 142.6 27.55 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.369 1.584 . . . . 0.0 111.725 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 p -60.54 -22.55 63.75 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.287 -1.508 . . . . 0.0 113.213 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.8 p -86.64 -13.49 45.46 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.813 1.645 . . . . 0.0 114.71 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -172.81 129.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 120.066 1.303 . . . . 0.0 112.897 -171.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -131.42 -57.46 1.01 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.138 0.975 . . . . 0.0 112.78 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 t -80.26 -29.17 38.31 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.1 t -75.2 132.43 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.728 0.811 . . . . 0.0 109.983 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.21 7.84 3.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.982 1.313 . . . . 0.0 114.498 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -65.92 139.25 58.25 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.944 -1.098 . . . . 0.0 112.615 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -157.88 -162.62 1.19 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.35 1.06 . . . . 0.0 112.314 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m -124.8 146.42 49.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.451 1.5 . . . . 0.0 110.717 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 150.11 26.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.593 -0.692 . . . . 0.0 111.968 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -143.42 136.72 28.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.251 1.02 . . . . 0.0 110.944 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.51 128.35 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.617 1.167 . . . . 0.0 108.846 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -130.41 151.45 50.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.469 1.508 . . . . 0.0 112.543 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -105.37 138.75 41.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.332 1.453 . . . . 0.0 110.585 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.69 167.63 18.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.14 0.976 . . . . 0.0 111.021 -170.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -83.8 143.66 29.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.072 1.349 . . . . 0.0 110.617 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.03 -49.06 72.5 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.507 0.723 . . . . 0.0 110.522 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.7 -24.39 65.6 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.96 -46.09 15.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.355 0.98 . . . . 0.0 110.287 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.69 -30.73 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.971 0.908 . . . . 0.0 112.252 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -91.78 -21.5 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.88 1.672 . . . . 0.0 112.759 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.31 118.71 15.21 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.383 0.992 . . . . 0.0 112.048 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.46 75.49 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.445 1.021 . . . . 0.0 114.607 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.1 m -123.67 163.47 21.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.132 1.773 . . . . 0.0 111.795 -171.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -109.99 159.86 16.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.575 1.15 . . . . 0.0 109.961 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -157.89 169.2 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.9 tpp85 -163.93 132.65 3.74 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.146 1.778 . . . . 0.0 110.727 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.61 127.53 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -152.73 64.89 0.79 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.973 0.892 . . . . 0.0 110.679 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -80.57 69.11 7.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.364 1.065 . . . . 0.0 111.177 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.7 p -35.14 -64.56 0.27 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.425 2.29 . . . . 0.0 115.328 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.84 -29.24 68.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.47 -39.51 74.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.565 0.746 . . . . 0.0 112.448 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -67.99 -30.51 69.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 112.093 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -76.09 -36.98 58.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.612 1.165 . . . . 0.0 113.333 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -162.93 -52.98 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -72.24 148.73 91.38 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -153.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.06 -37.4 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.714 2.943 . . . . 0.0 113.145 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 68.64 119.64 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.602 2.361 . . . . 0.0 116.934 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.4 89.38 1.36 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.396 3.397 . . . . 0.0 110.981 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.92 -41.43 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.739 1.616 . . . . 0.0 113.956 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.03 -36.08 79.34 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.554 0.615 . . . . 0.0 111.512 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.07 -27.87 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.035 0.934 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.6 mm -68.19 -47.29 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.14 0.882 . . . . 0.0 110.647 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.03 -38.13 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.771 -0.58 . . . . 0.0 110.801 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -67.25 -41.15 86.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.705 -0.622 . . . . 0.0 111.166 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.2 m -64.82 -39.55 93.76 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.541 1.136 . . . . 0.0 111.992 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.75 95.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.36 -0.838 . . . . 0.0 111.665 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -68.75 -11.17 59.99 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 173.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.25 -35.74 14.31 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.41 1.084 . . . . 0.0 111.174 168.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.3 mmm -72.44 -20.21 61.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.712 1.605 . . . . 0.0 113.819 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.26 124.22 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.902 1.228 . . . . 0.0 111.623 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.0 -4.56 85.55 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.069 -1.406 . . . . 0.0 115.323 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 150.81 47.61 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.073 1.937 . . . . 0.0 111.009 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -129.18 149.79 50.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.874 1.67 . . . . 0.0 112.301 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.7 mtm -144.03 158.96 43.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 0.0 111.234 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -152.83 -32.88 0.13 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -171.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.59 -28.45 51.63 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -90.12 150.02 22.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.232 1.013 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.33 157.1 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.592 -0.693 . . . . 0.0 111.328 172.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.77 -42.28 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m -64.2 -45.67 87.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.899 0.772 . . . . 0.0 111.367 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -75.98 -32.16 59.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.864 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -57.85 -40.12 79.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.198 0.908 . . . . 0.0 111.366 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.04 -55.23 31.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.895 1.678 . . . . 0.0 112.938 169.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.07 -43.61 98.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.432 -0.792 . . . . 0.0 112.339 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.79 -34.94 79.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.238 1.015 . . . . 0.0 111.195 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.65 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 26.3 t80 -61.19 -55.65 29.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.829 169.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.39 -20.45 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 120.304 1.411 . . . . 0.0 113.992 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -73.01 -37.96 66.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.526 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -71.99 -27.64 62.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.893 1.224 . . . . 0.0 113.442 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.65 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 83.3 mt -66.41 -46.89 75.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.218 0.917 . . . . 0.0 111.77 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -69.5 -94.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.677 1.191 . . . . 0.0 108.633 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.7 t80 70.77 -6.99 1.13 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.236 2.614 . . . . 0.0 112.993 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.28 -69.54 1.28 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 127.22 2.343 . . . . 0.0 111.92 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.84 1.14 33.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.26 1.024 . . . . 0.0 113.269 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 125.617 1.567 . . . . 0.0 112.484 170.067 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.63 162.8 28.41 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.347 1.059 . . . . 0.0 112.602 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.6 m -68.14 153.38 95.52 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.897 0.879 . . . . 0.0 112.96 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.28 149.67 53.91 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.067 3.178 . . . . 0.0 113.404 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -162.72 163.23 26.94 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.46 1.504 . . . . 0.0 111.01 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -137.54 100.17 4.14 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.551 1.14 . . . . 0.0 109.45 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -114.21 115.26 45.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.145 0.978 . . . . 0.0 110.677 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.2 150.1 36.83 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.25 2.634 . . . . 0.0 111.069 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -108.59 160.31 27.67 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.457 1.503 . . . . 0.0 111.664 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.51 134.5 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.782 1.655 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.8 -10.38 74.71 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.855 1.216 . . . . 0.0 114.685 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.13 142.76 31.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.773 1.287 . . . . 0.0 111.539 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.66 128.1 48.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.627 1.203 . . . . 0.0 108.074 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.15 126.65 61.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 105.978 -170.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -74.84 129.67 38.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.06 120.04 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.621 1.569 . . . . 0.0 109.051 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -80.93 90.27 5.92 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -81.58 31.24 0.35 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt 82.53 72.76 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.652 1.981 . . . . 0.0 110.922 155.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.79 1.46 76.94 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.829 1.204 . . . . 0.0 113.353 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -138.67 140.2 38.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.239 1.815 . . . . 0.0 110.653 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -98.06 119.71 37.18 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.645 0.778 . . . . 0.0 110.427 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -125.92 178.62 5.63 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.695 1.598 . . . . 0.0 111.042 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -137.97 157.24 46.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.441 0.696 . . . . 0.0 112.606 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.55 25.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 120.74 32.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.671 1.589 . . . . 0.0 108.589 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.0 110.24 5.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 pt -100.06 -20.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.34 170.57 42.19 Favored Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.71 0.804 . . . . 0.0 112.591 -170.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 19.11 66.24 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.335 1.445 . . . . 0.0 115.749 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -127.08 141.73 51.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.62 1.71 . . . . 0.0 112.736 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.9 156.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.658 1.183 . . . . 0.0 113.117 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 mm -112.49 132.42 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.184 1.794 . . . . 0.0 107.632 169.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -149.31 148.77 29.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.737 1.153 . . . . 0.0 111.896 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.0 tp -83.41 106.35 15.1 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 91.66 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.194 1.398 . . . . 0.0 111.032 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.18 141.91 44.74 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.129 3.22 . . . . 0.0 116.289 -168.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.41 -14.38 11.78 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.758 2.972 . . . . 0.0 111.766 169.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -63.75 -2.15 1.66 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.333 2.253 . . . . 0.0 116.703 -169.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -76.15 45.18 0.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.636 1.574 . . . . 0.0 112.007 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -58.28 -35.1 29.76 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -58.58 152.03 58.34 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.985 3.124 . . . . 0.0 113.245 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.72 -44.71 2.79 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.09 1.329 . . . . 0.0 113.198 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.83 147.35 43.43 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.216 1.008 . . . . 0.0 113.035 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.33 17.36 3.13 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 125.074 1.321 . . . . 0.0 114.776 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.2 m -171.38 156.42 4.56 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.96 2.104 . . . . 0.0 110.804 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -59.9 -17.9 40.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.354 1.461 . . . . 0.0 114.427 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 p -70.96 -21.34 62.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.932 1.293 . . . . 0.0 113.585 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t 73.35 129.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 128.095 2.558 . . . . 0.0 112.551 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -107.38 -25.21 11.54 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.7 p -93.52 -88.29 0.23 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.056 0.942 . . . . 0.0 110.617 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.8 128.57 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.446 1.498 . . . . 0.0 111.543 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.2 tp 61.23 10.75 3.16 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.938 2.095 . . . . 0.0 116.029 169.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 m -66.37 -15.38 63.24 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 119.964 -1.71 . . . . 0.0 115.365 -170.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -77.08 -43.35 34.63 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.9 p -170.74 162.85 7.84 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.69 1.596 . . . . 0.0 111.084 -169.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.86 156.35 28.71 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.117 -0.989 . . . . 0.0 111.27 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.68 135.05 37.87 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 0.0 111.289 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.52 122.19 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -127.36 157.07 40.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.428 1.491 . . . . 0.0 112.26 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -101.55 142.39 32.99 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.139 1.375 . . . . 0.0 110.398 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.75 164.08 21.28 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.095 0.958 . . . . 0.0 111.23 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -74.67 140.67 44.39 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.23 1.412 . . . . 0.0 110.414 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.3 tp -53.81 -57.27 11.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.173 0.989 . . . . 0.0 110.873 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.54 -21.94 66.61 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.48 -41.66 65.76 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.188 0.904 . . . . 0.0 110.878 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.29 -54.55 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.616 0.766 . . . . 0.0 110.87 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.1 -6.61 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.87 -28.23 54.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.116 0.865 . . . . 0.0 113.179 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.39 22.93 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.612 1.101 . . . . 0.0 114.736 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 79.8 m -130.76 148.47 52.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.238 1.415 . . . . 0.0 112.44 -172.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.6 m -76.56 157.37 32.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -158.02 172.45 18.42 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 155.52 2.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 128.173 2.589 . . . . 0.0 112.443 169.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.34 146.72 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.983 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -130.35 -80.85 0.54 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 51.47 49.73 20.35 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.878 2.071 . . . . 0.0 112.541 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -49.35 -57.04 7.6 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.677 -1.265 . . . . 0.0 113.402 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.19 -27.14 69.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.362 1.065 . . . . 0.0 113.444 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -24.94 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.876 0.87 . . . . 0.0 112.238 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -89.55 -30.84 17.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.514 1.125 . . . . 0.0 112.646 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.58 -37.58 88.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.73 0.812 . . . . 0.0 111.898 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.7 -71.55 0.09 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.91 129.89 40.43 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -145.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.88 67.19 5.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.897 3.065 . . . . 0.0 110.46 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.413 ' HB3' HD11 ' A' ' 92' ' ' ILE . 27.8 ttt180 -66.45 137.36 95.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.39 123.11 11.84 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.155 2.57 . . . . 0.0 110.33 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' HA ' HD12 ' A' ' 92' ' ' ILE . 2.5 t -65.25 -31.68 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.53 -0.747 . . . . 0.0 112.297 -169.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -54.74 -37.75 66.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.687 1.131 . . . . 0.0 112.4 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.04 -28.5 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.518 0.727 . . . . 0.0 110.909 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 87' ' ' ARG . 21.7 mt -69.63 -44.22 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.437 1.095 . . . . 0.0 110.42 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.86 -46.43 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.291 1.037 . . . . 0.0 109.837 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -64.21 -40.73 96.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.457 0.703 . . . . 0.0 111.565 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.0 t -61.33 -43.66 98.49 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.079 -1.013 . . . . 0.0 111.639 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.8 93.78 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.104 -0.997 . . . . 0.0 111.893 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.47 -25.39 68.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.197 0.999 . . . . 0.0 113.536 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -81.35 -35.27 31.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.174 0.99 . . . . 0.0 112.999 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.2 mmm -73.38 -30.39 63.26 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -54.78 126.61 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.488 1.04 . . . . 0.0 111.193 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.88 -9.52 55.2 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.027 1.775 . . . . 0.0 114.263 -173.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -83.5 141.32 31.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.128 1.464 . . . . 0.0 111.11 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.98 155.06 18.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.69 1.596 . . . . 0.0 111.159 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 23.2 ptp -161.85 152.71 17.84 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -150.46 41.06 0.78 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.086 1.755 . . . . 0.0 110.268 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.84 -28.46 69.5 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.305 1.842 . . . . 0.0 115.279 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -172.1 -169.83 0.68 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.679 1.992 . . . . 0.0 110.379 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 pt -54.43 150.75 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.828 0.851 . . . . 0.0 110.504 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.78 -37.95 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.2 p -62.87 -45.55 92.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.067 0.849 . . . . 0.0 111.7 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -70.56 -35.14 72.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.019 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -61.29 -41.97 97.86 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.446 1.475 . . . . 0.0 110.911 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.2 m -64.36 -48.91 73.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.759 2.024 . . . . 0.0 112.508 170.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.84 -45.74 92.51 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.478 -0.764 . . . . 0.0 112.241 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -53.01 -45.42 67.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.644 1.978 . . . . 0.0 110.683 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.22 -58.9 6.55 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.723 1.209 . . . . 0.0 112.335 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.32 -26.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.031 1.287 . . . . 0.0 113.472 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -61.86 -52.28 64.76 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 115.981 -1.961 . . . . 0.0 107.449 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -56.93 -25.4 57.38 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 122.41 2.368 . . . . 0.0 114.849 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -68.47 -33.26 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.666 1.121 . . . . 0.0 112.841 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -105.95 -13.43 15.49 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -58.11 -22.01 48.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.666 2.787 . . . . 0.0 113.069 -168.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -71.67 -11.94 73.51 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.862 -0.965 . . . . 0.0 115.414 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -134.57 2.92 3.25 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.68 1.24 . . . . 0.0 114.216 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 125.246 1.418 . . . . 0.0 112.891 177.594 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.02 175.96 10.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.722 1.209 . . . . 0.0 112.63 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -61.97 -38.44 49.01 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -62.11 141.54 88.96 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.878 2.385 . . . . 0.0 112.944 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.48 17.28 12.94 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.007 1.723 . . . . 0.0 111.289 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -160.2 175.69 12.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.926 2.491 . . . . 0.0 109.752 -174.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -142.87 128.06 10.07 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.96 0.904 . . . . 0.0 109.903 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.7 142.14 25.48 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.553 2.835 . . . . 0.0 110.635 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -115.66 138.91 24.18 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.189 0.995 . . . . 0.0 111.712 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.13 130.24 28.24 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.407 2.738 . . . . 0.0 111.32 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.07 42.37 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.169 1.842 . . . . 0.0 115.304 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -89.35 164.62 14.82 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 110.446 169.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -119.65 148.6 43.16 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.582 1.182 . . . . 0.0 113.012 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -123.99 130.34 73.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.561 2.344 . . . . 0.0 108.221 -161.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -88.71 120.88 30.51 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.79 124.28 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.461 1.504 . . . . 0.0 108.456 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -90.78 63.92 5.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.304 1.441 . . . . 0.0 109.579 -173.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -61.41 2.32 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -148.79 -129.48 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -162.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.33 33.83 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.635 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.75 158.53 2.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.566 2.746 . . . . 0.0 112.008 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -112.9 155.35 24.87 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.887 1.675 . . . . 0.0 109.783 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 164.81 34.91 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.569 -0.707 . . . . 0.0 112.885 174.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -97.88 149.82 21.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.19 140.35 27.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.424 1.09 . . . . 0.0 112.613 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.95 117.53 35.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.846 2.058 . . . . 0.0 108.983 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -76.56 86.82 3.26 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.885 1.274 . . . . 0.0 111.804 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -74.77 -23.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.11 177.88 27.03 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.584 1.088 . . . . 0.0 111.486 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.38 81.89 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.726 0.81 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.33 -11.83 31.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.33 2.395 . . . . 0.0 114.671 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.89 140.47 36.14 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.108 1.454 . . . . 0.0 113.126 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.0 149.54 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 0.0 113.703 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -108.35 123.04 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -137.8 149.76 46.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.231 -0.918 . . . . 0.0 111.512 -169.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.59 118.98 29.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.881 0.472 . . . . 0.0 110.07 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.7 130.95 62.23 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.04 158.89 45.33 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.279 2.652 . . . . 0.0 112.772 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.57 -12.5 15.23 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.914 3.076 . . . . 0.0 113.456 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 t -159.93 149.41 17.95 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.454 1.025 . . . . 0.0 112.054 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -81.05 172.7 13.39 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.037 1.335 . . . . 0.0 113.001 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -49.76 123.93 15.42 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 125.215 1.406 . . . . 0.0 112.359 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.83 -19.82 58.69 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.669 2.913 . . . . 0.0 114.697 -170.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.18 -8.25 85.15 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 119.082 0.856 . . . . 0.0 114.573 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 66.8 9.71 6.98 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.694 2.397 . . . . 0.0 115.172 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.72 -1.63 73.6 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.952 1.263 . . . . 0.0 115.448 -174.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.4 p -82.83 143.51 30.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.975 1.387 . . . . 0.0 112.563 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.1 m -60.92 -11.68 8.72 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.867 -1.145 . . . . 0.0 114.047 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.3 p -68.81 -15.11 63.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.67 1.588 . . . . 0.0 114.249 169.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 136.71 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.72 1.145 . . . . 0.0 113.814 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -136.18 14.34 3.28 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.42 1.488 . . . . 0.0 112.384 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.0 p -160.82 -83.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.577 1.151 . . . . 0.0 112.021 -172.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.7 t -105.83 125.16 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.938 1.695 . . . . 0.0 110.106 -176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.4 mp -88.36 -31.92 18.65 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.362 1.065 . . . . 0.0 112.984 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.0 p -94.78 153.88 17.54 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -163.68 -145.87 0.1 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.202 2.201 . . . . 0.0 109.453 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 m -120.11 154.95 33.97 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.464 1.505 . . . . 0.0 109.985 169.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.16 150.42 30.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.444 -0.785 . . . . 0.0 111.23 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.94 133.7 16.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.725 0.81 . . . . 0.0 110.654 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.03 121.9 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -128.06 156.7 42.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.739 1.616 . . . . 0.0 112.853 -170.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.33 139.98 38.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.067 1.347 . . . . 0.0 110.625 171.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.74 178.87 5.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.497 1.519 . . . . 0.0 109.811 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -96.1 142.49 28.23 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.317 1.447 . . . . 0.0 110.325 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.2 tp -55.35 -49.66 71.67 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.518 -0.739 . . . . 0.0 111.099 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.77 -25.63 63.23 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.28 -42.38 14.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.995 0.816 . . . . 0.0 111.342 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.98 -40.8 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 118.13 0.423 . . . . 0.0 111.305 172.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.5 -47.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.264 1.026 . . . . 0.0 111.613 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.21 -117.55 11.81 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -171.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.58 0.86 61.54 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.039 1.304 . . . . 0.0 115.056 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.82 166.44 22.05 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.942 1.371 . . . . 0.0 113.587 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -82.35 156.26 24.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.881 0.873 . . . . 0.0 110.998 169.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -161.05 156.73 25.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.019 0.927 . . . . 0.0 113.314 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -153.08 140.04 19.19 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.92 0.888 . . . . 0.0 111.827 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.92 133.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -158.01 70.12 0.55 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.344 1.058 . . . . 0.0 111.499 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -80.12 61.06 3.84 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.807 -1.183 . . . . 0.0 111.998 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.8 p -43.2 -67.62 0.26 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.496 1.918 . . . . 0.0 114.842 -169.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -58.08 -27.16 63.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.993 0.917 . . . . 0.0 113.142 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.2 -48.5 28.6 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.757 -0.589 . . . . 0.0 111.572 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -78.67 -7.59 57.84 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.4 -31.81 73.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 113.34 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.76 -36.41 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -126.45 139.26 34.19 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -137.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -94.6 54.99 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.09 1 C-N-CA 125.439 4.093 . . . . 0.0 111.737 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 147.82 46.84 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.41 100.4 1.14 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.955 3.104 . . . . 0.0 109.211 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.14 -25.26 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.327 1.051 . . . . 0.0 113.207 -169.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.58 -33.21 75.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.74 0.816 . . . . 0.0 112.338 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.0 -34.37 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.603 -0.685 . . . . 0.0 110.172 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.5 -44.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.611 0.764 . . . . 0.0 110.756 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.08 -40.13 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.669 0.788 . . . . 0.0 111.24 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.9 m -66.44 -43.18 86.31 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.416 -0.802 . . . . 0.0 111.237 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -34.66 78.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.049 0.939 . . . . 0.0 112.71 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.22 -45.17 94.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.77 1.168 . . . . 0.0 111.812 171.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.69 -13.49 61.33 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.96 -36.46 13.42 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.556 1.143 . . . . 0.0 112.501 168.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -72.38 -30.42 64.66 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.122 1.369 . . . . 0.0 113.573 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.43 128.45 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.809 0.731 . . . . 0.0 111.159 171.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.44 -9.11 58.94 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.484 1.516 . . . . 0.0 114.468 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -71.65 145.75 48.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.387 1.594 . . . . 0.0 111.01 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.81 143.95 50.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.009 1.724 . . . . 0.0 111.549 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -141.5 158.32 44.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.077 1.351 . . . . 0.0 111.363 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -161.96 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -72.39 -34.99 68.32 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.2 m -71.74 163.15 28.32 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -175.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.69 133.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.908 0.883 . . . . 0.0 108.629 171.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.1 t -57.67 -42.75 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 m -61.05 -47.97 83.91 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.568 -0.707 . . . . 0.0 111.075 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -67.44 -34.22 76.75 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.846 -0.534 . . . . 0.0 112.235 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.15 -38.5 83.31 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.099 0.96 . . . . 0.0 111.866 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 81.7 m -69.7 -48.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.433 1.093 . . . . 0.0 111.896 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.2 -46.96 86.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.057 0.543 . . . . 0.0 112.018 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -65.35 -32.55 74.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.75 -1.219 . . . . 0.0 111.531 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.44 -58.6 7.55 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.307 -0.871 . . . . 0.0 110.885 170.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.76 -25.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.0 m -69.41 -39.97 77.6 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.221 173.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.62 -27.19 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.278 1.399 . . . . 0.0 113.248 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.97 -38.37 82.64 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.545 1.066 . . . . 0.0 112.983 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 34.44 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -39.44 61.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 127.238 2.215 . . . . 0.0 112.493 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.91 44.54 0.1 Allowed Glycine 0 N--CA 1.475 1.263 0 C-N-CA 126.463 1.982 . . . . 0.0 111.528 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 pttm 91.72 -22.63 0.08 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 130.451 3.501 . . . . 0.0 110.172 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.253 1.262 1 C-N-CA 132.741 4.417 . . . . 0.0 113.516 169.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 120.32 0.105 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.52 152.19 45.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.988 0.915 . . . . 0.0 112.628 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.6 p -167.9 155.39 7.95 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.499 1.52 . . . . 0.0 111.848 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.45 157.1 45.32 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.574 2.85 . . . . 0.0 111.587 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -73.68 -16.1 61.22 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -160.78 137.64 8.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.979 1.712 . . . . 0.0 109.749 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.84 128.92 4.01 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 111.051 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.15 136.61 11.63 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.074 2.516 . . . . 0.0 110.214 169.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -85.45 154.81 59.69 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.428 0.691 . . . . 0.0 110.959 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.97 123.64 11.9 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.138 1.892 . . . . 0.0 109.228 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 -2.3 81.8 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.705 1.622 . . . . 0.0 115.198 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.95 156.79 17.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 1.587 . . . . 0.0 111.734 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.2 pt? -112.42 160.75 17.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.753 1.221 . . . . 0.0 113.581 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mt -144.31 131.91 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.994 1.318 . . . . 0.0 110.471 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.92 121.75 33.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.822 1.249 . . . . 0.0 107.633 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.7 mt -126.6 123.54 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.945 0.898 . . . . 0.0 110.488 -172.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.93 51.72 1.8 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.895 1.678 . . . . 0.0 110.71 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.06 -40.96 82.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.726 1.21 . . . . 0.0 111.86 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 mt -158.8 172.38 18.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.624 1.969 . . . . 0.0 108.192 -168.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.65 -7.39 20.98 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -73.88 -35.52 64.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.349 1.06 . . . . 0.0 113.483 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 68.28 106.52 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.309 2.244 . . . . 0.0 109.509 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -101.39 149.39 24.1 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -94.63 136.98 34.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.062 0.945 . . . . 0.0 109.431 168.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.73 159.06 42.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.194 0.998 . . . . 0.0 112.493 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.39 121.66 29.61 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.419 2.287 . . . . 0.0 107.782 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -77.97 97.65 5.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.576 0.626 . . . . 0.0 110.26 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.7 pt -73.7 -3.54 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.79 137.14 4.07 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.526 1.06 . . . . 0.0 114.293 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.23 -20.51 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 129.953 3.301 . . . . 0.0 117.575 169.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.88 -19.81 0.05 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.211 1.386 . . . . 0.0 115.132 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -89.9 147.89 23.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.182 1.491 . . . . 0.0 113.466 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 m -127.82 146.29 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.211 1.404 . . . . 0.0 112.13 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.48 139.62 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -158.19 158.95 35.54 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.119 -0.988 . . . . 0.0 111.942 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -98.81 136.25 39.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.222 0.609 . . . . 0.0 111.124 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.89 141.16 21.91 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 109.686 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.15 165.14 33.5 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.641 2.894 . . . . 0.0 112.469 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -70.32 -2.66 10.95 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.363 2.708 . . . . 0.0 115.493 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -57.04 132.29 52.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.584 1.154 . . . . 0.0 112.2 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.28 132.83 42.46 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.381 -0.824 . . . . 0.0 112.966 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -69.53 -50.2 19.77 Favored Pre-proline 0 CA--C 1.555 1.139 0 CA-C-O 118.005 -0.998 . . . . 0.0 113.614 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.41 168.48 22.79 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.924 3.083 . . . . 0.0 111.497 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.08 29.58 1.87 Allowed Glycine 0 N--CA 1.474 1.223 0 C-N-CA 125.058 1.313 . . . . 0.0 113.969 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 136.52 41.8 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.615 1.566 . . . . 0.0 112.503 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.02 139.89 7.28 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.207 1.384 . . . . 0.0 112.065 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.0 m 60.23 27.98 17.54 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.973 1.309 . . . . 0.0 112.855 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.3 p -151.08 -169.09 3.29 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.506 1.523 . . . . 0.0 112.009 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 t -79.44 6.72 9.53 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 120.56 -1.337 . . . . 0.0 113.275 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 52' ' ' SER . 15.0 p -146.88 146.92 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.894 1.278 . . . . 0.0 111.815 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -130.75 14.38 5.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.007 1.323 . . . . 0.0 113.535 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.403 ' H ' HG22 ' A' ' 50' ' ' VAL . 22.8 m -73.46 63.54 0.8 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.952 1.701 . . . . 0.0 112.628 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.12 151.02 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.385 1.474 . . . . 0.0 113.076 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.3 tp -130.77 -32.52 1.67 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.238 1.415 . . . . 0.0 112.754 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.7 m -80.87 -70.86 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.514 0.726 . . . . 0.0 110.888 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 64.69 -58.15 0.25 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 128.708 2.803 . . . . 0.0 112.896 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m -120.82 169.01 10.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.454 2.301 . . . . 0.0 109.891 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.22 155.41 40.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.951 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -138.57 129.94 27.35 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.853 0.861 . . . . 0.0 111.095 -170.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.94 128.95 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.194 0.597 . . . . 0.0 110.11 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -137.67 169.87 17.04 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.878 1.671 . . . . 0.0 112.248 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -127.12 143.04 51.36 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.922 1.689 . . . . 0.0 111.872 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -153.76 179.54 8.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.449 1.9 . . . . 0.0 110.623 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -102.56 140.25 37.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 110.332 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.26 -47.91 71.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.015 1.326 . . . . 0.0 111.631 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.14 -33.34 70.77 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.84 -45.32 51.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.378 0.99 . . . . 0.0 110.27 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.19 -32.31 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.736 1.214 . . . . 0.0 112.605 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.82 -20.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.888 1.675 . . . . 0.0 112.547 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 116.13 8.36 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.253 0.933 . . . . 0.0 111.911 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.6 7.55 74.29 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.574 1.083 . . . . 0.0 115.041 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.3 m -121.15 143.94 48.84 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.121 1.369 . . . . 0.0 112.468 -171.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 80.8 m -85.04 152.11 23.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.448 0.699 . . . . 0.0 109.674 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -158.18 161.44 37.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.631 0.772 . . . . 0.0 112.977 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -144.61 139.51 28.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.861 1.664 . . . . 0.0 110.536 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.9 t -80.61 138.32 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -126.62 142.1 51.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.813 0.845 . . . . 0.0 112.846 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -137.48 39.59 2.44 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.288 1.435 . . . . 0.0 111.337 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.7 t -57.9 -69.05 0.19 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.571 -1.33 . . . . 0.0 113.725 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.7 mt -72.31 -27.05 62.2 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.39 -0.819 . . . . 0.0 112.181 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.18 -42.14 98.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.637 0.775 . . . . 0.0 112.923 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.03 -8.61 59.09 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -82.56 -36.01 26.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -113.11 -45.0 3.2 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -169.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -142.34 155.04 64.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -133.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.87 -21.36 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.606 3.537 . . . . 0.0 113.122 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 69.18 117.61 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 128.441 2.696 . . . . 0.0 115.408 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.54 88.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 123.733 2.956 . . . . 0.0 108.58 169.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.71 -38.74 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.997 -169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -38.79 81.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.539 0.609 . . . . 0.0 111.721 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.43 -38.16 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.79 0.723 . . . . 0.0 111.305 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.68 -47.36 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 119.281 0.946 . . . . 0.0 110.323 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 90.8 mt -61.41 -40.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.206 1.002 . . . . 0.0 110.94 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.1 t -63.42 -42.93 98.73 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.434 0.694 . . . . 0.0 111.408 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -58.96 -40.54 85.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.321 -0.862 . . . . 0.0 112.248 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.9 -52.57 59.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.49 0.716 . . . . 0.0 111.982 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.82 -22.72 67.05 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.34 -50.03 12.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.165 0.986 . . . . 0.0 112.367 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 ptm -83.46 -14.13 53.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -170.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -55.54 125.4 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -8.45 59.06 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.391 1.472 . . . . 0.0 114.297 -169.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -70.63 153.97 42.33 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.576 1.688 . . . . 0.0 110.779 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -127.64 142.24 51.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.79 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -140.43 149.25 42.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.072 0.949 . . . . 0.0 113.059 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -154.28 -152.33 0.4 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.664 1.586 . . . . 0.0 111.262 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.9 t80 72.35 -53.77 0.69 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.871 2.869 . . . . 0.0 113.885 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.1 m -69.41 162.99 26.22 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.734 1.214 . . . . 0.0 112.379 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 tt -63.3 144.25 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 121.378 -0.826 . . . . 0.0 109.898 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.33 -27.63 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.8 t -64.14 -49.11 73.44 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.367 -0.833 . . . . 0.0 111.151 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -68.71 -28.7 67.07 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.933 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -57.34 -42.31 81.72 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.862 1.665 . . . . 0.0 111.191 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -45.11 53.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.957 1.303 . . . . 0.0 112.968 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.24 -41.41 90.06 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.117 -0.99 . . . . 0.0 112.69 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.85 -36.36 83.24 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.602 -1.311 . . . . 0.0 110.784 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.27 -58.0 10.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.482 0.713 . . . . 0.0 110.706 170.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -65.97 -27.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.954 1.252 . . . . 0.0 113.486 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -68.92 -33.97 74.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.819 1.19 . . . . 0.0 111.429 172.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -66.38 -23.14 66.28 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.61 -61.38 1.89 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.456 -0.778 . . . . 0.0 111.758 169.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -72.63 5.6 2.99 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -53.35 -24.75 12.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.251 2.22 . . . . 0.0 112.459 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.41 -24.51 11.01 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 127.573 2.511 . . . . 0.0 114.615 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.56 -19.94 0.47 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.252 1.021 . . . . 0.0 113.019 177.617 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 120.464 0.173 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.15 157.57 35.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.287 1.035 . . . . 0.0 112.773 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 m -70.91 148.35 94.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.93 0.892 . . . . 0.0 112.738 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.93 163.27 37.35 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.523 2.815 . . . . 0.0 111.535 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -157.13 152.57 26.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.684 1.193 . . . . 0.0 111.771 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -160.28 132.05 6.03 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.09 1.756 . . . . 0.0 108.635 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -110.77 117.39 50.62 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.222 0.609 . . . . 0.0 112.107 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.57 139.47 12.72 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 108.378 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -85.8 148.65 49.07 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.536 -0.728 . . . . 0.0 111.529 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.56 128.02 20.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.182 2.588 . . . . 0.0 109.957 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.48 82.86 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.938 1.733 . . . . 0.0 115.039 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.6 162.96 12.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -100.9 110.72 22.81 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 127.64 2.376 . . . . 0.0 113.636 -168.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.23 132.35 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.099 1.359 . . . . 0.0 109.92 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -96.54 116.98 29.98 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.07 120.29 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.317 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -81.72 63.16 5.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.675 1.19 . . . . 0.0 109.47 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -62.24 -29.38 70.36 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.317 1.047 . . . . 0.0 113.122 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.46 -144.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.092 1.357 . . . . 0.0 110.456 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.27 31.11 0.81 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.274 1.416 . . . . 0.0 114.706 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -168.44 154.87 7.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.786 2.835 . . . . 0.0 110.093 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -104.65 128.45 52.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.969 0.907 . . . . 0.0 110.812 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -108.76 134.69 51.12 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.878 1.271 . . . . 0.0 110.786 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -79.78 144.65 33.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.82 145.31 37.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.346 1.458 . . . . 0.0 111.521 169.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.14 118.19 36.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.244 1.818 . . . . 0.0 107.948 173.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -74.09 94.7 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.537 0.735 . . . . 0.0 110.64 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 pt -74.04 -8.8 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.668 -1.27 . . . . 0.0 114.15 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.97 133.83 2.91 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.738 0.685 . . . . 0.0 114.29 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 63.39 -19.56 0.06 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.634 3.173 . . . . 0.0 117.284 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.52 -21.44 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.509 1.528 . . . . 0.0 114.683 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.87 144.45 30.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.949 1.375 . . . . 0.0 113.002 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.83 145.62 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.135 1.374 . . . . 0.0 112.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.8 mm -107.45 138.64 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.753 1.621 . . . . 0.0 107.643 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -153.68 146.47 24.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.502 1.047 . . . . 0.0 112.091 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.12 118.79 31.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 109.844 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.9 119.49 75.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.855 1.262 . . . . 0.0 108.96 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -74.28 165.33 32.1 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.714 2.943 . . . . 0.0 112.261 -173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.24 133.49 19.5 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.667 2.244 . . . . 0.0 110.051 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -168.85 -172.47 1.6 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.542 1.137 . . . . 0.0 112.017 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.33 162.25 23.25 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.049 1.34 . . . . 0.0 113.046 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -150.42 168.04 11.79 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 125.427 1.491 . . . . 0.0 112.328 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.07 147.88 41.8 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.017 3.144 . . . . 0.0 113.844 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.26 -10.2 50.54 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.727 1.156 . . . . 0.0 113.504 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.07 164.36 15.57 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.723 1.609 . . . . 0.0 112.902 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.53 161.37 26.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.304 0.954 . . . . 0.0 113.897 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.1 p -81.52 -10.15 59.54 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.527 1.131 . . . . 0.0 113.348 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 m -172.08 167.97 5.92 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.972 2.909 . . . . 0.0 109.777 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.0 m 70.46 -28.94 0.18 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.274 2.229 . . . . 0.0 115.515 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -155.75 144.77 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.116 1.766 . . . . 0.0 110.815 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -154.65 49.14 0.59 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.068 1.347 . . . . 0.0 110.915 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.4 m -75.71 61.06 1.34 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.577 1.551 . . . . 0.0 111.059 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.89 152.77 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.552 1.541 . . . . 0.0 111.01 -169.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.6 tp -150.66 -73.54 0.16 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.005 1.322 . . . . 0.0 109.32 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -167.07 131.85 2.01 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.232 1.813 . . . . 0.0 111.075 169.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -82.6 169.53 16.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.822 1.249 . . . . 0.0 111.805 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m -77.24 161.68 27.95 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.201 -0.937 . . . . 0.0 111.935 169.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.21 159.11 28.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.014 0.926 . . . . 0.0 111.04 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -152.58 138.46 18.05 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.652 -0.655 . . . . 0.0 112.197 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.4 t -82.54 125.76 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.551 1.14 . . . . 0.0 109.406 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.47 175.15 9.79 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.959 1.704 . . . . 0.0 112.004 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -141.21 143.95 34.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.645 1.578 . . . . 0.0 112.24 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -178.78 -165.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.434 2.694 . . . . 0.0 109.249 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -103.79 150.0 24.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.7 tp -50.94 -57.87 7.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.123 1.769 . . . . 0.0 111.477 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 69' ' ' VAL . 17.7 pm0 -57.27 -33.44 67.62 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.088 0.955 . . . . 0.0 113.409 -174.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.04 -30.03 58.27 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.371 -0.831 . . . . 0.0 112.015 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.49 -45.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.204 1.401 . . . . 0.0 111.785 172.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 66' ' ' GLU . 34.7 m -84.62 -6.13 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.4 7.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 119.145 0.884 . . . . 0.0 111.777 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.28 7.72 78.23 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.835 1.207 . . . . 0.0 115.07 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.36 151.84 42.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.593 1.557 . . . . 0.0 112.549 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.61 160.12 19.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.874 0.87 . . . . 0.0 110.63 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -161.67 168.15 23.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.339 1.056 . . . . 0.0 113.44 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -167.23 149.98 6.21 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.122 1.769 . . . . 0.0 110.147 176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.16 138.82 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 119.735 1.152 . . . . 0.0 110.153 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -132.32 130.69 41.11 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.013 1.325 . . . . 0.0 111.977 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -123.43 25.84 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.202 1.801 . . . . 0.0 113.299 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.7 m -60.82 -21.45 63.16 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.547 -1.345 . . . . 0.0 114.577 -171.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 mt -93.27 -39.25 11.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.806 0.842 . . . . 0.0 113.025 169.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.58 -35.06 71.8 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.439 1.018 . . . . 0.0 111.819 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -52.88 -29.12 26.44 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.401 2.28 . . . . 0.0 113.052 171.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -87.26 -14.91 39.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.494 1.118 . . . . 0.0 112.993 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -122.03 -64.64 1.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -138.71 149.7 63.17 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -135.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 -11.55 15.27 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 125.183 3.922 . . . . 0.0 114.074 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 81.21 96.48 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 127.586 2.354 . . . . 0.0 114.012 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.99 80.89 2.74 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.745 2.963 . . . . 0.0 108.528 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.77 -29.58 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.64 -39.5 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.465 1.03 . . . . 0.0 111.428 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.09 -34.23 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.387 -0.821 . . . . 0.0 110.247 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.9 mt -76.71 -39.69 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.995 0.918 . . . . 0.0 111.566 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.04 -45.32 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.551 -0.718 . . . . 0.0 110.979 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.9 p -68.21 -29.98 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.337 -0.852 . . . . 0.0 112.413 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -59.7 -46.64 88.47 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.059 -1.025 . . . . 0.0 111.192 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.65 92.09 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.079 -1.013 . . . . 0.0 112.428 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -67.42 -15.7 63.82 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -90.14 -38.35 13.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.977 1.311 . . . . 0.0 112.113 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.4 mmm -70.46 -25.09 63.02 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.361 1.464 . . . . 0.0 113.999 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -48.59 127.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.105 0.866 . . . . 0.0 111.804 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.87 81.4 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.127 1.346 . . . . 0.0 115.114 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -73.62 138.94 45.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.6 1.7 . . . . 0.0 110.7 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -98.08 156.12 16.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.363 1.465 . . . . 0.0 112.173 170.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 mtm -144.43 159.26 43.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.33 1.852 . . . . 0.0 111.44 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -158.61 -32.8 0.07 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -70.11 151.97 44.86 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.453 1.101 . . . . 0.0 113.879 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 t 76.76 -179.04 0.14 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.858 2.063 . . . . 0.0 113.803 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 pt -76.61 149.28 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.643 1.177 . . . . 0.0 110.558 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.91 -35.43 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.833 0.742 . . . . 0.0 112.542 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 p -64.35 -47.08 80.69 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.809 0.844 . . . . 0.0 112.485 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -67.95 -37.18 81.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.229 -0.919 . . . . 0.0 111.249 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -59.58 -46.56 88.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.289 0.95 . . . . 0.0 111.819 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.7 p -73.33 -37.34 66.15 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.495 -0.753 . . . . 0.0 112.797 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.25 -54.57 44.13 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.045 0.839 . . . . 0.0 111.355 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -56.1 -39.5 72.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.607 1.163 . . . . 0.0 111.224 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -56.43 -58.64 7.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.183 0.993 . . . . 0.0 111.294 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.3 m -64.98 -33.2 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.174 1.352 . . . . 0.0 113.253 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.7 m -68.36 -31.98 71.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.135 1.334 . . . . 0.0 111.544 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.51 -25.46 66.69 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.526 1.512 . . . . 0.0 112.327 169.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.62 -56.48 5.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.155 0.889 . . . . 0.0 110.976 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -75.96 5.7 6.19 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -57.7 -23.31 51.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.798 2.039 . . . . 0.0 113.434 -170.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -40.22 -36.32 0.89 Allowed Glycine 0 N--CA 1.474 1.185 0 C-N-CA 128.839 3.114 . . . . 0.0 117.465 -169.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -138.68 16.52 2.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.2 1.0 . . . . 0.0 112.77 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 126.203 1.801 . . . . 0.0 112.565 -178.51 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 tpp . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.905 -0.569 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.28 157.59 27.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.477 1.035 . . . . 0.0 112.901 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -97.42 151.34 37.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.604 1.162 . . . . 0.0 112.297 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.69 163.61 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.842 3.028 . . . . 0.0 112.075 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -85.6 15.7 4.43 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.636 1.174 . . . . 0.0 113.315 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -118.3 102.08 8.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.971 1.308 . . . . 0.0 111.407 -172.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -171.07 105.04 0.4 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 126.882 2.073 . . . . 0.0 107.917 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.66 129.74 28.93 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.331 2.688 . . . . 0.0 113.15 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.79 140.36 21.29 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.867 1.267 . . . . 0.0 108.136 169.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.23 131.37 21.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.244 1.296 . . . . 0.0 109.919 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.99 83.27 Favored Glycine 0 N--CA 1.469 0.859 0 C-N-CA 124.678 1.132 . . . . 0.0 114.66 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.77 168.81 9.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.19 1.495 . . . . 0.0 113.103 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.4 mt -102.99 111.35 23.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.922 1.689 . . . . 0.0 113.857 -168.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.6 mt -97.17 129.06 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 109.86 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.35 120.99 37.65 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.293 1.437 . . . . 0.0 107.559 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -121.47 121.91 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.297 1.039 . . . . 0.0 109.967 -174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -77.19 67.55 3.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.638 1.175 . . . . 0.0 111.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -64.8 -47.57 77.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.011 1.324 . . . . 0.0 113.451 -170.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -148.38 37.81 0.85 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.614 0.721 . . . . 0.0 112.583 -158.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.38 72.06 Favored Glycine 0 N--CA 1.477 1.41 0 O-C-N 121.396 -0.815 . . . . 0.0 113.012 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -162.02 146.86 12.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.887 2.475 . . . . 0.0 109.498 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -89.92 116.81 28.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.493 0.663 . . . . 0.0 111.42 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -94.15 145.1 24.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.583 1.553 . . . . 0.0 109.927 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -84.07 144.61 28.95 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.08 151.79 41.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.763 1.225 . . . . 0.0 112.945 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.83 120.06 41.13 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.245 2.218 . . . . 0.0 108.565 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.49 92.92 1.93 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.576 0.751 . . . . 0.0 111.609 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 pt -81.81 -21.22 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.94 -179.17 31.68 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 124.919 1.247 . . . . 0.0 110.945 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.07 96.74 0.82 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.133 0.968 . . . . 0.0 110.764 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.44 -0.45 89.28 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.168 1.842 . . . . 0.0 114.483 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -99.67 139.32 35.5 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.031 1.916 . . . . 0.0 112.148 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -138.63 149.94 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.87 129.01 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 168.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -145.11 149.22 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.502 1.046 . . . . 0.0 111.952 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.488 HD11 ' HB1' ' A' ' 58' ' ' ALA . 58.0 tp -90.93 123.8 34.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.213 0.605 . . . . 0.0 110.27 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.85 111.31 41.53 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.986 1.314 . . . . 0.0 107.555 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.77 165.48 16.0 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.002 3.135 . . . . 0.0 114.016 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.83 160.42 37.44 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.189 2.593 . . . . 0.0 111.159 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -80.04 5.2 14.78 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -126.7 152.71 46.42 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.027 1.731 . . . . 0.0 111.176 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -160.48 158.87 25.88 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.289 1.836 . . . . 0.0 110.348 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.77 119.96 7.26 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.306 2.004 . . . . 0.0 110.318 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.5 14.06 64.3 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.378 0.989 . . . . 0.0 115.528 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.76 156.41 30.62 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.343 1.071 . . . . 0.0 113.18 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.34 120.11 3.22 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.474 1.511 . . . . 0.0 112.309 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.1 p -85.68 -23.88 27.25 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.0 p -80.54 -19.58 45.42 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.6 p -174.05 -77.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.011 1.724 . . . . 0.0 110.567 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.1 p -175.88 145.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 128.312 2.645 . . . . 0.0 109.592 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.288 17.2 p90 60.84 12.15 3.64 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.343 2.657 . . . . 0.0 115.247 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -70.03 40.79 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.986 2.514 . . . . 0.0 114.7 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.4 m -137.61 153.23 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.972 2.109 . . . . 0.0 111.274 -173.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.3 tp -72.83 137.69 45.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.693 1.197 . . . . 0.0 111.117 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.6 p -77.33 136.07 38.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.703 0.763 . . . . 0.0 112.356 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -168.22 144.08 3.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.258 1.423 . . . . 0.0 110.445 -172.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 p -90.17 164.13 14.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 36' ' ' LEU . . . -79.79 154.37 28.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.594 1.157 . . . . 0.0 110.74 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -133.01 135.32 45.37 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.957 0.903 . . . . 0.0 111.491 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.31 125.41 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 169.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.42 156.83 42.55 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.078 1.751 . . . . 0.0 112.798 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -111.4 138.6 47.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.826 1.65 . . . . 0.0 111.016 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -170.18 173.93 5.62 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.869 1.268 . . . . 0.0 110.72 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -93.07 144.95 24.76 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.267 -0.895 . . . . 0.0 112.397 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 tp -53.75 -50.23 66.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.94 1.296 . . . . 0.0 111.07 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 69' ' ' VAL . 12.6 pt-20 -55.61 -30.92 61.76 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.764 1.226 . . . . 0.0 114.044 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.82 -39.96 25.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.452 -0.78 . . . . 0.0 111.779 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.46 -41.01 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.195 0.598 . . . . 0.0 111.507 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 66' ' ' GLU . 33.9 m -70.26 -40.47 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.565 1.075 . . . . 0.0 112.165 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 18.86 61.18 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.148 0.885 . . . . 0.0 115.0 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.08 -8.35 72.95 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.377 1.465 . . . . 0.0 114.633 -173.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.2 m -78.36 169.43 18.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.091 1.357 . . . . 0.0 112.305 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.3 m -71.38 155.59 40.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.84 0.856 . . . . 0.0 113.213 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.95 154.25 27.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.045 1.338 . . . . 0.0 112.664 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -142.05 167.4 22.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.467 1.907 . . . . 0.0 109.881 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.18 134.54 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 119.172 0.897 . . . . 0.0 109.744 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -158.73 129.2 6.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -139.18 57.09 1.67 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 110.566 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.8 m -49.42 -40.72 37.49 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -169.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.44 -34.43 72.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.145 0.884 . . . . 0.0 113.276 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 -26.94 60.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.653 0.781 . . . . 0.0 111.715 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -73.41 -33.73 65.13 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.989 0.916 . . . . 0.0 111.458 169.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.08 -32.86 74.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 112.01 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -168.12 150.4 5.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.841 1.656 . . . . 0.0 113.841 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 80.17 147.94 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 127.196 2.198 . . . . 0.0 115.448 152.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.26 165.4 16.74 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 124.439 3.426 . . . . 0.0 110.542 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -137.47 146.42 53.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 120.953 -1.092 . . . . 0.0 113.678 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.86 83.09 2.33 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.015 3.143 . . . . 0.0 109.476 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -36.92 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.494 1.118 . . . . 0.0 113.203 -169.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -72.23 -35.79 68.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.085 0.857 . . . . 0.0 111.793 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -74.93 -29.92 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.887 0.875 . . . . 0.0 110.13 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.92 -42.36 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.288 1.035 . . . . 0.0 111.535 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.7 -40.55 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.722 0.809 . . . . 0.0 110.449 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.1 m -65.76 -42.25 91.13 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.503 -0.748 . . . . 0.0 111.783 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.2 t -61.79 -40.96 97.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.509 1.123 . . . . 0.0 111.64 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.66 71.79 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.634 0.774 . . . . 0.0 111.308 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -67.32 -15.18 63.54 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.39 -42.84 14.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.276 1.031 . . . . 0.0 113.033 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.6 ptm -81.31 -25.26 36.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -50.01 128.56 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.685 0.755 . . . . 0.0 112.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -15.92 52.53 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.727 1.632 . . . . 0.0 113.964 -170.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -78.63 163.56 25.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.769 1.785 . . . . 0.0 112.215 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.59 150.33 50.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.7 1.6 . . . . 0.0 112.594 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -141.71 159.01 43.09 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.963 1.305 . . . . 0.0 112.407 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -154.38 -3.28 0.17 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -74.77 141.74 44.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.075 -1.016 . . . . 0.0 113.064 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.9 t 71.3 -176.19 0.19 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.346 1.859 . . . . 0.0 114.19 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.5 pt -75.12 152.35 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.644 1.177 . . . . 0.0 111.105 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.1 m -53.83 -38.4 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.1 m -70.67 -38.91 73.81 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.134 0.879 . . . . 0.0 111.904 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -72.06 -35.67 69.36 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.626 -0.671 . . . . 0.0 111.671 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.71 -42.02 82.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.113 0.965 . . . . 0.0 111.209 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -51.56 67.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.762 1.625 . . . . 0.0 113.16 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.41 -45.67 93.37 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.199 -0.938 . . . . 0.0 112.307 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -56.75 -40.33 75.58 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.988 1.715 . . . . 0.0 111.075 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.511 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 26.0 t80 -63.2 -52.69 61.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.563 1.145 . . . . 0.0 112.035 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.6 -20.7 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 120.521 1.51 . . . . 0.0 114.216 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -71.86 -43.23 65.83 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.141 0.882 . . . . 0.0 109.387 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -62.37 -25.36 67.87 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 53.4 mt -71.94 -58.64 3.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.863 0.756 . . . . 0.0 110.563 169.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ptt85 -76.29 9.19 2.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -58.27 -19.93 38.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.888 2.075 . . . . 0.0 113.739 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.66 -38.92 7.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.875 2.179 . . . . 0.0 114.247 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -137.23 5.47 2.76 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 C--O 1.252 1.202 0 C-N-CA 125.758 1.623 . . . . 0.0 114.821 -174.781 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.8 165.2 25.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.242 1.017 . . . . 0.0 112.759 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.5 m -66.92 146.58 99.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.864 0.866 . . . . 0.0 112.848 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.59 -18.69 13.47 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.355 2.703 . . . . 0.0 113.688 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -158.45 167.32 29.99 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.361 1.464 . . . . 0.0 111.211 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -153.53 134.2 13.72 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.196 1.399 . . . . 0.0 109.52 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.26 108.65 41.64 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 124.166 0.986 . . . . 0.0 111.633 -169.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.69 156.63 62.91 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.391 2.727 . . . . 0.0 111.352 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -99.84 141.31 22.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 0.0 111.664 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.01 129.82 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.255 1.97 . . . . 0.0 110.045 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.09 8.15 75.96 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 118.233 -1.315 . . . . 0.0 114.43 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -117.25 157.61 25.75 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.596 1.698 . . . . 0.0 113.935 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.75 127.32 39.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.543 1.937 . . . . 0.0 113.496 -168.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.52 126.41 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.205 1.802 . . . . 0.0 109.577 -174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.4 122.26 34.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.53 125.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.885 1.274 . . . . 0.0 109.296 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.1 53.07 1.65 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.269 1.427 . . . . 0.0 111.677 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -25.61 66.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -169.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -159.26 26.8 0.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -161.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.87 6.4 72.42 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 124.263 0.935 . . . . 0.0 114.015 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.65 148.19 30.8 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.322 2.249 . . . . 0.0 109.385 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -82.86 107.41 15.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.569 0.747 . . . . 0.0 110.116 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -107.22 154.8 20.69 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.804 1.242 . . . . 0.0 111.206 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.14 168.11 22.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.168 2.187 . . . . 0.0 110.674 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' CD2' HD13 ' A' ' 120' ' ' LEU . 8.7 tp -142.71 121.17 12.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.089 1.756 . . . . 0.0 109.22 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.77 116.36 14.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.421 1.088 . . . . 0.0 110.918 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.0 pt -107.2 -16.06 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.62 39.02 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 126.228 1.87 . . . . 0.0 110.294 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.31 92.31 0.28 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.066 0.936 . . . . 0.0 112.067 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.82 87.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.111 1.815 . . . . 0.0 114.503 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -100.67 135.29 42.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.238 1.519 . . . . 0.0 111.76 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.54 150.84 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.161 0.984 . . . . 0.0 113.139 -173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 mt -105.93 141.78 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -156.62 152.79 27.62 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 111.617 -169.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -96.36 125.18 40.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.472 0.709 . . . . 0.0 110.266 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.51 136.1 33.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.248 1.019 . . . . 0.0 109.215 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.95 169.4 22.5 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 112.678 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -60.68 -28.7 86.99 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.837 3.025 . . . . 0.0 115.571 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.8 m -99.03 150.51 21.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.897 1.279 . . . . 0.0 113.031 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -62.37 136.68 58.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.787 0.835 . . . . 0.0 111.969 173.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.42 -47.04 98.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -81.73 -0.18 10.23 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.803 3.002 . . . . 0.0 113.159 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.74 -122.53 7.15 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -171.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.34 56.15 1.68 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.405 1.482 . . . . 0.0 112.936 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.55 105.05 2.04 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.1 m -56.32 -29.51 61.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.225 1.41 . . . . 0.0 114.651 -169.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -66.71 -20.53 65.99 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -113.71 -49.58 2.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.051 1.34 . . . . 0.0 113.365 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.4 m -151.78 160.49 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.898 1.279 . . . . 0.0 113.14 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -163.09 -37.0 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.156 1.383 . . . . 0.0 113.01 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.3 p -77.68 -32.97 53.44 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 p -150.94 133.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.694 1.998 . . . . 0.0 108.895 170.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.6 mt -101.41 -5.04 25.84 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.5 m -140.82 162.22 35.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.25 1.02 . . . . 0.0 113.526 -172.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -149.83 -66.16 0.21 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.427 1.091 . . . . 0.0 111.964 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 p -171.18 155.46 4.36 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.092 1.757 . . . . 0.0 110.368 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.75 159.36 33.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.838 -0.539 . . . . 0.0 111.173 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.57 134.06 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.629 0.772 . . . . 0.0 111.108 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.6 t -83.75 126.14 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.678 0.791 . . . . 0.0 109.213 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -134.36 172.06 13.42 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.787 1.635 . . . . 0.0 112.191 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -151.97 125.79 9.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.267 1.027 . . . . 0.0 112.18 -171.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -169.38 -161.47 0.3 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.861 2.064 . . . . 0.0 110.959 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 -85.34 146.43 27.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -51.0 -52.46 42.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.334 1.854 . . . . 0.0 111.374 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -56.99 -30.33 64.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.65 -45.16 17.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.381 0.992 . . . . 0.0 110.722 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.02 -34.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.122 0.569 . . . . 0.0 112.238 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -82.27 -45.49 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.144 0.978 . . . . 0.0 111.113 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.21 23.1 65.91 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 119.359 0.981 . . . . 0.0 114.867 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.3 2.26 70.99 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.206 1.384 . . . . 0.0 115.066 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -72.01 171.11 12.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 118.93 1.365 . . . . 0.0 112.852 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.85 152.17 31.44 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.428 0.691 . . . . 0.0 111.192 169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -158.81 169.65 23.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.438 1.095 . . . . 0.0 113.287 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -168.09 151.76 5.99 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.891 1.677 . . . . 0.0 110.899 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.5 t -85.86 137.76 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 169.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -161.24 108.3 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.377 1.871 . . . . 0.0 108.635 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -83.17 -32.92 26.36 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.421 -0.799 . . . . 0.0 112.95 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t 74.78 -51.47 0.68 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 129.122 2.969 . . . . 0.0 113.273 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -96.66 -33.13 11.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.91 -25.62 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.283 0.947 . . . . 0.0 112.463 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -75.19 -14.52 60.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.346 1.058 . . . . 0.0 112.963 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -96.08 -34.8 11.59 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.098 1.359 . . . . 0.0 112.327 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -172.55 165.82 5.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.118 1.767 . . . . 0.0 112.719 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 89.74 154.28 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 129.975 3.31 . . . . 0.0 115.446 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.96 -31.79 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.298 3.332 . . . . 0.0 113.434 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 ttp-105 70.76 111.99 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.611 2.764 . . . . 0.0 114.683 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -80.44 90.11 1.26 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.726 2.951 . . . . 0.0 110.329 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 t -54.43 -40.14 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.638 1.175 . . . . 0.0 112.451 -173.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -68.58 -42.92 77.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 111.286 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.4 t -73.23 -30.76 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.899 0.88 . . . . 0.0 110.217 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.1 -41.06 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.425 1.09 . . . . 0.0 111.761 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.44 -36.8 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 119.642 1.11 . . . . 0.0 110.882 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -66.69 -41.46 88.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.126 -0.984 . . . . 0.0 111.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.5 m -63.84 -41.97 97.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.506 1.123 . . . . 0.0 111.655 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.86 -49.55 77.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.765 0.826 . . . . 0.0 111.411 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -56.51 -43.62 79.96 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.746 . . . . 0.0 112.332 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.28 -31.23 70.04 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.2 mtp -73.9 -17.78 60.99 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.72 125.99 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 120.549 1.522 . . . . 0.0 110.623 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.09 66.92 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.625 1.583 . . . . 0.0 114.592 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.44 151.06 32.9 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 111.797 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -87.23 158.2 19.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.011 1.324 . . . . 0.0 110.367 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtp -143.8 148.4 35.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.577 1.551 . . . . 0.0 110.866 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -167.19 -152.7 0.13 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.927 1.291 . . . . 0.0 111.646 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 62.93 22.93 13.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.117 1.767 . . . . 0.0 114.609 169.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.3 p -166.8 156.76 11.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.142 1.377 . . . . 0.0 112.274 -171.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.88 146.22 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.612 1.165 . . . . 0.0 108.606 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 96.6 t -49.93 -39.36 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.776 1.23 . . . . 0.0 113.221 -170.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -56.58 -49.52 74.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.047 0.939 . . . . 0.0 112.192 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -74.85 -34.29 62.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.485 -0.759 . . . . 0.0 111.924 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -57.84 -43.84 86.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.635 1.107 . . . . 0.0 111.917 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.68 -38.45 54.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.7 -46.53 85.06 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.941 -1.099 . . . . 0.0 112.39 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -64.19 -35.32 80.43 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.784 -1.197 . . . . 0.0 110.639 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -58.78 -59.36 5.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.986 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 120' ' ' LEU . 13.0 m -64.99 -25.59 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.688 1.586 . . . . 0.0 113.662 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -69.66 -37.28 76.66 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.495 1.043 . . . . 0.0 110.805 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -66.59 -20.2 65.95 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.662 1.119 . . . . 0.0 112.952 170.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.441 HD13 ' CD2' ' A' ' 26' ' ' LEU . 59.1 mt -76.12 -65.16 0.95 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.385 0.993 . . . . 0.0 110.352 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.4 ptt85 -75.2 14.28 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -52.91 -23.67 7.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.156 2.183 . . . . 0.0 112.632 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.68 -45.05 7.04 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 128.091 2.758 . . . . 0.0 114.435 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -139.36 -5.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 124.555 1.142 . . . . 0.0 112.128 174.288 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 119.883 -0.103 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.88 -37.07 18.04 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -78.54 155.41 78.72 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.622 0.769 . . . . 0.0 113.041 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.57 158.53 31.77 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.817 3.011 . . . . 0.0 112.947 170.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -79.04 119.7 22.55 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.327 0.584 . . . . 0.0 112.297 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -135.04 105.5 6.38 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.689 1.196 . . . . 0.0 109.523 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -151.28 81.45 6.11 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.019 1.328 . . . . 0.0 109.433 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.45 123.69 6.66 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.875 2.383 . . . . 0.0 110.422 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.35 161.27 27.71 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 125.538 1.535 . . . . 0.0 111.049 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.75 135.98 51.28 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.621 2.214 . . . . 0.0 113.145 -169.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.2 -17.59 58.89 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.381 1.467 . . . . 0.0 114.815 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.38 149.72 22.87 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.441 1.121 . . . . 0.0 112.337 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -107.51 140.3 40.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.645 1.212 . . . . 0.0 111.548 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt -125.4 127.45 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.807 2.043 . . . . 0.0 107.936 -159.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -88.68 119.78 29.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -123.19 134.71 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.459 1.104 . . . . 0.0 109.653 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -78.09 66.48 3.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.328 1.051 . . . . 0.0 110.181 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -47.16 77.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.56 1.944 . . . . 0.0 113.788 -169.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.24 37.5 0.44 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -166.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.85 12.23 56.92 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.173 0.892 . . . . 0.0 113.832 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -166.39 134.98 2.93 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.835 2.054 . . . . 0.0 109.729 -171.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.06 128.05 34.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.778 1.631 . . . . 0.0 112.386 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.27 151.04 47.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.154 . . . . 0.0 112.063 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -85.7 147.29 26.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.11 138.46 37.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.41 1.484 . . . . 0.0 111.568 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.26 121.22 41.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.429 1.891 . . . . 0.0 109.111 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.8 111.62 8.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.227 1.011 . . . . 0.0 111.303 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 pt -104.16 -20.82 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.53 172.42 40.27 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.91 101.39 0.12 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.513 1.157 . . . . 0.0 112.253 -172.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.95 -2.0 76.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.691 1.615 . . . . 0.0 115.488 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -98.44 137.94 36.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.625 1.713 . . . . 0.0 112.826 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.94 153.59 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.799 1.239 . . . . 0.0 112.431 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.47 126.44 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -136.07 160.07 39.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.303 0.956 . . . . 0.0 111.345 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.3 tp -85.3 137.55 32.89 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.8 123.8 44.33 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.156 1.382 . . . . 0.0 107.626 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.85 167.41 27.3 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.168 2.579 . . . . 0.0 112.081 -172.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -63.65 149.03 91.87 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.237 2.625 . . . . 0.0 110.649 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.9 m -89.74 77.56 7.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.307 0.575 . . . . 0.0 111.048 -174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -77.84 60.74 2.34 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.804 1.242 . . . . 0.0 110.584 172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -58.81 -47.73 98.14 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.43 164.09 31.25 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.284 2.656 . . . . 0.0 111.827 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.1 48.02 3.26 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 125.019 1.295 . . . . 0.0 113.182 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.39 159.9 33.31 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.439 1.895 . . . . 0.0 114.397 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.31 -130.71 4.54 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 125.705 1.621 . . . . 0.0 111.474 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.4 m -74.46 -1.93 23.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.466 1.106 . . . . 0.0 113.313 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.9 p -74.52 173.77 9.9 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.321 2.248 . . . . 0.0 113.3 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.5 m -72.26 33.74 0.06 Allowed 'General case' 0 N--CA 1.481 1.104 0 O-C-N 120.059 -1.651 . . . . 0.0 113.959 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -164.9 142.52 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.928 2.091 . . . . 0.0 110.106 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -143.83 14.99 1.74 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.034 1.334 . . . . 0.0 113.592 -172.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.3 t -83.53 -172.95 4.44 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 p -168.17 139.4 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 127.901 2.48 . . . . 0.0 109.337 -173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.0 tt -86.79 -28.73 22.79 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.033 0.933 . . . . 0.0 112.327 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -152.65 125.09 8.21 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.653 0.781 . . . . 0.0 112.133 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -83.32 136.14 34.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.151 1.38 . . . . 0.0 112.109 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m 73.53 158.58 0.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.703 2.001 . . . . 0.0 113.447 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.55 164.7 14.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.203 1.001 . . . . 0.0 111.005 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.04 137.76 26.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.353 1.061 . . . . 0.0 111.492 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.89 127.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.57 1.148 . . . . 0.0 110.857 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -129.67 148.91 51.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.008 1.723 . . . . 0.0 112.855 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -95.05 138.86 32.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.847 1.259 . . . . 0.0 109.403 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -163.22 169.05 19.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.604 1.162 . . . . 0.0 110.8 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -90.42 141.63 28.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.245 1.018 . . . . 0.0 111.244 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 tp -53.29 -47.3 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.496 1.119 . . . . 0.0 111.494 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.78 -31.49 66.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.52 -43.59 26.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.151 0.887 . . . . 0.0 110.914 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 t -60.87 -38.36 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 122.574 0.35 . . . . 0.0 111.51 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.36 -47.01 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.34 18.19 62.77 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.48 1.036 . . . . 0.0 114.955 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.69 -2.62 82.69 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.593 1.568 . . . . 0.0 114.868 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 65.4 m -76.25 176.59 7.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.149 1.38 . . . . 0.0 113.065 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -71.3 150.02 45.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.355 1.062 . . . . 0.0 112.5 173.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -157.72 152.17 24.88 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.645 1.178 . . . . 0.0 113.247 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -136.02 157.86 45.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.395 1.878 . . . . 0.0 110.047 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.09 126.21 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.4 0.68 . . . . 0.0 109.977 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -167.3 113.05 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.892 1.277 . . . . 0.0 110.645 -174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -83.68 71.87 10.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.232 1.013 . . . . 0.0 108.592 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 p -33.31 -64.11 0.21 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.159 2.583 . . . . 0.0 115.823 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.0 mt -84.17 -27.1 28.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.44 -37.6 84.14 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.733 -0.604 . . . . 0.0 111.259 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -59.3 -28.54 66.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.015 1.326 . . . . 0.0 113.381 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -86.8 -29.16 22.49 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.77 -38.8 3.05 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 117.109 2.263 . . . . 0.0 117.109 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -155.22 159.48 31.71 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -134.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -98.3 1.51 1.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 1 C-N-CA 125.558 4.172 . . . . 0.0 114.197 169.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -12.61 125.28 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 130.401 3.48 . . . . 0.0 117.097 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.48 121.89 9.62 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.334 3.356 . . . . 0.0 112.902 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.3 -34.79 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.021 0.928 . . . . 0.0 112.473 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.84 -35.23 79.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.64 0.654 . . . . 0.0 111.707 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.37 -37.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.468 0.707 . . . . 0.0 110.211 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.46 -41.54 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.699 0.681 . . . . 0.0 110.933 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -64.26 -42.58 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.895 0.771 . . . . 0.0 111.313 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.2 m -62.88 -42.03 99.62 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.668 -0.645 . . . . 0.0 111.563 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -62.1 -45.42 93.59 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.504 1.122 . . . . 0.0 111.515 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.27 86.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.953 0.901 . . . . 0.0 112.145 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.2 -49.89 75.84 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.651 -0.656 . . . . 0.0 111.815 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -60.79 -30.91 70.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.2 mmm -73.75 -13.17 60.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 114.164 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.6 t -57.07 125.99 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.88 1.218 . . . . 0.0 110.704 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.95 75.44 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.173 1.368 . . . . 0.0 114.608 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -74.97 143.15 43.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.251 1.525 . . . . 0.0 110.45 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -112.38 151.69 29.5 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.259 1.824 . . . . 0.0 111.228 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.81 147.08 13.26 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -145.48 59.16 1.27 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.786 1.635 . . . . 0.0 109.34 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -65.8 -32.01 73.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.916 1.286 . . . . 0.0 113.618 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 t -165.58 -162.81 0.61 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.486 1.514 . . . . 0.0 110.29 -170.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.2 pt -60.1 150.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.09 0.956 . . . . 0.0 109.803 169.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.4 -36.28 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.9 m -63.37 -53.26 55.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.537 0.608 . . . . 0.0 111.363 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -70.49 -28.49 65.02 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 121.256 -0.902 . . . . 0.0 111.968 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -60.57 -33.5 72.8 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.392 1.451 . . . . 0.0 111.086 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.37 -40.93 25.63 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.624 1.169 . . . . 0.0 113.254 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -63.7 -41.0 98.18 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.289 -1.507 . . . . 0.0 112.073 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -65.35 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.776 -1.203 . . . . 0.0 110.701 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.84 -55.84 25.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.748 1.219 . . . . 0.0 111.749 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.01 -30.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 120.218 1.372 . . . . 0.0 112.79 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -69.13 -39.21 79.03 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.633 -1.175 . . . . 0.0 111.124 173.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.86 -28.66 66.31 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.217 1.372 . . . . 0.0 112.932 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.4 mt -67.32 -52.46 40.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.394 0.997 . . . . 0.0 111.246 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -92.68 16.05 13.08 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -62.69 -24.91 67.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.527 1.931 . . . . 0.0 114.45 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.15 -68.84 1.48 Allowed Glycine 0 N--CA 1.473 1.129 0 C-N-CA 125.661 1.6 . . . . 0.0 114.166 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -101.47 -12.13 18.78 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.254 1.312 0 C-N-CA 124.594 1.157 . . . . 0.0 113.017 -175.915 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 ttm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.75 173.01 12.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.107 0.963 . . . . 0.0 112.326 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -58.93 -44.7 99.24 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.58 139.65 23.07 Favored 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 122.007 1.752 . . . . 0.0 112.876 -171.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -145.59 175.34 10.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.37 2.268 . . . . 0.0 110.012 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -120.12 151.74 38.62 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.524 -1.36 . . . . 0.0 111.419 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 102.23 95.95 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 130.954 3.702 . . . . 0.0 108.765 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.17 127.67 27.26 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.043 3.162 . . . . 0.0 112.795 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -103.78 143.88 27.54 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.881 1.272 . . . . 0.0 110.236 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.68 122.73 10.17 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.989 1.793 . . . . 0.0 109.816 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.52 15.42 66.14 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.682 1.134 . . . . 0.0 114.827 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -122.12 165.22 16.44 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.996 1.398 . . . . 0.0 111.924 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.76 154.64 33.88 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -169.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -128.47 142.88 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.217 2.607 . . . . 0.0 109.081 -160.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.15 123.72 48.3 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.102 1.361 . . . . 0.0 107.335 168.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.24 125.91 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 110.485 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -79.69 65.45 4.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.502 1.121 . . . . 0.0 110.366 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -61.46 -33.69 74.18 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.0 32.12 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.788 1.235 . . . . 0.0 113.757 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.63 -18.51 52.44 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.654 1.597 . . . . 0.0 114.791 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -74.08 -31.16 62.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 73.77 99.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.279 2.632 . . . . 0.0 110.302 -172.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -102.52 148.7 25.2 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.647 1.179 . . . . 0.0 111.297 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -87.82 151.54 22.79 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 169.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.01 39.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.303 1.041 . . . . 0.0 112.466 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.5 OUTLIER -115.56 125.2 52.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.647 1.979 . . . . 0.0 108.776 177.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -80.29 100.35 8.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.064 0.946 . . . . 0.0 110.682 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 pt -89.01 -14.15 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.73 -171.26 37.35 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.03 97.0 0.16 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 111.675 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.92 25.15 58.58 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.15 1.833 . . . . 0.0 115.572 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.272 6.8 p90 -144.1 149.24 36.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.459 2.129 . . . . 0.0 115.503 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.06 157.15 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -168.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mm -107.44 139.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.491 2.317 . . . . 0.0 106.348 168.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -156.33 161.67 40.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.14 1.336 . . . . 0.0 112.418 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.64 123.6 48.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.033 0.933 . . . . 0.0 111.642 -171.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.6 113.11 61.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.154 1.382 . . . . 0.0 108.582 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.61 167.65 9.6 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.09 3.194 . . . . 0.0 115.734 -169.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -56.82 163.3 7.52 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.214 3.276 . . . . 0.0 113.657 171.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.3 p 62.19 19.25 10.79 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.408 2.283 . . . . 0.0 114.138 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 77.44 -50.4 0.53 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 128.836 2.854 . . . . 0.0 109.653 -170.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -167.7 126.28 1.0 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 127.791 2.437 . . . . 0.0 109.379 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.85 121.79 10.59 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.371 2.714 . . . . 0.0 112.399 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.48 24.3 75.23 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.139 0.876 . . . . 0.0 115.169 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.72 -29.67 69.5 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.568 1.184 . . . . 0.0 113.536 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.55 -40.3 0.93 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.581 2.039 . . . . 0.0 116.568 169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.0 t -70.28 130.63 42.53 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.288 1.044 . . . . 0.0 113.216 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.7 m -57.87 -20.48 36.93 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.211 1.404 . . . . 0.0 113.455 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.8 m -73.35 -8.92 57.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.002 1.321 . . . . 0.0 113.827 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.69 -43.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -85.78 -7.35 58.8 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.2 p -62.75 -17.22 60.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.907 1.683 . . . . 0.0 114.042 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.9 m -61.83 -21.95 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.135 0.974 . . . . 0.0 113.401 170.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 74.06 -51.19 0.69 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 128.946 2.899 . . . . 0.0 111.777 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 t -142.76 156.74 45.04 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.093 1.757 . . . . 0.0 110.546 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.06 157.41 2.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.356 1.863 . . . . 0.0 110.951 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -77.85 160.13 28.51 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 163.01 26.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.178 0.991 . . . . 0.0 110.206 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.81 138.56 42.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.086 0.954 . . . . 0.0 111.14 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.9 t -85.67 123.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.942 0.897 . . . . 0.0 108.707 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.83 171.6 10.56 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.796 1.638 . . . . 0.0 112.042 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -146.95 139.82 25.14 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.337 1.455 . . . . 0.0 111.841 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -176.68 -178.07 0.86 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.449 1.9 . . . . 0.0 111.866 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -72.66 148.29 44.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.11 -59.78 4.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.26 1.024 . . . . 0.0 110.617 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -65.78 -18.13 65.12 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.95 -34.28 64.24 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.431 1.014 . . . . 0.0 110.916 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.85 -54.76 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.867 0.867 . . . . 0.0 111.236 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.63 3.21 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.99 -21.0 43.95 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.51 24.34 4.16 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 125.337 1.446 . . . . 0.0 113.69 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 54.0 m -125.72 161.9 26.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.956 1.302 . . . . 0.0 114.298 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 97.4 m -96.99 149.55 21.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.917 1.287 . . . . 0.0 108.756 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -166.16 158.61 14.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -147.61 152.15 37.42 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.758 1.623 . . . . 0.0 110.792 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.54 129.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -162.79 133.52 4.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.063 0.545 . . . . 0.0 110.913 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -153.85 49.82 0.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.974 0.893 . . . . 0.0 112.635 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.8 m -56.56 -30.02 62.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 tp -71.84 -39.28 69.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.396 0.998 . . . . 0.0 112.069 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -41.6 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.186 0.994 . . . . 0.0 110.644 169.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.0 -11.82 50.66 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.16 0.984 . . . . 0.0 113.58 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.78 -22.64 60.81 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.205 0.911 . . . . 0.0 113.036 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.81 -43.23 0.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 119.619 3.192 . . . . 0.0 119.619 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -100.38 147.74 33.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 121.0 1.727 . . . . 0.0 114.031 -154.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.53 -27.99 3.06 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.769 2.979 . . . . 0.0 112.715 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ttp-105 74.12 115.03 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.613 2.765 . . . . 0.0 115.014 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.1 91.12 1.22 Allowed 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.121 3.214 . . . . 0.0 109.623 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 t -50.11 -46.72 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.476 1.511 . . . . 0.0 113.742 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -38.28 84.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.679 0.672 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.7 -35.31 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.788 0.835 . . . . 0.0 111.952 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.5 mm -63.7 -49.11 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 119.898 1.226 . . . . 0.0 110.727 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.59 -39.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.558 0.743 . . . . 0.0 110.692 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -68.07 -40.45 82.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.217 0.607 . . . . 0.0 111.107 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m -61.76 -44.77 96.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.099 0.959 . . . . 0.0 111.363 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.31 74.53 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.155 0.982 . . . . 0.0 111.578 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.91 -18.6 65.45 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.17 -44.44 16.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.649 1.113 . . . . 0.0 112.397 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.1 ptm -77.44 -17.43 58.1 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.6 p -42.23 125.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.632 0.773 . . . . 0.0 112.251 170.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.14 -4.16 86.42 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.988 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -72.02 160.53 32.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.407 2.103 . . . . 0.0 111.365 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.73 151.19 48.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.681 1.592 . . . . 0.0 112.213 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.6 mtm -144.41 143.74 31.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.371 1.068 . . . . 0.0 112.94 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -145.72 -151.23 0.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.659 1.184 . . . . 0.0 111.227 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.7 t80 71.22 -56.72 0.62 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.8 2.84 . . . . 0.0 114.134 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.4 m -72.77 162.75 29.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.789 1.236 . . . . 0.0 112.789 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 pt -63.6 150.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.634 0.773 . . . . 0.0 111.536 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.46 -29.56 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.7 p -67.94 -45.15 75.07 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.47 -0.769 . . . . 0.0 111.241 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.03 -30.05 67.24 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.42 -0.8 . . . . 0.0 112.213 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.99 -43.41 77.61 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.494 1.043 . . . . 0.0 110.949 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.0 m -66.39 -46.88 75.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.528 1.531 . . . . 0.0 113.22 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -64.74 -42.65 95.02 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.128 -0.982 . . . . 0.0 112.369 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -62.22 -34.12 75.88 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 111.292 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.524 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 29.1 t80 -59.53 -55.57 32.84 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.111 0.868 . . . . 0.0 111.274 170.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.56 -20.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -71.02 -42.66 69.26 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.742 1.155 . . . . 0.0 110.331 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -63.15 -24.81 68.06 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.633 1.106 . . . . 0.0 112.988 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 80.0 mt -73.56 -59.52 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.661 0.664 . . . . 0.0 111.785 169.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -76.51 8.34 3.61 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -56.53 -27.34 57.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.053 2.141 . . . . 0.0 112.83 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.75 -25.42 55.85 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 126.931 2.205 . . . . 0.0 115.142 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -149.51 14.73 0.87 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.254 1.32 0 CA-C-O 116.958 -1.496 . . . . 0.0 113.552 175.4 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.21 -165.05 0.24 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.594 1.958 . . . . 0.0 113.325 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -170.86 156.19 4.83 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 127.142 2.177 . . . . 0.0 110.936 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.51 158.79 50.44 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.408 2.739 . . . . 0.0 111.708 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -158.14 155.88 29.92 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.091 1.356 . . . . 0.0 111.081 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.64 155.3 12.5 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.732 1.613 . . . . 0.0 110.906 -173.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.75 91.04 41.51 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.281 1.032 . . . . 0.0 110.727 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.47 149.36 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.548 2.832 . . . . 0.0 111.364 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.29 159.82 16.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 126.528 1.931 . . . . 0.0 110.942 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.32 143.76 71.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.652 2.235 . . . . 0.0 112.818 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.38 61.96 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.495 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -114.61 157.12 23.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.203 1.502 . . . . 0.0 112.018 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.99 160.02 16.36 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 123.297 1.522 . . . . 0.0 111.044 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.2 mt -137.1 129.42 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 125.575 1.55 . . . . 0.0 107.247 -159.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.32 124.47 33.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.028 0.931 . . . . 0.0 108.516 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.16 137.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.999 2.12 . . . . 0.0 108.692 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.59 62.37 4.64 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -57.65 -45.35 85.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.003 1.721 . . . . 0.0 115.217 -169.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -145.92 29.07 1.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -156.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.84 87.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.541 1.067 . . . . 0.0 113.126 -169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.3 155.64 44.52 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 110.415 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.47 133.9 51.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.567 1.547 . . . . 0.0 111.752 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -150.85 145.9 25.98 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.259 1.424 . . . . 0.0 110.794 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -89.51 162.54 15.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.89 136.99 20.84 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.417 2.287 . . . . 0.0 109.933 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.72 117.0 33.36 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.254 1.822 . . . . 0.0 109.176 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -73.75 111.24 8.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.414 1.085 . . . . 0.0 111.753 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 pt -98.82 -20.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.83 -179.96 40.79 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.832 1.682 . . . . 0.0 110.5 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.11 95.01 0.08 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.363 1.082 . . . . 0.0 113.279 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.07 -2.08 85.08 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.664 2.078 . . . . 0.0 114.486 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -95.76 137.08 35.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.25 1.525 . . . . 0.0 112.105 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.18 152.79 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.752 1.221 . . . . 0.0 112.972 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.46 132.69 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -149.04 156.92 42.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.468 -0.77 . . . . 0.0 111.033 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.3 145.0 32.36 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.85 103.26 16.17 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 168.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.63 166.29 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.909 2.406 . . . . 0.0 113.002 -169.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.56 137.51 81.72 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.62 2.88 . . . . 0.0 111.896 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.5 m -167.31 170.18 11.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.436 2.294 . . . . 0.0 109.481 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -87.46 107.2 18.45 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.866 -1.146 . . . . 0.0 108.512 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -77.74 -47.42 2.34 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -169.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -85.29 170.58 9.34 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.579 2.853 . . . . 0.0 111.73 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.33 44.99 2.75 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.198 1.38 . . . . 0.0 113.299 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.14 154.76 22.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.41 1.484 . . . . 0.0 113.503 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.91 -18.81 52.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.364 1.459 . . . . 0.0 114.325 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.0 m -72.23 141.73 48.98 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.744 1.272 . . . . 0.0 111.195 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.9 p -62.17 -14.92 42.34 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 p -74.04 -13.48 60.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.741 1.616 . . . . 0.0 114.076 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.36 174.31 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.367 1.467 . . . . 0.0 112.507 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -155.4 -29.82 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.537 1.135 . . . . 0.0 113.607 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.4 m -64.2 154.93 33.4 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.592 1.157 . . . . 0.0 112.531 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 p -155.03 145.74 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.155 0.982 . . . . 0.0 111.546 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -127.95 137.99 52.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.834 1.653 . . . . 0.0 109.763 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -172.07 -170.51 0.75 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.075 1.35 . . . . 0.0 112.074 -174.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.5 m120 71.24 -38.91 0.43 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 128.916 2.886 . . . . 0.0 115.499 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.6 m -70.46 166.95 19.34 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.194 0.998 . . . . 0.0 113.199 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.56 162.33 40.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.608 1.563 . . . . 0.0 110.485 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -154.16 137.95 16.18 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.122 -0.986 . . . . 0.0 112.065 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.4 t -82.27 127.97 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.469 1.108 . . . . 0.0 109.928 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -138.34 155.28 48.71 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.123 1.369 . . . . 0.0 112.898 -170.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -98.37 138.81 35.06 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 110.071 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -163.52 172.18 14.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.211 1.404 . . . . 0.0 110.087 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -94.17 144.29 25.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.07 -1.019 . . . . 0.0 112.293 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.49 -46.34 73.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.224 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.89 -34.24 58.87 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.35 -38.7 23.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.799 0.84 . . . . 0.0 111.591 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.8 -36.48 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.54 0.736 . . . . 0.0 111.744 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.6 t -80.09 -50.36 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.715 1.206 . . . . 0.0 111.182 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.42 63.59 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 119.287 0.949 . . . . 0.0 115.132 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.27 -3.94 60.15 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.736 1.636 . . . . 0.0 115.228 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -70.01 171.05 10.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.117 1.459 . . . . 0.0 113.679 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.16 149.47 39.0 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.834 0.854 . . . . 0.0 111.168 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -158.03 160.2 37.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.107 0.963 . . . . 0.0 113.535 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -157.75 144.12 17.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.307 1.043 . . . . 0.0 111.706 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.48 130.72 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.409 -0.807 . . . . 0.0 109.055 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -169.44 118.51 0.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.33 1.452 . . . . 0.0 110.415 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -98.46 0.15 44.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.9 p 56.97 -49.74 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.175 1 C-N-CA 133.397 4.679 . . . . 0.0 118.039 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 mt -114.48 -23.79 9.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.764 1.625 . . . . 0.0 113.604 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -35.75 77.69 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.283 -0.886 . . . . 0.0 112.067 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -66.65 -16.73 64.42 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.676 1.19 . . . . 0.0 112.921 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -93.25 -30.45 15.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.507 1.123 . . . . 0.0 113.15 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -114.82 -43.59 3.12 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -169.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -153.89 162.19 27.38 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -139.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -88.81 -33.16 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 124.537 3.491 . . . . 0.0 113.761 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 66.7 132.85 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 128.902 2.881 . . . . 0.0 115.984 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.37 94.09 1.07 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.49 2.793 . . . . 0.0 110.461 172.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 t -57.67 -39.71 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.169 0.988 . . . . 0.0 112.564 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.75 -39.81 76.52 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.634 0.652 . . . . 0.0 111.542 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.9 -35.92 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.416 0.686 . . . . 0.0 109.95 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.283 24.8 mt -77.92 -33.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.304 -0.855 . . . . 0.0 112.045 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.0 mt -65.51 -40.28 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.177 1.353 . . . . 0.0 110.369 169.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -65.81 -38.92 90.23 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.842 -0.536 . . . . 0.0 110.877 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.1 m -63.64 -46.55 85.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.208 1.003 . . . . 0.0 111.743 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.46 91.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.488 0.715 . . . . 0.0 112.082 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -62.61 -48.59 78.73 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 111.911 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -60.52 -30.3 69.65 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.197 -0.94 . . . . 0.0 113.204 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 86.7 mtp -75.42 -4.91 42.24 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.92 1.288 . . . . 0.0 114.454 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -56.19 121.94 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.016 1.28 . . . . 0.0 109.311 171.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.41 -2.42 60.92 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.228 1.394 . . . . 0.0 115.086 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.66 127.13 31.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.654 1.727 . . . . 0.0 110.482 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -99.93 132.52 45.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.941 2.097 . . . . 0.0 111.681 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -117.3 174.6 6.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.66 1.984 . . . . 0.0 110.38 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -126.52 -160.04 0.96 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.315 1.046 . . . . 0.0 112.442 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -73.32 150.1 42.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 112.985 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.0 m 176.82 171.8 0.47 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.299 3.039 . . . . 0.0 108.645 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.46 123.62 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.43 -35.66 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.81 0.844 . . . . 0.0 112.494 -169.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -55.43 -56.36 21.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.457 0.703 . . . . 0.0 111.423 173.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.25 -34.88 78.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.211 -0.931 . . . . 0.0 111.853 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.4 -44.77 92.75 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.901 1.228 . . . . 0.0 111.374 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 16.0 p -77.37 -37.25 52.55 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.907 0.883 . . . . 0.0 113.034 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.43 -45.57 92.5 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.568 1.076 . . . . 0.0 112.206 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -62.87 -36.24 82.64 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.599 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.43 -55.26 33.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.722 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.02 -24.25 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 120.545 1.521 . . . . 0.0 113.316 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 m -70.21 -39.09 75.34 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.446 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.38 -23.39 66.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.483 1.038 . . . . 0.0 113.367 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.45 -60.21 2.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.723 1.147 . . . . 0.0 111.01 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -77.69 6.41 7.41 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -26.04 27.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.76 2.024 . . . . 0.0 112.077 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.3 -17.67 32.65 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 127.249 2.357 . . . . 0.0 115.183 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -134.15 -28.78 1.31 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.415 1.086 . . . . 0.0 112.922 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.416 0.15 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.95 159.73 32.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.232 1.013 . . . . 0.0 112.822 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.5 m -70.36 147.53 95.16 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 124.05 0.94 . . . . 0.0 112.528 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.54 -16.35 9.32 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.468 2.779 . . . . 0.0 113.802 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -67.94 150.28 48.71 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.203 1.001 . . . . 0.0 113.663 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -93.04 135.07 34.55 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.774 1.23 . . . . 0.0 110.619 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -160.89 129.25 2.93 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.528 1.131 . . . . 0.0 110.178 170.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.63 143.72 27.45 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.805 3.003 . . . . 0.0 110.752 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.09 132.5 23.69 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.043 0.937 . . . . 0.0 111.601 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.8 132.84 25.82 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.263 2.642 . . . . 0.0 111.316 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.401 ' HA3' HG13 ' A' ' 89' ' ' VAL . . . 81.52 -4.23 74.35 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.714 1.149 . . . . 0.0 114.947 -175.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -105.09 168.07 9.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 122.652 1.215 . . . . 0.0 113.234 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.0 113.13 25.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.814 1.646 . . . . 0.0 112.353 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.68 127.85 43.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 124.796 1.238 . . . . 0.0 108.574 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -90.91 116.72 28.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.9 mm -105.65 112.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.392 1.477 . . . . 0.0 109.142 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 73.94 8.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.783 0.72 . . . . 0.0 109.804 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.25 3.77 2.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.0 mt 102.57 126.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 131.577 3.951 . . . . 0.0 110.708 158.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.61 -3.82 39.85 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.202 0.905 . . . . 0.0 113.67 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -171.22 160.35 6.22 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.853 2.461 . . . . 0.0 110.836 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -127.41 127.32 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.994 1.318 . . . . 0.0 110.463 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -108.74 151.3 26.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.913 1.285 . . . . 0.0 111.721 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -90.18 145.07 25.31 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 122.181 -0.325 . . . . 0.0 111.057 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.55 34.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.266 1.026 . . . . 0.0 111.67 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.7 119.32 33.99 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.623 1.569 . . . . 0.0 108.42 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -72.58 96.02 1.91 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 118.558 0.617 . . . . 0.0 111.123 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 pt -84.78 -22.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.18 173.34 30.65 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 124.731 1.158 . . . . 0.0 110.344 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.55 90.76 0.56 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.688 0.756 . . . . 0.0 110.537 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.15 -0.12 47.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.895 2.188 . . . . 0.0 115.109 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.46 140.39 49.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.284 1.542 . . . . 0.0 112.544 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.58 151.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.5 mm -110.65 129.29 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 168.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.17 157.06 43.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.262 0.937 . . . . 0.0 112.773 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.75 120.9 38.96 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.782 0.833 . . . . 0.0 110.938 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.33 120.53 66.55 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.89 1.276 . . . . 0.0 108.167 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.91 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.714 2.942 . . . . 0.0 113.209 -169.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.44 163.59 12.43 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.477 3.452 . . . . 0.0 112.926 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 t -159.41 171.14 20.3 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 91.59 154.37 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 130.729 3.612 . . . . 0.0 112.676 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -74.21 120.33 80.82 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.22 1.008 . . . . 0.0 112.204 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.82 142.17 68.5 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.078 2.518 . . . . 0.0 110.748 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.62 -21.96 12.58 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.124 0.869 . . . . 0.0 113.896 -170.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 46.67 -132.21 1.18 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.623 1.969 . . . . 0.0 112.734 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.77 12.41 70.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.883 1.23 . . . . 0.0 115.21 174.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 83.4 p -104.95 173.95 6.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.384 1.474 . . . . 0.0 112.926 -175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 p -69.61 -22.63 63.48 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.843 -1.161 . . . . 0.0 112.322 169.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.1 p -83.29 -30.27 27.71 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.089 0.956 . . . . 0.0 113.418 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -162.8 133.27 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.676 1.19 . . . . 0.0 112.425 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -139.61 -18.06 0.97 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.074 1.35 . . . . 0.0 113.919 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 p -82.61 -31.37 28.92 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.98 149.9 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.686 1.594 . . . . 0.0 111.462 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -80.93 -33.36 34.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.555 0.742 . . . . 0.0 112.454 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 t -165.45 125.94 1.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.735 1.214 . . . . 0.0 110.583 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -84.68 147.0 27.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.237 1.015 . . . . 0.0 111.044 170.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -70.77 160.94 31.78 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.01 159.88 32.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.49 1.116 . . . . 0.0 109.607 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.44 136.37 29.41 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 111.312 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.69 121.32 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.461 1.105 . . . . 0.0 108.213 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -124.92 156.61 37.71 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.219 1.407 . . . . 0.0 112.418 -171.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -111.07 137.3 48.88 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.707 1.603 . . . . 0.0 110.846 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.39 171.37 10.63 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.037 0.935 . . . . 0.0 111.426 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -84.56 140.0 31.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.694 1.598 . . . . 0.0 110.246 172.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 tp -56.33 -48.38 76.86 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.354 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.32 -28.91 63.5 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.86 -41.33 19.11 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.735 0.814 . . . . 0.0 111.23 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.56 -37.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.979 0.512 . . . . 0.0 111.441 170.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.01 -50.11 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.142 0.977 . . . . 0.0 111.915 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.46 24.16 65.52 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 119.754 1.161 . . . . 0.0 114.788 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.17 1.25 64.97 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.346 1.45 . . . . 0.0 115.305 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.1 m -71.97 170.61 13.44 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 118.842 1.321 . . . . 0.0 113.269 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.19 149.11 32.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.231 1.012 . . . . 0.0 111.668 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -159.27 154.2 24.88 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -148.73 157.54 43.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.401 1.88 . . . . 0.0 110.662 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.8 t -88.49 139.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-N 119.123 0.874 . . . . 0.0 110.065 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -156.17 64.5 0.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.425 1.49 . . . . 0.0 111.213 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.79 65.67 5.03 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.704 -1.248 . . . . 0.0 110.139 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -48.39 -56.64 7.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.569 1.948 . . . . 0.0 114.477 -170.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.92 -32.05 72.23 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.71 -44.3 90.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.744 -0.597 . . . . 0.0 111.626 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -61.39 -31.62 71.53 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.617 0.767 . . . . 0.0 112.393 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -40.86 63.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.427 1.091 . . . . 0.0 113.557 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.9 -39.35 4.27 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -148.58 158.15 40.57 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.671 2.101 . . . . 0.0 116.671 -134.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.83 -22.32 0.89 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.195 3.263 . . . . 0.0 114.098 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 20.97 116.63 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 131.459 3.904 . . . . 0.0 118.614 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.64 116.42 3.93 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.683 2.922 . . . . 0.0 111.7 -171.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.401 HG13 ' HA3' ' A' ' 11' ' ' GLY . 2.1 t -65.69 -32.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.524 1.129 . . . . 0.0 112.923 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -63.39 -35.55 80.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.591 0.632 . . . . 0.0 111.607 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.19 -38.23 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.734 0.814 . . . . 0.0 110.047 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.7 mt -74.01 -35.38 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.655 -0.653 . . . . 0.0 112.273 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.42 -37.02 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.117 -0.989 . . . . 0.0 110.399 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 m -66.41 -43.52 85.5 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.579 -0.701 . . . . 0.0 111.709 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -53.35 -43.41 67.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.144 0.978 . . . . 0.0 112.222 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.29 79.45 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.569 -0.707 . . . . 0.0 111.969 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -66.63 -14.91 63.03 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.66 -39.4 14.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.322 1.049 . . . . 0.0 111.897 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.2 mtp -75.58 -18.33 59.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.02 126.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.813 1.188 . . . . 0.0 111.845 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.65 -7.43 81.86 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.395 1.474 . . . . 0.0 115.009 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -70.65 151.67 44.7 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.621 1.711 . . . . 0.0 110.675 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -132.18 149.94 52.27 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.612 1.565 . . . . 0.0 112.385 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 69.2 mtm -149.48 158.37 44.12 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.422 1.489 . . . . 0.0 111.332 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -140.17 16.46 2.43 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.176 -0.953 . . . . 0.0 112.869 171.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.97 143.38 26.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.849 -171.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 68.73 -171.82 0.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.046 1.738 . . . . 0.0 114.24 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.0 144.97 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.305 1.442 . . . . 0.0 108.869 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -34.69 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -170.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -67.16 -35.04 78.84 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.724 -0.61 . . . . 0.0 112.157 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -77.44 -32.37 54.52 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 121.409 -0.807 . . . . 0.0 111.736 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.06 -45.34 83.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 20.7 p -74.26 -37.52 63.71 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 121.704 -0.623 . . . . 0.0 112.679 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.77 -43.22 99.36 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.26 -0.9 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -56.67 -49.01 76.32 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 110.054 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -55.3 -52.11 64.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.246 1.018 . . . . 0.0 112.441 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.0 -32.72 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 120.167 1.349 . . . . 0.0 113.09 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 m -61.44 -47.34 86.18 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 116.428 -1.749 . . . . 0.0 108.774 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -56.98 -25.56 58.43 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 121.042 1.746 . . . . 0.0 114.208 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.15 -47.11 72.03 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.016 1.28 . . . . 0.0 111.88 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -92.54 -3.1 55.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -62.49 -24.37 67.44 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.534 1.934 . . . . 0.0 112.3 -169.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.28 -24.84 76.38 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.377 0.989 . . . . 0.0 113.855 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.44 -20.64 2.63 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.255 1.364 0 C-N-CA 124.924 1.29 . . . . 0.0 112.389 177.243 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.3 mtm . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 120.356 0.122 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.86 158.97 37.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.217 1.407 . . . . 0.0 111.998 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -72.2 151.79 92.39 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.021 0.929 . . . . 0.0 112.909 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.36 148.64 34.21 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.495 2.796 . . . . 0.0 111.059 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -146.64 159.48 43.4 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.142 1.377 . . . . 0.0 111.826 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -160.83 174.97 13.09 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.991 1.716 . . . . 0.0 110.431 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -154.13 134.85 8.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.261 1.024 . . . . 0.0 112.064 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -81.41 155.67 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.283 2.656 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -102.51 151.21 38.18 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.891 . . . . 0.0 111.986 -177.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.97 136.76 39.18 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.683 2.255 . . . . 0.0 111.326 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.05 69.71 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.859 1.695 . . . . 0.0 114.637 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -94.64 165.77 12.35 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.187 1.493 . . . . 0.0 114.668 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -88.42 116.04 26.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.624 1.57 . . . . 0.0 111.892 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.43 121.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 109.229 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -99.34 103.58 15.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.574 1.95 . . . . 0.0 108.06 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.01 119.28 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.515 1.126 . . . . 0.0 109.426 -171.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.33 62.04 5.07 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.881 -1.137 . . . . 0.0 110.777 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -30.53 70.92 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -169.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.98 34.16 0.25 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -161.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.69 68.92 Favored Glycine 0 N--CA 1.479 1.531 0 C-N-CA 124.193 0.902 . . . . 0.0 113.48 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -164.47 149.08 9.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.416 2.286 . . . . 0.0 110.134 -172.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -74.22 106.34 5.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.164 1.385 . . . . 0.0 111.372 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -86.94 126.88 34.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.004 1.721 . . . . 0.0 109.279 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -82.47 150.15 27.19 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.588 -0.695 . . . . 0.0 112.814 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.94 159.84 44.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.113 1.365 . . . . 0.0 111.469 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.82 121.8 35.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.149 1.78 . . . . 0.0 108.466 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.89 90.37 3.51 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.701 0.682 . . . . 0.0 112.154 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.31 -18.43 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.23 -176.6 29.47 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 124.518 1.056 . . . . 0.0 111.629 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.83 90.0 0.78 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.007 0.908 . . . . 0.0 111.034 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 -3.78 80.06 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.348 1.928 . . . . 0.0 114.269 -174.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.68 138.64 35.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.655 1.727 . . . . 0.0 112.28 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.68 152.99 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mm -110.79 139.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.36 1.864 . . . . 0.0 106.697 168.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -157.89 134.7 9.88 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.38 0.991 . . . . 0.0 112.467 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.77 113.27 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.454 -0.779 . . . . 0.0 110.251 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.22 120.76 80.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.267 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.35 161.07 43.55 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.665 2.91 . . . . 0.0 112.943 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.78 164.14 18.31 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.645 2.897 . . . . 0.0 111.844 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.0 m -154.04 -139.25 0.08 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.773 2.029 . . . . 0.0 110.6 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -166.24 172.71 10.87 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.382 -1.449 . . . . 0.0 112.121 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -143.33 141.42 19.21 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.842 1.657 . . . . 0.0 110.054 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.39 117.86 4.52 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.407 2.738 . . . . 0.0 113.092 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.46 7.72 88.27 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.803 1.192 . . . . 0.0 115.769 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.0 134.53 57.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.913 0.885 . . . . 0.0 111.767 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.93 12.52 43.19 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.596 1.093 . . . . 0.0 113.838 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.8 m -133.51 -40.99 0.87 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 p -162.07 -53.79 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -172.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -78.97 -32.37 45.33 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -170.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 p -168.98 147.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.398 1.879 . . . . 0.0 109.915 -171.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -125.76 -5.94 6.88 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.0 p -92.21 -0.82 57.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.197 1.399 . . . . 0.0 114.516 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.07 114.73 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.413 1.085 . . . . 0.0 110.407 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 tp -82.72 -22.31 34.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.913 1.285 . . . . 0.0 112.775 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -59.73 -15.0 16.72 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -73.27 -11.83 60.64 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.99 -1.069 . . . . 0.0 113.716 171.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 m -113.62 155.54 25.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.927 1.291 . . . . 0.0 111.029 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.19 158.35 15.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.291 1.036 . . . . 0.0 111.55 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.92 135.05 32.43 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 0.0 111.83 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -80.69 114.29 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.971 1.308 . . . . 0.0 108.323 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -121.2 173.06 7.55 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.267 1.827 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.8 35.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.422 1.489 . . . . 0.0 111.82 -174.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 174.01 -159.47 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.93 2.892 . . . . 0.0 108.421 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.14 150.97 19.92 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.17 0.986 . . . . 0.0 113.446 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -50.34 -51.46 45.43 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.136 1.775 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -55.04 -29.85 58.31 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.01 -42.77 15.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.816 0.846 . . . . 0.0 111.337 174.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.61 -33.47 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.913 -0.492 . . . . 0.0 111.965 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.0 t -86.77 -46.98 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.511 1.124 . . . . 0.0 111.495 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.99 -121.48 24.9 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -172.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.14 1.04 62.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.651 1.12 . . . . 0.0 114.892 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.7 m -73.13 162.43 29.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.899 1.35 . . . . 0.0 113.921 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.2 m -79.44 151.14 31.04 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.871 0.869 . . . . 0.0 110.989 169.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -156.46 167.99 28.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.962 0.905 . . . . 0.0 112.852 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -161.7 159.22 27.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.6 1.56 . . . . 0.0 109.933 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -82.75 132.5 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.723 1.147 . . . . 0.0 109.175 169.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -80.3 -70.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.492 0.717 . . . . 0.0 112.051 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 63.37 8.89 3.72 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.535 1.934 . . . . 0.0 114.332 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.6 m -69.28 -36.28 76.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 119.076 -2.265 . . . . 0.0 113.506 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.5 mt -68.9 -37.92 79.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.997 0.519 . . . . 0.0 111.718 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -64.79 -43.64 92.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.513 -0.742 . . . . 0.0 111.116 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.29 -26.15 62.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.075 1.35 . . . . 0.0 112.873 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.57 -29.99 46.55 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.132 0.973 . . . . 0.0 112.41 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -126.19 -46.52 1.65 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.51 152.51 45.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -143.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.31 -10.08 12.42 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 124.565 3.51 . . . . 0.0 114.393 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 74.32 106.79 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.595 2.358 . . . . 0.0 114.377 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.47 71.54 6.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.721 2.948 . . . . 0.0 109.03 169.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 t -46.24 -38.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 126.436 1.894 . . . . 0.0 114.687 -169.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.69 -38.17 90.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.802 0.841 . . . . 0.0 111.703 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -75.63 -30.99 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.2 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.08 -45.52 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.491 0.587 . . . . 0.0 110.78 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.41 -39.56 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.822 -0.549 . . . . 0.0 110.376 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 m -63.5 -43.5 97.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.97 0.508 . . . . 0.0 111.592 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 t -59.37 -45.47 91.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 111.658 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.42 90.75 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.218 -0.926 . . . . 0.0 112.082 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.94 -19.07 64.94 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -82.32 -37.11 26.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.687 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.0 mtp -70.98 -32.01 68.73 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.4 p -44.54 129.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.14 -8.85 79.02 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.45 1.5 . . . . 0.0 114.837 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -78.99 159.59 27.58 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.949 1.875 . . . . 0.0 112.317 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -104.5 156.91 17.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.572 1.549 . . . . 0.0 112.012 176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.3 tpp -141.14 140.02 34.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.527 1.531 . . . . 0.0 110.292 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.37 -7.17 0.62 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -78.3 132.26 37.39 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.135 -0.978 . . . . 0.0 113.111 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 t 69.48 -175.9 0.2 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.3 1.84 . . . . 0.0 114.894 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.9 pt -75.14 157.64 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.822 1.649 . . . . 0.0 111.322 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.46 -38.46 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -169.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.5 m -59.11 -51.08 71.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.742 0.817 . . . . 0.0 111.679 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -75.48 -33.05 60.78 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.964 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.99 -46.08 75.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.067 1.303 . . . . 0.0 111.766 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.3 m -76.82 -38.4 53.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.055 0.942 . . . . 0.0 112.45 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.07 -45.16 93.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.249 -0.907 . . . . 0.0 112.412 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -58.36 -39.86 80.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.78 1.632 . . . . 0.0 110.565 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 10.9 t80 -61.68 -54.55 41.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.195 0.998 . . . . 0.0 112.154 171.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 m -67.67 -25.27 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.809 1.641 . . . . 0.0 113.742 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 m -72.4 -42.17 65.47 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 117.687 -1.149 . . . . 0.0 110.959 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.22 -18.11 59.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.261 1.391 . . . . 0.0 113.647 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 14.0 mt -64.41 -47.6 78.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.237 0.926 . . . . 0.0 110.12 168.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.3 mtm-85 -72.48 -92.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 70.36 -2.91 2.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 129.2 3.0 . . . . 0.0 113.028 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.3 -99.37 0.54 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 126.782 2.134 . . . . 0.0 114.226 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -82.65 9.46 9.5 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.174 1.39 . . . . 0.0 113.636 -171.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 127.088 2.155 . . . . 0.0 112.003 -179.18 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.03 162.34 29.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.966 0.907 . . . . 0.0 113.147 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 p -74.04 151.88 88.44 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.018 0.927 . . . . 0.0 112.765 175.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -77.94 160.56 30.43 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.73 2.953 . . . . 0.0 112.152 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -80.79 2.69 25.17 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.401 1.08 . . . . 0.0 113.741 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -152.63 131.04 12.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.563 1.945 . . . . 0.0 108.813 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -157.63 103.63 1.81 Allowed Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.722 0.809 . . . . 0.0 111.09 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.51 144.87 10.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.336 2.691 . . . . 0.0 109.701 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.39 159.5 23.66 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.841 1.257 . . . . 0.0 112.312 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.43 137.27 80.72 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.411 2.74 . . . . 0.0 114.924 -168.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.24 63.94 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 126.323 1.916 . . . . 0.0 115.182 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -96.63 154.76 17.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -169.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -94.23 112.67 24.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.73 1.612 . . . . 0.0 111.51 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.9 mt -101.29 127.22 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.034 1.334 . . . . 0.0 109.858 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.51 115.58 28.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.22 117.53 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.75 1.62 . . . . 0.0 108.068 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.63 -32.22 71.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.337 0.655 . . . . 0.0 112.681 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.03 -71.3 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 129.369 3.068 . . . . 0.0 115.251 174.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.74 26.23 0.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.34 1.456 . . . . 0.0 113.715 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.21 -59.5 0.38 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.657 1.599 . . . . 0.0 109.895 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.05 122.01 21.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.974 0.509 . . . . 0.0 109.919 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -94.21 150.37 20.37 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.793 0.837 . . . . 0.0 111.972 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -121.36 148.56 44.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.714 1.206 . . . . 0.0 111.794 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -89.8 149.53 22.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.213 0.605 . . . . 0.0 110.582 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.02 146.91 33.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.031 0.932 . . . . 0.0 112.927 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.54 117.86 35.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.175 1.79 . . . . 0.0 108.143 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -73.54 109.89 7.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.475 0.71 . . . . 0.0 110.286 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -100.75 -17.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.59 175.76 31.06 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 126.061 1.791 . . . . 0.0 109.595 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -69.68 86.31 0.48 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.013 0.906 . . . . 0.0 111.315 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.05 -13.49 37.49 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.188 2.327 . . . . 0.0 114.327 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.59 139.24 33.79 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.875 1.27 . . . . 0.0 112.735 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -135.35 151.91 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.88 1.272 . . . . 0.0 113.189 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.5 128.63 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -144.02 160.28 41.14 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.142 -0.974 . . . . 0.0 111.779 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.44 122.5 45.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.881 0.872 . . . . 0.0 111.141 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.63 117.47 68.18 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.528 1.531 . . . . 0.0 107.27 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.69 162.52 39.46 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.543 2.829 . . . . 0.0 114.409 -168.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 58' ' ' ALA . 86.7 Cg_endo -72.72 141.79 34.66 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.69 2.927 . . . . 0.0 109.716 170.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -168.16 -177.79 3.43 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.94 0.896 . . . . 0.0 112.69 -170.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -166.24 160.6 16.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.831 2.052 . . . . 0.0 112.409 -177.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -68.98 155.72 92.96 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.376 1.07 . . . . 0.0 112.062 170.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.14 -6.37 15.96 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.907 3.071 . . . . 0.0 115.151 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.52 -34.51 86.01 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 119.628 1.104 . . . . 0.0 112.962 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.05 -17.11 64.75 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.0 11.41 57.35 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.987 1.756 . . . . 0.0 113.828 171.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.7 m -129.12 179.42 5.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.604 1.561 . . . . 0.0 111.885 -175.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -58.26 -20.47 42.59 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.148 -1.595 . . . . 0.0 114.025 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.0 p -81.52 5.11 18.9 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.253 1.821 . . . . 0.0 114.113 173.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -41.08 133.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.266 1.826 . . . . 0.0 114.105 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 23.3 t80 93.56 -22.4 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 130.159 3.384 . . . . 0.0 112.652 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -64.47 -31.81 73.17 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 121.242 -0.911 . . . . 0.0 111.392 169.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -104.95 134.82 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.917 2.087 . . . . 0.0 107.496 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.9 mt -124.07 161.42 25.62 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.576 1.551 . . . . 0.0 110.432 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m -68.28 134.15 49.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -77.27 161.35 28.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.62 1.168 . . . . 0.0 111.199 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -82.33 160.17 22.92 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.4 -0.812 . . . . 0.0 112.595 171.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.427 ' HB2' ' HD3' ' A' ' 39' ' ' PRO . . . -75.36 156.11 35.81 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.298 1.039 . . . . 0.0 110.404 169.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -141.58 134.75 29.28 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.806 0.843 . . . . 0.0 111.379 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.82 126.84 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.09 0.956 . . . . 0.0 109.244 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -129.26 152.64 48.6 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.614 1.566 . . . . 0.0 112.151 -170.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -105.07 139.08 40.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.551 1.54 . . . . 0.0 110.37 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -167.01 172.96 9.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.622 1.169 . . . . 0.0 110.482 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.59 143.08 27.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 111.083 170.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 tp -55.05 -49.95 70.32 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.582 -0.699 . . . . 0.0 111.561 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -30.95 62.6 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -79.36 -40.34 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.819 0.736 . . . . 0.0 111.285 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.77 -37.92 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 122.099 -0.376 . . . . 0.0 111.187 171.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.47 -37.32 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.047 1.339 . . . . 0.0 112.767 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.78 20.75 74.55 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.86 0.743 . . . . 0.0 114.333 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.32 2.64 89.09 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.211 1.386 . . . . 0.0 114.785 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.27 -167.84 1.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.149 1.38 . . . . 0.0 113.004 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 79.7 m -84.35 150.99 25.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.16 1.384 . . . . 0.0 113.139 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -163.54 160.96 23.71 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.208 1.403 . . . . 0.0 113.222 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.1 153.5 11.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.061 1.744 . . . . 0.0 111.834 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.76 140.92 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.676 1.126 . . . . 0.0 110.617 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -146.93 87.32 1.68 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.318 1.447 . . . . 0.0 111.019 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.28 69.19 4.45 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.667 1.187 . . . . 0.0 108.792 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.8 p -60.26 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.621 1.968 . . . . 0.0 114.288 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 mt -60.43 -22.97 64.02 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.297 -0.877 . . . . 0.0 113.075 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.89 -37.09 60.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.98 1.712 . . . . 0.0 111.525 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -63.48 -20.54 65.68 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.842 1.257 . . . . 0.0 112.702 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -88.0 -25.35 23.18 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.084 1.354 . . . . 0.0 112.907 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.81 -29.71 1.68 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -169.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -120.34 122.91 28.49 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -132.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -70.77 -21.26 29.04 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.454 3.436 . . . . 0.0 115.744 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 69.16 83.13 0.17 Allowed Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 127.721 2.408 . . . . 0.0 114.888 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.38 95.97 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.8 3.0 . . . . 0.0 109.158 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.2 -41.38 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.665 0.786 . . . . 0.0 111.963 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.24 -35.86 78.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.587 0.63 . . . . 0.0 112.106 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -42.73 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.595 0.758 . . . . 0.0 110.084 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.6 mt -71.55 -34.23 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.812 -0.555 . . . . 0.0 112.101 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.87 -38.83 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.26 -0.9 . . . . 0.0 110.365 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -64.4 -42.32 96.17 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.571 -0.706 . . . . 0.0 111.303 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -56.97 -44.33 82.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.263 1.025 . . . . 0.0 111.832 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.93 87.81 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.337 -0.852 . . . . 0.0 112.184 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -67.53 -14.96 63.39 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.85 -36.71 15.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 111.864 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.3 mtp -70.75 -23.56 62.45 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.911 1.284 . . . . 0.0 113.767 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -46.66 123.61 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.489 1.04 . . . . 0.0 112.309 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.78 83.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.359 1.457 . . . . 0.0 115.193 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 160.57 30.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.747 1.773 . . . . 0.0 111.327 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -131.32 157.22 43.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.162 1.385 . . . . 0.0 112.973 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.6 mtm -143.76 159.28 42.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.531 1.532 . . . . 0.0 111.298 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -143.65 -1.53 1.0 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -86.43 152.49 22.64 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.642 1.177 . . . . 0.0 113.459 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 m 75.61 168.71 0.27 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.531 2.332 . . . . 0.0 114.107 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.68 147.49 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 109.062 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -49.98 -36.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 p -64.1 -49.39 72.42 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.391 -0.818 . . . . 0.0 111.366 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.36 -30.05 65.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.575 -0.703 . . . . 0.0 112.1 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.81 -41.05 85.86 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.092 1.314 . . . . 0.0 111.5 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.63 -43.36 76.48 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.272 1.029 . . . . 0.0 112.561 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.25 -44.13 92.75 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.269 -0.894 . . . . 0.0 112.319 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -37.78 81.35 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.53 -1.356 . . . . 0.0 111.355 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.521 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 9.5 t80 -58.29 -56.81 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.68 0.792 . . . . 0.0 111.256 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.4 m -68.48 -23.57 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.618 1.099 . . . . 0.0 113.806 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 m -70.7 -41.66 71.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.621 1.101 . . . . 0.0 110.337 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.61 -27.94 69.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.57 1.077 . . . . 0.0 112.853 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.521 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 73.8 mt -69.56 -57.23 5.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.822 0.737 . . . . 0.0 111.559 170.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -80.29 9.57 5.59 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -57.7 -25.25 60.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.381 1.873 . . . . 0.0 112.617 -172.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -46.12 -43.9 13.84 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 127.811 2.624 . . . . 0.0 115.178 -173.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -137.54 22.15 2.93 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.715 1.206 . . . . 0.0 113.57 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.115 1.366 . . . . 0.0 111.381 -177.779 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.56 165.31 25.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.373 1.069 . . . . 0.0 112.813 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.3 p -162.57 156.3 17.69 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 125.451 1.5 . . . . 0.0 111.634 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.44 154.38 45.35 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.485 2.79 . . . . 0.0 111.837 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -81.98 -3.09 53.6 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -125.01 139.31 53.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.572 1.549 . . . . 0.0 110.686 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -150.59 132.11 7.65 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.919 1.288 . . . . 0.0 109.681 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.92 145.98 28.98 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.703 2.269 . . . . 0.0 110.261 172.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -106.04 149.72 38.44 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.141 0.976 . . . . 0.0 110.938 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.98 130.62 26.35 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.627 2.218 . . . . 0.0 111.3 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.59 61.37 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.361 1.934 . . . . 0.0 114.921 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -91.1 161.96 14.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.539 1.669 . . . . 0.0 114.355 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.67 110.2 22.81 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.722 1.609 . . . . 0.0 112.228 -169.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -90.49 123.03 42.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.385 1.074 . . . . 0.0 109.154 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -94.29 117.43 30.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.71 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.587 1.155 . . . . 0.0 108.762 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.27 -30.34 71.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.408 1.083 . . . . 0.0 112.907 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.259 26.1 tpt180 54.36 -111.87 0.66 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.825 2.05 . . . . 0.0 111.358 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.0 mt -133.74 42.78 2.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.119 0.968 . . . . 0.0 111.263 -161.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.94 6.52 37.15 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.872 1.225 . . . . 0.0 114.98 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -156.41 119.31 4.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.969 1.308 . . . . 0.0 111.045 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.5 142.91 48.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.792 1.237 . . . . 0.0 112.261 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.51 165.54 36.12 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.028 0.931 . . . . 0.0 112.881 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -92.45 152.53 19.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.2 150.1 43.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.979 1.711 . . . . 0.0 111.151 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.99 118.56 36.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.53 1.932 . . . . 0.0 107.586 174.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -73.7 102.91 4.09 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.658 0.663 . . . . 0.0 110.338 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.21 -17.43 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.8 -174.27 43.11 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -64.3 95.58 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.778 0.799 . . . . 0.0 111.603 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.43 6.07 64.69 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.639 2.066 . . . . 0.0 116.207 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -120.19 141.7 49.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.9 1.85 . . . . 0.0 113.3 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.87 151.36 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.901 1.281 . . . . 0.0 112.604 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 mm -111.42 134.09 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.57 152.85 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.573 1.078 . . . . 0.0 112.129 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.44 113.28 24.61 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.95 116.09 50.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.175 -0.917 . . . . 0.0 108.694 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.72 158.86 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.183 2.589 . . . . 0.0 111.931 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.12 52.62 4.14 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.402 3.401 . . . . 0.0 111.107 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.4 p -88.28 137.72 32.07 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.832 1.653 . . . . 0.0 112.633 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.77 -65.91 0.77 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -58.51 -38.38 64.89 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -170.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -60.63 -28.93 87.43 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.1 3.2 . . . . 0.0 114.683 173.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.42 -41.07 5.87 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.508 0.575 . . . . 0.0 112.411 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.82 -132.02 0.18 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.148 1.779 . . . . 0.0 111.885 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.31 -156.03 10.84 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.296 -0.878 . . . . 0.0 114.363 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.4 p -83.43 -30.46 27.27 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.8 m -76.25 -21.02 56.84 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.262 -0.899 . . . . 0.0 113.342 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 t -169.08 148.0 3.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.902 2.081 . . . . 0.0 109.747 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.75 -1.07 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -77.19 -22.89 51.71 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -169.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.4 m -76.67 53.94 0.93 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.034 1.334 . . . . 0.0 112.972 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 p -43.18 145.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.996 2.518 . . . . 0.0 113.805 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.2 tp -58.32 -33.5 69.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.245 1.018 . . . . 0.0 113.156 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.7 p -165.91 161.36 17.58 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.981 1.712 . . . . 0.0 111.464 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -70.08 -41.96 73.41 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.382 -0.824 . . . . 0.0 112.883 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m -128.95 170.85 12.94 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.723 1.609 . . . . 0.0 110.245 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.53 144.78 37.37 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.097 -1.002 . . . . 0.0 110.751 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.43 133.71 38.88 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.964 0.906 . . . . 0.0 110.887 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.13 125.23 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.856 0.862 . . . . 0.0 109.803 172.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -135.31 157.14 47.66 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.371 1.468 . . . . 0.0 112.316 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -109.71 133.43 53.14 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.795 1.638 . . . . 0.0 110.885 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -151.99 171.85 17.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.423 1.489 . . . . 0.0 111.526 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -85.89 148.77 25.64 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.269 0.628 . . . . 0.0 111.652 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.8 tp -52.45 -62.15 1.82 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.875 1.27 . . . . 0.0 111.582 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -66.12 -20.1 66.05 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.71 -36.82 70.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.515 1.052 . . . . 0.0 111.26 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.76 -44.53 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.131 0.972 . . . . 0.0 112.125 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.67 -1.66 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.69 109.89 3.13 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.466 1.03 . . . . 0.0 112.681 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 6.78 89.22 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.998 1.285 . . . . 0.0 114.337 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -112.72 152.76 28.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 112.485 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.9 m -83.47 149.92 26.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.819 0.848 . . . . 0.0 110.227 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -160.47 159.9 31.41 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -146.05 163.08 36.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.298 2.239 . . . . 0.0 109.852 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.15 143.1 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.509 170.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.38 144.36 46.55 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.622 1.169 . . . . 0.0 113.146 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -137.52 22.62 2.93 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.757 1.623 . . . . 0.0 112.362 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.3 t -62.44 -47.78 82.56 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.219 -1.551 . . . . 0.0 113.819 -169.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -73.46 -33.93 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.596 0.358 . . . . 0.0 111.868 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.86 -36.95 77.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.806 0.842 . . . . 0.0 112.134 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -65.08 -17.97 64.91 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.381 1.072 . . . . 0.0 112.854 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -80.01 -22.64 42.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.364 -0.835 . . . . 0.0 112.53 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -117.4 -57.22 2.16 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.51 149.62 63.36 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -140.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.86 -14.98 21.36 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 124.771 3.647 . . . . 0.0 113.632 172.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 77.56 90.76 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 127.158 2.183 . . . . 0.0 112.788 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.37 81.31 2.51 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.576 2.85 . . . . 0.0 108.889 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.76 -36.27 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.162 0.985 . . . . 0.0 112.538 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.35 -36.37 76.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.72 0.691 . . . . 0.0 112.392 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.29 -40.09 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.414 0.686 . . . . 0.0 109.874 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.08 -38.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.804 . . . . 0.0 111.654 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.23 -38.65 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.206 -0.934 . . . . 0.0 111.049 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -64.27 -44.84 90.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.6 -0.687 . . . . 0.0 111.271 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.7 m -57.62 -44.56 85.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.339 1.055 . . . . 0.0 112.483 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.47 95.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.006 0.821 . . . . 0.0 112.49 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.54 -44.72 89.93 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.119 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.888 -1.133 . . . . 0.0 113.426 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.96 -9.49 58.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.3 t -55.47 127.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.933 1.242 . . . . 0.0 110.591 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.33 -0.59 78.28 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.177 1.37 . . . . 0.0 114.5 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -71.01 132.87 45.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.061 1.43 . . . . 0.0 110.429 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.81 138.54 48.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.753 1.621 . . . . 0.0 111.118 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.7 mtm -143.59 153.07 42.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.919 1.288 . . . . 0.0 112.127 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -149.86 -7.91 0.31 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -63.9 153.7 36.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 114.12 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t 62.91 -164.55 0.25 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 114.449 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -80.33 145.23 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.203 1.401 . . . . 0.0 108.443 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.36 -31.47 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 119.149 0.886 . . . . 0.0 112.629 -171.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 p -60.17 -53.54 56.56 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.343 1.057 . . . . 0.0 111.659 172.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -66.04 -33.25 75.37 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.665 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -56.26 -42.42 77.39 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.23 1.377 . . . . 0.0 111.079 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.22 -44.21 54.06 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.21 1.404 . . . . 0.0 112.981 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.26 -43.65 98.34 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.799 -1.188 . . . . 0.0 112.374 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.543 ' CD2' HE22 ' A' ' 119' ' ' GLN . 8.3 t-160 -63.73 -42.88 97.81 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.692 -1.255 . . . . 0.0 110.014 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.46 -53.66 48.26 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.419 1.487 . . . . 0.0 112.589 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 m -66.08 -25.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.404 1.456 . . . . 0.0 112.917 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -65.91 -46.13 79.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 117.315 -1.326 . . . . 0.0 109.793 170.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.543 HE22 ' CD2' ' A' ' 115' ' ' HIS . 1.8 mp0 -55.85 -32.31 63.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.766 1.167 . . . . 0.0 113.459 171.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.39 -58.21 3.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.352 0.978 . . . . 0.0 111.346 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -75.27 3.99 7.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.71 -24.11 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.854 2.062 . . . . 0.0 113.338 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.24 -32.4 1.68 Allowed Glycine 0 N--CA 1.474 1.23 0 C-N-CA 128.473 2.94 . . . . 0.0 117.816 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -140.07 16.75 2.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 118.692 1.246 . . . . 0.0 112.866 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.105 1.762 . . . . 0.0 112.674 -177.155 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.316 0.103 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.37 162.67 28.64 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.353 1.061 . . . . 0.0 112.783 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -67.25 145.76 98.7 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.955 0.902 . . . . 0.0 112.668 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.82 147.59 56.4 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.463 2.775 . . . . 0.0 111.513 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -140.54 153.21 46.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.764 1.626 . . . . 0.0 110.771 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -99.05 151.86 20.48 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.613 0.765 . . . . 0.0 112.238 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -150.7 111.37 3.15 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.818 1.647 . . . . 0.0 107.877 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.17 147.97 93.6 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.666 2.244 . . . . 0.0 111.185 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -103.29 156.09 35.88 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.479 1.112 . . . . 0.0 111.57 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.59 129.89 22.25 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.529 2.152 . . . . 0.0 111.945 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.68 -2.62 82.32 Favored Glycine 0 N--CA 1.467 0.739 0 C-N-CA 125.272 1.415 . . . . 0.0 114.769 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -83.96 146.96 27.73 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.853 1.326 . . . . 0.0 110.913 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.0 139.47 40.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.546 1.165 . . . . 0.0 111.55 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.34 131.81 65.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.975 2.11 . . . . 0.0 108.198 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -92.36 115.39 28.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.87 129.03 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.531 1.932 . . . . 0.0 108.322 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.47 -33.21 71.01 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.833 0.742 . . . . 0.0 112.48 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 57.35 -119.46 1.22 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.752 2.021 . . . . 0.0 111.259 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -132.27 58.39 1.75 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.044 0.926 . . . . 0.0 110.352 -160.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.76 -1.89 75.77 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.271 1.415 . . . . 0.0 114.626 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -156.41 127.29 6.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.082 1.353 . . . . 0.0 111.552 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.25 155.25 36.94 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.83 1.252 . . . . 0.0 113.87 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -153.65 172.27 17.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.473 1.109 . . . . 0.0 112.232 170.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -93.85 161.1 14.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.72 162.83 39.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.015 2.126 . . . . 0.0 110.926 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.07 125.11 38.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.109 1.764 . . . . 0.0 108.536 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.94 93.33 5.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.236 1.014 . . . . 0.0 111.423 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 pt -81.75 -20.93 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 176.43 32.27 Favored Glycine 0 N--CA 1.465 0.579 0 C-N-CA 125.05 1.309 . . . . 0.0 110.798 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.84 88.38 0.38 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.615 0.721 . . . . 0.0 111.095 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.11 58.62 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 127.011 2.243 . . . . 0.0 114.774 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -104.74 140.47 38.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.825 1.312 . . . . 0.0 112.523 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.8 155.42 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.39 1.076 . . . . 0.0 112.954 -170.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -112.4 139.81 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -148.15 155.02 40.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.584 1.084 . . . . 0.0 111.574 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.7 115.38 27.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.3 122.87 87.57 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.53 158.06 59.27 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.776 2.984 . . . . 0.0 114.561 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.18 169.98 19.41 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 124.344 3.363 . . . . 0.0 111.54 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -132.91 130.32 39.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.472 1.109 . . . . 0.0 110.849 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 58.09 36.17 25.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.51 1.524 . . . . 0.0 112.092 -170.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -54.28 157.9 4.32 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.163 1.785 . . . . 0.0 113.653 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.8 120.1 6.6 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.738 2.959 . . . . 0.0 111.714 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.49 29.27 6.02 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.92 1.248 . . . . 0.0 113.28 -169.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.88 -171.96 0.6 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.898 1.279 . . . . 0.0 113.127 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.48 50.67 2.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.951 1.738 . . . . 0.0 114.877 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.3 t -167.0 -154.88 0.17 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.086 2.155 . . . . 0.0 110.159 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.5 p -73.02 -13.1 61.16 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.36 -1.463 . . . . 0.0 114.462 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 m -176.96 -47.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 127.695 2.398 . . . . 0.0 112.042 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.78 148.39 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.598 1.159 . . . . 0.0 110.78 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -144.04 153.18 41.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.724 1.21 . . . . 0.0 111.919 -173.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 p 67.56 -42.66 0.45 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 129.499 3.12 . . . . 0.0 115.067 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -165.84 153.56 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 128.526 2.73 . . . . 0.0 108.708 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.07 147.73 23.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.524 0.73 . . . . 0.0 111.904 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.1 m -59.75 128.86 39.05 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.988 0.915 . . . . 0.0 113.468 -170.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -89.4 149.0 23.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.787 1.235 . . . . 0.0 111.128 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m -78.94 152.52 31.03 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 158.65 16.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.3 1.84 . . . . 0.0 109.596 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -143.06 134.56 26.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 0.0 111.618 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.97 126.77 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.397 0.679 . . . . 0.0 109.182 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -131.98 149.75 52.34 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.619 1.568 . . . . 0.0 112.446 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -103.72 133.76 48.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.445 1.498 . . . . 0.0 110.485 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -154.74 177.69 10.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.743 1.617 . . . . 0.0 111.073 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -90.48 154.17 19.84 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 168.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 tp -53.15 -47.34 68.82 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.48 -31.17 67.6 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.04 -35.8 59.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.451 1.023 . . . . 0.0 111.104 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.09 -38.96 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.525 1.13 . . . . 0.0 111.9 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -80.38 -39.34 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.387 0.675 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.61 15.92 64.79 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.048 0.84 . . . . 0.0 115.016 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.53 85.72 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.389 1.471 . . . . 0.0 114.684 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.8 m -81.54 -176.41 6.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.082 1.353 . . . . 0.0 112.745 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 83.6 m -73.21 157.42 37.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.199 1.0 . . . . 0.0 112.875 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -167.14 168.06 13.88 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.525 1.93 . . . . 0.0 110.853 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.09 151.54 12.17 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 0.0 112.756 169.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.5 t -70.91 133.88 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -153.9 73.86 0.96 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.937 0.895 . . . . 0.0 110.907 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.25 58.74 0.73 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.627 1.571 . . . . 0.0 111.483 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 p -43.41 -69.35 0.14 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.516 2.327 . . . . 0.0 114.724 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -67.37 -29.2 68.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.589 0.756 . . . . 0.0 112.74 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.4 -35.59 80.71 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.185 -0.947 . . . . 0.0 111.21 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -73.98 -12.58 60.68 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.218 1.007 . . . . 0.0 112.83 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -86.18 -38.35 17.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.156 0.889 . . . . 0.0 112.078 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -71.67 0.73 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -143.7 157.37 58.67 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -145.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.6 144.24 11.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.891 3.061 . . . . 0.0 108.073 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -124.3 153.5 68.77 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -169.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.03 84.21 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.141 3.228 . . . . 0.0 109.96 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.11 -30.97 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.695 1.198 . . . . 0.0 114.019 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.41 -36.69 83.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.226 0.921 . . . . 0.0 112.643 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.74 -33.86 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.067 0.947 . . . . 0.0 110.519 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -63.98 -46.56 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.64 -0.663 . . . . 0.0 110.215 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.15 -39.38 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.814 0.846 . . . . 0.0 110.873 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.3 m -64.77 -40.93 96.08 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.615 -0.678 . . . . 0.0 111.813 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 t -58.3 -46.82 85.41 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.539 -0.725 . . . . 0.0 111.028 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.14 89.24 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.43 -0.794 . . . . 0.0 112.249 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.13 -28.12 69.85 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.49 -34.11 41.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 172.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.4 mtp -78.99 -20.28 49.49 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.96 124.57 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.603 1.547 . . . . 0.0 110.933 170.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.76 -6.92 59.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.611 1.576 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -75.43 143.66 42.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 1.515 . . . . 0.0 110.507 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.82 155.08 36.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.883 1.673 . . . . 0.0 111.833 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.1 mtm -141.62 164.14 31.01 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.113 1.365 . . . . 0.0 111.587 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -139.4 -36.13 0.53 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -76.4 154.03 35.22 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -170.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.5 t 77.57 177.68 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.259 2.224 . . . . 0.0 113.788 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -80.53 149.27 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.747 1.219 . . . . 0.0 111.276 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -52.65 -37.38 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 p -63.21 -55.34 25.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.451 0.7 . . . . 0.0 111.164 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.6 -36.37 83.54 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.58 -0.7 . . . . 0.0 111.935 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.44 -41.22 80.03 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.517 1.053 . . . . 0.0 111.686 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.6 t -77.26 -42.19 38.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.264 1.026 . . . . 0.0 112.513 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.77 -44.14 97.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.325 1.05 . . . . 0.0 112.13 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.54 ' CD2' HE22 ' A' ' 119' ' ' GLN . 59.8 t60 -60.42 -46.11 91.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.788 1.235 . . . . 0.0 110.125 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -52.76 -54.84 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.209 . . . . 0.0 112.213 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.95 -29.72 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.343 1.429 . . . . 0.0 112.8 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.3 m -65.41 -38.37 89.74 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.967 1.258 . . . . 0.0 110.504 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.54 HE22 ' CD2' ' A' ' 115' ' ' HIS . 0.8 OUTLIER -61.33 -26.89 68.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 120.415 1.461 . . . . 0.0 113.217 169.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.9 mt -74.6 -57.6 3.82 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.275 -0.891 . . . . 0.0 111.516 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -77.08 12.11 1.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -58.04 -24.41 58.28 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.314 1.846 . . . . 0.0 112.519 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.69 -22.29 39.43 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.026 2.251 . . . . 0.0 115.31 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -146.82 -11.03 0.45 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.601 1.161 . . . . 0.0 112.82 179.716 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.362 0.125 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.21 162.92 27.55 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.372 1.069 . . . . 0.0 112.9 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 m -69.66 155.48 93.42 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.861 0.864 . . . . 0.0 112.918 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.5 152.61 66.74 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.554 2.836 . . . . 0.0 112.39 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 141.6 53.19 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -90.73 72.16 6.69 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.963 -1.086 . . . . 0.0 109.256 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -133.73 112.13 12.57 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.707 1.203 . . . . 0.0 108.767 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.88 144.89 12.4 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.332 2.688 . . . . 0.0 111.05 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.65 150.05 4.59 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.582 1.953 . . . . 0.0 111.053 -176.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.28 137.34 39.88 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.915 3.076 . . . . 0.0 113.553 -169.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.08 -11.41 65.15 Favored Glycine 0 N--CA 1.469 0.879 0 C-N-CA 126.028 1.775 . . . . 0.0 114.633 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.59 160.16 15.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 118.403 1.101 . . . . 0.0 113.003 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.22 113.87 27.32 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.916 1.686 . . . . 0.0 111.785 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.91 127.55 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 124.8 1.24 . . . . 0.0 109.482 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -96.01 121.12 37.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.407 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.93 130.65 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.973 1.309 . . . . 0.0 109.157 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -77.16 64.79 2.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.563 1.145 . . . . 0.0 110.442 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -54.14 -44.89 71.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.611 1.564 . . . . 0.0 114.803 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -153.29 26.93 0.52 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -160.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.9 -2.49 66.5 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.99 0.805 . . . . 0.0 113.064 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -140.78 159.86 41.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.148 2.179 . . . . 0.0 110.44 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -91.86 120.33 32.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.679 1.192 . . . . 0.0 111.464 -172.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -112.75 151.84 29.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.531 1.532 . . . . 0.0 111.09 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -86.97 153.69 21.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.42 36.22 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.354 1.462 . . . . 0.0 111.383 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.42 123.85 50.64 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.168 1.787 . . . . 0.0 108.175 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -74.32 103.11 4.59 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.5 0.591 . . . . 0.0 111.221 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 pt -94.88 -21.69 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.78 171.94 33.77 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.31 96.08 0.22 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.164 0.982 . . . . 0.0 111.689 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.93 3.76 82.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.91 1.719 . . . . 0.0 115.244 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -110.73 139.01 46.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.502 1.651 . . . . 0.0 112.367 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.97 152.47 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 113.713 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.5 mm -107.95 134.64 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 107.109 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -151.52 159.49 44.12 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.496 1.044 . . . . 0.0 111.894 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.43 122.83 43.81 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.393 0.677 . . . . 0.0 111.304 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.49 146.39 50.21 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.861 1.664 . . . . 0.0 110.414 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.53 158.07 51.63 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.592 2.861 . . . . 0.0 113.956 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.2 -25.29 7.3 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.665 2.91 . . . . 0.0 112.29 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.0 p -75.08 151.87 38.63 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.139 0.976 . . . . 0.0 113.153 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -86.63 87.13 7.38 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.416 1.087 . . . . 0.0 109.993 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -54.89 -33.08 14.51 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.09 -23.8 54.74 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.074 3.183 . . . . 0.0 114.619 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.36 134.28 3.2 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.764 1.173 . . . . 0.0 114.553 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.12 138.28 57.92 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.08 0.952 . . . . 0.0 111.382 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.13 -51.71 3.59 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.333 1.444 . . . . 0.0 112.534 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.3 t -62.12 -39.22 91.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.445 1.098 . . . . 0.0 112.06 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.0 p -91.28 20.39 5.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.834 1.254 . . . . 0.0 113.196 173.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 m 71.4 -37.76 0.4 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 128.554 2.742 . . . . 0.0 114.053 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.26 137.84 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.484 1.114 . . . . 0.0 110.522 169.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -131.47 -5.86 3.74 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.8 p -74.51 -39.8 62.17 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.216 -0.927 . . . . 0.0 113.252 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 t 78.37 129.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 128.358 2.663 . . . . 0.0 111.033 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 tt -101.75 -49.36 4.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.417 1.487 . . . . 0.0 110.173 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.2 m 68.79 87.68 0.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.402 2.281 . . . . 0.0 111.194 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -73.27 174.33 8.22 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.636 1.175 . . . . 0.0 113.317 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 m -86.74 156.74 19.82 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.852 -1.155 . . . . 0.0 111.338 169.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.11 153.71 43.0 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.527 0.731 . . . . 0.0 109.637 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -138.12 131.25 30.2 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 111.106 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.05 126.16 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.989 0.915 . . . . 0.0 109.245 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -131.48 157.23 44.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.545 1.538 . . . . 0.0 112.489 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -110.48 138.81 46.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.841 1.657 . . . . 0.0 110.077 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -166.11 170.38 13.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.227 1.011 . . . . 0.0 110.703 -171.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -85.39 145.44 27.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.319 -0.863 . . . . 0.0 111.55 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.6 tp -53.1 -50.66 63.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.068 0.947 . . . . 0.0 111.529 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -58.11 -28.88 65.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -85.64 -32.11 22.19 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.53 -40.64 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.471 0.578 . . . . 0.0 111.256 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.81 -44.33 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.83 0.852 . . . . 0.0 112.118 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.74 -124.82 35.33 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -175.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.75 0.62 63.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.959 1.266 . . . . 0.0 114.973 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.58 168.3 19.06 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.64 1.22 . . . . 0.0 113.924 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -77.13 155.27 32.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.86 1.264 . . . . 0.0 112.545 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.92 165.85 31.32 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.806 1.243 . . . . 0.0 113.355 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.12 163.88 33.43 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.345 1.858 . . . . 0.0 111.321 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.17 136.3 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.562 1.074 . . . . 0.0 109.81 171.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -150.29 124.96 9.72 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.876 1.27 . . . . 0.0 112.451 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.26 41.43 3.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.687 1.595 . . . . 0.0 111.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.0 p -57.05 -31.21 64.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -74.54 -44.71 49.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.54 0.736 . . . . 0.0 111.434 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -63.37 -36.92 85.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.038 0.935 . . . . 0.0 110.792 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -58.14 -17.06 15.83 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.302 1.441 . . . . 0.0 113.562 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -74.42 -19.29 60.46 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.029 -1.044 . . . . 0.0 113.404 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.95 -29.74 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 -173.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.43 152.24 63.22 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -150.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.24 -49.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.512 2.808 . . . . 0.0 112.443 170.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.25 96.45 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 127.421 2.288 . . . . 0.0 111.072 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.27 124.21 11.83 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.446 3.431 . . . . 0.0 114.892 -168.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 t -49.67 -47.66 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.981 2.113 . . . . 0.0 113.801 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.36 -34.65 78.64 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.93 -36.4 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.356 0.663 . . . . 0.0 110.227 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mm -77.0 -38.57 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.758 -0.589 . . . . 0.0 110.335 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.96 -41.07 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.935 0.494 . . . . 0.0 110.914 171.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -64.83 -40.93 95.98 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.527 -0.733 . . . . 0.0 110.96 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.3 m -64.87 -39.85 94.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.363 1.065 . . . . 0.0 112.28 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.62 98.17 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.12 -0.987 . . . . 0.0 111.751 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -68.7 -13.74 62.57 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.46 -37.41 15.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.534 1.061 . . . . 0.0 111.15 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.1 mmm -69.41 -25.57 64.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.637 1.575 . . . . 0.0 113.623 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -47.0 124.36 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.83 1.195 . . . . 0.0 111.986 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.88 1.49 79.85 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.503 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.47 147.77 44.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.811 1.806 . . . . 0.0 111.405 172.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -124.15 139.97 53.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 111.362 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.0 mtm -142.52 148.33 37.45 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.196 0.998 . . . . 0.0 112.908 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -147.55 22.83 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.358 1.063 . . . . 0.0 112.345 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -80.78 -19.04 45.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 t -162.34 175.7 11.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.21 1.004 . . . . 0.0 112.956 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.17 147.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.301 1.84 . . . . 0.0 109.787 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.51 -32.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -169.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.6 p -58.72 -65.71 0.61 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.76 1.224 . . . . 0.0 111.531 173.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -65.01 -30.82 71.82 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.816 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.83 -40.41 76.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.172 1.351 . . . . 0.0 111.127 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -44.07 59.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.644 1.178 . . . . 0.0 112.962 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.14 -45.38 94.9 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.367 -0.833 . . . . 0.0 111.605 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -60.32 -36.62 78.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.03 -60.59 3.54 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.291 1.437 . . . . 0.0 111.443 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.4 m -65.88 -30.03 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 120.476 1.489 . . . . 0.0 113.157 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 m -59.36 -56.2 25.01 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 116.514 -1.707 . . . . 0.0 107.783 170.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -55.35 -31.65 61.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.736 1.607 . . . . 0.0 114.67 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.15 -33.95 75.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.397 0.999 . . . . 0.0 112.385 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -118.2 16.06 14.03 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -72.65 -19.07 61.51 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.639 1.576 . . . . 0.0 112.826 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.43 -33.82 73.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.855 0.741 . . . . 0.0 113.577 -172.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -114.55 -16.05 11.93 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.955 1.302 . . . . 0.0 112.924 179.618 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.414 0.15 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.0 165.32 25.13 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.239 1.016 . . . . 0.0 112.764 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.4 p -161.77 155.38 18.12 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.111 1.364 . . . . 0.0 112.025 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.02 161.79 35.3 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.52 2.813 . . . . 0.0 111.701 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -76.32 -9.62 58.78 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -157.34 139.06 14.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.026 1.73 . . . . 0.0 109.458 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -155.51 124.04 2.97 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.133 0.973 . . . . 0.0 110.342 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.94 145.29 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.452 2.768 . . . . 0.0 110.687 171.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.04 160.26 26.74 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.303 1.841 . . . . 0.0 110.273 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.43 130.13 32.52 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.863 1.709 . . . . 0.0 110.697 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.23 -6.07 78.34 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.091 1.329 . . . . 0.0 115.437 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -65.47 140.06 58.56 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.8 1.3 . . . . 0.0 112.43 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.5 tp -87.11 89.89 8.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.72 1.608 . . . . 0.0 108.278 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.46 132.66 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.231 1.012 . . . . 0.0 108.879 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -102.27 107.47 18.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.819 1.647 . . . . 0.0 108.179 171.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.0 mm -86.73 123.45 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.702 2.001 . . . . 0.0 107.97 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.94 -32.89 74.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.302 2.0 mmt180 43.62 -142.49 0.15 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.713 2.005 . . . . 0.0 112.975 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.55 109.37 11.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.284 -167.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.17 -9.59 6.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.762 1.172 . . . . 0.0 115.179 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -166.05 124.46 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.798 1.639 . . . . 0.0 111.989 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.64 144.88 31.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.503 1.521 . . . . 0.0 111.675 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -144.09 165.37 27.99 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.231 -0.918 . . . . 0.0 113.456 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -88.13 157.13 18.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.71 137.69 20.36 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.927 1.691 . . . . 0.0 110.41 169.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.46 119.46 38.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.044 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -72.01 89.49 1.12 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.803 1.241 . . . . 0.0 111.747 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 pt -77.24 -20.32 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.21 -178.31 32.12 Favored Glycine 0 N--CA 1.462 0.433 0 C-N-CA 124.916 1.246 . . . . 0.0 110.878 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.87 86.19 0.51 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.639 0.733 . . . . 0.0 111.099 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.3 -6.84 46.63 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.884 2.183 . . . . 0.0 114.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -106.65 141.95 37.08 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.95 1.375 . . . . 0.0 112.813 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -137.95 153.28 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 mt -115.88 138.38 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.641 1.576 . . . . 0.0 107.002 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -157.61 138.24 13.02 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.154 -0.966 . . . . 0.0 113.275 -168.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.58 113.6 12.03 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.719 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.95 141.52 78.49 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.399 0.679 . . . . 0.0 109.855 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.34 157.13 62.35 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.632 2.888 . . . . 0.0 113.14 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.89 -11.75 18.06 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 124.16 3.24 . . . . 0.0 114.042 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.1 t -139.97 152.04 45.99 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.673 1.189 . . . . 0.0 111.523 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.28 144.73 56.41 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.267 1.427 . . . . 0.0 114.285 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -72.68 159.27 85.77 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -54.74 141.98 74.72 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.726 2.951 . . . . 0.0 113.491 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.73 -11.73 70.88 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.73 1.157 . . . . 0.0 115.051 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.06 169.06 16.8 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.054 1.342 . . . . 0.0 113.414 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.78 24.98 19.03 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.608 1.099 . . . . 0.0 114.265 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.3 t -153.48 164.46 38.16 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.803 1.241 . . . . 0.0 110.682 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -57.41 -20.56 30.75 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -78.0 -25.01 47.75 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.86 1.264 . . . . 0.0 114.014 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -155.41 108.51 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.976 1.711 . . . . 0.0 109.576 -173.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -150.11 -20.26 0.25 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 t -76.22 79.58 3.01 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.673 -1.267 . . . . 0.0 111.062 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.57 140.3 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.337 1.455 . . . . 0.0 110.813 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.5 tp -68.89 132.11 46.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.829 1.252 . . . . 0.0 111.257 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 t -160.68 91.72 0.92 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.436 0.694 . . . . 0.0 110.553 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 176.98 -55.3 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.397 2.279 . . . . 0.0 110.519 -170.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 p -166.27 156.49 12.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.143 2.177 . . . . 0.0 109.129 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.82 135.85 34.36 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.691 -0.631 . . . . 0.0 109.657 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.94 138.77 37.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.172 0.896 . . . . 0.0 110.318 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -80.57 118.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.168 0.587 . . . . 0.0 110.116 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -108.07 174.96 5.65 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -146.09 152.45 39.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.462 1.505 . . . . 0.0 112.298 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 175.35 -164.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.843 2.857 . . . . 0.0 109.597 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -77.0 151.08 35.78 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.21 -0.931 . . . . 0.0 112.889 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.95 -46.66 75.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.179 0.991 . . . . 0.0 111.177 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 69' ' ' VAL . 16.4 pt-20 -58.82 -29.71 67.09 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -80.5 -39.29 28.23 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.445 -0.785 . . . . 0.0 111.459 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.02 -46.69 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 174.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 66' ' ' GLU . 31.7 m -70.99 -41.97 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.827 0.851 . . . . 0.0 112.262 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.46 -116.31 9.16 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 119.342 0.974 . . . . 0.0 110.72 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.94 -2.92 64.27 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.476 1.036 . . . . 0.0 114.835 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 55.8 m -79.95 157.9 26.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.781 1.29 . . . . 0.0 113.326 -172.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 74.6 m -74.59 167.08 22.46 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.343 1.057 . . . . 0.0 111.878 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -155.16 163.21 40.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.492 1.117 . . . . 0.0 111.745 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -140.16 169.65 17.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.398 1.879 . . . . 0.0 109.961 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.35 127.55 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -103.64 -54.77 2.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 47.3 47.8 16.57 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.325 1.45 . . . . 0.0 111.797 -171.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.3 p -54.2 -60.26 3.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.674 1.589 . . . . 0.0 113.749 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.41 -29.43 70.13 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -65.15 -51.48 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.696 0.398 . . . . 0.0 110.373 169.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -60.72 -27.0 67.58 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 121.179 -0.951 . . . . 0.0 113.026 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -68.17 -33.54 74.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -158.91 -15.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -146.88 130.4 8.25 Favored Pre-proline 0 CA--C 1.55 0.967 0 O-C-N 120.728 -1.233 . . . . 0.0 113.752 -133.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.86 -46.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.749 2.3 . . . . 0.0 112.173 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 128.99 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 129.495 3.118 . . . . 0.0 114.557 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.52 97.8 0.46 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.322 2.682 . . . . 0.0 110.227 169.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -15.87 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -169.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -63.91 -34.78 78.72 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.769 0.713 . . . . 0.0 110.824 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -74.88 -32.74 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.374 0.67 . . . . 0.0 110.382 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.93 -44.56 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.522 0.729 . . . . 0.0 111.631 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.54 -36.25 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.623 0.769 . . . . 0.0 110.607 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -65.1 -45.08 86.66 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.619 0.768 . . . . 0.0 111.637 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.8 m -58.94 -40.77 85.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.584 1.153 . . . . 0.0 112.168 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.14 94.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.501 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -63.42 -21.27 66.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.36 -34.7 21.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 112.554 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 mtp -77.52 -27.81 51.82 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -56.29 123.0 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 120.076 1.307 . . . . 0.0 110.617 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.58 -9.49 62.47 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.793 1.663 . . . . 0.0 115.038 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -78.68 156.23 29.08 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.479 1.64 . . . . 0.0 110.464 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -147.35 154.59 41.09 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.104 1.362 . . . . 0.0 114.34 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.1 mtm -147.15 163.99 34.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.314 1.846 . . . . 0.0 112.022 -170.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -157.19 -45.31 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -77.94 71.13 4.4 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.04 1.336 . . . . 0.0 113.709 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 m -175.88 170.43 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.411 2.684 . . . . 0.0 110.228 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.96 146.41 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.308 -0.87 . . . . 0.0 109.252 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.46 -40.1 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 120.666 -1.271 . . . . 0.0 113.218 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.7 m -60.63 -43.44 97.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.208 0.603 . . . . 0.0 110.846 173.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -70.71 -29.75 66.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.774 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -58.15 -46.83 84.98 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.644 1.565 . . . . 0.0 110.911 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.0 m -66.5 -48.65 69.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.651 1.181 . . . . 0.0 112.197 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -58.52 -48.32 81.22 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.562 0.745 . . . . 0.0 111.409 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.25 -33.8 76.85 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.938 -1.101 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -58.88 -58.0 10.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.946 0.794 . . . . 0.0 110.787 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.82 -21.58 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 119.551 1.069 . . . . 0.0 113.598 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -71.93 -40.82 68.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.355 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.22 -26.21 68.24 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 120.038 1.29 . . . . 0.0 112.654 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.02 -46.48 67.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.983 0.811 . . . . 0.0 112.405 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -94.37 9.7 37.22 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.454 1.901 . . . . 0.0 114.285 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -58.65 -21.66 54.6 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.049 2.139 . . . . 0.0 113.789 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.88 68.28 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.479 1.037 . . . . 0.0 114.314 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -140.59 -22.4 0.81 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 169.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 124.945 1.298 . . . . 0.0 112.793 175.008 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttm . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 110.664 -0.124 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.02 160.57 31.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.485 1.114 . . . . 0.0 112.832 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -172.52 161.97 4.07 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 126.934 2.094 . . . . 0.0 111.122 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.09 150.83 54.19 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.782 2.988 . . . . 0.0 112.847 171.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -162.84 -65.31 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.092 0.957 . . . . 0.0 112.652 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -83.2 52.33 2.17 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.829 1.252 . . . . 0.0 110.724 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -94.89 125.21 51.86 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.161 -0.923 . . . . 0.0 109.894 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.5 150.12 35.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.751 2.301 . . . . 0.0 111.318 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -100.64 142.1 23.95 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.753 0.821 . . . . 0.0 110.973 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.3 132.51 24.21 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.682 1.588 . . . . 0.0 110.468 -170.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.87 66.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.691 1.615 . . . . 0.0 114.574 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.13 165.99 11.97 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.579 1.69 . . . . 0.0 113.885 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.4 mt -90.64 113.11 25.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.26 1.424 . . . . 0.0 111.655 -169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.22 117.9 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.966 0.906 . . . . 0.0 108.629 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.58 117.52 28.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -122.71 134.25 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.859 1.264 . . . . 0.0 109.3 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -77.76 66.05 3.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.017 0.927 . . . . 0.0 110.47 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -36.12 82.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.299 1.44 . . . . 0.0 114.41 -169.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.77 26.38 0.74 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -152.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.76 7.81 77.64 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.285 0.945 . . . . 0.0 112.965 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -167.71 160.26 12.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.746 2.819 . . . . 0.0 109.183 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -64.51 138.23 58.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.599 1.56 . . . . 0.0 113.616 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.95 151.46 40.96 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.349 1.86 . . . . 0.0 108.72 169.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -98.84 156.79 16.69 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.2 157.09 44.17 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.897 1.679 . . . . 0.0 111.87 169.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.31 121.77 45.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.79 2.036 . . . . 0.0 108.541 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -75.05 92.43 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.153 0.888 . . . . 0.0 111.774 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 pt -84.44 -21.8 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.68 174.43 30.78 Favored Glycine 0 N--CA 1.463 0.454 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.05 94.73 0.67 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.534 0.683 . . . . 0.0 109.93 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.44 65.59 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.437 1.97 . . . . 0.0 115.273 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -113.75 140.2 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.361 1.58 . . . . 0.0 112.365 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 m -140.77 149.27 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mm -105.97 128.54 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -139.29 163.46 32.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.975 0.807 . . . . 0.0 111.043 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.23 137.51 32.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.67 138.6 21.07 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.457 1.503 . . . . 0.0 108.457 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.57 159.11 39.6 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.506 2.804 . . . . 0.0 113.728 -169.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.35 139.4 16.53 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.676 2.917 . . . . 0.0 109.788 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.1 m -75.54 -21.69 57.72 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -164.09 128.78 2.77 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.724 1.61 . . . . 0.0 110.196 172.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.88 -55.27 17.42 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -173.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 -30.4 16.27 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.378 2.719 . . . . 0.0 112.842 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.11 155.18 23.75 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.911 1.243 . . . . 0.0 113.672 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.35 153.32 18.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.196 1.398 . . . . 0.0 112.909 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.06 126.31 8.8 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 124.584 1.087 . . . . 0.0 110.539 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -61.33 -27.79 68.75 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -171.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.2 p -73.24 -29.68 62.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.226 1.011 . . . . 0.0 112.87 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.8 m -83.97 -39.76 19.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.325 1.05 . . . . 0.0 111.987 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.63 131.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.302 1.841 . . . . 0.0 110.805 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -109.01 -7.87 15.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.035 1.334 . . . . 0.0 113.71 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.1 m -75.4 -0.28 19.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.814 1.646 . . . . 0.0 115.246 -171.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.07 153.41 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.488 1.515 . . . . 0.0 111.526 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.92 151.44 27.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.921 0.888 . . . . 0.0 110.911 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.5 m -123.67 24.03 8.61 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.084 1.353 . . . . 0.0 111.396 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -61.35 160.67 10.37 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.2 p -85.98 163.48 17.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.131 1.372 . . . . 0.0 111.475 169.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.56 127.99 34.45 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -113.18 134.88 54.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.451 1.1 . . . . 0.0 111.314 -169.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.1 126.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.732 0.813 . . . . 0.0 110.515 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -139.3 153.88 47.83 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.914 1.286 . . . . 0.0 113.273 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -98.79 137.96 36.63 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.856 1.662 . . . . 0.0 110.689 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -165.7 172.22 12.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.538 1.135 . . . . 0.0 111.671 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -92.89 146.43 23.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.27 1.428 . . . . 0.0 112.103 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -51.47 -56.07 15.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 111.774 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -62.72 -25.16 68.03 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.47 -40.26 43.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.213 0.915 . . . . 0.0 111.12 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.2 t -68.13 -35.33 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.042 0.537 . . . . 0.0 111.959 173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.1 t -78.7 -39.34 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.003 0.921 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 20.11 65.35 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.007 0.822 . . . . 0.0 115.014 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.61 89.72 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.132 1.349 . . . . 0.0 114.859 -173.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.26 175.49 8.9 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.116 1.366 . . . . 0.0 112.555 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.6 m -69.68 150.72 46.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.258 1.023 . . . . 0.0 112.732 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -160.63 163.94 32.2 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.915 1.286 . . . . 0.0 113.506 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.05 163.43 23.26 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.788 2.035 . . . . 0.0 110.927 -175.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -109.0 145.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.596 1.089 . . . . 0.0 112.162 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -133.54 151.89 51.81 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.818 1.647 . . . . 0.0 113.45 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -144.93 31.11 1.15 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.989 1.716 . . . . 0.0 112.286 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -59.94 -35.82 75.74 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.23 -29.22 15.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.918 0.781 . . . . 0.0 112.54 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.62 -30.97 72.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.444 1.097 . . . . 0.0 112.213 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -67.17 -23.04 65.73 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.243 1.417 . . . . 0.0 113.093 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -88.75 -45.66 9.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -95.77 -34.64 11.83 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -168.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -141.13 158.19 65.06 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.49 -19.39 28.53 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.13 3.22 . . . . 0.0 113.207 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 66.93 75.63 0.31 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.355 1.862 . . . . 0.0 112.098 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.81 80.85 2.28 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.458 3.439 . . . . 0.0 110.257 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 t -46.45 -41.11 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.678 1.591 . . . . 0.0 114.344 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.97 -38.02 82.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.207 0.912 . . . . 0.0 111.21 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.14 -38.0 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.313 1.045 . . . . 0.0 109.902 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.53 -47.25 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.471 0.578 . . . . 0.0 110.379 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.71 -38.89 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.34 1.056 . . . . 0.0 111.852 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -65.86 -42.49 90.34 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.415 -0.803 . . . . 0.0 110.61 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.8 p -61.5 -38.57 87.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.438 0.695 . . . . 0.0 112.054 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.76 72.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.427 1.091 . . . . 0.0 111.404 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.46 -36.37 80.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.71 -37.7 79.71 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.6 ptm -81.68 -4.06 55.23 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.2 125.67 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.869 1.268 . . . . 0.0 109.227 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.99 -5.97 58.17 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.924 1.25 . . . . 0.0 114.469 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -66.06 147.82 52.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.262 1.531 . . . . 0.0 110.491 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.76 135.0 45.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.459 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -141.64 140.77 33.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.555 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -149.83 27.05 0.8 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.777 1.231 . . . . 0.0 112.318 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.8 -8.9 59.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.8 t -158.06 178.05 10.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.841 1.256 . . . . 0.0 111.842 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 146.55 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.432 1.493 . . . . 0.0 110.203 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.3 t -49.66 -39.33 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 124.807 1.243 . . . . 0.0 113.926 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.4 p -58.73 -57.54 12.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.831 0.852 . . . . 0.0 111.787 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -64.97 -34.32 78.15 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.519 -0.738 . . . . 0.0 112.152 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -59.54 -35.48 74.29 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.612 1.096 . . . . 0.0 111.418 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -42.6 67.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.036 0.935 . . . . 0.0 112.801 172.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -62.24 -45.99 90.85 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.97 -1.081 . . . . 0.0 112.254 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -52.87 -44.86 67.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.761 2.024 . . . . 0.0 110.615 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.47 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 11.3 t80 -61.33 -54.24 46.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.433 1.493 . . . . 0.0 112.37 173.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.3 m -69.23 -22.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 120.561 1.528 . . . . 0.0 114.215 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -70.42 -40.12 74.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.145 169.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -64.36 -23.91 67.46 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.411 1.005 . . . . 0.0 113.668 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.47 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 36.5 mt -72.86 -60.79 2.06 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.213 0.915 . . . . 0.0 111.337 169.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -73.95 4.27 5.62 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -56.7 -26.04 55.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.338 2.255 . . . . 0.0 113.219 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -43.98 -51.83 7.04 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 127.75 2.595 . . . . 0.0 115.645 -169.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -128.04 5.73 5.94 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 C--O 1.25 1.093 0 C-N-CA 124.787 1.235 . . . . 0.0 111.879 170.713 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.01 162.95 28.12 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.024 0.929 . . . . 0.0 112.627 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 m -172.4 155.37 3.36 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 126.877 2.071 . . . . 0.0 110.6 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.64 148.05 41.31 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.15 2.567 . . . . 0.0 111.627 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -137.31 24.44 2.96 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.322 1.449 . . . . 0.0 111.77 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.01 134.67 34.63 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.969 -1.082 . . . . 0.0 111.157 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -94.15 116.61 66.63 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.491 0.716 . . . . 0.0 110.111 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.11 145.21 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.587 2.192 . . . . 0.0 110.098 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.14 139.47 21.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.707 0.803 . . . . 0.0 110.83 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 127.91 15.91 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.769 2.312 . . . . 0.0 110.305 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.01 2.17 90.66 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.181 1.372 . . . . 0.0 114.246 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 169.33 8.63 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.003 1.321 . . . . 0.0 112.604 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.38 130.14 54.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.531 1.533 . . . . 0.0 113.987 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mt -111.77 144.15 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.365 2.266 . . . . 0.0 110.61 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -108.94 116.67 32.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.29 128.93 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.446 1.499 . . . . 0.0 109.571 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -80.24 68.61 6.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.761 1.225 . . . . 0.0 110.847 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -34.65 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -169.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pp -156.9 27.33 0.32 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.17 10.23 58.63 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.108 0.861 . . . . 0.0 113.844 -172.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -163.36 145.01 9.61 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.586 2.354 . . . . 0.0 110.146 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -75.32 120.73 21.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.946 1.298 . . . . 0.0 112.354 -176.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -103.07 140.58 37.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.767 1.227 . . . . 0.0 110.041 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -73.62 146.7 44.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.106 0.563 . . . . 0.0 112.123 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.74 142.14 24.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 121.67 43.72 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.029 1.732 . . . . 0.0 108.945 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -76.67 105.29 7.65 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.797 0.839 . . . . 0.0 111.005 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.3 pt -97.1 -20.83 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.91 174.16 32.46 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 124.987 1.28 . . . . 0.0 110.163 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.04 94.73 0.51 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.789 0.804 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.69 64.43 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.839 2.161 . . . . 0.0 115.446 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -112.54 133.99 54.3 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.598 1.699 . . . . 0.0 112.246 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.45 152.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.884 1.274 . . . . 0.0 112.709 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 mm -109.36 128.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.775 1.63 . . . . 0.0 106.844 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -144.95 159.52 42.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.422 1.01 . . . . 0.0 112.026 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.0 115.78 28.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.596 0.758 . . . . 0.0 110.038 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.76 70.18 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.664 1.586 . . . . 0.0 109.815 169.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.33 155.01 68.6 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.897 3.065 . . . . 0.0 114.772 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -84.53 -4.73 10.07 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 124.649 3.566 . . . . 0.0 114.472 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.2 m 76.8 -41.31 0.39 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 128.058 2.543 . . . . 0.0 112.513 -174.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -150.88 159.19 44.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.637 1.975 . . . . 0.0 111.06 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -68.01 167.07 18.86 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.712 0.805 . . . . 0.0 112.999 171.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -53.17 -27.98 39.78 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 124.28 3.32 . . . . 0.0 115.972 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.21 23.73 5.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.539 1.066 . . . . 0.0 114.907 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.7 -20.83 23.76 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.758 1.623 . . . . 0.0 114.547 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.73 101.06 0.79 Allowed Glycine 0 N--CA 1.467 0.731 0 C-N-CA 125.609 1.576 . . . . 0.0 109.408 169.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.5 p -165.44 -178.79 5.14 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.126 1.37 . . . . 0.0 112.32 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 m -68.86 -19.44 64.24 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.734 -1.229 . . . . 0.0 112.128 169.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.5 p -82.54 -37.24 25.46 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.129 -0.982 . . . . 0.0 113.217 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -157.48 154.53 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.403 1.881 . . . . 0.0 110.367 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -160.5 -34.83 0.05 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.119 0.968 . . . . 0.0 112.727 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 p -74.06 41.05 0.13 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.222 2.209 . . . . 0.0 112.964 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.26 153.65 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.668 1.987 . . . . 0.0 111.115 -170.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.7 tp -76.14 109.83 10.14 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.126 0.97 . . . . 0.0 111.322 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 t -87.51 138.41 31.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.338 0.655 . . . . 0.0 111.134 170.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.96 -170.4 2.14 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.45 1.5 . . . . 0.0 110.852 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.7 m -119.71 153.49 35.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.351 1.06 . . . . 0.0 110.784 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.27 159.99 33.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.515 0.726 . . . . 0.0 110.214 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -136.48 130.06 32.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.854 0.862 . . . . 0.0 109.951 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.9 t -83.79 123.19 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -145.25 153.26 41.12 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -94.1 137.77 32.91 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.186 1.794 . . . . 0.0 110.505 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -162.64 163.11 27.25 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.495 0.718 . . . . 0.0 111.893 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -76.05 140.16 41.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.829 173.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -52.56 -54.14 36.93 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.72 1.208 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.88 -23.92 67.57 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.84 -39.11 27.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.299 0.954 . . . . 0.0 111.343 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.52 -39.65 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.75 -0.594 . . . . 0.0 111.405 170.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.04 -45.55 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 112.345 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.03 61.99 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.25 0.932 . . . . 0.0 115.043 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.12 88.21 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.344 1.449 . . . . 0.0 114.891 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -82.5 171.51 14.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.956 1.302 . . . . 0.0 112.017 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.05 147.89 49.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -158.93 163.43 36.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 113.02 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.64 155.78 15.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.238 1.415 . . . . 0.0 112.354 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.73 136.96 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.662 0.664 . . . . 0.0 109.707 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -160.49 136.92 8.72 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.256 1.822 . . . . 0.0 109.516 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -154.37 52.3 0.66 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.888 0.852 . . . . 0.0 113.017 -169.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.9 m -50.67 -35.59 31.64 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -72.54 -39.81 67.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.787 0.835 . . . . 0.0 111.715 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.37 -40.58 93.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.021 0.928 . . . . 0.0 111.439 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -62.09 -17.9 59.06 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.381 1.072 . . . . 0.0 112.862 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -79.74 -30.8 40.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 -35.17 0.42 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 117.843 2.535 . . . . 0.0 117.843 -172.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.69 151.84 73.93 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -138.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.32 -24.11 2.1 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 124.083 3.189 . . . . 0.0 114.657 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 67.11 110.26 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 127.339 2.256 . . . . 0.0 115.668 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.64 89.92 1.25 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 124.134 3.223 . . . . 0.0 109.768 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 t -50.99 -39.67 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.275 1.43 . . . . 0.0 113.782 -169.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.4 -35.76 78.14 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.283 0.492 . . . . 0.0 111.832 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.93 -32.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.279 1.032 . . . . 0.0 110.396 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 mm -66.43 -47.68 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.93 -0.481 . . . . 0.0 110.57 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.49 -37.57 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.892 0.477 . . . . 0.0 110.763 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.1 m -65.25 -41.93 93.79 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.649 -0.657 . . . . 0.0 111.73 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -61.12 -48.13 83.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.639 -0.663 . . . . 0.0 110.909 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.13 88.15 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.7 0.8 . . . . 0.0 112.257 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -62.58 -46.76 86.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.512 0.725 . . . . 0.0 112.021 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.67 -30.79 70.12 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.259 -0.901 . . . . 0.0 113.27 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.9 mtp -75.73 -9.44 58.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.47 127.02 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.455 1.479 . . . . 0.0 111.343 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.13 -0.41 85.88 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.917 -1.491 . . . . 0.0 114.096 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -77.99 137.74 38.45 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.1 1.95 . . . . 0.0 111.023 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.93 165.22 22.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.382 1.073 . . . . 0.0 110.498 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.4 ttm -159.4 137.09 10.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 110.746 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -156.36 34.0 0.32 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.338 1.066 . . . . 0.0 111.185 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.69 -33.28 71.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.263 1.825 . . . . 0.0 114.131 -170.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.7 t -162.47 -157.05 0.44 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.174 1.39 . . . . 0.0 111.876 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.04 154.92 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.274 1.43 . . . . 0.0 109.861 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.15 -37.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -62.5 -49.11 76.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.429 0.692 . . . . 0.0 111.84 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -74.86 -27.95 60.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 117.545 -1.217 . . . . 0.0 112.238 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -58.51 -43.54 89.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.741 1.609 . . . . 0.0 110.215 170.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -51.82 68.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.476 1.91 . . . . 0.0 112.639 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -64.54 -41.89 96.06 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.051 0.841 . . . . 0.0 112.517 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -56.41 -44.11 80.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.391 1.476 . . . . 0.0 110.52 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 19.3 t80 -60.67 -56.9 15.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.468 1.507 . . . . 0.0 111.698 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.05 -19.32 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.096 1.316 . . . . 0.0 114.399 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 m -74.69 -38.22 62.44 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.112 1.324 . . . . 0.0 110.284 170.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -67.15 -28.11 67.86 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.641 1.11 . . . . 0.0 112.968 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.645 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 94.1 mt -67.46 -56.79 8.17 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.442 -0.786 . . . . 0.0 110.231 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -78.55 5.01 11.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.594 1.558 . . . . 0.0 113.946 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.04 -20.58 17.49 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.526 2.331 . . . . 0.0 113.136 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.52 -31.15 28.54 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.285 1.898 . . . . 0.0 113.697 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -135.2 -23.64 1.48 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 124.684 1.193 . . . . 0.0 113.358 -177.665 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.366 0.126 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.39 161.62 28.54 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.225 1.01 . . . . 0.0 112.613 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.6 p -166.37 163.32 11.58 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 125.499 1.52 . . . . 0.0 111.678 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.35 143.28 99.78 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.591 2.861 . . . . 0.0 112.815 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -139.64 156.3 46.92 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.319 1.448 . . . . 0.0 111.599 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -157.78 141.23 15.45 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.513 1.525 . . . . 0.0 109.301 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.2 134.25 8.24 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.42 152.37 15.62 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.647 2.898 . . . . 0.0 110.187 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.96 153.46 38.25 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.543 1.137 . . . . 0.0 111.191 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -67.89 131.88 25.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.886 1.724 . . . . 0.0 110.491 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -6.81 81.85 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 125.535 1.54 . . . . 0.0 114.525 -172.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.72 161.84 15.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.444 1.497 . . . . 0.0 111.89 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -118.83 160.12 22.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.963 1.363 . . . . 0.0 114.437 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mt -141.3 131.22 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.615 1.566 . . . . 0.0 109.57 -160.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -85.65 127.84 34.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -112.55 122.34 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.314 1.446 . . . . 0.0 109.112 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -82.27 92.9 7.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.594 1.158 . . . . 0.0 109.084 173.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -64.99 -72.02 0.17 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.438 1.095 . . . . 0.0 111.693 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.4 mt -150.37 -114.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -164.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.18 23.85 5.84 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.333 0.968 . . . . 0.0 111.957 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -169.29 167.69 10.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.987 2.515 . . . . 0.0 111.867 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -121.26 163.4 18.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.233 1.413 . . . . 0.0 111.911 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.12 -174.07 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.658 1.583 . . . . 0.0 110.872 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -120.81 157.75 29.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.7 43.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.504 1.522 . . . . 0.0 113.083 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' HB2' HD13 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -125.72 123.64 39.32 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.771 2.428 . . . . 0.0 108.162 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -79.97 104.43 10.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 0.0 111.507 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.4 pt -94.48 -15.21 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.87 177.8 37.11 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 124.39 0.995 . . . . 0.0 110.877 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.73 91.57 0.45 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.669 0.747 . . . . 0.0 110.37 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 0.73 58.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.629 2.062 . . . . 0.0 115.069 -176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.56 138.94 47.45 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.924 1.862 . . . . 0.0 112.589 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.42 152.37 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mm -108.45 137.85 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 127.044 2.138 . . . . 0.0 106.715 168.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.98 141.17 18.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.235 0.925 . . . . 0.0 111.73 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.86 121.54 30.4 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.351 0.66 . . . . 0.0 110.01 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.13 113.77 43.67 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 168.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.3 169.45 21.26 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.028 2.485 . . . . 0.0 112.75 -169.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.12 153.56 32.2 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.372 3.381 . . . . 0.0 113.661 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -160.24 154.68 23.7 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.959 1.304 . . . . 0.0 110.59 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -104.7 143.15 33.49 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.314 1.045 . . . . 0.0 112.454 -173.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -63.84 153.9 82.75 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.218 0.607 . . . . 0.0 112.243 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.58 166.08 30.73 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.362 2.708 . . . . 0.0 112.223 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.71 10.76 78.62 Favored Glycine 0 N--CA 1.473 1.101 0 C-N-CA 124.48 1.038 . . . . 0.0 115.3 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.56 143.71 28.8 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.407 1.483 . . . . 0.0 113.413 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.0 21.67 79.7 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.167 0.889 . . . . 0.0 114.432 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 t -140.43 170.24 16.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.569 1.185 . . . . 0.0 111.982 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.4 m -59.56 -18.89 44.57 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.614 -1.304 . . . . 0.0 114.373 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.0 p -77.19 -21.61 53.68 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.945 1.298 . . . . 0.0 113.502 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.5 122.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 128.289 2.636 . . . . 0.0 110.599 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -132.72 0.04 3.53 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.737 1.215 . . . . 0.0 113.815 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.4 t -93.68 -168.88 1.98 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.295 1.038 . . . . 0.0 111.696 170.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.95 138.93 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.687 1.195 . . . . 0.0 111.362 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.67 27.01 0.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.659 1.183 . . . . 0.0 113.607 -172.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.0 p -86.34 136.02 33.3 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.107 0.955 . . . . 0.0 112.492 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -80.93 152.34 28.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.421 1.488 . . . . 0.0 111.618 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 m -70.86 155.16 41.13 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.248 -0.907 . . . . 0.0 111.788 170.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.58 158.82 30.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.368 1.067 . . . . 0.0 111.299 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -143.08 132.35 23.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.376 1.071 . . . . 0.0 111.167 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.65 125.82 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.074 0.95 . . . . 0.0 109.992 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.1 171.67 13.68 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.78 1.632 . . . . 0.0 112.203 -170.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -142.01 141.72 32.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.864 1.666 . . . . 0.0 111.611 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.252 14.7 pt-20 174.1 -160.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.269 3.028 . . . . 0.0 110.145 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.9 mtm105 -95.02 148.25 22.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 tp -53.88 -51.87 62.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.537 1.535 . . . . 0.0 111.229 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.45 -25.31 67.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.74 -44.57 23.1 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.418 1.008 . . . . 0.0 110.458 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.33 -34.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.155 0.982 . . . . 0.0 112.125 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.9 -17.77 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.027 1.731 . . . . 0.0 112.873 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.25 118.54 15.26 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.181 -0.95 . . . . 0.0 112.221 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 4.81 90.18 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.677 1.132 . . . . 0.0 114.619 -174.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.73 176.75 7.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.906 2.082 . . . . 0.0 112.107 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -121.02 167.96 12.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.394 1.478 . . . . 0.0 109.64 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -156.0 165.97 34.87 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -158.39 136.22 10.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.998 1.319 . . . . 0.0 110.939 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.8 136.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 118.825 0.738 . . . . 0.0 109.049 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -152.75 128.86 10.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.061 0.545 . . . . 0.0 111.672 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -145.41 40.57 1.21 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.258 1.023 . . . . 0.0 111.304 -172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -71.11 -43.92 66.68 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -169.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.4 tp -62.75 -35.3 79.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.276 0.63 . . . . 0.0 111.682 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.73 -28.34 67.27 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.349 1.46 . . . . 0.0 114.16 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -64.36 -19.65 65.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.446 1.098 . . . . 0.0 112.468 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -78.66 -16.24 57.54 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.097 0.959 . . . . 0.0 112.93 173.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.41 -75.59 0.58 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -131.03 153.61 81.82 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -139.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.63 -16.93 52.1 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 124.33 3.353 . . . . 0.0 114.367 169.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 72.65 86.65 0.1 Allowed Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 127.678 2.391 . . . . 0.0 113.101 171.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.52 93.67 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.628 2.885 . . . . 0.0 110.378 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.26 -38.77 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.139 0.976 . . . . 0.0 112.14 -172.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -69.1 -41.72 77.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.74 0.7 . . . . 0.0 111.866 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.64 -35.49 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.414 0.686 . . . . 0.0 110.316 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.4 -40.18 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.046 0.938 . . . . 0.0 111.914 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.4 -39.39 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.325 0.966 . . . . 0.0 111.074 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 m -65.63 -40.26 92.34 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.733 -0.604 . . . . 0.0 110.844 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -61.9 -47.18 86.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.268 1.027 . . . . 0.0 111.243 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.05 91.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.616 0.766 . . . . 0.0 112.535 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.95 -46.05 89.6 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.587 -0.695 . . . . 0.0 112.061 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.21 -30.14 70.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.09 -1.006 . . . . 0.0 113.37 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.61 -12.72 61.49 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.81 125.75 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.719 1.145 . . . . 0.0 111.047 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.94 -1.4 80.57 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.615 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -75.46 143.35 42.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.06 1.93 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -117.89 146.2 44.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.706 1.602 . . . . 0.0 111.88 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.6 157.25 44.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.981 1.312 . . . . 0.0 112.166 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -153.02 -33.8 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -173.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -72.21 157.89 36.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -171.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.6 t 75.88 -177.55 0.14 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.191 2.196 . . . . 0.0 113.03 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.7 mm -76.11 140.87 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.63 1.172 . . . . 0.0 109.004 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.13 -32.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -170.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.7 p -63.46 -48.44 77.69 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.361 -0.837 . . . . 0.0 111.527 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -67.19 -35.8 80.41 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.597 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.16 -45.52 79.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.596 1.543 . . . . 0.0 111.437 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.8 m -65.82 -49.43 68.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.284 1.434 . . . . 0.0 113.294 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.74 -41.55 99.25 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.567 0.747 . . . . 0.0 112.262 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.561 ' CD2' HE22 ' A' ' 119' ' ' GLN . 34.4 t60 -64.76 -42.26 95.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.111 1.364 . . . . 0.0 110.221 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' A' ' 120' ' ' LEU . 8.6 t80 -54.6 -52.46 62.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.021 1.329 . . . . 0.0 112.04 169.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.421 ' HA ' HD12 ' A' ' 120' ' ' LEU . 13.8 m -68.72 -18.33 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.815 1.189 . . . . 0.0 113.992 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -75.6 -45.39 37.87 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.698 169.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.561 HE22 ' CD2' ' A' ' 115' ' ' HIS . 0.8 OUTLIER -54.49 -34.57 61.86 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.82 1.191 . . . . 0.0 113.397 170.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.615 HD11 ' CZ ' ' A' ' 116' ' ' PHE . 78.7 mt -64.98 -59.45 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.907 0.776 . . . . 0.0 111.452 171.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -80.48 11.13 3.9 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.79 -19.45 62.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.543 1.937 . . . . 0.0 113.94 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -47.29 -37.75 11.84 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.908 2.194 . . . . 0.0 116.639 -169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -140.74 7.89 2.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.623 1.211 . . . . 0.0 113.622 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.638 1.575 . . . . 0.0 112.289 175.334 . . . . . . . . 0 0 . 1 stop_ save_